Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.7404828354423871,-2.923028135160764,0.0,0.0,0.0,71/87,19.37%,RPS24;RPS9;RPL18A;RPL19;RPS12;RPL26;RPS29;RPL41;RPS15;RPL24;RPS23;RPL5;RPS27;RPS19;RPL38;RPLP1;RPS8;RPL10A;RPL27A;RPL13;RPS18;RPL27;RPS16;RPL35A;RPS6;RPL21;RPS3;RPL39;RPS17;RPS7;RPL37A;RPL4;RPS25;RPS15A;RPL6;RPL11;RPLP0;RPLP2;RPS21;RPS28;RPL28;RPL32;RPL8;RPL13A;RPL30;SRP14;RPS20;RPS4X;RPL18;RPS13;RPS2;RPL14;RPL22;RPS26;RPS10;RPL23;RPL17;RPL29;RPS5;RPS14;UBA52;ZFAND2B;SRP9;RPL12;RPL9;RPL37;RPS11;SEC61A1;RPL7;RPL31;RPL7A
prerank,cytoplasmic translation (GO:0002181),-0.7314386202526124,-2.9197227110467234,0.0,0.0,0.0,62/91,13.69%,RPS24;RPS9;RPL18A;RPL19;RPS12;RPL26;RPS29;RPL41;RPS15;RPL24;RPS23;RPL5;RPS27;RPS19;RPL38;RPLP1;RPS8;RPL10A;RPL27A;RPL13;RPS18;RPL27;RPS16;RPL35A;RPS6;RPL21;RPS3;RPL39;RPS17;RPS7;RPL37A;RPL4;RPS25;RPS15A;RPL6;RPL11;RPLP0;RPS21;RPS28;RPL28;RPL32;RPL8;RPL13A;RPL30;RPS20;RPS4X;RPL18;RPS13;RPS2;RPL14;RPL22;RPS26;RPS10;EIF4A1;RPL23;RPL17;RPL29;GSPT2;RPL22L1;RPS5;RPS14;UBA52
prerank,cotranslational protein targeting to membrane (GO:0006613),-0.7167943165281282,-2.8663180774974166,0.0,0.0,0.0,73/91,19.37%,RPS24;RPS9;RPL18A;RPL19;RPS12;RPL26;RPS29;RPL41;RPS15;RPL24;RPS23;RPL5;RPS27;RPS19;RPL38;RPLP1;RPS8;RPL10A;RPL27A;RPL13;RPS18;RPL27;RPS16;RPL35A;RPS6;RPL21;RPS3;RPL39;RPS17;RPS7;RPL37A;RPL4;RPS25;RPS15A;ARL6IP1;RPL6;RPL11;RPLP0;RPLP2;RPS21;RPS28;RPL28;RPL32;RPL8;RPL13A;RPL30;SRP14;RPS20;RPS4X;RPL18;RPS13;RPS2;RPL14;RPL22;RPS26;RPS10;TRAM1;RPL23;RPL17;RPL29;RPS5;RPS14;SSR2;UBA52;SRP9;RPL12;RPL9;RPL37;RPS11;SEC61A1;RPL7;RPL31;RPL7A
prerank,protein targeting to ER (GO:0045047),-0.6936691555597391,-2.813440030237161,0.0,0.0,0.0,74/99,19.88%,RPS24;RPS9;RPL18A;RPL19;RPS12;RPL26;RPS29;RPL41;RPS15;RPL24;RPS23;RPL5;RPS27;RPS19;RPL38;RPLP1;RPS8;RPL10A;RPL27A;RPL13;RPS18;RPL27;RPS16;RPL35A;RPS6;RPL21;RPS3;RPL39;RPS17;RPS7;RPL37A;RPL4;RPS25;RPS15A;RPL6;RPL11;RPLP0;RPLP2;RPS21;RPS28;RPL28;RPL32;RPL8;RPL13A;RPL30;SRP14;RPS20;RPS4X;RPL18;RPS13;RPS2;RPL14;RPL22;SPCS2;RPS26;RPS10;SPCS1;RPL23;RPL17;RPL29;RPS5;RPS14;UBA52;ZFAND2B;SRP9;RPL12;RPL9;RPL37;RPS11;SEC61A1;RPL7;RPL31;RPL7A;SEC61G
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.6561297580875849,-2.670300800187594,0.0,0.0,0.0,73/110,19.37%,RPS24;RPS9;RPL18A;RPL19;RPS12;RPL26;RPS29;RPL41;RPS15;RPL24;RPS23;RPL5;RPS27;RPS19;RPL38;RPLP1;PPP2R1A;RPS8;RPL10A;RPL27A;RPL13;RPS18;RPL27;RPS16;RPL35A;RPS6;RPL21;RPS3;RPL39;RPS17;RPS7;RPL37A;RPL4;RPS25;RPS15A;RPL6;RPL11;RPLP0;RPLP2;RPS21;RPS28;RPL28;RPL32;RPL8;RPL13A;RPL30;RPS20;RPS4X;RPL18;RPS13;RPS2;RPL14;RPL22;RPS26;PNRC2;RPS10;RPL23;RPL17;RPL29;GSPT2;RPS5;RPS14;UBA52;DCP1A;RPL12;RPL9;RPL37;RPS11;RNPS1;PABPC1;RPL7;RPL31;RPL7A
prerank,peptide biosynthetic process (GO:0043043),-0.6156046248325155,-2.6268674688126867,0.0,0.0,0.0,91/153,21.28%,RPS24;DMD;RPS9;RPL18A;RPL19;RPS12;RPL26;RPS29;RPL41;RPS15;RPL24;RPS23;RPL5;RPS27;RPS19;RPL38;RPLP1;RPS8;RPL10A;RPL27A;RPL13;RPS18;RPL27;RPS16;RPL35A;RPS6;RPL21;RPS3;RPL39;RPS17;RPS7;RPL37A;RPL4;RPS25;EEF1A1;RPS15A;RPL6;RPL11;RPLP0;RPLP2;RPS21;RPS28;RPL28;RPL32;RPL8;RPL13A;RPL30;RPS20;RPS4X;RPL18;RPS13;RPS2;RPL14;RPL22;RPS26;ASMT;MRPS18A;RPS10;IGHMBP2;RPL23;RPL17;GGT5;PABPC4;RPL29;GSPT2;RPS5;RPS14;SRBD1;MRPL28;COPS5;HBS1L;RPL12;RPL9;GGT7;RPL37;RPS11;MRPL35;MRPS5;RPL7;RPL31;RPL7A;MRPL34;HARS1;GGT1;YARS2;FARSB;PCSK5;RPL3;MRPL52;MRPL23;MRPL9
prerank,translation (GO:0006412),-0.5644785978238847,-2.5197355984080585,0.0,0.0,0.0,107/208,23.16%,RPS24;RPS9;RPL18A;RPL19;RPS12;RPL26;RPS29;RPL41;RPS15;RPL24;RPS23;RPL5;RPS27;RPS19;RPL38;RPLP1;RPS8;RPL10A;RPL27A;RPL13;RPS18;RPL27;RPS16;RPL35A;RPS6;RPL21;RPS3;EEF1G;RPL39;RPS17;RPS7;RPL37A;RPL4;RPS25;EEF1A1;RPS15A;RPL6;RPL11;RPLP0;RPLP2;RPS21;RPS28;RPL28;RPL32;RPL8;RPL13A;RPL30;RPS20;RPS4X;GTPBP1;RPL18;RPS13;EEF2;RPS2;RPL14;LARS2;RPL22;RPS26;ASMT;MRPS18A;KARS1;CARS1;EEF1E1;RPS10;IGHMBP2;RPL23;RPL17;PABPC4;RPL29;GSPT2;RPL22L1;RPS5;FASTKD2;RPS14;UBA52;IARS1;MRPL57;RARS2;SRBD1;MRPL28;COPS5;HBS1L;RPL12;RPL9;RPL37;RPS11;MRPL47;MRPL35;MRPS5;RPL7;RPL31;RPL7A;MRPL34;HARS1;YARS2;FARSB;RPL3;MRPS2;MRPL52;MRPL23;MRPL9;GSPT1;MRPS12;RPL23A;TUFM;MRPL11;N6AMT1
prerank,zinc ion homeostasis (GO:0055069),-0.7399979673650523,-2.343915732608904,0.0,0.0,0.0,16/28,14.55%,SLC39A10;MT1H;MT1M;MT1A;MT1B;MT1X;MT1F;MT1E;MT1G;SLC39A6;SLC30A1;SLC39A14;SLC39A12;MT2A;SLC39A13;SLC39A8
prerank,cellular zinc ion homeostasis (GO:0006882),-0.7443603180715038,-2.3314204116621666,0.0,0.0,0.0,16/26,14.55%,SLC39A10;MT1H;MT1M;MT1A;MT1B;MT1X;MT1F;MT1E;MT1G;SLC39A6;SLC30A1;SLC39A14;SLC39A12;MT2A;SLC39A13;SLC39A8
prerank,chemical synaptic transmission (GO:0007268),-0.49988278228840444,-2.3248321331660358,0.0,0.0,0.0,115/284,22.08%,GRM7;NRXN1;NLGN1;DLG2;GRID2;SLC12A7;KCND2;SYT1;RIMS1;CACNA1E;GRIA4;GRM3;GRIK2;CACNB2;CHRM3;HSPA8;GRM5;LIN7A;PTCHD1;GRIK4;GRIA1;PTPRN2;KCNQ3;KIF1B;SLC6A1;GABRA2;RIT2;AMPH;CACNB4;PLP1;HTR2C;GABBR2;HOMER1;CALM1;CHRM2;GABRB3;SNAP25;GRIN2A;SNCA;GABRA3;GRIK1;GLRA3;DLGAP1;DLGAP2;SYN3;GRIA3;GABRA4;SLC1A1;CDH8;GRIN2B;STXBP1;EXOC4;APBA2;PRKAR1A;GABARAP;MBP;RIC3;SLC1A4;CPLX1;SDCBP;GRIA2;SLC1A2;SYN1;SLC12A5;NLGN3;LRP6;GRIN1;GABRB1;SNPH;GABRG3;MINK1;DVL1;SLC12A6;PCDHB16;GAD2;RPS6KA1;PRKAR2B;NAPA;SLC6A5;SHISA6;SYN2;GABRB2;KIF5A;HRH1;STAC3;GRIK3;RPS6KA2;HTR2B;GABRA5;HTR4;SNAPIN;CHRNA4;CAMK4;CACNA1A;HTR2A;SYPL1;AKAP5;GLRA2;GLRA1;HRH2;KCNA1;SLC17A6;CHRFAM7A;CHRNA7;CAMKK2;SLC32A1;GABRA1;APBA3;KCNMB4;PENK;SLC18A2;SNCG;ATXN3;SCN2B;DTNA
prerank,regulation of cation channel activity (GO:2001257),-0.5795172559454822,-2.2798594090599265,0.0,0.0,0.0,38/89,14.19%,PDE4D;NLGN1;DLG2;GRIA4;LRRC7;KCNAB1;MEF2C;CACNB2;DMD;FGF14;FGF12;PTK2B;GRIA1;CACNB4;NETO1;FKBP1A;HOMER1;CALM1;ANK3;GRIN2A;CALM2;OPRM1;GRIA3;GRIN2B;CAMK2D;CTSS;CAMK2A;GRIA2;SELENON;SHISA9;GRIN1;MINK1;NOS1;FGF13;CAPN1;SHISA6;STAC;RELN
prerank,anterograde trans-synaptic signaling (GO:0098916),-0.5025332003005265,-2.2682055215555734,0.0,0.0,0.0,94/224,22.08%,GRM7;NRXN1;NLGN1;DLG2;SLC12A7;KCND2;SYT1;CACNA1E;GRIA4;GRM3;GRIK2;CACNB2;CHRM3;GRM5;PTCHD1;GRIK4;GRIA1;KCNQ3;SLC6A1;GABRA2;RIT2;AMPH;CACNB4;PLP1;HTR2C;GABBR2;HOMER1;CALM1;CHRM2;GABRB3;SNAP25;GRIN2A;SNCA;GABRA3;GRIK1;GLRA3;DLGAP1;GRIA3;GABRA4;SLC1A1;GRIN2B;EXOC4;APBA2;PRKAR1A;GABARAP;MBP;CPLX1;SDCBP;GRIA2;SLC1A2;SYN1;SLC12A5;NLGN3;LRP6;GRIN1;GABRB1;GABRG3;MINK1;SLC12A6;PCDHB16;GAD2;RPS6KA1;PRKAR2B;SLC6A5;SYN2;GABRB2;KIF5A;HRH1;RPS6KA2;HTR2B;GABRA5;HTR4;CHRNA4;CAMK4;CACNA1A;HTR2A;SYPL1;AKAP5;GLRA2;GLRA1;HRH2;KCNA1;CHRFAM7A;CHRNA7;CAMKK2;GABRA1;APBA3;KCNMB4;PENK;SLC18A2;SNCG;ATXN3;SCN2B;DTNA
prerank,glutamate receptor signaling pathway (GO:0007215),-0.6973879713160249,-2.2504072664975996,0.0,0.0,0.0,19/37,10.98%,GRM7;GRID2;GRIA4;GRM3;PLCB1;GRIK2;GRIN3A;GRM5;GRIK4;PTK2B;HOMER1;GRIN2A;GRIK1;GRIA3;GRIN2B;GRIA2;GRM8;GRIN1;KCNB1
prerank,cellular response to copper ion (GO:0071280),-0.8502933067789273,-2.246982805676783,0.0,0.0,0.0,9/16,4.03%,MT1H;MT1M;MT1A;MT1B;MT1X;MT1F;MT1E;MT1G;SNCA
prerank,response to copper ion (GO:0046688),-0.786651291076603,-2.205910093381671,0.0,6.900791869055879e-05,0.001,9/20,4.03%,MT1H;MT1M;MT1A;MT1B;MT1X;MT1F;MT1E;MT1G;SNCA
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),-0.49972687538840216,-2.177274131838287,0.0,0.00032347461886199434,0.005,81/168,19.37%,RPS24;RPS9;RPL18A;RPL19;RPS12;RPL26;RPS29;RPL41;DIS3L2;RPS15;RPL24;RPS23;RPL5;RPS27;RPS19;RPL38;RPLP1;PPP2R1A;RPS8;RPL10A;RPL27A;RPL13;RPS18;RPL27;RPS16;RPL35A;RPS6;RPL21;RPS3;RPL39;RPS17;RPS7;RPL37A;RPL4;RPS25;RPS15A;RPL6;RPL11;RPLP0;RPLP2;RPS21;RPS28;RPL28;RPL32;RPL8;RPL13A;RPL30;RPS20;RPS4X;RPL18;RPS13;RPS2;RPL14;RPL22;RPS26;ATM;PNRC2;RPS10;RPL23;RPL17;RPL29;GSPT2;RPS5;RPS14;UBA52;DCP1A;MTPAP;RPL12;PELO;RPL9;XRN2;RPL37;CNOT2;ERI1;RPS11;RNPS1;PABPC1;EXOSC4;RPL7;RPL31;RPL7A
prerank,modulation of chemical synaptic transmission (GO:0050804),-0.5415331958043123,-2.165883295421367,0.0,0.0003653360401264878,0.006,32/107,8.74%,GRM7;NLGN1;GRID2;LRRC4C;NRG3;SLC12A2;SYT1;RIMS1;RIMS2;GRM3;DGKI;CDH2;MEF2C;GRIK2;GRM5;ABR;GRIK4;MCTP1;HOMER1;GRIK1;DLGAP1;DLGAP2;SYN3;BTBD9;DGKZ;CPLX1;LRP8;CAMK2A;CNTNAP4;GRM8;SYN1;NLGN3
prerank,rRNA metabolic process (GO:0016072),-0.49004538246191004,-2.10845857689731,0.0,0.0019552243628991658,0.029,78/160,21.38%,RPS24;RPS9;RPL18A;RPL19;RPL26;RPL41;RPS15;RPL24;RPL5;RPS27;RPS19;RPL38;RPLP1;RPL10A;RPL27A;RPL13;RPL27;RPS16;RPL35A;RPS6;RPL21;RPL39;RPS17;RPS7;RPL37A;RPL4;RPS25;RPL6;RPL11;RPLP0;RPLP2;RPS28;RPL28;RPL32;RPL8;RPL13A;RPL30;RPL18;NOL11;RPS2;RRP7A;DDX54;RPL14;DDX49;RPL22;DDX47;WDR36;BYSL;HELQ;EXOSC2;NVL;RPL23;RPL17;RPL29;TEX10;RPS14;UBA52;NOP56;MAPT;RPL12;RPL9;ESF1;XRN2;RPL37;IMP3;DEDD2;EXOSC4;SNU13;RPL7;RPL31;RPL7A;UTP6;MDN1;BMS1;RPL3;HEATR1;UTP11;PIH1D2
prerank,rRNA processing (GO:0006364),-0.47911887299475747,-2.069098992383031,0.0,0.003922555378200184,0.058,81/172,21.38%,RPS24;RPS9;RPL18A;RPL19;RPL26;RPL41;RPS15;RPL24;RPL5;RPS27;RPS19;RPL38;RPLP1;RPL10A;RPL27A;RPL13;RPL27;RPS16;RPL35A;RPS6;RPL21;RPL39;RPS17;RPS7;RPL37A;RPL4;RPS25;RPL6;RPL11;RPLP0;RPLP2;RPS28;RPL28;RPL32;RPL8;RPL13A;RPL30;RPL18;NOL11;RPS2;RRP7A;DDX54;RPL14;DDX49;RPL22;DDX47;WDR36;BYSL;HELQ;MAK16;EXOSC2;NVL;RPL23;RPL17;RPL29;TEX10;MRPL1;THUMPD1;RPS14;UBA52;NOP56;SART1;RPL12;RPL9;ESF1;XRN2;RPL37;IMP3;ERI1;EXOSC4;SNU13;RPL7;RPL31;RPL7A;UTP6;MDN1;BMS1;RPL3;HEATR1;UTP11;PIH1D2
prerank,regulation of trans-synaptic signaling (GO:0099177),-0.6440841391236937,-2.0646090957435956,0.0,0.00403696324339769,0.063,17/33,17.85%,NLGN1;GRID2;LRRC4C;NRG3;GRIK2;ABR;GRIK4;GRIK1;BTBD9;LRP8;NLGN3;BCR;NGF;RELN;GRIK3;NTF3;CACNA1A
prerank,neurotransmitter secretion (GO:0007269),-0.597600714758963,-2.047884692724766,0.0,0.004584097455872834,0.075,17/44,11.31%,NRXN1;SYT1;RIMS1;RIMS2;HSPA8;LIN7A;PTPRN2;PCLO;SNAP25;SNCA;SYN3;STXBP1;CPLX1;SYN1;SNPH;DVL1;GAD2
prerank,positive regulation of cell junction assembly (GO:1901890),-0.5651244165940426,-2.0408869817823074,0.0,0.004752136218918026,0.081,26/56,18.00%,TEK;CNTNAP2;NRXN1;NLGN1;PTPRD;GRID2;PTPRJ;CLDN5;KDR;SYNDIG1;IL1RAPL1;IL1RAP;EPHB1;MYOC;NLGN3;VEGFA;LRRC4B;ACE2;CLSTN1;CAV1;RAC1;COL16A1;SLITRK2;SRPX2;EPHB3;PPM1F
prerank,cellular response to cadmium ion (GO:0071276),-0.6881295291199394,-2.0389622966206824,0.0,0.004815552586884647,0.085,13/24,12.49%,MT1H;MT1M;MT1A;MT1B;MT1X;MT1F;MT1E;MT1G;MAPK8;MAPK3;AKT1;EGFR;MT2A
prerank,positive regulation of synapse assembly (GO:0051965),-0.6512331205427933,-2.0347661492211713,0.0,0.004830554308339116,0.089,16/27,17.00%,NRXN1;NLGN1;PTPRD;GRID2;SYNDIG1;SEMA4D;IL1RAPL1;IL1RAP;EPHB1;NLGN3;LRRC4B;CLSTN1;AGRN;SLITRK2;SRPX2;EPHB3
prerank,response to cadmium ion (GO:0046686),-0.6744736815768415,-2.0307176525408046,0.0,0.004885760643291563,0.094,13/26,12.49%,MT1H;MT1M;MT1A;MT1B;MT1X;MT1F;MT1E;MT1G;MAPK8;MAPK3;AKT1;EGFR;MT2A
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",-0.5787514033414962,-2.029289237865437,0.0,0.004777471293961763,0.094,17/46,9.60%,GRM7;NRXN1;NLGN1;SHANK3;SYT1;GRM3;DGKI;CDH2;MEF2C;GRM5;PTK2B;HOMER1;GRIK1;DGKZ;GRM8;NLGN3;ATAD1
prerank,regulation of dendritic spine development (GO:0060998),-0.726018276973194,-2.0118574814771484,0.0,0.006019024019120962,0.121,6/19,2.04%,NLGN1;SHANK3;MEF2C;PPFIA2;GRIN3A;TANC2
prerank,ribosome biogenesis (GO:0042254),-0.4634081270420299,-2.005541134317077,0.0,0.006469492377239888,0.132,82/187,21.38%,RPS24;RPS9;RPL18A;RPL19;RPL26;RPL41;RPS15;RPL24;RPL5;RPS27;RPS19;RPL38;RPLP1;RPL10A;RPL27A;RPL13;RPL27;RPS16;RPL35A;RPS6;RPL21;RPL39;RPS17;RPS7;RPL37A;RPL4;RPS25;RPL6;RPL11;RPLP0;RPLP2;RPS28;RPL28;RPL32;RPL8;RPL13A;RPL30;RPL18;NOL11;RPS2;RRP7A;DDX54;RPL14;DDX49;RPL22;NPM1;DDX47;WDR36;BYSL;HELQ;EXOSC2;NIP7;NVL;RPL23;RPL17;XPO1;RPL29;TEX10;RPS14;UBA52;NOP56;URB2;RPL12;RPL9;ESF1;XRN2;RPL37;IMP3;EXOSC4;SNU13;NOC2L;RPL7;MALSU1;RPL31;RPL7A;UTP6;MDN1;BMS1;RPL3;HEATR1;UTP11;PIH1D2
prerank,cellular response to zinc ion (GO:0071294),-0.7514317807658331,-2.0029279337524413,0.0,0.006460568939478178,0.137,8/15,2.74%,MT1H;MT1M;MT1A;MT1B;MT1X;MT1F;MT1E;MT1G
prerank,action potential (GO:0001508),-0.5768960545176758,-2.000393550827642,0.0,0.006624760194293645,0.147,23/44,20.62%,KCND2;DMD;KCNMB2;AKAP6;KCNJ2;SCN1A;ANK3;SCN2A;CACNA1G;YWHAH;KCNB1;SCN8A;SCN9A;KCNQ1;SRI;KCNE4;KCNA2;GNAQ;GNA14;SCN3A;CHRNA4;KCNA1;KCNMB4
prerank,ribosomal large subunit assembly (GO:0000027),-0.6716847684598568,-1.9853374922642013,0.0,0.007947040958880481,0.183,13/24,22.71%,RPL24;RPL5;RPL6;RPL11;RPLP0;TRAF7;DHX30;PPAN;FASTKD2;NLE1;MDN1;RPL3;RPL23A
prerank,angiogenesis involved in wound healing (GO:0060055),-0.8336695253832807,-1.9796627142918728,0.0,0.008507382476070451,0.2,8/11,8.85%,ADIPOR2;KDR;CD34;GATA2;PRCP;NDNF;MCAM;VEGFA
prerank,regulation of cell communication by electrical coupling (GO:0010649),-0.7833301439324853,-1.9794158802244444,0.0,0.00824958300709862,0.2,10/13,14.47%,PDE4D;CALM1;ANK3;CALM2;SLC8A1;CALM3;CAMK2D;SRI;CAV1;CASQ2
prerank,signal release from synapse (GO:0099643),-0.5768274637668332,-1.9756168887612626,0.002544529262086514,0.008585396942972463,0.216,16/43,11.31%,NRXN1;SYT1;RIMS1;HSPA8;LIN7A;PTPRN2;PCLO;SNAP25;SNCA;SYN3;STXBP1;CPLX1;SYN1;SNPH;DVL1;GAD2
prerank,chloride transmembrane transport (GO:1902476),-0.5588213012367438,-1.9716553245702195,0.0,0.00878372222189827,0.226,25/48,20.35%,SLC12A7;SLC12A2;ANO1;SLC6A1;GABRA2;ANO3;GABRB3;GABRA3;GLRA3;CLCN3;GABRA4;SLC1A1;ANO4;SLC12A5;GABRB1;GABRG3;CLCN1;SLC12A6;ANO2;GABRB2;GABRA5;ANO5;GLRA2;GLRA1;GABRA1
prerank,inorganic anion transmembrane transport (GO:0098661),-0.5292850035652698,-1.9664784381375762,0.0,0.009517342119406235,0.25,31/63,20.35%,SLC12A7;SLC12A2;SLC26A2;ANO1;SLC6A1;GABRA2;ANO3;GABRB3;GABRA3;GLRA3;CLCN3;XPR1;SLC5A5;GABRA4;SLC1A1;SLC5A6;ANO4;SLC12A5;GABRB1;GABRG3;CLCN1;SLC12A6;SLC25A30;ANO2;GABRB2;GABRA5;SLC20A2;ANO5;GLRA2;GLRA1;GABRA1
prerank,cellular macromolecule biosynthetic process (GO:0034645),-0.41934359639709806,-1.9586338812161004,0.0,0.010602973452860183,0.282,137/306,23.29%,RPS24;THRB;RPS9;RPL18A;RPL19;RPS12;RPL26;RPS29;RPL41;RPS15;RPL24;RPS23;RPL5;RPS27;PTMA;RPS19;RPL38;RPLP1;FUT9;RPS8;RPL10A;RPL27A;RPL13;RPS18;RPL27;RPS16;RPL35A;RPS6;RPL21;RPS3;EEF1G;RPL39;RPS17;RPS7;RPL37A;EXT1;RPL4;RPS25;EEF1A1;RPS15A;RPL6;RPL11;RPLP0;RPLP2;RPS21;RPS28;RPL28;RPL32;RPL8;MRE11;MCM9;RPL13A;RPL30;RPS20;RPS4X;GTPBP1;RPL18;RPS13;EEF2;RPS2;FAM111A;CLSPN;RPL14;RPL22;TBRG1;ALAS1;RPS26;ASMT;MRPS18A;ATM;POLA1;RPS10;IGHMBP2;BARD1;PWP1;RPL23;RPL17;PABPC4;RPL29;GCNT1;POLR3A;GSPT2;XAB2;RPS5;RPS14;ORC6;NFKBIB;ST3GAL4;POLD2;CDK2;SRBD1;MMS19;MRPL28;COPS5;HBS1L;RPL12;POLR2J;RMI2;SET;CDC45;RPL9;RRAGC;BRCA1;RPL37;RAD1;RPS11;BCL3;RNPS1;KAT7;POLE;RFC4;CHEK1;MRPL35;MRPS5;RPL7;RPL31;RPL7A;MRPL34;HARS1;POLD1;YARS2;FARSB;UPF1;RPL3;MRPL52;MRPL23;ATRIP;MRPL9;ATR;HOXD3;GSPT1;MRPS12;RPL23A;TUFM;DONSON;MRPL11;POLE3
prerank,regulation of neurotransmitter receptor activity (GO:0099601),-0.5429644309340318,-1.957321322679757,0.0,0.01048738764310466,0.285,22/57,14.19%,NLGN1;DLG2;GRIA4;LRRC7;MEF2C;PTK2B;GRIA1;NETO1;GRIN2A;DLGAP1;DLGAP2;OPRM1;GRIA3;GRIN2B;CAMK2A;GRIA2;SHISA9;GRIN1;MINK1;CAPN1;SHISA6;RELN
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),-0.7860319815194641,-1.9545291134458713,0.0,0.010775851918602645,0.3,8/12,12.95%,PDE4D;CALM1;CALM2;GJD3;CALM3;CAMK2D;SRI;CAV1
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),0.7798212420162509,1.9197650991518693,0.0,0.953444131133428,0.532,6/16,3.96%,IGFBP3;IGFBP5;PHIP;GHRH;BMP2;IGFBP6
prerank,ribosomal small subunit biogenesis (GO:0042274),-0.5743184901468444,-1.9178825269861766,0.0,0.018761527893995676,0.478,15/39,13.32%,RPS24;RPS15;RPS27;RPS19;RPS16;RPS6;RPS17;RPS7;RPS25;RPS28;NOL11;RRP7A;NPM1;RPS5;RPS14
prerank,neuron cell-cell adhesion (GO:0007158),-0.7448876659088806,-1.9164773732169915,0.0,0.018632138046450874,0.488,9/14,11.02%,NRXN1;NLGN1;CNTN4;NCAM2;ASTN1;ASTN2;NINJ2;NLGN3;RET
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),-0.6239509002976835,-1.9089562787673025,0.0,0.020357336013714842,0.527,12/24,14.47%,PDE4D;DMD;AKAP6;FKBP1A;CALM1;CALM2;CALM3;CAMK2D;SELENON;NOS1;SRI;CASQ2
prerank,regulation of cardiac muscle contraction (GO:0055117),-0.5903101194314649,-1.9075842049452447,0.0,0.02017277995210056,0.53,13/34,13.61%,PDE4D;PDE4B;ATP1B1;RYR2;SMAD7;CALM1;CALM2;SLC8A1;CALM3;NOS1;KCNQ1;SRI;ATP2A2
prerank,ribonucleoprotein complex biogenesis (GO:0022613),-0.5258111002975832,-1.9042291336904373,0.0,0.020725901033993965,0.544,20/57,11.77%,RPS24;RPL26;RPS15;RPL5;RPS19;RPL38;RPS16;RPL35A;RPS6;RPS17;RPS7;RPS25;RPL11;RPS28;RPL14;NPM1;BYSL;NIP7;NVL;XPO1
prerank,nucleoside triphosphate metabolic process (GO:0009141),0.7914831199432414,1.897906928780212,0.001953125,0.683886562362065,0.653,4/14,2.43%,ENPP3;CMPK2;ENPP1;DCTPP1
prerank,ribosome assembly (GO:0042255),-0.5502337651918963,-1.8941338139465551,0.0,0.023186660680027758,0.586,23/47,24.46%,RPS15;RPL24;RPL5;RPS27;RPS19;RPL6;RPL11;RPLP0;RPS28;RRP7A;NPM1;TRAF7;RPS5;PPAN;RPS14;MTERF3;NLE1;C1QBP;MDN1;RPL3;MRPS2;RPL23A;EIF6
prerank,negative regulation of vascular permeability (GO:0043116),-0.7622180851495884,-1.8920852730727014,0.0,0.02338018288679041,0.597,9/12,9.24%,SLIT2;PTPRJ;CLDN5;SH3GL2;CEACAM1;PDE3A;VEGFA;RAMP2;PDE2A
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.675186522378695,1.8851750954109519,0.0,0.5612126838675631,0.714,9/26,11.57%,EYA2;EYA1;FGFR1;TERT;BCL2;MCL1;BCL2L1;EYA4;MAP2K5
prerank,regulation of smoothened signaling pathway (GO:0008589),0.5915265294733986,1.8824477998929636,0.0,0.44211340845502,0.735,22/50,19.41%,RORA;DCDC2;GLI3;FBXL17;ZIC1;GLI1;MGRN1;CREBBP;GLIS2;IFT81;SUFU;RAB34;IHH;BTRC;TTC23;EVC;TUBD1;GAS8;DLG5;PTCH1;WDR11;GAS1
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),-0.704752525800337,-1.8815917223269611,0.004301075268817204,0.026670826447106395,0.649,7/15,12.24%,ATP1B1;KCNJ3;KCNJ2;ATP1A1;KCND3;KCNJ8;KCNQ1
prerank,response to cytokine (GO:0034097),0.5080128897875383,1.8807706670028932,0.0,0.36285470921049273,0.748,47/141,15.99%,ALDH1A2;PTPN13;DPYSL3;SMAD3;COL3A1;SELP;SP100;PID1;EIF2AK2;CXCL16;NFAT5;TRIM56;AFF3;IL6ST;TIMP3;ANXA1;PTPN14;PTPN4;IKBKE;BCL2;MCL1;HAX1;HDAC4;BST2;PTPN2;PTPN9;STAT1;LGALS9;NUB1;CD274;TIMP2;IFITM1;IFNLR1;PTPN6;BCL2L1;IRAK3;ADAR;TRIM21;CRNN;PTPN18;TBK1;PML;IL23R;CXCR4;APP;TAF9;IFNAR2
prerank,retinoid metabolic process (GO:0001523),0.561946792580714,1.8585095926994315,0.0,0.423103019337329,0.86,11/71,5.07%,ALDH1A2;ALDH1A1;GPC6;RBP1;ABCA4;APOA2;HSPG2;RDH10;SDC2;RBP4;RDH5
prerank,regulation of cAMP-mediated signaling (GO:0043949),-0.6066181618118309,-1.8541119956395786,0.002288329519450801,0.037630880660945346,0.776,10/24,14.08%,PDE4D;PEX5L;PDE3B;PRKAR1A;PDE11A;RAPGEF2;PDE3A;PDE2A;PRKAR2B;APLNR
prerank,ncRNA processing (GO:0034470),-0.4228448864435928,-1.853961813751618,0.0,0.03692627812380514,0.778,85/200,21.38%,RPS24;RPS9;RPL18A;RPL19;RPL26;RPL41;RPS15;RPL24;RPL5;RPS27;RPS19;RPL38;RPLP1;LIN28B;RPL10A;RPL27A;INTS7;RPL13;RPL27;RPS16;RPL35A;RPS6;RPL21;RPL39;RPS17;RPS7;RPL37A;RPL4;RPS25;INTS10;RPL6;RPL11;RPLP0;RPLP2;RPS28;RPL28;RPL32;RPL8;RPL13A;RPL30;RPL18;NOL11;RPS2;RRP7A;DDX54;RPL14;DDX49;RPL22;DDX47;WDR36;BYSL;KARS1;HELQ;SMAD1;EXOSC2;NVL;RPL23;RPL17;RPL29;TEX10;RPP30;RPS14;UBA52;NOP56;INTS12;RPL12;RPL9;ESF1;XRN2;RPL37;IMP3;DICER1;EXOSC4;SNU13;ZCCHC8;RPL7;RPL31;RPL7A;UTP6;MDN1;BMS1;RPL3;HEATR1;UTP11;PIH1D2
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.7159172505199903,1.8509691623757647,0.0,0.41015088609230865,0.894,7/18,4.99%,PDPN;SMAD3;DDR2;BMP2;IL6;EFEMP2;CLASP1
prerank,negative regulation of cartilage development (GO:0061037),0.7733440138201948,1.84067085769101,0.0,0.4134759633097803,0.919,4/13,5.16%,EFEMP1;ADAMTS12;PTHLH;TGFBR1
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),0.6899859638866518,1.837909512989884,0.0017985611510791368,0.3434543633929516,0.926,8/21,11.57%,EYA2;EYA1;TERT;BCL2;MCL1;BCL2L1;EYA4;MAP2K5
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.6899859638866518,1.837909512989884,0.0017985611510791368,0.3434543633929516,0.926,8/21,11.57%,EYA2;EYA1;TERT;BCL2;MCL1;BCL2L1;EYA4;MAP2K5
prerank,regulation of small molecule metabolic process (GO:0062012),0.6479734778855729,1.8374286455444548,0.005136986301369863,0.3137378903339222,0.926,5/28,6.37%,PDK1;RORA;PANK2;FMO5;PPARA
prerank,epithelial structure maintenance (GO:0010669),0.8027733862902039,1.834742989983351,0.0019880715705765406,0.29620460992778447,0.928,4/11,3.36%,CXADR;MUC2;PIWIL4;RBP4
prerank,ganglioside metabolic process (GO:0001573),-0.641415930997453,-1.8346361422734851,0.0,0.04744984489162823,0.858,8/20,14.23%,ST6GALNAC3;ST8SIA4;ST8SIA6;HEXB;ST6GALNAC4;ST6GALNAC5;NEU1;GM2A
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),0.5827671074814282,1.826476239947218,0.0,0.3056660593440186,0.945,14/46,9.50%,ALDH1A1;LGR4;RBPJ;LAMA4;WNT10B;ACOT11;FOXC2;NRDC;TLE3;TLR4;NR1H3;NOVA1;MAP2K6;DOCK7
prerank,regulation of NMDA receptor activity (GO:2000310),-0.5683135818046506,-1.826004364444166,0.007177033492822967,0.051735642571245403,0.889,14/32,9.11%,NLGN1;DLG2;GRIA4;LRRC7;MEF2C;PTK2B;GRIA1;GRIN2A;OPRM1;GRIA3;GRIN2B;CAMK2A;GRIA2;GRIN1
prerank,regulation of postsynaptic membrane potential (GO:0060078),-0.5739889198549459,-1.8180565095372134,0.0024630541871921183,0.05639406739914031,0.916,12/34,10.05%,GRID2;MEF2C;GABRA2;GRIN2A;GABRA3;GABRA4;RAB3GAP1;GRIN2B;AKT1;NLGN3;GRIN1;GABRG3
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.6345549423698889,1.8168554094064782,0.0,0.3228980745008549,0.961,9/30,6.51%,TGFBR3;SMAD3;FSTL1;SMURF2;FSTL3;TWSG1;LATS2;NREP;DKK3
prerank,positive regulation of nervous system development (GO:0051962),-0.5306057056175103,-1.8139229694875874,0.0,0.058337732017556355,0.93,15/42,17.00%,NRXN1;NLGN1;PTPRD;GRID2;SYNDIG1;IL1RAPL1;IL1RAP;OPRM1;EPHB1;NLGN3;LRRC4B;CLSTN1;SLITRK2;SRPX2;EPHB3
prerank,inorganic cation import across plasma membrane (GO:0098659),-0.46860772911460674,-1.811512674009988,0.0,0.059097614811942444,0.933,25/75,15.71%,SLC12A7;SLC12A2;SLC9A2;SLC39A10;ATP1B1;SLC24A2;ABCC9;KCNJ3;KCNJ2;SLC6A1;ATP1A1;SLC8A1;SLC39A6;HCN2;SLC39A14;SLC12A5;SLC39A12;KCNJ6;SLC12A6;KCNJ8;KCNJ15;SLC39A8;SLC9A5;ATP1A3;KCNK9
prerank,regulation of stress fiber assembly (GO:0051492),0.5409071126160716,1.8081408729370552,0.0,0.33536276187106256,0.974,20/74,7.17%,PHLDB2;CGNL1;ARHGAP6;LPAR1;ROCK2;CCN2;PPM1E;DLC1;TACSTD2;ARHGAP28;NRP1;S100A10;ALMS1;TPM1;CLASP1;TGFBR1;EPHA1;ASAP3;CD47;ARHGEF10L
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),0.7166334541610482,1.802454516262735,0.005385996409335727,0.33828743711993814,0.979,2/16,0.29%,PDK1;RORA
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),0.6302943015113637,1.801925560518743,0.0053285968028419185,0.32073938562668486,0.979,14/29,17.59%,GHR;IL31RA;STAT2;FER;STAT5B;STAMBP;STAT1;CCL2;PIAS1;STAT4;SOCS6;PKD2;IFNAR2;STAT5A
prerank,regulation of humoral immune response (GO:0002920),0.5829502341529569,1.8004951080632756,0.0015923566878980893,0.3084449174508561,0.98,11/44,9.38%,CFH;VTN;CFHR2;GATA6;CD55;SERPING1;C5AR2;C2;PHB2;PROS1;CPB2
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),0.6625032588828227,1.7984362463429162,0.0035650623885918,0.29980486805578627,0.982,5/24,4.74%,SULF1;RORA;IL6ST;IL6;ARNT
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),-0.6407831580233234,-1.796949611077782,0.002320185614849188,0.0684684022353417,0.956,8/18,9.11%,NRXN1;NLGN1;SHANK3;RIMS1;RIMS2;PTK2B;NLGN3;GRIN1
prerank,modified amino acid transport (GO:0072337),0.7227813697463883,1.7935525145847264,0.003929273084479371,0.30119280604669996,0.983,4/15,3.91%,PDPN;SLC6A13;SLC19A1;SLC16A12
prerank,epithelial tube morphogenesis (GO:0060562),-0.5627756993122347,-1.7894327765360871,0.0,0.074214319698909,0.962,15/32,13.22%,SLIT2;MEF2C;COL4A1;RYR2;PAK1;ACVRL1;SOX17;MET;RASIP1;CTNNB1;BMP4;RHOB;PRKX;ACVR1;CSF1R
prerank,regulation of vascular endothelial growth factor production (GO:0010574),0.6542394448734304,1.7880866311006787,0.0017985611510791368,0.3084836036313969,0.986,5/26,4.74%,SULF1;RORA;IL6ST;IL6;ARNT
prerank,eye morphogenesis (GO:0048592),0.6924733351795922,1.7859237258724563,0.007633587786259542,0.30354584022420433,0.989,9/19,11.60%,EFEMP1;FBN1;COL5A2;SHROOM2;COL5A1;SKI;MFAP2;NKD1;MFAP5
prerank,cardiac muscle cell membrane repolarization (GO:0099622),-0.7354668037989907,-1.7810315752505461,0.004291845493562232,0.07999470574523987,0.973,6/11,12.24%,ATP1B1;KCNJ3;KCNJ2;ATP1A1;KCND3;KCNQ1
prerank,negative regulation of chondrocyte differentiation (GO:0032331),0.7377612282143946,1.7807905010001217,0.003898635477582846,0.3092102310224218,0.991,6/14,13.85%,EFEMP1;ADAMTS12;PTHLH;TGFBR1;RFLNA;ADAMTS7
prerank,regulation of gastrulation (GO:0010470),0.7251281159083749,1.7791210937905468,0.01107011070110701,0.3023789243420773,0.993,5/14,5.19%,PHLDB2;OSR1;DAG1;CLASP1;PHLDB1
prerank,chloride transport (GO:0006821),-0.4705421894886485,-1.7791158236187792,0.0,0.08059648986376644,0.975,30/74,19.29%,SLC4A10;SLC12A7;SLC26A7;SLC12A2;ANO1;CLIC5;SLC6A1;GABRA2;ANO3;GABRB3;GABRA3;GLRA3;CLCN3;GABRA4;SLC1A1;ANO4;SLC12A5;GABRB1;GABRG3;CLCN1;SLC12A6;TTYH3;ANO2;GABRB2;TTYH1;FXYD1;GABRA5;ANO5;GLRA2;GLRA1
prerank,regulation of bone mineralization (GO:0030500),0.55752696431813,1.7784381706566694,0.0016181229773462784,0.29332542962722474,0.993,15/55,4.75%,BMP6;WNT4;PTN;ENPP1;DDR2;OSR1;ECM1;BMPR1A;BMP2K;NELL1;KL;ADGRV1;BMP2;BCOR;BMP7
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.7597080809142505,1.7771253803504294,0.0038461538461538464,0.2760026864494404,0.994,5/12,11.92%,FHL2;RCAN1;ATP2B4;GSK3B;HOMER3
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.7597080809142505,1.7771253803504294,0.0038461538461538464,0.2760026864494404,0.994,5/12,11.92%,FHL2;RCAN1;ATP2B4;GSK3B;HOMER3
prerank,negative regulation of metabolic process (GO:0009892),0.5458507754558536,1.7716870503232438,0.0,0.2846683908905531,0.995,14/54,9.50%,ALDH1A1;LGR4;RBPJ;LAMA4;WNT10B;ACOT11;FOXC2;NRDC;TLE3;TLR4;NR1H3;NOVA1;MAP2K6;DOCK7
prerank,mesenchymal cell differentiation (GO:0048762),0.557136149400134,1.7626582483417237,0.003257328990228013,0.3086372811485792,1.0,14/51,8.47%,RANBP3L;TGFBR3;WNT4;ROCK2;RBPJ;FGFR1;FOXC1;FBXL17;BMP2;LOXL3;BMP7;TGFBR1;GSK3B;WNT5A
prerank,dendrite self-avoidance (GO:0070593),-0.6630693662285178,-1.7611043848694634,0.00234192037470726,0.09751169798698114,0.988,7/16,10.36%,BSG;CNTN4;CNTN6;ROBO4;NPTN;CNTN2;EMB
prerank,membrane repolarization during action potential (GO:0086011),-0.6901715261627384,-1.7605135731704937,0.0066518847006651885,0.09666284210580023,0.99,6/13,13.29%,ATP1B1;KCNJ2;ATP1A1;KCND3;KCNQ1;KCNE4
prerank,positive regulation of regulated secretory pathway (GO:1903307),-0.6469846641493824,-1.7549881655548136,0.002173913043478261,0.10150951711645641,0.992,11/17,27.64%,NLGN1;RAB27A;SCAMP5;CACNA1G;SYT4;KCNB1;RAB15;SYT10;CACNA1I;DOC2B;UNC13D
prerank,sequestering of extracellular ligand from receptor (GO:0035581),0.7281213797354553,1.7547124774516998,0.005802707930367505,0.32701118921594025,1.0,5/13,3.96%,FBN1;FSTL1;LTBP1;NBL1;BMP2
prerank,cartilage development (GO:0051216),0.552403784341055,1.7537004810436092,0.008375209380234505,0.31967014951419276,1.0,9/49,4.50%,SULF1;SOX5;CREB3L2;OSR1;WNT10B;WNT2B;ITGB8;BMP2;WNT5B
prerank,regulation of AMPA receptor activity (GO:2000311),-0.5858713546993575,-1.7529251922732865,0.0022624434389140274,0.10230980461348652,0.994,16/25,29.81%,NLGN1;SHANK3;MEF2C;NLGN3;SHISA9;MINK1;ADRB2;SHISA6;RELN;SHANK1;GSG1L;SHISA7;MAPK8IP2;CACNG5;CACNG7;SHISA8
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),-0.5612553035137285,-1.751018018816185,0.004830917874396135,0.10264106382379067,0.994,10/27,10.30%,PDE4D;CACNB2;DMD;CACNB4;FKBP1A;CALM1;CALM2;CAMK2D;SELENON;NOS1
prerank,positive regulation of behavior (GO:0048520),-0.7313378551537421,-1.7509699166752293,0.00784313725490196,0.10113433958720253,0.994,3/10,1.17%,NLGN1;SGIP1;MEF2C
prerank,diterpenoid metabolic process (GO:0016101),0.554157067925141,1.749390605451363,0.0,0.32552244827328336,1.0,10/55,5.07%,ALDH1A1;GPC6;RBP1;ABCA4;APOA2;HSPG2;RDH10;SDC2;RBP4;RDH5
prerank,cell junction assembly (GO:0034329),-0.4311818612356117,-1.7470679389279655,0.0,0.1040214749738608,0.995,32/100,11.05%,DNM3;ADGRL3;NRXN1;NLGN1;CTNND2;ITGA6;SHANK3;CLDN5;SPOCK2;CDH2;KIRREL3;CDH11;GPM6A;CDH12;ACTB;CDH1;ACTG1;SHANK2;GJC1;CDH10;TLN2;CDH8;NRCAM;CDH22;CDH7;CDH20;VMP1;NLGN3;DNER;VASP;DBNL;PCDHB16
prerank,regulation of T cell chemotaxis (GO:0010819),0.7624856928351634,1.7464791737418435,0.007692307692307693,0.32694324221520876,1.0,5/11,14.09%,CXCL10;STK39;OXSR1;WNT5A;WNK1
prerank,Fc-gamma receptor signaling pathway (GO:0038094),-0.4614861647763016,-1.7464176763929273,0.0,0.10304136949931166,0.995,22/71,13.65%,MYO10;PLCG2;ELMO1;PIK3R1;ACTB;NCKAP1;PAK1;ACTG1;WIPF3;MAPK3;HSP90AB1;ARPC3;ARPC4;ARPC2;LYN;ARPC1A;FCER1G;VAV1;DOCK1;SYK;HSP90AA1;RAC1
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),-0.5957052651540933,-1.7462948388490334,0.004454342984409799,0.10153433767933265,0.995,9/21,12.95%,PDE4D;DMD;SMAD7;INPP5K;PAQR3;RASSF2;RACK1;DDIT4;CAV1
prerank,detection of calcium ion (GO:0005513),-0.6859880619862793,-1.745599483516427,0.00646551724137931,0.10077185773488953,0.995,6/13,6.94%,SYT1;KCNMB2;RYR2;CALM1;CALM2;CALM3
prerank,ribosomal large subunit biogenesis (GO:0042273),-0.4815648595957753,-1.7433266803482674,0.0,0.10184668695439213,0.995,24/54,20.89%,RPL26;RPL24;RPL5;RPL10A;RPL35A;RPL6;RPL11;RPLP0;RPL14;NPM1;TRAF7;MAK16;NIP7;NVL;MRPL1;PPAN;NLE1;SNU13;NOC2L;RPL7;MALSU1;RPL7A;MDN1;RPL3
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.5232833376956108,1.7411061595246053,0.0032102728731942215,0.3367390796352393,1.0,16/65,7.92%,PDPK1;FBN1;SMAD3;LTBP1;SMURF2;PPM1A;SNX6;LDLRAD4;TGFB1I1;PMEPA1;WFIKKN1;TGFBR1;BCL9L;PPARA;TGFBR2;SKI
prerank,regulation of muscle cell differentiation (GO:0051147),-0.5531314467427891,-1.7408341633145616,0.0023584905660377358,0.1030682557013989,0.995,8/31,7.15%,CTNNA2;BOC;CDH2;MEF2C;PTBP1;CTNNB1;HDAC9;TCF3
prerank,positive regulation of cation transmembrane transport (GO:1904064),-0.5141767040189174,-1.7402967877924564,0.007751937984496124,0.10238928442897065,0.996,15/41,13.71%,KCNMB2;KCNMA1;AKAP6;KCNJ3;KCNJ2;NOS1AP;GABBR2;ANK3;CTSS;NOS1;ACE2;KCNJ6;KCNQ1;KCNJ15;STAC
prerank,vasodilation (GO:0042311),-0.684240047121582,-1.7393367183336184,0.01037344398340249,0.10213171966202703,0.998,6/13,14.97%,NOS3;KCNMA1;KLF2;NOS1;ADRB2;SOD1
prerank,receptor signaling pathway via STAT (GO:0097696),0.6280458292340333,1.7391512094952024,0.008896797153024912,0.3340536215215659,1.0,13/25,17.59%,GHR;IL31RA;STAT2;STAT5B;STAMBP;STAT1;CCL2;PIAS1;STAT4;SOCS6;PKD2;IFNAR2;STAT5A
prerank,negative regulation of transmembrane transport (GO:0034763),-0.7480333748893127,-1.7364196682763844,0.006048387096774193,0.10405070698999734,0.998,4/10,7.21%,PRKCB;THBS1;INPP5K;AKT1
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),-0.5437118797817464,-1.7361943500424353,0.0,0.10286842582102083,0.998,17/31,26.68%,SYT1;SCAMP5;RAB3GAP1;STXBP1;CACNA1G;SYT4;SYT7;KCNB1;SYT9;SYT2;SYT6;SYT10;SYT5;CACNA1I;DOC2B;CBARP;SYT17
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),-0.42256464279486816,-1.7350372870549424,0.0,0.10284940201640884,0.999,35/107,15.20%,SLC39A10;ATP1B1;SLC24A2;RYR2;TPT1;MT1H;MT1M;MT1A;MT1B;MT1X;MT1F;MT1E;MT1G;HTR2C;ATP2C1;SLC8A1;CCL14;SLC39A6;NPTN;ATP2A3;SLC30A1;SLC39A14;CXCL12;CALR;SLC39A12;SLC10A7;CD40;TMCO1;MT2A;CAV1;SLC39A13;ATP2A2;SLC39A8;CCL19;ATP13A4
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),-0.4556045433856278,-1.7341746267217082,0.002881844380403458,0.10243589930362357,0.999,24/73,15.74%,MYO10;PLCG2;ELMO1;PIK3R1;ACTB;NCKAP1;PAK1;ACTG1;WIPF3;MAPK3;HSP90AB1;ARPC3;ARPC4;ARPC2;LYN;ARPC1A;FCER1G;VAV1;DOCK1;SYK;HSP90AA1;RAC1;NR4A3;PLCG1
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.4345633956673676,1.7287072705766797,0.0,0.3650698799082521,1.0,67/248,16.51%,BICC1;TCF7L2;RNF220;WLS;LRRK1;MCC;LGR4;PRICKLE1;ZEB2;RBMS3;TLE1;MLLT3;TBL1XR1;SMURF2;WNT3A;PPM1A;KANK1;PTK7;GLI3;INVS;DACT1;BMP2;IGFBP6;TLE3;GLI1;TMEM64;LATS2;LYPD6;SIAH2;LRP4;PLEKHA4;DKK3;CTNND1;GSK3B;PSMB10;WNT5A;STK3;AMFR;PSMA3;USP8;LZTS2;PSME4;USP47;LRRK2;PSMA5;PPM1B;NKD1;PTPRU;CUL3;DVL3;BTRC;NOG;FRMD8;WNK1;USP34;TLE6;NPHP3;ILK;STK4;RNF146;SOX4;DAB2;IGFBP4;TNKS2;AXIN2;WWTR1;TBL1X
prerank,ribosomal small subunit assembly (GO:0000028),-0.6666011874413306,-1.7274437195383017,0.0043859649122807015,0.10884878915015349,1.0,7/16,13.32%,RPS15;RPS27;RPS19;RPS28;RRP7A;RPS5;RPS14
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.5095268271540172,1.727014323012036,0.0,0.3613159611516249,1.0,17/74,6.94%,PHLDB2;PDPN;SMAD3;FOXC1;EPHA3;LDLRAD4;GLIPR2;DAG1;TGFB1I1;BMP2;IL6;CLASP1;TGFBR1;PHLDB1;BCL9L;USF3;TGFBR2
prerank,adherens junction organization (GO:0034332),-0.49099210999186693,-1.7258975686966893,0.0025575447570332483,0.10932446811015835,1.0,17/48,9.09%,CADM1;CADM2;CDH2;CDH11;CDH12;SMAD7;ACTB;CDH1;CDH10;CTNNB1;CDH8;CDH22;CDH4;CDH7;CDH20;JAM3;RAMP2
prerank,positive regulation of muscle cell differentiation (GO:0051149),-0.5866746873078124,-1.7217385172394704,0.0044742729306487695,0.11290656367529339,1.0,6/24,7.15%,CTNNA2;BOC;CDH2;MEF2C;CTNNB1;TCF3
prerank,dendritic spine organization (GO:0097061),-0.5629317169232908,-1.7206186578004543,0.004405286343612335,0.1126726792420099,1.0,12/26,20.27%,CTNND2;SHANK3;INSR;DOCK10;EPHB1;LGMN;ITGA3;PAK3;SHANK1;EPHB3;MTMR2;CHRNA7
prerank,cAMP-mediated signaling (GO:0019933),-0.5782579318630057,-1.7188682138210567,0.00683371298405467,0.11354358473437315,1.0,10/24,10.76%,PDE4D;RIMS2;ADGRG6;AKAP6;CAP2;EPHA5;RAPGEF2;PDE3A;PDE2A;ADCY2
prerank,excitatory postsynaptic potential (GO:0060079),-0.6376110825699585,-1.7185662885136164,0.011337868480725623,0.11241137486696819,1.0,7/19,9.11%,GRID2;MEF2C;GRIN2A;RAB3GAP1;GRIN2B;AKT1;GRIN1
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",-0.5838192977431074,-1.7172061562486696,0.009153318077803204,0.11275311919542327,1.0,8/25,9.11%,GRID2;MEF2C;GRIN2A;RAB3GAP1;GRIN2B;AKT1;NLGN3;GRIN1
prerank,branching morphogenesis of an epithelial tube (GO:0048754),-0.5018600467099348,-1.7155049714067623,0.002421307506053269,0.11327156939350294,1.0,17/39,12.83%,SLIT2;TIE1;COL4A1;KDR;PAK1;SIX1;MET;RASIP1;CTNNB1;SEMA3E;BMP4;VEGFA;LRP6;NOTCH4;FGF2;PAX2;LRP5
prerank,extracellular structure organization (GO:0043062),0.43936210672947856,1.7135082289163086,0.0,0.40501621187717757,1.0,42/204,6.80%,TNC;COL4A3;FBN1;COL23A1;COL4A6;LAMC1;COL4A4;COL5A2;VTN;COL3A1;FN1;ADAMTSL5;LAMA2;LAMA4;COL4A5;DDR2;NID1;ADAMTS12;ECM2;ADAMTS10;HSPG2;NID2;ITGB8;DAG1;ICAM4;ITGA5;ADAMTS1;ADAMTSL4;ITGA9;DCN;ADAMTS6;ITGA10;LAMC3;LOXL1;TGFBR1;THSD4;SERPINE1;COL5A1;MMP14;VCAM1;CD47;COL18A1
prerank,metal ion homeostasis (GO:0055065),-0.4963096167276616,-1.710812079304413,0.0024752475247524753,0.1173702918246363,1.0,12/40,12.95%,TMTC2;SLC12A7;SLC12A2;ANK3;SNCA;SLC8A1;CNNM4;SELENON;SLC12A5;GRIN1;SLC12A6;CAV1
prerank,response to peptide hormone (GO:0043434),0.5603530365796642,1.710681717065118,0.003257328990228013,0.4059549234336655,1.0,15/43,17.59%,TGFBR3;ROCK2;IGFBP5;STAT2;ANXA1;STAT5B;CRY1;EPM2AIP1;STAT1;EIF2B3;STAT4;MEAK7;KHK;TRIM16;STAT5A
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),0.6755601629261986,1.7104571634066097,0.014414414414414415,0.3965615914537834,1.0,5/17,7.81%,BMP6;SASH1;CD55;TRIM5;LY96
prerank,pyrimidine nucleobase metabolic process (GO:0006206),0.7420376650898703,1.7102083311174132,0.009487666034155597,0.3877691378753041,1.0,5/12,14.32%,DPYSL3;CTPS1;DPYD;UMPS;ALDH6A1
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),-0.45375344759412245,-1.7099960517503594,0.0029069767441860465,0.11688416832628194,1.0,21/70,13.65%,MYO10;PLCG2;ELMO1;PIK3R1;ACTB;NCKAP1;PAK1;ACTG1;WIPF3;MAPK3;HSP90AB1;ARPC3;ARPC4;ARPC2;LYN;ARPC1A;VAV1;DOCK1;SYK;HSP90AA1;RAC1
prerank,positive regulation of stem cell differentiation (GO:2000738),0.6795686351269489,1.709972239390536,0.0108499095840868,0.3795810662290619,1.0,4/16,2.27%,SOX5;PTN;FOXC1;TACSTD2
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),-0.6771428949564327,-1.7077966113205045,0.008298755186721992,0.1184794576414801,1.0,9/13,26.33%,SYT1;SCAMP5;CACNA1G;SYT4;KCNB1;SYT10;CACNA1I;DOC2B;HYAL3
prerank,defense response to tumor cell (GO:0002357),0.7615185465750185,1.7035482043081784,0.009671179883945842,0.39551131563282094,1.0,5/10,4.87%,RBMS3;DLEC1;PRF1;DAPK1;PLK5
prerank,integrin-mediated signaling pathway (GO:0007229),0.5087426123178717,1.703258448655454,0.004580152671755725,0.38765241026004965,1.0,21/73,12.34%,TEC;PTN;COL3A1;FN1;PLPP3;MPIG6B;CCM2;ITGB8;NRP1;FBLN1;ITGA5;ADAMTS1;ITGBL1;ITGA10;PTPRA;CD47;ITGA11;PLEK;PTK2;CUL3;FYB1
prerank,synapse assembly (GO:0007416),-0.45756351486096475,-1.7017000966335127,0.0,0.12442598248444278,1.0,23/67,11.23%,DNM3;ADGRL3;NRXN1;NLGN1;GRID2;SHANK3;SPOCK2;CDH2;KIRREL3;GPM6A;GABRA2;LRRTM3;CDH1;GABRB3;SHANK2;NRCAM;NLGN3;LGI2;DNER;DVL1;DBNL;PCDHB16;FGF13
prerank,positive regulation of biomineral tissue development (GO:0070169),0.5581106114724228,1.699654768861673,0.009933774834437087,0.3932280032765928,1.0,11/40,4.75%,BMP6;WNT4;PTN;WNT6;OSR1;BMPR1A;NELL1;KL;ADGRV1;BMP2;BMP7
prerank,negative regulation of stress fiber assembly (GO:0051497),0.6095194695115713,1.6968912291613008,0.010344827586206896,0.3962723029237315,1.0,7/24,4.99%,PHLDB2;CGNL1;ARHGAP6;DLC1;TACSTD2;ARHGAP28;CLASP1
prerank,regulation of complement activation (GO:0030449),0.5673651897953871,1.6967812343823494,0.003289473684210526,0.38823508250499,1.0,10/40,9.38%,CFH;VTN;CFHR2;CD55;SERPING1;C5AR2;C2;PHB2;PROS1;CPB2
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),-0.6456720373850086,-1.6928987198364494,0.01050420168067227,0.1354958852941028,1.0,5/15,8.22%,GRM7;GRM3;GRM5;HOMER1;GRM8
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),0.5556098194462789,1.6889413846938917,0.007936507936507936,0.41191207446142325,1.0,11/40,6.94%,TCF7L2;PDPN;SMAD3;FOXC1;GLIPR2;TGFB1I1;BMP2;IL6;TGFBR1;BCL9L;TGFBR2
prerank,regulation of immune effector process (GO:0002697),0.5591126943869836,1.6886251528343532,0.00487012987012987,0.4046198675944352,1.0,10/41,9.38%,CFH;VTN;CFHR2;CD55;SERPING1;C5AR2;C2;PHB2;PROS1;CPB2
prerank,external encapsulating structure organization (GO:0045229),0.43361353530908325,1.6872270257981457,0.0,0.4026302925952001,1.0,41/205,6.80%,TNC;COL4A3;FBN1;COL23A1;COL4A6;LAMC1;COL4A4;COL5A2;VTN;COL3A1;FN1;ADAMTSL5;LAMA2;LAMA4;COL4A5;DDR2;NID1;ADAMTS12;ECM2;ADAMTS10;HSPG2;NID2;ITGB8;DAG1;ICAM4;ITGA5;ADAMTS1;ADAMTSL4;ITGA9;DCN;ADAMTS6;ITGA10;LAMC3;LOXL1;THSD4;SERPINE1;COL5A1;MMP14;VCAM1;CD47;COL18A1
prerank,positive regulation of lipid metabolic process (GO:0045834),0.6334536460989324,1.685975259919479,0.008912655971479501,0.39951446210130004,1.0,8/22,12.63%,ZBTB20;APOA2;SORBS1;CREBL2;PPARA;SIRT4;DISP3;EEF1A2
prerank,endothelial cell proliferation (GO:0001935),-0.6198828500750518,-1.6834751757325803,0.01126126126126126,0.1477689565560499,1.0,7/17,9.91%,TEK;BMPER;BMPR2;CD34;ACVRL1;BMP4;PRKX
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.4765600509647599,1.6829970293846097,0.002967359050445104,0.40323022597958486,1.0,22/95,8.20%,PDPK1;TGFBR3;SMAD3;ZEB2;SMURF2;PPM1A;SNX6;LDLRAD4;TGFB1I1;PMEPA1;WFIKKN1;LATS2;TGFBR1;NREP;BCL9L;PPARA;DKK3;CREBBP;TGFBR2;SKI;CDKN2B;RNF111
prerank,negative regulation of wound healing (GO:0061045),0.5833633026129624,1.67860242933111,0.01060070671378092,0.4127838821384662,1.0,9/28,12.41%,PHLDB2;TFPI;VTN;CASK;CLASP1;SERPINE1;SERPINE2;EPPK1;CD109
prerank,cellular response to type I interferon (GO:0071357),0.5549059658348239,1.6782430350937456,0.013071895424836602,0.39938656186462906,1.0,18/41,15.99%,RSAD2;SP100;GBP2;STAT2;IFIT2;IFI35;BST2;OASL;STAT1;IFITM1;OAS2;IFI27;ADAR;IFIT1;JAK1;IFIT3;IRF9;IFNAR2
prerank,type I interferon signaling pathway (GO:0060337),0.5549059658348239,1.6782430350937456,0.013071895424836602,0.39938656186462906,1.0,18/41,15.99%,RSAD2;SP100;GBP2;STAT2;IFIT2;IFI35;BST2;OASL;STAT1;IFITM1;OAS2;IFI27;ADAR;IFIT1;JAK1;IFIT3;IRF9;IFNAR2
prerank,regulation of stem cell proliferation (GO:0072091),0.6562790751313858,1.6753806493946566,0.02097902097902098,0.40296105943882293,1.0,5/17,8.62%,EIF2AK2;GJA1;FBLN1;TERT;YAP1
prerank,dendritic spine morphogenesis (GO:0060997),-0.6470645963576663,-1.6726332373792487,0.014893617021276596,0.16268427249105033,1.0,7/15,17.00%,CTNND2;SHANK3;DOCK10;EPHB1;PAK3;SHANK1;EPHB3
prerank,embryonic heart tube development (GO:0035050),-0.642481857229165,-1.6700000532910453,0.01279317697228145,0.1650114351384351,1.0,7/14,17.72%,RYR2;SOX17;TBX2;NDRG4;SOX18;ACVR1;HES1
prerank,ethanol metabolic process (GO:0006067),0.7140113159874586,1.6693022531964403,0.016822429906542057,0.4206743416452802,1.0,4/12,16.54%,ALDH1A1;ALDH2;ACSS1;SULT1A1
prerank,synapse organization (GO:0050808),-0.4016316096184993,-1.666923639440671,0.0,0.16760019994232814,1.0,34/125,11.05%,APBB2;DNM3;ADGRL3;NRXN1;NLGN1;CTNND2;PTPRD;LRRC4C;SHANK3;SPOCK2;CDH2;CACNB2;PPFIA2;KIRREL3;GRM5;GPM6A;SLC6A1;CACNB4;CDH1;ANK3;SNCA;GPHN;SHANK2;ARHGAP39;NRCAM;SEMA3E;NLGN3;CNTN2;L1CAM;DNER;DVL1;LRRC4B;DBNL;PCDHB16
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.6154951564681083,1.6663599097317645,0.012345679012345678,0.4250528028365793,1.0,6/23,6.51%,TGFBR3;SMAD3;SMURF2;LATS2;NREP;DKK3
prerank,ganglioside biosynthetic process (GO:0001574),-0.6271869492114075,-1.6649816813237444,0.006726457399103139,0.16854817076771694,1.0,5/15,9.05%,ST6GALNAC3;ST8SIA4;ST8SIA6;ST6GALNAC4;ST6GALNAC5
prerank,modulation of excitatory postsynaptic potential (GO:0098815),-0.5472040056267542,-1.6643120910828628,0.0048543689320388345,0.16800522604574622,1.0,14/26,20.27%,NRXN1;NLGN1;SHANK3;RIMS1;RIMS2;PTK2B;NLGN3;GRIN1;TMEM108;RELN;SHANK1;MTMR2;TMEM25;CHRNA7
prerank,regulation of acute inflammatory response (GO:0002673),0.6500727514063561,1.6640896494797555,0.016853932584269662,0.4270356335137831,1.0,4/18,5.96%,IL6ST;OSM;IL6;CREB3L3
prerank,positive regulation of synaptic transmission (GO:0050806),-0.43703196912607645,-1.6638057546724059,0.0,0.1669129033327891,1.0,14/72,6.94%,NRXN1;NLGN1;SHANK3;SYT1;RIMS1;RIMS2;GRIK2;SLC24A2;PTK2B;GRIN2A;SHANK2;GRIN2B;NPTN;LGMN
prerank,gene expression (GO:0010467),-0.35458952039557096,-1.662904979032474,0.0,0.16656875301663898,1.0,142/348,23.10%,RPS24;THRB;RPS9;RPL18A;RPL19;RPS12;ADARB1;RPL26;RPS29;RPL41;RPS15;RPL24;RPS23;RPL5;RPS27;PTMA;RPS19;RPL38;RPLP1;RPS8;SETX;RPL10A;RPL27A;RPL13;RPS18;RPL27;RPS16;RPL35A;RPS6;RPL21;RPS3;RPL39;SORL1;RPS17;TSPAN14;RPS7;RPL37A;RPL4;RPS25;EEF1A1;RPS15A;RPL6;ADARB2;RPL11;RPLP0;RPLP2;RPS21;RPS28;RPL28;RPL32;RPL8;RPL13A;RPL30;SRSF2;RPS20;RPS4X;RPL18;RPS13;CPSF2;RPS2;SRSF1;APOBEC1;SYMPK;DDX54;HNRNPK;RPL14;RPL22;ZC3H11A;DDX17;THOC2;RPS26;ASMT;HHEX;MRPS18A;AAAS;RPS10;IGHMBP2;PWP1;RPL23;RPL17;PABPC4;NUP93;RPL29;POLR3A;GSPT2;XAB2;RPS5;FASTKD2;RPS14;TASP1;NFKBIB;RAE1;HNRNPF;SRBD1;MMS19;MRPL28;COPS5;HBS1L;RPL12;POLR2J;RPL9;RBM3;RRAGC;XRN2;RPL37;DEDD2;RPS11;BCL3;DUSP11;RNPS1;SRSF9;MRPL35;POLDIP3;MRPS5;NXT1;RPL7;RPL31;RPL7A;TSPAN33;MRPL34;RBM15B;HARS1;YARS2;FARSB;UPF1;ALKBH5;RPL3;MRPL52;MRPL23;MRPL9;NUP62;SRSF6;HOXD3;GSPT1;CHTOP;CPSF3;ANGPT2;NUP188;MRPS12;RPL23A;U2AF1;MRPL11
prerank,regulation of chondrocyte differentiation (GO:0032330),0.6133204049315285,1.6628265298225233,0.009057971014492754,0.42515029201154186,1.0,6/24,5.17%,EFEMP1;SOX5;ADAMTS12;PTHLH;TGFBR1;MBOAT2
prerank,fat-soluble vitamin metabolic process (GO:0006775),0.6341009796366376,1.6620832883136534,0.019572953736654804,0.42088154469474043,1.0,2/22,0.84%,ALDH1A2;RBP1
prerank,positive regulation of Wnt signaling pathway (GO:0030177),0.44244280773015854,1.657650553610735,0.0,0.43145249545105435,1.0,29/152,10.32%,RNF220;SULF1;WLS;LRRK1;LGR4;ZEB2;TBL1XR1;SMURF2;WNT3A;PPM1A;KANK1;PTK7;DACT1;BMP2;TERT;WNT5B;SALL1;LYPD6;PLEKHA4;CDC73;SKI;PSMB10;PSMA3;USP8;PSME4;USP47;LRRK2;PSMA5;PPM1B
prerank,response to zinc ion (GO:0010043),-0.5515127478213926,-1.6563579766563696,0.009478672985781991,0.1754315083976772,1.0,8/25,2.74%,MT1H;MT1M;MT1A;MT1B;MT1X;MT1F;MT1E;MT1G
prerank,carbohydrate homeostasis (GO:0033500),0.49209469013403306,1.652760783354663,0.0031446540880503146,0.44501487199557116,1.0,12/67,7.53%,TCF7L2;LEPR;MCU;PRKAA2;GCGR;RBP4;CRY2;CRY1;IL6;APPL2;PTPN2;NGFR
prerank,chondrocyte differentiation (GO:0002062),0.570307368682442,1.6527473317387082,0.01718213058419244,0.4381376780385798,1.0,8/32,4.50%,SULF1;SOX5;CREB3L2;OSR1;WNT10B;WNT2B;BMP2;WNT5B
prerank,positive regulation of response to biotic stimulus (GO:0002833),0.552121547090978,1.6523020532906367,0.010657193605683837,0.4328969318374096,1.0,10/38,11.03%,BMP6;SASH1;DDX60;FPR2;IFI35;GBP5;OASL;LY96;ANKRD17;POLR3F
prerank,cardiac myofibril assembly (GO:0055003),0.667838074931784,1.6510594087655297,0.020793950850661626,0.4309316955085614,1.0,5/15,8.03%,PDGFRA;CSRP3;NEBL;PDGFRB;MEF2A
prerank,cellular response to metal ion (GO:0071248),-0.3897584079031568,-1.6503625785339042,0.0,0.18364470967893556,1.0,29/123,8.84%,NLGN1;DLG2;SLC12A2;SYT1;MEF2C;PLCG2;ITPKB;MT1H;MT1M;MT1A;MT1B;MT1X;MT1F;MT1E;MT1G;CDH1;ANK3;SNCA;MAPK8;RYR3;MAPK3;KCNH1;LGMN;AKT1;CAMK2D;SYT4;SYT7;B2M;CPNE4
prerank,response to interferon-gamma (GO:0034341),0.5000233536005685,1.6493452362429286,0.0030257186081694403,0.4313677732744499,1.0,23/67,16.20%,GBP6;SP100;GBP2;CXCL16;DAPK1;TLR4;GBP5;BST2;CD47;GBP4;STAT1;CCL2;LGALS9;NUB1;WNT5A;IFITM1;GBP7;TLR2;TRIM21;SLC26A6;CCL25;IL23R;GBP3
prerank,negative regulation of osteoclast differentiation (GO:0045671),0.6428010537430202,1.6490479544996977,0.024734982332155476,0.42591300143918975,1.0,5/18,10.17%,FBN1;FSTL3;TLR4;CARTPT;MAFB
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",-0.58332314053833,-1.6457243269793398,0.015486725663716814,0.18984078431772727,1.0,4/18,2.25%,NRXN1;NLGN1;SHANK3;PTK2B
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),-0.6468218907268901,-1.6427009755629172,0.016227180527383367,0.1929932846824623,1.0,4/12,17.04%,CEACAM1;ERLIN1;ACADVL;BRCA1
prerank,regulation of glucose import (GO:0046324),0.573608644538414,1.6419894283790644,0.017513134851138354,0.44750357080983166,1.0,9/30,9.78%,PRKAG2;PID1;ENPP1;OSBPL8;SORBS1;APPL2;CREBL2;RHOQ;APPL1
prerank,protein localization to synapse (GO:0035418),-0.6581329532517178,-1.6416573622907367,0.017928286852589643,0.19334395101360677,1.0,3/12,3.28%,NRXN1;NLGN1;PCLO
prerank,negative regulation of cell migration (GO:0030336),0.44037144583486526,1.6396502474292385,0.0,0.4509431423016252,1.0,39/137,13.03%,PHLDB2;SULF1;IGFBP3;ROBO1;DPYSL3;PODN;MCC;COL3A1;AFDN;IGFBP5;GJA1;DLC1;TACSTD2;KANK1;BMPR1A;LDLRAD4;DAG1;DUSP10;MIA3;TPM1;CLASP1;VCL;SERPINE1;EPHA1;BST2;CLIC4;RNF20;NGFR;EPHA4;STK24;RAP2C;IFITM1;ATP1B2;PTPRU;FOXO3;EPPK1;SLURP1;NOG;ARPIN
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.4941791470649359,1.6382057281090565,0.0046439628482972135,0.45067460572109463,1.0,12/63,8.05%,TCF7L2;DEPTOR;SP100;FGFR1;PHIP;WWOX;SH3RF1;CFLAR;TGFBR1;SIAH2;TNFRSF12A;ZMYND11
prerank,positive regulation of smoothened signaling pathway (GO:0045880),0.6140939611931286,1.6382008861166188,0.012522361359570662,0.44441523619719053,1.0,9/21,17.23%,DCDC2;GLI1;RAB34;IHH;TTC23;EVC;TUBD1;GAS8;DLG5
prerank,negative regulation of immune effector process (GO:0002698),0.6754931233443557,1.6376037355591113,0.03148148148148148,0.44098493786812504,1.0,6/13,9.78%,ENPP3;CD55;FER;RC3H1;CD47;APPL1
prerank,negative regulation of viral genome replication (GO:0045071),0.5340378132219963,1.6369559840772563,0.019400352733686066,0.43737069183522187,1.0,19/40,20.23%,RSAD2;ZC3HAV1;EIF2AK2;BST2;PARP10;OASL;IFITM1;RESF1;OAS2;ILF3;IFIT1;SRPK1;TASOR;IFIH1;SHFL;SETDB1;TNIP1;RNASEL;MPHOSPH8
prerank,regulation of neurotransmitter transport (GO:0051588),-0.6183992882802949,-1.6360037923671888,0.00683371298405467,0.2015969197474674,1.0,6/16,8.65%,RIMS1;MEF2C;MCTP1;CPLX1;CAMK2A;SYN1
prerank,regulation of monooxygenase activity (GO:0032768),-0.5654535684254749,-1.6355997224920118,0.013574660633484163,0.20028553093415116,1.0,10/23,12.95%,NOS3;NOSTRIN;NOS1AP;CALM1;SNCA;AKT1;CYGB;EGFR;HSP90AA1;CAV1
prerank,protein mono-ADP-ribosylation (GO:0140289),0.7205366893845264,1.6303143016877133,0.048355899419729204,0.4577311742840155,1.0,8/11,12.48%,PARP14;PARP9;PARP3;PARP10;PARP12;PARP11;TIPARP;PARP16
prerank,ceramide catabolic process (GO:0046514),-0.6320679838625115,-1.6283872065095288,0.017316017316017316,0.21144026286787215,1.0,6/14,18.67%,ACER3;ACER2;HEXB;NEU1;GM2A;GLA
prerank,"synaptic transmission, glutamatergic (GO:0035249)",-0.5941157231358261,-1.6267312045201137,0.01818181818181818,0.21229700268859644,1.0,9/18,16.24%,GRID2;GRIK2;GRIK4;GRIK1;CDH8;SLC1A4;GRIA2;NAPA;GRIK3
prerank,sodium ion import across plasma membrane (GO:0098719),-0.6072066395821926,-1.626718736814367,0.022727272727272728,0.21035161458049212,1.0,5/17,6.59%,SLC12A2;SLC9A2;SLC6A1;SLC8A1;HCN2
prerank,water transport (GO:0006833),0.6956630123483548,1.6258845509420108,0.021568627450980392,0.46978237561214525,1.0,1/12,0.30%,PDPN
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),-0.5794782950743468,-1.6243331642750114,0.016241299303944315,0.2128894291603739,1.0,7/19,4.93%,CSGALNACT1;HS6ST3;HS6ST2;NDST3;HS3ST5;XYLT1;EXT1
prerank,positive regulation of smooth muscle cell migration (GO:0014911),0.6361450982859281,1.6240220693201117,0.02120141342756184,0.47104996811434935,1.0,7/17,9.50%,VTN;DOCK5;IGFBP5;NRP1;ADAMTS1;PDGFRB;DOCK7
prerank,secretion (GO:0046903),-0.6338671049947959,-1.6229428608440002,0.01762114537444934,0.21350986732841745,1.0,5/14,10.70%,RIMS1;TPD52;FBLN5;NPR1;SLC22A6
prerank,connective tissue development (GO:0061448),0.5564647988207361,1.6221753930686686,0.019400352733686066,0.47282249856821323,1.0,4/35,2.92%,SULF1;SOX5;CREB3L2;ITGB8
prerank,cellular response to BMP stimulus (GO:0071773),0.4853642994549143,1.62173665525566,0.007898894154818325,0.468429315493953,1.0,21/66,16.33%,TGFBR3;BMP6;SMAD3;RGMA;ADAMTS12;RGMB;BMPR1A;HIVEP1;BMP2;BMP7;BMP8B;USP9X;SLC33A1;SMAD6;ZFYVE16;SMAD4;HFE;ADAMTS7;GDF15;ACVR2B;SMAD2
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),-0.6658792227292573,-1.620410905016777,0.017857142857142856,0.214558674761132,1.0,7/11,19.53%,FKBP1A;CALM1;CALM2;CALM3;SRI;CASQ2;GSTO1
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),-0.6658792227292573,-1.620410905016777,0.017857142857142856,0.214558674761132,1.0,7/11,19.53%,FKBP1A;CALM1;CALM2;CALM3;SRI;CASQ2;GSTO1
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.44462642027630833,1.6196191229656223,0.0014347202295552368,0.4709214596564441,1.0,34/128,12.58%,TGFBR3;BMP6;SMAD3;ZMIZ1;COL3A1;RGMA;SMURF2;RGMB;BMPR1A;CDH5;TWSG1;TGFB1I1;HIVEP1;LRRC32;BMP2;PARD6A;BMP7;PRKCZ;TGFBR1;APPL2;TGFBR2;BMP8B;USP9X;SLC33A1;SKI;RNF111;SMAD6;APPL1;ZFYVE16;PTK2;TGFBRAP1;SMAD4;MAP3K7;HFE
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),-0.6922371620532985,-1.619088358614632,0.01956521739130435,0.21511986367519376,1.0,6/10,12.86%,PDE4B;CACNB2;NOS1AP;CALM1;CALM3;SRI
prerank,energy reserve metabolic process (GO:0006112),0.6240310502664635,1.618317582608412,0.01967799642218247,0.4707523580628363,1.0,5/19,9.09%,LEPR;PRKAG2;PID1;GSK3B;PYGM
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),0.6119442058911783,1.6179424666073312,0.01289134438305709,0.466414368652994,1.0,10/23,15.64%,PARP14;PARP9;NR1H3;PTPN2;STAT1;PIAS1;SUMO1;OTOP1;JAK1;TXK
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.42012984407172266,1.6167394494673744,0.0,0.4660687304232195,1.0,48/186,16.40%,BICC1;TCF7L2;MCC;PRICKLE1;RBMS3;RNF213;TLE1;MLLT3;GLI3;WWOX;APCDD1;INVS;DACT1;BMP2;IGFBP6;TLE3;GLI1;TMEM64;LATS2;SIAH2;LRP4;DKK3;CTNND1;GSK3B;PSMB10;WNT5A;STK3;AMFR;PSMA3;LZTS2;PSME4;PSMA5;NKD1;PTPRU;CUL3;VGLL4;DVL3;NOG;FRMD8;HIC1;RNF43;TLE6;NPHP3;STK4;DAB2;IGFBP4;AXIN2;WWTR1
prerank,positive regulation of T cell chemotaxis (GO:0010820),0.7242888107934877,1.6165241545489306,0.031007751937984496,0.46128627953098195,1.0,4/10,14.09%,STK39;OXSR1;WNT5A;WNK1
prerank,endothelial cell development (GO:0001885),-0.5373700602890036,-1.616341684020475,0.018306636155606407,0.2186390712353439,1.0,8/25,9.94%,PDE4D;PECAM1;PPP1R16B;MET;ROBO4;RAPGEF2;PDE2A;SOX18
prerank,peptidyl-lysine trimethylation (GO:0018023),0.6005740091790333,1.6159272722574711,0.013377926421404682,0.45814177575032816,1.0,11/26,20.40%,KMT2A;METTL21C;ETFBKMT;SETD4;SETD1B;TET2;SETD5;ATPSCKMT;KMT5C;SETD2;KMT5B
prerank,acylglycerol biosynthetic process (GO:0046463),0.6050108304726225,1.6138867468942382,0.017452006980802792,0.46070436740136067,1.0,7/23,17.18%,AGMO;PLA2G4A;PLCE1;MOGAT3;DGAT2;LPGAT1;LPIN2
prerank,peptidyl-methionine modification (GO:0018206),0.6790414434542825,1.6136607722731617,0.02443609022556391,0.45628295578146877,1.0,5/12,15.22%,APOA2;NAA16;NAA30;NAA15;PDF
prerank,actin cytoskeleton reorganization (GO:0031532),0.48865630312211794,1.6133637925916715,0.004702194357366771,0.4524605549794509,1.0,13/63,4.40%,MCU;CXADR;NRK;AUTS2;PARVA;INSRR;PTK7;NRP1;FER;ANXA1;ANTXR1;KIT;EFS
prerank,regulation of microtubule-based process (GO:0032886),0.5305805498873724,1.612777063377501,0.006611570247933884,0.44960035801534376,1.0,8/36,7.66%,PHLDB2;DIAPH1;PRKAA2;EPHA3;MAP6;CLASP1;PHLDB1;GSK3B
prerank,regulation of postsynapse organization (GO:0099175),-0.5288281671100861,-1.612525612511776,0.01179245283018868,0.22424849577641193,1.0,11/28,15.56%,SHANK3;PPFIA2;TANC2;HOMER1;IL1RAPL1;ARHGAP44;ABI3;LZTS3;SRCIN1;ABHD17A;CFL1
prerank,positive regulation of bone mineralization (GO:0030501),0.5433368437417404,1.6120294966268938,0.01353637901861252,0.4474861452085099,1.0,10/35,4.75%,BMP6;WNT4;PTN;OSR1;BMPR1A;NELL1;KL;ADGRV1;BMP2;BMP7
prerank,myotube differentiation (GO:0014902),-0.5792854851471491,-1.6120175034898303,0.021739130434782608,0.22317160904526714,1.0,8/17,15.36%,ADGRB3;MEF2C;JAM2;KCNH1;MYEF2;NOS1;SIX4;SORT1
prerank,regulation of potassium ion transmembrane transport (GO:1901379),-0.440832161757195,-1.6084852313429798,0.005305039787798408,0.22866309264382365,1.0,18/54,12.95%,DPP10;KCNAB1;KCNMB2;KCNMA1;AKAP6;KCNJ3;KCNJ2;NOS1AP;GABBR2;KCNIP4;KCNIP1;DPP6;NEDD4L;CACNA1D;KCNJ6;KCNQ1;KCNJ15;CAV1
prerank,negative regulation of actin filament polymerization (GO:0030837),-0.5510996199881553,-1.6081901313858147,0.023758099352051837,0.227239537380385,1.0,8/22,6.43%,SLIT2;SSH2;TMSB4X;KANK3;KANK4;TMSB10;HIP1R;CYRIB
prerank,central nervous system neuron differentiation (GO:0021953),-0.488638131051689,-1.605736586450157,0.004819277108433735,0.23027006766447056,1.0,15/33,27.35%,MDGA2;GRID2;NTRK2;TOX;CTNNB1;LRP6;SPOCK1;MAPT;MAP2;LHX1;CBLN1;ZC4H2;CEND1;LMX1A;CHD5
prerank,regulation of extracellular matrix disassembly (GO:0010715),0.6608406441753202,1.6052682910626754,0.032,0.46860153868522064,1.0,5/15,4.99%,PDPN;DPP4;DDR2;IL6;CLASP1
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),-0.6196840487709028,-1.603063415762265,0.01948051948051948,0.23369328700090997,1.0,5/13,12.90%,SLC4A10;GRIK2;RAB3GAP1;SHISA9;SHISA6
prerank,regulation of membrane repolarization (GO:0060306),-0.6243452757905139,-1.6013414836172317,0.017130620985010708,0.2352479948161149,1.0,6/13,14.47%,AKAP6;KCNJ2;NEDD4L;KCNQ1;CAV1;CASQ2
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),0.6118499321517148,1.6012760526690306,0.023090586145648313,0.4803885062772608,1.0,4/21,5.17%,PLA1A;PLA2G4A;OSBPL8;MBOAT2
prerank,neuronal action potential (GO:0019228),-0.5554744487172596,-1.6006424896741591,0.016587677725118485,0.23479231442740622,1.0,11/22,20.62%,KCNMB2;SCN1A;ANK3;SCN2A;CACNA1G;SCN8A;SCN9A;KCNA2;SCN3A;KCNA1;KCNMB4
prerank,regulation of dendrite extension (GO:1903859),-0.5772043441814415,-1.5988023858037614,0.01411764705882353,0.23662645627389275,1.0,16/18,40.36%,SYT1;RIMS1;RIMS2;SYT4;NEDD4L;SYT2;ITSN2;PLAA;SYT17;CPNE5;CPNE9;UNC13A;SYT3;RASAL1;RNF157;CPNE6
prerank,COPII-coated vesicle cargo loading (GO:0090110),0.64202695583522,1.5983693248625752,0.03262955854126679,0.4865758101328179,1.0,8/14,20.81%,MIA3;SEC23A;SEC24D;SEC24C;SEC24B;SAR1A;SEC31A;SEC23B
prerank,positive regulation of dendrite extension (GO:1903861),-0.5869440333419461,-1.5968736483629051,0.023310023310023312,0.23834661867731785,1.0,16/17,40.36%,SYT1;RIMS1;RIMS2;SYT4;NEDD4L;SYT2;ITSN2;PLAA;SYT17;CPNE5;CPNE9;UNC13A;SYT3;RASAL1;RNF157;CPNE6
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),-0.49294667535056025,-1.594629659348804,0.009411764705882352,0.24121606675190163,1.0,12/35,10.76%,PDE4D;RIMS2;ADGRG6;AKAP6;CAP2;EPHA5;HTR2C;RAPGEF2;GUCY1B1;PDE3A;PDE2A;ADCY2
prerank,histone H3-K4 trimethylation (GO:0080182),0.708150817330249,1.5939471235024987,0.035842293906810034,0.4998705590258991,1.0,3/11,12.91%,KMT2A;SETD1B;TET2
prerank,proteoglycan biosynthetic process (GO:0030166),-0.49377389440843655,-1.593322553686708,0.009615384615384616,0.24181202804196092,1.0,7/31,5.42%,CSGALNACT1;BMPR2;NDST3;XYLT1;EXT1;B3GAT2;CHST9
prerank,interleukin-27-mediated signaling pathway (GO:0070106),0.6531034386244678,1.5923645284818497,0.03683241252302026,0.5010225251784238,1.0,5/13,13.11%,IL6ST;OASL;STAT1;OAS2;JAK1
prerank,negative regulation of signaling receptor activity (GO:2000272),0.574046056907247,1.592323570793317,0.016453382084095063,0.495884781520284,1.0,6/25,6.37%,CBLB;SNX6;SLC6A9;CNRIP1;ERRFI1;PPARA
prerank,canonical Wnt signaling pathway (GO:0060070),0.48377160170390693,1.5916676875013025,0.005970149253731343,0.49312436799339743,1.0,17/68,12.89%,TCF7L2;WNT4;WNT6;PLPP3;WNT10B;WNT3A;WNT2B;FZD2;WNT5B;BCL9L;TCF7L1;GSK3B;WNT5A;LRRK2;TCF7;DVL3;PORCN
prerank,negative regulation of ATP metabolic process (GO:1903579),0.6264993963659933,1.5908001076223957,0.030575539568345324,0.49162398231098464,1.0,4/17,6.37%,PID1;NUPR1;HDAC4;PPARA
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.4201473483684165,1.5905892410590239,0.0,0.48747541698682206,1.0,42/161,16.40%,BICC1;TCF7L2;MCC;PRICKLE1;RBMS3;TLE1;MLLT3;GLI3;INVS;DACT1;BMP2;IGFBP6;TLE3;GLI1;TMEM64;LATS2;SIAH2;LRP4;DKK3;CTNND1;GSK3B;PSMB10;WNT5A;STK3;AMFR;PSMA3;LZTS2;PSME4;PSMA5;NKD1;PTPRU;CUL3;DVL3;NOG;FRMD8;TLE6;NPHP3;STK4;DAB2;IGFBP4;AXIN2;WWTR1
prerank,substantia nigra development (GO:0021762),-0.47372670838887576,-1.5904539164830236,0.01288659793814433,0.24595572353293332,1.0,17/37,17.74%,GNB4;ACTB;PLP1;CALM1;CALM2;MBP;YWHAH;CALM3;INA;S100A1;BASP1;TTBK1;HSPA5;YWHAQ;SUDS3;RAD1;CKB
prerank,regulation of smooth muscle cell migration (GO:0014910),0.6079929845125037,1.5899299629568033,0.023381294964028777,0.48519387487095683,1.0,8/20,8.88%,IGFBP3;VTN;IGFBP5;BMPR1A;NRP1;SERPINE1;PDGFRB;PLAU
prerank,regulation of dendritic spine morphogenesis (GO:0061001),-0.5006662252488303,-1.58982683925138,0.01937046004842615,0.24507863469760777,1.0,13/31,15.56%,NLGN1;SHANK3;PPFIA2;TANC2;ARHGAP44;CAPRIN2;LRP8;ABI3;DBNL;LZTS3;SRCIN1;RELN;CFL1
prerank,positive regulation of cation channel activity (GO:2001259),-0.47388109397466754,-1.5898187090214098,0.00997506234413965,0.24317204472950427,1.0,19/40,24.60%,SHANK3;TMSB4X;AKAP6;CALM1;ANK3;CALM2;CALM3;CTSS;NLGN3;ADRB2;STAC;RELN;STAC3;GSTO1;LRRC38;HAP1;LRRC55;HTT;CASQ1
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),0.6631687947562234,1.5897365566562531,0.030141843971631204,0.481104252243247,1.0,3/14,3.02%,KMT2A;AUTS2;MYB
prerank,actin filament bundle assembly (GO:0051017),0.5527392163409,1.589394804405221,0.012779552715654952,0.47762049521832933,1.0,6/33,4.72%,DPYSL3;PAWR;CALD1;SHROOM2;MYO1B;BAIAP2L1
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.5481313358054517,1.5884176012307885,0.02249134948096886,0.4766084859453984,1.0,10/33,9.57%,TCF7L2;PDPK1;NUPR1;IL11;CDH5;ANGPT1;SERPINE1;PPARA;YAP1;CAST
prerank,negative regulation of blood coagulation (GO:0030195),0.5205540805548609,1.5883876518284121,0.01951219512195122,0.4721663214290424,1.0,9/38,9.38%,TFPI;VTN;PDGFRA;SERPING1;GP1BA;SERPINE1;SERPINE2;PLAU;CPB2
prerank,acetylcholine receptor signaling pathway (GO:0095500),-0.5706950645091456,-1.5878025606227424,0.010683760683760684,0.2454194410640396,1.0,11/20,31.12%,PLCB1;CHRM3;CHRM2;LYPD1;AGRN;GNAQ;CHRNA7;LY6H;RGS10;LY6G6D;GNA11
prerank,regulation of histone H3-K4 methylation (GO:0051569),0.6462494852297583,1.5859985516492463,0.028680688336520075,0.47692632859996875,1.0,4/16,4.70%,KMT2A;AUTS2;MYB;BCOR
prerank,glucose homeostasis (GO:0042593),0.45604936912107585,1.5857936086651279,0.010638297872340425,0.47330074735104827,1.0,15/83,9.01%,TCF7L2;LEPR;MCU;PRKAA2;GCGR;RBP4;CRY2;NUCKS1;CRY1;IL6;APPL2;CARTPT;PTPN2;NGFR;HKDC1
prerank,monovalent inorganic cation homeostasis (GO:0055067),-0.5315574671698065,-1.5856586314259618,0.030660377358490566,0.24823740843425318,1.0,5/23,10.96%,SLC12A7;SLC12A2;CLCN3;SLC12A5;SLC12A6
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),0.6422542838596091,1.585175561929299,0.026022304832713755,0.4715651615453322,1.0,5/17,3.00%,SULF1;FSTL1;FSTL3;CASK;TWSG1
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),-0.4296834958531426,-1.5840047508508561,0.00821917808219178,0.2498666112404027,1.0,22/59,11.21%,CADM1;HMCN1;BSG;PECAM1;ROBO2;CDH2;KIRREL3;TENM3;CNTN4;CNTN6;CDH1;PTPRM;ROBO4;NPTN;CDH4;CEACAM1;CNTN2;L1CAM;PTPRT;EMB;FAT2;CD84
prerank,megakaryocyte differentiation (GO:0030219),0.6935263610154989,1.5829036655775575,0.036290322580645164,0.4759367361017381,1.0,6/11,11.59%,MPIG6B;IL11;KIT;UBA5;CDKN2B;SH2B3
prerank,positive regulation of actin filament bundle assembly (GO:0032233),0.501886256176243,1.5822841503097302,0.01694915254237288,0.47371689466878675,1.0,13/51,7.17%,LPAR1;ROCK2;CCN2;PPM1E;NRP1;S100A10;SYNPO2;SYNPO;TPM1;TGFBR1;EPHA1;CD47;ARHGEF10L
prerank,axon development (GO:0061564),-0.40779879648056355,-1.581483998922913,0.0030303030303030303,0.2531884853138718,1.0,29/78,21.15%,GRM7;CTNNA2;CNTN4;DCC;ACTB;PLP1;KLF7;ANK3;S100B;NRCAM;MAP1B;SHTN1;RTN4RL1;L1CAM;NEFH;PAX2;PAK3;GAP43;MAPK8IP3;BRSK2;MAPT;SLITRK2;EPHB3;SLITRK1;CCK;AMIGO1;NTNG1;NTNG2;DSCAML1
prerank,cation transmembrane transport (GO:0098655),0.5070246626950369,1.5810538777873522,0.014586709886547812,0.47369103849060656,1.0,5/44,2.88%,TRPM3;SLC7A2;ATP1A2;TRPM6;SLC6A9
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),-0.6650611330850811,-1.5808668453793764,0.028384279475982533,0.2524833710797464,1.0,6/10,14.08%,PDE4D;PDE3B;PDE11A;PDE3A;PDE2A;APLNR
prerank,actin filament bundle organization (GO:0061572),0.546001183223746,1.5802535868703877,0.022151898734177215,0.47252388307733706,1.0,8/33,9.75%,DPYSL3;PAWR;CALD1;SHROOM2;MYO1B;BAIAP2L1;LIMA1;RFLNA
prerank,circulatory system development (GO:0072359),0.43227139187441455,1.5796979173871057,0.0042796005706134095,0.47044619992850184,1.0,25/118,8.79%,FBN1;AKAP13;CXADR;COL3A1;FN1;OSR1;FOXC1;HEG1;HSPG2;FOXC2;CDH5;RBP4;ADAP2;MTHFD1;BMP2;BCOR;TGFBR1;NCOA6;SALL1;PLCE1;POPDC2;TGFBR2;MEF2A;PRICKLE4;CACNA1C
prerank,hepaticobiliary system development (GO:0061008),0.6075460952057219,1.5786126900753483,0.029250457038391225,0.4705189932837006,1.0,3/20,1.07%,TGFBR3;WNT4;PRKCSH
prerank,cellular response to nerve growth factor stimulus (GO:1990090),-0.5460837924876167,-1.5782498668027232,0.02050113895216401,0.25620734767273473,1.0,11/22,16.45%,NTRK2;SH3GL2;STMN2;RAPGEF2;AKT1;RAB35;NGF;TMEM108;MAPT;RAP1A;NTF3
prerank,negative regulation of actin filament bundle assembly (GO:0032232),0.5571893181192681,1.5768629051585803,0.022968197879858657,0.4731731175307977,1.0,7/27,4.99%,PHLDB2;CGNL1;ARHGAP6;DLC1;TACSTD2;ARHGAP28;CLASP1
prerank,regulation of actomyosin structure organization (GO:0110020),0.6650656588353052,1.5741514428221326,0.025145067698259187,0.4792822160744253,1.0,4/13,6.18%,ROCK2;AKAP13;ALMS1;ASAP3
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),0.5654546616374911,1.5740659893408218,0.027303754266211604,0.4754530254443571,1.0,7/26,14.28%,LGR4;APPL2;BIRC3;APPL1;TLR2;IRAK3;FLOT2
prerank,postsynaptic membrane organization (GO:0001941),-0.563589061011977,-1.57379571716453,0.03349282296650718,0.26419298293354376,1.0,5/17,8.74%,NRXN1;NLGN1;SHANK3;GPHN;NLGN3
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),-0.5250341645285405,-1.5733439433326073,0.030373831775700934,0.2631941722411239,1.0,14/27,25.52%,CTNNA2;HOMER1;IL1RAPL1;CCDC88A;EFHC2;AKT1;MBOAT1;MARK1;BRSK2;NTNG1;NTNG2;CAMK2G;TREM2;FRMD7
prerank,negative regulation of cell development (GO:0010721),0.5629472223056163,1.5722899066782967,0.02631578947368421,0.47798025919229864,1.0,7/25,9.75%,FBN1;WNT3A;PTHLH;IL6;APPL2;GSK3B;RFLNA
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),-0.5412209137897688,-1.5722892436620712,0.0267639902676399,0.26351706352233056,1.0,9/22,17.86%,PDE4B;CACNB2;DMD;CACNB4;NOS1AP;SRI;STAC;STAC3;HPCA
prerank,neural tube development (GO:0021915),0.6394534838936895,1.5714118599316425,0.04633204633204633,0.4771599406745965,1.0,3/15,3.73%,ALDH1A2;ARL13B;DACT1
prerank,retinoic acid metabolic process (GO:0042573),0.6586378539133164,1.571210592005613,0.03787878787878788,0.47390389109720926,1.0,4/14,14.80%,ALDH1A2;SCPEP1;BCO2;ALDH8A1
prerank,cellular transition metal ion homeostasis (GO:0046916),-0.3875569658091656,-1.570856932275116,0.006756756756756757,0.26472037678556537,1.0,30/91,16.61%,ABCG2;SLC39A10;TFRC;MT1H;MT1M;MT1A;MT1B;MT1X;MT1F;MT1E;MT1G;SLC40A1;ATOX1;FTH1;FTL;SLC39A6;SLC31A1;SLC30A1;SLC39A14;SLC22A17;SLC39A12;HMOX2;SLC31A2;MT2A;CYBRD1;SLC39A13;SLC39A8;SOD1;ATP6V0A2;SCARA5
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),-0.5444365865075779,-1.5702073588736645,0.019656019656019656,0.26398507658218906,1.0,14/22,26.74%,AKAP6;ATP1B1;RYR2;CALM1;CALM2;CALM3;VMP1;STAC;STAC3;GSTO1;HAP1;HTT;CASQ1;JPH2
prerank,potassium ion import across plasma membrane (GO:1990573),-0.46545284440356877,-1.5701929570329958,0.015957446808510637,0.2620994688923163,1.0,15/41,15.71%,SLC12A7;SLC12A2;ATP1B1;ABCC9;KCNJ3;KCNJ2;ATP1A1;HCN2;SLC12A5;KCNJ6;SLC12A6;KCNJ8;KCNJ15;ATP1A3;KCNK9
prerank,response to X-ray (GO:0010165),0.6658374194571959,1.5699104144606282,0.04380952380952381,0.47436607717178647,1.0,6/14,8.70%,PRAP1;XRRA1;ANXA1;NUCKS1;IKBIP;XRCC4
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),-0.5707871357029717,-1.5690975787068697,0.037037037037037035,0.26242096399071435,1.0,7/18,13.59%,ELOVL5;ACSL3;ELOVL7;TECR;ACSL5;HSD17B12;ACSBG1
prerank,beta-catenin-TCF complex assembly (GO:1904837),0.5466668505130221,1.5689205728882742,0.03130434782608696,0.47395852945000794,1.0,13/29,16.38%,TCF7L2;TLE1;TERT;TLE3;BCL9L;TCF7L1;CREBBP;CDC73;TCF7;LEO1;SMARCA4;PYGO1;AXIN2
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),0.69756211234901,1.5688974099736015,0.041015625,0.4701535326307148,1.0,4/11,3.96%,EFNB2;WNT3A;FRS2;BMP2
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),-0.36826427336710277,-1.5688290303328623,0.0,0.261134225836467,1.0,44/159,11.21%,CADM1;ADGRL3;NLGN1;HMCN1;PTPRD;GRID2;LRRC4C;BSG;PECAM1;ROBO2;CLDN5;CDH2;KIRREL3;CDH11;TENM2;TGFB2;CDH12;TENM3;CNTN4;CNTN6;CDH1;PTPRM;IL1RAPL1;UNC5D;ATP2C1;CDH10;ROBO4;CDH8;TENM4;CDH22;NPTN;CDH4;CEACAM1;CDH7;CDH20;CLDN14;CNTN2;L1CAM;PTPRT;LRRC4B;EMB;FAT2;PCDHB16;CD84
prerank,retrograde axonal transport (GO:0008090),-0.5783513302054892,-1.5682757889263188,0.018306636155606407,0.2604300942638732,1.0,7/16,14.97%,DLG2;ACTR10;KIF1C;DYNC1H1;TMEM108;KIF5A;SOD1
prerank,positive regulation of Rho protein signal transduction (GO:0035025),0.5455916222335341,1.5682410569544072,0.03236797274275979,0.46875648663684966,1.0,5/30,4.20%,ROBO1;LPAR1;AKAP13;COL3A1;F2RL3
prerank,protein ADP-ribosylation (GO:0006471),0.5638650558943098,1.566720619528593,0.024958402662229616,0.47067616431299003,1.0,11/28,12.48%,PARP14;ZC3HAV1;PARP9;PARP3;ARF4;PARP10;PARP12;PARP11;SIRT4;TIPARP;PARP16
prerank,aspartate family amino acid catabolic process (GO:0009068),0.602556924763045,1.5664783580977817,0.04119850187265917,0.46779985627414433,1.0,4/19,6.79%,DDO;HYKK;PHYKPL;ASPA
prerank,regulation of epithelial cell proliferation (GO:0050678),0.4519690376962209,1.565165559578317,0.004608294930875576,0.46876044961144164,1.0,18/85,12.11%,TCF7L2;TGFBR3;BMP6;MCC;LAMC1;FGF1;OSR1;NUPR1;TGFA;DUSP10;ANGPT1;CDC73;CDKN2B;YAP1;MTSS1;FGF18;NR4A1;EPPK1
prerank,epithelial to mesenchymal transition (GO:0001837),0.4986235698711304,1.563964783643895,0.026446280991735537,0.4694065392880305,1.0,11/47,8.47%,TGFBR3;WNT4;ROCK2;RBPJ;FGFR1;BMP2;LOXL3;BMP7;TGFBR1;GSK3B;WNT5A
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),-0.42121485072946074,-1.5637119004213027,0.011560693641618497,0.26816764736145693,1.0,35/69,31.41%,COX6C;COX4I1;SDHC;NDUFV1;NDUFC1;NDUFA8;NDUFS7;NDUFB4;UQCRH;UQCR11;NDUFA1;COX8A;NDUFA4;NDUFB2;NDUFA12;COX6A1;NDUFA11;COX7B;NDUFB7;SDHD;NDUFB10;UQCC3;NDUFC2;NDUFA13;NDUFA9;UQCR10;UQCRQ;NDUFA10;COX4I2;SDHAF2;NDUFS6;NDUFV3;COX5B;NDUFS1;NDUFA2
prerank,BMP signaling pathway (GO:0030509),0.4752044635667201,1.5622361542608676,0.01957585644371941,0.4719313865783215,1.0,17/62,12.69%,TGFBR3;BMP6;SMAD3;RGMA;RGMB;BMPR1A;HIVEP1;BMP2;BMP7;BMP8B;USP9X;SLC33A1;SMAD6;ZFYVE16;SMAD4;HFE;NOG
prerank,xenobiotic transport (GO:0042908),-0.5897412265385317,-1.5621078088099183,0.02242152466367713,0.26955206915553204,1.0,5/16,5.48%,ABCG2;SLC47A1;SLC7A5;ABCA3;SLC15A2
prerank,pteridine-containing compound metabolic process (GO:0042558),-0.6152692559407338,-1.5617355291572048,0.03571428571428571,0.2685069756831003,1.0,5/13,12.81%,NOS3;CALM1;AKT1;GCH1;HSP90AA1
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),-0.5817255362925795,-1.5604835143369309,0.020179372197309416,0.2692717153803029,1.0,4/17,3.91%,KCNAB1;AKAP6;NOS1AP;ANK3
prerank,central nervous system neuron development (GO:0021954),-0.5956246240338265,-1.5599729772375492,0.028077753779697623,0.2684944247241752,1.0,7/15,15.98%,NTRK2;LHX6;HSP90AB1;RAPGEF2;HSP90AA1;MAPT;MAP2
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.4601413901150783,1.5598071910246756,0.01791044776119403,0.4770319148824863,1.0,17/74,11.57%,TCF7L2;EYA2;EYA1;PHIP;SH3RF1;TERT;CFLAR;BCL2;TGFBR1;MCL1;SERPINE1;SIAH2;GSK3B;ZMYND11;BCL2L1;EYA4;MAP2K5
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.44788370045620357,1.5594399168005204,0.016320474777448073,0.4746897912271107,1.0,16/86,8.20%,SULF1;BMP6;FOXD1;RBPJ;ZEB2;BMPR1A;CDH5;TWSG1;TGFB1I1;BMP2;BMP7;TGFBR1;CREBBP;BMP8B;CDKN2B;RNF111
prerank,regulation of synapse assembly (GO:0051963),-0.45109183436223554,-1.5579198800908483,0.0103359173126615,0.27096491885300894,1.0,20/46,18.07%,NRXN1;NLGN1;PTPRD;GRID2;ROBO2;MEF2C;SYNDIG1;IL1RAPL1;SNCA;IL1RAP;EPHB1;NLGN3;LRRC4B;IL1RAPL2;CLSTN1;SLITRK2;SRPX2;EPHB3;SLITRK1;LRFN5
prerank,neuromuscular process controlling balance (GO:0050885),-0.6253131048979366,-1.5577290997138826,0.02286902286902287,0.2695242280297155,1.0,2/12,0.74%,NRXN1;PCDH15
prerank,positive regulation of Ras protein signal transduction (GO:0046579),0.4771922480377621,1.5573944125789194,0.012441679626749611,0.47844114949162553,1.0,8/61,4.20%,ROBO1;LPAR1;RASGRF1;AKAP13;COL3A1;AUTS2;NOTCH2;F2RL3
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.4236647948234371,1.5573789508256766,0.004155124653739612,0.47486829413371456,1.0,22/129,10.32%,RNF220;WLS;LRRK1;LGR4;ZEB2;TBL1XR1;SMURF2;WNT3A;PPM1A;KANK1;PTK7;DACT1;LYPD6;PLEKHA4;PSMB10;PSMA3;USP8;PSME4;USP47;LRRK2;PSMA5;PPM1B
prerank,aerobic electron transport chain (GO:0019646),-0.4219274362110823,-1.5569217669932498,0.005780346820809248,0.26930911526595624,1.0,35/68,31.41%,COX6C;COX4I1;SDHC;NDUFV1;NDUFC1;NDUFA8;NDUFS7;NDUFB4;UQCRH;UQCR11;NDUFA1;COX8A;NDUFA4;NDUFB2;NDUFA12;COX6A1;NDUFA11;COX7B;NDUFB7;SDHD;NDUFB10;UQCC3;NDUFC2;NDUFA13;NDUFA9;UQCR10;UQCRQ;NDUFA10;COX4I2;SDHAF2;NDUFS6;NDUFV3;COX5B;NDUFS1;NDUFA2
prerank,axonogenesis (GO:0007409),-0.33994892357633966,-1.5563955352968049,0.0,0.26854522358323973,1.0,71/237,12.81%,SLIT2;NRXN1;CTNNA2;UNC5C;BSG;ROBO2;SHANK3;NCAM1;SEMA6D;EFNA5;RPS6KA5;ENAH;DAB1;TNR;NRP2;CNTN4;EPHA5;DOK6;PIK3R1;NOTCH1;DCC;NTN4;ACTB;CNTN6;NOTCH3;SH3KBP1;GAB1;KLF7;SEMA4D;SEMA3C;ANK3;SEMA6A;LAMA1;LAMA3;PRKCQ;UNC5D;EPHB1;S100B;ROBO4;NRCAM;SEMA7A;MAPK3;HSP90AB1;NPTN;SPTB;SEMA3E;MAP1B;SHTN1;EPHA6;NLGN3;TUBB3;CNTN2;L1CAM;CXCL12;VASP;SEMA3G;SEMA6B;EMB;RET;NEFH;PAX2;PTPRO;ULK1;GFRA2;PAK3;LRTM1;KIF5C;VLDLR;PIK3CD;SEMA3A;HSP90AA1
prerank,positive regulation of BMP signaling pathway (GO:0030513),0.5596907807352236,1.5536882148188362,0.03986135181975736,0.4849243502872446,1.0,5/25,2.80%,SULF1;FOXD1;RBPJ;BMPR1A;CDH5
prerank,regulation of ossification (GO:0030278),0.5218733177570348,1.5532747244324914,0.026936026936026935,0.48260779262228687,1.0,11/36,9.65%,PTN;RBPJ;ENPP1;DDR2;ECM1;BMP2K;BMP2;CHSY1;LRP4;WNT5A;SMAD6
prerank,positive regulation of cell differentiation (GO:0045597),0.39581027609540065,1.5532462133429452,0.001256281407035176,0.4791484628102256,1.0,38/237,8.67%,TCF4;RANBP3L;MEDAG;IGFBP3;PDPN;SOX5;BMP6;WNT4;PTN;RIN2;SMAD3;CCN2;FGFR1;DDR2;FOXC1;IL6ST;GJA1;TACSTD2;BMPR1A;NBL1;GLIPR2;NELL1;TGFB1I1;KCTD11;BMP2;IL6;BMP7;TMEM64;TGFBR1;CPNE1;BCL9L;CREBL2;TGFBR2;CTNNA1;IL18;MEF2A;YAP1;ZEB1
prerank,potassium ion homeostasis (GO:0055075),-0.5167094355302835,-1.5514094912104932,0.031746031746031744,0.27780423110507113,1.0,8/23,10.96%,SLC12A7;SLC12A2;KCNMA1;ATP1B1;KCNJ2;ATP1A1;SLC12A5;SLC12A6
prerank,ventricular cardiac muscle tissue development (GO:0003229),0.5730255420339565,1.5513594514500788,0.047619047619047616,0.48246389123913874,1.0,3/23,4.92%,TNNC1;TGFBR3;TPM1
prerank,negative regulation of cell differentiation (GO:0045596),0.39981357673446727,1.5512675282964412,0.00816326530612245,0.4792340129215876,1.0,44/181,14.83%,RANBP3L;EFEMP1;RORA;SMAD3;COL5A2;ENPP1;OSR1;ADAMTS12;WNT10B;LDLRAD4;MYB;ADGRV1;EID2B;PTHLH;SUZ12;IL6;BMP7;TMEM64;TGFBR1;DTX1;COL5A1;NR1H3;USF3;PPARA;CRP;CDC73;SKI;WNT5A;YAP1;IGF2;NOCT;SMAD6;SUFU;LRP3;DISP3;IQCB1;NOG;EFNA1;PAF1;ADAMTS7;LEO1;RUNX1T1;ABCA1;NPHP3
prerank,fluid transport (GO:0042044),0.6566564300057425,1.551025854458207,0.04271844660194175,0.4765454547425065,1.0,2/12,5.94%,PDPN;SLC4A11
prerank,neuron development (GO:0048666),-0.36792233580914446,-1.5505905150108865,0.0037174721189591076,0.27774118911161494,1.0,36/141,11.75%,FRY;CNTNAP2;NLGN1;MEF2C;TENM2;TGFB2;GPM6A;TENM3;CNTN4;EPHA5;MYT1L;PLP1;GPM6B;PBX3;STX3;NTRK2;PTPRM;ATP8A2;VSX1;SH3GL2;RP1;TENM4;HMGB1;MYOC;STMN2;RAPGEF2;UNK;THOC2;RAB35;L1CAM;LYN;MANF;RUNX1;MICALL2;ZFYVE27;ULK1
prerank,negative regulation of hemostasis (GO:1900047),0.6726652873553325,1.5504698952306581,0.03824091778202677,0.475263234747131,1.0,4/12,8.66%,TFPI;VTN;SERPINE1;SERPINE2
prerank,regulation of hormone secretion (GO:0046883),0.6487740200614868,1.550355474467941,0.05040322580645161,0.4721261473184809,1.0,4/15,3.55%,OSM;SNX6;IL11;ANXA1
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),-0.6415793590278193,-1.5500949306984377,0.03870967741935484,0.2768909346530273,1.0,4/11,10.30%,CACNB2;NOS1AP;CAMK2D;NOS1
prerank,regulation of phospholipase activity (GO:0010517),0.6922889902092064,1.5488824554159446,0.05202312138728324,0.4742053237449866,1.0,2/10,1.20%,PDPK1;FGFR1
prerank,ceramide biosynthetic process (GO:0046513),-0.45603856694675404,-1.5484312244059941,0.01818181818181818,0.2786990962346972,1.0,9/40,11.79%,ST6GALNAC3;SGMS1;ST8SIA4;CERS4;ST8SIA6;DEGS2;ST6GALNAC4;ST6GALNAC5;SGMS2
prerank,regulation of macrophage migration (GO:1905521),-0.6501577417814663,-1.5476838724742428,0.036511156186612576,0.27842717257665267,1.0,3/10,6.40%,MTUS1;PTK2B;EMILIN1
prerank,calcium-ion regulated exocytosis (GO:0017156),-0.5014867695870903,-1.5475766788496745,0.026004728132387706,0.27687461959180976,1.0,13/27,28.15%,SYT1;RIMS1;RIMS2;SYT4;SYT7;SYT9;SYT2;SYT6;SYT10;SYT5;DOC2B;SYT17;VAMP2
prerank,nucleoside phosphate catabolic process (GO:1901292),0.6591555038829469,1.5465833427601465,0.041501976284584984,0.47934466168190276,1.0,4/13,5.14%,ENPP3;ENPP1;DCTPP1;ENTPD7
prerank,extracellular matrix organization (GO:0030198),0.38675927243778957,1.5455739391866352,0.0,0.47946948777020315,1.0,46/276,6.80%,FLRT2;TNC;COL4A3;FBN1;COL23A1;COL4A6;LAMC1;COL4A4;COL5A2;VTN;COL3A1;FN1;ADAMTSL5;LAMA2;LAMA4;COL4A5;DDR2;NID1;ADAMTS12;ECM2;ADAMTS10;HSPG2;NID2;ITGB8;DAG1;ICAM4;ITGA5;ADAMTS1;ADAMTSL4;ITGA9;DCN;ADAMTS6;ITGA10;LOXL3;LAMC3;BMP1;LOXL1;TGFBR1;COL20A1;THSD4;SERPINE1;COL5A1;MMP14;VCAM1;CD47;COL18A1
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),0.6460925478848879,1.5443824086870457,0.04114490161001789,0.4804930010149169,1.0,5/14,7.85%,CD55;PTPN22;TGFBR2;IL18;LGALS9
prerank,heart development (GO:0007507),0.41048270974895684,1.5436687132247804,0.004213483146067416,0.4796332940328361,1.0,28/150,8.79%,FLRT2;TGFBR3;FBN1;AKAP13;CXADR;COL3A1;FN1;OSR1;FOXC1;HEG1;CSRP3;DLC1;FOXC2;RBP4;ADAP2;MTHFD1;BMP2;BCOR;BMP7;TGFBR1;NCOA6;SALL1;PLCE1;POPDC2;TGFBR2;MEF2A;PRICKLE4;CACNA1C
prerank,"synaptic transmission, GABAergic (GO:0051932)",-0.6507273057912301,-1.5426449145222212,0.031578947368421054,0.28568627319790485,1.0,7/10,20.35%,GABRA2;GABRA3;GABRA4;GABRG3;GABRB2;GABRA5;GABRA1
prerank,regulation of secretion by cell (GO:1903530),-0.4294376651443908,-1.542580668776427,0.014164305949008499,0.28403659333034004,1.0,15/54,14.48%,SYT1;RIMS1;RIMS2;MEF2C;NSF;MCTP1;STXBP5L;RAB3C;CPLX1;SCG5;CAMK2A;SYN1;CPLANE2;RAB12;RHBDF2
prerank,regulation of nitric-oxide synthase activity (GO:0050999),-0.47636354294062794,-1.5414375884198226,0.01182033096926714,0.28467052321694464,1.0,13/36,12.95%,NOS3;NOSTRIN;NOS1AP;CALM1;SCARB1;AKT1;CYGB;GCH1;NUS1;S100A1;EGFR;HSP90AA1;CAV1
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.5455919338586129,-1.5413621633199366,0.024608501118568233,0.28310498642801746,1.0,4/21,4.41%,PRKCH;SLC39A10;PRKCB;RPS3
prerank,regulation of lamellipodium morphogenesis (GO:2000392),0.6622674401603177,1.541133929755331,0.07818930041152264,0.4853692218390742,1.0,4/11,13.03%,PDPN;KANK1;ENPP2;ARPIN
prerank,wound healing (GO:0042060),0.4687798033119092,1.540652769057461,0.027156549520766772,0.48366568231404433,1.0,16/62,12.69%,SMAD3;COL3A1;PDGFRA;FGF1;MYOF;PPL;CFLAR;MIA3;TPM1;TGFBR1;CLDN1;WNT5A;DCBLD2;FUT10;EPPK1;NOG
prerank,negative regulation of viral process (GO:0048525),0.4710265608094767,1.5389849526608939,0.018808777429467086,0.4862667827640579,1.0,18/57,15.00%,RSAD2;ZC3HAV1;EIF2AK2;TRIM5;BST2;PARP10;OASL;STAT1;IFITM1;OAS2;ILF3;TRIM21;IFIT1;TRIM26;SRPK1;CHMP3;IFIH1;PML
prerank,negative regulation of cell projection organization (GO:0031345),0.4851514936296321,1.5382925443164082,0.02145214521452145,0.4855157200062861,1.0,8/48,8.24%,EFNB2;DPYSL3;LPAR1;WNT3A;KANK1;CBFA2T2;PTPN9;EPHA4
prerank,protein oxidation (GO:0018158),0.6782042586494834,1.5369407110874986,0.0562015503875969,0.48728339285432015,1.0,4/11,11.77%,APOA2;LOXL3;LOXL1;LOXL4
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.4331639005023039,1.5369346797796137,0.01308139534883721,0.48406280675428903,1.0,27/112,12.26%,SOX5;TGFBR3;WNT4;SMAD3;ZMIZ1;COL3A1;CLEC3B;BMPR1A;CDH5;WWOX;TWSG1;LRRC32;PARD6A;PRKCZ;TGFBR1;APPL2;TGFBR2;USP9X;PDCD5;SKI;WNT5A;SMAD6;APPL1;PTK2;TGFBRAP1;SMAD4;MAP3K7
prerank,tetrahydrobiopterin metabolic process (GO:0046146),-0.645146341539844,-1.5367695664603618,0.04148471615720524,0.2908874285466015,1.0,5/11,12.81%,NOS3;CALM1;AKT1;GCH1;HSP90AA1
prerank,positive regulation of cellular senescence (GO:2000774),-0.6404732716390308,-1.5366304587797472,0.0457516339869281,0.2894924267068143,1.0,4/10,10.91%,YPEL3;B2M;ABI3;EEF1E1
prerank,maintenance of gastrointestinal epithelium (GO:0030277),0.6607575770425543,1.5360386402570545,0.045283018867924525,0.48409789130400976,1.0,4/12,13.44%,MUC2;RBP4;TLR4;STRAP
prerank,positive regulation of telomerase activity (GO:0051973),-0.48688960467476294,-1.535537420304351,0.02689486552567237,0.2901281105165703,1.0,11/33,16.15%,PRKCQ;NEK7;PARM1;CTNNB1;MAPK3;HSP90AB1;NVL;KLF4;HSP90AA1;PNKP;PKIB
prerank,regulation of glucose metabolic process (GO:0010906),0.5273434698697781,1.5348618577113549,0.039603960396039604,0.48475058585774483,1.0,3/34,3.27%,PDK1;RORA;GCGR
prerank,regulation of wound healing (GO:0061041),0.5076290167702125,1.5339502936900622,0.03436988543371522,0.48490735798402157,1.0,14/42,12.53%,VTN;KANK1;CASK;ANXA1;GP1BA;SERPINE1;TNFRSF12A;CLDN1;INSL3;PLAU;PTK2;EPPK1;CD109;CADM4
prerank,positive regulation of acute inflammatory response (GO:0002675),0.629200563917318,1.5326165131905567,0.047524752475247525,0.48646469343877463,1.0,4/14,5.96%,IL6ST;OSM;IL6;CREB3L3
prerank,positive regulation of protein secretion (GO:0050714),0.45534404862155486,1.532420894387888,0.023006134969325152,0.4840150057706409,1.0,13/69,11.28%,TCF7L2;WLS;BMP6;MCU;RBP4;APBB1;TLR4;UNC13B;PPID;DNM1L;HCAR2;TLR2;NLGN2
prerank,epithelial cell migration (GO:0010631),0.5192771665115291,1.5321402763644485,0.030821917808219176,0.4818821613879785,1.0,7/37,3.84%,DPP4;FSTL1;ZEB2;KANK2;KANK1;NRP1;KIT
prerank,regulation of steroid metabolic process (GO:0019218),0.5556788012998376,1.5313096320570843,0.03590664272890485,0.48197907677355356,1.0,3/23,6.21%,RORA;PANK2;FMO5
prerank,divalent inorganic cation homeostasis (GO:0072507),-0.5120163732349593,-1.5308449576848862,0.024154589371980676,0.298868723034921,1.0,8/25,12.95%,TMTC2;ANK3;SNCA;SLC8A1;CNNM4;SELENON;GRIN1;CAV1
prerank,regulation of neuronal synaptic plasticity (GO:0048168),-0.49598806847322896,-1.5308435656026915,0.03731343283582089,0.2970914865949557,1.0,9/29,12.90%,SLC4A10;GRIK2;NETO1;MCTP1;RAB3GAP1;CAMK2A;SHISA9;ZDHHC2;SHISA6
prerank,dicarboxylic acid transport (GO:0006835),0.5562001265935193,1.5305799628947547,0.03690685413005272,0.481363531318074,1.0,5/28,2.57%,PDPN;SLC1A3;SLC13A3;GJA1;SLC19A1
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),-0.4791887089051939,-1.5304660673009243,0.038461538461538464,0.2963335579841451,1.0,13/29,22.51%,ELOVL5;ACSL3;ELOVL7;TECR;ACSL5;ACACA;HSD17B12;ACLY;SCD;ACSBG1;HSD17B8;FASN;GCDH
prerank,synaptic vesicle exocytosis (GO:0016079),-0.45846005474394774,-1.528856299272886,0.015544041450777202,0.29805908407443754,1.0,10/40,9.75%,SYT1;RIMS1;RIMS2;STX3;PCLO;SNAP25;SNCA;CPLX1;SYT7;SNPH
prerank,porphyrin-containing compound catabolic process (GO:0006787),-0.5966282870304548,-1.528177974387891,0.029535864978902954,0.29611661109690834,1.0,3/14,10.42%,ABCG2;BLVRA;HMOX2
prerank,heme catabolic process (GO:0042167),-0.5966282870304548,-1.528177974387891,0.029535864978902954,0.29611661109690834,1.0,3/14,10.42%,ABCG2;BLVRA;HMOX2
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.3948416888582651,1.5275387456245342,0.0,0.4889752362448155,1.0,39/208,12.33%,PDPK1;WLS;RORA;LPAR1;AKAP13;TLE1;ZFAND6;ECM1;GJA1;PPM1A;TRAF5;LITAF;CFLAR;IKBKE;ROR1;MTDH;GOLT1B;OPTN;CPNE1;MIER1;PELI2;TRIM5;BIRC3;BST2;JMJD8;STAT1;LGALS9;VAPA;RIPK2;ZMYND11;WNT5A;ANKRD17;BRD4;NLRX1;PPM1B;UBE2V1;RHOC;MAP3K7;TRIM21
prerank,positive regulation of ATP metabolic process (GO:1903580),0.527177518447685,1.5265773098121178,0.046632124352331605,0.48949859719223654,1.0,6/32,6.37%,ZBTB20;PID1;PRKAA2;NUPR1;ARNT;PPARA
prerank,negative regulation of epithelial cell proliferation (GO:0050680),0.4557572652655429,1.5262329708193576,0.01800327332242226,0.48760233892055554,1.0,12/66,7.93%,SULF1;ROBO1;TGFBR3;MCC;NR2F2;NUPR1;CASK;DUSP10;KLF9;STAT1;CDC73;CDKN2B
prerank,chordate embryonic development (GO:0043009),0.47367880953158853,1.5241855890083977,0.024013722126929673,0.49177606884160097,1.0,11/55,8.99%,ALDH1A2;SULF1;FGFR1;ARNT2;RBP4;DACT1;BMP2;BMP7;TGFBR1;WNT5A;IGF2
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),0.6150597947218256,1.52324273155176,0.051094890510948905,0.4919042212285598,1.0,4/16,8.23%,SELP;NFAT5;IL6;FUT4
prerank,NLS-bearing protein import into nucleus (GO:0006607),0.6396120086961649,1.5230824339479556,0.05849056603773585,0.48951382700876556,1.0,5/13,7.24%,CBLB;RANBP2;KPNA6;KPNA7;KPNA4
prerank,regulation of transforming growth factor beta production (GO:0071634),0.6049671161927397,1.5230441135755575,0.04061895551257253,0.4867235152631699,1.0,7/18,11.51%,SMAD3;FN1;LTBP1;ITGB8;LRRC32;LGALS9;SMAD4
prerank,skeletal system development (GO:0001501),0.40335831264273053,1.5226551013259026,0.0027472527472527475,0.4851925322056728,1.0,39/148,16.89%,SULF1;SOX5;BMP6;FBN1;AKAP13;FGFR1;CREB3L2;GJA1;ITGB8;WWOX;RBP4;PTHLH;BMP2;BMP1;BMP7;TGFBR1;MMP14;BMP8B;WNT5A;IGF2;COL13A1;PRELP;RFLNA;SUFU;IHH;ANKRD11;RPS6KA3;NOG;NPR3;GDF11;RAB33B;EIF2AK3;SOX4;SPEF2;EVC;INHA;SH3PXD2B;COL1A2;COL9A2
prerank,regulation of viral genome replication (GO:0045069),0.47292654265537587,1.5222924805532658,0.021666666666666667,0.4833315995120894,1.0,19/56,15.71%,RSAD2;ZC3HAV1;EIF2AK2;PPARA;BST2;PARP10;OASL;STAU1;IFITM1;PPID;OAS2;TMEM39A;ADAR;ILF3;IFIT1;SRPK1;TARBP2;IFIH1;PKN2
prerank,regulation of BMP signaling pathway (GO:0030510),0.44719423566943367,1.521594285832533,0.016666666666666666,0.48284830839571957,1.0,11/73,3.96%,SULF1;FOXD1;RBPJ;FSTL1;SMURF2;BMPR1A;FSTL3;NBL1;CDH5;TWSG1;BMP2
prerank,regulation of regulated secretory pathway (GO:1903305),-0.4656647032617702,-1.5201496229355094,0.0171990171990172,0.3127081799197784,1.0,18/34,27.64%,SYT1;RIMS1;RIMS2;RAB27A;SYT4;SYT7;SYN1;SYT9;SYT2;SNAPIN;RIMS4;RAB15;SYT6;VPS18;SYT10;SYT5;SYT17;UNC13D
prerank,histone ubiquitination (GO:0016574),0.570511254223701,1.5179538188900388,0.04,0.4924292920503809,1.0,8/21,14.19%,UBE2U;DTX3L;RNF20;CDC73;WAC;HUWE1;PAF1;LEO1
prerank,positive regulation of cell aging (GO:0090343),-0.6212937860481572,-1.517849306586525,0.05054945054945055,0.3164352128210023,1.0,4/11,10.91%,YPEL3;B2M;ABI3;EEF1E1
prerank,positive regulation of transporter activity (GO:0032411),0.6482131033521507,1.516028591158032,0.07116104868913857,0.49607167140430386,1.0,3/13,6.02%,KMT2A;STK39;NR1H3
prerank,negative regulation of reproductive process (GO:2000242),0.5956070182393984,1.5157538479785087,0.07088122605363985,0.4942077693317935,1.0,3/17,7.74%,SULF1;GJA1;NPPC
prerank,regulation of osteoblast differentiation (GO:0045667),0.4282112050623075,1.515012451501628,0.017857142857142856,0.4941010606871999,1.0,19/82,11.16%,RANBP3L;BMP6;WNT4;DDR2;IL6ST;BMPR1A;NELL1;BMP2;IL6;BMP7;TMEM64;SKI;YAP1;NOCT;IFITM1;SMAD6;SUFU;LRP3;PTK2
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.6705226804285972,1.5147231332185924,0.07706766917293233,0.49229231942998053,1.0,4/10,3.41%,ATP1A2;STK39;OSR1;NEDD4
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.4835006279803401,1.5142692131582571,0.028938906752411574,0.49113375103117307,1.0,9/49,7.50%,PARP14;GHR;IL31RA;IL6ST;OSM;PARP9;KIT;IL6;IL18
prerank,negative regulation of growth (GO:0045926),-0.363150285847686,-1.5128920240890082,0.0,0.3259731814352732,1.0,29/121,10.66%,APBB2;SLIT2;PTPRJ;SMARCA2;TGFB2;BMPR2;NOTCH1;MT1H;MT1M;MT1A;MT1B;MT1X;MT1F;MT1E;MT1G;ADAM15;PPP2R1A;RERG;ACVRL1;SOX17;CCN3;CAPRIN2;NDRG3;STK11;ING1;IP6K2;CCAR2;RACK1;NPR1
prerank,dicarboxylic acid catabolic process (GO:0043649),0.6506416474486032,1.5122889565034476,0.05973025048169557,0.49469109304275993,1.0,3/13,8.36%,DDO;ASPA;GLUL
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.5099627183312273,1.5115520969778289,0.038394415357766144,0.49447390799067986,1.0,15/37,21.58%,TNPO1;DYNLL1;IFT88;IFT57;DYNC2I1;IFT81;DYNC2LI1;WDR19;IFT20;TTC21B;IFT52;KIF3C;CEP131;SSX2IP;TRIP11
prerank,Wnt signaling pathway (GO:0016055),0.43178935934243495,1.5109033519634902,0.01680672268907563,0.4938210096247466,1.0,19/92,12.89%,TCF7L2;WLS;WNT4;WNT6;PLPP3;WNT10B;WNT3A;WNT2B;FZD2;WNT5B;BCL9L;TCF7L1;GSK3B;WNT5A;LRRK2;TCF7;DVL3;BTRC;PORCN
prerank,positive regulation of response to external stimulus (GO:0032103),0.4090476666451442,1.5108673919066353,0.00980392156862745,0.49120383742287804,1.0,24/128,11.69%,BMP6;PTN;SASH1;IL16;DDX60;FPR2;OSM;IFI35;TLR4;ZBP1;SERPINE1;OPTN;PDGFRB;GBP5;CD47;OASL;IL18;LY96;SETD4;WNT5A;ANKRD17;POLR3F;TLR2;NFKBIZ
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),-0.5260200351336546,-1.5102970601119647,0.040268456375838924,0.33015557121865036,1.0,9/21,7.24%,PDE4D;DMD;AKAP6;RYR2;CALM1;CALM2;SLC8A1;CALM3;CAMK2D
prerank,positive regulation of stress fiber assembly (GO:0051496),0.4923706277589315,1.5100270746695201,0.03486529318541997,0.4911667116569937,1.0,11/44,7.17%,LPAR1;ROCK2;CCN2;PPM1E;NRP1;S100A10;TPM1;TGFBR1;EPHA1;CD47;ARHGEF10L
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.5050198119328175,1.509594037084044,0.03289473684210526,0.489907341826838,1.0,5/39,5.28%,TCF7L2;MCU;GHRH;RBP4;UCN
prerank,bone development (GO:0060348),0.506425666188902,1.5092078253089607,0.031096563011456628,0.4885332540717882,1.0,6/39,7.92%,RANBP3L;SULF1;AKAP13;GJA1;SBDS;SKI
prerank,regulation of platelet activation (GO:0010543),0.5708479788959034,1.5076684795360298,0.04452054794520548,0.4910258051718703,1.0,5/21,4.67%,TEC;SELP;PDGFRA;PLA2G4A;TLR4
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),-0.6161057996051602,-1.5071811093222982,0.05220883534136546,0.3354255356897684,1.0,6/11,19.16%,PINK1;RACK1;ATF4;PARK7;NR4A3;NONO
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),0.6696128082615177,1.506709783710142,0.06420233463035019,0.4916474463204864,1.0,6/10,18.50%,CPEB1;CDC73;PAF1;LEO1;CPEB3;DHX36
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.5165782973989936,-1.5061754272160288,0.04044943820224719,0.33610365279523685,1.0,8/23,13.59%,ELOVL5;ACSL3;FAR2;ELOVL7;TECR;ACSL5;HSD17B12;ACSBG1
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.626120190010564,1.5055685483687067,0.05182341650671785,0.49308443790501766,1.0,3/13,4.74%,CBLB;SNX6;ERRFI1
prerank,protein modification by small protein conjugation (GO:0032446),0.36675245348204943,1.5044919229520637,0.00117096018735363,0.49412860051566676,1.0,81/361,15.01%,RNF220;PDZRN3;EYA1;RNF152;RNF213;SPSB1;SMURF2;TRIM10;HIF3A;FBXO11;FBXL17;NEDD4;UBA5;DTX4;EPAS1;MYCBP2;TRIM17;KLHL21;RANBP2;SPSB4;DTX1;TPR;CUL4A;TRIM5;DTX3L;FBXO9;MGRN1;ANAPC11;USP9X;RNF20;CDC73;FBXL3;WAC;FBH1;TRIM24;KLHL18;NUB1;RNF111;PIAS1;AMFR;UBE2Z;PJA2;UBE2C;SUMO1;FBXL7;FBXO4;WWP2;FBXO24;KEAP1;HUWE1;RFWD3;RTF1;CUL3;KLHL13;NSMCE2;TRIM21;EGR2;BTRC;HECW2;UBE2E3;UBE2Q2;FBXW11;TRIM26;TRIM7;ASB5;ARRB1;PEX2;PAF1;CDC27;RNF39;RNF43;RNF103-CHMP3;RNF181;POM121;LEO1;BRAP;IFIH1;RCHY1;VHL;BIRC6;UBE2R2
prerank,regulation of fat cell differentiation (GO:0045598),0.4442299796845431,1.5044320846601391,0.017830609212481426,0.49169473457700025,1.0,19/74,14.97%,MEDAG;RORA;SMAD3;ENPP1;WNT10B;BMP2;IL6;TMEM64;CREBL2;FTO;WNT5A;YAP1;NOCT;AAMDC;LRP3;RARRES2;RUNX1T1;CARM1;PTPRQ
prerank,cellular biogenic amine catabolic process (GO:0042402),0.6721542445256301,1.5030526929120755,0.07606679035250463,0.49377748559074175,1.0,6/10,20.20%,HNMT;SARDH;COMT;DMGDH;LRTOMT;ALDH7A1
prerank,fibrinolysis (GO:0042730),0.6194496768055666,1.5028589648101984,0.05893909626719057,0.49169103835725514,1.0,5/13,12.98%,GP1BA;SERPINE1;PLAU;CPB2;PLAT
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),-0.49167707890197265,-1.5013536225449413,0.05215419501133787,0.34591576140920227,1.0,9/23,15.22%,MYO10;KIF1B;KIF1C;CCDC88A;TUBA1A;KIF5C;DYNC1I2;KIF5A;TUBA1B
prerank,synaptic vesicle cycle (GO:0099504),-0.47461139362650784,-1.5010803294146045,0.0502283105022831,0.34459046370265717,1.0,8/30,8.10%,NLGN1;RIMS1;SYNDIG1;PCLO;SNAP25;SNCA;CPLX1;SYT7
prerank,lipid translocation (GO:0034204),-0.5162782081344666,-1.5003978511331268,0.04212860310421286,0.3442632543675252,1.0,7/21,8.59%,ATP8A1;ATP10A;ATP11B;ATP8A2;ATP11A;ATP8B2;ATP8B1
prerank,positive regulation of neuron migration (GO:2001224),-0.6358433450835809,-1.4999433933423199,0.0486815415821501,0.3434363984357012,1.0,8/11,23.89%,SEMA6A;DAB2IP;ARHGEF2;RAPGEF2;SHTN1;SEMA3A;PLAA;NSMF
prerank,response to sterol (GO:0036314),0.6641667341498456,1.4999162639938435,0.05928853754940711,0.4990624796607563,1.0,3/11,6.94%,RORA;TGFBR1;TGFBR2
prerank,NADH dehydrogenase complex assembly (GO:0010257),-0.4081080169594427,-1.4986578892346738,0.0221606648199446,0.3425960343647349,1.0,30/56,35.26%,NDUFV1;NDUFC1;NDUFA8;NDUFS7;NDUFB4;NDUFA1;NDUFB2;NDUFA12;NDUFA11;NDUFAF4;NDUFB7;NDUFB10;NDUFC2;NDUFA13;NDUFA9;NDUFAF8;FOXRED1;NDUFAF7;BCS1L;NDUFAF3;NDUFA10;TIMM21;NDUFS6;NDUFV3;NDUFS1;NDUFA2;TMEM126B;NUBPL;NDUFA6;NDUFS2
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),-0.4081080169594427,-1.4986578892346738,0.0221606648199446,0.3425960343647349,1.0,30/56,35.26%,NDUFV1;NDUFC1;NDUFA8;NDUFS7;NDUFB4;NDUFA1;NDUFB2;NDUFA12;NDUFA11;NDUFAF4;NDUFB7;NDUFB10;NDUFC2;NDUFA13;NDUFA9;NDUFAF8;FOXRED1;NDUFAF7;BCS1L;NDUFAF3;NDUFA10;TIMM21;NDUFS6;NDUFV3;NDUFS1;NDUFA2;TMEM126B;NUBPL;NDUFA6;NDUFS2
prerank,histone H2B ubiquitination (GO:0033523),0.6834775769339153,1.4978008829162113,0.05576923076923077,0.5034677868653316,1.0,6/10,14.19%,DTX3L;RNF20;CDC73;WAC;PAF1;LEO1
prerank,regulation of steroid biosynthetic process (GO:0050810),0.6534245357091593,1.4976632814570028,0.06031128404669261,0.5013025393163781,1.0,2/11,3.96%,WNT4;BMP2
prerank,regulation of response to biotic stimulus (GO:0002831),0.5475391733000502,1.4970016105246151,0.042662116040955635,0.5010691030443999,1.0,8/28,9.78%,GATA6;CD55;PTPN22;APPL2;TRIM5;BIRC3;ERAP1;APPL1
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),0.5668681518791615,1.4967876000432965,0.061567164179104475,0.4993405592010591,1.0,6/22,8.35%,SH3D19;TIMP3;NRDC;PTPN3;SNX9;TIMP2
prerank,response to muscle stretch (GO:0035994),-0.5641967232756973,-1.4953888898534644,0.046218487394957986,0.3490656804481372,1.0,5/15,5.50%,CDH2;DMD;RYR2;CTNNB1;SLC8A1
prerank,protein K63-linked ubiquitination (GO:0070534),0.49008472104397877,1.495240097831635,0.02891156462585034,0.5022292332928047,1.0,12/41,13.63%,RNF152;TRIM56;TRAF5;NEDD4;TRIM5;WWP2;UBE2V1;HECTD1;TRIM21;UBE2E3;PRPF19;BFAR
prerank,negative regulation of multicellular organismal process (GO:0051241),0.3868528279070355,1.495152094911728,0.006839945280437756,0.49996030155777954,1.0,36/199,9.65%,ROBO1;ALDH1A1;MCC;LGR4;ROCK2;RBPJ;LAMA4;WNT10B;APOA2;GJA1;TACSTD2;ACOT11;FOXC2;LDLRAD4;TWSG1;DUSP10;BMP2;NRDC;IL17D;TLE3;TLR4;PARP3;CHSY1;WWC2;NR1H3;FOXP3;ATP2B4;LRP4;USF3;NOVA1;GSK3B;TIFAB;MAP2K6;ADM;DOCK7;SMAD6
prerank,cardiac conduction system development (GO:0003161),0.5514424212997763,1.4949724818879644,0.05733558178752108,0.4979766851841767,1.0,5/24,2.36%,NOTCH2;GJB6;GATA6;GJA1;BMPR1A
prerank,histone H3-K4 methylation (GO:0051568),0.5359388146191996,1.4949007994600103,0.053156146179401995,0.49572753098869987,1.0,6/26,12.91%,KMT2A;WDR5B;KMT2C;SETD4;SETD1B;TET2
prerank,Rac protein signal transduction (GO:0016601),-0.5347302448153148,-1.49436998489606,0.05084745762711865,0.3496966954249649,1.0,9/18,15.87%,ELMO1;EPS8;TIAM1;NCKAP1;RHOG;DBNL;RAC1;RHOH;HACD3
prerank,cardiac muscle cell contraction (GO:0086003),-0.5311281941476611,-1.4938599857453343,0.044543429844097995,0.349102156407964,1.0,7/19,9.86%,FGF12;KCNJ2;SCN1A;ATP1A1;CACNA1G;CAMK2D;CACNA1D
prerank,potassium ion transmembrane transport (GO:0071805),-0.3539628386671352,-1.492447972436083,0.0037593984962406013,0.35070045694323876,1.0,38/135,15.71%,SLC12A7;SLC12A2;KCNB2;KCND2;SLC9A2;KCNQ5;KCNAB1;KCNK5;ATP1B1;SLC24A2;ABCC9;KCNJ3;KCNH7;KCNJ2;KCNC2;KCNQ3;HCN1;ATP1A1;KCNK10;SLC9A8;HCN2;KCNH1;TMEM175;KCNH5;SLC12A5;KCND3;KCNJ6;SLC12A6;KCNB1;KCNJ8;KCNQ1;KCNJ15;KCNE4;KCNC1;SLC9A5;KCNA2;ATP1A3;KCNK9
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),-0.6334947449715522,-1.4912309580939536,0.05060728744939271,0.35195139722376856,1.0,5/10,16.74%,KCNAB1;ANK3;CAV1;KCNE4;KCNRG
prerank,positive regulation of phospholipase activity (GO:0010518),0.5526850213646873,1.490626672537437,0.06093189964157706,0.5072033543414269,1.0,6/22,6.11%,PDPK1;PDGFRA;FGFR1;KIT;ARF4;PDGFRB
prerank,regulation of dendrite morphogenesis (GO:0048814),-0.4620651939925145,-1.4902535998611344,0.03058823529411765,0.35251545131093787,1.0,10/32,9.49%,PTPRD;ADGRB3;TNIK;HECW1;SEMA4D;IL1RAPL1;CAPRIN2;YWHAH;RAPGEF2;NEDD4L
prerank,regulation of protein export from nucleus (GO:0046825),0.5564570020369815,1.4901788267201028,0.056896551724137934,0.5062661600391052,1.0,5/23,7.66%,TCF7L2;SP100;PTPN14;TPR;GSK3B
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.5196440191841059,1.4899342669970455,0.04529616724738676,0.5045380067811439,1.0,6/31,5.16%,TNNC1;TGFBR3;RBPJ;BMPR1A;TPM1;TGFBR1
prerank,positive regulation of protein polymerization (GO:0032273),-0.3937828152972952,-1.4895971344184153,0.008426966292134831,0.35226181694311903,1.0,30/65,24.84%,NAV3;PTK2B;NCKAP1;PAK1;RPS3;MET;LMOD1;CDC42EP3;PINK1;VASP;CDC42EP1;CDC42EP5;FES;TTBK1;HSP90AA1;RAC1;EVL;MAPT;PYCARD;TPPP;ARF6;CDK5RAP2;PFN2;CARMIL1;DCTN1;PRKCE;ARL2;MAPRE1;PFN1;OCLN
prerank,regulation of transmembrane transport (GO:0034762),-0.4738966720460566,-1.4895444819908619,0.03695150115473441,0.350590937278346,1.0,11/31,12.30%,SLC2A1;PRKCB;KCNJ3;KCNJ2;ACTB;SNCA;NEDD4L;ACE2;KCNJ6;KCNJ8;KCNJ15
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),0.6087992251851508,1.4890626038069987,0.06422018348623854,0.5051001026350114,1.0,3/15,6.52%,USP18;STAT2;PTPN2
prerank,dermatan sulfate biosynthetic process (GO:0030208),0.6297652377792995,1.4884686811247954,0.06639839034205232,0.5046049300904766,1.0,3/12,4.93%,UST;DCN;DSE
prerank,response to nitric oxide (GO:0071731),-0.5950286049890113,-1.4879994836073658,0.05,0.3525819433159262,1.0,5/13,15.18%,FOXO1;KCNC2;GUCY1B1;CDK2;CCL19
prerank,pyrimidine-containing compound catabolic process (GO:0072529),0.6105107079706726,1.4878931742752697,0.05197132616487455,0.504143285465485,1.0,5/16,12.91%,DPYSL3;DPYD;UPP1;NT5C;TET2
prerank,regulation of biomineral tissue development (GO:0070167),0.5455600213767958,1.4877548560085525,0.0542907180385289,0.5021263178910931,1.0,5/26,2.75%,ROCK2;ENPP1;DDR2;ECM1;BMP2K
prerank,female gamete generation (GO:0007292),0.5316294248627322,1.4870351609186048,0.04878048780487805,0.5019982637936465,1.0,4/29,7.42%,DIAPH2;PTN;NANOS2;USP9X
prerank,peptidyl-lysine dimethylation (GO:0018027),0.5866145173720045,1.4859360641195292,0.06097560975609756,0.503284333527516,1.0,4/18,11.07%,KMT2A;SETD4;SETD7;SETD1B
prerank,negative regulation of cell motility (GO:2000146),0.41016249259192394,1.4857508987486825,0.01447178002894356,0.5014083869382324,1.0,33/108,13.03%,SULF1;ROBO1;DPYSL3;PODN;AFDN;IGFBP5;DLC1;TACSTD2;KANK1;LDLRAD4;DAG1;FBLN1;DUSP10;MIA3;TPM1;VCL;SERPINE1;EPHA1;BST2;SPINT2;CLIC4;RNF20;NGFR;EPHA4;STK24;RAP2C;IFITM1;PTPRU;FOXO3;EPPK1;SLURP1;NOG;ARPIN
prerank,cellular response to organic substance (GO:0071310),0.41120095500364157,1.4856368202211017,0.013024602026049204,0.49940579082234676,1.0,35/116,16.19%,PTPN13;DPYSL3;SMAD3;PID1;GHR;IGFBP5;NFAT5;CLEC3B;BMPR1A;NCOA3;PTPN14;STAT5B;PTPN4;PLK5;TGFBR1;HAX1;PTPN2;PTPN9;TGFBR2;RAMP1;IL18;CCL2;LRRK2;TIPARP;PTPN6;MAP2K5;CRNN;PTPN18;ACVR1C;NCOA2;TBK1;ADRA2A;ACVR2B;CXCR4;URI1
prerank,positive regulation of ossification (GO:0045778),0.4934541316423848,1.4848300816606463,0.041025641025641026,0.4997155838328736,1.0,10/39,4.75%,BMP6;WNT4;PTN;OSR1;BMPR1A;NELL1;KL;ADGRV1;BMP2;BMP7
prerank,liver development (GO:0001889),0.5242095513334621,1.484766616920007,0.05555555555555555,0.49753207713217285,1.0,17/32,23.52%,TGFBR3;WNT4;PRKCSH;ANXA1;IL6;DNAAF1;ARID5B;NPHP3;PKD2;PCK2;CEBPB;CCDC39;CITED2;XBP1;CDK5RAP3;CEBPA;CEBPG
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.5080152406605428,-1.4846896449065083,0.052980132450331126,0.35943829234226965,1.0,14/22,21.71%,RPS15;RPS7;RPS20;UBB;SPRED2;ATM;EEF1E1;RPL23;EIF5A;SPRED3;RPL37;SPRED1;MSX1;ATR
prerank,regulation of cellular component movement (GO:0051270),0.4719587361381846,1.483336884278872,0.03328050713153724,0.499875744620312,1.0,8/49,5.16%,PDPN;TGFBR3;ROCK2;DIAPH1;SP100;ARHGAP18;MYCBP2;TGFBR1
prerank,myofibril assembly (GO:0030239),0.4707995575104431,1.482442471625276,0.031096563011456628,0.5006000479976744,1.0,8/42,6.96%,PDGFRA;TMOD3;CSRP3;CFLAR;TPM1;CSRP1;PDGFRB;ACTN2
prerank,positive regulation of response to wounding (GO:1903036),0.550688489049286,1.4822122574986496,0.07142857142857142,0.4989031306551486,1.0,7/24,11.16%,PTN;VTN;KANK1;ANXA1;CLDN1;INSL3;PTK2
prerank,nitric oxide mediated signal transduction (GO:0007263),-0.5529653584240312,-1.4817033241661162,0.03958333333333333,0.36509279662898086,1.0,6/16,10.30%,NOS3;KCNC2;NDNF;GUCY1B1;GUCY1A1;NOS1
prerank,negative regulation of signal transduction (GO:0009968),0.3711795644085771,1.481187295564303,0.005063291139240506,0.5000423830937946,1.0,60/249,15.20%,SULF1;IGFBP3;LEPROT;LGR4;KANK2;PID1;TLE1;ENPP1;ADAMTS12;IGFBP5;MPIG6B;KANK1;FSTL3;GLI3;WWOX;APCDD1;NEDD4;DACT1;DCN;BMP2;CRY1;NTN1;BCL2;PRKCZ;DLK1;MMP14;SIAH2;DKK3;PTPN2;CD47;MGRN1;GLIS2;LRRK2;APPL1;SUFU;WWP2;PLEK;NKD1;IRAK3;PALM;RPGRIP1L;VGLL4;CADM4;BTRC;PTPN1;NOG;PTPN18;ARRB1;PIP4K2B;BDNF;HIC1;RNF43;BRAP;TRIB1;LRPAP1;NCK1;NIBAN2;CSNK2A2;TNS2;GDF15
prerank,positive regulation of T cell migration (GO:2000406),0.5703163972718509,1.4809698352097322,0.04797047970479705,0.49840889360814455,1.0,7/20,15.87%,CXCL10;STK39;OXSR1;TNFRSF14;WNT5A;WNK1;APP
prerank,negative regulation of cholesterol transport (GO:0032375),0.6609132795964517,1.4804664136904284,0.07884615384615384,0.4976081104699742,1.0,1/10,2.03%,APOA2
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.5696687246989941,-1.4804162529689455,0.060324825986078884,0.36621971618935784,1.0,6/15,14.75%,SMAD7;RPL5;RPS7;RPL11;RPL23;PARK7
prerank,renal system development (GO:0072001),0.4636799373794805,1.4797213098067659,0.02926829268292683,0.4976062145151066,1.0,11/52,8.79%,SULF1;WNT4;FOXC1;RBP4;IFT88;ARL3;TGFBR1;SALL1;LRP4;STAT1;GREB1L
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),-0.41278085783343127,-1.4793997356024375,0.016216216216216217,0.367012982256252,1.0,22/54,22.62%,SMAD7;RPL5;IVNS1ABP;RPS3;RPL11;CTNNB1;AKT1;GNL3L;CAV1;COPS9;CAMLG;PARK7;PER2;N4BP1;SIRT7;MINAR1;VPS28;UFL1;PRMT3;PRR7;SH3RF2;DCUN1D3
prerank,alanine transport (GO:0032328),-0.624696449209986,-1.4785828140711608,0.04294478527607362,0.36714139360396564,1.0,3/10,11.13%,SLC6A6;SLC1A4;SLC36A1
prerank,embryonic eye morphogenesis (GO:0048048),0.6500325261968617,1.4783103866365714,0.07518796992481203,0.4997856005201755,1.0,2/11,0.45%,EFEMP1;FBN1
prerank,nuclear migration (GO:0007097),0.6243550913708956,1.4776409663132095,0.08118081180811808,0.49968519759652164,1.0,5/13,12.79%,SYNE3;SYNE2;CLMN;DOCK7;FBXW11
prerank,carnitine shuttle (GO:0006853),0.6298019696573864,1.477105079563232,0.09248554913294797,0.4991798660071746,1.0,2/11,1.61%,PRKAG2;PRKAA2
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),0.5146833723110454,1.4766853096503527,0.05172413793103448,0.4981433356328024,1.0,11/29,20.33%,USP18;STAT2;ZBP1;PTPN2;WNT5A;PTPN6;PTPN1;MUL1;IFNAR2;RNASEL;UBE2K
prerank,regulation of potassium ion transport (GO:0043266),-0.45447217030828485,-1.4762729822249627,0.03981264637002342,0.3712103238289256,1.0,9/31,10.30%,DPP10;KCNAB1;PTK2B;KCNIP4;ANK3;KCNIP1;DPP6;CACNA1D;NOS1
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.6121555170419197,1.476124927110442,0.05825242718446602,0.4977281411584135,1.0,6/14,17.64%,DDX60;OASL;ANKRD17;TLR2;PUM2;USP15
prerank,myoblast differentiation (GO:0045445),0.5992123099425998,1.4759756452966812,0.08333333333333333,0.49592395127808137,1.0,2/14,4.66%,TCF7L2;EPAS1
prerank,negative regulation of proteolysis (GO:0045861),0.49677110996879337,1.4759006237030996,0.048414023372287146,0.49394082029120495,1.0,13/34,12.98%,ECM1;TIMP3;CSTB;PTPN3;SNX12;EPHA4;TIMP2;SERPINE2;LRRK2;DNAJC1;TRIM21;EFNA1;PLAT
prerank,regulation of cell morphogenesis (GO:0022604),0.513774181528393,1.4757989167145014,0.07473309608540925,0.4920658264225404,1.0,13/30,16.76%,PDPN;SH3D19;PHIP;MYO9A;BCL9L;CAPZB;FMNL2;MOV10;ZMYM6;SPARC;PDZD8;ZMYM3;WTIP
prerank,cellular response to cytokine stimulus (GO:0071345),0.3569101740876283,1.4746816206362638,0.0011737089201877935,0.49332528805152,1.0,91/416,16.20%,PTPN13;DPYSL3;RORA;LEPR;TEC;GBP6;SMAD3;FN1;CXCL10;IL16;PID1;AXL;STK39;GHR;OXSR1;ADAMTS12;IL31RA;ZFAND6;GBP2;FOXC1;STAT2;NFAT5;IL6ST;SHMT1;GAB2;OSM;VIM;IL11;FER;IL34;ANXA1;PTPN14;KIT;DAPK1;RC3H1;STAT5B;PTPN4;IL6;GSDME;TLR4;BCL2;MCL1;HAX1;TPR;VCAM1;GBP5;NOS2;PTPN2;PTPN9;CD47;GBP4;IL18;OPRD1;STAT1;GSK3B;CCL2;LGALS9;WNT5A;ZEB1;IL13RA1;IFNLR1;PTPN6;BCL2L1;GBP7;TLR2;IRAK3;TCF7;STAT4;SH2B3;FOXO3;CSF1;IFIT1;CRNN;PTPN18;JAK1;IL22;ADAMTS7;POU2F1;RHOU;WNK1;SLC26A6;TBK1;GREM2;CCL25;IL23R;SOCS6;CXCR4;ICAM1;IFNAR2;MUC1;GBP3
prerank,nucleotide metabolic process (GO:0009117),0.545576434517519,1.4745748815429014,0.05114638447971781,0.49142240694921996,1.0,4/23,9.45%,ENPP3;CMPK2;FHIT;AK5
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.4723911819572134,1.4741853932210944,0.03814262023217247,0.490566379845234,1.0,7/46,7.59%,TCF7L2;IGFBP3;IGFBP5;IL6;PDGFRB;IL18;STAT1
prerank,positive regulation of cell-substrate junction organization (GO:0150117),-0.4949885422059447,-1.4741622415305944,0.03488372093023256,0.3744945312094576,1.0,11/24,18.62%,TEK;PTPRJ;KDR;PIK3R1;MYOC;IQSEC1;VEGFA;RAC1;COL16A1;PPM1F;ARF6
prerank,filopodium assembly (GO:0046847),-0.5615135405176784,-1.4741418055213282,0.05399568034557235,0.3726634633046247,1.0,4/16,6.47%,DNM3;FGD5;SPATA13;FGD6
prerank,positive regulation of developmental growth (GO:0048639),-0.420277602917304,-1.4731939256650706,0.04155124653739612,0.3733122407372095,1.0,18/49,15.43%,SYT1;RIMS1;RIMS2;PLCB1;INSR;SEMA4D;MACF1;SEMA7A;SHTN1;SYT4;L1CAM;NEDD4L;DBNL;ZFYVE27;NGF;AGRN;SYT2;MAPT
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),-0.5789652908530987,-1.4730831247033958,0.06493506493506493,0.37174087525900223,1.0,4/12,8.10%,SYT1;RIMS1;RIMS2;SYT7
prerank,regulation of interleukin-2 production (GO:0032663),-0.4372526597510143,-1.472970706615382,0.03787878787878788,0.37021048675053997,1.0,14/43,14.81%,PDE4D;PDE4B;NAV3;PLCG2;CD34;RPS3;HDAC7;HAVCR2;MALT1;CD80;CD86;RUNX1;PNP;PTPRC
prerank,response to calcium ion (GO:0051592),-0.3550715363119776,-1.4724121847083884,0.00625,0.36972007260800555,1.0,36/102,21.51%,NLGN1;SYT1;MEF2C;KCNMB2;PLCG2;TRPC3;KCNMA1;THBS1;ITPKB;RYR2;HOMER1;CALM1;CALM2;RYR3;KCNH1;CALM3;LGMN;CAMK2D;SYT4;SYT7;CPNE4;CAV1;SYT9;SYT2;CASQ2;ADD1;ADCY8;SLC25A13;HPCA;ECT2;CPNE7;SYT6;KCNMB4;TTN;SLC25A12;TRPM2
prerank,glycerolipid metabolic process (GO:0046486),-0.5987342689708965,-1.4709553577737622,0.06593406593406594,0.371819715264635,1.0,6/11,21.10%,DGKB;DGKZ;DGKG;GAL3ST1;PGP;PNPLA3
prerank,regulation of glycolytic process (GO:0006110),0.4376035290706033,1.470906370807552,0.02909647779479326,0.4986910392115284,1.0,10/68,7.19%,ZBTB20;PRKAG2;PRKAA2;NUPR1;ARNT;RANBP2;TPR;HDAC4;PPARA;JMJD8
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.5015614445568303,1.470837961967809,0.04817275747508306,0.4967516596953768,1.0,14/36,21.65%,PARP14;AXL;PARP9;ZBP1;CASP4;CPNE1;WNT5A;CSF1;TXK;CXCR4;IL7;UBE2K;HIF1A;RIPK1
prerank,melanocyte differentiation (GO:0030318),0.6378896867991716,1.470673027077369,0.056795131845841784,0.4951441579389416,1.0,3/11,3.84%,LRMDA;ENPP1;KIT
prerank,cellular response to lipid (GO:0071396),0.38756001894025566,1.4698563175457295,0.00516795865633075,0.49574709898107316,1.0,30/191,8.47%,RORA;TFPI;ATP1A2;ROCK2;CXCL10;WNT6;PID1;AXL;WNT10B;LDOC1;WNT3A;EPHA3;PTK7;VIM;NCOA3;IL6;ADCY5;WNT5B;TLR4;SERPINE1;ZNF35;NR1H3;ADCY1;MAP4K1;CDC73;CCL2;LY96;CD274;FAM210B;WNT5A
prerank,negative regulation of sprouting angiogenesis (GO:1903671),-0.6118438290582151,-1.4694223899812526,0.05241090146750524,0.3737984760721362,1.0,4/11,4.03%,THBS1;KLF2;EPN2;SEMA6A
prerank,cellular response to drug (GO:0035690),-0.4893338777407673,-1.4691204010405023,0.060948081264108354,0.37261275748610856,1.0,7/25,12.24%,MEF2C;PDE4B;TFRC;ACER2;GAS6;AIM2;KCNQ1
prerank,regulation of cardiac muscle cell contraction (GO:0086004),-0.48381516161582916,-1.4688852465836524,0.0332541567695962,0.37141355737734194,1.0,16/27,27.40%,PDE4D;PDE4B;CTNNA3;RYR2;CAMK2D;FGF13;SRI;CAV1;ATP2A2;DSG2;GJA5;STC1;PLN;PKP2;HCN4;RANGRF
prerank,negative regulation of ossification (GO:0030279),0.5346880207493289,1.4683379175301345,0.0627177700348432,0.49869462576980467,1.0,7/23,9.65%,RBPJ;ENPP1;ECM1;BCOR;CHSY1;LRP4;SMAD6
prerank,acylglycerol homeostasis (GO:0055090),0.5524809101067547,1.4674889364027406,0.0627177700348432,0.4991985059899873,1.0,3/20,7.50%,RORA;NR1H3;IL18
prerank,cell proliferation in forebrain (GO:0021846),0.64612402086156,1.466461143094786,0.07307692307692308,0.5004044994675664,1.0,3/10,9.50%,WNT3A;NUMB;DOCK7
prerank,positive regulation of protein export from nucleus (GO:0046827),0.5967037694498579,1.4653722301258505,0.06557377049180328,0.501748400607725,1.0,3/15,7.66%,TCF7L2;TPR;GSK3B
prerank,regulation of cytoskeleton organization (GO:0051493),0.40808658577208246,1.4649307591507728,0.010043041606886656,0.5010984554911655,1.0,24/108,11.97%,PHLDB2;ROCK2;DIAPH1;ARHGAP18;PRKAA2;DLC1;EPHA3;SMIM22;MAP6;CLASP1;PHLDB1;RHOBTB2;PDGFRB;RHOF;BST2;CELSR1;CLIC4;GSK3B;RHOQ;SYDE1;IQGAP2;TJP1;PTK2;RHOC
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",-0.4343912944325185,-1.464465394768789,0.03865979381443299,0.3806661696571542,1.0,20/38,31.41%,NDUFV1;NDUFC1;NDUFA8;NDUFS7;NDUFB4;NDUFA1;NDUFA4;NDUFB2;NDUFA12;NDUFA11;NDUFB7;NDUFB10;NDUFC2;NDUFA13;NDUFA9;NDUFA10;NDUFS6;NDUFV3;NDUFS1;NDUFA2
prerank,axon guidance (GO:0007411),-0.33121060403514724,-1.4629165094882552,0.0,0.38275735015423373,1.0,71/201,14.99%,SLIT2;NRXN1;UNC5C;BSG;ROBO2;SHANK3;PLXNA4;NCAM1;SEMA6D;EFNA5;RPS6KA5;ENAH;DAB1;TNR;NRP2;CNTN4;EPHA5;DOK6;PIK3R1;NOTCH1;DCC;NTN4;CNTN6;NOTCH3;SH3KBP1;GAB1;KLF7;TMEFF1;PTPRM;SEMA4D;SEMA3C;SEMA6A;LAMA1;LAMA3;PRKCQ;UNC5D;EPHB1;ROBO4;SEMA7A;MAPK3;NPTN;SPTB;SEMA3E;EPHA6;VEGFA;TUBB3;CNTN2;L1CAM;CXCL12;VASP;SEMA3G;RHOG;SEMA6B;EMB;RET;PTPRO;GFRA2;LRTM1;KIF5C;VLDLR;PIK3CD;SEMA3A;GAP43;NFIB;RAC1;EVL;RELN;RHOH;GFRA1;KIF5A;LGI1
prerank,negative regulation of lipid storage (GO:0010888),0.5713627527258821,1.4607259093777332,0.07719928186714542,0.5122954168155893,1.0,6/19,6.65%,OSBPL8;IL6;NR1H3;PPARA;PTPN2;CRP
prerank,polyamine metabolic process (GO:0006595),-0.5723930279916156,-1.4595169244042658,0.06352459016393443,0.3894057982393711,1.0,6/13,26.91%,HDAC6;OAZ2;SMS;SRM;SAT2;PAOX
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),-0.48701055105553626,-1.4586606396995851,0.04408352668213457,0.3895952722752642,1.0,6/26,10.31%,ACER3;NOS3;ACER2;AKT1;NOS1;GCH1
prerank,actin-myosin filament sliding (GO:0033275),0.4783625371339934,1.458450401670015,0.04421768707482993,0.5150017362169342,1.0,6/38,10.08%,TNNC1;VIM;DES;TPM1;ACTN2;TPM4
prerank,muscle filament sliding (GO:0030049),0.4783625371339934,1.458450401670015,0.04421768707482993,0.5150017362169342,1.0,6/38,10.08%,TNNC1;VIM;DES;TPM1;ACTN2;TPM4
prerank,manganese ion transport (GO:0006828),-0.5575863939014509,-1.456604978454916,0.06564551422319474,0.39304383435598694,1.0,6/14,7.83%,TRPC3;TRPC5;TRPC4;ATP2C1;TRPC6;SLC39A14
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),-0.41294197344132066,-1.4561008385590128,0.038860103626943004,0.3925421939308604,1.0,8/44,3.31%,KCNMB2;KCNMA1;AKAP6;ATP1B1;KCNJ3;KCNJ2;NOS1AP;GABBR2
prerank,dermatan sulfate metabolic process (GO:0030205),0.6062160037633305,1.4557279265192675,0.07768924302788845,0.5217846238779011,1.0,3/13,4.93%,UST;DCN;DSE
prerank,calcium ion transmembrane import into cytosol (GO:0097553),-0.4256861882835028,-1.4554925196470592,0.0392156862745098,0.3922570581903201,1.0,16/41,18.16%,PLCG2;SLC24A2;RYR2;HTR2C;GRIN2A;RYR3;SLC8A1;GRIN2B;GRIN1;FGF2;PTPRC;ERO1A;CCL19;HTR2B;IBTK;HTR2A
prerank,defense response to virus (GO:0051607),0.4154370189963024,1.4553407596189705,0.03139013452914798,0.5208008131104664,1.0,24/100,12.44%,RSAD2;CXCL10;EIF2AK2;STAT2;TRIM56;PRF1;IFIT2;IL6;BCL2;ZBP1;TRIM5;BST2;OASL;STAT1;ZMYND11;PHB2;MOV10;IFITM1;IFNLR1;BCL2L1;TLR2;OAS2;IFI27;IFIT1
prerank,presynapse assembly (GO:0099054),-0.5391168981934518,-1.455084098303289,0.0603448275862069,0.39155763975343666,1.0,7/16,10.22%,NLGN1;PTPRD;LRRTM3;PCLO;IL1RAPL1;NLGN3;DVL1
prerank,negative regulation of protein autophosphorylation (GO:0031953),0.6441595470638926,1.4550187740781775,0.08266129032258064,0.5197611390378716,1.0,3/10,7.09%,ENPP1;ERRFI1;MVP
prerank,brain morphogenesis (GO:0048854),-0.5808226352511323,-1.4539400578140405,0.07317073170731707,0.39282042194706335,1.0,5/12,17.37%,CTNNA2;SHANK3;PAX2;VPS51;BBS2
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),0.4856553105232965,1.4537002458759072,0.038461538461538464,0.521801855899382,1.0,8/37,7.66%,PHLDB2;PRKAA2;EPHA3;SKA1;MAP6;CLASP1;PHLDB1;GSK3B
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),-0.608050716647883,-1.4531096200147529,0.08739837398373984,0.39327391276689444,1.0,7/10,28.36%,SNCA;AKT1;SLC45A3;PTH1R;PRKCE;IRS1;PMAIP1
prerank,regulation of inflammatory response (GO:0050727),0.3747803062869819,1.4530955537401864,0.009055627425614488,0.521626530668352,1.0,27/190,8.47%,ENPP3;RORA;USP18;CASP12;IL16;ADAMTS12;FPR2;OSM;SNX6;CDH5;TNFAIP8L2;ANXA1;IFI35;IL6;TLR4;LACC1;ZBP1;CASP4;SERPINE1;NR1H3;PPARA;BIRC3;PTPN2;CD47;IL18;SETD4;WNT5A
prerank,cellular protein metabolic process (GO:0044267),-0.3039961743423501,-1.4530741643785996,0.0,0.39158685258050796,1.0,144/396,21.35%,ST8SIA4;CDH2;RPS24;CHRM3;ST3GAL6;CST3;SPARCL1;RPS9;RPL18A;RPL19;RPS12;RPL26;RPS29;RPL41;RPS15;RPL24;RPS23;RPL5;RPS27;RPS19;CPE;RPL38;RPLP1;SCG3;IGFBP7;RPS8;RPL10A;RPL27A;GAS6;RPL13;RPS18;ABCA3;RPL27;RPS16;RPL35A;RPS6;RPL21;RPS3;GOLM1;RPL39;RPS17;RPS7;RPL37A;RPL4;RPS25;EEF1A1;DAB2IP;RPS15A;MSRA;RPL6;RPL11;RPLP0;RPLP2;RPS21;RPS28;RPL28;RPL32;RPL8;RPL13A;RPL30;MSLN;MBTPS1;RPS20;RPS4X;RPN2;RPL18;LGMN;RPS13;MSRB2;BMP4;MSRB3;FBXL2;RPS2;RPL14;RPL22;MMP15;FDXR;SPCS2;SEC11C;MSRB1;RPS26;ASMT;SPP1;SCG2;MRPS18A;SERP1;QPCT;ZDHHC2;RPS10;IGHMBP2;EVA1A;SPCS1;RPL23;RPL17;PABPC4;PIGH;RPL29;MGAT4A;RAB12;GSPT2;RPS5;RPS14;UBA52;PHEX;SEPHS1;PLOD2;ERO1A;QSOX1;SRBD1;MRPL28;COPS5;HBS1L;RPL12;MEN1;PSENEN;RPL9;FUCA2;UBE2D3;MMP1;MATN3;RPL37;RPS11;MFGE8;LGALS1;LMCD1;MRPL35;MRPS5;RABGGTA;RPL7;RPL31;RPL7A;FBXO22;MRPL34;HARS1;YARS2;FARSB;PCSK5;PENK;RPL3;MRPL52;MRPL23;MRPL9;C3;NTAQ1
prerank,positive regulation of osteoblast differentiation (GO:0045669),0.4687692106853614,1.4514724765303402,0.05454545454545454,0.5250048622192033,1.0,9/43,4.75%,BMP6;WNT4;DDR2;IL6ST;BMPR1A;NELL1;BMP2;IL6;BMP7
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),0.5512168053013796,1.4511147938557953,0.07924528301886792,0.5220643199940602,1.0,3/20,4.74%,ZBTB20;PRKAA2;ARNT
prerank,positive regulation of glycolytic process (GO:0045821),0.5512168053013796,1.4511147938557953,0.07924528301886792,0.5220643199940602,1.0,3/20,4.74%,ZBTB20;PRKAA2;ARNT
prerank,regulation of telomerase activity (GO:0051972),-0.4285533649636815,-1.4496516019431787,0.038560411311053984,0.3986901135111266,1.0,14/45,16.15%,PRKCQ;NEK7;PARM1;CTNNB1;MAPK3;HSP90AB1;TERF1;ATM;NVL;KLF4;HSP90AA1;PNKP;MEN1;PKIB
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.3449126293341876,1.4496047194981623,0.0,0.524897316266192,1.0,108/476,16.62%,TCF4;CREB5;KMT2A;RORA;WNT4;SMAD3;ZMIZ1;NR2F2;SP100;ELF1;CREB3L2;ARNT2;MLLT3;IL31RA;TBL1XR1;TEAD1;FOXC1;TRIM56;PHIP;GATA6;WNT3A;RGMB;PPM1A;ZIC2;FOXC2;GLI3;MYB;PARP9;FZD2;TGFB1I1;PRDM11;ZIC1;BMP2;RFX3;APBB1;IL6;GLI1;BMP7;NIF3L1;TGFBR1;NCOA6;SALL1;LBHD1;NSD3;NR1H3;FOXP3;DTX3L;HDAC4;CREBL2;PPARA;CREBBP;GLIS2;NSD1;SFR1;RNF20;STAT1;WAC;ARHGEF11;NEK4;QRICH1;RNF111;CRLF3;TEAD2;WNT5A;YAP1;KAT6B;RLF;EPC1;NAA16;ELF4;BRD4;MAFB;ATF7IP;UBE2V1;NAA15;ELF2;SMAD4;HIVEP3;PPP3CB;FOXO3;ILF3;DVL3;EGR2;BTRC;MAP2K1;FBXW11;MED12;SERTAD3;KAT6A;KDM8;VHL;NIBAN2;HDAC2;RARA;MAP3K2;PML;ILK;SP3;SMARCA4;SOX4;DNAJC2;SMARCC1;SMAD2;TRIM16;NFATC2;TBL1X;PSRC1;ANKRD49
prerank,metal ion transport (GO:0030001),-0.3678800769799214,-1.4494093727499129,0.022222222222222223,0.39744345749914256,1.0,20/86,10.29%,CACNA1E;GRIN3A;TRPC3;RYR2;TPT1;TRPC5;TRPC4;RYR3;ATP2C1;SLC8A1;CNNM4;ATP2A3;SLC30A1;NIPAL3;CAMK2A;RAMP2;NIPAL4;CACNA1D;NIPA2;NIPA1
prerank,negative regulation of cell population proliferation (GO:0008285),0.3521609928263964,1.4492565708971696,0.0035971223021582736,0.5241033582108477,1.0,92/351,17.79%,ALDH1A2;IGFBP3;PDPN;TGFBR3;PODN;COL4A3;MCC;KANK2;EIF2AK2;TPTE;IGFBP5;NUPR1;GATA6;LDOC1;DLC1;PDS5B;OSM;NELL1;FBLN1;RBP4;ADAMTS1;TGFB1I1;DUSP10;PTHLH;PTPN14;SLC16A2;BMP2;IGFBP6;IFI35;IL6;BTG3;GSDME;BTG4;MORC3;APPL2;FOXP3;PTPN2;COL18A1;PARP10;ZBTB7C;POU1F1;CLMN;CDC73;PDCD5;SKI;CDKN2B;WNT5A;MTSS1;IFITM1;SMAD6;NUPR2;CGRRF1;IFNLR1;PTPN6;CDH13;PTPRU;SH2B3;EPPK1;VGLL4;NUDT6;SLURP1;NOG;MAP2K1;RBM5;PEX2;ACVR1C;MDM4;IFIT3;TRIB1;WDR6;FRK;ABI1;VHL;NIBAN2;PML;TNS2;KAT2B;P3H3;SOX4;KDM2B;PKD2;APP;AXIN2;NF2;S100A11;CDKN3;GAS8;OGN;DLG5;DNAJB2;PPP2R5C;TENM1
prerank,ceramide metabolic process (GO:0006672),-0.4071820908970495,-1.4480176246832488,0.02702702702702703,0.39903362713094737,1.0,7/49,3.39%,ST6GALNAC3;SGMS1;ACER3;ACER2;CERS4;PPP2R1A;DEGS2
prerank,fat cell differentiation (GO:0045444),0.44342523907638776,1.4479599623846413,0.04715447154471545,0.5262365080407326,1.0,12/57,12.36%,TCF7L2;PID1;IL11;OSBPL8;WNT5B;FAM120B;ALOXE3;SMAD6;ERAP1;MAFB;NR4A1;EGR2
prerank,kidney development (GO:0001822),0.439482702625845,1.4477761182035112,0.03492063492063492,0.5247114009415441,1.0,13/65,8.79%,SULF1;WNT4;KANK2;OSR1;FOXC1;IFT88;ARL3;BMP7;TGFBR1;SALL1;LRP4;CTSH;GREB1L
prerank,negative regulation of cell communication (GO:0010648),0.5396303102565256,1.4462389114036405,0.07760141093474426,0.5276236969979312,1.0,4/21,2.68%,IGFBP3;MPIG6B;OSM;IL11
prerank,cell-cell junction assembly (GO:0007043),-0.39246435715621797,-1.445927420803603,0.015665796344647518,0.40298613073710154,1.0,19/63,9.09%,CTNND2;CLDN5;CDH2;CDH11;CDH12;SMAD7;ACTB;ACTG1;GJC1;GJD3;CDH10;CTNNB1;TLN2;CDH8;CDH22;CDH7;CDH20;JAM3;RAMP2
prerank,calcineurin-NFAT signaling cascade (GO:0033173),0.668521913406876,1.445338412809745,0.07129094412331406,0.5265100918737438,1.0,6/10,19.06%,NFAT5;NFATC4;PPP3CB;ADGRB2;NFATC2;NFATC3
prerank,calcineurin-mediated signaling (GO:0097720),0.668521913406876,1.445338412809745,0.07129094412331406,0.5265100918737438,1.0,6/10,19.06%,NFAT5;NFATC4;PPP3CB;ADGRB2;NFATC2;NFATC3
prerank,negative regulation of immune system process (GO:0002683),0.6026803723616335,1.4453262893763046,0.08759124087591241,0.5244993480045707,1.0,3/16,6.03%,COL3A1;IL17D;FOXP3
prerank,anterior/posterior axis specification (GO:0009948),0.6011656852108987,1.444603291546991,0.08128544423440454,0.5248507330666207,1.0,3/15,13.25%,WLS;SKI;TASOR
prerank,cation transport (GO:0006812),-0.3310126250796976,-1.4441505497629956,0.0,0.4058220146922907,1.0,36/166,12.30%,SLC6A6;SLC47A1;PIEZO2;SLC12A2;KCNB2;KCNAB1;KCNMB2;KCNK5;SLC9B2;KCNMA1;ATP1B1;ANO1;ABCC9;KCNJ3;KCNJ2;SCN1A;SLC7A1;SLC5A5;SLC38A5;SLC8A1;SLC1A1;SLC5A6;SCN2A;TRPC6;KCNH1;TMEM63C;GRIN1;KCND3;NEDD4L;KCNJ6;SLC36A1;FGF13;SCN8A;KCNJ8;SCN9A;KCNJ15
prerank,defense response to protozoan (GO:0042832),0.6247240157933973,1.4436500062539854,0.10617760617760617,0.5260764308990901,1.0,4/12,11.05%,GBP6;GBP2;GBP4;GBP7
prerank,epithelium development (GO:0060429),0.40377325769567024,1.4433847448083443,0.032305433186490456,0.5249154642510696,1.0,17/107,8.12%,ALDH1A2;WNT4;KANK2;OSR1;GATA6;DAG1;DACT1;MTHFD1;BMP2;LOXL3;ERRFI1;VCL;SALL1;ANXA4;STAT1;GSTK1;ANXA7
prerank,regulation of response to interferon-gamma (GO:0060330),0.6111933525376847,1.4430970609638163,0.08285163776493257,0.5238642447698536,1.0,6/14,13.11%,PARP9;PTPN2;STAT1;PIAS1;SUMO1;JAK1
prerank,ameboidal-type cell migration (GO:0001667),-0.41775815961751744,-1.4430935642680298,0.026455026455026454,0.4067372732900662,1.0,19/51,12.74%,SEMA6D;ERBB4;PHACTR4;TBX1;ITGA4;SEMA4D;SEMA3C;SEMA6A;CCN3;PKN1;SEMA7A;SEMA3E;AKT1;AMOT;SEMA3G;SEMA6B;FAT2;PKN3;SEMA3A
prerank,negative regulation by host of viral transcription (GO:0043922),-0.5815262594546382,-1.44287066183909,0.07494646680942184,0.40552381280597694,1.0,4/12,9.20%,PSMC3;INPP5K;TFAP4;HDAC1
prerank,base conversion or substitution editing (GO:0016553),-0.5890259323178725,-1.4414863738570876,0.0823045267489712,0.40725768014355707,1.0,3/11,7.38%,ADARB1;ADARB2;APOBEC1
prerank,mesoderm formation (GO:0001707),-0.5250763572144469,-1.44109438502803,0.06150341685649203,0.40647934106064476,1.0,4/17,10.15%,BMPR2;ITGB4;ITGA8;ITGA3
prerank,regulation of heart rate by cardiac conduction (GO:0086091),-0.4319761399311683,-1.4403311718052383,0.04020100502512563,0.40673839830999253,1.0,11/38,13.29%,CACNB2;CTNNA3;KCNJ3;KCNJ2;CACNA1G;CAMK2D;KCND3;CACNA1D;KCNQ1;CAV1;KCNE4
prerank,ganglion development (GO:0061548),-0.6117384895950263,-1.4385015067022913,0.08074534161490683,0.4099115375383556,1.0,6/11,12.74%,UNC5C;NRP2;CTNNB1;FZD3;TUBB3;SEMA3A
prerank,sphingoid biosynthetic process (GO:0046520),-0.6057488435442108,-1.4383557449231956,0.06981519507186858,0.4068195275563676,1.0,2/11,2.19%,ACER3;ACER2
prerank,sphingosine biosynthetic process (GO:0046512),-0.6057488435442108,-1.4383557449231956,0.06981519507186858,0.4068195275563676,1.0,2/11,2.19%,ACER3;ACER2
prerank,myeloid cell development (GO:0061515),0.5563095400869313,1.4368249188129183,0.099644128113879,0.5429179595584391,1.0,8/18,18.98%,MPIG6B;ANXA2;KIT;TLR2;SH2B3;ALAS2;APP;DMTN
prerank,potassium ion transport (GO:0006813),-0.3461362198185478,-1.4367767815213075,0.017421602787456445,0.40937392863718536,1.0,28/120,12.30%,KCNB2;KCND2;SLC9A2;KCNQ5;KCNAB1;KCNMB2;KCNK5;KCNMA1;SLC24A2;ABCC9;KCNJ3;KCNH7;KCNJ2;KCNC2;KCNQ3;HCN1;KCNK10;SLC9A8;HCN2;KCNH1;TMEM175;KCNH5;KCND3;KCNJ6;KCNB1;KCNJ8;KCNQ1;KCNJ15
prerank,phospholipid transport (GO:0015914),-0.40353758521311517,-1.4360221063985796,0.031578947368421054,0.40949122007596334,1.0,16/52,14.19%,ATP8A1;ATP10A;ATP11B;PITPNC1;PITPNA;ABCA3;ATP8A2;ATP11A;ATP8B2;SCARB1;PRELID2;PRELID1;ATP8B1;SCARB2;MFSD2A;TMEM30A
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),-0.5329366762381791,-1.4354425273557434,0.06993006993006994,0.40923751338526193,1.0,7/16,17.78%,PPP1R16B;THBS1;GATA2;VEGFA;FGF2;APLNR;DLL4
prerank,heterochromatin organization (GO:0070828),-0.5477107305057072,-1.4354092927273001,0.0706401766004415,0.4076262668279093,1.0,2/14,3.43%,MECOM;PRDM16
prerank,engulfment of apoptotic cell (GO:0043652),-0.5405258199704468,-1.4352774144382758,0.08067940552016985,0.4062426291876548,1.0,8/15,17.36%,THBS1;XKR4;XKR6;RHOG;MEGF10;RAC1;RHOH;RHOBTB1
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.6198044914827617,-1.4346618937095095,0.09586056644880174,0.4060623101234453,1.0,3/10,6.63%,SHANK3;NETO1;NPTN
prerank,inositol phosphate metabolic process (GO:0043647),-0.41077982604726476,-1.434148752256378,0.04477611940298507,0.4055759960999177,1.0,14/46,15.74%,INPP4B;PLCB1;PLCB4;PLCG2;ITPKB;INPP5D;CALM1;IP6K2;IMPA1;FGF2;PLCH1;PPIP5K2;PPIP5K1;PLCG1
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.326184176924159,1.4330241601177092,0.0,0.5537051524724774,1.0,359/1668,16.51%,TCF7L2;TCF4;CREB5;KMT2A;RORA;ZBTB20;SOX5;FHL2;BMP6;TSHZ2;ZKSCAN2;EBF1;FOXD1;SMAD3;RBPJ;ZEB2;ZHX2;MXI1;ARID4A;ATXN1;KANK2;ZMIZ1;NR2F2;CXCL10;SP100;ELF1;KCNIP3;RGMA;CREB3L2;FGF1;PID1;PRDM6;AUTS2;ARNT2;OSR1;TBL1XR1;TEAD1;SMURF2;FOXC1;NFIA;LBX1;STAT2;NFYC;NFAT5;PHIP;ZNF697;GATA6;SPIB;TCF24;WNT3A;KDM7A;MAF;HIF3A;CSRP3;PPM1A;ZBTB4;BMPR1A;ZNF395;SSBP2;OSM;NR6A1;FSTL3;ZIC2;FOXC2;IL11;GLI3;NFATC4;WWOX;MYB;NCOA3;ZIC4;MBD2;TRAK1;PARP9;CDK8;TGFA;LDB2;HIVEP2;IKZF2;TNRC6B;PRRX2;HIVEP1;CRY2;NUCKS1;HOXC6;DACT1;ZBTB8A;HOXC4;KIT;ZIC1;DCN;LITAF;BMP2;STAT5B;RFX3;CRY1;BRWD1;GABPB2;GABPB1;APBB1;CREB3L4;IL6;KMT2C;MIER3;ZFP30;EPAS1;HLF;TLR4;GLI1;BCOR;ARNT;EN2;SIM2;ZNF276;AEBP1;UXT;MTDH;GLIS3;GZF1;NCOA6;SALL1;OTP;PRRX1;ZNF3;MGA;TCF12;KDM3B;SERPINE1;KLF5;HAX1;MIER1;HDGFL3;SP9;TPR;ZNF35;MLLT10;CREB3L3;WWC2;NR1H3;FOXP3;ARF4;ATP2B4;BCL9L;ANXA4;HDAC4;ZKSCAN4;PPARA;TCF7L1;TSHZ3;VGLL3;CREBBP;RARB;POGZ;GLIS2;PCGF5;NSD1;ZBTB37;ZBTB7C;POU1F1;KLF9;USP9X;HOXA2;CREBRF;IL18;DPF2;STAT1;CDC73;SKI;CDKN2B;ZSCAN21;MEF2A;RIPK2;RNF111;CRLF3;PIAS1;ZNF25;VPS72;TEAD2;ATF7;BAX;BAZ1B;CUX1;TNRC6A;WNT5A;ZNF182;ZFP37;SP8;YAP1;RHOQ;ZEB1;SAP130;CCNH;CRTC1;KAT6B;MOV10;RLF;DLG1;EPC1;GLYR1;IGF2;ZNF394;ELF4;MNAT1;ZBTB3;SUMO1;GATAD2B;CREM;SMAD6;CDK7;TOX4;HDGFL2;CDK12;SP110;E4F1;EBF4;SOX21;NUPR2;BRD4;PBX1;RFXANK;TAF7;SUFU;PFKM;MAFB;MSC;MAPK14;WWP2;CUX2;TCEA1;PPID;BAZ1A;HEYL;ZNF292;MYSM1;CIR1;CBX7;CDH13;ZNF235;TLR2;FNIP1;ELF2;RFXAP;TCF7;SMAD4;STAT4;MAP2K5;HIVEP3;EGR3;RTF1;PPP3CB;ATN1;FOXO3;NR4A1;CRTC3;ACTL6A;RBBP8;LHX9;IFI27;ZNF219;KDM5B;DVL3;EGR2;ZKSCAN7;MAML2;RPS6KA3;SS18;SRCAP;THAP1;NOG;EFNA1;HOXA10;BPTF;KDM2A;TET2;NFIC;MED12;CBX4;ARRB1;MZF1;BHLHE41;NR3C1;BRD8;GMEB1;MED20;PKNOX1;WASL;PEX2;PAF1;NFE2L1;NRF1;SENP1;HIC1;ARID5B;ZNF462;POU2F1;ZNF205;KAT6A;BRWD3;GTF2H4;PRDM5;MDM4;NCOA2;SALL2;DMTF1;RFX2;TLE6;FUS;NCK1;TBK1;FRK;VHL;THAP3;ZBTB21;ZNF569;RBM14;ZBTB12;HDAC2;IFRD1;RARA;ZNF18;MAMSTR;SP3;ZFX;ZNF383;HOXB4;TEF;SMARCA4;KAT2B;ACVR2B;SOX4;PHF20L1;IRF9;PER3;KDM2B;TXK;DAB2;VEZF1;LIN9;PRKD2;PKD2;POU5F1;ELK4;APP;TAF9;CTDSP1;ZNF260;CPEB3;MUC1;JDP2;SMARCC1;URI1;DRGX;SMAD2;WWTR1;BCL11B;ZNF483;POU6F1;NFATC2;TBL1X
prerank,ATP synthesis coupled proton transport (GO:0015986),-0.5171447527406086,-1.432417205165507,0.0706401766004415,0.40829397692252745,1.0,12/17,25.74%,ATP5F1A;ATP5MC1;ATP5PO;ATP5F1B;ATP5PD;ATP5F1D;VPS9D1;ATP5F1E;ATP5ME;ATP5MG;ATP5MC3;ATP5MF
prerank,collagen fibril organization (GO:0030199),0.41294400652869845,1.4315296624358496,0.021021021021021023,0.556533942023718,1.0,15/88,6.80%,COL4A3;COL23A1;COL4A6;COL4A4;COL5A2;COL3A1;COL4A5;DDR2;LOXL3;BMP1;LOXL1;TGFBR1;COL20A1;COL5A1;COL18A1
prerank,response to ethanol (GO:0045471),-0.5602511716712674,-1.431503910759756,0.0709812108559499,0.4089921810044241,1.0,7/14,19.29%,GRIN3A;GRIN2A;GRIN2B;GRIN1;SOD1;GLRA2;GLRA1
prerank,central nervous system development (GO:0007417),-0.31121815412617415,-1.430069679775492,0.0,0.411036257509583,1.0,49/250,10.51%,ADGRL3;ADGRL2;CNTNAP2;ROBO2;SLC2A1;CDH2;MEIS2;COL4A1;CNTN4;WWP1;ZFHX3;MOG;CNTN6;PBX3;NCKAP1;SHROOM4;VIT;GRIN2A;GRIK1;SERPINI1;SNTG2;ADGRG1;S100B;APOD;SH3GL2;ADAM22;AHI1;MAL;DCLK1;RAB3GAP1;NRCAM;GRIN2B;MBP;SCYL2;EIF2B2;ALDH5A1;ZIC3;ZBTB16;SOX6;LSR;NDRG4;BAG6;GRIN1;ADAM23;SPOCK1;DNER;DHX30;SEMA6B;DDIT4
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.38676236343208975,1.4300436294066685,0.015647226173541962,0.5592089440953775,1.0,31/140,9.99%,ARHGAP29;CGNL1;ARHGAP6;RASGRF1;TIAM2;AKAP13;ARHGAP21;ARHGAP10;ARHGAP20;ARHGAP18;DLC1;ARHGAP28;ARHGAP32;TRIP10;FGD4;ARHGAP12;PLCE1;MYO9A;RHOF;FAM13B;TAGAP;RALBP1;PLEKHG2;ARHGEF11;ARHGAP26;RHOQ;SYDE1;GMIP;ARHGEF12;SOS2;NGEF
prerank,regulation of vasoconstriction (GO:0019229),-0.47033411544065307,-1.4297358382325813,0.040865384615384616,0.41039264830159355,1.0,8/27,12.95%,CHRM3;KCNMB2;BMPR2;ADRA1B;ECE1;ACE;ACE2;CAV1
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.4428641328524787,1.4295226405825388,0.0514018691588785,0.5589868032061381,1.0,10/57,7.50%,PARP14;GHR;IL31RA;IL6ST;OSM;PARP9;KIT;IL6;PTPN2;IL18
prerank,cellular response to steroid hormone stimulus (GO:0071383),0.5675573280095781,1.4280070140076553,0.08576642335766424,0.5619977090592089,1.0,3/17,4.75%,TFPI;ATP1A2;BMP7
prerank,response to prostaglandin E (GO:0034695),0.63345610036342,1.4278805755609523,0.11560693641618497,0.5602571929487762,1.0,1/10,0.37%,TGFBR3
prerank,regulation of exocytosis (GO:0017157),-0.4097841051334858,-1.4274574846476447,0.029490616621983913,0.41460325214428295,1.0,25/46,28.15%,SYT1;RIMS2;RAB27A;NSF;CADPS;IL1RAPL1;SNCA;STXBP5L;RAB27B;RAB3C;CPLX1;STXBP6;CPLANE2;RAB12;CLASP2;EXPH5;RAB15;SYTL4;ATP6AP1;HAP1;RAB8B;RAB3B;CHMP6;UNC13D;VAMP2
prerank,neuron projection development (GO:0031175),-0.32507916697331585,-1.4268358098798573,0.011538461538461539,0.4147277330561598,1.0,53/168,17.00%,FRY;GRM7;CNTNAP2;NLGN1;CTNND2;SHANK3;TNIK;GPM6A;CNTN4;DOCK10;PLP1;GPM6B;NCKAP1;STX3;TRIO;PAK1;PTPRM;NYAP2;EPHB1;DAB2IP;SH3GL2;DCLK1;HMGB1;MYOC;STMN2;RAPGEF2;SHTN1;UBB;RAB35;L1CAM;LYN;MINK1;DBNL;MANF;NEFH;MICALL2;ZFYVE27;ALS2;ULK1;PAK3;NGF;MAPK8IP3;TMEM108;BICDL1;LGI1;MYO16;MAPT;MAP2;NTF3;STMN4;SHANK1;SNAPIN;EPHB3
prerank,amino acid transport (GO:0006865),0.4509986151325265,1.4265107410174074,0.07511737089201878,0.56263576005227,1.0,5/49,4.20%,SLC7A11;PDPN;SLC7A2;SLC6A12;SLC7A14
prerank,cellular defense response (GO:0006968),0.4691303640751573,1.4264640398628656,0.07504078303425775,0.5606782987603611,1.0,6/40,9.33%,DCDC2;PRF1;CCR9;ADORA2A;LY96;LSP1
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.3357414062808725,1.4263370289758566,0.0011135857461024498,0.5590158798265873,1.0,133/572,16.98%,TCF7L2;FHL2;BMP6;SMAD3;RBPJ;ZEB2;ZHX2;MXI1;ATXN1;KANK2;NR2F2;SP100;KCNIP3;PRDM6;OSR1;TBL1XR1;SMURF2;FOXC1;GATA6;PPM1A;ZBTB4;NR6A1;FOXC2;GLI3;NFATC4;WWOX;MYB;MBD2;PARP9;NEDD4;LDB2;HIVEP1;CRY2;DACT1;BMP2;CRY1;APBB1;MIER3;BCOR;AEBP1;UXT;MTDH;GLIS3;GZF1;SALL1;OTP;ZNF3;MIER1;TPR;WWC2;NR1H3;FOXP3;HDAC4;PPARA;CREBBP;RARB;GLIS2;NSD1;USP9X;DPF2;STAT1;CDC73;SKI;MEF2A;ZNF25;VPS72;CUX1;ZFP37;YAP1;ZEB1;SAP130;DLG1;EPC1;IGF2;SUMO1;GATAD2B;CREM;E4F1;NUPR2;TAF7;SUFU;WWP2;CUX2;PPID;CIR1;CBX7;FNIP1;SMAD4;MAP2K5;RTF1;ATN1;FOXO3;IFI27;ZNF219;THAP1;NOG;EFNA1;BPTF;NFIC;CBX4;MZF1;BHLHE41;NR3C1;PEX2;PAF1;HIC1;ARID5B;ZNF205;PRDM5;MDM4;TLE6;FRK;VHL;ZBTB21;HDAC2;RARA;SMARCA4;ACVR2B;PER3;KDM2B;DAB2;POU5F1;ELK4;CPEB3;JDP2;URI1;SMAD2;POU6F1;TBL1X;ZBTB5;DNMT3A;NIPBL;RNF2
prerank,inositol phosphate biosynthetic process (GO:0032958),-0.5901224219649279,-1.425720562027094,0.084,0.4158189959097385,1.0,5/11,15.55%,ITPKB;IP6K2;FGF2;PPIP5K2;PPIP5K1
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.3937640550995515,1.4257026893893654,0.02158273381294964,0.5591183392142629,1.0,22/113,12.61%,TCF7L2;BMP6;PTN;LAMC1;FGF1;NOTCH2;OSR1;ECM1;NRP1;VEGFD;TGFA;BMP2;ARNT;TGFBR1;CLDN1;WNT5A;YAP1;AKT3;CDH13;EGR3;NR4A1;CRNN
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.4841233017611136,1.425562523365302,0.07478260869565218,0.5575380918882067,1.0,17/33,23.90%,GLI1;PLK5;APPL2;ATP2B4;CDC73;PHB2;SUSD2;APPL1;PTPN6;CRNN;PAF1;INO80;PTEN;FBXW7;PKD1;PSME3;TAF1
prerank,triglyceride biosynthetic process (GO:0019432),0.563106352970689,1.4250018391747823,0.08440366972477065,0.5574174848422583,1.0,7/18,20.04%,AGMO;MOGAT3;DGAT2;LPGAT1;LPIN2;PCK2;DGAT1
prerank,negative regulation of fat cell differentiation (GO:0045599),0.4893714185836421,1.4242210345290938,0.0726643598615917,0.5578720548055142,1.0,8/34,11.15%,RORA;SMAD3;ENPP1;WNT10B;IL6;WNT5A;YAP1;LRP3
prerank,embryonic skeletal system development (GO:0048706),0.48698337804491104,1.4239319172528417,0.07394366197183098,0.5567126400667569,1.0,7/35,8.47%,SULF1;PDGFRA;OSR1;RBP4;HOXC4;DYNC2I1;WNT5A
prerank,aminoglycan metabolic process (GO:0006022),-0.6172256074125264,-1.4238918944596861,0.08369098712446352,0.4191350999949928,1.0,5/10,24.29%,XYLT1;B3GAT2;CHST9;B3GAT1;B3GAT3
prerank,positive regulation of muscle hypertrophy (GO:0014742),0.578714212275884,1.4234723984443085,0.10734463276836158,0.5562584505839685,1.0,3/15,8.03%,ROCK2;IL6ST;MEF2A
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.4591055861084494,1.423274169261583,0.05342237061769616,0.5549834295105456,1.0,10/48,11.59%,ROBO1;PARP14;USP18;STAT2;IL6;NR1H3;PTPN2;OTOP1;IRAK3;SH2B3
prerank,regulation of interleukin-4 production (GO:0032673),-0.49593343307891347,-1.4217332897830428,0.06511627906976744,0.42281680471405014,1.0,8/21,12.61%,LEF1;SLC7A5;PRKCQ;ZFPM1;HAVCR2;FCER1G;CD86;SYK
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.5771519377871708,1.4214183431093772,0.09596928982725528,0.559339773552871,1.0,3/15,6.33%,EIF2AK2;TLR4;GBP5
prerank,high-density lipoprotein particle assembly (GO:0034380),0.6416636141659288,1.4206130853147587,0.1007905138339921,0.5599987115221964,1.0,4/10,17.50%,APOA2;BMP1;ABCA1;ABCA7
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),-0.5225114072161441,-1.420483565437539,0.06136363636363636,0.4244859991211837,1.0,8/18,17.69%,NLGN1;RIMS1;RIMS2;RAB3GAP1;SYN1;RAP1A;SNAPIN;RIMS4
prerank,cellular response to sterol (GO:0036315),0.6006065668592642,1.4200562388328417,0.1111111111111111,0.5597856181273051,1.0,2/13,0.60%,RORA;GRAMD1C
prerank,positive regulation of immune system process (GO:0002684),0.5689629785920496,1.4198488615869265,0.0762081784386617,0.5584608617657841,1.0,5/16,10.70%,RSAD2;ANXA1;MIA3;LGALS9;HCAR2
prerank,regulation of actin filament depolymerization (GO:0030834),0.5954766917154406,1.4196697907638605,0.09664694280078895,0.5570317876833637,1.0,3/12,10.49%,PLEKHH2;LIMA1;PLEK
prerank,regulation of lipid metabolic process (GO:0019216),0.4022460931321122,1.4195705887536239,0.03793626707132018,0.5554274107618061,1.0,11/88,6.91%,RORA;CHD9;PRKAG2;C1QTNF2;TBL1XR1;NFYC;NCOA6;PANK2;PPARA;CREBBP;LACTB
prerank,positive regulation of myoblast differentiation (GO:0045663),0.5641024757387323,1.41844403869327,0.09195402298850575,0.5573473235971195,1.0,2/16,0.16%,RANBP3L;IGFBP3
prerank,positive regulation of cell growth (GO:0030307),-0.3528720449951902,-1.4182537491931877,0.01892744479495268,0.42851019174252014,1.0,28/96,15.43%,SYT1;RIMS1;RIMS2;AKAP6;TGFB2;SEMA4D;H3-3A;MACF1;SEMA7A;AKT1;SDCBP;DDX49;SHTN1;SYT4;L1CAM;NEDD4L;DBNL;EXOSC2;ZFYVE27;RPS6KA1;EGFR;NGF;CEP43;MFSD2A;SYT2;TAF9B;LGI1;MAPT
prerank,regulation of neuron projection development (GO:0010975),-0.32918918687197596,-1.4178779370090213,0.007326007326007326,0.4277061312690379,1.0,48/163,13.08%,CTNNA2;LRRC4C;ITGA6;SHANK3;CSMD3;LRRC7;CDH2;PPFIA2;TENM3;TANC2;PTK2B;DCC;RIT2;FUT9;PAK1;NTRK2;SETX;IL1RAPL1;PRAG1;SERPINI1;TOX;DAB2IP;ARHGAP44;SNX3;STMN2;NDNF;NPTN;RAPGEF2;CCDC88A;EFHC2;AKT1;PAQR3;RTN4RL1;MBOAT1;NDRG4;SPOCK1;ABI3;LYN;RET;LZTS3;PTPRO;SCARB2;PAK3;MARK1;FES;SRCIN1;SEMA3A;MFSD2A
prerank,cellular response to nitrogen compound (GO:1901699),0.5426672586047314,1.4178483719556045,0.09457092819614711,0.5573619750802907,1.0,3/20,7.18%,ROCK2;ATP2B4;SPIDR
prerank,response to hexose (GO:0009746),0.5113172186946672,1.4175486116806004,0.09074733096085409,0.5563404896763469,1.0,2/25,2.03%,TCF7L2;APOA2
prerank,eye development (GO:0001654),0.43664083098346507,1.4174298276970192,0.050393700787401574,0.5547912614750666,1.0,11/54,10.07%,EFEMP1;FBN1;COL5A2;FOXC1;SHROOM2;RBP4;COL5A1;SKI;CACNA1C;MAB21L1;PBX1
prerank,response to glucose (GO:0009749),0.4564704589088584,1.4165066192017277,0.054009819967266774,0.5558906969575561,1.0,5/46,5.35%,TCF7L2;ZBTB20;PRKAA2;APOA2;UNC13B
prerank,T cell activation (GO:0042110),0.4205393249163032,1.4129635505312863,0.041474654377880185,0.5655952144799586,1.0,9/69,6.52%,LEPR;DPP4;CXADR;CTPS1;NHEJ1;KIT;PTPN22;FOXP3;PTPN2
prerank,embryonic appendage morphogenesis (GO:0035113),-0.5692624018423341,-1.412881105615578,0.10272536687631027,0.43950650500311966,1.0,4/12,9.04%,TGFB2;MBNL1;FBXW4;LRP6
prerank,cardiac muscle tissue morphogenesis (GO:0055008),0.4954419303884101,1.4126654238674263,0.07612456747404844,0.564586278341352,1.0,4/29,4.92%,TNNC1;TGFBR3;BMP2;TPM1
prerank,sphingolipid metabolic process (GO:0006665),-0.3473735428055457,-1.4123483201719367,0.019417475728155338,0.4392217645368117,1.0,27/108,16.97%,ST6GALNAC3;SGMS1;ACER3;SERINC1;ELOVL5;ACER2;CERS4;CERT1;PPM1L;PPP2R1A;DEGS2;ELOVL7;SPNS2;HEXB;TECR;GLTP;NEU1;SGMS2;CERK;GM2A;PLPP1;GAL3ST1;PRKD1;HACD3;SPTSSA;ORMDL3;SGPP1
prerank,anion transmembrane transport (GO:0098656),0.41995441909893644,1.4116900098967415,0.05817610062893082,0.565697631071889,1.0,8/67,3.91%,SLC7A2;SLC1A3;SLC13A3;SLC6A13;SLC13A4;SLC19A1;SLC6A9;SLC16A12
prerank,peptidyl-glutamic acid modification (GO:0018200),-0.47541348474995815,-1.4115596141599271,0.0746987951807229,0.43966873959261715,1.0,8/24,26.68%,AGBL4;TTLL7;TTLL5;NAA10;TTLL8;CEP41;VKORC1;TTLL3
prerank,membrane lipid biosynthetic process (GO:0046467),-0.3896754424696994,-1.4112570957339472,0.027624309392265192,0.438703635562556,1.0,11/58,4.60%,SGMS1;ACER3;ELOVL5;ACER2;CERS4;CERT1;PPM1L;ST8SIA6;DEGS2;ELOVL7;SPNS2
prerank,protein ubiquitination (GO:0016567),0.33641471836205566,1.409986572178749,0.0011376564277588168,0.5698458549472928,1.0,103/471,15.52%,RNF220;PDZRN3;SASH1;RNF152;RNF213;SPSB1;SMURF2;TRIM10;HIF3A;HERC6;RNF217;FBXO11;FBXL17;SH3RF1;TRIP12;NEDD4;NHLRC3;RC3H1;DTX4;EPAS1;MYCBP2;BCL2;TRIM17;RNF19A;KLHL21;KLHL22;UBE2U;SPSB4;DTX1;DZIP3;SIAH2;CUL4A;PELI2;TRIM5;DTX3L;FBXO9;MGRN1;NPEPPS;ANAPC11;USP9X;RNF20;CDC73;FBXL3;WAC;FBH1;TRIM24;KLHL18;NUB1;PSMB10;RNF111;AMFR;UBE2Z;PJA2;UBE2C;PSMA3;FBXL20;PSME4;LONRF1;FBXL7;FBXO4;PSMA5;WWP2;FBXO24;KEAP1;BLMH;HUWE1;UBE2V1;RFWD3;RTF1;CUL3;KLHL13;TRIM21;BTRC;HECW2;UBE2E3;UBE2Q2;FBXW11;TRIM26;TRIM7;ASB5;ARRB1;PEX2;PAF1;CDC27;PRPF19;RNF39;BFAR;RNF43;RNF103-CHMP3;LNPEP;RNF181;FBXL4;DDA1;LEO1;BRAP;RCHY1;VHL;BIRC6;UBE2R2;FBXL13;FBXL12;RNF146;MUL1
prerank,defense response to bacterium (GO:0042742),0.3967025908345365,1.4097377069018806,0.03488372093023256,0.5686039549897213,1.0,19/105,11.25%,GBP6;SELP;COLEC12;GBP2;FPR2;ANXA3;IL6;TLR4;SERPINE1;OPTN;NOS2;CRP;GBP4;TNFRSF14;PLA2G6;ANKRD17;GBP7;TLR2;OAS2
prerank,regulation of response to external stimulus (GO:0032101),0.3896286928312816,1.4090206584687872,0.036011080332409975,0.5690162241549583,1.0,21/121,10.02%,EFNB2;PDGFRA;USP18;CASP12;ADAMTS12;GATA6;CD55;ANXA1;GP1BA;LACC1;PTPN22;ZBP1;CASP4;APPL2;TRIM5;BIRC3;WNT5A;STK24;ERAP1;APPL1;BRD4
prerank,myelination (GO:0042552),-0.4061472928283916,-1.4089285171058106,0.05974025974025974,0.44326940052479824,1.0,21/46,22.64%,ADGRG6;ACER3;PLP1;CMTM8;MAL;MYOC;MBP;EIF2B2;SCN2A;SCN8A;NFASC;ABCD2;TNFRSF21;ACSBG1;GAL3ST1;TPPP;AMIGO1;BCAS1;PLLP;B4GALT6;MAL2
prerank,negative regulation of neuron projection development (GO:0010977),0.44051138056633105,1.408674501341059,0.06634304207119741,0.568240028562778,1.0,11/56,9.99%,EFNB2;DPYSL3;LPAR1;WNT3A;KANK1;CBFA2T2;LRP4;PTPN9;NGFR;EPHA4;NGEF
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.4988570597975177,1.4043834720997337,0.10301953818827708,0.5807499084257082,1.0,9/26,19.51%,CBLB;SNX6;TGFA;ERRFI1;ADRA2A;SOCS4;APP;SHC1;HBEGF
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),-0.5978525573352846,-1.4035388592610298,0.10495049504950495,0.45643904974363286,1.0,4/10,8.94%,PTPRJ;SNCA;APOD;NDRG4
prerank,defense response to symbiont (GO:0140546),0.4032346514547278,1.4032787799891573,0.04,0.5825403492357614,1.0,24/92,14.41%,RSAD2;EIF2AK2;STAT2;TRIM56;PRF1;IFIT2;IL6;BCL2;ZBP1;TRIM5;BST2;OASL;STAT1;ZMYND11;MOV10;IFITM1;IFNLR1;BCL2L1;TLR2;OAS2;IFI27;IFIT1;IFIT3;IFIH1
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),-0.5438257145154407,-1.4020438534466169,0.10714285714285714,0.4589989494113191,1.0,5/14,10.48%,NOS3;ECE1;ACE;ENPEP;ACE2
prerank,regulation of lamellipodium organization (GO:1902743),0.5572705652746344,1.4016122840369858,0.1254681647940075,0.5863435890254037,1.0,4/14,12.29%,PDPN;FER;CAPZB;EPHA2
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),-0.5525303647596501,-1.4014798987183368,0.09307359307359307,0.458769439371964,1.0,5/12,15.47%,INSR;SETX;SMCR8;ADRB2;IRGM
prerank,gonad development (GO:0008406),0.46679598525623267,1.4008142850003227,0.06655574043261231,0.587200048273405,1.0,7/41,8.47%,WNT4;NR2F2;GATA6;WNT2B;KIT;SALL1;WNT5A
prerank,regulation of dopamine secretion (GO:0014059),-0.46352375691711284,-1.4007532195748766,0.060948081264108354,0.4590353668281594,1.0,12/25,26.68%,SYT1;SNCA;SYT4;SYT7;SYT9;SYT2;KCNA2;CHRNA4;SYT6;SYT10;SYT5;SYT17
prerank,focal adhesion assembly (GO:0048041),-0.4858800745592814,-1.400503898012072,0.1026252983293556,0.458010315516045,1.0,9/21,11.94%,ACTN1;PTPRK;THSD1;PEAK1;TESK2;RCC2;TRIP6;BCR;ARHGEF7
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.5684579056130366,1.4001991014434194,0.10344827586206896,0.5872313894777147,1.0,7/16,17.01%,LEPROT;PARP14;PTPN2;SH2B3;VHL;NF2;PPP2CA
prerank,somite development (GO:0061053),0.6121423540758681,1.3999574438686537,0.13851992409867173,0.5861004005089326,1.0,5/11,19.05%,MTHFD1;LOXL3;IHH;PTCH1;MEOX2
prerank,gliogenesis (GO:0042063),-0.5332326349423308,-1.3991003235115196,0.11570247933884298,0.4601695603948938,1.0,6/15,14.19%,CDH2;TGFB2;CDK6;PAX2;NFIB;RELN
prerank,actin filament polymerization (GO:0030041),0.4972771945238118,1.3988522692071321,0.0941385435168739,0.5878146805207016,1.0,3/29,0.81%,GAS7;ARHGAP6;DIAPH1
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),-0.5702122944537701,-1.3984702327633654,0.12055335968379446,0.4601594955299642,1.0,5/11,25.16%,AKAP6;NOS1AP;LRRC38;LRRC55;TREM2
prerank,lipid phosphorylation (GO:0046834),-0.5811566767344745,-1.39807232756232,0.09871244635193133,0.45950255767628734,1.0,4/10,6.91%,DGKB;DGKI;DGKH;DGKZ
prerank,positive regulation of tissue remodeling (GO:0034105),0.6327395898657571,1.3977650047631545,0.12547528517110265,0.5894246828325936,1.0,2/10,7.50%,ROCK2;IL18
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.4446350463736769,1.3970001225637445,0.06761006289308176,0.5900588251018278,1.0,7/47,3.38%,PDPN;DOCK5;TACSTD2;KANK1;NRP1;FBLN1;S100A10
prerank,cellular response to interferon-gamma (GO:0071346),0.40655304213082094,1.3966096176013647,0.03056768558951965,0.5894686150029412,1.0,27/88,16.20%,GBP6;SP100;GBP2;DAPK1;TLR4;TRIM5;VCAM1;GBP5;CD47;OASL;GBP4;STAT1;CCL2;LGALS9;WNT5A;GBP7;TLR2;OAS2;TRIM21;TRIM26;JAK1;SLC26A6;CCL25;PML;IRF9;ICAM1;GBP3
prerank,negative regulation of cell junction assembly (GO:1901889),0.5068397505575302,1.3961882907844432,0.08108108108108109,0.5888949520936192,1.0,4/25,2.25%,PHLDB2;ARHGAP6;ROCK2;DLC1
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),-0.4640765774235436,-1.3960604054591068,0.0696629213483146,0.4633074477625964,1.0,13/26,24.84%,NAV3;PAK1;RPS3;MET;STMN2;FES;RAC1;MAPT;CDK5RAP2;DCTN1;ARL2;MAPRE1;OCLN
prerank,positive regulation of wound healing (GO:0090303),0.48305122584901167,1.3958344517703054,0.08710217755443886,0.5882173963477109,1.0,11/36,15.39%,VTN;PLPP3;KANK1;FOXC2;ANXA1;SERPINE1;CLDN1;INSL3;PTK2;SMOC2;ADRA2A
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),0.5132048088586713,1.3958091252018856,0.10071942446043165,0.5863989648942874,1.0,3/23,4.74%,ZBTB20;PRKAA2;ARNT
prerank,positive regulation of biosynthetic process (GO:0009891),0.4610153741142328,1.3957985466723462,0.06365159128978225,0.584538803451068,1.0,8/40,9.15%,ZBTB20;WNT4;VIM;SORBS1;TLR4;CREBL2;PPARA;SIRT4
prerank,neuropeptide signaling pathway (GO:0007218),-0.3801400626641529,-1.3956688927589256,0.0440771349862259,0.4626163749164842,1.0,17/58,20.74%,CPE;SORCS1;SORCS3;GLRA3;OPRM1;SORL1;RAPGEF2;CYSLTR2;NXPH2;CYSLTR1;PPY;SORT1;GPR37;GLRA2;GLRA1;GRP;PENK
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),-0.523285641693078,-1.3952593023957844,0.07789473684210527,0.4621243211142303,1.0,6/18,15.17%,PLCB1;CHRM3;CHRM2;OPRM1;AGRN;GNAQ
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.39401936760833883,1.3949623014823853,0.05198776758409786,0.5853174831945762,1.0,19/86,10.74%,BMP6;TEC;VTN;EPHA7;GHR;OSM;IL11;NRP1;ITGA5;ANGPT1;IL6;PRKCZ;HAX1;TNFRSF14;RIPK2;IGF2;RAP2C;PTPN6;ENPP2
prerank,peptidyl-tyrosine modification (GO:0018212),0.43390895623296366,1.394309126693685,0.06554878048780488,0.5855131105881882,1.0,13/56,8.24%,EFEMP1;TEC;PDGFRA;FGFR1;DDR2;EPHA3;FER;KIT;TPST1;EPHA1;PDGFRB;TTL;EPHA4
prerank,organic anion transport (GO:0015711),-0.3698071463628774,-1.3933174714401435,0.0449438202247191,0.46583435022934233,1.0,22/76,17.23%,ABCG2;ABCC4;SLC4A10;SLC26A7;SLCO1C1;SLCO2A1;CA4;CA2;LRRC8C;SLC52A3;SLC22A6;SLC25A42;SLC35B1;CYB5R1;CYB5RL;SLC35A2;SLC4A7;SLC39A8;SLC25A19;SLCO4A1;ABCC5;SLC52A2
prerank,regulation of neurotransmitter secretion (GO:0046928),-0.4354894101532858,-1.392929503070574,0.09024390243902439,0.4652031592291681,1.0,8/32,8.65%,RIMS1;RIMS2;MEF2C;MCTP1;CPLX1;SLC30A1;CAMK2A;SYN1
prerank,regulation of cation transmembrane transport (GO:1904062),-0.4371828482713658,-1.3926533646459243,0.08374384236453201,0.46428911072334017,1.0,7/29,5.00%,DPP10;KCNAB1;FGF12;KCNIP4;HOMER1;KCNIP1;DPP6
prerank,negative regulation of signaling (GO:0023057),0.5051338886722736,1.3925618901486825,0.09090909090909091,0.5894108307470305,1.0,5/25,5.68%,IGFBP3;MPIG6B;OSM;IL11;OPTN
prerank,positive regulation of histone methylation (GO:0031062),0.5189109617605977,1.391363198670154,0.07979626485568761,0.5915015977065017,1.0,6/24,13.47%,KMT2A;AUTS2;MYB;JARID2;SMAD4;PAF1
prerank,embryonic heart tube morphogenesis (GO:0003143),-0.409792536659866,-1.3912353527320462,0.05825242718446602,0.466735440026244,1.0,17/43,23.48%,MEF2C;RYR2;NOTCH1;SOX17;AHI1;ZIC3;TBX2;NDRG4;SOX18;ACVR1;APLNR;VANGL2;HES1;DLL1;SRF;TBX6;BBS7
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),-0.42499842796284454,-1.3908264184931776,0.065,0.466176398368901,1.0,16/33,28.07%,MEF2C;THBS1;NOTCH1;ACVRL1;HMGB1;FGF2;KLF4;RGCC;DLL4;CARD10;VASH1;ANGPT2;ANGPT4;HDAC5;CSNK2B;PDCD10
prerank,cardiac muscle tissue development (GO:0048738),0.4458374842779785,1.3908183375432006,0.07617504051863858,0.5915333647281279,1.0,10/50,4.75%,AKAP13;NOTCH2;GJB6;GATA6;CSRP3;GJA1;BMPR1A;RBP4;BMP2;BMP7
prerank,positive regulation of Notch signaling pathway (GO:0045747),0.4577086488547901,1.3907451882734554,0.07278481012658228,0.5898989764369665,1.0,9/39,8.62%,ROBO1;TSPAN5;RBPJ;ZMIZ1;IL6ST;BMP2K;AAK1;CREBBP;YAP1
prerank,skeletal muscle contraction (GO:0003009),0.5306986771252116,1.390051873823713,0.09774436090225563,0.5904276575505999,1.0,1/19,0.28%,TNNC1
prerank,heart process (GO:0003015),-0.5486187371930122,-1.3900386582924456,0.10714285714285714,0.4666944874740346,1.0,4/14,14.97%,SGCZ;SGCD;ACE;SOD1
prerank,acylglycerol metabolic process (GO:0006639),-0.41153256617994555,-1.3898185928071831,0.04556962025316456,0.46558433842674346,1.0,12/37,17.57%,DGKB;DGKI;DGKH;MGLL;ABHD2;SEL1L;DGKZ;CAV1;DGKG;ABHD6;PLAAT3;LPL
prerank,regulation of lipid biosynthetic process (GO:0046890),0.4880424299401065,1.389769262346119,0.08888888888888889,0.5894753475147158,1.0,7/32,9.15%,ZBTB20;PRKAG2;PRKAA2;SORBS1;CREBL2;PPARA;SIRT4
prerank,T cell differentiation (GO:0030217),0.460614571583223,1.3894098071795011,0.0698051948051948,0.5887979437297369,1.0,7/40,6.52%,LEPR;GLI3;NHEJ1;ANXA1;KIT;PTPN22;PTPN2
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.5310905326121821,1.3890523625826086,0.11754068716094032,0.5882527282605524,1.0,4/21,3.43%,IGFBP5;GJA1;BMPR1A;ADAMTS1
prerank,negative regulation of leukocyte migration (GO:0002686),-0.5936772141774662,-1.3889366423470246,0.09090909090909091,0.46628148783438284,1.0,2/10,6.40%,SLIT2;EMILIN1
prerank,negative regulation of focal adhesion assembly (GO:0051895),0.5645452262309262,1.3888649864218583,0.11510791366906475,0.5853013910847509,1.0,3/16,2.25%,PHLDB2;ARHGAP6;DLC1
prerank,negative regulation of cell-substrate junction organization (GO:0150118),0.5645452262309262,1.3888649864218583,0.11510791366906475,0.5853013910847509,1.0,3/16,2.25%,PHLDB2;ARHGAP6;DLC1
prerank,unsaturated fatty acid metabolic process (GO:0033559),0.4521747913074171,1.3888174316522235,0.07936507936507936,0.5836402245101271,1.0,9/41,11.00%,PTGS1;PLA2G4A;ACSL1;PLA2G4C;PTGR1;ALOXE3;SCP2;EPHX1;SCD5
prerank,negative regulation of cation transmembrane transport (GO:1904063),0.5460916563340859,1.388456152338345,0.10223048327137546,0.5829702216500929,1.0,2/18,1.49%,ATP1A2;STK39
prerank,phosphatidylcholine catabolic process (GO:0034638),0.615875295850208,1.3874113187568506,0.13671875,0.5845660907437125,1.0,3/10,10.74%,PLA2G4A;PLA2G6;ENPP2
prerank,negative regulation of coagulation (GO:0050819),0.5782652773019111,1.3867395229987611,0.11272727272727273,0.5850875635150812,1.0,4/14,8.66%,TFPI;VTN;SERPINE1;SERPINE2
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),0.5475978696910658,1.3862955766150116,0.10131332082551595,0.584848591485387,1.0,6/18,10.34%,PDPK1;COL4A3;FGFR1;CCL2;IGF2;AKT3
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.48861493732070704,1.385242209978617,0.10332749562171628,0.5864300819399307,1.0,4/27,2.51%,FN1;PDGFRA;DDR2;S100A6
prerank,chemokine-mediated signaling pathway (GO:0070098),0.4568763227238437,1.3843874103306566,0.0928,0.5874389510773379,1.0,10/42,14.90%,CXCL10;STK39;OXSR1;FOXC1;CCL2;ACKR3;SH2B3;WNK1;RBM15;CCL25
prerank,neurotransmitter uptake (GO:0001504),0.6004438740253079,1.3837004288547519,0.12966601178781925,0.5879897105906013,1.0,6/12,18.30%,ATP1A2;SLC1A3;GLUL;SLC38A1;SLC22A2;SLC29A1
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),0.4024595537628525,1.383696662729208,0.0374251497005988,0.586225087800293,1.0,21/87,12.26%,TGFBR3;SMAD3;ZMIZ1;COL3A1;BMPR1A;CDH5;TWSG1;LRRC32;PARD6A;PRKCZ;TGFBR1;APPL2;TGFBR2;USP9X;SKI;SMAD6;APPL1;PTK2;TGFBRAP1;SMAD4;MAP3K7
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),-0.5557930325667365,-1.3833068236421726,0.10580912863070539,0.48038887484537973,1.0,6/13,16.14%,PDE8A;MET;RACK1;PARK7;NR4A3;GPR37
prerank,positive regulation of interleukin-2 production (GO:0032743),-0.4588992570997884,-1.383167626842172,0.09610983981693363,0.47905446630622067,1.0,10/25,14.81%,PDE4D;PDE4B;PLCG2;RPS3;MALT1;CD80;CD86;RUNX1;PNP;PTPRC
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.5171212517264555,1.3808784012533053,0.10946196660482375,0.593990971931266,1.0,8/21,21.06%,SAMD4A;TUT4;PAN3;CNOT3;CNOT9;TUT7;PARN;PAN2
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),0.40865036698621904,1.3806000862788221,0.05812220566318927,0.5931499033770559,1.0,10/75,3.88%,SULF1;COL4A3;WNT4;ROCK2;CXCL10;FOXC1;THBS2;HSPG2;ADAMTS1;DCN
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.4414142555358294,1.379815309851677,0.054365733113673806,0.5939980404415348,1.0,6/46,7.66%,TCF7L2;SMAD3;NEDD4;ZIC1;TPR;GSK3B
prerank,nucleotide-sugar metabolic process (GO:0009225),-0.558411528406013,-1.3793609648971252,0.09859154929577464,0.48831914635849183,1.0,6/12,12.96%,CSGALNACT1;FUT8;GFPT2;PARG;GFUS;GFPT1
prerank,cardiocyte differentiation (GO:0035051),0.6226786447385546,1.3791170413425236,0.12180746561886051,0.5946170344049688,1.0,3/10,3.96%,AKAP13;GATA6;BMP2
prerank,regulation of Rho protein signal transduction (GO:0035023),0.40876640496980715,1.379107338876664,0.047839506172839504,0.5928763554855976,1.0,10/72,4.20%,ROBO1;LPAR1;AKAP13;KANK2;COL3A1;HEG1;DLC1;KANK1;NRP1;F2RL3
prerank,positive regulation of neuroblast proliferation (GO:0002052),-0.580251603254751,-1.379082905642753,0.09615384615384616,0.48723300698689914,1.0,3/10,8.85%,CTNNB1;FZD3;VEGFA
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.5167062223385964,-1.3787375556672792,0.12307692307692308,0.48644298027106064,1.0,7/17,21.97%,CALM1;CALM2;HSP90AB1;CALM3;PTPRC;PPP1R15B;PPP1R15A
prerank,triglyceride catabolic process (GO:0019433),-0.4878593979055408,-1.3778834463639127,0.11805555555555555,0.48713205521207276,1.0,9/19,42.09%,LPL;PNPLA3;LIPH;FABP3;LIPC;FABP4;FABP7;FABP12;FABP5
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.3137243363478063,1.3777424277771282,0.0,0.595670430436412,1.0,348/1646,16.65%,TCF7L2;TCF4;CREB5;KMT2A;EFEMP1;RORA;ZBTB20;SOX5;TSHZ2;WNT4;ZKSCAN2;EBF1;FOXD1;SMAD3;PRICKLE1;RBPJ;ZEB2;ZHX2;MXI1;ARID4A;ATXN1;ZMIZ1;NR2F2;SP100;ELF1;CREB3L2;TLE1;ARNT2;MLLT3;OSR1;IL31RA;TBL1XR1;TEAD1;SMURF2;FOXC1;NFIA;LBX1;STAT2;NFYC;NFAT5;TRIM56;PHIP;ZNF697;GATA6;SPIB;TCF24;WNT3A;KDM7A;MAF;HIF3A;RGMB;SAMD13;PPM1A;ZBTB4;ZNF395;DENND4A;SSBP2;NR6A1;FSTL3;ZIC2;SNX6;FOXC2;RBFOX2;GLI3;NFATC4;MYB;ZIC4;MBD2;ZMYND15;TRAK1;PARP9;TGFA;TCEAL7;FZD2;HIVEP2;IKZF2;TGFB1I1;PRRX2;EID2B;HIVEP1;CRY2;NUCKS1;HOXC6;PRDM11;ZBTB8A;HOXC4;PERM1;KIT;ZIC1;LITAF;BMP2;STAT5B;RFX3;CRY1;LOXL3;BRWD1;APBB1;CREB3L4;IL6;ZFP30;EPAS1;HLF;GLI1;BCOR;ARNT;BMP7;EN2;SIM2;ZNF276;UXT;MTDH;GLIS3;GZF1;NIF3L1;TGFBR1;NCOA6;SALL1;CBFA2T2;PRRX1;ZNF3;LBHD1;MGA;TCF12;KDM3B;KLF5;NSD3;BAZ2A;HDGFL3;SP9;ZNF35;CREB3L3;WWC2;NR1H3;FOXP3;ATP2B4;TESMIN;ANXA4;DTX3L;HDAC4;ZKSCAN4;CREBL2;PPARA;TCF7L1;TSHZ3;DKK3;PBXIP1;VGLL3;CREBBP;GLIS2;PCGF5;NSD1;ZBTB37;ZBTB7C;POU1F1;SFR1;KLF9;HOXA2;CREBRF;RNF20;DPF2;STAT1;WAC;ARHGEF11;NEK4;ZSCAN21;QRICH1;MEF2A;ZMYND11;NFXL1;RNF111;CRLF3;PIAS1;PHB2;ZNF25;TEAD2;ATF7;BAZ1B;CUX1;WNT5A;ZNF182;ZFP37;SP8;YAP1;ZEB1;CCNH;KAT6B;RLF;EPC1;IGF2;ZNF394;NAA16;ELF4;MNAT1;ZBTB3;USP47;SCMH1;SUMO1;CREM;SMAD6;TOX4;HDGFL2;SP110;E4F1;EBF4;JARID2;SOX21;NUPR2;BRD4;PBX1;RFXANK;TAF7;SUFU;MAFB;MSC;CDK16;MAPK14;PSPC1;WWP2;CUX2;GMNN;BAZ1A;ATF7IP;HEYL;ZNF292;UBE2V1;CIR1;POLR3F;ZNF235;TGFBRAP1;RRP8;NAA15;ELF2;RFXAP;TCF7;SMAD4;STAT4;SCML4;HIVEP3;BCL7A;EGR3;PPP3CB;ZNHIT3;FOXO3;NR4A1;ACTL6A;RBBP8;LHX9;ZNF219;VGLL4;ILF3;ZFAT;KDM5B;DVL3;EGR2;ZKSCAN7;OGG1;RPS6KA3;BTRC;SRCAP;THAP1;MAP2K1;HOXA10;FBXW11;BPTF;KDM2A;NFIC;MED12;CBX4;ARRB1;MZF1;BHLHE41;NR3C1;GMEB1;SERTAD3;MED20;PKNOX1;NFE2L1;NRF1;HIC1;ARID5B;POU2F1;ZNF205;KAT6A;BRWD3;ERCC6;PRDM5;KDM8;MDM4;NCOA2;SALL2;RBM15;DMTF1;RFX2;FUS;RUNX1T1;CARM1;VHL;NIBAN2;ZBTB21;ZNF569;ZBTB12;HDAC2;IFRD1;RARA;MAP3K2;PML;ZNF18;UIMC1;MAMSTR;ILK;SP3;ZFX;SETD5;ZNF383;HOXB4;TEF;SMARCA4;ACVR2B;SOX4;PHF20L1;IRF9;KDM2B;DNAJC2;VEZF1;LIN9;ERN2;POU5F1;ELK4;CTDSP1;ZNF260;JDP2;SMARCC1;URI1;DRGX;SMAD2;TRIM16;RING1;WWTR1;BCL11B;ZNF483;POU6F1;SPINDOC;NFATC2;TBL1X;PSRC1;CCAR1;ANKRD49;ZBTB5
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.5046230028518662,-1.3776978372437418,0.10762331838565023,0.4859038427968836,1.0,11/16,25.74%,ATP5F1A;ATP5MC1;ATP5PO;ATP5F1B;ATP5PD;ATP5F1D;ATP5F1E;ATP5ME;ATP5MG;ATP5MC3;ATP5MF
prerank,protein deneddylation (GO:0000338),-0.594727427256432,-1.3776236625195017,0.11976047904191617,0.4843880395817699,1.0,6/10,30.83%,COPS6;COPS5;COPS2;GPS1;COPS4;TOR1A
prerank,carbohydrate biosynthetic process (GO:0016051),-0.4749440094053705,-1.3774707732679077,0.08941176470588236,0.48314898030115055,1.0,5/21,9.05%,FUT8;ST3GAL6;FUT9;ST8SIA6;ST6GALNAC5
prerank,negative regulation of activated T cell proliferation (GO:0046007),0.6335546799388914,1.3773286500941422,0.11937377690802348,0.5952175618680494,1.0,4/10,7.89%,RC3H1;FOXP3;LGALS9;CD274
prerank,regulation of neuron migration (GO:2001222),-0.4637996059170641,-1.3770847109706872,0.0835214446952596,0.4825651114116366,1.0,15/26,23.89%,CTNNA2;SEMA6A;ADGRG1;DAB2IP;ARHGEF2;NEXMIF;RAPGEF2;SHTN1;CAMK2A;SEMA3A;SRGAP2;NTNG1;NTNG2;PLAA;NSMF
prerank,hippo signaling (GO:0035329),0.4972575568192061,1.3763936322639847,0.10243055555555555,0.596613620262507,1.0,12/26,17.62%,TEAD1;AMOTL1;LATS2;DCHS1;TEAD2;STK3;YAP1;TJP1;STK4;WWTR1;YWHAE;CASP3
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),0.5227105591853207,1.3761833291371026,0.11711711711711711,0.595509757929867,1.0,6/19,5.16%,TGFBR3;RBPJ;BMPR1A;RBP4;GLI1;TGFBR1
prerank,basement membrane organization (GO:0071711),0.5682966182002406,1.3760073344032913,0.13221601489757914,0.5943609093015437,1.0,3/14,2.53%,FLRT2;NID1;NID2
prerank,positive regulation of dendritic spine development (GO:0060999),-0.4847670357070618,-1.3758881664473486,0.08078602620087336,0.48424376649667733,1.0,10/20,23.47%,NLGN1;SHANK3;CAPRIN2;LRP8;DBNL;RELN;SHANK1;LLPH;CAPRIN1;FOXO6
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.4208474404348428,1.3756999795618683,0.07003257328990228,0.5936606159903217,1.0,20/62,17.39%,ELOF1;MLLT3;POLR2D;CDC73;CCNH;MNAT1;CDK7;CDK12;TCEA1;POLR2C;IWS1;RTF1;PAF1;POLR2F;GTF2H4;LEO1;MLLT1;AFF4;GTF2H2;CDK13
prerank,embryonic organ development (GO:0048568),0.41621418226779716,1.3744965958573414,0.07142857142857142,0.5957100195209665,1.0,16/61,12.67%,KMT2A;RBPJ;TEAD1;BMPR1A;GLI3;RBP4;KIT;SALL1;RARB;TGFBR2;TEAD2;COL13A1;PBX1;NES;SH2B3;RARRES2
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),-0.5169211008811625,-1.3735790730127304,0.08855291576673865,0.48894033957938693,1.0,13/14,48.11%,CSTF2;CPSF2;CSTF2T;CPSF1;CPSF4L;CPSF6;TUT1;NUDT21;ERN1;CPSF7;NCBP1;CPSF4;NCBP2
prerank,positive regulation of type 2 immune response (GO:0002830),0.5536540732474489,1.3733919072977285,0.11753731343283583,0.5975547967549956,1.0,4/14,7.50%,RSAD2;IL6;PRKCZ;IL18
prerank,granulocyte differentiation (GO:0030851),-0.49755457144280224,-1.3729308473406243,0.10191082802547771,0.4891295653436534,1.0,7/18,17.25%,LEF1;CBFA2T3;TAL1;CDK2;CDKN1A;CDK4;RXRA
prerank,positive regulation of potassium ion transport (GO:0043268),-0.41082460675296556,-1.3728883498893123,0.07216494845360824,0.48755527245233227,1.0,7/38,3.31%,KCNMB2;KCNMA1;AKAP6;KCNJ3;KCNJ2;NOS1AP;GABBR2
prerank,T-helper cell differentiation (GO:0042093),-0.5345514133199513,-1.3725844625994654,0.08686868686868687,0.4867592524008721,1.0,3/14,9.13%,LEF1;HMGB1;ZFPM1
prerank,regulation of lipid storage (GO:0010883),0.5072456486255718,1.3720643997362778,0.1056338028169014,0.6001885734402591,1.0,5/22,7.66%,IL6;IKBKE;PTPN2;CRP;FTO
prerank,regulation of stem cell differentiation (GO:2000736),0.3870280667558047,1.3711212991050432,0.05164992826398852,0.6014800334566094,1.0,15/89,10.29%,KMT2A;PTN;PDGFRA;EIF2AK2;TACSTD2;BMPR1A;OSM;MYB;TCF12;SLC4A11;PSMB10;YAP1;PSMA3;PSME4;PSMA5
prerank,Rho protein signal transduction (GO:0007266),0.42708938979274896,1.3708224291097615,0.07993730407523511,0.6007665051328552,1.0,8/53,7.75%,ARHGAP29;PDPN;ARHGAP6;ROCK2;NTN1;CELSR1;NGFR;ARHGEF11
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),0.5417625165779116,1.3707618191782138,0.12022900763358779,0.5992222564506506,1.0,4/16,5.23%,FOXD1;FGF1;BMP2;SALL1
prerank,protein import into nucleus (GO:0006606),0.4131192443663695,1.3704001003100559,0.05763239875389408,0.5987511374359863,1.0,13/66,12.16%,CBLB;PRICKLE1;TNPO1;RANBP2;APPL2;TPR;KPNA6;KPNA7;KPNA4;PHB2;APPL1;IPO7;EIF4ENIF1
prerank,intracellular sterol transport (GO:0032366),0.5729880644455153,1.3693043047502593,0.12686567164179105,0.6006224507290778,1.0,8/13,29.75%,NPC1;STAR;ABCA1;SERAC1;VPS4A;OSBPL2;ABCG1;STARD4
prerank,positive regulation of cell-cell adhesion (GO:0022409),0.4463800862557415,1.3691660522998916,0.10118043844856661,0.5993445608778312,1.0,9/41,13.11%,AFDN;PLPP3;FSTL3;BMP7;CD47;TJP1;PTPRU;ADAM19;JAK1
prerank,positive regulation of cellular catabolic process (GO:0031331),0.3704566375786362,1.3689555408603151,0.04317548746518106,0.5983010372287771,1.0,27/132,12.93%,ZBTB20;RNF152;SH3D19;ZC3HAV1;PRKAA2;DACT1;DAPK1;DCN;RC3H1;NRDC;ARNT;MTDH;OPTN;TRIM5;DTX3L;PPARA;PIK3C2A;GSK3B;SNX9;MOV10;LRRK2;TPCN1;FOXO3;VGLL4;TRIM21;PTPN1;SUPV3L1
prerank,regulation of ion transport (GO:0043269),-0.357910146428263,-1.3686535649866696,0.036939313984168866,0.4962843199890759,1.0,23/76,14.85%,NKAIN2;SYT1;KCNJ3;KCNJ2;ANK3;SNCA;ATP1A1;NKAIN3;CA2;YWHAH;NKAIN1;SYT4;SYT7;SIK1;B2M;NEDD4L;NOS1;KCNJ6;KCNJ8;KCNJ15;SYT9;SYT2;KCNA2
prerank,camera-type eye development (GO:0043010),0.5102063467999282,1.368383035079536,0.10218978102189781,0.5984178302897554,1.0,6/25,11.37%,EFEMP1;FBN1;SHROOM2;SKI;CACNA1C;NES
prerank,negative regulation of hormone secretion (GO:0046888),0.6070286791618099,1.3680702724468365,0.1494949494949495,0.5976334279037017,1.0,3/10,2.68%,GJA1;OSM;IL11
prerank,regulation of osteoclast differentiation (GO:0045670),0.4757242415124757,1.3678395223560145,0.08873720136518772,0.5967545824240861,1.0,7/33,12.04%,FBN1;FSTL3;PRXL2A;TLR4;CARTPT;MAFB;CSF1
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.5865498317003073,1.367416919573505,0.1586998087954111,0.5932052906790524,1.0,5/12,13.48%,ANAPC11;ESPL1;CUL3;NSMCE2;CDC27
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),0.5865498317003073,1.367416919573505,0.1586998087954111,0.5932052906790524,1.0,5/12,13.48%,ANAPC11;ESPL1;CUL3;NSMCE2;CDC27
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.5865498317003073,1.367416919573505,0.1586998087954111,0.5932052906790524,1.0,5/12,13.48%,ANAPC11;ESPL1;CUL3;NSMCE2;CDC27
prerank,interleukin-35-mediated signaling pathway (GO:0070757),0.5838905701754221,1.366695734158046,0.14015151515151514,0.5939181748663629,1.0,4/11,13.11%,IL6ST;STAT1;STAT4;JAK1
prerank,phosphatidylserine metabolic process (GO:0006658),0.47509090187517794,1.3663975325930382,0.10391822827938671,0.5932351698101125,1.0,4/32,5.17%,PLA1A;PLA2G4A;OSBPL8;MBOAT2
prerank,cellular amino acid catabolic process (GO:0009063),0.39411431416320736,1.3656812931170996,0.051775147928994084,0.5938143962370693,1.0,30/87,22.45%,HAL;DDO;SHMT1;HYKK;PHYKPL;NOS2;ALDH4A1;ASPA;ACADSB;HGD;GLUL;AMT;HNMT;BCKDHA;ABAT;BLMH;ACAT1;SARDH;ALDH6A1;HIBADH;ACAD8;MCCC1;CARNMT1;PRODH;DBT;ALDH7A1;HOGA1;HAAO;IVD;MCCC2
prerank,zinc ion transmembrane transport (GO:0071577),-0.471185411896293,-1.3655199814065377,0.0867579908675799,0.5036880895369227,1.0,7/22,14.55%,SLC39A10;SLC39A6;SLC30A1;SLC39A14;SLC39A12;SLC39A13;SLC39A8
prerank,regulation of fatty acid oxidation (GO:0046320),0.5468818812239447,1.3654947138580849,0.12313432835820895,0.592707253060795,1.0,4/16,9.15%,PRKAG2;APPL2;PPARA;SIRT4
prerank,intracellular pH reduction (GO:0051452),-0.42048971405811797,-1.3650889852023782,0.0855106888361045,0.5033008939418995,1.0,13/33,21.48%,ATP6V0A1;CLCN3;ATP6V1B2;ATP6V0C;RAB38;DMXL2;ATP6V1D;RAB39A;ATP6V0A2;ATP6V1G2;ATP6V0E2;ATP6V1F;ATP6V0D2
prerank,regulation of innate immune response (GO:0045088),0.4241502780798736,1.3650276379003659,0.084375,0.5926294433362004,1.0,18/57,17.00%,USP18;FPR2;PARP9;IFI35;PTPN22;APPL2;GBP5;BIRC3;ERAP1;APPL1;PTPN6;POLR3F;IRAK3;TRIM21;PTPN1;MUL1;IFNAR2;RNF135
prerank,cardiac muscle cell action potential (GO:0086001),-0.43477492072036683,-1.3650249520182955,0.08354430379746836,0.5018284013674861,1.0,12/30,12.24%,DMD;ATP1B1;FGF12;KCNJ2;SCN1A;ATP1A1;SLC8A1;HCN2;CACNA1G;KCND3;CACNA1D;KCNQ1
prerank,negative regulation of histone acetylation (GO:0035067),-0.564744281011531,-1.3636627777536543,0.1300639658848614,0.5038502068745802,1.0,5/11,19.08%,SNCA;CTBP1;SET;BRCA1;NOC2L
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),-0.49368668595935405,-1.3636031368310466,0.11210762331838565,0.5022913881689048,1.0,9/17,19.56%,SMAD7;CALM1;CALM2;INPP5K;CALM3;SPRED2;DDIT4;SPRED3;SPRED1
prerank,glycosphingolipid biosynthetic process (GO:0006688),-0.49005224268131303,-1.363533960673789,0.10368663594470046,0.5007570075525655,1.0,5/16,9.05%,ST6GALNAC3;ST8SIA4;ST8SIA6;ST6GALNAC4;ST6GALNAC5
prerank,regulation of macrophage cytokine production (GO:0010935),-0.534342847378806,-1.3630167086596012,0.13203463203463203,0.500563295574179,1.0,5/13,9.50%,PLCG2;TGFB2;SEMA7A;TGFB3;CD74
prerank,polyol metabolic process (GO:0019751),-0.3931463204995218,-1.361177105420462,0.05822784810126582,0.5041478511988955,1.0,13/46,15.74%,INPP4B;PLCB1;PLCB4;PLCG2;ITPKB;INPP5D;CALM1;IP6K2;IMPA1;PLCH1;PPIP5K2;PPIP5K1;PLCG1
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.5736375932209572,1.3608282729226797,0.11730769230769231,0.6049015827241634,1.0,4/13,10.34%,PDPK1;FGFR1;IGF2;AKT3
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),-0.558660821251082,-1.3603915393612571,0.12475247524752475,0.504672161363729,1.0,5/11,13.77%,ANK3;PRKCQ;LYN;SYK;PLAUR
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.3732439823557184,1.3593853347218556,0.04105571847507331,0.6080680290723797,1.0,22/121,8.99%,BMP6;TEC;PARP14;VTN;GHR;IL31RA;IL6ST;OSM;IL11;NRP1;PARP9;ITGA5;IL34;ANGPT1;KIT;IL6;HAX1;IL18;TNFRSF14;RIPK2;EPHA4;IGF2
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),-0.5624895003423437,-1.3589408392391404,0.11042944785276074,0.5053813205546436,1.0,6/10,27.43%,VLDLR;AP2B1;AP2A2;AP2A1;CLTA;AP2M1
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),-0.5624895003423437,-1.3589408392391404,0.11042944785276074,0.5053813205546436,1.0,6/10,27.43%,VLDLR;AP2B1;AP2A2;AP2A1;CLTA;AP2M1
prerank,membrane organization (GO:0061024),-0.2996086871895208,-1.3587805361269334,0.009259259259259259,0.5042053330424883,1.0,51/227,13.89%,DNM3;SGIP1;SGCZ;SYT1;RIMS1;HIP1;FNBP1L;HSPA8;TFRC;AMPH;CERT1;ACTB;SH3KBP1;REEP1;EPN2;CHRM2;ANK3;LPCAT2;ACTG1;HIP1R;ATP2C1;SH3GL2;SNX3;DYSF;FNBP1;GLTP;CCDC88A;ARPC3;ARPC4;ARPC2;NSFL1C;UBB;REPS2;LDLRAP1;VPS33B;CNTN2;M6PR;MFN2;SERP1;ARPC1A;CBL;ADRB2;SCARB2;NUP93;SYNGR2;EGFR;NAPA;FZD4;UBA52;SYT9;SYT2
prerank,positive regulation of protein modification process (GO:0031401),-0.30898181082224163,-1.3582031601924283,0.012987012987012988,0.5040994410385441,1.0,50/203,13.77%,TEK;PECAM1;LIMCH1;ERBB4;LIMK2;PPP1R16B;EFNA5;PDE8A;TNIK;INSR;TFRC;KDR;VEGFC;NOS1AP;PAK1;TBX1;CSNK1D;NTRK2;CAMTA1;CALM1;GAS6;SEMA4D;CALM2;PTBP1;RAB3GAP1;PIK3R3;MAPK3;NPTN;CALM3;BMP4;AKT1;ACE;SYMPK;PINK1;ACVR2A;VEGFA;CCND1;FAS;CD74;LYN;RACK1;CD40;FGF2;EGFR;HSP90AA1;CSF1R;HRAS;RAC1;KRAS;PLAUR
prerank,pyrimidine-containing compound metabolic process (GO:0072527),0.5851204985160079,1.3576526784930658,0.14901960784313725,0.6122826278991577,1.0,1/11,0.23%,ENPP3
prerank,cellular modified amino acid biosynthetic process (GO:0042398),-0.47168680189449397,-1.356610515589264,0.08533916849015317,0.5067636103748631,1.0,10/20,31.31%,GATM;OPLAH;GCLC;PLOD2;PTDSS1;GGT1;MTHFS;HAGH;MGST2;GCLM
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.45283133104627715,1.3561481077958826,0.10784313725490197,0.6153851427613584,1.0,7/38,10.32%,RORA;TLE1;PPM1A;STAT1;ZMYND11;NLRX1;PPM1B
prerank,cristae formation (GO:0042407),-0.43780060910123364,-1.3561018753193956,0.09534883720930233,0.5065248886709262,1.0,15/27,31.79%,ATP5F1A;ATP5MC1;ATP5PO;SAMM50;ATP5F1B;ATP5PD;ATP5F1D;UQCC3;ATP5F1E;ATP5ME;ATP5MG;ATP5MC3;ATP5MF;LETM1;CHCHD3
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.4039614802815882,1.3552631571452343,0.06845238095238096,0.6167276472948151,1.0,15/76,11.12%,UACA;SASH1;EIF2AK2;NFAT5;PPM1A;IFI35;TLR4;BMP7;PTPN22;CPNE1;LGALS9;PHB2;DLG1;PPM1B;TLR2
prerank,oxoacid metabolic process (GO:0043436),0.4846270601835021,1.3551379257467795,0.11971830985915492,0.6154420281841119,1.0,11/27,21.01%,DDO;ENPP1;TPST1;LIPT1;THAP4;HAO1;SULT1A1;ABHD14B;GRHPR;SULT6B1;AGXT
prerank,negative regulation of anoikis (GO:2000811),0.5622654317808229,1.3547426451123186,0.1320754716981132,0.6150697442087935,1.0,5/14,11.16%,TLE1;ITGA5;BCL2;MCL1;PTK2
prerank,negative regulation of phosphorylation (GO:0042326),0.397647638423227,1.3543008727217374,0.06382978723404255,0.6148439928862515,1.0,13/85,9.30%,PTPN13;IGFBP3;PID1;PLPP3;NUPR1;DYNLL1;FBLN1;BMP7;HDAC4;PPARA;CDKN2B;MYADM;LRRK2
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.36008992093655295,1.353840995571942,0.03145478374836173,0.6147688338550367,1.0,32/158,14.55%,WLS;LPAR1;AKAP13;ECM1;GJA1;PPM1A;TRAF5;LITAF;CFLAR;IKBKE;ROR1;MTDH;GOLT1B;MIER1;PELI2;TRIM5;BIRC3;BST2;JMJD8;LGALS9;VAPA;RIPK2;ANKRD17;BRD4;UBE2V1;RHOC;MAP3K7;TRIM21;TIFA;TICAM1;ZDHHC17;TBK1
prerank,defense response to Gram-positive bacterium (GO:0050830),0.4489674482051207,1.352735321312286,0.119281045751634,0.616792839416346,1.0,9/40,12.67%,GBP6;GBP2;IL6;CRP;GBP4;TNFRSF14;GBP7;TLR2;RARRES2
prerank,release of sequestered calcium ion into cytosol (GO:0051209),-0.4445839533825325,-1.3527264570846151,0.10633484162895927,0.514369740777826,1.0,12/26,18.16%,PLCG2;RYR2;HTR2C;RYR3;FGF2;PTPRC;ERO1A;CCL19;HTR2B;IBTK;SLC8B1;HTR2A
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.3990555898487832,1.3526954783920209,0.07270029673590504,0.615245320536183,1.0,14/72,13.75%,FLRT2;FGFR1;FGF1;RBFOX2;FRS2;POLR2D;KL;HNRNPH1;FGF18;FLRT1;POLR2C;NOG;SHOC2;POLR2F
prerank,establishment of endothelial barrier (GO:0061028),-0.4307893629968554,-1.3526553440792422,0.08545034642032333,0.5128912733417955,1.0,13/29,18.43%,PDE4D;PECAM1;PPP1R16B;ROBO4;RAPGEF2;PDE2A;SOX18;RAPGEF6;F11R;TJP2;RAP1A;MARVELD2;RAB1B
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.4866660735742829,1.3522121501651199,0.11030741410488246,0.6151566940134897,1.0,9/26,18.62%,KANK2;CRY2;CRY1;STRN3;HEYL;SMARCA4;DAB2;CNOT9;CLOCK
prerank,calcium import into the mitochondrion (GO:0036444),0.6098175643522734,1.352089524098555,0.14538310412573674,0.6139510433124905,1.0,2/10,1.57%,MCU;MICU1
prerank,development of primary male sexual characteristics (GO:0046546),0.4673673735839845,1.3516185216132788,0.09949409780775717,0.6137344381453363,1.0,5/34,3.84%,WNT4;GATA6;WNT2B;LHFPL2;KIT
prerank,regulation of cell killing (GO:0031341),0.5530535318206693,1.3512410636931393,0.14666666666666667,0.61342613220397,1.0,5/16,8.47%,CFH;CD55;IL11;NOXO1;WNT5A
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),-0.4718350494275471,-1.350935279581269,0.11587982832618025,0.5161993311991732,1.0,8/20,7.24%,DMD;ATP1B1;RYR2;CALM1;CALM2;SLC8A1;CALM3;CAMK2D
prerank,synaptic vesicle endocytosis (GO:0048488),-0.4129718355787095,-1.3508104134534638,0.0815347721822542,0.5148747595359389,1.0,7/33,10.02%,DNM3;NLGN1;SYT1;AMPH;SNCA;NLGN3;SNAP91
prerank,positive regulation of ruffle assembly (GO:1900029),-0.5283631588979127,-1.3506781689298673,0.12871287128712872,0.5135853328681045,1.0,10/13,39.13%,NLGN1;EPS8;HRAS;FAM98A;PFN1;CARMIL2;PLEKHM1;NDEL1;EPS8L2;P2RY12
prerank,protein export from nucleus (GO:0006611),0.48164979955389586,1.3500816427087392,0.12299465240641712,0.6154602223154839,1.0,10/27,21.85%,RANBP3L;TPR;DUSP16;EGR2;STRADB;RAN;RANBP17;STYX;XPO5;PKD1
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),-0.5167922973188761,-1.3500314805750206,0.11513859275053305,0.5136710593760498,1.0,12/13,48.11%,CSTF2;CPSF2;CSTF2T;CPSF1;CPSF4L;CPSF6;TUT1;NUDT21;CPSF7;NCBP1;CPSF4;NCBP2
prerank,negative regulation of supramolecular fiber organization (GO:1902904),-0.357148684041321,-1.3492908064589935,0.06963788300835655,0.5142093092702356,1.0,25/72,18.17%,SLIT2;SHANK3;SSH2;NAV3;KANK3;HSPA8;KANK4;SNCA;HIP1R;ARHGEF2;STMN2;EMILIN1;CYRIB;PFDN5;TUBB4A;FGF13;PFDN2;CLASP2;TWF1;MAP2;SSH3;SHANK1;PFDN4;MID1IP1;STMN1
prerank,ATP transport (GO:0015867),0.6127624909000371,1.3490885423565202,0.15163147792706333,0.6171475255864086,1.0,4/10,14.25%,SLC17A9;CD47;SLC25A24;SLC25A4
prerank,axonal transport (GO:0098930),-0.4072642118369754,-1.3490260430871766,0.0725,0.5133233149156224,1.0,16/36,26.45%,SYBU;KIF1B;DYNC1H1;AP3S2;TMEM108;KIF3B;AP3B2;SOD1;MAPT;SNAPIN;AP3D1;DCTN1;KIF4A;HAP1;NEFL;BLOC1S4
prerank,positive regulation of inflammatory response (GO:0050729),0.38422588095113014,1.3490042046481079,0.07456140350877193,0.6157605639686382,1.0,16/86,11.69%,IL16;NUPR1;IL6ST;OSM;IFI35;IL6;TLR4;ZBP1;SERPINE1;CREB3L3;CD47;IL18;SETD4;WNT5A;TLR2;NFKBIZ
prerank,negative regulation of protein polymerization (GO:0032272),-0.443261580635246,-1.3488544596470817,0.09302325581395349,0.5121570559731302,1.0,14/27,20.10%,SLIT2;SSH2;KANK3;KANK4;SNCA;HIP1R;STMN2;CYRIB;TUBB4A;TWF1;MAP2;SSH3;STMN1;PFN2
prerank,myoblast fusion (GO:0007520),-0.5374318704763678,-1.347762956763844,0.1111111111111111,0.5136285593677035,1.0,4/12,10.30%,ADGRB3;JAM2;KCNH1;NOS1
prerank,regulation of Wnt signaling pathway (GO:0030111),0.3740959411747011,1.3476945342616937,0.06286549707602339,0.6183901700521681,1.0,23/108,13.86%,SULF1;WLS;DCDC2;TLE1;KANK1;PTK7;WWOX;APCDD1;DACT1;BMP2;TERT;SALL1;FOXP3;TCF7L1;CDC73;SKI;LRRK2;NKD1;TLR2;VGLL4;BTRC;HIC1;RNF43
prerank,negative regulation of small molecule metabolic process (GO:0062014),0.509731967619602,1.3476420673786116,0.15875912408759124,0.6169333896825194,1.0,2/20,4.06%,WNT4;CRY1
prerank,histone modification (GO:0016570),0.37204325148717393,1.3472115680850174,0.0502092050209205,0.6166774235916812,1.0,25/109,15.59%,EYA2;EYA1;TBL1XR1;MIER3;UBE2U;NSD3;BAZ2A;MIER1;HDAC4;CREBBP;NSD1;BAZ1B;KAT6B;HLCS;HUWE1;EYA4;ATXN7;BRD8;KAT6A;PRDM5;USP36;CARM1;RBM14;HDAC2;PHF20L1
prerank,anterograde axonal transport (GO:0008089),-0.4098406061875767,-1.3456850010827968,0.1038961038961039,0.5180785822488345,1.0,13/37,17.02%,DLG2;KIF1B;KIF1C;RAB27B;AP3S2;KIF5C;MAPK8IP3;KIF3B;AP3B2;KIF5A;SOD1;SNAPIN;AP3D1
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.37538036366088356,1.3449648194232866,0.06607929515418502,0.6224012791970681,1.0,18/104,7.92%,PDPK1;SMAD3;SMURF2;PPM1A;BMPR1A;FSTL3;NBL1;SNX6;LDLRAD4;TGFB1I1;PMEPA1;BMP2;WFIKKN1;TGFBR1;BCL9L;PPARA;TGFBR2;SKI
prerank,protein kinase B signaling (GO:0043491),-0.4624896731185839,-1.3442022172560468,0.08333333333333333,0.5207558890543856,1.0,6/23,11.27%,KDR;SETX;GAS6;PIK3R3;AKT1;PAX2
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.4663743391572962,1.3429618588905414,0.12315270935960591,0.6275120578455271,1.0,12/29,21.82%,SMAD3;TUT4;SNIP1;ADAR;TARBP2;ZC3H7B;SMAD2;HNRNPA2B1;PUM2;TUT7;PUS10;SRRT
prerank,energy derivation by oxidation of organic compounds (GO:0015980),0.48712285056621973,1.3429502673258475,0.14821428571428572,0.6259208088614184,1.0,2/24,1.34%,LEPR;PID1
prerank,cardiolipin metabolic process (GO:0032048),0.5709007580808507,1.3423738357168646,0.14864864864864866,0.626121713589171,1.0,5/13,19.81%,PLA2G4A;PLA2G6;PLA2G5;HADHA;SLC27A1
prerank,regulation of lipid kinase activity (GO:0043550),-0.5674835521417352,-1.341795349542923,0.13701431492842536,0.5261323802033504,1.0,6/11,23.08%,PIK3R1;PIK3R3;WDR81;RBL1;RBL2;PPP2R5A
prerank,membrane depolarization (GO:0051899),-0.4186325851381331,-1.3414990146363703,0.08747044917257683,0.525432762402292,1.0,13/32,17.85%,CACNA1E;CACNB4;SCN1A;SCN2A;CACNA1G;YWHAH;SCN8A;SCN9A;CAV1;P2RX7;SCN3A;CHRNA4;CACNA1A
prerank,B cell receptor signaling pathway (GO:0050853),-0.40965868795669974,-1.341424461287463,0.11084905660377359,0.524011953043668,1.0,12/32,14.87%,MEF2C;PRKCB;PLCG2;RFTN1;PLEKHA1;BMX;CD38;BCAR1;SYK;PIK3CD;PTPRC;LAT2
prerank,inositol phosphate-mediated signaling (GO:0048016),0.5265926216394491,1.3413040453278053,0.12041884816753927,0.6280082232990373,1.0,8/19,19.06%,NFAT5;NFATC4;PLCE1;NMUR1;PPP3CB;ADGRB2;NFATC2;NFATC3
prerank,intermediate filament organization (GO:0045109),0.530446514534077,1.3411152629507421,0.1326923076923077,0.627010377799958,1.0,7/17,19.31%,VIM;DES;EPPK1;KRT9;BFSP1;DNAJB6;DSP
prerank,negative regulation of transposition (GO:0010529),0.5273268226613361,1.340810711325155,0.16074766355140188,0.6263517424938403,1.0,3/16,8.81%,TUT4;PIWIL4;MOV10
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.30847317946277303,1.3406144837012248,0.0,0.6253557528533186,1.0,226/1082,16.62%,TCF7L2;TCF4;CREB5;KMT2A;RORA;BMP6;WNT4;SMAD3;RBPJ;ZEB2;ZMIZ1;NR2F2;CXCL10;SP100;ELF1;ELOF1;RGMA;CREB3L2;FGF1;PID1;AUTS2;ARNT2;MLLT3;OSR1;IL31RA;TBL1XR1;TEAD1;FOXC1;NFIA;NFAT5;TRIM56;PHIP;GATA6;SPIB;WNT3A;RGMB;CSRP3;PPM1A;BMPR1A;ZNF395;SSBP2;OSM;FSTL3;ZIC2;FOXC2;IL11;GLI3;WWOX;MYB;NCOA3;PARP9;CDK8;FZD2;LDB2;TGFB1I1;HIVEP1;PRDM11;HOXC4;ZIC1;DCN;LITAF;BMP2;STAT5B;RFX3;GABPB2;GABPB1;APBB1;CREB3L4;IL6;KMT2C;EPAS1;HLF;TLR4;GLI1;ARNT;BMP7;GLIS3;NIF3L1;TGFBR1;NCOA6;SALL1;LBHD1;TCF12;SERPINE1;KLF5;HAX1;NSD3;MLLT10;CREB3L3;NR1H3;FOXP3;ARF4;BCL9L;DTX3L;HDAC4;CREBL2;PPARA;CREBBP;RARB;POGZ;GLIS2;PCGF5;NSD1;POU1F1;SFR1;CREBRF;RNF20;IL18;DPF2;STAT1;WAC;ARHGEF11;SKI;CDKN2B;NEK4;ZSCAN21;QRICH1;MEF2A;RIPK2;RNF111;CRLF3;TEAD2;WNT5A;YAP1;RHOQ;CRTC1;KAT6B;RLF;EPC1;GLYR1;IGF2;NAA16;ELF4;CDK7;E4F1;UTP15;BRD4;PBX1;RFXANK;TAF7;PFKM;MAFB;TCEA1;ATF7IP;HEYL;MYSM1;UBE2V1;CDH13;TLR2;NAA15;ELF2;RFXAP;SMAD4;MAP2K5;HIVEP3;PPP3CB;FOXO3;NR4A1;CRTC3;ILF3;DVL3;EGR2;MAML2;RPS6KA3;BTRC;SS18;SERTAD2;MAP2K1;HOXA10;FBXW11;BPTF;TET2;NFIC;MED12;ARRB1;MZF1;NR3C1;BRD8;SERTAD3;WASL;NRF1;SENP1;ZNF462;POU2F1;KAT6A;THOC5;ERCC6;KDM8;NCOA2;SALL2;NCK1;TBK1;VHL;NIBAN2;THAP3;RBM14;HDAC2;RARA;MAP3K2;PML;EIF2AK3;ILK;SP3;HOXB4;SMARCA4;KAT2B;SOX4;DNAJC2;TXK;DAB2;VEZF1;PRKD2;PKD2;POU5F1;ELK4;APP;TAF9;SMARCC1;SMAD2;TRIM16;WWTR1;BCL11B;NFATC2;TBL1X;PSRC1;ANKRD49
prerank,inorganic cation transmembrane transport (GO:0098662),-0.2912479237038841,-1.340519216280735,0.00980392156862745,0.5251202577922435,1.0,63/268,14.85%,SLC6A6;SLC12A2;KCNB2;KCND2;SLC9A2;KCNQ5;KCNAB1;KCNK5;TRPC3;ATP1B1;SLC24A2;ABCC9;KCNH7;KCNJ2;KCNC2;KCNQ3;SLC6A1;SCN1A;SLC40A1;HCN1;FKBP1A;GAS6;TRPC5;ATP1A1;TRPC4;SLC25A27;RYR3;ATP2C1;SLC8A1;KCNK10;SLC9A8;SLC39A6;HCN2;SCN2A;ATP2A3;CACNA1G;TRPC6;UCP2;KCNH1;TMEM175;ATP6V0C;KCNH5;SLC30A1;SLC39A14;KCND3;ATP5PO;CACNA1D;KCNB1;SLC36A1;SCN8A;KCNJ8;TMCO1;ATP5F1B;SCN9A;KCNQ1;SLC6A5;SLC39A13;ATP2A2;KCNC1;SLC6A11;SLC39A8;SLC9A5;KCNA2
prerank,prostanoid biosynthetic process (GO:0046457),0.5473446069714591,1.3401292981219133,0.1183206106870229,0.6253124365655649,1.0,2/15,1.37%,PTGS1;PLA2G4A
prerank,ether lipid metabolic process (GO:0046485),0.5496881389994189,1.3399142992027575,0.14972273567467653,0.6244627038366886,1.0,2/14,8.09%,AGMO;PLA2G6
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),-0.40321339848050364,-1.3398423658816303,0.10024449877750612,0.5254942325945697,1.0,9/37,5.85%,CADM1;NLGN1;HMCN1;PTPRD;GRID2;TENM2;TENM3;IL1RAPL1;TENM4
prerank,regulation of fibroblast proliferation (GO:0048145),0.4334762255737368,1.339684169506496,0.10066006600660066,0.6235925927482211,1.0,9/45,8.47%,FN1;PDGFRA;DDR2;S100A6;MORC3;PARP10;CDC73;SKI;WNT5A
prerank,negative regulation of glucose transmembrane transport (GO:0010829),0.5993829619175346,1.3393097870315396,0.16512059369202226,0.6231995509478976,1.0,3/10,5.69%,PID1;ENPP1;APPL2
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),0.5315636244160531,1.3388001558904867,0.1384335154826958,0.6233168080789923,1.0,6/17,12.69%,RBPJ;NOTCH2;BMPR1A;BMP2;HEYL;NOG
prerank,cellular glucan metabolic process (GO:0006073),0.5949240602263314,1.3383866144138998,0.1727447216890595,0.6231664830116665,1.0,3/11,9.09%,PRKAG2;GSK3B;PYGM
prerank,positive regulation of signal transduction (GO:0009967),0.3387158563601271,1.3377894706626179,0.029224904701397714,0.6235397857251791,1.0,48/238,12.43%,SULF1;ROBO1;WLS;BMP6;TSPAN5;DCDC2;SASH1;RBPJ;ZMIZ1;VTN;FGF1;AXL;IL6ST;PHIP;GHRH;KANK1;BMP2K;NRP1;ITGA5;DACT1;BMP2;TERT;LOXL3;SORBS1;IL6;GLI1;ARNT;PRKCZ;AAK1;TGFBR1;SALL1;CREBBP;CDC73;LY96;SKI;BAX;YAP1;IGF2;LRRK2;CUX2;RAB34;TLR2;NLGN2;IHH;DSTYK;P2RY6;CCBE1;MAML2
prerank,sulfur amino acid metabolic process (GO:0000096),-0.4439605022422795,-1.3377571036953297,0.10457516339869281,0.5298849712119769,1.0,11/24,23.77%,MTHFR;MSRA;TXN2;GCLC;MTRR;SMS;CTH;ADO;MPST;AHCY;NOX4
prerank,actin filament network formation (GO:0051639),-0.5483753507389393,-1.337555806485466,0.1414141414141414,0.5287673378348253,1.0,7/11,30.94%,ACTN1;PLS3;LCP1;FHOD3;CARMIL1;SPIRE2;CARMIL2
prerank,chromatin organization involved in regulation of transcription (GO:0034401),0.5603431230226074,1.3373345217489112,0.1564245810055866,0.6234189015915632,1.0,2/13,1.19%,ZMIZ1;ELOF1
prerank,interleukin-6-mediated signaling pathway (GO:0070102),0.5267796195706869,1.335881631388236,0.13577981651376148,0.6264420992547868,1.0,7/18,13.11%,IL6ST;FER;IL6;STAT1;YAP1;SMAD4;JAK1
prerank,nuclear transport (GO:0051169),-0.5021033433288481,-1.3357345611756324,0.12646370023419204,0.5325178091186644,1.0,7/16,23.65%,NPM1;AAAS;XPO1;ANP32A;NXT1;RBM15B;BANF1
prerank,regulation of defense response to virus by host (GO:0050691),0.48269340173057934,1.3348487292911977,0.11764705882352941,0.6283516840873968,1.0,9/30,15.52%,PARP9;PTPN22;RNF216;DTX3L;STAT1;IFNLR1;TARBP2;IL23R;MUL1
prerank,regulation of cellular metabolic process (GO:0031323),0.42624690550877875,1.3338090311059485,0.10543657331136738,0.6299615017249194,1.0,7/45,6.94%,PID1;TBC1D16;PANK2;ARF4;MPV17;PPARA;SSH1
prerank,lipid homeostasis (GO:0055088),0.4137981753758995,1.3334949522227684,0.09554140127388536,0.629502563942999,1.0,20/57,24.83%,ZBTB20;RBP1;PRKAA2;ACOXL;NR1H3;DGAT2;ABCA1;ABHD5;ACOX1;ANGPTL3;RCN3;XBP1;FBXW7;NR1D2;CEBPA;PRKAA1;TM6SF2;ABHD8;THADA;IRS2
prerank,negative regulation of interleukin-17 production (GO:0032700),0.586001648010213,1.3326377065411152,0.16929133858267717,0.6306009050396507,1.0,2/10,6.03%,TLR4;FOXP3
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.3092887066579668,1.3322679147000442,0.0,0.6302843246111219,1.0,179/807,16.51%,TCF7L2;FHL2;BMP6;WNT4;FOXD1;SMAD3;PRICKLE1;RBPJ;ZEB2;ZHX2;MXI1;ARID4A;ATXN1;KANK2;NR2F2;SP100;KCNIP3;PRDM6;TLE1;OSR1;TBL1XR1;SMURF2;FOXC1;GATA6;SAMD13;PPM1A;ZBTB4;NR6A1;ZIC2;SNX6;FOXC2;RBFOX2;GLI3;WWOX;MYB;MBD2;ZMYND15;PARP9;TCEAL7;LDB2;EID2B;HIVEP1;CRY2;PRDM11;DACT1;BMP2;RFX3;CRY1;LOXL3;APBB1;MIER3;BCOR;BMP7;AEBP1;UXT;MTDH;GLIS3;GZF1;SALL1;OTP;CBFA2T2;ZNF3;MIER1;TPR;WWC2;NR1H3;FOXP3;HDAC4;PPARA;TSHZ3;DKK3;PBXIP1;CREBBP;RARB;GLIS2;NSD1;USP9X;DPF2;STAT1;CDC73;SKI;MEF2A;ZMYND11;PHB2;ZNF25;VPS72;CUX1;WNT5A;ZFP37;YAP1;ZEB1;SAP130;KAT6B;DLG1;EPC1;IGF2;USP47;SCMH1;SUMO1;GATAD2B;CREM;E4F1;JARID2;NUPR2;TAF7;SUFU;PSPC1;WWP2;CUX2;PPID;GMNN;ATF7IP;HEYL;CIR1;CBX7;FNIP1;SMAD4;MAP2K5;SCML4;BCL7A;RTF1;ATN1;FOXO3;LHX9;IFI27;ZNF219;VGLL4;ILF3;BTRC;THAP1;NOG;EFNA1;FBXW11;BPTF;KDM2A;NFIC;CBX4;MZF1;BHLHE41;NR3C1;PEX2;PAF1;HIC1;ARID5B;POU2F1;ZNF205;KAT6A;PRDM5;KDM8;MDM4;RBM15;TLE6;RUNX1T1;FRK;VHL;NIBAN2;ZBTB21;HDAC2;RARA;PML;UIMC1;SP3;SMARCA4;ACVR2B;PER3;KDM2B;DAB2;ERN2;POU5F1;ELK4;CPEB3;MUC1;JDP2;URI1;SMAD2;RING1;POU6F1;SPINDOC;TBL1X
prerank,interleukin-1-mediated signaling pathway (GO:0070498),-0.328927767088292,-1.3320257115205574,0.03715170278637771,0.5417184927226013,1.0,28/94,21.19%,PLCB1;ST18;RPS6KA5;IL1R1;NOD1;IL1RAP;PSMC3;MAPK3;PSMD14;UBB;PSMD3;PSMD4;PSMD6;PSMA6;PSMA4;PSMB8;UBA52;PSMA8;NOD2;PSME1;TOLLIP;IRAK1;PSMD7;PSMC6;IKBKB;PSMB5;PSMC5;PSMB1
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),-0.5060909028920311,-1.331829257452876,0.14408602150537633,0.5406980819401289,1.0,6/15,13.20%,JMY;ARPC3;ARPC4;ARPC2;ARPC1A;WASHC1
prerank,digestive tract development (GO:0048565),0.4583854511368291,1.3315037970240478,0.12521150592216582,0.631219652423776,1.0,8/32,7.18%,GATA6;GLI3;KIT;GLI1;SALL1;CLMP;RARB;DNAAF1
prerank,positive regulation of T cell cytokine production (GO:0002726),0.502985724550257,1.3313929951077061,0.13368983957219252,0.6299975093490829,1.0,5/20,7.50%,RSAD2;CD55;IL6;PRKCZ;IL18
prerank,regulation of angiogenesis (GO:0045765),0.3453694243254598,1.3307011652641512,0.04325032765399738,0.630766879999542,1.0,29/192,8.47%,SULF1;PDPK1;COL4A3;ROCK2;SASH1;CXCL10;SP100;FGF1;ECM1;FOXC1;GATA6;THBS2;CEMIP2;HSPG2;CDH5;ITGB8;VEGFD;ANXA3;ADAMTS1;DCN;IL6;MTDH;SERPINE1;EPHA1;ATP2B4;CTSH;STAT1;GLUL;WNT5A
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),0.5129698178109076,1.3306661738575458,0.14128440366972478,0.6293211578001171,1.0,2/19,0.82%,MCU;CAMK1D
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.40273353891514024,1.330516755153079,0.08626198083067092,0.6283141746343436,1.0,20/64,17.39%,ELOF1;MLLT3;POLR2D;CDC73;CCNH;MNAT1;CDK7;CDK12;TCEA1;POLR2C;IWS1;RTF1;PAF1;POLR2F;GTF2H4;LEO1;MLLT1;AFF4;GTF2H2;CDK13
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.4755709886618709,1.3297481695765412,0.147008547008547,0.629392006551706,1.0,6/26,10.17%,FBN1;FSTL3;TLR4;CARTPT;PTPN2;MAFB
prerank,iron ion transmembrane transport (GO:0034755),-0.5588524860139685,-1.3296470704717747,0.14285714285714285,0.5452590428912737,1.0,5/10,16.61%,SLC40A1;SLC39A14;SLC39A8;ABCC5;SCARA5
prerank,actin polymerization or depolymerization (GO:0008154),0.4178994010794833,1.3288035955897086,0.11488673139158576,0.6308564640540638,1.0,4/50,0.81%,GAS7;ARHGAP6;MICAL3;DIAPH1
prerank,Golgi localization (GO:0051645),0.5856572326033203,1.3284820686522776,0.152,0.6303499345173103,1.0,3/11,11.70%,ARHGAP21;UVRAG;ARCN1
prerank,phagosome acidification (GO:0090383),-0.44324084767825833,-1.3279274471839013,0.09178743961352658,0.5487321490858625,1.0,11/26,21.48%,ATP6V0A1;ATP6V1B2;ATP6V0C;RAB38;ATP6V1D;RAB39A;ATP6V0A2;ATP6V1G2;ATP6V0E2;ATP6V1F;ATP6V0D2
prerank,negative regulation of glycolytic process (GO:0045820),0.5807644346540056,1.3270452145486515,0.17613636363636365,0.6318118758995143,1.0,3/10,6.37%,NUPR1;HDAC4;PPARA
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),0.5807644346540056,1.3270452145486515,0.17613636363636365,0.6318118758995143,1.0,3/10,6.37%,NUPR1;HDAC4;PPARA
prerank,regulation of axon regeneration (GO:0048679),0.5737216006135848,1.3269883996225575,0.16022099447513813,0.6305001341880463,1.0,3/12,8.57%,PTN;EPHA4;STK24
prerank,negative regulation of transforming growth factor beta production (GO:0071635),0.5868111439233097,1.325752595423552,0.1801980198019802,0.6331595395047739,1.0,2/10,1.96%,FN1;GATA6
prerank,negative regulation of cellular protein localization (GO:1903828),0.45828023194635953,1.3255939286853275,0.11964285714285715,0.6321975225916636,1.0,6/34,7.66%,LEPROT;ROCK2;LATS2;ACTN2;CTNNA1;GSK3B
prerank,receptor clustering (GO:0043113),-0.4303521429157603,-1.3253447997648193,0.115,0.5545046870708946,1.0,5/27,3.73%,NRXN1;NLGN1;DLG2;LRRC7;ITGA4
prerank,regulation of signal transduction (GO:0009966),0.3413506131052041,1.3247850377678507,0.041223404255319146,0.6332339724565397,1.0,24/190,6.75%,SULF1;IGFBP3;RORA;DCDC2;SP100;ELF1;GRK3;IGFBP5;MPIG6B;CD55;FBXL17;IGFBPL1;NUCKS1;ZIC1;IGFBP6;GLI1;PLCE1;DTX1;ZDHHC3;FOXP3;TRIM5;TCF7L1;PTPN2;CREBBP
prerank,mesonephros development (GO:0001823),0.5736354678162785,1.3240070488954516,0.16635514018691588,0.6341867662187624,1.0,3/11,4.75%,FGF1;OSR1;BMP7
prerank,protein phosphorylation (GO:0006468),0.31917899241430986,1.3239488359337743,0.012471655328798186,0.632921901488887,1.0,114/478,15.94%,IGFBP3;PDPK1;PDK1;EFEMP1;TGFBR3;TEC;ROCK2;CAMK1D;NRK;PDGFRA;PRKAG2;FGFR1;STK32B;GRK3;FAM20C;STK39;DDR2;PRKAA2;OXSR1;EIF2AK2;TSSK3;INSRR;BMPR1A;EPHA3;BMP2K;EPHA8;FAM20A;FER;CDK8;KIT;DAPK1;BMP2;TAOK3;CRY1;IKBKE;TLR4;PRKCZ;TOP1;LATS2;MAP3K1;AAK1;TGFBR1;MORC3;MAPK6;EPHA1;PDGFRB;TGFBR2;MAP4K1;FAM20B;GSK3B;CCL2;NEK4;WNK4;MAP2K6;EPHA4;BAZ1B;STK24;STK3;SIK3;CCNH;LRRK2;PPP4R1;COQ8B;TLK2;CDK7;CDK12;MUSK;CDK16;MAPK14;AKT3;HIPK3;GRK5;PTPN6;TLR2;PTK2;IRAK3;PPP3CB;MAP3K7;ILF3;RPS6KA3;MASTL;DAPK2;MAP2K1;MAP3K13;STRADB;JAK1;SRPK1;MAPK9;GTF2H4;ACVR1C;WNK1;TRIB1;ALK;MAPKAPK5;TBK1;FRK;NUAK2;ABI1;BIRC6;RARA;CSNK2A2;EIF2AK3;RYK;ILK;LIMK1;CDKL3;STK4;ACVR2B;TXK;PKN2;PRKD2;ERN2;APP;IGF1R
prerank,regulated exocytosis (GO:0045055),-0.3031785422639952,-1.3239386718975454,0.02109704641350211,0.556928199936978,1.0,33/173,10.13%,PCDH7;ABCC4;VWF;PECAM1;SYT1;RIMS1;RIMS2;ACTN1;TMSB4X;TGFB2;THBS1;VEGFC;PCLO;SCG3;CALM1;RAB11FIP1;GAS6;SNAP25;SNCA;STXBP1;CYRIB;CDC37L1;RAB27B;CPLX1;STEAP2;A2M;SYT4;SYT7;VEGFA;TGFB3;CHID1;LYN;FAM3C
prerank,phospholipid translocation (GO:0045332),-0.4267245115185914,-1.3236043655136618,0.10926365795724466,0.5562131500403216,1.0,11/28,18.33%,ATP8A1;ATP10A;ATP11B;ATP8A2;ATP11A;ATP8B2;ATP8B1;MFSD2A;TMEM30A;P2RX7;ABCB4
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),0.5285294402873211,1.3231800878787372,0.16176470588235295,0.6339700305434907,1.0,4/17,4.73%,EFNB2;ROBO1;NRP1;MIA3
prerank,positive regulation of protein binding (GO:0032092),0.4074784277238106,1.3231363333009976,0.10771704180064309,0.6326380665899056,1.0,21/56,17.86%,TCF7L2;VTN;WNT3A;DACT1;BMP2;TERT;DTX3L;SPPL3;GSK3B;RIPK2;STK3;AMFR;LRRK2;TRIM21;HFE;BDNF;STK4;APP;RAN;PPP2CA;LRP1
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),0.5315791717379063,1.3230713199052653,0.14885496183206107,0.6313513663719693,1.0,7/16,12.98%,PDGFRA;NRP1;FER;PDGFRB;PIK3C2A;PTPN1;PLAT
prerank,diol biosynthetic process (GO:0034312),-0.508669750255754,-1.3228588524357858,0.13588110403397027,0.5567730366698335,1.0,3/15,10.31%,ACER3;ACER2;GCH1
prerank,bicarbonate transport (GO:0015701),-0.4393180791463078,-1.3228228451027233,0.111358574610245,0.5552408036910431,1.0,8/25,14.55%,SLC4A10;SLC26A7;CA4;CA2;CYB5R1;CYB5RL;SLC4A7;SLC39A8
prerank,stabilization of membrane potential (GO:0030322),0.5426533084512342,1.3221613683372269,0.13595706618962433,0.632844342682159,1.0,1/16,0.04%,KCNK2
prerank,positive regulation of erythrocyte differentiation (GO:0045648),0.47580928217924306,1.3216861657651455,0.14795008912655971,0.6328143352116189,1.0,7/25,11.85%,STAT5B;ARNT;BRD1;STAT1;FAM210B;MAPK14;FOXO3
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.3159189380020279,1.321395716711695,0.007829977628635347,0.6322218552008539,1.0,80/509,11.16%,TCF7L2;PDPK1;WLS;LPAR1;ROCK2;SASH1;AKAP13;FN1;SELP;PDGFRA;FGFR1;FGF1;AXL;ECM1;EIF2AK2;KSR1;NUPR1;NFAT5;DDX60;FAM110C;GAB2;GJA1;PPM1A;OSM;IL11;EPHA8;OSBPL8;FRS2;TRAF5;TGFA;KL;NEDD4;ADGRV1;ANGPT1;KIT;DCN;LITAF;BMP2;CFLAR;IFI35;IL6;IKBKE;ROR1;GSDME;TLR4;BCL2;MTDH;TGFBR1;GOLT1B;HAX1;CPNE1;MIER1;PELI2;PDGFRB;TRIM5;BIRC3;BST2;OASL;JMJD8;IL18;LGALS9;VAPA;RIPK2;PHB2;BAX;WNT5A;IGF2;ANKRD17;PIK3R5;MST1R;BRD4;DNM1L;FGF18;PTPN6;BCL2L1;UBE2V1;CDH13;TLR2;FNIP1;PTK2
prerank,regulation of muscle contraction (GO:0006937),0.4826874417289205,1.3210762771188247,0.1286231884057971,0.6317934830554617,1.0,4/26,5.56%,TNNC1;ATP1A2;TPM1;PLCE1
prerank,positive regulation of interferon-alpha production (GO:0032727),0.5058378242620808,1.3207780069239607,0.14954954954954955,0.6312877516846135,1.0,7/19,19.59%,TLR4;STAT1;RIPK2;IFIH1;TBK1;DHX36;SETD2
prerank,regulation of GTPase activity (GO:0043087),-0.3031660126977707,-1.320245255640361,0.029304029304029304,0.5612869972280209,1.0,46/177,15.18%,CHN2;DOCK9;PRKG1;FGD5;ITGA6;PLXNA4;EFNA5;BCAR3;EPHA5;DOCK10;NET1;LRCH1;NTRK2;SEMA4D;ADAP1;TBC1D30;CPEB2;DAB2IP;ARHGAP44;RASIP1;RAB3GAP1;CCL14;FGD6;RAPGEF2;RGS7;RCC2;ARHGAP15;RGS6;TMED2;ARHGAP27;RACK1;CAV2;CD40;DOCK8;ALS2;ARHGEF7;VAV1;RGP1;RAPGEF6;F11R;HRAS;AGRN;EVI5;SOD1;SNX18;CCL19
prerank,second-messenger-mediated signaling (GO:0019932),0.3843904695761073,1.3199282081852497,0.0903522205206738,0.6325803393669998,1.0,13/82,9.49%,PDPK1;RCAN2;MCU;FPR2;ACKR2;CCR9;DGKD;RCAN1;PLCE1;NOS2;ACKR3;LRRK2;NMUR1
prerank,positive regulation of developmental process (GO:0051094),0.34921308644516136,1.3196886154563872,0.05170068027210884,0.6318629986951453,1.0,36/164,15.52%,PHLDB2;SOX5;PTN;MCU;FOXD1;CCN2;FGFR1;SMURF2;GJA1;BMPR1A;NCOA3;DAG1;DCN;BMP2;BMP1;BMP7;CLASP1;PHLDB1;RALBP1;ADGRL1;WNT5A;SYDE1;TAPT1;DNM1L;ENPP2;DVL3;RPS6KA3;MAP3K13;RTN4;TLE6;ALK;VHL;NIBAN2;MIEF1;SHLD2;MUL1
prerank,positive regulation of protein kinase activity (GO:0045860),-0.31078355545753467,-1.3194864044849868,0.04477611940298507,0.5617838418100515,1.0,42/148,16.16%,TNIK;GRM5;TGFB2;INSR;PTK2B;PAK1;CALM1;GAS6;SNCA;CALM2;EMP2;MMD;DAB2IP;HSP90AB1;RAPGEF2;PAK5;CCDC88A;CALM3;RASSF2;ACE;STK11;LRP8;CLSPN;VEGFA;MINK1;LCP2;BORA;ADRB2;ALS2;PAK3;JTB;SRCIN1;TTBK1;HSP90AA1;CSF1R;RELN;PTPRC;PAK4;CCL19;CDKN1A;IRGM;RAP1A
prerank,protein localization to membrane (GO:0072657),-0.29754204290901265,-1.3193259193110594,0.01652892561983471,0.560605631530426,1.0,47/187,14.15%,DPP10;NRXN1;NLGN1;DLG2;BSG;KCNB2;SHANK3;LRRC7;EFR3B;CACNB2;TNIK;ATP1B1;LIN7A;RFTN1;CPE;CDH1;KCNIP4;ITGA4;GAS6;ANK3;MAP7;EMP2;TSPAN14;DPP6;STXBP1;INPP5K;RAPGEF2;RAB38;RAB3C;TM9SF3;TMED2;LRP6;RAMP2;DVL1;ZDHHC2;KCNB1;FGF13;ZFYVE27;RAB12;RAPGEF6;CAV1;RAB40B;F11R;AGRN;EHD4;CLASP2;ABHD17A
prerank,lipid oxidation (GO:0034440),-0.532144509249804,-1.3192171293160706,0.13911290322580644,0.5592664327187636,1.0,1/12,0.45%,ADIPOR2
prerank,protein monoubiquitination (GO:0006513),0.4455182635695317,1.3187609505454425,0.12387791741472172,0.6332608615856284,1.0,12/36,15.01%,KLHL22;DTX3L;MGRN1;RNF20;CDC73;WAC;HUWE1;CUL3;TRIM21;PAF1;LEO1;UBE2R2
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.5859780918411237,1.3186522155375002,0.15977443609022557,0.6321791126279129,1.0,4/12,14.75%,NR1H3;PPARA;CRP;ABCA1
prerank,positive regulation of cardiocyte differentiation (GO:1905209),0.5847179568915134,1.3185503516283517,0.17768595041322313,0.6310373444453152,1.0,2/11,2.09%,EFNB2;WNT3A
prerank,lung development (GO:0030324),0.45286801682555833,1.3182979733969111,0.11694915254237288,0.630410619508772,1.0,6/33,7.18%,PDPN;FGF1;RBP4;LOXL3;ERRFI1;DNAAF1
prerank,"phagocytosis, engulfment (GO:0006911)",-0.40593284269936075,-1.3182727967864687,0.11083123425692695,0.5602702177369785,1.0,16/36,25.32%,ELMO1;THBS1;XKR4;XKR6;RHOG;MEGF10;DOCK1;RAC1;RHOH;RHOBTB1;FCGR1A;ITGB2;AIF1;BIN2;MSR1;ADGRB1
prerank,photoreceptor cell development (GO:0042461),-0.5056362308668554,-1.3182102745334134,0.12603305785123967,0.5587880801346969,1.0,6/14,16.58%,RORB;RP1;AHI1;VEGFA;MFSD2A;CEP290
prerank,negative regulation of gene expression (GO:0010629),0.3275425628961033,1.3178082869460528,0.02631578947368421,0.6306634961911662,1.0,66/302,16.03%,ROBO1;WNT4;PARP14;LGR4;ROCK2;RBMS3;SAMD4A;NOTCH2;PRKAA2;EIF2AK2;IGFBP5;SHMT1;PTBP3;BMPR1A;ITGB8;TWSG1;PARP9;TNRC6B;SLC24A3;SUZ12;DAPK1;BMP2;TERT;STOX1;PTPN22;IGF2BP1;SNX12;CPNE1;FOXP3;ATP2B4;NANOS2;NOS2;PARP10;DCP2;OPRD1;LGALS9;ANXA7;MYADM;TNRC6A;YAP1;MOV10;EPC1;NOCT;JARID2;TIPARP;WWP2;IGF2BP2;LRP3;EIF4ENIF1;ILF3;SLFN14;MAP2K1;DDX6;PTBP2;ATP2B1;TASOR;METTL16;SRGN;FLOT2;VHL;GIGYF2;EIF2AK3;KAT2B;APP;CNOT9;CPEB3
prerank,peptidyl-lysine modification (GO:0018205),0.372297961600346,1.3175488440515437,0.07591240875912408,0.6300315834261498,1.0,27/99,16.55%,EYA1;SENP7;LOXL3;LOXL1;LIPT1;RANBP2;TPR;HDAC4;METTL21C;ETFBKMT;PIAS1;SIRT4;SUMO1;ESCO1;LOXL4;SENP6;SENP3;NSMCE2;EGR2;SENP1;POM121;IFIH1;P3H4;KAT2B;P3H3;ATPSCKMT;NUP37
prerank,cellular potassium ion homeostasis (GO:0030007),-0.5268377518070829,-1.317480641447823,0.140625,0.5592516743880702,1.0,5/13,4.08%,SLC12A2;KCNMA1;ATP1B1;KCNJ2;ATP1A1
prerank,regulation of neutrophil chemotaxis (GO:0090022),0.4855259145118405,1.3168510669703068,0.14795008912655971,0.6307616241379002,1.0,4/23,5.14%,MCU;DPP4;CAMK1D;C5AR2
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),-0.4225528251637395,-1.316528234970558,0.10714285714285714,0.5604609895423828,1.0,11/30,13.29%,FGF12;RYR2;KCNJ2;SCN1A;ATP1A1;GJC1;CACNA1G;NEDD4L;CACNA1D;KCNQ1;KCNE4
prerank,regulation of chemotaxis (GO:0050920),0.4606550063906308,1.316501891731054,0.13322091062394603,0.6303428486769693,1.0,5/30,6.52%,EFNB2;PDGFRA;MYCBP2;PDGFRB;PTPN2
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),0.5950946149551505,1.3162056165820941,0.16898608349900596,0.6297867021745317,1.0,2/11,8.57%,PDK1;STK24
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),0.5772253554722975,1.3161467029932703,0.15169660678642716,0.6285757922142129,1.0,4/11,6.94%,TGFBR3;BMP2;TGFBR1;TGFBR2
prerank,smoothened signaling pathway (GO:0007224),0.4453271081702578,1.316093022973633,0.15719063545150502,0.6273153326515917,1.0,8/32,11.55%,EVC2;GLI3;ARL13B;GLI1;GPC2;CC2D2A;DISP3;IHH
prerank,chromatin-mediated maintenance of transcription (GO:0048096),0.5686846210709486,1.316039645785016,0.1844106463878327,0.6260539637283316,1.0,2/11,1.19%,ZMIZ1;ELOF1
prerank,negative regulation of bone mineralization (GO:0030502),0.557320882930102,1.3160376029521652,0.16306483300589392,0.6246602454963529,1.0,5/13,13.77%,ENPP1;ECM1;BCOR;RFLNA;SRGN
prerank,long-term synaptic potentiation (GO:0060291),-0.4618438885322754,-1.3158050485878656,0.11951219512195121,0.5609711885635815,1.0,6/21,6.63%,SLC24A2;PTK2B;GRIN2A;SHANK2;GRIN2B;NPTN
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),0.39627225028046004,1.3157319704187085,0.10179640718562874,0.6242979435581816,1.0,11/67,6.11%,EFEMP1;TEC;PDGFRA;FGFR1;DDR2;GHR;EPHA3;FER;KIT;EPHA1;PDGFRB
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.3051406744389195,1.3156065419668737,0.0010672358591248667,0.6232589822682046,1.0,167/834,15.89%,TCF7L2;TCF4;KMT2A;RORA;BMP6;SMAD3;RBPJ;ZEB2;ZMIZ1;NR2F2;CXCL10;ELF1;RGMA;FGF1;PID1;AUTS2;ARNT2;OSR1;TBL1XR1;TEAD1;FOXC1;NFIA;NFAT5;PHIP;GATA6;SPIB;WNT3A;CSRP3;BMPR1A;ZNF395;SSBP2;OSM;FSTL3;FOXC2;IL11;GLI3;WWOX;MYB;NCOA3;CDK8;LDB2;HIVEP1;HOXC4;DCN;LITAF;BMP2;STAT5B;RFX3;TERT;GABPB2;GABPB1;APBB1;CREB3L4;IL6;KMT2C;EPAS1;HLF;TLR4;GLI1;ARNT;GLIS3;NCOA6;SALL1;TCF12;SERPINE1;KLF5;HAX1;MLLT10;CREB3L3;NR1H3;FOXP3;ARF4;BCL9L;HDAC4;PPARA;CREBBP;RARB;POGZ;GLIS2;PCGF5;POU1F1;CREBRF;IL18;NGFR;DPF2;STAT1;CDC73;SKI;CDKN2B;ZSCAN21;MEF2A;RIPK2;RNF111;CRLF3;WNT5A;YAP1;RHOQ;CRTC1;KAT6B;RLF;EPC1;GLYR1;IGF2;ELF4;CDK7;CDK12;E4F1;BRD4;PBX1;RFXANK;TAF7;PFKM;TCEA1;HEYL;MYSM1;CDH13;TLR2;RFXAP;SMAD4;MAP2K5;PPP3CB;FOXO3;NR4A1;CRTC3;DVL3;EGR2;MAML2;RPS6KA3;SS18;HOXA10;BPTF;TET2;NFIC;MED12;ARRB1;MZF1;NR3C1;BRD8;WASL;NRF1;SENP1;ZNF462;POU2F1;KAT6A;NCOA2;LEO1;SALL2;NCK1;TBK1;THAP3;RBM14;HDAC2;RARA;SP3;HOXB4;SMARCA4;KAT2B;SOX4;TXK;DAB2;VEZF1;PRKD2;PKD2;POU5F1;ELK4;APP;TAF9
prerank,endocrine system development (GO:0035270),0.5019681228106863,1.3150908134328658,0.15225563909774437,0.6235455504751083,1.0,4/21,6.51%,WNT4;TGFBR1;SALL1;DKK3
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),0.5233701498665808,1.3149937688510531,0.14579439252336449,0.62242604273898,1.0,2/17,0.82%,MCU;CAMK1D
prerank,glycerolipid catabolic process (GO:0046503),-0.4721872350858699,-1.3148926227410123,0.11883408071748879,0.5618924774214387,1.0,5/19,5.90%,GPCPD1;MGLL;ABHD2;GDPD1;ENPP6
prerank,negative regulation of macromolecule metabolic process (GO:0010605),0.3412183611589595,1.3135593545831568,0.05333333333333334,0.6254602165939728,1.0,32/182,10.31%,ROBO1;WNT4;PARP14;ROCK2;RBMS3;NOTCH2;PRKAA2;BMPR1A;ITGB8;PARP9;TNRC6B;SLC24A3;BMP2;TERT;STOX1;PTPN22;OPTN;SNX12;CPNE1;ATP2B4;NOS2;PARP10;OPRD1;LGALS9;ANXA7;MYADM;TNRC6A;YAP1;MOV10;NOCT;TIPARP;WWP2
prerank,regulation of myoblast differentiation (GO:0045661),0.43924498546115226,1.313260464378607,0.11804384485666104,0.6249877531649206,1.0,3/32,3.65%,RANBP3L;IGFBP3;EID2B
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),0.5567132320157305,1.311389842206177,0.15369649805447472,0.6292904675429009,1.0,7/13,17.54%,ENTPD7;RHOQ;LRRK2;EFL1;OPA1;RAN;GNAI3
prerank,cellular response to increased oxygen levels (GO:0036295),-0.548136171577137,-1.3110422991744186,0.16596638655462184,0.5715231837055046,1.0,8/11,33.46%,FOXO1;FAS;CAV1;ATP6V0A2;ATP6AP1;TMEM199;ATP6V1A;ATP6V1G1
prerank,blood vessel endothelial cell migration (GO:0043534),0.4918188903524752,1.3107826519811387,0.152753108348135,0.62978652649462,1.0,5/22,4.73%,EFNB2;ROBO1;CDH5;NRP1;MIA3
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),0.4965286169424027,1.3103197109066704,0.1617391304347826,0.6297650388872786,1.0,4/20,5.16%,TGFBR3;RBPJ;BMP2;TGFBR1
prerank,protein auto-ADP-ribosylation (GO:0070213),0.56919596941642,1.310252004491916,0.17472118959107807,0.6285673477737184,1.0,7/12,16.18%,PARP3;PARP10;PARP12;PARP11;TIPARP;PARP16;TNKS2
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),0.4404596208924705,1.3102425476688697,0.1460101867572156,0.62720815189208,1.0,10/37,10.27%,IL17D;IL6;ADCY7;TLR4;APPL2;GBP5;PPARA;NOS2;APPL1;MAPK14
prerank,response to iron ion (GO:0010039),0.567579421855122,1.3099913735847768,0.14682539682539683,0.626652736986641,1.0,4/12,12.58%,BMP6;BCL2;ACO1;HFE
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),0.5609064670306646,1.3091285259328287,0.18568665377176016,0.6279388445735318,1.0,3/13,5.16%,BMP6;BMPR1A;TGFBR1
prerank,amino sugar metabolic process (GO:0006040),-0.5621285067167474,-1.3090876308078394,0.1483050847457627,0.5758631266694059,1.0,4/10,12.96%,CSGALNACT1;FN3K;GFPT2;GFPT1
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),-0.5542205970620876,-1.3089941128811666,0.18376068376068377,0.5744790251818864,1.0,4/10,7.81%,PDE3B;ACER2;NEXMIF;JAM3
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.4949223945263802,1.308873603388018,0.14109347442680775,0.6273736381177252,1.0,5/23,5.70%,UACA;PPM1A;IFI35;BMP7;CPNE1
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.584823624692066,1.3087600844207232,0.20114942528735633,0.6263298011961504,1.0,3/10,6.02%,IFI35;PTPN22;NR1H3
prerank,negative regulation of cell-substrate adhesion (GO:0010812),-0.3877533180672737,-1.3087338165232454,0.08333333333333333,0.5735625787486092,1.0,14/39,14.03%,EFNA5;THBS1;ACER2;NOTCH1;ADAM15;MYOC;NEXMIF;SEMA3E;RCC2;AP1AR;SPOCK1;PTPRO;FZD4;ACTN4
prerank,regulation of cell-matrix adhesion (GO:0001952),-0.3460625699867605,-1.308557529998835,0.07331378299120235,0.5724532178427109,1.0,16/64,6.95%,LIMCH1;EFNA5;PEAK1;THBS1;ACER2;PTK2B;GPM6B;ADAM15;UTRN;MACF1;EMP2;ACTG1;CDK6;MYOC;NEXMIF;SEMA3E
prerank,positive regulation of interleukin-13 production (GO:0032736),0.602685343503558,1.3082673991421565,0.18164435946462715,0.6264662842022002,1.0,6/10,24.66%,PRKCZ;IL18;LGALS9;RARA;SPHK2;GATA3
prerank,calcium ion homeostasis (GO:0055074),-0.32601956643267066,-1.3081617819274989,0.054140127388535034,0.5719930723668122,1.0,27/95,18.16%,TMTC2;ATP1B1;SLC24A2;RYR2;TPT1;HTR2C;SNCA;ATP2C1;SLC8A1;CCL14;NPTN;ATP2A3;SLC30A1;SELENON;GRIN1;CXCL12;CALR;SLC10A7;CD40;TMCO1;CAV1;ATP2A2;CCL19;ATP13A4;HTR2B;SLC8B1;HTR2A
prerank,cellular response to organonitrogen compound (GO:0071417),-0.31992612737359977,-1.3074538610517596,0.046875,0.5723559906144128,1.0,29/99,20.03%,SLIT2;MEF2C;AKAP6;ACTB;HCN1;CDH1;GABRB3;RYR3;SLC5A5;CTNNB1;INPP5K;HCN2;RAPGEF2;PDE3A;GABRB1;PDE2A;RRAGB;KCNQ1;GABRB2;CPEB4;HRH1;SPAAR;RAP1A;RRAGC;BRCA1;P2RX7;GLRA2;GLRA1;LAMTOR2
prerank,positive regulation of focal adhesion assembly (GO:0051894),-0.4690811819741473,-1.306799690953056,0.13501144164759726,0.5727168526679762,1.0,8/19,18.00%,TEK;PTPRJ;KDR;MYOC;VEGFA;RAC1;COL16A1;PPM1F
prerank,positive regulation of protein autophosphorylation (GO:0031954),-0.442325442913044,-1.3065835465098852,0.12529002320185614,0.5718154042174671,1.0,8/22,13.39%,CALM1;CALM2;MRE11;CALM3;RASSF2;ACE;VEGFA;NEK10
prerank,regulation of hydrolase activity (GO:0051336),-0.3450650791636614,-1.306529857417432,0.07356948228882834,0.5703941853907231,1.0,21/71,12.95%,CHN2;PRKG1;FGD5;PLXNA4;EFNA5;EPHA5;NTRK2;ADAP1;DAB2IP;ARHGAP44;RASIP1;RAB3GAP1;FGD6;ARHGAP15;CAMK2A;ARHGAP27;NOS1;SCARB2;VAV1;RAPGEF6;CAV1
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),-0.5292056432839624,-1.3064555727746732,0.14814814814814814,0.5674161616869288,1.0,3/12,5.12%,AKAP6;CAMTA1;PTBP1
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),-0.5292056432839624,-1.3064555727746732,0.14814814814814814,0.5674161616869288,1.0,3/12,5.12%,AKAP6;CAMTA1;PTBP1
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),-0.48409075978764526,-1.3062735543679047,0.1489841986455982,0.5663805650572672,1.0,9/16,37.53%,CADM1;RAET1E;LAMP1;RASGRP1;SLAMF6;NECTIN2;CD226;IL12A;CRTAM
prerank,brain development (GO:0007420),-0.30799260514648424,-1.3056753690350509,0.03754266211604096,0.5666453570784142,1.0,24/136,9.11%,ADGRL3;ADGRL2;CNTNAP2;CTNNA2;ROBO2;SHANK3;CDH2;MEIS2;COL4A1;CNTN4;ZFHX3;PBX3;SHROOM4;GRIN2A;ADGRG1;APOD;RAB3GAP1;GRIN2B;SCYL2;RAPGEF2;SOX6;NDRG4;BAG6;GRIN1
prerank,negative regulation of protein phosphorylation (GO:0001933),0.34665743310968533,1.3056421613944869,0.0784313725490196,0.633493943589773,1.0,25/150,10.69%,PTPN13;IGFBP3;PDPK1;DEPTOR;PRKAG2;PID1;ENPP1;PLPP3;PPM1E;LDLRAD4;FBLN1;PMEPA1;ERRFI1;PRKCZ;EPHA1;MVP;PPEF2;MYADM;DTNBP1;LRRK2;SMAD6;GPD1L;TAF7;DNAJC3;PTPN6
prerank,negative regulation of sequestering of calcium ion (GO:0051283),-0.4350161873087581,-1.3052156126233878,0.1351981351981352,0.5665463864596514,1.0,11/24,18.16%,PLCG2;RYR2;HTR2C;RYR3;FGF2;PTPRC;ERO1A;CCL19;HTR2B;IBTK;HTR2A
prerank,positive regulation of cell communication (GO:0010647),-0.4145258746805157,-1.3045636275443535,0.1261682242990654,0.566964089862224,1.0,6/28,3.91%,SYT1;RIMS1;RIMS2;GRIK2;HOMER1;ANK3
prerank,regulation of osteoblast proliferation (GO:0033688),0.5188965623759876,1.3044966104868823,0.15711645101663585,0.6356567935261265,1.0,3/17,3.96%,EIF2AK2;NELL1;BMP2
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.5905890068848539,1.304101127455557,0.17786561264822134,0.635587399559514,1.0,3/10,4.74%,VTN;ITGA5;ARNT
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.5894948063821839,1.3031759395394054,0.1935483870967742,0.6369104075492121,1.0,5/10,17.01%,PARP14;PTPN2;SH2B3;NF2;PPP2CA
prerank,cell-substrate junction assembly (GO:0007044),-0.3999214422960105,-1.3026475581827954,0.11604938271604938,0.5710653090136275,1.0,12/33,11.94%,ITGA6;ACTN1;PTPRK;THSD1;PEAK1;ITGB4;LAMA3;TESK2;RCC2;TRIP6;BCR;ARHGEF7
prerank,peptidyl-threonine phosphorylation (GO:0018107),0.40136756496363635,1.302187721079719,0.11243611584327087,0.6387381957340371,1.0,14/59,15.77%,PDPK1;ROCK2;STK39;OXSR1;TGFBR1;TGFBR2;GSK3B;LRRK2;HIPK3;MAP2K1;WNK1;TBK1;CSNK2A2;PRKD2
prerank,oligosaccharide metabolic process (GO:0009311),-0.37229744433153544,-1.3019827402188127,0.11382113821138211,0.5714425980955876,1.0,9/46,9.65%,ST6GALNAC3;ST8SIA4;FUT8;ST3GAL6;FUT9;ST8SIA6;ST6GALNAC4;ST6GALNAC5;NEU1
prerank,embryonic organ morphogenesis (GO:0048562),0.4258134847618371,1.3018856824288438,0.11655405405405406,0.6382388740469066,1.0,6/42,6.97%,EFEMP1;FBN1;PDGFRA;RBP4;HOXC4;DYNC2I1
prerank,branching involved in blood vessel morphogenesis (GO:0001569),-0.5098296481247433,-1.3016639818683968,0.15637860082304528,0.5708537887030823,1.0,6/13,10.95%,COL4A1;KDR;CTNNB1;SEMA3E;VEGFA;NOTCH4
prerank,transport along microtubule (GO:0010970),0.5547948333950042,1.3009893034185092,0.18786692759295498,0.6396248104474586,1.0,7/13,23.84%,ARHGAP21;SPG11;APP;BORCS5;BAG3;CLIP3;COPG1
prerank,peptidyl-lysine monomethylation (GO:0018026),0.5960564232335402,1.3006700524850676,0.17692307692307693,0.6392442112728856,1.0,6/10,29.21%,SETD4;SETD7;SETD2;SETD6;SMYD2;EHMT1
prerank,maturation of 5.8S rRNA (GO:0000460),0.508238910280712,1.3005976967888446,0.1801125703564728,0.638097763696159,1.0,6/17,17.86%,MPHOSPH6;NSA2;WDR12;EXOSC10;RPF1;C1D
prerank,actin nucleation (GO:0045010),-0.45248504685577423,-1.3001192632462644,0.1318181818181818,0.5738783596562789,1.0,7/21,13.20%,LMOD1;JMY;ARPC3;ARPC4;ARPC2;ARPC1A;WASHC1
prerank,entry into host (GO:0044409),-0.5128669228763958,-1.2998635465197,0.1662921348314607,0.5730315753102,1.0,6/13,15.88%,CDH1;MET;CTNNB1;CBL;PPIA;CBLL1
prerank,protein import into peroxisome matrix (GO:0016558),-0.5123502717811326,-1.2995213078853507,0.17463617463617465,0.5723924806667857,1.0,4/12,15.68%,PEX5L;PEX26;PEX10;PEX16
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.3503301644566256,1.2987491468881525,0.06666666666666667,0.642652367053874,1.0,20/150,6.11%,TCF7L2;PDPK1;PDGFRA;FGFR1;FGF1;AXL;FAM110C;GAB2;OSM;OSBPL8;FRS2;TGFA;KL;ANGPT1;KIT;MTDH;TGFBR1;HAX1;CPNE1;PDGFRB
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.34526637359371454,-1.2987067985638336,0.06451612903225806,0.5732898477749536,1.0,26/70,24.51%,PSMC3;NCF2;MFSD6;PSMD14;PSMD3;B2M;CALR;FCER1G;PSMD4;PSMD6;PSMA6;PSMA4;PSMB8;CYBB;PSMA8;PSME1;FCGR1A;PSMD7;PSMC6;IKBKB;PSMB5;PSMC5;PSMB1;SEC22B;PSMD11;PSMD8
prerank,regulation of histone H3-K9 acetylation (GO:2000615),0.5748554234987483,1.298320667623823,0.17063492063492064,0.6425920480606747,1.0,1/10,0.14%,KMT2A
prerank,regulation of blood coagulation (GO:0030193),0.4652648995532059,1.297989232825045,0.14165261382799327,0.6423320591695322,1.0,5/27,8.66%,TFPI;VTN;GP1BA;SERPINE1;SERPINE2
prerank,inositol lipid-mediated signaling (GO:0048017),0.41228631136485944,1.2977384718994793,0.11254019292604502,0.6416865013519185,1.0,10/50,6.63%,PDGFRA;FGFR1;GAB2;ADAP2;PLCD3;PI4KA;PLCE1;PDGFRB;PLCB3;PIK3C2A
prerank,microvillus organization (GO:0032528),-0.5251221197972378,-1.2973635551985327,0.15843621399176955,0.5757252110754811,1.0,7/13,20.81%,TNIK;FXYD5;RAPGEF2;MINK1;RAPGEF6;RAP1A;STK26
prerank,regulation of cell growth (GO:0001558),-0.28890993731931186,-1.297248794487669,0.025210084033613446,0.5745412802287573,1.0,48/204,15.67%,APBB2;SLIT2;NRG3;PTPRJ;AKAP6;SMARCA2;TGFB2;BMPR2;TFRC;NET1;ADAM15;PPP2R1A;RERG;ACVRL1;SOX17;H3-3A;PRKCQ;CCN3;FAM107A;CAPRIN2;PAK5;AKT1;CAMK2D;NDRG3;CEACAM1;SDCBP;STK11;DDX49;ING1;IP6K2;SPOCK1;CCAR2;RACK1;KIF26A;NPR1;EXOSC2;RPS6KA1;BCAR1;EGFR;CEP43;MFSD2A;DCUN1D5;JADE1;TAF9B;PAK4;LGI1;CDKN1A;ENO1
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.5368883093656212,1.296051359249304,0.17374517374517376,0.6456205218865141,1.0,6/15,13.97%,IL17D;IL6;TLR4;GBP5;APPL1;TICAM1
prerank,positive regulation of cell population proliferation (GO:0008284),0.31180992655074496,1.2954768933132295,0.023446658851113716,0.6461074589721784,1.0,64/423,11.72%,TCF7L2;EFNB2;TGFBR3;BMP6;PTN;DPP4;LAMC1;RBPJ;FN1;PDGFRA;FGFR1;FGF1;PID1;DDR2;OSR1;IL31RA;IL6ST;PHIP;GHRH;WNT3A;GAB2;GJA1;BMPR1A;OSM;S100A6;IL11;FER;VEGFD;TGFA;IL34;PTHLH;BMP2;TERT;GLP2R;IL6;GLI1;BCL2;STOX1;TGFBR1;EPHA1;PDGFRB;HDAC4;BST2;CD47;TGFBR2;STAMBP;CTSH;IL18;STAT1;WNT5A;YAP1;IGF2;IL13RA1;DNAJA2;MST1R;GRK5;FGF18;PTPN6;CDH13;TJP1;PTK2;NES;DISP3;CUL3
prerank,steroid hormone mediated signaling pathway (GO:0043401),-0.5175586362448027,-1.295370022166838,0.14978902953586498,0.5784221424022038,1.0,7/13,19.46%,ABHD2;ESR1;NR3C2;BMP4;CALCOCO1;PLPP1;ESR2
prerank,inner ear receptor cell stereocilium organization (GO:0060122),0.5888777961030405,1.2953627686993114,0.2055888223552894,0.645122863474715,1.0,2/10,4.24%,ADGRV1;IFT88
prerank,lipid catabolic process (GO:0016042),0.5115457320600625,1.295153276048895,0.18148820326678766,0.6443932488898015,1.0,1/18,0.18%,PLA1A
prerank,cellular response to oxygen levels (GO:0071453),-0.547229021527647,-1.2951489926383624,0.1554192229038855,0.5775294975831798,1.0,10/10,45.32%,CPEB4;ATP6V0A2;ATP6AP1;TMEM199;PICK1;ATP6V1A;ATP6V1G1;NDUFS2;ATP6V0D1;CCDC115
prerank,endocardial cushion development (GO:0003197),-0.4560048199067902,-1.2951271806458604,0.15883668903803133,0.5760449888281264,1.0,9/21,14.61%,NOS3;TGFB2;BMPR2;NOTCH1;ACVRL1;BMP4;TBX2;ACVR1;HEY1
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),-0.4933651175221615,-1.2950883005381069,0.1497005988023952,0.5745933278980284,1.0,6/14,16.15%,PRKAR1A;RAPGEF2;ADRB2;PRKAR2B;PKIG;PKIB
prerank,resolution of meiotic recombination intermediates (GO:0000712),0.5128124054588412,1.2944961840750027,0.1873873873873874,0.6451402122921499,1.0,4/16,10.86%,SLX4;TOP2B;FANCM;CENPX
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.41761857168868666,1.2942947076936542,0.13592233009708737,0.6444136016246372,1.0,10/43,12.23%,IGFBP5;GJA1;BMPR1A;ADAMTS1;IL6;PDGFRB;IL18;STAT1;CDH13;P2RY6
prerank,membrane assembly (GO:0071709),-0.39637319272721705,-1.293882554362496,0.13817330210772832,0.5766826145965142,1.0,9/34,8.74%,NRXN1;NLGN1;PTPRD;RFTN1;ANK3;IL1RAPL1;EMP2;NSFL1C;NLGN3
prerank,cardiac ventricle morphogenesis (GO:0003208),0.42643870962363156,1.2936888656789545,0.13926174496644295,0.6450074334905785,1.0,6/41,6.94%,TNNC1;TGFBR3;RBPJ;BMPR1A;TPM1;TGFBR2
prerank,homeostasis of number of cells (GO:0048872),-0.5320067736034135,-1.293637643747492,0.1670235546038544,0.57587016381422,1.0,3/12,4.39%,NOS3;NOTCH1;CCN3
prerank,JNK cascade (GO:0007254),-0.3847334189603949,-1.2935774574772951,0.10904255319148937,0.5745375995425787,1.0,13/40,19.11%,NOD1;MAP3K5;MAPK8;ARHGEF6;MAPK10;MAP3K11;UBB;MAP4K3;MINK1;UBA52;NOD2;GPS1;IRAK1
prerank,gas transport (GO:0015669),-0.5563495627812619,-1.2934663899137715,0.17684210526315788,0.5733270990733668,1.0,3/10,11.57%,CA2;CYGB;IPCEF1
prerank,microvillus assembly (GO:0030033),-0.5132395138475823,-1.2931619196065174,0.14743589743589744,0.5726473738198996,1.0,7/14,20.81%,TNIK;FXYD5;RAPGEF2;MINK1;RAPGEF6;RAP1A;STK26
prerank,negative regulation of cell growth (GO:0030308),-0.31121836745630577,-1.2926714000457475,0.06779661016949153,0.5725378174001732,1.0,25/121,11.75%,APBB2;SLIT2;PTPRJ;DIP2B;SMARCA2;TGFB2;BMPR2;DCC;ADAM15;PPP2R1A;RERG;ACVRL1;SOX17;CCN3;CAPRIN2;NDRG3;STK11;ING1;IP6K2;CCAR2;SEMA3G;RACK1;NPR1;FGF13;ULK1
prerank,clathrin coat assembly (GO:0048268),-0.49879198676357384,-1.2923836526861614,0.1740976645435244,0.5718718824052917,1.0,3/15,4.85%,SGIP1;HIP1;HIP1R
prerank,cellular response to thyroid hormone stimulus (GO:0097067),-0.5229158125158363,-1.2919051389494831,0.16071428571428573,0.5716131845001047,1.0,5/12,11.06%,THRB;LMO2;CTSB;CTSS;CTSL
prerank,mRNA modification (GO:0016556),-0.4520200069100895,-1.291328172473661,0.15258215962441316,0.571753128517954,1.0,12/22,28.50%,PUS7;PUS3;VIRMA;ZC3H13;CBLL1;TRMT6;TRUB1;METTL8;TRMT10C;RPUSD2;METTL14;TRMT61A
prerank,peptidyl-asparagine modification (GO:0018196),-0.415613764346818,-1.2911061009067595,0.14928909952606634,0.5708733986112954,1.0,11/31,22.34%,FUT8;MGAT5;RPN2;ALG5;LMAN1;DPM2;OSTC;STT3B;UBE2J1;HIF1AN;DDOST
prerank,positive regulation by host of viral transcription (GO:0043923),-0.4753564420497559,-1.2908526682176302,0.16919739696312364,0.5701622445628578,1.0,5/15,14.89%,LEF1;CTDP1;TFAP4;SMARCB1;TAF11
prerank,monocarboxylic acid metabolic process (GO:0032787),0.35548988664104875,1.2905641914436543,0.07396449704142012,0.6535577204831655,1.0,23/117,10.98%,ALDH1A2;PCCA;ACOT11;LDHAL6B;PANK2;PPARA;ALDH4A1;ME2;NPC1;PTGR1;GLO1;AMACR;ACADSB;ECHDC3;NAAA;PCCB;SCP2;BTD;HLCS;ACOT1;ABAT;HACL1;SCPEP1
prerank,regulation of catecholamine secretion (GO:0050433),-0.41326338822853215,-1.2905458154699185,0.12984054669703873,0.569572768064764,1.0,13/29,26.68%,SYT1;SNCA;SYT4;SYT7;KCNB1;SYT9;SYT2;KCNA2;CHRNA4;SYT6;SYT10;SYT5;SYT17
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",-0.5470122340688196,-1.290261564481277,0.17932489451476794,0.5689756390547186,1.0,8/10,23.91%,ATP5F1A;ATP5MC1;ATP5PO;ATP5PD;ATP5F1D;VPS9D1;ATP5MG;ATP5MC3
prerank,nuclear membrane disassembly (GO:0051081),-0.48554545540801125,-1.290088792553915,0.1540130151843818,0.567984081074948,1.0,9/14,37.67%,PRKCB;NEK9;CTDNEP1;VRK1;DCTN1;PLK1;CDK1;CCNB2;CCNB1
prerank,regulation of neutrophil migration (GO:1902622),-0.5448534685865726,-1.2900768373873137,0.17547568710359407,0.5665851701517433,1.0,7/10,32.78%,JAM3;RHOG;RAC1;RHOH;BST1;MPP1;RAC2
prerank,negative regulation of cation channel activity (GO:2001258),-0.4270378078757857,-1.2897490613973857,0.13163972286374134,0.5660241823057143,1.0,11/26,25.23%,KCNAB1;FKBP1A;CALM1;CALM2;CALM3;SRI;CASQ2;GSTO1;GPR35;EPO;CBARP
prerank,regulation of stem cell population maintenance (GO:2000036),0.4990195305113071,1.2891893601238593,0.16453382084095064,0.6565461975700405,1.0,2/18,3.02%,PTN;NCOA3
prerank,regulation of smooth muscle contraction (GO:0006940),-0.4545289463760257,-1.2889217333701704,0.16743119266055045,0.5668003347179785,1.0,5/20,12.95%,KCNB2;CHRM3;CHRM2;ADRB2;CAV1
prerank,positive regulation of neutrophil migration (GO:1902624),0.5023557285933984,1.2889072124401617,0.1717902350813743,0.6561484749982462,1.0,2/18,0.82%,MCU;CAMK1D
prerank,osteoclast differentiation (GO:0030316),0.47249833768575467,1.2883801952029041,0.1711229946524064,0.6563513981718784,1.0,6/22,12.29%,GAB2;ANXA2;GLO1;MAPK14;CSF1;EPHA2
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.4688849977158886,1.2881815349981145,0.15009041591320071,0.6556488027746706,1.0,10/25,20.27%,LSM1;SF3B3;DDX23;SLU7;SRSF4;TXNL4A;SCAF11;PRPF3;SNRNP40;KHSRP
prerank,nervous system development (GO:0007399),-0.262748652728854,-1.2881545190689982,0.0,0.5675381992502193,1.0,84/429,12.44%,RAPGEF5;DNM3;ADGRL3;NRXN1;NLGN1;NAV2;ROBO2;LSAMP;SHANK3;SLC2A1;MERTK;ST8SIA4;SPOCK2;CDH2;ERBB4;MEF2C;ADGRG6;NAV3;CHRM3;KIRREL3;EFNA5;GPM6A;FGF12;CNTN4;WWP1;MYT1L;MBNL1;MOG;GPM6B;CNTN6;NCKAP1;CDH1;RBFOX3;RBFOX1;CHRM2;TRPC5;SEMA6A;GRIK1;SERPINI1;MET;SHANK2;SNTG2;EPHB1;S100B;PCDH1;SH3GL2;ADAM22;AHI1;MAL;DCLK1;MOBP;NRCAM;APBA2;MBP;EIF2B2;SCN2A;ALDH5A1;ZIC3;ZBTB16;SOX6;NINJ2;MBD5;NLGN3;VEGFA;L1CAM;ADAM23;SPOCK1;DNER;CNTFR;DHX30;DVL1;SEMA6B;DBNL;PCDHB16;FGF13;FGF2;SCN8A;NRSN1;NFASC;GFRA2;IL1RAPL2;NGF;NPAS2;VLDLR
prerank,endothelial cell differentiation (GO:0045446),-0.5156051289481524,-1.2880781943737971,0.17959183673469387,0.5663390334673265,1.0,6/12,9.94%,TIE1;BMPR2;KDR;ACVRL1;SCUBE1;SOX18
prerank,negative regulation of neuron death (GO:1901215),-0.3153240304937746,-1.2871022479160776,0.04747774480712166,0.5676654444405997,1.0,27/93,17.94%,MEF2C;PTK2B;CD34;NTRK2;SIX1;SNCA;SORL1;FOXQ1;NDNF;LGMN;AKT1;TNFRSF1B;PINK1;TGFB3;NGF;ATF4;GRN;SIX4;PARK7;SOD1;CPEB4;CLCF1;BTBD10;SET;NTF3;TOX3;ADAM8
prerank,pulmonary valve development (GO:0003177),-0.46255456011568685,-1.2869673988731585,0.1464968152866242,0.5666161587065552,1.0,8/18,8.00%,SLIT2;ROBO2;NOS3;TGFB2;BMPR2;NOTCH1;BMP4;TNFRSF1B
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.4157718187476307,1.2866949299509334,0.14170692431561996,0.6591489344442147,1.0,20/44,23.49%,ROCK2;ZC3HAV1;TNRC6B;RC3H1;NANOS2;FTO;TNRC6A;MOV10;EIF4ENIF1;METTL16;GIGYF2;CPEB3;DHX36;NANOS1;ROCK1;KHSRP;ZC3H12A;PNPT1;ZFP36L2;YTHDF3
prerank,cell differentiation in spinal cord (GO:0021515),-0.5391269735033215,-1.2857008902468592,0.18958333333333333,0.568802997679559,1.0,2/10,7.13%,MDGA2;SOX6
prerank,body fluid secretion (GO:0007589),-0.49248806583578275,-1.2848007464325848,0.15086206896551724,0.5698915540093499,1.0,4/15,12.79%,ERBB4;VEGFA;NPR1;PRLR
prerank,cellular response to peptide (GO:1901653),0.39646602512772194,1.2846607026651038,0.12615384615384614,0.6643727455376005,1.0,13/56,8.24%,FPR2;LDOC1;GJA1;VIM;SNX6;TLR4;PTPN22;CASP4;VCAM1;NGFR;GSK3B;RIPK2;EPHA4
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.3693069016257086,1.2844592054504909,0.10730253353204174,0.6636660315428966,1.0,17/87,13.75%,FLRT2;FGFR1;FGF1;RBFOX2;FRS2;POLR2D;KL;HNRNPH1;CCL2;FGF18;FLRT1;POLR2C;EGR3;DSTYK;NR4A1;SHOC2;POLR2F
prerank,eye photoreceptor cell development (GO:0042462),-0.4906358849119047,-1.2838934502841859,0.1511111111111111,0.5710084506192541,1.0,5/15,16.58%,RORB;RP1;VEGFA;RPGRIP1;CEP290
prerank,protein dephosphorylation (GO:0006470),0.34443141944851813,1.2828872598717158,0.09195402298850575,0.6673332983684294,1.0,34/135,12.79%,PTPN13;EYA2;EYA1;PPP2R2B;TPTE;PPM1E;PPM1A;DUSP10;PTPN14;PTPN4;PTPN3;PTPN22;PTPRA;MTMR3;PTPN2;DUSP16;PTPN9;SSH1;PTPN21;PPEF2;PPP4R2;CTDSP2;PPP4R1;PPM1B;PTPN6;PPP1CB;EYA4;PTPRU;PPP3CB;DUSP5;BTRC;PTPN1;PTPN18;FBXW11
prerank,regulation of hemopoiesis (GO:1903706),0.5716538120574459,1.28274273397779,0.19922630560928434,0.6663990693176176,1.0,5/10,10.82%,PTN;IL17D;CREBBP;MAFB;MYSM1
prerank,negative regulation of Notch signaling pathway (GO:0045746),-0.40553662390250955,-1.2824089898517042,0.14788732394366197,0.5739098037836131,1.0,15/28,23.70%,NOTCH3;BEND6;GATA2;AKT1;LFNG;YTHDF2;EGFL7;EGFR;HEY1;EGF;DLL4;DLL1;HIF1AN;RITA1;TCIM
prerank,regulation of gene expression (GO:0010468),0.29774105693783426,1.2823607175116603,0.0031982942430703624,0.666310770046668,1.0,170/903,14.70%,ROBO1;EFEMP1;RORA;BMP6;WNT4;PARP14;FOXD1;ROCK2;SMAD3;RBPJ;ATXN1;RBMS3;FN1;AFDN;WNT6;FGF1;PID1;PRDM6;TLE1;NOTCH2;PRKAA2;ARNT2;OSR1;FOXC1;NFIA;NFYC;AFF3;TRIM10;WNT3A;GJA1;PTBP3;ZBTB4;BMPR1A;ZNF395;DENND4A;SSBP2;CDH5;ITGB8;NELL1;MYB;PARP9;GCGR;SLC26A9;TNRC6B;SLC24A3;PRRX2;PRDM11;AHNAK;PTHLH;PERM1;ANGPT1;RC3H1;BMP2;PKP3;RFX3;TERT;APBB1;IL6;TLR4;BMP7;TRIM17;GZF1;STOX1;PTPN22;TGFBR1;IGF2BP1;NSD3;SNX12;CPNE1;BAZ2A;ZNF35;WWC2;FOXP3;ATP2B4;TESMIN;TRIM5;HDAC4;CREBL2;TCF7L1;NOS2;CRP;CREBBP;POGZ;PARP10;NSD1;CTSH;CLK4;POU1F1;NOVA1;RNF20;OPRD1;HNRNPH1;PDCD5;GSK3B;LGALS9;ZSCAN21;ANXA7;NFXL1;TEAD2;ATF7;MYADM;TNRC6A;WNT5A;ZFP37;YAP1;DTNBP1;KAT6B;MOV10;IGF2;TAPBP;NOCT;CREM;MUSK;FUBP1;SOX21;TIPARP;RFXANK;SUFU;MAFB;MSC;MAPK14;PSPC1;WWP2;CUX2;TDRD7;FGF18;IGF2BP2;UBE2V1;TLR2;LRP3;TGFBRAP1;TCF7;IHH;NFKBIZ;ADAM19;ZNHIT3;HNRNPH3;CSF1;ZNF219;ZFAT;TRIM21;OGG1;HFE;CRNN;THAP1;NOG;MAP2K1;TRIM26;PTBP2;MZF1;NR3C1;SERTAD3;MAPK9;METTL16;RNF39;HIC1;ZNF462;ZNF205;TICAM1;AFF1;PRDM5;NCOA2;USP36;FLOT2;DMTF1;PABPN1;FUS;CARM1;VHL;ZC3H7B
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),-0.49364417306929553,-1.2819726409771606,0.15964523281596452,0.5738129202977673,1.0,5/14,15.74%,THBS1;ITGA4;CD40;RGCC;PLCG1
prerank,peptide cross-linking (GO:0018149),0.4714550673779991,1.2818991195598626,0.18673647469458987,0.6663711390916695,1.0,3/25,3.55%,COL3A1;FN1;ANXA1
prerank,regulation of T cell mediated immunity (GO:0002709),-0.5499422810528457,-1.2817486324907483,0.17670682730923695,0.5730453706874289,1.0,2/10,8.00%,HMGB1;TNFRSF1B
prerank,protein autoubiquitination (GO:0051865),0.38857792952399106,1.2806774948335977,0.12280701754385964,0.6690342641683827,1.0,13/61,15.98%,RNF220;RNF213;SH3RF1;TRIM17;DTX3L;AMFR;WWP2;CUL3;TRIM21;BFAR;RNF181;RNF146;RNF185
prerank,positive regulation of gene silencing by miRNA (GO:2000637),0.45317564964128826,1.2803546019482892,0.15129151291512916,0.6687068085030023,1.0,12/27,23.55%,TNRC6B;IL6;EIF4ENIF1;MAP2K1;DDX6;WTIP;PUM2;DDX5;AJUBA;RIPK1;DHX9;TGFB1
prerank,peptidyl-threonine modification (GO:0018210),0.3837157580487277,1.2801529681601655,0.12807881773399016,0.6679875717114238,1.0,16/66,15.77%,PDPK1;ROCK2;STK39;OXSR1;TGFBR1;GALNT2;GALNT1;TGFBR2;GSK3B;LRRK2;HIPK3;MAP2K1;WNK1;TBK1;CSNK2A2;PRKD2
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),-0.3619765210414756,-1.2798514681695368,0.12860892388451445,0.5768444021169308,1.0,18/48,15.74%,PDE4D;UBASH3B;DMD;AKAP6;PTK2B;FKBP1A;CALM1;SNCA;CALM2;CEMIP;CALM3;CAMK2D;SELENON;NOS1;SRI;APLNR;CASQ2;PLCG1
prerank,positive regulation of insulin secretion (GO:0032024),0.43346316214938685,1.2797351082630317,0.16258741258741258,0.6679479649544607,1.0,7/36,13.28%,TCF7L2;MCU;RBP4;PLA2G6;NLGN2;PPP3CB;BAIAP3
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),0.5587449081059512,1.278748681529918,0.20958083832335328,0.6696547089087015,1.0,1/10,0.56%,DPP4
prerank,alpha-amino acid catabolic process (GO:1901606),0.45259143174468747,1.2780367003502,0.1696113074204947,0.6705418767993101,1.0,7/29,13.18%,DDO;ALDH4A1;ACADSB;HGD;BLMH;ACAT1;SARDH
prerank,sulfation (GO:0051923),0.5610029296188065,1.277766051778986,0.22244488977955912,0.6700762458368749,1.0,1/11,0.28%,UST
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.3064721556375273,1.2775867149024,0.01596351197263398,0.6693225358150199,1.0,109/497,16.48%,TCF7L2;WNT4;FOXD1;PRICKLE1;RBPJ;ZHX2;ARID4A;ATXN1;NR2F2;TLE1;SAMD4A;ENPP1;SMURF2;EIF2AK2;IGFBP5;GATA6;SHMT1;SAMD13;ZBTB4;ZIC2;SNX6;RBFOX2;GLI3;MYB;MBD2;ZMYND15;TCEAL7;EID2B;CRY2;PRDM11;DAPK1;BMP2;RFX3;CRY1;LOXL3;BCOR;BMP7;GZF1;SALL1;CBFA2T2;IGF2BP1;CDAN1;FOXP3;HDAC4;TSHZ3;NANOS2;DKK3;PBXIP1;GLIS2;DPF2;GSK3B;ZMYND11;PHB2;WNT5A;ZEB1;KAT6B;EPC1;USP47;SCMH1;SUMO1;JARID2;TAF7;PSPC1;WWP2;GMNN;ATF7IP;IGF2BP2;HEYL;CIR1;SMAD4;SCML4;BCL7A;TSPYL2;LHX9;ZNF219;EIF4ENIF1;VGLL4;ILF3;BTRC;FBXW11;DDX6;CBX4;BHLHE41;NR3C1;ARID5B;POU2F1;KAT6A;PRDM5;KDM8;RBM15;RUNX1T1;NIBAN2;ZBTB21;HDAC2;GIGYF2;RARA;PML;PDS5A;UIMC1;EIF2AK3;SP3;SMARCA4;ERN2;CNOT9;CPEB3;SMAD2;RING1;S100A11;SPINDOC
prerank,calcium-mediated signaling (GO:0019722),0.36159288088802577,1.27738888465457,0.12063953488372094,0.6686009588534997,1.0,15/93,9.49%,PDPK1;RCAN2;MCU;SELP;FPR2;ACKR2;CCR9;RCAN1;PLCE1;VCAM1;ADGRL1;ACKR3;CACNA1C;LRRK2;NMUR1
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),-0.39920431637850035,-1.2772005694361253,0.136986301369863,0.582982493043976,1.0,12/33,20.33%,H3-3A;ESR1;PKN1;HDAC6;TRIM68;CALR;RUNX1;CBFB;KDM4C;PARK7;SAFB2;UFL1
prerank,positive regulation of signaling (GO:0023056),-0.3869461695504993,-1.2764091527147632,0.12051282051282051,0.583845424750111,1.0,8/37,7.01%,SYT1;RIMS1;RIMS2;GRIK2;NSF;HOMER1;SNCA;ECE1
prerank,tRNA aminoacylation for protein translation (GO:0006418),-0.3747773871493778,-1.2763503649325176,0.13243243243243244,0.5825571820391763,1.0,18/42,33.70%,LARS2;KARS1;CARS1;EEF1E1;EARS2;TARS3;IARS1;RARS2;VARS2;HARS1;YARS2;FARSB;YARS1;TARS1;WARS2;NARS1;PARS2;QARS1
prerank,cell part morphogenesis (GO:0032990),0.5343241650925452,1.2762754172379107,0.18386491557223264,0.6708592564075807,1.0,5/13,13.49%,PID1;PACSIN2;DNM1L;SUPV3L1;WASF1
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),-0.46429583605645885,-1.2761633546439513,0.14908256880733944,0.5816220246473316,1.0,9/17,37.53%,CADM1;RAET1E;LAMP1;RASGRP1;SLAMF6;NECTIN2;CD226;IL12A;CRTAM
prerank,regulation of epithelial cell migration (GO:0010632),0.3942117773884707,1.275548138099855,0.13445378151260504,0.671847422977805,1.0,13/51,11.16%,PTN;MCC;SASH1;DOCK5;TACSTD2;GLIPR2;DUSP10;CLASP1;CTSH;GLUL;INSL3;ENPP2;PTK2
prerank,neurotransmitter biosynthetic process (GO:0042136),0.5279526268505134,1.2750401118211299,0.17782026768642448,0.6721347732019793,1.0,3/14,15.92%,MOXD1;SLC5A7;SLC22A2
prerank,regulation of microtubule polymerization (GO:0031113),-0.3773711449613034,-1.2750207762728678,0.12293144208037825,0.5832805312190951,1.0,18/40,24.84%,NAV3;PAK1;SNCA;RPS3;MET;STMN2;TUBB4A;FES;PRUNE1;RAC1;MAPT;MAP2;STMN1;CDK5RAP2;DCTN1;ARL2;MAPRE1;OCLN
prerank,regulation of receptor internalization (GO:0002090),-0.38404567758093633,-1.274604812353085,0.1070559610705596,0.583071245930206,1.0,14/35,19.10%,INSR;ANKRD13A;ATXN2;AHI1;SCYL2;SDCBP;VEGFA;ATAD1;SFRP4;EGF;NTF3;TBC1D5;RIN3;MTMR2
prerank,leukotriene metabolic process (GO:0006691),0.4919031285432598,1.2744619666044457,0.1869328493647913,0.6725924607092928,1.0,3/19,6.87%,PLA2G4A;DPEP2;PTGR1
prerank,positive regulation of phospholipase C activity (GO:0010863),0.42289821504862946,1.2743440699500261,0.1455160744500846,0.6716504210430516,1.0,12/40,15.64%,ARHGAP6;LPAR1;PDGFRA;FGFR1;KIT;PDGFRB;PHB2;NMUR1;P2RY6;BDNF;NTRK3;TXK
prerank,positive regulation of embryonic development (GO:0040019),0.4880553715392334,1.274342640907743,0.1808695652173913,0.6703301936231827,1.0,3/19,2.09%,WNT4;OSR1;WNT3A
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.4132515141874721,1.2740340586258774,0.11642743221690591,0.6699766383313129,1.0,10/46,5.98%,ATRNL1;LAMC1;FN1;RADIL;PARVA;NRP1;FER;ANTXR1;LAMC3;EPHA1
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),-0.32660146045618316,-1.2735051713154075,0.07796610169491526,0.5846447043869163,1.0,37/79,27.91%,ACTR10;SH3GL2;MFSD6;CTSD;OSBPL1A;LGMN;AP1S1;CTSS;AP1S2;DYNC1H1;CD74;KIF26A;FCER1G;KIF18A;CTSL;KIF15;KIF3B;DYNC1I2;KIF5A;DYNLL2;AP1B1;ACTR1B;CAPZA2;SAR1B;AP2B1;KIF23;AP1S3;DCTN1;KIF22;KIF4A;RACGAP1;DCTN6;AP2A2;AP2A1;CLTA;AP2M1;KLC2
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),-0.5030860354440002,-1.2734333612855313,0.15271966527196654,0.5834358641691697,1.0,9/13,28.24%,SHANK3;LGMN;ZDHHC2;RELN;ADCY8;AKAP5;CHRNA7;SHISA7;SQSTM1
prerank,negative regulation of GTPase activity (GO:0034260),-0.4377692344464582,-1.272592748931259,0.1513157894736842,0.5843635888385732,1.0,7/22,13.60%,LRCH1;CPEB2;DAB2IP;RCC2;TMED2;F11R;HRAS
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.5328510656081011,1.2724640699506653,0.18994413407821228,0.6736712260679535,1.0,4/14,14.09%,STK39;OXSR1;WNT5A;WNK1
prerank,cellular response to growth factor stimulus (GO:0071363),0.33852090502966653,1.2724342011636574,0.08089260808926081,0.6724635401489912,1.0,30/151,11.85%,PDPK1;SOX5;BMP6;WNT4;SMAD3;ADAMTS12;FOXC1;CLEC3B;BMPR1A;NRP1;WWOX;ANXA1;BMP2;STAT5B;BMP7;PLK5;TGFBR1;APPL2;TGFBR2;PDCD5;CCL2;ACAP2;WNT5A;APPL1;MAPK14;SMAD4;MAP2K5;EGR3;DSTYK;NR4A1
prerank,positive regulation of myeloid cell differentiation (GO:0045639),0.43092279289176344,1.2717310473252919,0.16552901023890784,0.6734940639842248,1.0,8/33,11.85%,MTURN;STAT5B;ARNT;BRD1;STAT1;FAM210B;MAPK14;FOXO3
prerank,triglyceride homeostasis (GO:0070328),0.4615398749841728,1.2716508255694263,0.16034482758620688,0.6724282586498526,1.0,4/26,12.05%,RORA;NR1H3;IL18;DGAT2
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),0.5255536758745469,1.271585959225871,0.20446096654275092,0.6713115967978337,1.0,4/13,4.69%,TGFBR3;RBPJ;BMPR1A;GLI1
prerank,DNA damage checkpoint signaling (GO:0000077),-0.4088470403004907,-1.2708740173801754,0.14393939393939395,0.5881861475448572,1.0,13/28,24.83%,INTS7;CLSPN;DOT1L;MAP3K20;ATM;HINFP;RAD1;CHEK1;ATRIP;ATR;DONSON;FBXO6;RHNO1
prerank,regulation of cellular amino acid metabolic process (GO:0006521),-0.3546132375077009,-1.2708341523438127,0.1092896174863388,0.5868697406683694,1.0,20/53,24.51%,PSMC3;OAZ1;PSMD14;OAZ2;PSMD3;PSMD4;PSMD6;PSMA6;PSMA4;PSMB8;BCKDK;PSMA8;PSME1;PSMD7;PSMC6;PSMB5;PSMC5;PSMB1;PSMD11;PSMD8
prerank,post-translational protein modification (GO:0043687),0.3120351867910098,1.2702283719427736,0.04518430439952437,0.6741802372238066,1.0,48/332,12.85%,IGFBP3;CP;TNC;FBN1;LAMC1;FSTL1;FN1;PRKCSH;LTBP1;FAM20C;SPSB1;IGFBP5;APOA2;HIF3A;FSTL3;SDC2;FBXO11;RCN1;ITIH2;IL6;EPAS1;MIA3;KLHL21;KLHL22;SPSB4;APLP2;CUL4A;FBXO9;FBXL3;NUB1;PSMB10;CHM;PSMA3;FBXL20;PSME4;FBXL7;DNAJC3;FBXO4;PSMA5;KEAP1;ESCO1;CUL3;KLHL13;CSF1;ANO8;BTRC;FBXW11;ASB5
prerank,regulation of cell population proliferation (GO:0042127),0.29617507668967186,1.2701209540740825,0.01639344262295082,0.6732458834204197,1.0,138/691,16.58%,TCF7L2;ALDH1A2;IGFBP3;EFNB2;PDPN;PODN;BMP6;COL4A3;PTN;DPP4;KANK2;FN1;CXCL10;PDGFRA;FGFR1;FGF1;IL31RA;EIF2AK2;KSR1;TPTE;NUPR1;STAT2;IL6ST;PHIP;GHRH;LDOC1;WNT3A;GAB2;DLC1;PDS5B;BMPR1A;OSM;IL11;RBFOX2;FER;SMIM22;VEGFD;TGFA;ADAMTS1;IL34;TGFB1I1;PTHLH;PTPN14;KIT;BMP2;IGFBP6;STAT5B;IFI35;GLP2R;IL6;BTG3;GSDME;GLI1;BCL2;STOX1;BTG4;TGFBR1;EPHA1;FOXP3;PDGFRB;HDAC4;PTPN2;CD47;COL18A1;TGFBR2;STAMBP;CTSH;ZBTB7C;POU1F1;CLMN;STAT1;CDC73;PDCD5;SKI;CDKN2B;PIAS1;SETD4;YAP1;IGF2;IL13RA1;DNAJA2;MST1R;IFITM1;SMAD6;NUPR2;CGRRF1;GRK5;FGF18;IFNLR1;PTPN6;CDH13;TJP1;PTK2;STAT4;PTPRU;SH2B3;CUL3;CSF1;NUDT6;CADM4;SLURP1;MAP2K1;TRAPPC14;TCIRG1;RBM5;NPR3;MDM4;IFIT3;ALK;WDR6;FRK;ABI1;VHL;NIBAN2;BIRC6;HDAC2;RARA;PML;NTRK3;TNS2;RAB33B;PDF;MEAK7;ADRA2A;KAT2B;CCKBR;P3H3;SOX4;PKD2;APP;IGF1R;INHA;AXIN2;NF2;WWTR1;S100A11;NOX1;CCAR1
prerank,positive regulation of RNA splicing (GO:0033120),-0.40812909866310276,-1.2696961498285015,0.13625866050808313,0.588847570530829,1.0,9/29,27.90%,PIK3R1;CELF4;SETX;TRA2A;RBM3;HNRNPLL;SLC38A2;RBMXL1;RBM20
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.4440466049537937,1.269573577559059,0.1620745542949757,0.6738236806949959,1.0,6/32,6.45%,PHLDB2;ARHGAP6;DLC1;CASK;SERPINE1;RASA1
prerank,regulation of cartilage development (GO:0061035),0.49840007058122077,1.2680401099990497,0.1963963963963964,0.6775535300503108,1.0,5/18,5.17%,SOX5;PTHLH;BMP2;BMP1;MBOAT2
prerank,response to thyroid hormone (GO:0097066),-0.5010047389366615,-1.2678732556975036,0.17647058823529413,0.5926990365847241,1.0,5/13,11.06%,THRB;LMO2;CTSB;CTSS;CTSL
prerank,positive regulation of leukocyte migration (GO:0002687),0.44551251651713303,1.2674968844259755,0.19528619528619529,0.678051299895378,1.0,3/27,4.73%,PTN;IL6;MIA3
prerank,retinal metabolic process (GO:0042574),0.5462179175165093,1.2669053779862836,0.2303370786516854,0.6786446444160036,1.0,4/12,14.80%,ABCA4;RDH10;BCO2;ALDH8A1
prerank,negative regulation of blood pressure (GO:0045776),-0.5026437065448592,-1.2661350061197585,0.1781115879828326,0.5964001078610548,1.0,4/13,10.30%,NOS3;BMPR2;PRCP;NOS1
prerank,metanephric mesenchyme development (GO:0072075),0.5716342562308929,1.266014809524926,0.22664015904572565,0.6801207856900485,1.0,3/10,7.59%,WNT4;OSR1;STAT1
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),0.4638063853314286,1.265537553540254,0.16055846422338568,0.6803960016723152,1.0,7/26,13.84%,RSAD2;IFI35;PTPN22;NR1H3;PJA2;TLR2;RTN4
prerank,positive regulation of growth (GO:0045927),-0.33907984258478563,-1.265499858924611,0.09164420485175202,0.5969184966733337,1.0,19/64,18.30%,PLCB1;AKAP6;TGFB2;INSR;RFTN1;H3-3A;AKT1;SDCBP;DDX49;EXOSC2;RPS6KA1;EGFR;CEP43;MFSD2A;TAF9B;LGI1;CDKN2AIP;PPM1F;EXOSC4
prerank,peptidyl-threonine dephosphorylation (GO:0035970),0.4784090577375695,1.2651840387346702,0.16605166051660517,0.6802060198006217,1.0,6/22,12.11%,PPM1E;PPM1A;DUSP10;DUSP16;PPM1B;DUSP5
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.48805137597910175,1.2649112798855981,0.18374558303886926,0.6798028078001811,1.0,5/19,11.82%,BMP6;AFDN;TJP1;PTPRU;ADAM19
prerank,neurotransmitter transport (GO:0006836),-0.3390793425058702,-1.2648462524585848,0.09876543209876543,0.5974839323707383,1.0,18/73,11.31%,NRXN1;SYT1;RIMS1;PPFIA2;HSPA8;LIN7A;PTPRN2;GABRA2;SNAP25;SYN3;SLC1A1;STXBP1;CPLX1;SLC1A2;SYN1;SNPH;DVL1;GAD2
prerank,amino acid import (GO:0043090),-0.43268604052559895,-1.2642433376273163,0.14757709251101322,0.5978638557503833,1.0,6/21,5.64%,SLC6A6;SLC47A1;SLC7A5;SLC6A1;SLC7A1;SLC1A1
prerank,maintenance of blood-brain barrier (GO:0035633),-0.39369212104772194,-1.2634488223530431,0.15517241379310345,0.5987644584983061,1.0,12/30,7.81%,PECAM1;SLC12A2;CLDN5;ESAM;DMD;ACTB;JAM2;ACTG1;SLC1A1;MBP;LSR;JAM3
prerank,histone monoubiquitination (GO:0010390),0.4531414046339443,1.2632877130455118,0.19818181818181818,0.683774217693775,1.0,10/24,16.98%,BCOR;DTX3L;RNF20;CDC73;WAC;PAF1;LEO1;KDM2B;RING1;RNF2
prerank,embryonic skeletal system morphogenesis (GO:0048704),0.4308188046173408,1.2632694639516007,0.17229729729729729,0.6825428427451863,1.0,6/31,6.97%,PDGFRA;OSR1;HOXC4;TGFBR1;TGFBR2;DYNC2I1
prerank,transcription by RNA polymerase II (GO:0006366),0.3117165067142379,1.2630364750323442,0.048426150121065374,0.6819913506021202,1.0,85/305,20.50%,RORA;SOX5;RBPJ;CCN2;ELOF1;NOTCH2;MLLT3;TBL1XR1;TEAD1;MAF;NR6A1;POLR2D;PCF11;PIR;GLIS3;PRRX1;DTX1;NR1H3;RPRD2;PPARA;CREBBP;RARB;CDC73;INTS9;TRIM24;TEAD2;YAP1;CCNH;MNAT1;NABP1;NOCT;CDK7;CDK12;TAF7;TCEA1;POLR2C;IWS1;INTS14;RTF1;NR4A1;MAML2;NFIC;NR3C1;MED20;PKNOX1;PAF1;POLR2F;POU2F1;INTS3;GTF2H4;ERCC6;LEO1;PABPN1;RARA;INTS8;MLLT1;CSTF3;SNAPC3;KAT2B;IRF9;TAF9;DDX21;WWTR1;TBL1X;AFF4;GTF2H2;CDK13;SLBP;INTS13;PMF1;NFYA;ESRRA;WDR33;PGR;E2F2;SNAPC5;RPRD1B;INTS6;SETD2;DDX5;NABP2;RNGTT;MED26;POLR2K;GMEB2
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.37338505679068945,1.2629266454090131,0.12957317073170732,0.6810837485818927,1.0,12/73,9.63%,ROBO1;COL4A3;SMAD3;CASP12;DLC1;TNFSF15;CFLAR;CASP4;IFT57;NGFR;BAX;CASP8AP2
prerank,regulation of p38MAPK cascade (GO:1900744),0.4230347684126739,1.262906590425254,0.17003367003367004,0.6798755001823691,1.0,8/35,8.89%,SASH1;RELL1;DUSP10;BMP2;PTPN22;LGALS9;PJA2;DLG1
prerank,protein polyubiquitination (GO:0000209),0.31380088514007404,1.2621390987213956,0.05425400739827373,0.6809692447867717,1.0,66/297,15.52%,SASH1;RNF152;RNF213;SPSB1;SMURF2;TRIM56;HERC6;RNF217;TRAF5;FBXO11;FBXL17;TRIP12;NEDD4;TTC3;NHLRC3;RC3H1;BCL2;RNF19A;UBE2U;RNF216;DZIP3;SIAH2;PELI2;TRIM5;DTX3L;FBXO9;NPEPPS;ANAPC11;RNF20;FBXL3;PSMB10;ANAPC1;AMFR;UBE2C;PSMA3;FBXL20;PSME4;LONRF1;FBXL7;FBXO4;PSMA5;WWP2;FBXO38;BLMH;HUWE1;UBE2V1;HECTD1;CUL3;IFI27;TRIM21;BTRC;HECW2;UBE2E3;UBE2Q2;FBXW11;CDC27;PRPF19;BFAR;LNPEP;FBXL4;DDA1;UBE2R2;FBXL13;FBXL12;RNF146;MUL1
prerank,respiratory tube development (GO:0030323),0.4469265962338362,1.261670764145449,0.1708185053380783,0.6811702679297291,1.0,5/28,7.18%,PDPN;FGF1;RBP4;LOXL3;DNAAF1
prerank,protein O-linked glycosylation (GO:0006493),0.3557865491275271,1.2614101528193613,0.11764705882352941,0.6806686865869865,1.0,15/96,7.45%,TMTC4;GALNT18;GALNT14;GALNT15;MUC2;GXYLT2;GALNT12;TRAK1;TMTC1;LARGE1;GALNT2;GALNT1;RXYLT1;POMT2;GCNT4
prerank,regulation of cell junction assembly (GO:1901888),-0.4096560116999339,-1.2612433373247074,0.17016317016317017,0.6037545423953996,1.0,9/27,16.16%,PRKCH;CLDN5;MEF2C;RAPGEF2;RUNX1;CBFB;F11R;APLNR;RAP1A
prerank,inhibitory synapse assembly (GO:1904862),-0.5298951604438631,-1.2612258988489045,0.2063157894736842,0.6023851666302659,1.0,7/11,24.44%,GABRA2;GABRB3;LGI2;FGF13;GABRB2;GABRA1;PLXNB1
prerank,positive regulation of JNK cascade (GO:0046330),-0.33201389061334424,-1.2607058563078901,0.12112676056338029,0.6025614846343416,1.0,24/70,17.54%,PLCB1;PTK2B;TPD52L1;MAP3K5;DAB2IP;HMGB1;RASSF2;MAP3K11;SDCBP;MFHAS1;DUSP22;MAPK8IP1;MINK1;GADD45G;ANKRD6;SEMA3A;HRAS;SH3RF3;CCL19;NOD2;CD27;DUSP15;LTBR;PYCARD
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),0.39867604479960805,1.260203558268467,0.13853503184713375,0.6831924321200713,1.0,12/51,12.67%,PTN;CXCL10;FPR2;VEGFD;IL34;IL6;SERPINE1;LGALS9;PTK2;ANO6;CSF1;RARRES2
prerank,negative regulation of cell cycle (GO:0045786),0.3758996201568065,1.2601586144196792,0.12195121951219512,0.6820755275013383,1.0,18/73,13.23%,SMAD3;NR2F2;NUPR1;FOXC1;BMP2;BTG3;BMP7;PTPN3;LATS2;BTG4;NPPC;NUPR2;GMNN;IPO7;NR4A1;TSPYL2;NUDT6;HECA
prerank,negative regulation of endothelial cell proliferation (GO:0001937),0.427915328488719,1.259999346866123,0.1793103448275862,0.6813090214651589,1.0,6/35,7.71%,SULF1;COL4A3;NR2F2;NGFR;STAT1;CCL2
prerank,positive regulation of secretion (GO:0051047),-0.5311487957145866,-1.2597480548590667,0.19130434782608696,0.6040772544648529,1.0,2/11,10.66%,ACSL3;NPR1
prerank,2-oxoglutarate metabolic process (GO:0006103),0.5360512122680116,1.2592203620413438,0.17540322580645162,0.6824715142627957,1.0,6/13,24.31%,IDH1;D2HGDH;IDH2;PHYH;ADHFE1;OGDH
prerank,regulation of protein targeting to membrane (GO:0090313),-0.4115928530274062,-1.2585661527419205,0.15476190476190477,0.6060583925394314,1.0,8/28,15.70%,ANK3;CEMIP;INPP5K;MTCL1;MFF;KCNB1;HRAS;C2CD5
prerank,regulation of tau-protein kinase activity (GO:1902947),-0.5481455164837108,-1.258565854891382,0.20077220077220076,0.6046405799690588,1.0,4/10,17.52%,SORL1;HSP90AB1;HSP90AA1;NAB2
prerank,pancreas development (GO:0031016),0.5351443006999452,1.258126237895975,0.21200750469043153,0.6845464751199585,1.0,2/12,7.18%,TCF7L2;DNAAF1
prerank,regulation of cellular amine metabolic process (GO:0033238),-0.35298345858136576,-1.2580152633639157,0.11375661375661375,0.604851175101732,1.0,19/50,24.51%,PSMC3;OAZ1;PSMD14;OAZ2;PSMD3;PSMD4;PSMD6;PSMA6;PSMA4;PSMB8;PSMA8;PSME1;PSMD7;PSMC6;PSMB5;PSMC5;PSMB1;PSMD11;PSMD8
prerank,positive regulation of binding (GO:0051099),0.3679813839684838,1.2578516472220347,0.14954682779456194,0.6841348154655942,1.0,20/84,12.58%,TCF7L2;VTN;FOXC1;WNT3A;PARP9;DACT1;BMP2;TERT;DTX3L;CLN5;SPPL3;GSK3B;SKI;RIPK2;STK3;AMFR;LRRK2;GMNN;TRIM21;HFE
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),0.4803979296201182,1.2578452983005306,0.18302828618968386,0.6828872531010858,1.0,5/20,7.71%,TLR4;MTDH;PTPN22;IL18;CCL2
prerank,mRNA destabilization (GO:0061157),0.42248140582844773,1.2577935372838625,0.18226600985221675,0.6817742969045439,1.0,16/38,23.49%,ROCK2;TUT4;POLR2D;RC3H1;FTO;MOV10;METTL16;GIGYF2;CPEB3;TUT7;DHX36;ROCK1;KHSRP;ZC3H12A;ZFP36L2;YTHDF3
prerank,cardiac muscle contraction (GO:0060048),0.4296488007084988,1.2567855970062582,0.1708185053380783,0.6836802312986047,1.0,5/34,8.06%,TNNC1;ATP1A2;CSRP3;TPM1;SCN3B
prerank,presynaptic endocytosis (GO:0140238),-0.4141780282771277,-1.256652189814205,0.18604651162790697,0.607486543473737,1.0,5/24,8.74%,NLGN1;SYT1;AMPH;SNCA;NLGN3
prerank,gland development (GO:0048732),0.3861377554731545,1.2565746042993866,0.12322274881516587,0.6830465726073143,1.0,7/59,6.51%,TGFBR3;WNT4;PRKCSH;ANXA1;TGFBR1;SALL1;DKK3
prerank,transition metal ion transport (GO:0000041),-0.3838053588155539,-1.256488200147285,0.12056737588652482,0.606555476647113,1.0,10/35,7.54%,TRPC3;TFRC;ATOX1;TRPC5;FTH1;TRPC4;ATP2C1;SLC31A1;TRPC6;SLC30A1
prerank,neural crest cell development (GO:0014032),-0.3775027036527189,-1.256200946190032,0.1358695652173913,0.6059729775396623,1.0,12/44,10.34%,SEMA6D;CDH2;ERBB4;PHACTR4;TBX1;SEMA4D;SEMA3C;SEMA6A;SEMA7A;SEMA3E;SEMA3G;SEMA6B
prerank,regulation of adaptive immune response (GO:0002819),0.4942363801095164,1.2560519132369066,0.1978798586572438,0.6834368194830943,1.0,2/18,4.56%,IL6ST;ADCY7
prerank,water-soluble vitamin metabolic process (GO:0006767),0.37240487134523126,1.2560103802793425,0.1393841166936791,0.682314907831879,1.0,13/68,9.92%,MMAB;ENPP1;PCCA;SHMT1;SLC19A1;AOX1;MTHFD1;PANK2;PCCB;LMBRD1;BTD;PDXK;HLCS
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),-0.47482951101654947,-1.2558588779977107,0.16523605150214593,0.6055757081898036,1.0,5/14,15.10%,DMD;ATP1B1;ANK3;ACTN4;GLRX
prerank,cellular response to virus (GO:0098586),0.44052473356998345,1.2558531319436546,0.19444444444444445,0.6815226734682491,1.0,13/30,22.66%,CXCL10;IL6;GSDME;LGALS9;BAX;MAPK14;IFIH1;GBF1;ARF1;HIF1A;ZC3H12A;RIOK3;LGALS8
prerank,GTP metabolic process (GO:0046039),0.5137461121964351,1.2556728399046595,0.1891891891891892,0.6808440430555427,1.0,7/15,17.54%,ENTPD7;RHOQ;LRRK2;EFL1;OPA1;RAN;GNAI3
prerank,regulation of multicellular organism growth (GO:0040014),0.5162504552364989,1.255238732614598,0.19889502762430938,0.6809057461806244,1.0,7/15,18.82%,GHR;GHRH;STAT5B;GDF15;APP;STAT5A;PTCH1
prerank,secondary palate development (GO:0062009),0.5157773147188242,1.254740887747309,0.21794871794871795,0.6811202180725267,1.0,6/14,11.51%,TGFBR3;WNT3A;LRRC32;TGFBR2;WNT5A;SMAD4
prerank,sphingolipid catabolic process (GO:0030149),-0.46845256823544096,-1.2543704666344475,0.19183673469387755,0.6086306739844257,1.0,2/15,2.19%,ACER3;ACER2
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),-0.5200018429900922,-1.2543653283912857,0.22107438016528927,0.6072346227168437,1.0,5/11,18.56%,NOL11;DDX11;SMARCB1;PWP1;SIRT7
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),-0.4487564416732537,-1.2539331946029493,0.205607476635514,0.6071377108075322,1.0,7/20,9.49%,SLC12A2;KCNMA1;ATP1B1;KCNJ2;ATP1A1;SLC8A1;NEDD4L
prerank,regulation of viral entry into host cell (GO:0046596),-0.39635580017475636,-1.2538671548785616,0.15165876777251186,0.605925219854153,1.0,10/30,18.15%,LY6E;HS3ST5;SNX3;MID2;CD74;TRIM68;TRIM62;IFITM3;IFITM2;LGALS1
prerank,negative regulation of autophagosome assembly (GO:1902902),0.527215590619714,1.2533737772553473,0.20703125,0.6840046503426664,1.0,7/13,15.69%,NUPR1;LRRK2;TMEM39A;SCFD1;CHMP4A;CHMP4B;FEZ2
prerank,regulation of ion transmembrane transport (GO:0034765),-0.3865457571227968,-1.2530431518450853,0.1473922902494331,0.6070829199263329,1.0,11/33,17.14%,CHRM3;AKAP6;KCNJ3;KCNJ2;NEDD4L;KCNJ6;KCNJ8;KCNQ1;KCNJ15;CASQ2;P2RX7
prerank,smooth muscle cell differentiation (GO:0051145),-0.5203754319161333,-1.2528441824612746,0.19088937093275488,0.6062787812966354,1.0,6/12,14.61%,MEF2C;MRTFB;BMP4;TMEM204;APLNR;HEY1
prerank,inner mitochondrial membrane organization (GO:0007007),-0.34888293341461074,-1.2523663535612244,0.15206185567010308,0.6062936478187256,1.0,21/47,25.74%,ATP5F1A;ATP5MC1;ATP5PO;GHITM;SAMM50;TIMM8B;ATP5F1B;ATP5PD;MAIP1;ATP5F1D;MTX3;MTX1;TIMM22;UQCC3;NDUFA13;ATP5F1E;TIMM10;ATP5ME;ATP5MG;ATP5MC3;ATP5MF
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.3868394119384637,1.2522356802593788,0.15562403697996918,0.6864744568247065,1.0,15/56,13.48%,ADAMTS1;ANXA1;STOX1;CCND3;ANAPC11;KLHL18;ESPL1;PHB2;UBE2C;ANKRD17;BRD4;CUL3;NSMCE2;RAD51B;CDC27
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),-0.5302886174308258,-1.2521201631972332,0.226890756302521,0.6055562760174024,1.0,3/10,5.29%,CSGALNACT1;XYLT1;B3GAT2
prerank,cellular copper ion homeostasis (GO:0006878),-0.49250222975740043,-1.2520240762262855,0.17307692307692307,0.6044740795890556,1.0,7/14,26.84%,ATOX1;SLC31A1;SLC31A2;MT2A;CCDC22;COX19;ABCB6
prerank,organic hydroxy compound biosynthetic process (GO:1901617),0.3976562291156883,1.2518150031482849,0.1639871382636656,0.6865661876883942,1.0,10/44,12.53%,PRKAG2;CYP7B1;HSD17B1;CYP27A1;AMACR;INSIG2;SCP2;SLC27A2;LBR;CH25H
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),-0.5006428532276952,-1.2513347229035068,0.2024793388429752,0.6051384195051138,1.0,5/13,15.87%,ELOVL5;ELOVL7;TECR;TECRL;HACD3
prerank,positive regulation of microtubule polymerization (GO:0031116),-0.40698108493743745,-1.251179762469376,0.14705882352941177,0.6042142886199622,1.0,12/28,24.84%,NAV3;PAK1;RPS3;MET;FES;RAC1;MAPT;CDK5RAP2;DCTN1;ARL2;MAPRE1;OCLN
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.308095748188518,1.2508369039730665,0.055487053020961775,0.6885278948222371,1.0,62/348,13.33%,ROBO1;BMP6;FOXD1;ROCK2;SMAD3;RBPJ;RBMS3;FN1;AFDN;WNT6;FGF1;PID1;TLE1;OSR1;WNT3A;GJA1;ANXA2;CDH5;ITGB8;GCGR;SLC26A9;TNRC6B;SLC24A3;ANGPT1;BMP2;PKP3;IL6;TLR4;BMP7;STOX1;PTPN22;TGFBR1;DTX3L;CRP;CTSH;PDCD5;GSK3B;LGALS9;TNRC6A;WNT5A;YAP1;DTNBP1;MOV10;RESF1;MUSK;FUBP1;MAPK14;CUX2;FGF18;ATF7IP;TLR2;LRP3;MAP2K5;ADAM19;CSF1;HFE;PTPN1;NOG;MAP2K1;ARRB1;TASOR;MAPK9
prerank,regulation of collagen biosynthetic process (GO:0032965),0.47922040014345785,1.2506972532405078,0.1853932584269663,0.6877305975520428,1.0,3/19,4.44%,WNT4;VIM;IL6
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.510491309783564,-1.2500913198819252,0.20394736842105263,0.606023491814334,1.0,7/11,36.50%,UQCRH;UQCR11;UQCC3;UQCR10;UQCRQ;CYCS;UQCRB
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.3327215008345196,-1.2499072081455236,0.10511363636363637,0.6051761334301565,1.0,24/67,24.51%,PSMC3;NCF2;PSMD14;PSMD3;B2M;CALR;PSMD4;PSMD6;PSMA6;PSMA4;PSMB8;CYBB;PSMA8;PSME1;FCGR1A;PSMD7;PSMC6;IKBKB;PSMB5;PSMC5;PSMB1;SEC22B;PSMD11;PSMD8
prerank,long-term memory (GO:0007616),0.48540755561526294,1.2495848977708885,0.20037105751391465,0.6898731719870198,1.0,3/19,8.78%,RASGRF1;NFATC4;PJA2
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),-0.5019132827659177,-1.2491678198689642,0.1894093686354379,0.6059050335005648,1.0,6/12,16.41%,DMD;ATP1B1;ANK3;NOS1;GLRX;FXYD1
prerank,regulation of synapse maturation (GO:0090128),-0.5416720510148038,-1.249113676702847,0.20675944333996024,0.6047159273065414,1.0,3/10,5.14%,NRXN1;ARHGEF15;DAB2IP
prerank,neutral amino acid transport (GO:0015804),-0.4141239060524013,-1.2490025977070882,0.16502463054187191,0.6036988720399764,1.0,8/28,13.49%,SLC6A6;SLC7A5;SLC38A5;SLC1A1;SLC1A4;SLC43A2;SLC36A1;SLC3A2
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),-0.4601773660757097,-1.2487509977177678,0.1932059447983015,0.6030814583403187,1.0,7/16,16.37%,NOS1AP;SCARB1;AKT1;GCH1;NUS1;S100A1;HTR2B
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.30164271279985844,1.2487504481763032,0.0286368843069874,0.6911754151820106,1.0,85/417,15.24%,TCF7L2;WNT4;FOXD1;PRICKLE1;RBPJ;ZHX2;ARID4A;ATXN1;NR2F2;TLE1;SMURF2;GATA6;SAMD13;ZBTB4;ZIC2;SNX6;RBFOX2;GLI3;MYB;MBD2;ZMYND15;TCEAL7;EID2B;CRY2;PRDM11;BMP2;RFX3;CRY1;LOXL3;BCOR;BMP7;GZF1;NIF3L1;SALL1;CBFA2T2;FOXP3;HDAC4;TSHZ3;DKK3;PBXIP1;GLIS2;DPF2;ZMYND11;PHB2;WNT5A;ZEB1;KAT6B;EPC1;USP47;SCMH1;SUMO1;JARID2;TAF7;PSPC1;WWP2;GMNN;ATF7IP;HEYL;CIR1;SMAD4;SCML4;BCL7A;LHX9;ZNF219;VGLL4;ILF3;BTRC;FBXW11;CBX4;BHLHE41;NR3C1;ARID5B;POU2F1;KAT6A;PRDM5;KDM8;RBM15;RUNX1T1;NIBAN2;ZBTB21;HDAC2;RARA;PML;UIMC1;SP3
prerank,regulation of macrophage chemotaxis (GO:0010758),-0.4303334376511927,-1.248514413939835,0.17173913043478262,0.6024229924593076,1.0,6/21,13.22%,MTUS1;THBS1;PTK2B;MAPK3;CMKLR1;CSF1R
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),-0.3821577028543424,-1.2484238017084,0.1568627450980392,0.6013235021497476,1.0,9/35,7.63%,NLGN1;CDH11;CDH12;ATP2C1;CDH10;CDH8;CDH22;CDH7;CDH20
prerank,protein localization to cell surface (GO:0034394),-0.4147553282946745,-1.247919199469001,0.15180722891566265,0.6013810597522918,1.0,8/26,10.57%,PTPRK;EMP2;FBLN5;CTNNB1;RIC3;JAM3;PIGU;PIGK
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),-0.4690311803543807,-1.2474153285697105,0.21935483870967742,0.6016009587667838,1.0,7/16,7.24%,DMD;RYR2;CALM1;CALM2;SLC8A1;CALM3;CAMK2D
prerank,positive regulation of MAPK cascade (GO:0043410),0.31449338031173446,1.2472410250199013,0.06840796019900497,0.6946577134734815,1.0,38/245,9.48%,ROBO1;LPAR1;ROCK2;CCN2;PDGFRA;FGFR1;FGF1;NOTCH2;EIF2AK2;KSR1;FPR2;MTURN;OSM;IL11;GLIPR2;EPHA8;NRP1;IL34;ANGPT1;KIT;BMP2;TAOK3;IL6;ROR1;GSDME;PRKCZ;PTPN22;PELI2;PDGFRB;TRIM5;CCL2;ACKR3;LGALS9;PHB2;IGF2;LRRK2;PIK3R5;MST1R
prerank,negative regulation of translation (GO:0017148),0.3626377216592535,1.2468208608297375,0.13193403298350825,0.6947635188756122,1.0,20/87,16.03%,ROCK2;SAMD4A;EIF2AK2;IGFBP5;SHMT1;DAPK1;IGF2BP1;TPR;NANOS2;CPEB1;FTO;IGF2BP2;EIF4ENIF1;ILF3;DDX6;METTL16;GIGYF2;EIF2AK3;CNOT9;CPEB3
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.46657755456843847,1.2462696126458552,0.19141323792486584,0.6952218628487464,1.0,6/22,9.78%,BPIFB1;IFI35;PTPN22;APPL2;NR1H3;APPL1
prerank,O-glycan processing (GO:0016266),0.3866535950501492,1.2461252162141354,0.15728476821192053,0.6944595162656476,1.0,9/54,9.83%,GALNT14;GALNT15;MUC2;GXYLT2;GALNT12;GALNT2;GALNT1;GCNT4;C1GALT1C1
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.4470106586092522,1.2460439659068845,0.1742957746478873,0.6934526876552621,1.0,6/26,7.66%,FHL2;RCAN1;ATP2B4;EFHB;SPPL3;GSK3B
prerank,heart looping (GO:0001947),-0.3720976155468318,-1.2459404448747862,0.16312056737588654,0.604571063550641,1.0,14/39,23.48%,MEF2C;NOTCH1;SOX17;AHI1;ZIC3;TBX2;NDRG4;SOX18;APLNR;VANGL2;DLL1;SRF;TBX6;BBS7
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),-0.43200807137786357,-1.2456310901935614,0.17162471395881007,0.6041240481833026,1.0,7/21,4.93%,HS6ST3;HS6ST2;NDST3;HS3ST4;HS3ST5;XYLT1;EXT1
prerank,aortic valve development (GO:0003176),-0.38236471521079635,-1.2455890847756137,0.17422434367541767,0.6029055023663221,1.0,10/34,8.00%,SLIT2;ROBO2;NOS3;TIE1;BMPR2;NOTCH1;ELN;EMILIN1;BMP4;TNFRSF1B
prerank,cellular response to alkaloid (GO:0071312),-0.45232350156196055,-1.2454284145778467,0.20612244897959184,0.6021077105590775,1.0,6/17,16.12%,RYR2;RYR3;CASP7;SLC8A1;CASQ2;RAD51
prerank,negative regulation of synaptic transmission (GO:0050805),-0.4225218551330053,-1.2454091678799213,0.18764302059496568,0.6008354888195767,1.0,8/23,19.34%,SLC24A2;SHANK2;STXBP1;SLC30A1;ATAD1;GRIK3;MTMR2;TMEM25
prerank,prostaglandin biosynthetic process (GO:0001516),0.4882166894100617,1.2449307577798239,0.21851851851851853,0.6957008253920594,1.0,2/18,1.37%,PTGS1;PLA2G4A
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.4783003696242629,1.244775877414806,0.20471014492753623,0.6949434307110169,1.0,6/19,14.68%,ROBO1;DCN;CCBE1;CADM4;SMOC2;MYO1C
prerank,carboxylic acid transmembrane transport (GO:1905039),0.4091348573503754,1.2439794905293382,0.17857142857142858,0.6962527958077992,1.0,3/40,2.57%,SLC7A11;SLC13A3;SLC19A1
prerank,regulation of actin polymerization or depolymerization (GO:0008064),0.4349100407575952,1.2437987790581533,0.1797945205479452,0.6955316788819673,1.0,6/28,7.40%,ARHGAP18;ARHGAP28;HAX1;RASA1;PLEKHG2;DBN1
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),0.47498888044499277,1.243665798643815,0.19889502762430938,0.6947044098386581,1.0,4/20,10.95%,MCU;MICU1;PHB2;PMPCB
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.5187584955402611,1.2435159951210757,0.2,0.6939506833745385,1.0,1/14,0.15%,SULF1
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.34611440459708315,1.2432759758742262,0.12588401697312587,0.6935159825450913,1.0,15/108,8.35%,UACA;ROBO1;COL4A3;SMAD3;CASP12;DLC1;DAPK1;TNFSF15;CFLAR;CASP4;IFT57;NGFR;PDCD5;LGALS9;BAX
prerank,central nervous system myelination (GO:0022010),-0.517620621628465,-1.2428174522377866,0.2302771855010661,0.6069932007852206,1.0,7/11,33.59%,PLP1;TENM4;B4GALT6;CLU;CNTNAP1;B4GALT5;ABCA2
prerank,androgen receptor signaling pathway (GO:0030521),0.5459079184581157,1.242552794068151,0.21673003802281368,0.694582909868516,1.0,2/11,3.83%,ZMIZ1;PMEPA1
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.4794621515622879,-1.2425100131585656,0.18705035971223022,0.6065750949685287,1.0,8/15,19.88%,RYR2;RAB3GAP1;SRP14;SPCS2;SPCS1;ZFAND2B;SEC61A1;SEC61G
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.3765481594682955,1.2416801506300652,0.16588419405320814,0.6962097766136981,1.0,17/56,16.13%,BMP6;BMPR1A;LDLRAD4;TWSG1;PMEPA1;BMP2;BMP7;TGFBR1;BMP8B;SMAD6;SMAD4;HFE;NOG;GDF11;GDF15;DAB2;INHA
prerank,regulation of T cell differentiation in thymus (GO:0033081),-0.4890845035601432,-1.24131998752836,0.2058165548098434,0.6087421034376735,1.0,10/13,37.03%,TOX;BMP4;SOD1;CAMK4;ADAM8;ZC3H8;CLPTM1;VNN1;FOXJ1;TESPA1
prerank,organic substance transport (GO:0071702),-0.29961049864249417,-1.2412838788210032,0.07,0.6074934737143195,1.0,36/120,23.41%,ATP8A1;ABCG2;SLC47A1;LRP1B;SLCO2A1;ABCA3;SPNS2;SCAMP5;LMAN2L;RAB38;SCAMP1;SCAMP2;VPS33B;RAMP2;SLC22A6;MFSD2A;ABCD2;SLC22A5;GM2A;SLC50A1;CHMP1A;CHMP1B;CEP290;MFSD12;PEX19;CHMP2B;CD320;SLC35F3;DISP1;SLC19A2;CHKA;SLC18A2;CENPF;ABCA13;CHMP2A;SLCO1B1
prerank,response to interleukin-4 (GO:0070670),-0.5305943356180315,-1.2412168268516297,0.2082514734774067,0.6064048449764448,1.0,1/10,0.14%,LEF1
prerank,positive regulation of collagen biosynthetic process (GO:0032967),0.48895126804470856,1.2411521322916141,0.22862453531598512,0.6966148858720839,1.0,2/16,2.52%,WNT4;VIM
prerank,odontogenesis of dentin-containing tooth (GO:0042475),0.5130707381310226,1.2404617884876465,0.2049335863377609,0.697605901511125,1.0,6/15,14.82%,WNT6;FOXC1;BMP2;EDA;ANKRD11;HDAC2
prerank,glucose transmembrane transport (GO:1904659),-0.45619082861572546,-1.2403690476123403,0.1895424836601307,0.6075498894167408,1.0,9/18,32.83%,SLC2A1;PPARD;SLC2A9;SORT1;SLC2A4;SLC2A2;SLC2A10;SLC5A3;SLC2A3
prerank,negative regulation of cellular component movement (GO:0051271),0.5042389298421064,1.2401488611387583,0.2283464566929134,0.6973884722231328,1.0,5/15,6.82%,TGFBR3;SP100;TACSTD2;FBLN1;SPINT2
prerank,protein N-linked glycosylation via asparagine (GO:0018279),-0.40271368029783305,-1.2395992092761086,0.17899761336515513,0.6084356803444476,1.0,10/30,22.34%,FUT8;MGAT5;RPN2;ALG5;LMAN1;DPM2;OSTC;STT3B;UBE2J1;DDOST
prerank,regulation of endothelial cell migration (GO:0010594),0.35683020428151596,1.2390734549504603,0.13411078717201166,0.6995673473715249,1.0,12/85,3.88%,PTN;RIN2;ROCK2;SASH1;NR2F2;SP100;FGF1;FOXC2;NRP1;ANXA3;ANGPT1;DCN
prerank,activin receptor signaling pathway (GO:0032924),0.5040581466502948,1.2388819184680548,0.2128060263653484,0.698951527203834,1.0,5/15,16.33%,SMAD3;TGFBR1;ACVR1C;ACVR2B;SMAD2
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.4662205790503735,1.2386346647488022,0.1894353369763206,0.6984565314932025,1.0,4/23,8.09%,PLA2G4A;MBOAT2;PLA2G4C;PLA2G6
prerank,bile acid and bile salt transport (GO:0015721),-0.41746251786384764,-1.2382692231218606,0.1780821917808219,0.6109805296529549,1.0,8/24,23.41%,ABCC4;SLCO1C1;CEACAM1;ATP8B1;RXRA;STARD5;SLC10A3;SLCO1B1
prerank,regulation of mitochondrial fission (GO:0090140),0.45612546181742775,1.23826595931702,0.21206581352833637,0.6983711519337531,1.0,11/24,21.45%,MCU;STAT2;DCN;RALBP1;LRRK2;DNM1L;MIEF1;MUL1;MYO19;SPIRE1;VPS35
prerank,protein polyglutamylation (GO:0018095),-0.5222022712707325,-1.2381443490412816,0.1962025316455696,0.6100248182263548,1.0,2/11,5.77%,TTLL7;TTLL5
prerank,positive regulation of cell adhesion (GO:0045785),-0.3185098070458156,-1.2380324310696045,0.07242339832869081,0.6090000543438692,1.0,17/74,13.65%,FRMD5;PTPRJ;TGFB2;ZFHX3;SMAD7;STX3;VIT;ADGRG1;NDNF;VEGFA;CXCL12;ATM;RET;MEGF10;SYK;EPB41L4B;RAC1
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),-0.4863820595308931,-1.2372427284362155,0.18550106609808104,0.6099216234035194,1.0,7/13,22.46%,SORL1;GCC2;INSIG1;BRSK2;TMEM30A;SAR1B;CD81
prerank,regulation of cellular pH (GO:0030641),-0.4021934133365173,-1.2370637064632717,0.19612590799031476,0.6090625661170975,1.0,8/29,14.68%,SLC4A10;SLC9A2;CA2;SLC9A8;SLC9B1;ATP5F1B;SLC4A7;SLC9A5
prerank,negative regulation of defense response (GO:0031348),0.36540640531158963,1.236948155375622,0.14528593508500773,0.7012850853980536,1.0,8/77,6.52%,ENPP3;RORA;FPR2;CDH5;TNFAIP8L2;NR1H3;PPARA;PTPN2
prerank,cellular response to cAMP (GO:0071320),-0.3882356382413871,-1.236893375323058,0.1760204081632653,0.6082512120012714,1.0,8/30,12.24%,AKAP6;HCN1;SLC5A5;INPP5K;HCN2;RAPGEF2;PDE2A;KCNQ1
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),-0.38779528533492924,-1.2366437766812186,0.14705882352941177,0.6076696666807926,1.0,8/29,14.75%,SMAD7;RPS2;PINK1;FEM1A;DCUN1D2;DCUN1D5;DCUN1D1;PARK7
prerank,cellular response to amyloid-beta (GO:1904646),0.4153254350952773,1.236331074784344,0.17863105175292154,0.7019237463940577,1.0,13/35,15.95%,FPR2;GJA1;SNX6;TLR4;CASP4;VCAM1;NGFR;GSK3B;EPHA4;CACNA2D1;APP;IGF1R;ICAM1
prerank,striated muscle tissue development (GO:0014706),-0.40193862682467013,-1.2361670811519574,0.16898148148148148,0.6077353417248611,1.0,8/29,8.44%,SGCZ;PGM5;MEF2C;SGCD;BMPR2;SIX1;MYL6;TBX2
prerank,cellular response to hydrogen peroxide (GO:0070301),-0.38076274192105297,-1.2358085666352874,0.15914489311163896,0.6075534485400319,1.0,9/33,11.27%,NET1;SETX;MAP3K5;RPS3;PLEKHA1;RHOB;HDAC6;SIGMAR1;PAX2
prerank,apical protein localization (GO:0045176),-0.5151846887724931,-1.2357993770196005,0.22580645161290322,0.6063044471332077,1.0,8/10,17.16%,ACTB;GOPC;MAL;JAM3;ATP8B1;SHROOM3;INSC;VANGL2
prerank,negative regulation of BMP signaling pathway (GO:0030514),0.38506097094287395,1.2357985309022257,0.17540983606557378,0.7024979025252465,1.0,14/51,15.53%,FBN1;FSTL1;SMURF2;BMPR1A;FSTL3;NBL1;BMP2;SKI;SMAD6;SMAD4;NOG;CHRDL1;GREM2;ACVR2B
prerank,regulation of protein kinase B signaling (GO:0051896),0.3225084719127892,1.235233625305168,0.09605263157894736,0.7030683979598626,1.0,23/193,6.37%,TCF7L2;PDPK1;PDGFRA;FGFR1;FGF1;AXL;TPTE;FAM110C;GAB2;OSM;OSBPL8;FRS2;DAG1;TGFA;KL;ANGPT1;KIT;MTDH;TGFBR1;HAX1;CPNE1;PDGFRB;PPARA
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),-0.4123953623252841,-1.235047554137839,0.17464114832535885,0.6072965612452496,1.0,11/26,29.71%,PDE8A;AKT1;PINK1;ATF4;PPIA;PARK7;GPR37;GPR37L1;PYCR1;VNN1;HSPB1
prerank,organonitrogen compound catabolic process (GO:1901565),0.3860521962085092,1.2349453797095116,0.17940199335548174,0.7027190882689812,1.0,13/57,14.02%,PLA2G4A;CPQ;ANPEP;GGACT;NPEPPS;CLN5;TRIM24;PLA2G6;ERAP1;ENPP2;CLPX;AMDHD2;LNPEP
prerank,fatty-acyl-CoA metabolic process (GO:0035337),-0.42603019367791095,-1.2349413445813864,0.17248908296943233,0.6062947301634847,1.0,8/20,22.51%,ACSL3;FAR2;ACACA;ACLY;SCD;HSD17B8;FASN;GCDH
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),-0.4872053947128615,-1.2348049171455058,0.19624217118997914,0.6054576840962062,1.0,7/13,17.72%,MGAT5;DOT1L;PTPRT;PIGU;PTPRC;EGF;HES1
prerank,Notch signaling involved in heart development (GO:0061314),0.5468187003339315,1.2347335856245083,0.22727272727272727,0.7022185474271819,1.0,2/11,1.51%,RBPJ;NOTCH2
prerank,icosanoid metabolic process (GO:0006690),0.4070150702577369,1.2347111569040783,0.1910828025477707,0.701106026841937,1.0,8/40,12.95%,PTGS1;PLA2G4A;DPEP2;PLA2G4C;PTGR1;ALOXE3;EPHX1;PON3
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.5035127764195427,1.234001565103584,0.2196078431372549,0.7021240492878443,1.0,3/15,8.07%,SH3D19;NRDC;SNX9
prerank,positive regulation of B cell proliferation (GO:0030890),-0.3936252703133204,-1.2338989534940357,0.18509615384615385,0.6067636745291969,1.0,10/29,22.46%,MEF2C;TFRC;CD38;CD74;CD40;PTPRC;CLCF1;CD320;MIF;CD81
prerank,cytoskeleton organization (GO:0007010),0.3399905230121405,1.2336764480986642,0.14305750350631136,0.7019320586198707,1.0,22/114,11.97%,MICAL3;DIAPH1;ARHGAP10;SH3D19;SYNE3;PHIP;FGD4;BRWD1;DES;TPM1;PLCE1;RHOBTB2;RHOF;PACSIN2;CAPZB;CCL2;FMNL2;CNN2;CECR2;SPRYD3;ZMYM6;RHOC
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.395916098323559,1.2335417088963712,0.16639477977161501,0.7011717590832353,1.0,13/45,16.13%,BMP6;BMPR1A;TWSG1;BMP2;BMP7;TGFBR1;BMP8B;SMAD4;HFE;GDF11;GDF15;DAB2;INHA
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),-0.5239585226078229,-1.2333758440465974,0.23333333333333334,0.6069837122042645,1.0,5/10,19.08%,SNCA;CTBP1;SET;BRCA1;NOC2L
prerank,regulation of insulin secretion (GO:0050796),0.34686935939468483,1.233234390923548,0.136431784107946,0.7009156127109267,1.0,15/101,11.81%,TCF7L2;MCU;DPP4;RAPGEF4;ITPR1;RBP4;RFX3;IL6;ADCY5;NOS2;CACNA1C;SIRT4;CDK16;NLGN2;PPP3CB
prerank,embryonic digestive tract development (GO:0048566),0.48813257346290767,1.233223247919847,0.20817120622568094,0.699765028835127,1.0,4/18,6.77%,PDGFRA;GLI3;SALL1;RARB
prerank,negative regulation of myeloid cell differentiation (GO:0045638),-0.4315397873010476,-1.232995927077436,0.20224719101123595,0.6067909420410017,1.0,5/20,7.09%,MEIS2;PTK2B;CDK6;HOXB8;ZBTB16
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.4241297240643389,1.2327203734443113,0.19550173010380623,0.7001427581497455,1.0,7/30,14.94%,LEPROT;NPEPPS;PDCD5;HUWE1;RHOU;USP36;CSNK2A2
prerank,DNA strand elongation involved in DNA replication (GO:0006271),-0.4440532101124567,-1.2325775743610776,0.19730941704035873,0.6067797426009751,1.0,10/18,31.21%,GINS3;POLA1;POLD2;POLE;LIG3;RFC4;POLE3;GINS4;PCNA;GINS2
prerank,positive regulation of collagen metabolic process (GO:0010714),0.4766567388230537,1.23249752796745,0.2224231464737794,0.6996467615280396,1.0,2/17,2.52%,WNT4;VIM
prerank,negative regulation of chemotaxis (GO:0050922),-0.39394599234594607,-1.2320098779976139,0.1596244131455399,0.6071680338083069,1.0,12/31,10.34%,SLIT2;ROBO2;SEMA6D;THBS1;NOTCH1;SEMA4D;SEMA3C;SEMA6A;SEMA7A;SEMA3E;SEMA3G;SEMA6B
prerank,purine ribonucleotide metabolic process (GO:0009150),0.36991704964743344,1.2315916439225059,0.1554160125588697,0.7011962519977535,1.0,18/68,17.54%,AMPD3;ENPP1;ACOT11;PTHLH;TPST1;ENTPD7;RHOQ;LRRK2;ACOT9;ACOT1;ACAT1;EPHA2;EFL1;OPA1;SULT1A1;ABHD14B;RAN;GNAI3
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),-0.31715122761072295,-1.2312625494764053,0.12110726643598616,0.6067122031503057,1.0,36/78,27.91%,ACTR10;SH3GL2;CTSD;OSBPL1A;LGMN;AP1S1;CTSS;AP1S2;DYNC1H1;CD74;KIF26A;FCER1G;KIF18A;CTSL;KIF15;KIF3B;DYNC1I2;KIF5A;DYNLL2;AP1B1;ACTR1B;CAPZA2;SAR1B;AP2B1;KIF23;AP1S3;DCTN1;KIF22;KIF4A;RACGAP1;DCTN6;AP2A2;AP2A1;CLTA;AP2M1;KLC2
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),-0.31715122761072295,-1.2312625494764053,0.12110726643598616,0.6067122031503057,1.0,36/78,27.91%,ACTR10;SH3GL2;CTSD;OSBPL1A;LGMN;AP1S1;CTSS;AP1S2;DYNC1H1;CD74;KIF26A;FCER1G;KIF18A;CTSL;KIF15;KIF3B;DYNC1I2;KIF5A;DYNLL2;AP1B1;ACTR1B;CAPZA2;SAR1B;AP2B1;KIF23;AP1S3;DCTN1;KIF22;KIF4A;RACGAP1;DCTN6;AP2A2;AP2A1;CLTA;AP2M1;KLC2
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),0.4404273250046341,1.2311165572060385,0.1972318339100346,0.7015317736749602,1.0,5/29,8.09%,PLA2G4A;MBOAT2;NR1H3;PLA2G4C;PLA2G6
prerank,positive regulation of heterochromatin assembly (GO:0031453),0.5480176180716871,1.2306952568750424,0.23684210526315788,0.7016458678010635,1.0,7/11,20.23%,TPR;RESF1;ATF7IP;TASOR;PPHLN1;SETDB1;MPHOSPH8
prerank,neuron projection extension (GO:1990138),0.42495359311599895,1.2298635642967346,0.1890971039182283,0.7029954253938597,1.0,11/32,15.72%,ALCAM;AUTS2;NRP1;CPNE1;USP9X;FLRT1;PPP3CB;SPG11;CDKL3;IQGAP1;FLRT3
prerank,visual perception (GO:0007601),0.35633633096655676,1.2298319347711644,0.1422087745839637,0.7019187827830735,1.0,16/84,15.15%,EFEMP1;RDH10;ZIC2;ADGRV1;MYO9A;TULP2;COL18A1;CRYBB3;IMPG2;EYA4;ATXN7;CRYBA1;OPA1;EML2;PDE6C;CEP250
prerank,regulation of embryonic development (GO:0045995),0.41735988698051707,1.2297479663969586,0.18855218855218855,0.7009700681222756,1.0,5/34,5.19%,PHLDB2;DAG1;TRIP12;CLASP1;PHLDB1
prerank,cellular response to interleukin-4 (GO:0071353),-0.5272621505109352,-1.229470078601212,0.23412698412698413,0.6104340888308927,1.0,1/10,0.14%,LEF1
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),-0.378719493666048,-1.2292213521073398,0.1791767554479419,0.6098660009239479,1.0,17/32,32.15%,FOXN3;MRE11;CLSPN;BABAM1;ATM;CDKN1A;BRCA1;CHEK1;DTL;DONSON;TAOK2;CDC14B;BLM;TOPBP1;PLK1;CDK1;TICRR
prerank,neuron projection regeneration (GO:0031102),0.5684238210980138,1.228459647489548,0.25196850393700787,0.7037673322210464,1.0,2/10,5.80%,PTN;NREP
prerank,carbohydrate derivative transport (GO:1901264),-0.4423644904620137,-1.2277290710204036,0.22675736961451248,0.6129667345199439,1.0,6/18,15.72%,SLC15A2;SCARB1;SLC10A7;VLDLR;MFSD2A;SLC25A19
prerank,positive regulation of phosphatase activity (GO:0010922),-0.4328388124529701,-1.2276052827477473,0.19863013698630136,0.6120330691922687,1.0,5/21,6.94%,MEF2C;CALM1;CALM2;HSP90AB1;CALM3
prerank,thymus development (GO:0048538),-0.48474990603320356,-1.2273739426339378,0.22540983606557377,0.6114143932129946,1.0,8/13,29.53%,TBX1;SIX1;SOD1;EPHB3;HES1;FOXE1;FADD;FGF10
prerank,immunoglobulin mediated immune response (GO:0016064),-0.5212424305317414,-1.2272405903262518,0.22391304347826088,0.6105658688380451,1.0,7/10,41.11%,CD74;FCER1G;CD27;CD81;TLR8;FCGR2B;CARD9
prerank,regulation of establishment of cell polarity (GO:2000114),0.4964773341035157,1.2263497560159655,0.23783783783783785,0.7093315630780347,1.0,3/16,2.80%,ROCK2;KANK1;CDH5
prerank,mitochondrion morphogenesis (GO:0070584),0.5315196534700354,1.2262234985995895,0.19699812382739212,0.7085363503319285,1.0,7/11,24.58%,PID1;DNM1L;SUPV3L1;WASF1;PNPT1;SLIRP;MTM1
prerank,retinol metabolic process (GO:0042572),0.509021644235746,1.2261972282818192,0.2281639928698752,0.707420449198017,1.0,2/14,3.36%,RDH10;RBP4
prerank,negative regulation of protein modification process (GO:0031400),0.360460968131837,1.2260494023939845,0.16717325227963525,0.7066813482382845,1.0,12/79,10.16%,PTPN13;IGFBP3;PID1;PLPP3;PRKAA2;FBLN1;SNTA1;ATP2B4;GSK3B;MYADM;LRRK2;XRCC1
prerank,ERBB2 signaling pathway (GO:0038128),-0.3913424375129801,-1.2256642402238176,0.2009685230024213,0.6136905129196428,1.0,9/31,18.67%,ERBB4;PIK3R1;GAB1;MYOC;EGFR;HSP90AA1;EGF;ERBIN;NRG2
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),0.54931217555989,1.225652699220782,0.24399260628465805,0.7066993531875966,1.0,3/10,3.41%,STK39;OSR1;NEDD4
prerank,regulation of cell migration (GO:0030334),0.29912149482422,1.2254941687745668,0.05125148986889154,0.7059719831676287,1.0,72/382,12.69%,PLXNA2;SULF1;ROBO1;DPYSL3;SEMA3D;PDPN;PODN;ROCK2;SASH1;AFDN;PDGFRA;FGF1;SYNE2;CXCL16;IGFBP5;FAM110C;LMO4;DLC1;KANK1;CDH5;LDLRAD4;FER;DAG1;NUMB;SMIM22;LDB2;ANXA1;DUSP10;KIT;BMP2;WNT5B;MIA3;AMOTL1;TPM1;VCL;TGFBR1;FAM83H;SERPINE1;APPL2;MMP14;EPHA1;PDGFRB;SEMA4B;MGAT3;BST2;CTSH;CLIC4;CLDN1;RNF20;NGFR;EPHA4;MYADM;STK24;SERPINE2;PLAU;RAP2C;IFITM1;APPL1;FGF18;NKD1;ENPP2;CDH13;TJP1;PTK2;PTPRU;FOXO3;RHOC;CSF1;EPPK1;ARSB;SLURP1;NOG
prerank,positive regulation of sprouting angiogenesis (GO:1903672),0.4969662723280336,1.224977153690902,0.26003824091778205,0.7063833193260979,1.0,6/15,13.11%,PDPK1;FGF1;ITGA5;JMJD8;TJP1;JAK1
prerank,positive regulation of fat cell differentiation (GO:0045600),0.3917033031154587,1.2247282528640222,0.19206349206349208,0.705952149425689,1.0,16/47,22.02%,MEDAG;BMP2;BMP7;TMEM64;CREBL2;NOCT;AAMDC;RARRES2;CARM1;NAPEPLD;ASXL2;CEBPB;PTGS2;XBP1;CDS1;ZC3H12A
prerank,positive regulation of cyclase activity (GO:0031281),-0.46655355014387684,-1.2247128845043975,0.2175824175824176,0.6150877767285673,1.0,5/14,10.30%,NOS3;MAPK8;MAPK3;CACNA1D;NOS1
prerank,cell chemotaxis (GO:0060326),0.373481388285791,1.224086969964436,0.17993630573248406,0.706738604116893,1.0,15/60,15.74%,LPAR1;PDGFRA;PARVA;ACKR2;CCR9;NRP1;KIT;PDGFRB;ACKR3;EGR3;NR4A1;EPHA2;CCL25;CCRL2;CXCR4
prerank,positive regulation of phosphorylation (GO:0042327),0.3111749947824168,1.2240765701440144,0.09734513274336283,0.7056112299918921,1.0,57/240,15.94%,ZBTB20;LEPR;ROCK2;EPHA7;PDGFRA;FGFR1;FGF1;AXL;DDR2;PRKAA2;FPR2;WNT3A;INSRR;LMO4;EPHA3;EPHA8;FAM20A;NRP1;VEGFD;IL34;ANGPT1;KIT;BMP2;SLCO3A1;ROR1;ARNT;CCND3;RAD50;EPHA1;PELI2;PDGFRB;RALBP1;FBH1;EPHA4;IGF2;LRRK2;MST1R;MUSK;FGF18;FNIP1;PTK2;DSTYK;EPHA2;DVL3;RARRES2;EFNA1;ARRB1;KCTD20;ALK;P2RY1;NTRK3;RYK;ILK;STK4;DAB2;APP;IGF1R
prerank,regulation of anoikis (GO:2000209),0.4663665425717088,1.224069119301406,0.22965641952983726,0.7044827540132748,1.0,5/19,11.16%,TLE1;ITGA5;BCL2;MCL1;PTK2
prerank,positive regulation of endothelial cell migration (GO:0010595),0.35495161769792644,1.2239420994682633,0.14962962962962964,0.7037357745943762,1.0,11/84,3.83%,PDPK1;RIN2;ROCK2;SASH1;FGFR1;FGF1;PLPP3;FOXC2;NRP1;ANXA3;ANGPT1
prerank,respiratory system development (GO:0060541),0.41976816569057007,1.2238514560600249,0.1972318339100346,0.7028538005334614,1.0,5/32,7.18%,PDPN;FGF1;RBP4;LOXL3;DNAAF1
prerank,negative regulation of mononuclear cell migration (GO:0071676),-0.49921459372186344,-1.2234617414860087,0.2222222222222222,0.6172898302364785,1.0,4/12,7.21%,SLIT2;PLCB1;CCN3;AKT1
prerank,regulation of phospholipase C activity (GO:1900274),0.4950742224833634,1.2230919464672902,0.2314990512333966,0.7041016049510607,1.0,4/15,6.11%,PDGFRA;FGFR1;KIT;PDGFRB
prerank,regulation of neuron apoptotic process (GO:0043523),-0.30710452008587297,-1.2229951283149247,0.08794788273615635,0.6174169217515777,1.0,28/96,17.94%,GRID2;MEF2C;TGFB2;PTK2B;TRIM2;NTRK2;SIX1;CTNNB1;FOXQ1;NDNF;LGMN;PINK1;SIGMAR1;TGFB3;KCNB1;NGF;ATF4;AKT1S1;GRN;SIX4;PARK7;SOD1;CPEB4;CLCF1;SET;NTF3;TOX3;ADAM8
prerank,nerve growth factor signaling pathway (GO:0038180),-0.5237405099994363,-1.2228500906201865,0.2332657200811359,0.6165752977548868,1.0,4/10,16.45%,RAPGEF2;NGF;RAP1A;NTF3
prerank,cellular metal ion homeostasis (GO:0006875),-0.30197588411894394,-1.2223967251723558,0.11419753086419752,0.6166532310012818,1.0,26/102,15.34%,SLC12A2;KCNMA1;ATP1B1;SLC24A2;RYR2;TPT1;KCNJ2;HTR2C;ATP1A1;ATP2C1;SLC8A1;CCL14;NPTN;ATP2A3;SLC30A1;CXCL12;NEDD4L;CALR;SLC10A7;CD40;TMCO1;CAV1;ATP2A2;CCL19;ATP13A4;ATP1A3
prerank,regulation of mononuclear cell migration (GO:0071675),-0.4138821217393862,-1.2223243042425873,0.18867924528301888,0.6156082570261358,1.0,7/23,13.22%,SLIT2;THBS1;STK10;MAPK3;LYN;CMKLR1;CSF1R
prerank,cellular response to catecholamine stimulus (GO:0071870),-0.4179045224025096,-1.222293148381046,0.20902612826603326,0.6144490022828569,1.0,7/23,15.32%,PDE4B;RYR2;SNCA;MAPK3;KCNQ1;ATF4;NR4A3
prerank,tube closure (GO:0060606),0.4227145459100238,1.2220214864821712,0.19197207678883071,0.7062565049110625,1.0,6/31,7.92%,PRICKLE1;LMO4;DLC1;MTHFD1;CELSR1;SKI
prerank,regulation of oxidative stress-induced cell death (GO:1903201),-0.4987561129852287,-1.2219351751300767,0.22474226804123712,0.6142216445421967,1.0,4/11,28.63%,PINK1;PARK7;STK26;MMP3
prerank,photoperiodism (GO:0009648),0.43342197382389425,1.2208246407935819,0.21853146853146854,0.7087606152332113,1.0,11/28,19.62%,FBXL17;CRY2;CRY1;FBXL3;CRTC1;PPP1CB;PML;FBXL12;PER3;CLOCK;BHLHE40
prerank,negative regulation of neurogenesis (GO:0050768),0.40159023923991183,1.2205491325306912,0.1875,0.7084350987479852,1.0,6/34,7.53%,PTN;WNT3A;IL6;APPL2;LRP4;NGFR
prerank,positive regulation of neuron death (GO:1901216),0.39091384919762684,1.2201552049471973,0.20751633986928106,0.7085259605901937,1.0,7/46,8.47%,EFNB2;EPHA7;NUPR1;TLR4;GSK3B;BAX;WNT5A
prerank,regulation of JNK cascade (GO:0046328),-0.3017373412927412,-1.2196489433107764,0.12269938650306748,0.619640734060574,1.0,33/101,17.54%,MECOM;PLCB1;PTK2B;TPD52L1;PHLPP1;MAP3K5;EPHB1;DAB2IP;HMGB1;RASSF2;MAP3K11;SDCBP;MFHAS1;PINK1;DUSP22;MAPK8IP1;MINK1;GADD45G;ANKRD6;EGFR;SEMA3A;MAPK8IP3;HRAS;SH3RF3;CCL19;CYLD;NOD2;COPS5;MEN1;CD27;DUSP15;LTBR;PYCARD
prerank,7-methylguanosine mRNA capping (GO:0006370),0.42416514647644105,1.2194258457452614,0.2071917808219178,0.7085345750821268,1.0,15/31,27.65%,POLR2D;CCNH;MNAT1;CDK7;POLR2C;POLR2F;GTF2H4;GTF2H2;RNGTT;POLR2K;POLR2H;CMTR1;GTF2F1;ERCC2;ERCC3
prerank,7-methylguanosine RNA capping (GO:0009452),0.42416514647644105,1.2194258457452614,0.2071917808219178,0.7085345750821268,1.0,15/31,27.65%,POLR2D;CCNH;MNAT1;CDK7;POLR2C;POLR2F;GTF2H4;GTF2H2;RNGTT;POLR2K;POLR2H;CMTR1;GTF2F1;ERCC2;ERCC3
prerank,regulation of protein neddylation (GO:2000434),-0.515315514743428,-1.2193813164030194,0.22894168466522677,0.619215905610714,1.0,6/10,14.48%,RPL5;RPL11;DCUN1D2;COPS9;DCUN1D5;DCUN1D1
prerank,positive regulation of interleukin-4 production (GO:0032753),-0.4467813461469964,-1.2192456533163998,0.21621621621621623,0.6183370700023694,1.0,6/17,12.61%,SLC7A5;PRKCQ;HAVCR2;FCER1G;CD86;SYK
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),0.42388777167137065,1.2192053447124618,0.21392190152801357,0.7081137265865692,1.0,10/28,15.07%,PID1;ENPP1;KANK1;PRKCZ;APPL2;PTPN2;PTPN1;PIP4K2B;NCK1;TNS2
prerank,primary neural tube formation (GO:0014020),0.42745679438221384,1.218931193852603,0.19014084507042253,0.7077840097981518,1.0,6/30,7.92%,PRICKLE1;LMO4;DLC1;MTHFD1;CELSR1;SKI
prerank,positive regulation of T-helper cell differentiation (GO:0045624),0.5009786319156935,1.2185525571054077,0.2565543071161049,0.7078028583488377,1.0,6/14,14.88%,MYB;ANXA1;PRKCZ;IL18;NFKBIZ;RARA
prerank,regulation of insulin receptor signaling pathway (GO:0046626),0.3980846853074291,1.2181537346989475,0.1936026936026936,0.7078671725414523,1.0,12/43,15.07%,PID1;ENPP1;KANK1;NUCKS1;SORBS1;PRKCZ;PTPN2;IGF2;PTPN1;PIP4K2B;NCK1;TNS2
prerank,leukotriene biosynthetic process (GO:0019370),0.5079956338493048,1.218102347900482,0.2302025782688766,0.7068717512820865,1.0,2/14,2.96%,PLA2G4A;GGTA1
prerank,regulation of keratinocyte differentiation (GO:0045616),0.4346029980934877,1.2180599285528564,0.23519163763066203,0.7058670069224345,1.0,4/24,4.74%,ROCK2;FOXC1;NCOA3;ERRFI1
prerank,mRNA polyadenylation (GO:0006378),0.43848572550761966,1.2177709850498568,0.23378839590443687,0.7044879748151445,1.0,15/26,24.46%,PCF11;PAPOLG;CDC73;PAF1;LEO1;TENT2;CSTF3;APP;PAPOLB;GRSF1;WDR33;TENT4B;PNPT1;CLP1;PAPOLA
prerank,RNA polyadenylation (GO:0043631),0.43848572550761966,1.2177709850498568,0.23378839590443687,0.7044879748151445,1.0,15/26,24.46%,PCF11;PAPOLG;CDC73;PAF1;LEO1;TENT2;CSTF3;APP;PAPOLB;GRSF1;WDR33;TENT4B;PNPT1;CLP1;PAPOLA
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.40799904274102483,1.2174901018356827,0.20481927710843373,0.7041879822472311,1.0,6/34,13.97%,LGR4;BPIFB1;TLR4;LY96;IRAK3;TICAM1
prerank,regulation of kinase activity (GO:0043549),0.3441830731945243,1.217404131036815,0.15797101449275364,0.7033571874572506,1.0,22/89,12.29%,EPHA7;PDGFRA;FGFR1;AXL;DDR2;INSRR;LMO4;EPHA3;EPHA8;LDB2;KIT;ROR1;PLCE1;RAD50;EPHA1;PDGFRB;EPHA4;MST1R;MUSK;DSTYK;TSPYL2;EPHA2
prerank,defense response to Gram-negative bacterium (GO:0050829),0.39392256732202624,1.2173685830684478,0.1938610662358643,0.7023458582136464,1.0,7/42,7.90%,SELP;IL6;TLR4;SERPINE1;OPTN;NOS2;TNFRSF14
prerank,negative regulation of cellular process (GO:0048523),0.28920485591542805,1.2172837875618805,0.053167420814479636,0.7015097843638347,1.0,119/521,17.79%,ALDH1A2;PLXNA2;IGFBP3;PDPN;TGFBR3;PODN;COL4A3;SMAD3;KANK2;CCN2;SP100;ENPP1;EIF2AK2;TPTE;NUPR1;LDOC1;GJA1;DLC1;PDS5B;OSM;CASK;FBLN1;PIWIL4;ADAMTS1;TGFB1I1;PRDM11;PTHLH;SUZ12;PTPN14;ANGPT1;BMP2;IGFBP6;IFI35;APBB1;IL6;BTG3;GSDME;MIA3;BMP7;BCL2;BTG4;APPL2;NR1H3;FOXP3;RASA1;BST2;PTPN2;COL18A1;ZBTB7C;POU1F1;CLMN;CDC73;PDCD5;SKI;CDKN2B;CRLF3;IFITM1;SMAD6;SUSD2;DCBLD2;NUPR2;CGRRF1;GMNN;IFNLR1;PTPN6;CDH13;TLR2;SMAD4;PTPRU;SH2B3;NR4A1;TSPYL2;VGLL4;NUDT6;PARP16;SERTAD2;SLURP1;NDUFS3;MAP2K1;DACT2;RBM5;SERTAD3;RTN4;MDM4;IFIT3;LRPAP1;WDR6;NCK1;FRK;ABI1;VHL;NIBAN2;PML;TNS2;EIF2AK3;CHMP4B;SMARCA4;KAT2B;MUL1;P3H3;SOX4;PKD2;APP;INHA;AXIN2;NF2;S100A11;PSRC1;PPP2CA;CDKN3;GAS8;PODXL;DLG5;OSGIN2;TXNIP;DNAJB2;OSGIN1;PPP2R5C;TENM1
prerank,establishment of protein localization to plasma membrane (GO:0061951),0.4148426216803506,1.2171588583345803,0.2045060658578856,0.7007784962333484,1.0,6/36,5.68%,AFDN;SPTBN1;VAMP5;TRARG1;RAB10;OPTN
prerank,positive regulation of bone resorption (GO:0045780),-0.49860507410545996,-1.2171249402209106,0.24254473161033796,0.6230427270452147,1.0,5/11,22.10%,SPP1;SYK;ADAM8;ATP6AP1;TNFRSF11A
prerank,nonribosomal peptide biosynthetic process (GO:0019184),-0.48966566543051737,-1.2168421858041267,0.21912350597609562,0.6226670763347484,1.0,7/12,31.31%,OPLAH;GCLC;GGT1;HAGH;MGST2;BDH2;GCLM
prerank,entrainment of circadian clock by photoperiod (GO:0043153),0.43716453490189733,1.2167613764982632,0.22614840989399293,0.7008606482689701,1.0,9/27,15.61%,FBXL17;CRY2;CRY1;FBXL3;CRTC1;PPP1CB;PML;FBXL12;PER3
prerank,regulation of MAPK cascade (GO:0043408),0.32282667162597617,1.2162691386937436,0.11934156378600823,0.7012248270231206,1.0,21/157,6.19%,TGFBR3;LPAR1;ROCK2;NRK;FN1;EPHA7;FGFR1;KSR1;OSM;IL11;EPHA8;DAG1;PRDM11;KIT;BMP2;TAOK3;IL6;ROR1;GSDME;PELI2;TRIM5
prerank,blood vessel morphogenesis (GO:0048514),0.3786953797477129,1.2161672165399637,0.19032761310452417,0.7004358503487909,1.0,10/54,8.56%,EFNB2;TGFBR3;RBPJ;CCM2;ITGB8;NRP1;TGFBR1;RASA1;TGFBR2;ADM
prerank,regulation of lymphocyte activation (GO:0051249),-0.49300415577648204,-1.2152533705749455,0.23565573770491804,0.6259557990142253,1.0,8/12,37.57%,KAT2A;PAG1;LAT;IKZF3;THEMIS2;CCL5;CRTAM;LCK
prerank,glycogen metabolic process (GO:0005977),0.4353412811345385,1.2152485892141243,0.21153846153846154,0.7020958180388182,1.0,6/27,11.43%,PRKAG2;PYGB;GYG1;GSK3B;PYGM;STBD1
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.48296134632392684,1.2147998016419923,0.2340036563071298,0.702330439581155,1.0,3/17,7.50%,CD55;TLR4;IL18
prerank,cellular protein modification process (GO:0006464),0.2813995395726029,1.2147432044356243,0.024922118380062305,0.7014223510660149,1.0,194/982,15.91%,PTPN13;IGFBP3;CP;PDPK1;PDK1;UST;TNC;FBN1;TEC;PARP14;LAMC1;ROCK2;FSTL1;NRK;ZC3HAV1;COL3A1;FN1;PRKCSH;PRKAG2;FGFR1;LTBP1;GRK3;FAM20C;SPSB1;STK39;GALNTL5;PRKAA2;OXSR1;EIF2AK2;TPTE;IGFBP5;TSSK3;APOA2;HIF3A;PPM1E;PPM1A;BMPR1A;FSTL3;SDC2;BMP2K;FAM20A;FER;MAN2A1;FBXO11;PARP9;CDK8;RCN1;ANXA1;DUSP10;ITIH2;PTPN14;DAPK1;BMP2;TAOK3;PTPN4;LARGE1;IL6;IKBKE;LOXL1;EPAS1;MIA3;PTPN3;PRKCZ;ARAF;LATS2;MAP3K1;AAK1;PTPN22;TGFBR1;LIPT1;MORC3;KLHL21;KLHL22;SPSB4;PARP3;APLP2;CUL4A;MAPK6;PTPRA;ARF4;MTMR3;DUSP16;PTPN9;FBXO9;NPC1;PARP10;TGFBR2;SSH1;PTPN21;MAP4K1;FAM20B;GSK3B;FBXL3;CCL2;NUB1;NEK4;WNK4;PPEF2;PSMB10;PPP4R2;FUT4;MANBA;CHM;CTDSP2;STK24;STK3;SIK3;PSMA3;SIRT4;FBXL20;PSME4;LRRK2;PPP4R1;COQ8B;TLK2;TRIOBP;CDK7;CDK12;HLCS;FUT10;TIPARP;FBXL7;DNAJC3;CDK16;FBXO4;PSMA5;WWP2;PPM1B;AKT3;HIPK3;GRK5;KEAP1;PTPN6;PPP1CB;IRAK3;PTPRU;CUL3;KLHL13;PPP3CB;CSF1;DUSP5;ANO8;FNTB;ILF3;PARP16;BTRC;PTPN1;PTPN18;DAPK2;MAP2K1;FBXW11;ASB5;MAP3K13;PORCN;PLAT;STRADB;JAK1;SRPK1;WDR45B;MAPK9;PPM1M;ALG1;ACVR1C;FBXL4;WNK1;DDA1;TRIB1;CHRDL1;TBK1;FRK;NUAK2;VHL;BIRC6;RARA;PTPRR;FBXL13;EIF2AK3;RYK;PDF;ILK;FBXL12;LIMK1;ASB3;CDKL3;STK4;ACVR2B;SOCS6;TXK;PKN2;PRKD2;ERN2;IGFBP4;APP;CTDSP1
prerank,striated muscle contraction (GO:0006941),0.3713553968303185,1.2143151153285727,0.184640522875817,0.7016312756917812,1.0,7/53,10.20%,TNNC1;ATP1A2;CSRP3;TPM1;ARHGEF11;SCN3B;RCSD1
prerank,cell-cell junction maintenance (GO:0045217),0.5395181235497194,1.2142831566090777,0.2625482625482625,0.7006400312380691,1.0,4/11,11.28%,PARD6A;MYADM;TJP1;NLGN2
prerank,skeletal system morphogenesis (GO:0048705),0.39469004194106855,1.2141657255618032,0.19230769230769232,0.6999554940567869,1.0,12/42,15.86%,PDGFRA;FGFR1;WWOX;HOXC4;TGFBR1;DYNC2I1;SKI;RFLNA;ANKRD11;RAB33B;HOXB4;SPEF2
prerank,muscle cell differentiation (GO:0042692),-0.38586744487333,-1.2138971006231107,0.18414322250639387,0.6286198616923462,1.0,6/32,3.45%,SYNE1;SGCZ;MEF2C;DMD;MRTFB;TBX1
prerank,response to metal ion (GO:0010038),-0.3254707492293961,-1.2131524881754574,0.13924050632911392,0.629476759376243,1.0,18/67,17.19%,TRPC3;KCNMA1;THBS1;MT1A;MT1X;HOMER1;CALM1;SNCA;CALM2;GPHN;CALM3;NEDD4L;PPP1CA;MT2A;CAV1;MAPT;ATP5F1D;SLC25A13
prerank,skin development (GO:0043588),0.3650498175534695,1.2130556601113074,0.1765625,0.7022739347210114,1.0,23/65,21.85%,COL5A2;COL3A1;GATA6;ANXA1;ERRFI1;COL5A1;CLIC4;CLDN1;ALOXE3;WNT5A;KRT9;EPHA2;DACT2;OPN3;COL1A2;TXNIP;CASP3;DSP;WNT10A;COL1A1;PIP5K1A;TGM1;PKD1
prerank,lipid transport (GO:0006869),-0.30363532703364127,-1.2127210386827962,0.10682492581602374,0.6294622507691942,1.0,16/97,8.59%,ATP8A1;ABCC4;SLCO1C1;SLCO2A1;CERT1;PITPNC1;PITPNA;ABCA3;SPNS2;PPARD;GLTP;SCARB1;CEACAM1;PRELID2;PRELID1;ATP8B1
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),0.4094588227533065,1.2122959380761547,0.21598639455782312,0.7034824948863173,1.0,7/34,8.47%,RBP4;IL6;LACC1;PTPN22;TNFRSF14;PHB2;WNT5A
prerank,male gonad development (GO:0008584),0.422112192012293,1.2122055490844368,0.19591141396933562,0.7026615804187096,1.0,4/34,3.84%,WNT4;GATA6;WNT2B;KIT
prerank,neuron differentiation (GO:0030182),-0.28048401656376054,-1.2119817294480766,0.08045977011494253,0.6304015726635248,1.0,29/165,11.11%,PTPRD;MEF2C;TENM2;TGFB2;TENM3;EPHA5;ACSL3;MYT1L;RORB;PBX3;FUT9;NTRK2;IL1RAPL1;ATP8A2;VSX1;MET;LHX6;CTNNB1;TENM4;FZD3;MYEF2;THOC2;VEGFA;LRP6;SPOCK1;SNPH;DDIT4;MANF;RUNX1
prerank,negative regulation of peptidase activity (GO:0010466),0.3876773059076308,1.2118439867387063,0.2144026186579378,0.7027028828266426,1.0,11/47,12.46%,VTN;ECM1;TIMP3;SERPING1;CSTB;SERPINB7;SERPINE1;TIMP2;SERPINE2;SERPINB8;SERPINE3
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),-0.4296168847985304,-1.2116845441990765,0.22009569377990432,0.6300118529747913,1.0,6/19,20.27%,SLCO1C1;KLF2;MAPK8;KLF4;EGF;CHRNA7
prerank,heart trabecula morphogenesis (GO:0061384),0.4760842963097839,1.2114527199229987,0.2438563327032136,0.7027819021428439,1.0,6/18,5.16%,TGFBR3;RBPJ;BMPR1A;RBP4;BMP7;TGFBR1
prerank,anion transport (GO:0006820),0.408830539081456,1.2113876335777571,0.21554770318021202,0.7018812503080536,1.0,5/33,3.74%,SLC13A3;SLC13A4;SLC19A1;SLC26A9;VDAC2
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),0.5136693099697984,1.2113325597961224,0.23616236162361623,0.7009456588601504,1.0,4/13,8.99%,SORBS1;PRKCZ;ECHDC3;IGF2
prerank,positive regulation of cellular component organization (GO:0051130),-0.2980873108165062,-1.211251819647683,0.09120521172638436,0.6300206904686951,1.0,30/107,18.33%,ATP10A;NRXN1;SHANK3;TGFB2;INSR;TFRC;SNCA;RPS3;DAB2IP;SLF1;VEGFA;TGFB3;NEDD4L;GNL3L;TAL1;RACK1;RUNX1;LMAN1;SYK;TMEM30A;RELN;MPP7;PARK7;BMF;CCL19;CBLL1;ADD1;MMP1;TPPP;ABCB4
prerank,positive regulation of hydrolase activity (GO:0051345),-0.286227998350457,-1.2107082871854407,0.08391608391608392,0.6303125337326427,1.0,34/137,15.18%,DOCK9;ITGA6;BCAR3;DOCK10;NET1;CALM1;SEMA4D;CALM2;MAPK8;RPS3;TBC1D30;RAB3GAP1;CCL14;RAPGEF2;CALM3;RGS7;MTCL1;RGS6;PINK1;ARHGAP27;RACK1;CAV2;CD40;DOCK8;ALS2;ARHGEF7;RGP1;RAPGEF6;F11R;HRAS;AGRN;EVI5;SNX18;CCL19
prerank,peroxisome organization (GO:0007031),-0.3930480614925766,-1.2105880160107558,0.17972350230414746,0.6294389828001095,1.0,12/25,27.45%,ABCD4;TMEM135;MFF;PEX10;ABCD2;PEX16;PLAAT3;PEX19;PEX11A;PEX3;LONP2;PEX11B
prerank,modulation by host of symbiont process (GO:0051851),-0.3741782394747811,-1.2099350859151665,0.2,0.6300288719796869,1.0,6/31,9.20%,LEF1;INPP5K;CTDP1;TFAP4;SMARCB1;HDAC1
prerank,embryonic digit morphogenesis (GO:0042733),0.47157843409034467,1.2095857321917007,0.24408014571949,0.705185762248969,1.0,6/18,14.82%,OSR1;GLI3;SALL1;CREBBP;NOG;HDAC2
prerank,apoptotic cell clearance (GO:0043277),-0.3832373632423646,-1.2089935715135163,0.18867924528301888,0.6313420584434396,1.0,11/30,17.36%,THBS1;XKR4;GAS6;HMGB1;SCARB1;XKR6;RHOG;MEGF10;RAC1;RHOH;RHOBTB1
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),0.3991958021816667,1.2087445060445068,0.2066772655007949,0.7065482821531208,1.0,11/35,19.63%,ZMIZ1;RBFOX2;NEDD4;PMEPA1;YAP1;NR3C1;TMF1;PPARGC1B;PGR;UBR5;DDX5
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.31364326558297373,1.2086758320483402,0.1258191349934469,0.7056744165722939,1.0,36/190,12.71%,UACA;RORA;CGNL1;DEPTOR;ITPR1;TLE1;PRKAA2;PPM1A;DGKD;DAG1;ARHGAP12;IFI35;BMP7;BCL2;MCL1;CPNE1;WWC2;ATP2B4;PPARA;MGRN1;STAMBP;STAT1;ZMYND11;PPEF2;MYADM;GPD1L;NLRX1;MAPK14;PPM1B;PLEK;BCL2L1;FNIP1;SH2B3;VGLL4;EPHA2;NDUFS3
prerank,retina homeostasis (GO:0001895),-0.4072509505841466,-1.2083612835724928,0.22654462242562928,0.6319159428790163,1.0,6/23,16.32%,ACTB;POTEF;ACTG1;B2M;SOD1;CDH3
prerank,oligosaccharide biosynthetic process (GO:0009312),-0.4258008788840766,-1.2079881943125566,0.2191142191142191,0.631668722188795,1.0,5/20,14.61%,FUT8;ST3GAL6;FUT9;ST6GALNAC5;ST3GAL4
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.484953486868661,1.207217977324153,0.2495446265938069,0.7089097838247521,1.0,4/17,18.72%,PLA2G4A;SERAC1;LPGAT1;PLA2G5
prerank,negative regulation of immune response (GO:0050777),0.32216662831180565,1.2065319275731148,0.1353887399463807,0.7098215282082766,1.0,23/154,12.33%,ENPP3;COL3A1;GHRH;ADORA2A;FER;PTHLH;RC3H1;GLP2R;IL6;ADCY5;ADCY7;MC2R;FOXP3;RXFP2;ADCY1;RAMP1;ADM;INSL3;MAPK14;PPM1B;GPR39;IRAK3;TRIM21
prerank,positive regulation of calcium ion transport (GO:0051928),-0.3695255466797702,-1.205124728774849,0.1687041564792176,0.6390000050825492,1.0,9/36,12.95%,CACNB2;TRPC3;TRPC6;CAMK2A;MYLK;GRIN1;CXCL12;CACNA1D;CAV1
prerank,cellular response to interleukin-6 (GO:0071354),0.4398593367412248,1.2046513956551335,0.2382608695652174,0.714487995717631,1.0,8/26,13.11%,PID1;IL6ST;FER;IL6;STAT1;YAP1;SMAD4;JAK1
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.32484499735490957,1.2041039205988804,0.12195121951219512,0.7150928024792786,1.0,40/138,15.94%,STYK1;PTN;EPHA7;PDGFRA;FGFR1;AXL;DDR2;IL31RA;IL6ST;INSRR;EPHA3;EPHA8;FRS2;FER;KIT;EFS;ROR1;EPHA1;PDGFRB;BDKRB2;NPPC;EPHA4;MTSS1;MST1R;POLR1G;MUSK;PTK2;PTPRU;CSF1;EPHA2;BDNF;SHC2;ALK;FRK;ABI1;GUCY2C;NTRK3;RYK;ACVR2B;IGF1R
prerank,actin filament depolymerization (GO:0030042),0.5175420393361336,1.2040965464978735,0.2648752399232246,0.7140068417090475,1.0,2/11,7.61%,MICAL3;DSTN
prerank,positive regulation of lipid biosynthetic process (GO:0046889),0.424531184927409,1.2039464357901253,0.2413793103448276,0.7134138753009036,1.0,6/29,9.15%,ZBTB20;SORBS1;NR1H3;CREBL2;PPARA;SIRT4
prerank,actin crosslink formation (GO:0051764),0.5212896179629602,1.2039306369222869,0.2381818181818182,0.7123976876921857,1.0,2/12,4.72%,DPYSL3;BAIAP2L1
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.321770458763647,1.203505324171017,0.14540466392318244,0.712607288785003,1.0,29/138,16.51%,RORA;RBPJ;CCN2;NOTCH2;TBL1XR1;TEAD1;NR6A1;POLR2D;NR1H3;PPARA;CREBBP;RARB;TEAD2;YAP1;CCNH;MNAT1;CDK7;TAF7;POLR2C;NR4A1;MAML2;NR3C1;POLR2F;GTF2H4;RARA;KAT2B;TAF9;WWTR1;TBL1X
prerank,androgen metabolic process (GO:0008209),-0.43825363461507655,-1.202818127311871,0.21777777777777776,0.6443225490270099,1.0,4/18,17.90%,SRD5A3;SPP1;HSD17B7;HSD17B10
prerank,regulation of feeding behavior (GO:0060259),0.5244119980421604,1.202730554856329,0.25147347740667975,0.7138118869197086,1.0,2/11,5.28%,LEPR;UCN
prerank,cellular response to lipopolysaccharide (GO:0071222),0.34392420268376966,1.2024592219970272,0.17066290550070523,0.7135246029658067,1.0,16/101,8.47%,CXCL10;AXL;LDOC1;VIM;IL6;TLR4;MTDH;PTPN22;SERPINE1;NR1H3;IL18;CDC73;CCL2;LY96;CD274;WNT5A
prerank,positive regulation of MAP kinase activity (GO:0043406),0.3670754772198967,1.202367763067835,0.18633540372670807,0.7127300641725665,1.0,14/66,12.35%,ROBO1;SASH1;FGFR1;FGF1;IL34;KIT;TAOK3;PDGFRB;LRRK2;PIK3R5;MST1R;FGF18;MAP3K7;DVL3
prerank,regulation of protein kinase C signaling (GO:0090036),0.4891735288763551,1.2022502409213431,0.25177304964539005,0.711993974644186,1.0,5/14,9.73%,DGKD;ADGRV1;MYADM;WNT5A;GPD1L
prerank,regulation of sensory perception of pain (GO:0051930),-0.4991002753003099,-1.2021034426903758,0.24385245901639344,0.6452651790928673,1.0,2/11,4.39%,MGLL;CCN3
prerank,positive regulation of dendrite development (GO:1900006),0.5324777390978043,1.2018519936009981,0.2767175572519084,0.7121127710706239,1.0,2/10,4.75%,PTN;BMP7
prerank,muscle contraction (GO:0006936),0.3237588962508834,1.2017817520048153,0.17163120567375886,0.7112519061122905,1.0,17/126,10.08%,TNNC1;ROCK2;MYOF;TMOD3;CALD1;VIM;DES;SORBS1;TPM1;VCL;SNTA1;ACTN2;BDKRB2;ARHGEF11;SSPN;NMUR1;TPM4
prerank,regulation of filopodium assembly (GO:0051489),-0.35701383486800914,-1.2013552635379707,0.17902813299232737,0.646170415148364,1.0,7/38,2.31%,MYO10;NLGN1;PPP1R16B;FNBP1L;TENM2;GPM6A;PIK3R1
prerank,myelination in peripheral nervous system (GO:0022011),-0.47536961355111557,-1.2007027027443427,0.23931623931623933,0.6469056120282648,1.0,5/13,18.02%,ADGRG6;MYOC;SOD1;NCMAP;DICER1
prerank,regulation of Rac protein signal transduction (GO:0035020),0.4835351604309066,1.2002091651455988,0.24817518248175183,0.7148951674103842,1.0,2/16,1.46%,RASGRF1;AUTS2
prerank,regulation of actin filament bundle assembly (GO:0032231),0.4280646994615347,1.1998806732276701,0.2328519855595668,0.7148258148883277,1.0,5/26,6.18%,ROCK2;ALMS1;SYNPO2;SYNPO;ASAP3
prerank,cholesterol efflux (GO:0033344),0.466078092876724,1.1997260763658923,0.24285714285714285,0.7142092088988303,1.0,5/20,17.50%,APOA2;NPC1;SOAT1;ABCA1;ABCA7
prerank,positive regulation of mitotic nuclear division (GO:0045840),0.4119278221926593,1.1997243366656045,0.2354948805460751,0.7131413536883362,1.0,9/34,13.48%,PHIP;TGFA;PDGFRB;ANAPC11;ESPL1;IGF2;CUL3;NSMCE2;CDC27
prerank,regulation of mRNA 3'-end processing (GO:0031440),0.520721407671033,1.1995456885574272,0.2379110251450677,0.7126035458311889,1.0,5/11,18.50%,CDC73;ZC3H3;PAF1;LEO1;DHX36
prerank,determination of bilateral symmetry (GO:0009855),-0.3987170918889633,-1.1994105306646399,0.22985781990521326,0.6493262504490565,1.0,10/24,26.43%,NOTCH1;TBX1;ZIC3;DNAH11;KIF3B;DLL1;ODAD2;BBS7;ODAD3;STIL
prerank,magnesium ion transport (GO:0015693),-0.48507475624093543,-1.1991854215393614,0.24696356275303644,0.6486816788888251,1.0,5/12,10.29%,CNNM4;NIPAL3;NIPAL4;NIPA2;NIPA1
prerank,positive regulation of myelination (GO:0031643),-0.49631672268881677,-1.1990553837693312,0.2598752598752599,0.647802964260932,1.0,5/11,18.02%,TENM4;TNFRSF1B;TPPP;NCMAP;DICER1
prerank,primary miRNA processing (GO:0031053),0.5440968391141293,1.1990012102678118,0.2698412698412698,0.7131427868932311,1.0,5/10,21.82%,SMAD3;SMAD2;HNRNPA2B1;PUS10;SRRT
prerank,sphingolipid biosynthetic process (GO:0030148),-0.3159545300114116,-1.1983788108058466,0.1497005988023952,0.6485570172744695,1.0,10/71,4.60%,SGMS1;ACER3;ELOVL5;ACER2;CERS4;CERT1;PPM1L;DEGS2;ELOVL7;SPNS2
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),0.38544245335500665,1.1979276512690955,0.19836065573770492,0.7152722564507445,1.0,6/45,6.63%,PDPK1;EFEMP1;DGKD;TGFA;PLCE1;PIK3C2A
prerank,cellular component disassembly (GO:0022411),-0.3280360427069964,-1.1978808462221875,0.15616438356164383,0.6487444911684812,1.0,16/53,17.94%,BSG;TLL1;ADAM15;MMP16;SCUBE1;A2M;CTSS;MMP15;HTRA1;CTSL;CAPN1;WASHC1;CAPNS1;MMP1;LCP1;ADAM8
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),0.5362889102679445,1.197506887197254,0.27289719626168224,0.71538166802898,1.0,4/11,17.31%,GRK3;ADM;ARRB1;GTF2H2
prerank,regulation of tissue remodeling (GO:0034103),0.467764233190695,1.1973132810474139,0.25045372050816694,0.7148814466340027,1.0,3/18,7.50%,LEPR;DDR2;IL18
prerank,phosphorylation (GO:0016310),0.294544501963886,1.1972476242771959,0.08568075117370892,0.7140422963855751,1.0,89/384,15.87%,IGFBP3;PDPK1;PDK1;TEC;ROCK2;NRK;EPHA7;PRKAG2;FGFR1;GRK3;FAM20C;STK39;PRKAA2;OXSR1;EIF2AK2;TSSK3;BMPR1A;BMP2K;FAM20A;FER;DGKD;CDK8;DAPK1;BMP2;TAOK3;IKBKE;PI4KA;PRKCZ;TOP1;LATS2;MAP3K1;AAK1;TGFBR1;MORC3;PANK2;MAPK6;TGFBR2;MAP4K1;FAM20B;GSK3B;CCL2;NEK4;WNK4;STK24;STK3;SIK3;GK5;LRRK2;PPP4R1;COQ8B;TLK2;CDK7;CDK12;CDK16;AKT3;HIPK3;GRK5;IRAK3;XYLB;PPP3CB;ILF3;DAPK2;MAP2K1;MAP3K13;STRADB;JAK1;SRPK1;MAPK9;ACVR1C;WNK1;TRIB1;ALK;TBK1;FRK;NUAK2;BIRC6;RARA;EIF2AK3;RYK;ILK;LIMK1;CDKL3;STK4;ACVR2B;TXK;PKN2;PRKD2;ERN2;APP
prerank,neuron projection morphogenesis (GO:0048812),-0.2782096354176266,-1.1972042352552101,0.10424710424710425,0.649486062916761,1.0,34/137,12.25%,CNTNAP2;NLGN1;CTNND2;CTNNA2;SHANK3;TNIK;GPM6A;CNTN4;DOCK10;DCC;ACTB;NCKAP1;TRIO;PAK1;KLF7;ANK3;NYAP2;EPHB1;S100B;DAB2IP;CTNNB1;DCLK1;NRCAM;MAP1B;SHTN1;UBB;MINK1;DVL1;DBNL;NEFH;PAX2;ALS2;PAK3;NGF
prerank,positive regulation of mitochondrial fission (GO:0090141),0.46416767901505906,1.1971062062276019,0.25693160813308685,0.7133849931363321,1.0,6/18,15.52%,MCU;DCN;RALBP1;DNM1L;MIEF1;MUL1
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.43909497135888137,1.196982800122381,0.23116438356164384,0.712684864645993,1.0,5/23,10.49%,NUPR1;CRY1;HDAC4;PPARA;PLEK
prerank,aerobic respiration (GO:0009060),-0.4185118182605042,-1.1969625557870627,0.24249422632794457,0.6489177244783186,1.0,8/20,24.28%,SDHC;ME3;NDUFS7;UQCRH;ATP5F1D;MTFR1L;MDH2;UQCR10
prerank,response to progesterone (GO:0032570),-0.4330256595763501,-1.1966579398190929,0.24835164835164836,0.6485273056004597,1.0,5/18,12.95%,TGFB2;THBS1;ABHD2;TGFB3;CAV1
prerank,amino acid import across plasma membrane (GO:0089718),0.4389399367802031,1.1964682097468564,0.24640287769784172,0.7131059140472069,1.0,5/24,3.88%,SLC7A2;SLC1A3;SLC6A13;SLC6A9;SLC16A2
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.40022456285765007,1.196097231182461,0.21453287197231835,0.7131786753975167,1.0,14/38,23.75%,LEPROT;HAX1;NPEPPS;LRRK2;HUWE1;RHOU;USP36;CSNK2A2;ATP5IF1;SREBF1;FBXW7;ATG13;HPS4;RNF31
prerank,negative regulation of smooth muscle cell migration (GO:0014912),0.5011689522027518,1.1960908711313611,0.26879699248120303,0.7121483578471433,1.0,5/14,5.64%,IGFBP3;IGFBP5;BMPR1A;TPM1;SERPINE1
prerank,mRNA methylation (GO:0080009),-0.4500034819706695,-1.1960173611268106,0.2446351931330472,0.6491422859874599,1.0,8/15,28.50%,VIRMA;ZC3H13;CBLL1;TRMT6;METTL8;TRMT10C;METTL14;TRMT61A
prerank,positive regulation of lymphocyte differentiation (GO:0045621),0.46343760405892465,1.1959759803402488,0.2508896797153025,0.7114556108604863,1.0,3/19,5.91%,ZMIZ1;AXL;MMP14
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.37106769449215693,1.1958841416371713,0.20161290322580644,0.71069465181242,1.0,15/52,21.06%,SAMD4A;TUT4;POLR2D;RC3H1;LSM1;DCP2;PAN3;DDX6;DIS3;CNOT3;CNOT9;TUT7;PATL1;PARN;PAN2
prerank,RNA metabolic process (GO:0016070),0.3285245573900492,1.1957216450066546,0.1485148514851485,0.7101406405445189,1.0,37/127,20.84%,CELF2;ATXN1;RBMS1;RBFOX2;POLR2D;RBMS2;PAPOLG;LSM1;NOVA1;HNRNPH1;FTO;HNRNPC;RBM39;SND1;POLR2C;HNRNPH3;ADAR;SUPV3L1;DHX8;RBM5;POLR2F;RBM6;TENT2;PABPN1;ALKBH1;HNRNPR;HNRNPA2B1;NUFIP1;RNASEH1;PCBP2;DHX36;RNASE3;SNRNP40;RNASEL;RNGTT;POLR2K;PARN
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),-0.45875579451548804,-1.1946561230163686,0.2494331065759637,0.6517317978031634,1.0,7/14,28.07%,THBS1;NOTCH1;KLF4;DLL4;CARD10;HDAC5;PDCD10
prerank,glycoprotein biosynthetic process (GO:0009101),-0.3093340075236936,-1.1945920654023272,0.14626865671641792,0.6507187790986146,1.0,17/79,15.86%,CSGALNACT1;ST8SIA4;ST3GAL6;BMPR2;XYLT1;FUT9;ST8SIA6;CHST9;ALG5;B3GNT2;SERP1;NUS1;GCNT1;BMPR1B;B3GNT9;ST3GAL4;B3GALNT2
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),0.43877929621063555,1.1944729714337687,0.24647887323943662,0.7127287776585274,1.0,3/25,4.20%,PDPK1;CXCL10;F2RL3
prerank,regulation of focal adhesion assembly (GO:0051893),0.37636509429152015,1.19403651337361,0.2099533437013997,0.7129741634158524,1.0,10/54,6.01%,PHLDB2;ARHGAP6;ROCK2;DLC1;EPHA3;NRP1;S100A10;CLASP1;VCL;PTPRA
prerank,regulation of DNA repair (GO:0006282),0.38627041036657844,1.1940157898472878,0.20032051282051283,0.7119945158625889,1.0,4/44,3.37%,EYA2;EYA1;POLH;TRIP12
prerank,negative regulation of neuron apoptotic process (GO:0043524),-0.31046889666673944,-1.1931896256440275,0.16857142857142857,0.6535340663698266,1.0,21/69,19.16%,MEF2C;PTK2B;NTRK2;SIX1;FOXQ1;NDNF;LGMN;PINK1;TGFB3;NGF;GRN;SIX4;PARK7;SOD1;CPEB4;CLCF1;SET;NTF3;TOX3;ADAM8;NONO
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.35136692460089186,1.1930622189413982,0.19490254872563717,0.7137773126854271,1.0,16/77,14.94%,TCF7L2;PHIP;SH3RF1;CFLAR;BCL2;TGFBR1;MCL1;SIAH2;ZMYND11;BCL2L1;NDUFS3;OPA1;TMEM14A;BDNF;BIRC6;CSNK2A2
prerank,replicative senescence (GO:0090399),0.514257128634769,1.192648798930865,0.27977315689981097,0.7140030433504863,1.0,3/12,5.64%,PLA2R1;TERT;SERPINE1
prerank,organic acid transport (GO:0015849),0.3406630893231267,1.1924834909791848,0.16519174041297935,0.7134391215059067,1.0,9/94,5.62%,SLC7A11;PDPN;SLC7A2;SLC13A3;SLC6A13;SLC19A1;SLC6A12;SLC7A14;ACSL1
prerank,urogenital system development (GO:0001655),0.5244758027265808,1.1922241801318354,0.26968503937007876,0.7131857436222393,1.0,2/11,3.55%,OSR1;ANXA1
prerank,cellular response to purine-containing compound (GO:0071415),-0.4988840875247401,-1.1920797879795366,0.24649298597194388,0.6553927112893794,1.0,5/10,21.51%,RYR2;RYR3;SLC8A1;CASQ2;TRPM2
prerank,C4-dicarboxylate transport (GO:0015740),-0.46359286921014753,-1.1919912556028545,0.2576419213973799,0.6544075002794814,1.0,7/14,30.58%,SLC1A1;SLC1A2;SLC25A30;SLC25A13;SLC25A12;LRRC8E;SLC13A5
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),0.4335168248771475,1.191263434951049,0.23104693140794225,0.715032868078501,1.0,4/23,7.09%,CBLB;SNX6;ERRFI1;MVP
prerank,positive regulation of dendrite morphogenesis (GO:0050775),-0.4271690429732779,-1.1912310637499397,0.23076923076923078,0.655322712550575,1.0,6/19,14.19%,PTPRD;IL1RAPL1;CAPRIN2;LRP8;DBNL;RELN
prerank,regulation of striated muscle contraction (GO:0006942),-0.399610585258732,-1.191128618351376,0.21103117505995203,0.6543836224215812,1.0,8/27,12.86%,DMD;RYR2;SMAD7;CALM1;CALM2;CALM3;NOS1;SRI
prerank,positive regulation of protein dephosphorylation (GO:0035307),-0.3756722968456267,-1.1910359408429412,0.2116788321167883,0.6534230510979927,1.0,8/32,7.58%,PPP1R16B;CAMTA1;CALM1;CALM2;PTBP1;HSP90AB1;CALM3;SYMPK
prerank,negative regulation of axonogenesis (GO:0050771),-0.3849495742363101,-1.190927187206358,0.2034313725490196,0.6525369622512937,1.0,11/27,20.76%,DIP2B;DCC;SEMA3G;FGF13;ULK1;MCF2;ARHGDIA;MAP2;EFNB3;OMG;TRIM46
prerank,positive regulation of protein targeting to membrane (GO:0090314),-0.40540388442883707,-1.1909177100176356,0.23448275862068965,0.6513422741744561,1.0,8/24,20.39%,ANK3;CEMIP;MTCL1;MFF;KCNB1;HRAS;C2CD5;ITGB2
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.49755392530265463,1.1908422745410143,0.2729044834307992,0.7152582962876848,1.0,2/13,2.97%,PLXNA2;NRP1
prerank,extracellular matrix disassembly (GO:0022617),-0.3272577878237056,-1.1904947325960458,0.15193370165745856,0.6512596862244847,1.0,16/53,17.94%,BSG;TLL1;ADAM15;MMP16;SCUBE1;A2M;CTSS;MMP15;HTRA1;CTSL;CAPN1;WASHC1;CAPNS1;MMP1;LCP1;ADAM8
prerank,positive regulation of cell-substrate adhesion (GO:0010811),0.3546200016164017,1.190173520234061,0.1882716049382716,0.7162675001211424,1.0,12/67,12.04%,PLEKHA2;DOCK5;FN1;ECM2;NRP1;S100A10;EPHA1;GSK3B;MYADM;TRIOBP;CDH13;CSF1
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),0.46832269496607376,1.1893832186783186,0.26159554730983303,0.7175794974546026,1.0,4/16,4.69%,TGFBR3;RBPJ;BMPR1A;GLI1
prerank,negative regulation of protein processing (GO:0010955),0.5073447328494497,1.1887365885918009,0.2631578947368421,0.7184291012742896,1.0,4/12,9.30%,SERPINE1;SNX12;SERPINE2;LRRK2
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),-0.3019410543078882,-1.188520111253178,0.1457725947521866,0.6556934179182868,1.0,39/87,33.08%,NDUFV1;NDUFC1;NDUFA8;NDUFS7;NDUFB4;NDUFA1;SAMM50;COX20;NDUFB2;NDUFA12;NDUFA11;NDUFAF4;NDUFB7;IMMP2L;NDUFB10;UQCC3;NDUFC2;NDUFA13;COX19;NDUFA9;NDUFAF8;FOXRED1;NDUFAF7;OMA1;BCS1L;PET100;NDUFAF3;NDUFA10;TIMM21;SDHAF2;COA5;NDUFS6;NDUFV3;NDUFS1;NDUFA2;SCO2;TMEM126B;NUBPL;COA3
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",-0.44568558668613717,-1.1881826313153607,0.24375,0.6554394950731782,1.0,5/15,13.38%,NLGN1;SYN3;STXBP1;CNTNAP4;USP46
prerank,response to interferon-alpha (GO:0035455),0.4765551607319938,1.1873292842393224,0.27289719626168224,0.721726128730442,1.0,6/16,12.15%,AXL;EIF2AK2;TPR;BST2;IFITM1;ADAR
prerank,aortic valve morphogenesis (GO:0003180),-0.3770997024253382,-1.1872243141522276,0.2222222222222222,0.6570193290514386,1.0,8/30,7.09%,SLIT2;ROBO2;NOS3;TIE1;NOTCH1;ELN;EMILIN1;BMP4
prerank,regulation of cell development (GO:0060284),-0.3502526808070737,-1.1866284659155295,0.20048899755501223,0.6575601531336331,1.0,14/36,20.22%,FOXO1;RPS19;CTNNB1;HDAC9;AKT1;YTHDF2;PRUNE1;GRN;HEY1;PER2;HES6;HES1;FBXO22;DLL1
prerank,diol metabolic process (GO:0034311),-0.4269539158884112,-1.1866217421587977,0.2242152466367713,0.6563769557564302,1.0,8/19,16.97%,NOS3;DEGS2;CALM1;AKT1;GCH1;HSP90AA1;PLPP1;SGPP1
prerank,negative regulation of osteoblast differentiation (GO:0045668),0.4030837249150937,1.1864506787987237,0.2434325744308231,0.7233696782218849,1.0,7/31,12.69%,RANBP3L;TMEM64;SKI;NOCT;SMAD6;SUFU;NOG
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.2926410855678849,1.1862963594128049,0.11910669975186104,0.7227953885417897,1.0,74/327,17.01%,EFEMP1;RORA;ATXN1;ZMIZ1;ARNT2;FOXC1;NFIA;NFYC;ZBTB4;ZNF395;DENND4A;SSBP2;MYB;PRRX2;PERM1;BMP2;RFX3;APBB1;GZF1;NIF3L1;TGFBR1;NSD3;BAZ2A;ZNF35;WWC2;FOXP3;TESMIN;CREBL2;TCF7L1;CREBBP;NSD1;POU1F1;RNF20;ZSCAN21;NFXL1;TEAD2;ATF7;ZFP37;KAT6B;IGF2;CREM;SOX21;SUFU;MAFB;MSC;PSPC1;UBE2V1;TGFBRAP1;TCF7;ZNHIT3;ZNF219;ZFAT;OGG1;THAP1;MZF1;NR3C1;SERTAD3;HIC1;ZNF205;NCOA2;DMTF1;FUS;CARM1;VHL;PML;SP3;ACVR2B;SOX4;POU5F1;WWTR1;NFATC2;CCAR1;WTIP;PPP2CA
prerank,ceramide transport (GO:0035627),-0.48372665647304747,-1.186210171971361,0.25252525252525254,0.6564523081327168,1.0,8/12,37.40%,CERT1;GLTP;SGPP1;ABCB4;ABCA13;ABCA2;PLEKHA3;CPTP
prerank,positive regulation of cell migration (GO:0030335),0.3005033904995795,1.186054032048329,0.12993630573248408,0.7224675187118301,1.0,36/253,9.06%,SEMA3D;PDPN;ROCK2;VTN;DOCK5;FN1;PDGFRA;FGF1;DDR2;SYNE2;SMURF2;CXCL16;FAM110C;CDH5;GLIPR2;NRP1;FER;NUMB;SMIM22;KIT;BMP2;WNT5B;MIA3;CLASP1;TGFBR1;FAM83H;MMP14;EPHA1;PDGFRB;SEMA4B;CTSH;CLDN1;MYADM;INSL3;PLAU;SYDE1
prerank,epidermal cell differentiation (GO:0009913),0.38834534024877104,1.1855960128237457,0.2395498392282958,0.722762116744683,1.0,13/41,21.26%,GATA6;ANXA1;GLI1;CLIC4;WNT5A;EPHA2;HDAC2;OPN3;TXNIP;CASP3;DSP;PIP5K1A;TGM1
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),0.4863893849445612,1.185486443814403,0.2829827915869981,0.7220502968268272,1.0,4/15,6.94%,PDGFRA;MTHFD1;TGFBR1;TGFBR2
prerank,negative regulation of interleukin-6 production (GO:0032715),0.4316167726440194,1.1846947037203248,0.2699490662139219,0.7233543584943909,1.0,6/27,13.07%,TLR4;C5AR2;PTPN22;PTPN6;IRAK3;ARRB1
prerank,negative regulation of receptor binding (GO:1900121),-0.5135373419496556,-1.1837366300568333,0.2782258064516129,0.6624307683351411,1.0,4/10,13.61%,ADAM15;ATP2A3;B2M;ATP2A2
prerank,neutrophil activation (GO:0042119),-0.48441389799896295,-1.1836898434745085,0.24899598393574296,0.6613693833514541,1.0,3/12,12.61%,PREX1;FCER1G;SYK
prerank,mitotic nuclear membrane disassembly (GO:0007077),-0.47854310387457405,-1.1836049050792643,0.2603938730853392,0.6604076604871238,1.0,8/12,37.67%,PRKCB;NEK9;CTDNEP1;VRK1;PLK1;CDK1;CCNB2;CCNB1
prerank,ribonucleoprotein complex assembly (GO:0022618),-0.28326748680452285,-1.1833951983859523,0.15498154981549817,0.6597832104282872,1.0,46/132,24.95%,RPS15;RPL24;CELF4;RPL5;RPS27;RPS19;RPL38;SETX;LUC7L3;RPL6;RPL11;RPLP0;RPS28;PUF60;HSP90AB1;RRP7A;SRSF1;SART3;TRAF7;HSP90AA1;EIF3A;XAB2;RPS5;PPAN;RPS14;SART1;SNRPB;NLE1;LUC7L;DICER1;SNRPF;SRSF9;GCFC2;PRMT5;MDN1;LSM4;RPL3;SNRPD1;SNRPD2;SRSF6;CELF6;RPL23A;ABT1;GEMIN8;EIF6;SRPK2
prerank,glial cell differentiation (GO:0010001),-0.38946118497885024,-1.183198940628531,0.2505694760820046,0.6591853524928906,1.0,13/28,29.96%,CDH2;ADGRG6;PAX2;NFIB;RELN;TPPP;SOX2;PTPRZ1;CDK5;SOX11;PICK1;FGF10;SLC8A3
prerank,striated muscle cell differentiation (GO:0051146),0.46813474375584974,1.1831595565208595,0.2446043165467626,0.726890970532942,1.0,4/16,7.92%,AKAP13;BMP2;POPDC2;SKI
prerank,cellular glucose homeostasis (GO:0001678),0.3966314153244165,1.1827618647609293,0.22504230118443316,0.7270317715890667,1.0,7/41,9.01%,ZBTB20;PRKAA2;NUCKS1;UNC13B;CARTPT;NGFR;HKDC1
prerank,zinc ion transport (GO:0006829),-0.4087853019872144,-1.1820365245604514,0.2336244541484716,0.6612820827855936,1.0,11/21,31.62%,SLC39A6;SLC30A1;SLC39A14;SLC39A13;SLC39A8;TRPM2;SLC30A5;SLC30A10;SLC30A9;SLC30A3;MT3
prerank,odontogenesis (GO:0042476),0.3988321311292098,1.181990382531152,0.24787775891341257,0.7281969871556621,1.0,6/35,6.91%,WNT6;OSR1;FOXC1;BMP2;BCOR;EDA
prerank,determination of heart left/right asymmetry (GO:0061371),-0.3487617247288441,-1.1817879146543668,0.220873786407767,0.660847805564044,1.0,14/42,23.48%,MEF2C;NOTCH1;SOX17;AHI1;ZIC3;TBX2;NDRG4;SOX18;APLNR;VANGL2;DLL1;SRF;TBX6;BBS7
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.4248571751794023,1.1817689988974602,0.2572402044293015,0.72778438688354,1.0,6/27,6.11%,PDGFRA;FPR2;AMBRA1;EPHA8;KIT;PDGFRB
prerank,regulation of RIG-I signaling pathway (GO:0039535),0.46391750192176523,1.1817389843368429,0.2513863216266174,0.7268378037652324,1.0,6/18,17.64%,DDX60;BIRC3;OASL;ANKRD17;PUM2;USP15
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),-0.3166989807013908,-1.1815124199715956,0.18666666666666668,0.6604970063654778,1.0,18/65,15.98%,PTPRJ;HIP1;BCAR3;SH3KBP1;HIP1R;DAB2IP;SH3GL2;CCDC88A;AKT1;CEACAM1;MVB12B;CBL;ARHGEF7;EGFR;PLAUR;RNF126;RHBDF2;EGF
prerank,nitric oxide biosynthetic process (GO:0006809),-0.4793540269658517,-1.1812431471527691,0.26991150442477874,0.6600526892864788,1.0,4/13,10.31%,NOS3;AKT1;NOS1;GCH1
prerank,motor neuron axon guidance (GO:0008045),-0.45908189383758574,-1.1812420449186463,0.24721603563474387,0.6588716542138872,1.0,8/15,22.30%,SLIT2;TMEFF1;RHOG;SEMA3A;RAC1;RHOH;CHN1;LHX1
prerank,lymphocyte chemotaxis (GO:0048247),0.41164880070999343,1.1804161368304285,0.25245901639344265,0.7297147597934539,1.0,6/34,7.71%,CXCL10;CXCL16;CYP7B1;CKLF;MSMP;CCL2
prerank,intraciliary retrograde transport (GO:0035721),0.5084172838453703,1.1802007411104072,0.2729044834307992,0.7293445098359246,1.0,4/12,17.89%,DYNC2I1;DYNC2LI1;WDR19;TTC21B
prerank,polyol biosynthetic process (GO:0046173),-0.4360674398424109,-1.1799175559991009,0.25614754098360654,0.6615223769036317,1.0,6/16,15.55%,ACER3;ITPKB;IP6K2;FGF2;PPIP5K2;PPIP5K1
prerank,negative regulation of cytoskeleton organization (GO:0051494),-0.38277683190139233,-1.1798162975740418,0.21822033898305085,0.6606423804470153,1.0,7/29,6.43%,SLIT2;SHANK3;SSH2;KANK3;KANK4;HIP1R;CYRIB
prerank,negative regulation of T-helper cell differentiation (GO:0045623),0.5166982075952403,1.1796405622660555,0.27419354838709675,0.729973605949572,1.0,3/11,6.03%,ANXA1;RC3H1;FOXP3
prerank,inositol phosphate catabolic process (GO:0071545),-0.467404152749281,-1.179607994181234,0.24206349206349206,0.6600810387218686,1.0,7/12,25.18%,INPP5K;IMPA1;IMPA2;INPP5J;NUDT3;INPP5B;SYNJ1
prerank,positive regulation of cell killing (GO:0031343),0.5060739497482765,1.1795612974516871,0.28875968992248063,0.7292011534125202,1.0,4/13,8.47%,PRF1;NOS2;NOXO1;WNT5A
prerank,regulation of gene expression by genetic imprinting (GO:0006349),0.5268224720159453,1.179388614314636,0.2804878048780488,0.7286780324529427,1.0,5/10,23.89%,PCGF5;IGF2;DNMT3A;PCGF3;MECP2
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.31819106448728635,1.1791918852099927,0.16481994459833796,0.728207115764329,1.0,17/142,8.79%,ATP1A2;LPAR1;SMAD3;PDGFRA;FPR2;ACKR2;CCR9;CD55;ADCY5;C5AR2;PLCE1;ATP2B4;BDKRB2;SPPL3;ACKR3;WNT5A;CACNA1C
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",0.5293584034990226,1.179155561853147,0.2925851703406814,0.7273048452000068,1.0,3/10,7.85%,CD55;TGFBR2;LGALS9
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.286913138718444,1.1791467395365651,0.12740384615384615,0.7263244342821094,1.0,82/366,16.76%,EFEMP1;RORA;ATXN1;ARNT2;FOXC1;NFIA;NFYC;ZBTB4;ZNF395;DENND4A;SSBP2;ORC5;MYB;PRRX2;NUCKS1;PERM1;BMP2;PKP3;RFX3;APBB1;GZF1;TGFBR1;NSD3;BAZ2A;ZNF35;WWC2;FOXP3;TESMIN;CREBL2;TCF7L1;CREBBP;NSD1;POU1F1;RNF20;ZSCAN21;NFXL1;TEAD2;ATF7;ZFP37;KAT6B;IGF2;ANKRD17;CREM;SOX21;SUFU;MAFB;MSC;PSPC1;GMNN;UBE2V1;TGFBRAP1;ESCO1;TCF7;ZNHIT3;FOXO3;ZNF219;ZFAT;OGG1;THAP1;MZF1;NR3C1;SERTAD3;HIC1;ZNF205;NCOA2;GEMIN5;DMTF1;FUS;MAPKAPK5;ORC3;CARM1;VHL;PML;SP3;ACVR2B;SOX4;POU5F1;APP;WWTR1;NFATC2;CCAR1;WTIP
prerank,nitric oxide metabolic process (GO:0046209),-0.46939064445161804,-1.1787752084228758,0.2695852534562212,0.6612917109315524,1.0,4/14,10.31%,NOS3;AKT1;NOS1;GCH1
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.3507517291334542,1.1786619476065856,0.22342064714946072,0.7266507214632707,1.0,14/66,10.69%,KANK2;ADAMTS1;ANXA1;DACT1;PLK5;CCND3;APPL2;CDC73;CCL2;CDKN2B;DLG1;ANKRD17;APPL1;PTPN6
prerank,long-chain fatty acid import into cell (GO:0044539),-0.5019845198587831,-1.1783526028527427,0.27976190476190477,0.661371034727774,1.0,2/10,2.16%,SLC2A1;ACSL3
prerank,negative regulation of cellular catabolic process (GO:0031330),0.3567774455496829,1.177836390949923,0.2260061919504644,0.7281459660525662,1.0,11/63,9.46%,LEPR;NUPR1;TIMP3;NELL1;PTPN3;BCL2;PTPN22;MCL1;KLHL22;TIMP2;TLK2
prerank,activation of protein kinase B activity (GO:0032148),0.41641063372951026,1.1778098847278575,0.2582236842105263,0.7272202283167734,1.0,10/29,17.88%,PDPK1;FGF1;OSBPL8;IL18;WNT5A;ADRA2C;NTRK3;ADRA2A;RICTOR;MAPKAP1
prerank,mitochondrial calcium ion homeostasis (GO:0051560),0.4443127820623425,1.1776178473586225,0.25359712230215825,0.7267797598230844,1.0,2/21,1.57%,MCU;MICU1
prerank,response to cholesterol (GO:0070723),0.47424624626071227,1.1775861319418461,0.2631578947368421,0.7258775125694584,1.0,3/17,6.94%,GRAMD1C;TGFBR1;TGFBR2
prerank,nucleoside catabolic process (GO:0009164),0.5217290284912287,1.1774864391983726,0.2822878228782288,0.7251960748654804,1.0,4/11,9.76%,DPYD;UPP1;NT5C;DERA
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),-0.5072039214044494,-1.1768276498022132,0.302713987473904,0.6646215049865256,1.0,7/10,33.34%,DLGAP1;DLGAP2;BEGAIN;NPTX2;CACNG5;NPTXR;NPTX1
prerank,mitochondrion distribution (GO:0048311),0.4974138789980062,1.1767917818372822,0.29282868525896416,0.7261900942142033,1.0,5/12,11.90%,TRAK1;MEF2A;LRRK2;DNM1L;ATCAY
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.4799074751072537,1.176608027504864,0.2766798418972332,0.7257372724709746,1.0,3/15,4.93%,UST;DCN;DSE
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.28713615175087187,1.1760292184557741,0.11189634864546526,0.726419928169812,1.0,89/390,16.11%,SULF1;FLRT2;EFNB2;STYK1;COL4A6;ROCK2;EPHA7;PDGFRA;FGFR1;FGF1;AXL;DDR2;GHR;IL31RA;FOXC1;PHIP;INSRR;EPHA3;SDC2;FOXC2;RBFOX2;EPHA8;NFATC4;FRS2;NRP1;FER;VEGFD;POLR2D;KL;SHB;ANGPT1;KIT;SORBS1;EFS;ROR1;EPHA1;PDGFRB;RASA1;PTPN2;PIK3C2A;BDKRB2;MVP;NGFR;HNRNPH1;GSK3B;EPHA4;RHOQ;IGF2;ZNF106;DNM1;MTSS1;MST1R;POLR1G;APPL1;MUSK;NGEF;MAPK14;FGF18;FLRT1;PTK2;POLR2C;CSF1;EPHA2;RARRES2;EFNA1;EFNB1;SHOC2;PLAT;TCIRG1;WASL;BDNF;ATP6V0B;POLR2F;SHC2;ALK;NCK1;FRK;ABI1;GIGYF2;NTRK3;EIF2AK3;RYK;GDF15;BAIAP2;ATP6V1E1;FLRT3;PRKD2;IGF1R;ATP6V1C1
prerank,termination of RNA polymerase I transcription (GO:0006363),0.4084609138463865,1.1758132738569387,0.22986577181208054,0.7261177133335532,1.0,17/30,27.68%,POLR1C;CCNH;MNAT1;POLR1G;CDK7;POLR2F;GTF2H4;GTF2H2;CAVIN1;TTF1;POLR2K;UBTF;POLR2H;POLR1A;ERCC2;ERCC3;TAF1D
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),0.41668988139396307,1.1757004365694579,0.2509090909090909,0.7254595014199766,1.0,3/26,3.98%,PDPK1;FOXC1;STAT5B
prerank,pyrimidine nucleoside metabolic process (GO:0006213),0.48882885233949824,1.1753857588194938,0.26851851851851855,0.7254135892004095,1.0,5/14,14.34%,DPYD;UPP1;NT5C;UMPS;ERH
prerank,blood vessel diameter maintenance (GO:0097746),-0.3623236920419083,-1.1751223674646736,0.1989795918367347,0.668072989117851,1.0,12/34,17.08%,EDNRA;NOS3;KCNMB2;KLF2;ECE1;ACE;NOS1;ACE2;NPR1;GCLC;HTR2B;PER2
prerank,gene silencing by miRNA (GO:0035195),0.40200006057468773,1.1750337761833622,0.2669983416252073,0.7254336019397554,1.0,12/32,21.46%,TNRC6B;SNIP1;TNRC6A;MOV10;ADAR;TARBP2;ZC3H7B;WTIP;RAN;PUM2;AJUBA;XPO5
prerank,vasculogenesis (GO:0001570),0.4077201674491497,1.1748756537328215,0.23809523809523808,0.7249037582240462,1.0,7/32,8.56%,TGFBR3;CCM2;ITGB8;PDGFRB;RASA1;TGFBR2;ADM
prerank,receptor-mediated endocytosis (GO:0006898),-0.2760335770448592,-1.1747747783926448,0.11619718309859155,0.6679131362738971,1.0,30/132,13.37%,DNM3;LRP1B;SGIP1;FNBP1L;INSR;TFRC;SNCA;SORL1;STAB1;HIP1R;SCARB1;AP1S1;NLGN3;LDLRAP1;ARHGAP27;LRP6;RAMP2;M6PR;CALR;SNAP91;FCER1G;CAV2;CTSL;ADRB2;SCARB2;VLDLR;SYK;HSP90AA1;CAV1;TMEM108
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),-0.3272690492259035,-1.174641291529659,0.16879795396419436,0.66713314113782,1.0,19/54,15.74%,MEF2C;NOS3;TMSB4X;THBS1;KDR;ACVRL1;GATA2;HMGB1;PRCP;ATP5F1A;AKT1;VEGFA;CD40;NUS1;FGF2;ATP5F1B;RGCC;PRKD1;PLCG1
prerank,cellular response to calcium ion (GO:0071277),-0.3067859421120363,-1.1744696898028386,0.1810344827586207,0.6664743479577205,1.0,19/67,18.71%,NLGN1;SYT1;MEF2C;PLCG2;ITPKB;RYR3;KCNH1;LGMN;CAMK2D;SYT4;SYT7;CPNE4;SYT9;SYT2;ADD1;ADCY8;HPCA;ECT2;CPNE7
prerank,regulation of fatty acid metabolic process (GO:0019217),0.46976188111943656,1.1742343935085198,0.2737226277372263,0.7257707508964426,1.0,4/17,6.37%,PRKAG2;PRKAA2;PANK2;PPARA
prerank,negative regulation of receptor internalization (GO:0002091),-0.4728682961775277,-1.1738425636300183,0.23829787234042554,0.6671567938087355,1.0,6/12,22.20%,ANKRD13A;ATXN2;SDCBP;RIN3;MTMR2;ANKRD13B
prerank,regulation of defense response (GO:0031347),0.34727993812759506,1.173800393339601,0.2116788321167883,0.7260549767585754,1.0,15/76,11.10%,USP18;CASP12;ADAMTS12;ANXA1;LACC1;PTPN22;ZBP1;CASP4;APPL2;BIRC3;WNT5A;ERAP1;APPL1;BRD4;NLRP6
prerank,cell-matrix adhesion (GO:0007160),0.3335185041401501,1.1737983204080469,0.2014388489208633,0.7250657227726028,1.0,18/95,9.10%,VTN;COL3A1;FN1;ADAMTS12;ECM2;DLC1;NID2;ITGB8;ITGBL1;ITGA10;SORBS1;VCL;VCAM1;THBS3;ACTN2;SIGLEC1;ITGA11;COL13A1
prerank,regulation of histone modification (GO:0031056),-0.46116536576568734,-1.1729129311485744,0.26963906581740976,0.6686722041286326,1.0,5/13,17.30%,MTHFR;PARG;PARK7;HPF1;NNMT
prerank,vascular transport (GO:0010232),0.33645713443779385,1.1727822039084657,0.22624434389140272,0.7270865363699088,1.0,12/81,4.01%,SLC7A2;LEPR;ATP1A2;SLC1A3;SLC13A3;SLC6A13;SLC19A1;SLC6A9;SLC24A3;SLC16A2;SLC16A12;SLCO3A1
prerank,inflammatory response (GO:0006954),0.3061540486198383,1.1726031076808456,0.16558861578266496,0.7266233128452926,1.0,27/195,8.78%,CXCL10;FPR2;HSPG2;ADORA2A;NFATC4;ANXA1;KIT;BMP2;LOXL3;IL17D;IL6;TPST1;TLR4;C5AR2;HDAC4;PLA2G4C;NOS2;CRP;ADCY1;BDKRB2;IL18;CCL2;LGALS9;SIGLEC1;RIPK2;ADM;PJA2
prerank,negative regulation of centrosome duplication (GO:0010826),-0.4871825368133099,-1.1724454783174076,0.27789473684210525,0.668904270208963,1.0,6/11,20.07%,NPM1;CCNF;BRCA1;TRIM37;KAT2A;CDK5RAP2
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),-0.34253444285943574,-1.172211399127508,0.2340966921119593,0.6684478585468167,1.0,12/39,11.23%,DMD;FGF14;FGF12;HECW1;FXYD5;NETO1;UTRN;ANK3;YWHAH;CAMK2D;NEDD4L;FGF13
prerank,negative regulation of dephosphorylation (GO:0035305),-0.42087310691779983,-1.1720488344696083,0.2336842105263158,0.6677563897522047,1.0,7/18,23.07%,PPP1R16B;INPP5K;MFHAS1;PPP1R26;SH3RF2;PPP1R15A;PPP1R8
prerank,mitochondrial genome maintenance (GO:0000002),0.5148589481986118,1.17191186857382,0.27631578947368424,0.7276296758672458,1.0,6/11,19.98%,MPV17;MEF2A;AKT3;OPA1;SLC25A4;LONP1
prerank,response to muramyl dipeptide (GO:0032495),0.5013586490031929,1.1717994435024135,0.30879345603271985,0.7269704023816042,1.0,4/12,8.04%,LDOC1;VIM;PTPN22;RIPK2
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),-0.3565606333494145,-1.1716525164274114,0.21686746987951808,0.6677489938435942,1.0,13/34,15.57%,TEK;PTK2B;PIK3R1;FLT1;DAB2IP;PIK3R3;WDR81;PIK3IP1;FGF2;WASHC1;CCL19;PRKD1;NOD2
prerank,regulation of autophagosome assembly (GO:2000785),0.3999307483954067,1.1710908989627267,0.2673434856175973,0.7281937344033637,1.0,13/33,16.33%,NUPR1;IFT88;MTMR3;LRRK2;TMEM39A;IFT20;SCFD1;NPRL3;PIP4K2B;CHMP4A;CHMP4B;FEZ2;RAB5A
prerank,positive regulation of nervous system process (GO:0031646),-0.415174695338513,-1.1707713417980166,0.24178403755868544,0.6690413728066984,1.0,7/18,18.02%,RIMS1;RIMS2;TENM4;TNFRSF1B;TPPP;NCMAP;DICER1
prerank,regulation of peptidase activity (GO:0052547),0.4471392806831286,1.1703392892927467,0.2759226713532513,0.7294349354522297,1.0,5/19,8.89%,ECM1;CSTB;NRDC;CTSH;PSMA3
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),0.4686567227184798,1.1702161743764172,0.2840690978886756,0.7288036745685069,1.0,9/16,24.79%,PARP9;PARP3;DTX3L;SHLD2;KMT5C;RIF1;KMT5B;SMCHD1;SHLD1
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),0.4281013339839217,1.1695515553875937,0.2763385146804836,0.7297949810270027,1.0,5/24,5.64%,PDPK1;IL11;CDH5;ANGPT1;SERPINE1
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),-0.4745036192418536,-1.1691477022544916,0.2634989200863931,0.6727211794412101,1.0,6/12,10.74%,PTPRJ;F3;SNCA;APOD;NDRG4;CBL
prerank,supramolecular fiber organization (GO:0097435),0.2898124025721461,1.168975905903496,0.13112745098039216,0.7304419308196395,1.0,45/333,10.08%,COL4A3;CGNL1;TNXB;COL23A1;TSPAN5;COL4A6;COL4A4;COL5A2;COL3A1;TMOD3;COL4A5;DDR2;SHROOM2;HSPG2;VIM;MYO1B;ARHGAP12;LOXL3;DES;BMP1;EFEMP2;LOXL1;TPM1;CLIP4;TGFBR1;COL20A1;NCKAP5L;KATNAL1;RHOBTB2;HDGFL3;COL5A1;SIAH2;RHOF;FAT1;COL18A1;DBN1;USP9X;CCDC13;DLG1;COL13A1;TUBGCP4;TRIOBP;SERF1A;FIGN;TPM4
prerank,negative regulation of interleukin-2 production (GO:0032703),-0.42791808783316393,-1.16892361347105,0.2685589519650655,0.6721670274908826,1.0,5/18,14.81%,NAV3;CD34;HDAC7;HAVCR2;PTPRC
prerank,positive regulation of p38MAPK cascade (GO:1900745),0.43589588437093724,1.1685260657045713,0.2638146167557932,0.7308368220555006,1.0,4/22,8.78%,SASH1;RELL1;BMP2;PJA2
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),-0.4174018475284407,-1.1673985191175382,0.268348623853211,0.6754651483462146,1.0,4/19,2.23%,PTPRJ;GRM5;RYR2;KDR
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.3706815676616695,-1.1672774649316087,0.24772727272727274,0.6746578836251538,1.0,10/29,23.52%,RPS19;RPS8;RPS16;RPS21;RPS14;UTP6;BMS1;HEATR1;WDR46;ABT1
prerank,peptidyl-amino acid modification (GO:0018193),0.5185359698752556,1.1661200978156168,0.29411764705882354,0.7368655480837678,1.0,4/10,21.68%,APOA2;PDF;TTLL4;METAP2
prerank,response to glucagon (GO:0033762),0.44700987304977985,1.1659311555853658,0.28130360205831906,0.7363743662782058,1.0,5/19,7.01%,GCGR;CRY1;ADCY5;ADCY7;ADCY1
prerank,cellular response to exogenous dsRNA (GO:0071360),0.491353680172951,1.1658704160996605,0.3038461538461538,0.735543360123665,1.0,4/12,15.52%,COLEC12;IFIT1;IFIH1;MUL1
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),0.43518082994573565,1.1654488112384171,0.285451197053407,0.7358008583679791,1.0,8/22,21.01%,ROCK2;IL6ST;MEF2A;SMAD4;P2RX4;ROCK1;SLC9A1;AGT
prerank,transport across blood-brain barrier (GO:0150104),0.3338474551604479,1.1653608853312754,0.22869955156950672,0.7350657620583279,1.0,12/83,4.01%,SLC7A2;LEPR;ATP1A2;SLC1A3;SLC13A3;SLC6A13;SLC19A1;SLC6A9;SLC24A3;SLC16A2;SLC16A12;SLCO3A1
prerank,outflow tract septum morphogenesis (GO:0003148),0.43170848674444234,1.165217687082502,0.2687385740402194,0.7344763873104432,1.0,8/24,11.51%,ROBO1;PARVA;GATA6;BMPR1A;NRP1;TGFBR2;SMAD6;SMAD4
prerank,regulation of phagocytosis (GO:0050764),-0.3244804084255116,-1.1650076934709448,0.18933333333333333,0.6799266943161649,1.0,13/53,10.46%,MERTK;RAB27A;GAS6;DOCK2;GATA2;SNX3;DYSF;SCARB1;SYT7;CALR;TUB;RACK1;FCER1G
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.4949126816541217,1.1641345503855087,0.29294755877034356,0.7366253348496533,1.0,4/13,12.43%,DCTPP1;NTHL1;NT5C;OGG1
prerank,negative regulation of protein localization to cell surface (GO:2000009),0.5079547606630259,1.1640702844290365,0.313953488372093,0.7358282213163597,1.0,2/11,6.96%,LEPROT;ACTN2
prerank,protein neddylation (GO:0045116),-0.4612263935888408,-1.1640170638132403,0.2838427947598253,0.6816854009953267,1.0,8/13,36.93%,DCUN1D2;DCUN1D5;DCUN1D1;UBE2F;DCUN1D3;NEDD8;UBE2M;RBX1
prerank,negative regulation of epithelial cell migration (GO:0010633),0.39672627057119747,1.1640152863287245,0.2517123287671233,0.7350163155725473,1.0,6/33,3.88%,MCC;NR2F2;SP100;TACSTD2;DUSP10;DCN
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),0.42776873044648334,1.1639661073234204,0.25886524822695034,0.7341623798180688,1.0,4/23,10.27%,EFNB2;WNT3A;MMP14;MAPK14
prerank,cGMP-mediated signaling (GO:0019934),-0.4703825505561909,-1.163884205803035,0.28958333333333336,0.6809409733429053,1.0,5/13,9.24%,KCNC2;HTR2C;GUCY1B1;PDE3A;PDE2A
prerank,diacylglycerol metabolic process (GO:0046339),-0.39314129613002013,-1.163760037018831,0.24504950495049505,0.6801120997815083,1.0,5/23,7.28%,DGKB;DGKI;DGKH;DGKZ;LIPE
prerank,bile acid metabolic process (GO:0008206),0.41440933961469223,1.1634747073873306,0.2629757785467128,0.7346776436426372,1.0,9/27,18.00%,CYP7B1;CYP27A1;NPC1;AMACR;SCP2;SLC27A2;CH25H;OSBPL9;GBA2
prerank,cellular response to mechanical stimulus (GO:0071260),-0.3352402038260949,-1.163205969090886,0.20107238605898123,0.6805551488123361,1.0,21/46,32.10%,PIEZO2;CRADD;TMEM150C;MAPK8;MAPK3;FAS;PDE2A;CD40;F11R;LTBR;CHEK1;CASP1;BAD;TNFRSF10B;TLR7;TNFRSF1A;MYD88;FADD;TLR5;MAP3K14;BCL10
prerank,ion homeostasis (GO:0050801),-0.36924228841798756,-1.1631590650767867,0.22706422018348624,0.679531591948808,1.0,6/30,9.49%,SLC4A10;KLHL3;UNC80;CAMK2D;SLC12A5;NEDD4L
prerank,N-terminal protein amino acid acetylation (GO:0006474),0.47329448251991746,1.1630739936288084,0.2713178294573643,0.7348933654059517,1.0,7/16,20.13%,CREBBP;NAA16;NAA30;NAA15;KAT2B;NAA35;NAA40
prerank,glucose catabolic process to pyruvate (GO:0061718),-0.38999957218206505,-1.1630058110658992,0.24875621890547264,0.6776536469294404,1.0,8/24,19.91%,PGK1;PKM;ALDOC;GPI;TPI1;PGAM1;ENO1;GAPDHS
prerank,canonical glycolysis (GO:0061621),-0.38999957218206505,-1.1630058110658992,0.24875621890547264,0.6776536469294404,1.0,8/24,19.91%,PGK1;PKM;ALDOC;GPI;TPI1;PGAM1;ENO1;GAPDHS
prerank,acidic amino acid transport (GO:0015800),0.46107403855860524,1.162891448005664,0.2954954954954955,0.7344909532939705,1.0,3/17,2.24%,SLC1A3;SLC6A13;GJA1
prerank,positive regulation of neurogenesis (GO:0050769),-0.3093472021071515,-1.1627784397784076,0.2159090909090909,0.6771842123033344,1.0,14/68,8.85%,SLIT2;PTPRD;ROBO2;SHANK3;PLXNA4;TIAM1;NTRK2;IL1RAPL1;OPRM1;CAPRIN2;CTNNB1;NPTN;FZD3;VEGFA
prerank,ion transport (GO:0006811),-0.2877667003793502,-1.1625304005639099,0.1605351170568562,0.6767708516185581,1.0,21/111,9.21%,SLC12A7;PIEZO2;SLC26A7;SLC12A2;SLC9A2;SLC26A2;SLC24A2;ANO1;ATP11B;SLC5A5;AQP11;SLC15A2;SLC8A1;SLC1A1;SLC9A8;TRPC6;TMEM63C;SLC1A2;SLC12A5;GRIN1;GABRB1
prerank,aorta morphogenesis (GO:0035909),0.46765092769121075,1.1624012023380825,0.27715355805243447,0.7348860718742876,1.0,4/17,6.11%,RBPJ;BMPR1A;EFEMP2;PDGFRB
prerank,regulation of actin filament-based process (GO:0032970),0.34492076503382346,1.1623651345924861,0.22408536585365854,0.7340147213793816,1.0,14/70,9.50%,ROCK2;ARHGAP18;DLC1;EPHA3;SMIM22;RHOBTB2;PDGFRB;RHOF;BST2;CELSR1;RHOQ;ABRACL;IQGAP2;CNN2
prerank,regulation of Ras protein signal transduction (GO:0046578),0.3300317053752164,1.16187385199814,0.23397913561847988,0.7344197409236551,1.0,11/85,7.00%,RASGRF1;AKAP13;KANK2;NOTCH2;DLC1;KANK1;DENND4A;PLCE1;SYNGAP1;STAMBP;DENND1A
prerank,negative regulation of endothelial cell migration (GO:0010596),-0.34908663728070255,-1.1614758865600319,0.2354368932038835,0.6786800144385,1.0,8/36,5.86%,SLIT2;MEF2C;THBS1;NOTCH1;ACVRL1;PTPRM;DAB2IP;HMGB1
prerank,histone mRNA catabolic process (GO:0071044),0.4745319852136769,1.1614527148102096,0.3078393881453155,0.734770889132627,1.0,9/15,21.39%,TUT4;LSM1;DCP2;XRN1;TENT2;SSB;EXOSC10;TUT7;TENT4B
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),-0.3820446798894406,-1.1611319673883158,0.21428571428571427,0.6784844553895601,1.0,7/25,16.03%,HSPA8;HSPA14;BAG1;HSPE1;DNAJB4;ERO1A;HSPA5
prerank,negative regulation of protein binding (GO:0032091),-0.31163755441452223,-1.1601675810790437,0.192090395480226,0.6801622127795757,1.0,22/71,15.98%,ACTB;ADAM15;ITGA4;MAPK8;SORL1;ATP2A3;AKT1;SYMPK;DDX11;B2M;ZFPM1;GNL3L;DVL1;RACK1;PPP1CA;ADRB2;TTBK1;CAV1;ATP2A2;PARK7;CDKN1A;MAP2
prerank,negative regulation of developmental process (GO:0051093),-0.30704235819655523,-1.1599370704992789,0.2094240837696335,0.6796890148646326,1.0,15/69,8.44%,NOS3;GRIN3A;CST3;TFRC;NOTCH1;DCC;TBX1;KLF7;GAS6;ARHGEF15;CDK6;BMP4;BCL11A;PINK1;TBX2
prerank,pyruvate metabolic process (GO:0006090),-0.3280527435646534,-1.1595581419794387,0.21333333333333335,0.6795851039168368,1.0,14/52,15.67%,BSG;ME1;PGK1;PKM;ME3;SLC16A1;ALDOC;GPI;TPI1;PGAM1;PGAM4;VDAC1;NR4A3;ENO1
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.43839218836322896,1.1594772484991074,0.25754884547069273,0.739693327412179,1.0,10/22,23.91%,CDC73;CDK12;BRD4;THOC5;ERCC6;LEO1;CDK13;EAPP;ELL;DDX39B
prerank,positive regulation of vascular permeability (GO:0043117),0.5020101984713272,1.1593042790940962,0.29867674858223064,0.7392530924193356,1.0,2/12,3.83%,BMP6;ANGPT1
prerank,cellular response to osmotic stress (GO:0071470),0.4380142517800249,1.1589210017414024,0.28623853211009176,0.7394271715400536,1.0,4/21,10.20%,STK39;OXSR1;SLC4A11;RCSD1
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),-0.35579631274650814,-1.1588493958032928,0.21513002364066194,0.6804870862076002,1.0,11/34,11.16%,KDR;NOTCH1;MT1G;VEGFC;FLT1;GAB1;SEMA6A;DAB2IP;VEGFA;RAMP2;NUS1
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.3912795208092674,-1.1583004850426764,0.28832951945080093,0.6808945339691306,1.0,9/23,24.81%,UBB;COPS6;UBA52;COPS5;COPS2;GPS1;COPS4;DDB2;RAD23B
prerank,triglyceride metabolic process (GO:0006641),0.36902883137649706,1.1579501761932645,0.2601880877742947,0.741270023054359,1.0,5/48,12.05%,AGMO;APOA2;MOGAT3;GK5;DGAT2
prerank,bone morphogenesis (GO:0060349),-0.4428397254516212,-1.1579039257054398,0.25,0.6809018272666651,1.0,5/14,13.13%,BMPR2;LRP6;SFRP4;LRP5;BMPR1B
prerank,negative regulation of lipid metabolic process (GO:0045833),-0.39902212241743584,-1.1578237359392536,0.25900900900900903,0.6799639877202688,1.0,5/22,7.57%,PDE3B;APOD;ASXL3;CCDC3;CEACAM1
prerank,cell-cell junction organization (GO:0045216),0.33386790344968437,1.1566980571744427,0.2192429022082019,0.7440227983192594,1.0,16/79,11.28%,SDK1;SDK2;SMAD3;CXADR;AFDN;CDH5;PKP3;PARD6A;CTNNA1;CTNND1;CLDN1;DCHS1;MYADM;CDH13;TJP1;NLGN2
prerank,motile cilium assembly (GO:0044458),0.5043793423877676,1.1566559765598923,0.3023255813953488,0.7431549976752873,1.0,3/12,8.28%,SPATA6;DNAAF1;RSPH9
prerank,positive regulation of defense response (GO:0031349),0.33207624968937055,1.1566020931436256,0.21893491124260356,0.7423251977777516,1.0,16/89,11.69%,IL16;FPR2;OSM;IFI35;TLR4;ZBP1;SERPINE1;OPTN;GBP5;CD47;IL18;SETD4;WNT5A;POLR3F;TLR2;NFKBIZ
prerank,plasma membrane bounded cell projection organization (GO:0120036),-0.27742753370950135,-1.1565304482800312,0.1605351170568562,0.682639234670135,1.0,32/124,16.98%,FRY;CNTNAP2;NLGN1;GPM6A;CNTN4;PLP1;GPM6B;STX3;PTPRM;PLEKHA1;SH3GL2;HMGB1;MYOC;STMN2;RAPGEF2;RAB35;L1CAM;LYN;MANF;MICALL2;ZFYVE27;ULK1;CSF1R;TMEM108;RAC1;BICDL1;LGI1;MAPT;MAP2;STMN4;MNS1;SNAPIN
prerank,antigen receptor-mediated signaling pathway (GO:0050851),-0.2622621416325739,-1.156448177026326,0.11940298507462686,0.6817533815155721,1.0,34/163,14.87%,PDE4D;PTPRJ;MEF2C;PDE4B;PRKCB;PLCG2;INPP5D;RFTN1;PIK3R1;MOG;PAK1;PRKCQ;PSMC3;PLEKHA1;BMX;EIF2B2;CD38;PSMD14;PSMD3;LCP2;MALT1;PSMD4;PSMD6;PSMA6;PSMA4;BCAR1;PAK3;PSMB8;SYK;PIK3CD;TNFRSF21;PSMA8;PTPRC;LAT2
prerank,response to unfolded protein (GO:0006986),-0.33203339726350145,-1.1562969663343803,0.1966824644549763,0.6810719885999625,1.0,14/48,18.94%,HSPA8;TM7SF3;DAB2IP;HSPA14;HSP90AB1;HSPE1;HSPA4;HSP90AA1;DNAJB4;TOR1B;HSPA5;HSPA4L;PACRG;STT3B
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.4878062293399149,1.1559866502563572,0.3287128712871287,0.7431759103430282,1.0,5/13,18.79%,ENPP1;TPST1;SULT1A1;ABHD14B;SULT6B1
prerank,negative regulation of angiogenesis (GO:0016525),0.3346543525380398,1.1556578206743306,0.22953216374269006,0.7431411447106934,1.0,11/84,6.08%,SULF1;COL4A3;ROCK2;CXCL10;FOXC1;THBS2;HSPG2;ADAMTS1;DCN;SERPINE1;ATP2B4
prerank,toll-like receptor 9 signaling pathway (GO:0034162),-0.4552311748846528,-1.1555781224252875,0.27459016393442626,0.681948976551555,1.0,5/13,27.00%,PIK3AP1;IRAK1;PIK3C3;TLR7;MYD88
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),0.49769793910917326,1.1546047954149323,0.29273084479371314,0.7453155464735517,1.0,4/10,17.59%,GHR;STAT5B;PTPN1;STAT5A
prerank,positive regulation of phosphate metabolic process (GO:0045937),-0.38268612547685205,-1.1545618549229215,0.24768518518518517,0.6837105456533,1.0,9/25,21.87%,ITGA6;THBS1;SNCA;SDCBP;EGFR;EGF;BTBD10;PTH1R;MIF
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),-0.29715988467136994,-1.154021732966086,0.18507462686567164,0.6840986910382746,1.0,28/75,21.15%,CTNNA2;MEF2C;CNTN4;DCC;ACTB;KLF7;ANK3;S100B;NRCAM;UNK;MAP1B;SHTN1;MINK1;DVL1;NEFH;PAX2;PAK3;MFSD2A;BRSK2;SLITRK2;MAP2;SLITRK1;CELSR2;CCK;ABITRAM;NTNG1;NTNG2;DSCAML1
prerank,histone H4-K16 acetylation (GO:0043984),0.44589436273841015,1.1539921064509848,0.3053173241852487,0.7460778012805372,1.0,1/19,0.14%,KMT2A
prerank,positive regulation of cell cycle phase transition (GO:1901989),0.4721247910290294,1.1539735581746342,0.28884462151394424,0.745173531540225,1.0,7/15,13.47%,GLI1;CDC73;KLHL18;PHB2;CUL3;CRNN;PAF1
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",-0.4339607106387974,-1.1535972180563854,0.2679324894514768,0.6841844278346325,1.0,4/16,8.42%,CELF4;PUF60;SRSF1;DDX17
prerank,folic acid-containing compound metabolic process (GO:0006760),0.4437976365120466,1.1532926175212481,0.3010752688172043,0.7461846773494769,1.0,3/19,3.94%,SHMT1;SLC19A1;MTHFD1
prerank,regulation of B cell receptor signaling pathway (GO:0050855),-0.4004545849490337,-1.1526387140913925,0.2678983833718245,0.6858430572433953,1.0,6/21,11.66%,PRKCH;SLC39A10;PRKCB;LYN;RUNX1;CBFB
prerank,multivesicular body organization (GO:0036257),-0.3605653759488385,-1.1525424042274781,0.2523809523809524,0.6849843106681623,1.0,13/31,27.49%,RAB27A;VPS37B;VPS37A;CHMP1A;CHMP1B;CHMP7;CHMP2B;VPS28;SNF8;CHMP2A;HGS;CHMP6;CHMP4C
prerank,glutathione biosynthetic process (GO:0006750),-0.4714229152828565,-1.1524165063275869,0.28007889546351084,0.6841913813429684,1.0,6/11,31.31%,OPLAH;GCLC;GGT1;HAGH;MGST2;GCLM
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.3388542499253091,1.1523761442960756,0.23201174743024963,0.7478924416359326,1.0,15/72,11.16%,FN1;SELP;PDGFRA;FGFR1;OSM;NEDD4;KIT;DCN;ROR1;HAX1;PDGFRB;IL18;PIK3R5;PTPN6;PTK2
prerank,fatty acid elongation (GO:0030497),-0.4562231479336435,-1.1521495438648852,0.28016359918200406,0.6839228647012234,1.0,3/13,6.50%,ELOVL5;ELOVL7;TECR
prerank,sarcomere organization (GO:0045214),0.40312020768887435,1.1519789403565852,0.27079646017699116,0.7480715661939292,1.0,4/27,6.96%,CSRP3;TPM1;CSRP1;ACTN2
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.45047658576993455,1.151610218359867,0.2859744990892532,0.7482502272989944,1.0,4/18,6.37%,TNFAIP8L2;MIA3;PTPN22;PPARA
prerank,negative regulation of myoblast differentiation (GO:0045662),0.48095088758778404,1.1515647706171033,0.2922201138519924,0.7474132293957804,1.0,2/13,3.65%,PRICKLE1;EID2B
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),-0.41051507595174874,-1.1515160492410794,0.28210526315789475,0.6846411366573009,1.0,9/20,12.74%,SEMA6D;SEMA4D;SEMA3C;SEMA6A;SEMA7A;SEMA3E;SEMA3G;SEMA6B;SEMA3A
prerank,cellular response to hexose stimulus (GO:0071331),0.4300066271354088,1.1510169660926226,0.27402135231316727,0.7480438739236888,1.0,7/23,17.32%,ZBTB20;PRKAA2;UNC13B;SLC26A6;SOX4;IGF1R;PCK2
prerank,negative regulation of inflammatory response (GO:0050728),0.3025789794952173,1.150070034814821,0.2,0.7498613564749086,1.0,21/182,8.87%,ENPP3;RORA;GHRH;FPR2;ADORA2A;CDH5;TNFAIP8L2;PTHLH;GLP2R;IL6;ADCY5;ADCY7;MC2R;NR1H3;PPARA;RXFP2;PTPN2;ADCY1;RAMP1;ADM;INSL3
prerank,pyroptosis (GO:0070269),0.46837056570601765,1.1500159815312585,0.2919847328244275,0.7490807229237115,1.0,3/15,5.51%,GSDME;ZBP1;CASP4
prerank,regulation of pseudopodium assembly (GO:0031272),-0.4903444895639935,-1.1499606661095827,0.2923387096774194,0.6868655828489199,1.0,4/10,13.20%,CDC42EP3;CDC42EP1;CDC42EP5;WASHC1
prerank,positive regulation of pseudopodium assembly (GO:0031274),-0.4903444895639935,-1.1499606661095827,0.2923387096774194,0.6868655828489199,1.0,4/10,13.20%,CDC42EP3;CDC42EP1;CDC42EP5;WASHC1
prerank,cholesterol homeostasis (GO:0042632),0.35381125640143085,1.1496818576379286,0.22102009273570325,0.7490865206094911,1.0,10/64,12.05%,RORA;APOA2;CYP7B1;NR1H3;NPC1;IL18;LIMA1;SOAT1;DISP3;DGAT2
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),-0.4897127529551842,-1.1491606337618276,0.27385892116182575,0.6881327808465998,1.0,2/10,7.57%,PRKG1;CEACAM1
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.5078696039313858,1.148960987577197,0.30177514792899407,0.7501535462905347,1.0,4/12,11.46%,ELF1;RC3H1;PTPN22;ELF2
prerank,negative regulation of protein kinase activity (GO:0006469),-0.29298123056270353,-1.14854091839979,0.1745152354570637,0.6887872552682135,1.0,29/88,15.23%,PTPRB;UBASH3B;ADARB1;SNCA;SORL1;DAB2IP;SLC8A1;INPP5K;AKT1;CEACAM1;SMCR8;NPM1;LRP6;SH3BP5L;PTPRT;DVL1;CEP85;PTPRO;SRCIN1;AKT1S1;LRP5;CEP43;CAV1;PRKRIP1;PPIA;PARK7;PTPRC;GNAQ;CDKN1A
prerank,cellular calcium ion homeostasis (GO:0006874),-0.2730901974483111,-1.1485021920508716,0.16326530612244897,0.687786777509087,1.0,45/133,23.63%,TRPC3;ATP1B1;SLC24A2;RYR2;TPT1;HTR2C;SLC35G1;MCUB;TRPC5;TRPC4;ATP2C1;SLC8A1;CCL14;NPTN;ATP2A3;TRPC6;CAMK2D;SLC30A1;CXCL12;CALR;SMDT1;SLC10A7;CAV2;CD40;TMCO1;CAV1;ATP2A2;CCDC47;CCL19;ATP13A4;MAIP1;ADCY8;HTR2B;TMEM178A;SLC8B1;HTR2A;TRPC7;CHRNA7;PTH1R;SLC24A5;ATP2B3;CLN3;CALB2;ATP13A1;STC1
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.30820370871217767,1.148402345903231,0.2074688796680498,0.7507478881905255,1.0,20/152,8.87%,LPAR1;ADGRD1;LGR4;CXCL10;GHRH;FPR2;AKAP12;ADORA2A;GCGR;PTHLH;GLP2R;ADCY5;ADCY7;MC2R;RXFP2;ADCY1;RAMP1;ADGRL1;ADM;INSL3
prerank,V(D)J recombination (GO:0033151),-0.4736201444240545,-1.1483490433286567,0.3054989816700611,0.6871558725578117,1.0,4/11,18.32%,HMGB1;TCF3;DCAF1;LIG3
prerank,SNARE complex assembly (GO:0035493),-0.48976839719559495,-1.1483056590428762,0.2916666666666667,0.6861629595588296,1.0,3/10,8.18%,SNCA;STXBP1;STXBP6
prerank,regulation of endothelial cell chemotaxis (GO:2001026),-0.4484463828432079,-1.1479778856237486,0.3022774327122153,0.6859588111779478,1.0,7/15,15.27%,TMSB4X;THBS1;NOTCH1;MET;LGMN;FGF2;PRKD1
prerank,cellular amide metabolic process (GO:0043603),0.32373592450428745,1.1471028387395175,0.24324324324324326,0.7535813363732016,1.0,15/102,9.97%,SMPD3;PLPP3;PCCA;SHMT1;ACOT11;SLC19A1;MTHFD1;AEBP1;PANK2;NAAA;PCCB;BTD;ACOT9;HLCS;ACOT1
prerank,negative regulation of axon extension (GO:0030517),-0.36323175835710625,-1.1469017606853307,0.25223214285714285,0.6879927843235301,1.0,10/30,12.74%,SEMA6D;DIP2B;SEMA4D;SEMA3C;SEMA6A;SEMA7A;SEMA3E;SEMA3G;SEMA6B;SEMA3A
prerank,microtubule anchoring at centrosome (GO:0034454),0.5146680641673347,1.1466583312507757,0.3235867446393762,0.753962828523422,1.0,2/10,10.29%,NINL;NIN
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),-0.38741247053550426,-1.1466339828665328,0.2684085510688836,0.6876845008239308,1.0,11/23,37.53%,CADM1;PIK3R6;RAET1E;LAMP1;RASGRP1;LILRB1;SLAMF6;NECTIN2;CD226;IL12A;CRTAM
prerank,mitotic chromosome condensation (GO:0007076),-0.37592833029907585,-1.1458480736395094,0.24945295404814005,0.6889323886432908,1.0,12/26,31.15%,MCPH1;SMC2;CHMP1A;SET;NCAPH2;NCAPH;TENT4A;TTN;CSNK2B;NCAPD2;PLK1;CDK1
prerank,sterol homeostasis (GO:0055092),0.3503896416532578,1.1456012056769516,0.23323170731707318,0.756107613936629,1.0,10/65,12.05%,RORA;APOA2;CYP7B1;NR1H3;NPC1;IL18;LIMA1;SOAT1;DISP3;DGAT2
prerank,protein autophosphorylation (GO:0046777),0.3085150341216944,1.1455892244206778,0.2037037037037037,0.7551792520065301,1.0,26/157,11.16%,PDPK1;TEC;PDGFRA;FGFR1;STK39;DDR2;OXSR1;EIF2AK2;INSRR;EPHA8;FER;KIT;DAPK1;TAOK3;AAK1;EPHA1;PDGFRB;MAP4K1;GSK3B;EPHA4;STK24;LRRK2;CDK12;MUSK;GRK5;PTK2
prerank,regulation of establishment of endothelial barrier (GO:1903140),0.44978559355209125,1.1454986219188272,0.28468468468468466,0.7544867325895392,1.0,3/17,5.01%,ROCK2;CDH5;VCL
prerank,positive regulation of DNA metabolic process (GO:0051054),0.3488625159692377,1.1453453809599539,0.25194401244167963,0.7539448137435267,1.0,25/61,23.89%,EYA2;EYA1;WRN;RAD50;PARP3;PDGFRB;USP9X;EYA4;SMOC2;ERCC6;PML;UIMC1;PRKD2;DHX36;BRCC3;STPG4;USP7;ERCC8;EYA3;RTEL1;SMCHD1;DHX9;CEBPG;ZCWPW1;MECP2
prerank,negative regulation of programmed cell death (GO:0043069),0.2820590581523087,1.144876500644372,0.16983372921615203,0.7543135103764428,1.0,73/355,16.52%,PDPN;FHL2;FSTL1;ARHGAP10;KANK2;AXL;NOTCH2;PRKAA2;OSR1;IL31RA;ZFAND6;NUPR1;IL6ST;PHIP;GATA6;PRAP1;SH3RF1;ANXA1;ANGPT1;CFLAR;IL6;BCL2;ARAF;MTDH;MCL1;HAX1;SIAH2;ARF4;ANXA4;BIRC3;RASA1;CTSH;GLO1;NGFR;GSK3B;ANXA5;RIPK2;PHB2;WNT5A;UBE2Z;NAA16;USP47;SMAD6;DNAJC3;HIPK3;GRK5;BCL2L1;TJP1;PTK2;NAA15;EGR3;DSTYK;RPS6KA3;API5;SUPV3L1;OPA1;CBX4;TMEM14A;BFAR;ERCC5;IFIT3;NUAK2;VHL;NIBAN2;BIRC6;HDAC2;FIGNL1;DAB2;TAF9;IGF1R;HSPA9;MGMT;OPN3
prerank,blood circulation (GO:0008015),0.370598402236767,1.144588924287732,0.2807308970099668,0.754188876667206,1.0,8/49,7.59%,COL4A3;ROCK2;CXCL10;MYOF;ADORA2A;SERPING1;BDKRB2;STAT1
prerank,pulmonary valve morphogenesis (GO:0003184),-0.418751571457753,-1.1437154415917377,0.2918454935622318,0.6938174856520162,1.0,5/17,2.33%,SLIT2;ROBO2;NOS3;TGFB2;NOTCH1
prerank,lipid modification (GO:0030258),-0.33947953590427177,-1.143412071835867,0.23097112860892388,0.6935611514706566,1.0,13/37,18.89%,DGKB;DGKI;DGKH;PLPPR1;PLPP5;DGKZ;MBOAT1;DGKG;PLPP1;PLPPR2;MBOAT7;SGPP1;PLPPR5
prerank,negative regulation of stem cell differentiation (GO:2000737),-0.4618596969641251,-1.14320702279103,0.30184804928131415,0.6930020703847409,1.0,3/12,17.72%,NOTCH1;YTHDF2;HES1
prerank,cellular response to inorganic substance (GO:0071241),-0.3969640972497777,-1.1431360020830301,0.30128205128205127,0.6920936660680028,1.0,4/21,8.49%,FOXO1;KCNC2;DDX11;GUCY1B1
prerank,serine family amino acid metabolic process (GO:0009069),0.4627703088222819,1.14308309665127,0.29981378026070765,0.7577207118484117,1.0,4/16,10.71%,SHMT1;MTHFD1;SEPSECS;SEPHS2
prerank,regulation of actin filament polymerization (GO:0030833),-0.3023977505891721,-1.142834610956885,0.2099125364431487,0.6917983218768009,1.0,26/69,21.33%,SLIT2;SSH2;ESAM;KANK3;KANK4;PTK2B;NCKAP1;HIP1R;LMOD1;CYRIB;CDC42EP3;VASP;CDC42EP1;DBNL;CDC42EP5;PAK3;EVL;TWF1;SSH3;PYCARD;ARF6;PFN2;ABITRAM;CARMIL1;HCLS1;PRKCE
prerank,regulation of interleukin-8 production (GO:0032677),0.3448584028683707,1.1425491549682383,0.25806451612903225,0.7583090581043378,1.0,15/69,13.07%,APOA2;ANXA1;IL17D;IL6;TLR4;C5AR2;PTPN22;SERPINE1;ANXA4;NOS2;CRP;LGALS9;TLR2;MAP2K5;ARRB1
prerank,non-motile cilium assembly (GO:1905515),0.40644584322975935,1.142181845427519,0.2768166089965398,0.7584645487283036,1.0,9/30,15.32%,ARL13B;IFT88;IFT57;TMEM107;CCDC13;C2CD3;RPGRIP1L;CEP250;TOGARAM1
prerank,protein localization to cell periphery (GO:1990778),-0.27418610662104637,-1.1417305772289117,0.12773722627737227,0.6938036334263032,1.0,34/133,14.01%,DPP10;BSG;KCNB2;EFR3B;CACNB2;TNIK;ATP1B1;LIN7A;CDH1;KCNIP4;GAS6;ANK3;MAP7;EMP2;TSPAN14;DPP6;STXBP1;INPP5K;RAPGEF2;RAB3C;TMED2;LRP6;RAMP2;ZDHHC2;KCNB1;FGF13;ZFYVE27;RAB12;RAPGEF6;CAV1;RAB40B;F11R;EHD4;CLASP2
prerank,response to retinoic acid (GO:0032526),0.35090953227207183,1.1415500270804235,0.2586466165413534,0.7593914360009649,1.0,11/59,8.47%,WNT6;WNT10B;GATA6;WNT3A;EPHA3;PTK7;RBP4;WNT5B;ZNF35;CTSH;WNT5A
prerank,branched-chain amino acid metabolic process (GO:0009081),0.4406495005097467,1.1413430663275095,0.27708703374777977,0.758048321265227,1.0,11/20,24.02%,ACADSB;BCKDHA;ACAT1;ALDH6A1;HIBADH;ACAD8;MCCC1;DBT;IVD;MCCC2;ECHS1
prerank,branched-chain amino acid catabolic process (GO:0009083),0.4406495005097467,1.1413430663275095,0.27708703374777977,0.758048321265227,1.0,11/20,24.02%,ACADSB;BCKDHA;ACAT1;ALDH6A1;HIBADH;ACAD8;MCCC1;DBT;IVD;MCCC2;ECHS1
prerank,regulation of plasminogen activation (GO:0010755),0.485552823961011,1.1413406543684224,0.3235867446393762,0.7571046115957074,1.0,4/12,11.00%,CLEC3B;SERPINE1;SERPINE2;PLGRKT
prerank,regulation of astrocyte differentiation (GO:0048710),0.49647900801677014,1.1412572312156726,0.3152610441767068,0.7564118949469325,1.0,5/12,12.69%,BMP2;IL6;EPHA4;SERPINE2;NOG
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),-0.2862130650723059,-1.1404473322054114,0.20116618075801748,0.6963349525282846,1.0,27/93,15.47%,PDE4D;DMD;BCAR3;TFRC;SMAD7;PAK1;GAS6;SNCA;CAPRIN2;INPP5K;HSP90AB1;AKT1;PAQR3;RASSF2;HDAC6;PINK1;VEGFA;NOS1;RACK1;DDIT4;EGFR;NGF;HSP90AA1;CAV1;PARK7;PRKD1;IRGM
prerank,muscle tissue morphogenesis (GO:0060415),0.45480552557953546,1.1395866913178039,0.31673306772908366,0.7603641902365198,1.0,3/16,4.57%,TGFBR3;BMP2;EFEMP2
prerank,positive regulation of neuron projection development (GO:0010976),-0.28656960560935846,-1.1393034716861279,0.16939890710382513,0.6984665563553387,1.0,25/85,12.44%,ITGA6;LRRC7;TENM3;PTK2B;RIT2;FUT9;NTRK2;SETX;SERPINI1;TOX;DAB2IP;CAPRIN2;SNX3;STMN2;NDNF;NPTN;RAPGEF2;LRP8;NDRG4;LYN;DBNL;RET;SCARB2;FES;VLDLR
prerank,regulation of neuron death (GO:1901214),-0.2904009125995563,-1.1390654930831943,0.20170454545454544,0.6980298849661504,1.0,15/82,10.51%,GRID2;MEF2C;DCC;CD34;TRIM2;MAP3K5;SNCA;SORL1;EPHB1;GRIN2B;AKT1;TNFRSF1B;UBB;SIGMAR1;DDIT4
prerank,sprouting angiogenesis (GO:0002040),0.361019069950983,1.1387899303700517,0.2786377708978328,0.761730080400119,1.0,8/51,4.73%,EFNB2;ROBO1;RNF213;PARVA;NRP1;VEGFD;ANGPT1;MIA3
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.29805015873949237,1.1382056179972921,0.20871862615587847,0.7625117649903154,1.0,33/166,16.51%,RORA;RBPJ;CCN2;NOTCH2;TBL1XR1;TEAD1;NR6A1;POLR2D;NCOA6;NR1H3;PPARA;CREBBP;RARB;POLR1C;TEAD2;YAP1;CCNH;MNAT1;POLR1G;CDK7;TAF7;POLR2C;NR4A1;MAML2;NR3C1;POLR2F;GTF2H4;RARA;KAT2B;TAF9;POLR3H;WWTR1;TBL1X
prerank,cellular response to chemical stress (GO:0062197),-0.28141827159665006,-1.1380380231559881,0.20615384615384616,0.6997452168476879,1.0,22/96,15.29%,FOXO1;PRR5L;SETX;SNCA;CPEB2;MSRA;NCF2;CHCHD2;PINK1;NUDT2;FAS;ATM;ATF4;CAV1;PYROXD1;CYBB;PPIA;PARK7;SOD1;ERO1A;PRKD1;PYCR2
prerank,morphogenesis of a polarized epithelium (GO:0001738),-0.4656388293474068,-1.1377983082219727,0.2985971943887776,0.6993046284406597,1.0,8/12,24.04%,ACTB;LAMA3;ACTG1;AHI1;ZDHHC7;VANGL2;TRAF3IP1;LAMA5
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),-0.49175980842243966,-1.1374325970818768,0.3008658008658009,0.6992219185027188,1.0,7/10,37.06%,RNF125;GPATCH3;C1QBP;UFD1;SEC14L1;TSPAN6;TKFC
prerank,negative regulation of smoothened signaling pathway (GO:0045879),0.4181058065751271,1.137023797956214,0.2954954954954955,0.7650304585274301,1.0,6/23,12.54%,ENPP1;GLI3;MGRN1;GLIS2;SUFU;BTRC
prerank,vacuolar acidification (GO:0007035),-0.39069370403203996,-1.136404821095357,0.29777777777777775,0.7010480717731606,1.0,9/21,24.52%,ATP6V0A1;DMXL2;GRN;ATP6AP2;ATP6V0A2;ATP6V0E2;ATP6V0D2;CLN3;TMEM199
prerank,response to purine-containing compound (GO:0014074),-0.4243980922073753,-1.136076926823555,0.2646420824295011,0.7009009326429201,1.0,3/17,2.18%,TRPC3;ABCC9;RYR2
prerank,response to amyloid-beta (GO:1904645),0.3684348493933509,1.1357361115396536,0.2854785478547855,0.7677156904432872,1.0,9/44,8.24%,FPR2;GJA1;SNX6;TLR4;CASP4;VCAM1;NGFR;GSK3B;EPHA4
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),-0.48639384615184966,-1.1355483825438255,0.3275862068965517,0.7012880910570474,1.0,3/10,9.75%,MAPK3;FAS;LYN
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),0.40024839861086103,1.1353701930911184,0.3017241379310345,0.7677394085873074,1.0,9/27,15.07%,PID1;ENPP1;KANK1;PRKCZ;PTPN2;PTPN1;PIP4K2B;NCK1;TNS2
prerank,actin filament organization (GO:0007015),0.30587025353129466,1.1349925933010743,0.21565934065934067,0.7678638347997346,1.0,29/151,14.68%,DPYSL3;CGNL1;MCU;TMOD3;SHROOM2;MYO1B;ARHGAP12;EFS;BAIAP2L1;NEBL;TPM1;RHOBTB2;RHOF;FAT1;VILL;DBN1;DSTN;DLG1;TRIOBP;RFLNA;TPM4;MYO1A;RHOC;WASL;TLE6;MYO15A;ABI1;MYO1E;MYO1C
prerank,cellular polysaccharide biosynthetic process (GO:0033692),-0.38020553556145076,-1.1346010174652124,0.30073349633251834,0.7029350263263235,1.0,12/25,27.94%,CSGALNACT1;NDST3;FUT9;EXT1;B3GNT2;B3GNT9;NDST4;B3GNT3;HAS1;HAS3;B4GAT1;B3GNT6
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.3678419633844505,1.1343154748201283,0.2707275803722504,0.7688816022647104,1.0,11/43,15.83%,SMAD3;TEAD1;NFATC4;TERT;KLF5;PPARA;NGFR;FOXO3;NR3C1;SMARCA4;POU5F1
prerank,positive regulation of monocyte chemotaxis (GO:0090026),0.4481118940744957,1.1341954937276129,0.3197781885397412,0.7682631405307118,1.0,4/17,11.41%,CXCL10;FPR2;SERPINE1;ANO6
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),0.3371496018567412,1.1341796422360242,0.26356589147286824,0.7673655994388409,1.0,11/70,10.29%,KMT2A;EIF2AK2;FOXC1;OSM;MYB;TCF12;PSMB10;YAP1;PSMA3;PSME4;PSMA5
prerank,regulation of SMAD protein signal transduction (GO:0060390),0.43199570686642175,1.1330322172213407,0.29927007299270075,0.7697428747433991,1.0,6/21,16.40%,BMP6;BMPR1A;TGFBR1;SMAD4;DAB2;WWTR1
prerank,folic acid metabolic process (GO:0046655),0.444882995173772,1.132978921872249,0.30091743119266057,0.7689470740660573,1.0,3/18,3.94%,SHMT1;SLC19A1;MTHFD1
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),0.4943009439012889,1.1328010589101705,0.33980582524271846,0.7684918619956369,1.0,2/12,10.29%,NINL;NIN
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),0.38328499155529366,1.1325252019105925,0.2857142857142857,0.7683422771311375,1.0,12/34,15.07%,PTPN13;DUSP10;PTPN22;PTPN2;DUSP16;PTPN9;PTPN6;DUSP5;PTPN1;PTPN18;PTPRQ;TNS2
prerank,prostanoid metabolic process (GO:0006692),0.4728071136180495,1.1323873866149943,0.32342007434944237,0.7677891602590609,1.0,2/13,6.87%,PTGS1;PTGR1
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.3197500330487045,1.13235935193779,0.25258493353028066,0.7669312513150506,1.0,16/110,8.56%,LPAR1;ADGRD1;LGR4;CXCL10;GHRH;ADORA2A;GCGR;PTHLH;ADCY5;ADCY7;MC2R;RXFP2;ADCY1;RAMP1;ADGRL1;ADM
prerank,regulation of transport (GO:0051049),-0.34692287339123346,-1.1322946298973664,0.2553699284009546,0.7084885094152009,1.0,9/36,8.21%,EPB41;ICA1;ACTB;SNCA;ACTG1;MBTPS1;WWC1;REEP5;PINK1
prerank,protein polymerization (GO:0051258),0.3497517136918715,1.1322769327223545,0.2724252491694352,0.7662421317573697,1.0,3/55,0.81%,GAS7;ARHGAP6;DIAPH1
prerank,sensory perception of light stimulus (GO:0050953),0.325843649696087,1.1320951433226976,0.24183976261127596,0.7658840606889548,1.0,14/87,13.05%,EFEMP1;RDH10;ZIC2;ADGRV1;MYO9A;TULP2;COL18A1;CRYBB3;IMPG2;EYA4;ATXN7;CRYBA1;OPA1;EML2
prerank,negative regulation of biomineral tissue development (GO:0070168),0.42610728328756303,1.131890957773089,0.31504424778761064,0.76554361492929,1.0,4/21,4.70%,ROCK2;ENPP1;ECM1;BCOR
prerank,glucose metabolic process (GO:0006006),-0.310124598281873,-1.131838662210634,0.23943661971830985,0.7086384292632812,1.0,18/58,21.55%,PPARD;PGK1;APOD;SLC39A14;ALDOC;GPI;TPI1;ATF4;MDH1;LRP5;PGAM1;ENO1;PER2;SLC25A13;CRTC2;GAPDHS;SLC25A12;MDH2
prerank,heterotypic cell-cell adhesion (GO:0034113),0.4105993822775694,1.1315421475642546,0.30671506352087113,0.7656161820925911,1.0,5/25,9.40%,CXADR;PARVA;ITGA5;VCAM1;DSC2
prerank,tyrosine metabolic process (GO:0006570),0.48968703388268386,1.130502396214458,0.33079847908745247,0.7676395483701032,1.0,2/11,12.98%,HGD;THAP4
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.3354278143641933,1.1303453169392086,0.26126126126126126,0.767153997412264,1.0,11/70,5.98%,ATRNL1;LAMC1;FN1;RADIL;PARVA;NRP1;FER;ARL13B;ANTXR1;LAMC3;EPHA1
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),-0.43915554416885627,-1.1298442039871275,0.30784708249496984,0.7135235490319758,1.0,10/14,37.57%,RPS3;CD81;CARD11;RELA;BCL10;NECTIN2;IKBKG;CD226;TESPA1;LCK
prerank,translational elongation (GO:0006414),-0.2803830677387528,-1.1297253373068854,0.20294117647058824,0.7127301480483236,1.0,49/101,36.94%,EEF1G;EEF1A1;GTPBP1;MRPL4;EEF2;GFM1;MRPS18A;RACK1;MRPL1;MRPS30;MRPS23;MRPL57;MRPL28;MRPL47;AURKAIP1;MRPL35;MRPS5;MRPL34;MRPS2;MRPL52;MRPL23;MRPL9;MRPS31;MRPL49;MRPS12;TUFM;LTN1;MRPL11;MRPL50;MRPS16;MRPS22;MRPS25;MRPL44;CHCHD1;MRPL51;EEF1D;MRPL32;MRPL54;MRPL43;MRPL2;MRPL24;EEF1B2;MRPL37;ERAL1;EEF2K;MRPL45;MRPL30;GTPBP2;MRPS24
prerank,regulation of cellular localization (GO:0060341),-0.32315854452737525,-1.1295718165829367,0.2442159383033419,0.7120665931481849,1.0,19/46,20.76%,EFNA5;EPHA5;HSP90AB1;CAMK2D;WWC1;REEP5;PINK1;DYNC1H1;LYN;DVL1;FES;HSP90AA1;LRP5;BRSK2;MAP2;PPM1F;MAD1L1;SPAG5;TRIM46
prerank,negative chemotaxis (GO:0050919),0.38685988551704403,1.1294461501696182,0.29442508710801396,0.7687170238796638,1.0,5/33,6.28%,ROBO1;SEMA3D;EPHA7;NTN1;SEMA4B
prerank,platelet degranulation (GO:0002576),-0.2719619685043578,-1.1293582407469787,0.2029520295202952,0.7115322785177952,1.0,23/118,10.88%,PCDH7;ABCC4;VWF;PECAM1;ACTN1;TMSB4X;TGFB2;THBS1;VEGFC;SCG3;CALM1;GAS6;STXBP1;CYRIB;CDC37L1;RAB27B;A2M;VEGFA;TGFB3;CHID1;LYN;FAM3C;MANF
prerank,regulation of protein phosphorylation (GO:0001932),0.2860740493783714,1.1288503547274875,0.20050761421319796,0.7696128361406912,1.0,43/256,13.07%,PTPN13;IGFBP3;LEPR;ROCK2;FN1;EPHA7;FGF1;PID1;PLPP3;STAT2;PHIP;FPR2;WNT3A;CDH5;FAM20A;FER;FBLN1;VEGFD;IL34;ANGPT1;BMP2;SLCO3A1;BMP7;CCND3;PLCE1;PELI2;RALBP1;NSD1;FBH1;MYADM;IGF2;LRRK2;MUSK;BRD4;FGF18;FNIP1;PTK2;TSPYL2;DVL3;CADM4;RARRES2;EFNA1;ARRB1
prerank,regulation of axon extension (GO:0030516),-0.3421997260935352,-1.1283065231359126,0.2637889688249401,0.7134925878898847,1.0,12/37,15.98%,DIP2B;MACF1;NRCAM;SEMA7A;SHTN1;L1CAM;SEMA3G;DBNL;ZFYVE27;SEMA3A;MAPT;MAP2
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.3878209406424547,1.1281764356843715,0.281195079086116,0.7705456518161101,1.0,8/33,15.46%,SMAD3;TEAD1;TERT;KLF5;NGFR;FOXO3;NR3C1;SMARCA4
prerank,neural tube closure (GO:0001843),0.38153443856579383,1.1279502500781484,0.2857142857142857,0.7703008721688657,1.0,6/34,7.92%,PRICKLE1;LMO4;DLC1;MTHFD1;CELSR1;SKI
prerank,artery morphogenesis (GO:0048844),-0.35965512874428696,-1.1278485447085618,0.2641509433962264,0.7137424836751761,1.0,8/30,8.85%,TGFB2;BMPR2;NOTCH1;SMAD7;TBX1;BMP4;TBX2;VEGFA
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),-0.3604939996245214,-1.1274435708392545,0.26252983293556087,0.7138121424713486,1.0,16/28,30.57%,STMN2;MAP1B;PRUNE1;CLASP2;MAPT;MAP2;SKA2;STMN4;STMN1;FKBP4;GAS2L1;ARL2;MAPRE1;SKA3;STMN3;CAMSAP1
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),-0.37348309295421056,-1.1273728453059115,0.28941176470588237,0.7128976631415357,1.0,5/24,8.21%,PTK2B;CTSC;PSMD14;UBB;PINK1
prerank,positive regulation of interferon-beta production (GO:0032728),0.38981711392617435,1.127143122882548,0.29081632653061223,0.7717541598806823,1.0,13/33,24.27%,TRIM56;TLR4;RIPK2;POLR3F;TLR2;OAS2;IFIH1;TBK1;RNF135;RIOK3;DHX9;TOMM70;POLR3B
prerank,response to lipopolysaccharide (GO:0032496),0.3074801841504203,1.1266274346168939,0.24420190995907232,0.7722739870456191,1.0,27/138,14.46%,SELP;CXCL10;AXL;LDOC1;VIM;FER;IL6;TLR4;PTPN22;SERPINE1;NR1H3;NOS2;CDC73;CCL2;LY96;LGALS9;CD274;WNT5A;NOCT;SMAD6;MAPK14;IRAK3;RPS6KA3;PAF1;TICAM1;TRIB1;PABPN1
prerank,cardiac muscle cell differentiation (GO:0055007),0.4251189442905857,1.1263597859119743,0.30590339892665475,0.7721130840161748,1.0,3/21,3.96%,AKAP13;CXADR;BMP2
prerank,positive regulation of DNA biosynthetic process (GO:2000573),-0.3117694384097325,-1.126146718281425,0.22281167108753316,0.7153533371260051,1.0,25/60,30.48%,PRKCQ;NEK7;PARM1;CTNNB1;MAPK3;HSP90AB1;ATM;NVL;FGF2;KLF4;HSP90AA1;RGCC;PNKP;PKIB;CCT5;RFC4;WRAP53;ATR;FGFR4;RFC5;RFC2;MAP3K4;CHTF18;MYC;PCNA
prerank,regulation of interferon-alpha production (GO:0032647),0.41716992424952254,1.1261429558368536,0.32149200710479575,0.7718392659723177,1.0,7/23,19.59%,TLR4;STAT1;RIPK2;IFIH1;TBK1;DHX36;SETD2
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),0.33940436053669837,1.126101916926763,0.2684049079754601,0.7710379946421915,1.0,14/72,13.11%,USP18;ELF1;AXL;CFLAR;ZBP1;BIRC3;PTPN2;STAT1;PIAS1;SUMO1;PTPN6;IRAK3;PTPN1;JAK1
prerank,positive regulation of heart rate (GO:0010460),-0.41826574997093485,-1.1260585633906193,0.32346723044397463,0.7145158585133912,1.0,5/17,13.61%,PDE4D;RYR2;ADRA1B;KCNQ1;ATP2A2
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.49222984712335793,1.1254803098280814,0.3422562141491396,0.7719470741228943,1.0,6/10,24.62%,NCK1;VHL;CITED2;SIRT2;BAG3;DNAJB1
prerank,regulation of mitochondrial membrane potential (GO:0051881),0.37273212458049987,1.1253167411053548,0.2743221690590112,0.7715274490770127,1.0,10/40,13.40%,PID1;BCL2;STOX1;SLC4A11;OPRD1;BAX;HEBP2;LRRK2;BCL2L1;BCO2
prerank,organophosphate ester transport (GO:0015748),-0.3811490670877578,-1.12529607363218,0.27640449438202247,0.7155314306392412,1.0,6/24,8.19%,PITPNC1;PITPNA;ABCA3;SCARB1;PRELID2;PRELID1
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.35508194134241916,1.1252393293117804,0.28482003129890454,0.7708222404927976,1.0,7/50,8.25%,SASH1;EIF2AK2;NFAT5;IFI35;TLR4;LGALS9;PHB2
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.32286127601515,1.124860044981918,0.26153846153846155,0.7709985953615153,1.0,16/88,11.97%,SMAD3;SMPD3;CDH5;SYNPO2;SYNPO;BMP7;SLX4;TPR;SPIDR;GSK3B;BAX;SUMO1;SLF2;PLEK;FNIP1;RHOC
prerank,positive regulation of stem cell proliferation (GO:2000648),0.45400329539946993,1.1247365749758154,0.29963235294117646,0.7704304682942362,1.0,2/17,4.00%,GJA1;TERT
prerank,protein destabilization (GO:0031648),0.3764446360137685,1.1244023437532848,0.29473684210526313,0.7704512150714306,1.0,12/32,15.52%,CREBBP;CTSH;CDC73;FBXL3;SERF1A;CUL3;TRIM21;BTRC;FBXW11;PEX2;KDM8;MUL1
prerank,carboxylic acid transport (GO:0046942),0.35311815626634907,1.1239370608424015,0.2708333333333333,0.7708646742398955,1.0,9/55,7.19%,SLC13A3;SLC6A13;SLC16A11;SLC6A9;SLC16A2;SLC16A12;SLC6A12;SLC16A5;SLC38A6
prerank,positive regulation of multicellular organismal process (GO:0051240),0.2790392399400712,1.1238975465172338,0.2087378640776699,0.7700640741913574,1.0,30/308,6.13%,PDPN;SOX5;LEPR;PTN;FOXD1;SMAD3;GHR;SMURF2;EIF2AK2;FOXC1;GHRH;GJA1;BMPR1A;GLIPR2;NCOA3;PLA2R1;ALMS1;TGFB1I1;BMP2;RFX3;TERT;IL6;BMP1;EPAS1;TGFBR1;UCN;ACSL1;SERPINE1;APPL2;BCL9L
prerank,hemidesmosome assembly (GO:0031581),-0.4723576495114926,-1.1237321964737725,0.3127659574468085,0.7189989109872442,1.0,3/11,4.11%,ITGA6;ITGB4;LAMA3
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),0.3815907988764642,1.12349360915344,0.30179445350734097,0.7702367827881961,1.0,4/33,4.92%,IGFBP3;IGFBP5;EFEMP2;TPM1
prerank,positive regulation of viral genome replication (GO:0045070),0.3895753687527117,1.1233786944264688,0.300509337860781,0.7696729597208091,1.0,10/29,15.71%,TOP2B;PPARA;STAU1;PPID;TMEM39A;ADAR;IFIT1;SRPK1;TARBP2;PKN2
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),-0.47756278512159955,-1.123371920791452,0.33405639913232105,0.7189630228114982,1.0,4/10,25.23%,CALM1;CALM3;GPR35;CBARP
prerank,positive regulation of interferon-gamma production (GO:0032729),-0.3186061316472705,-1.1232362268327378,0.23863636363636365,0.718275737939924,1.0,6/48,9.13%,PDE4D;PDE4B;SLC7A5;IL1R1;CYRIB;ZFPM1
prerank,regulation of RNA metabolic process (GO:0051252),0.3480311945524545,1.1229171930066006,0.27699530516431925,0.7701516852954857,1.0,19/59,18.89%,PTBP3;AHNAK;RC3H1;IGF2BP1;RASA1;OASL;CLK4;NOVA1;HNRNPH1;IGF2BP2;OAS2;HNRNPH3;PTBP2;USP36;FUS;MBNL2;AFF2;PCBP2;GRSF1
prerank,sensory perception of smell (GO:0007608),0.4880897327394854,1.1227902297549348,0.3415559772296015,0.7695962795035758,1.0,1/11,2.32%,BEST2
prerank,positive regulation of neuron differentiation (GO:0045666),0.3751547368840714,1.1223612391471038,0.29545454545454547,0.7699184380956551,1.0,6/40,5.70%,TCF4;FGFR1;NBL1;KCTD11;BMP2;CPNE1
prerank,regulation of intracellular pH (GO:0051453),-0.34969081673538505,-1.1223130593552997,0.2676056338028169,0.719853887969964,1.0,8/34,14.68%,SLC4A10;SLC9A2;CA2;SLC9A8;SLC9B1;ATP5F1B;SLC4A7;SLC9A5
prerank,regulation of neuron differentiation (GO:0045664),-0.2928658400175357,-1.1221481210566018,0.2358490566037736,0.7191752432487507,1.0,16/76,7.53%,NLGN1;BRINP3;MEF2C;BRINP1;CNTN4;ZFHX3;TIAM1;BEND6;SIX1;BRINP2;MMD;NRCAM;ARHGEF2;YWHAH;TCF3;VWC2
prerank,positive regulation of peptidase activity (GO:0010952),-0.3900423377001704,-1.1215409329798414,0.2905982905982906,0.7198383258659015,1.0,6/20,21.03%,PRELID1;PINK1;GRN;PSENEN;PSME1;NDUFA13
prerank,synaptic vesicle recycling (GO:0036465),-0.3487278034810192,-1.1214270700807063,0.2834101382488479,0.7190656638021382,1.0,6/31,8.74%,NLGN1;SYT1;AMPH;SNCA;SYT7;NLGN3
prerank,regulation of protein binding (GO:0043393),0.3119427008986232,1.1213117559930024,0.27058823529411763,0.772161793124945,1.0,33/114,18.40%,TCF7L2;VTN;CFHR2;WNT3A;IFIT2;DACT1;BMP2;TERT;DTX3L;HDAC4;EFHB;SPPL3;GSK3B;RIPK2;BAX;STK3;AMFR;LRRK2;NES;TRIM21;IFIT1;HFE;LRPAP1;STK4;DAB2;APP;GOLGA2;RAN;PPP2CA;GAS8;DNAJB2;LRP1;KDM1A
prerank,positive regulation of monooxygenase activity (GO:0032770),-0.3646002625474829,-1.1212738647198692,0.2733485193621868,0.7184274930783107,1.0,9/26,16.37%,NOS1AP;SCARB1;AKT1;GCH1;NUS1;S100A1;PARK7;CDH3;HTR2B
prerank,regulation of endopeptidase activity (GO:0052548),0.34631444012717877,1.1211485015629024,0.2896440129449838,0.7717344978956892,1.0,12/59,12.46%,VTN;TIMP3;SERPING1;SERPINB7;NRDC;SERPINE1;BIRC3;TIMP2;SERPINE2;PSMA3;SERPINB8;SERPINE3
prerank,positive regulation of gene expression (GO:0010628),0.2702120917757416,1.1209807597161328,0.17890995260663506,0.7713116857811513,1.0,56/442,11.15%,ROBO1;BMP6;FOXD1;ROCK2;SMAD3;RBPJ;RBMS3;FN1;PLD1;AFDN;WNT6;FGF1;PID1;TLE1;SAMD4A;OSR1;EIF2AK2;WNT3A;GJA1;VIM;CDH5;ITGB8;GCGR;PLA2R1;SLC26A9;TNRC6B;SLC24A3;ANGPT1;BMP2;PKP3;IL6;TLR4;BMP7;STOX1;PTPN22;TGFBR1;CRP;CTSH;POLR1C;PDCD5;GSK3B;LGALS9;BAZ1B;TNRC6A;WNT5A;YAP1;DTNBP1;MOV10;POLR1G;MUSK;FUBP1;MAPK14;CUX2;FGF18;TLR2;LRP3
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.3022248758072108,1.1208333101315688,0.2619047619047619,0.7708378967655425,1.0,22/136,13.07%,TCF7L2;SP100;NUPR1;MTURN;TCEAL7;BMP7;FOXP3;ANXA4;HDAC4;GLIS2;PARP10;PHB2;SUMO1;SUFU;WWP2;KEAP1;HEYL;IRAK3;MAP2K5;TRIM21;BTRC;ARRB1
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.44486108728830615,1.120403826150918,0.3314500941619586,0.7711509111339879,1.0,1/16,0.36%,LEPROT
prerank,negative regulation of complement activation (GO:0045916),0.5108907614696175,1.1201977993419066,0.3651685393258427,0.7708132576826632,1.0,2/10,2.94%,CD55;SERPING1
prerank,DNA biosynthetic process (GO:0071897),0.45060124579920446,1.120186099072313,0.330188679245283,0.7699457933816638,1.0,3/16,4.22%,POLH;TERT;WRN
prerank,N-acetylglucosamine metabolic process (GO:0006044),0.45651401227207533,1.119875666777496,0.31189083820662766,0.7699563979979006,1.0,6/15,19.93%,LARGE1;MGAT3;AMDHD2;EXTL2;NAGK;CHST3
prerank,cardiac muscle cell development (GO:0055013),0.43704013309787726,1.1197453899489331,0.3151183970856102,0.7693916881550154,1.0,4/20,6.11%,CXADR;PDGFRA;CSRP3;PDGFRB
prerank,regulation of proteasomal protein catabolic process (GO:0061136),-0.31631794759595827,-1.119723633094268,0.24087591240875914,0.7219348757445181,1.0,19/53,26.34%,PSMC3;DAB2IP;HSP90AB1;RAD23A;PSMD14;UBB;PINK1;XPO1;TMTC3;GNA12;FOXF2;PSME1;UBQLN4;PSMC6;UFL1;PSMC5;RAD23B;TREM2;F8A1
prerank,regulation of axon guidance (GO:1902667),0.4963088221434027,1.1196863490121773,0.3516068052930057,0.7686425041430083,1.0,2/10,4.85%,NRP1;MYCBP2
prerank,negative regulation of interferon-gamma production (GO:0032689),0.41365421207476283,1.1196860192480553,0.3003412969283277,0.7677392814589389,1.0,5/23,7.89%,AXL;TLR4;FOXP3;LGALS9;CD274
prerank,cellular response to interleukin-7 (GO:0098761),0.4416702103400925,1.1196165485749208,0.32407407407407407,0.7661369106614798,1.0,7/17,19.42%,STAT5B;BRWD1;JAK1;SMARCA4;STAT5A;IL7R;IL7
prerank,interleukin-7-mediated signaling pathway (GO:0038111),0.4416702103400925,1.1196165485749208,0.32407407407407407,0.7661369106614798,1.0,7/17,19.42%,STAT5B;BRWD1;JAK1;SMARCA4;STAT5A;IL7R;IL7
prerank,endocardial cushion morphogenesis (GO:0003203),-0.4081709834952694,-1.1194925153864874,0.31291028446389496,0.7214934735276766,1.0,8/18,14.61%,NOS3;TGFB2;NOTCH1;ACVRL1;BMP4;TBX2;ACVR1;HEY1
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),0.48596149971024866,1.1193953844365618,0.3373015873015873,0.7658745018817726,1.0,4/11,16.38%,LEPROT;SH2B3;VHL;NF2
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.37497876466806124,1.1192777312838502,0.29132569558101473,0.7652934441285735,1.0,6/37,4.92%,IGFBP5;GJA1;BMPR1A;ADAMTS1;EFEMP2;TPM1
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),-0.4680278642685588,-1.1186676276307246,0.33073929961089493,0.7228151445821464,1.0,2/11,2.33%,FOXO1;NOTCH1
prerank,maturation of SSU-rRNA (GO:0030490),-0.3476739594471965,-1.1186265037716077,0.29930394431554525,0.7218358596993724,1.0,11/34,22.29%,RPS19;RPS8;RPS16;RPS28;NOL11;RPS14;SNU13;UTP6;BMS1;HEATR1;WDR46
prerank,'de novo' posttranslational protein folding (GO:0051084),-0.35211059888976814,-1.118474891557932,0.3027295285359802,0.7212389163450942,1.0,7/30,16.03%,HSPA8;HSPA14;BAG1;HSPE1;DNAJB4;ERO1A;HSPA5
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),-0.3905938983475691,-1.1183348131717452,0.29653679653679654,0.7205471183557651,1.0,12/21,31.62%,HDAC6;PINK1;SIRT5;PAX2;ABCD2;PARK7;BRCA1;SLC18A2;SLC30A10;MMP3;TFAP2A;MT3
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),-0.4745264521874873,-1.118287480934271,0.32091097308488614,0.7196130195355526,1.0,9/10,43.96%,RCC2;ECT2;KNSTRN;SPAG5;RACGAP1;CCNB1;CDC42;NEK2;APC
prerank,regulation of calcium ion transmembrane transport (GO:1903169),0.4126859227402739,1.11813108687649,0.3118466898954704,0.7678320309150708,1.0,2/23,0.81%,ATP1A2;DIAPH1
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.46463830881262036,1.118101816675971,0.32629558541266795,0.767039595813905,1.0,3/14,8.39%,ACOXL;AMACR;SCP2
prerank,regulation of catabolic process (GO:0009894),-0.40924976234494936,-1.1176375973490922,0.29809725158562367,0.7204364541998222,1.0,11/18,33.34%,FAP;NEDD4L;ZDHHC2;ZDHHC7;HPGD;SNF8;HGS;CHMP6;FAM83D;MDM2;FURIN
prerank,negative regulation of response to wounding (GO:1903035),0.4301540707856164,1.1176001881318323,0.34991119005328597,0.7674965966233342,1.0,5/19,12.41%,CASK;SERPINE1;EPHA4;EPPK1;CD109
prerank,negative regulation of cellular metabolic process (GO:0031324),-0.3340288418051296,-1.1172983366278184,0.27386934673366836,0.7202967923208076,1.0,12/37,22.20%,ANKRD13A;ATXN2;SDCBP;PINK1;SIRT5;AP1AR;PAX2;BRCA1;RIN3;MTMR2;EDNRB;ANKRD13B
prerank,positive regulation of defense response to virus by host (GO:0002230),0.4224457765662532,1.116981477217378,0.33218588640275387,0.7683860708282678,1.0,4/24,7.59%,PARP9;PTPN22;DTX3L;STAT1
prerank,regulation of cellular senescence (GO:2000772),-0.3568388812026337,-1.1168135760591558,0.3076923076923077,0.7206255214529104,1.0,7/28,10.91%,YPEL3;CDK6;YBX1;RBL1;B2M;ABI3;EEF1E1
prerank,negative regulation of protein ubiquitination (GO:0031397),-0.31639802037749154,-1.1162387037541075,0.27297297297297296,0.7211992826146286,1.0,17/50,21.65%,SMAD7;IVNS1ABP;RPS3;AKT1;GNL3L;CAV1;CAMLG;PARK7;PER2;N4BP1;SIRT7;MINAR1;VPS28;UFL1;PRMT3;PRR7;SH3RF2
prerank,modulation by symbiont of host process (GO:0044003),-0.4803874023624969,-1.1162143801705096,0.3178947368421053,0.720223287746134,1.0,5/10,15.67%,PGK1;UBB;B2M;UBA52;ENO1
prerank,positive regulation of angiogenesis (GO:0045766),0.31070763337743057,1.116205814083538,0.2747093023255814,0.769731448891851,1.0,20/108,11.06%,PDPK1;SASH1;FGF1;ECM1;GATA6;FOXC2;CDH5;ITGB8;ITGA5;VEGFD;ANXA3;MTDH;SERPINE1;EPHA1;CTSH;JMJD8;WNT5A;ADAM12;FGF18;TJP1
prerank,ether lipid biosynthetic process (GO:0008611),0.5126900412968426,1.1160594736327296,0.3326848249027237,0.7692688499461081,1.0,2/10,6.30%,PLA2G4A;PLA2G4C
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.428496189915411,1.1156777279694188,0.33955223880597013,0.7694610220318904,1.0,6/20,17.11%,SULF1;DSTYK;NOG;SMOC2;PRKD2;GPC1
prerank,mature B cell differentiation involved in immune response (GO:0002313),0.480444917589651,1.1153943635668497,0.35315315315315315,0.7693579089602872,1.0,3/12,4.44%,DOCK11;NOTCH2;IL6
prerank,negative regulation of protein localization to cell periphery (GO:1904376),0.42138474440494655,1.115222558888282,0.3244274809160305,0.768968434455511,1.0,6/20,18.04%,PID1;NUMB;RHOQ;BCL2L1;DAB2;PPFIA1
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),0.41883087419388804,1.1150755821740708,0.3252336448598131,0.7684908241134967,1.0,7/20,19.14%,PID1;NUMB;RHOQ;BCL2L1;DAB2;PPFIA1;CSK
prerank,regulation of cholesterol esterification (GO:0010872),0.4970542846050625,1.1150213621750389,0.3393213572854291,0.7677565220971405,1.0,1/10,2.03%,APOA2
prerank,steroid biosynthetic process (GO:0006694),0.3463548398332139,1.1149176160608505,0.2976,0.7671993270207776,1.0,12/56,15.36%,PRKAG2;CYP7B1;HSD17B1;CYP27A1;AMACR;INSIG2;SCP2;SLC27A2;LBR;CH25H;STAR;OSBPL9
prerank,response to UV-B (GO:0010224),-0.4569067760756991,-1.1148550281286183,0.34549356223175964,0.7230991160471345,1.0,8/12,37.30%,STK11;CDKN1A;MFAP4;HYAL3;RELA;HYAL2;CRIP1;IL12A
prerank,protein targeting (GO:0006605),-0.2729380640900389,-1.1145576246757443,0.2112676056338028,0.7228856746795058,1.0,39/118,23.09%,NLGN1;AKAP6;RASSF9;SORL1;AQP11;RPL11;VPS37B;GABARAP;SRP14;SDCBP;MFF;SPCS2;ZDHHC14;ZDHHC20;MFN2;ZDHHC2;GDAP1;SPCS1;TIMM8B;ZDHHC24;NACA;RABGEF1;ZFAND2B;VPS37A;PEX16;ZDHHC7;AP4S1;AIP;PEX19;SEC61A1;TOMM20;YIF1B;TIMM22;SEC61G;AP1S3;ZDHHC23;ZDHHC9;TIMM10;HAP1
prerank,protein-containing complex assembly (GO:0065003),0.28039970089859056,1.1143103463651092,0.21482412060301506,0.7680945219567057,1.0,53/259,16.53%,TCF7L2;KMT2A;MCU;LAMC1;FN1;AFDN;TLE1;TEAD1;TGFA;TERT;TLE3;SEC23A;ST13;BCL9L;TCF7L1;CREBBP;SEC24D;CLDN1;CDC73;GSK3B;SNX9;RSPH9;TEAD2;YAP1;TAPBP;MNAT1;LRRK2;TUBGCP4;FBXL7;PPID;DNM1L;PPP6R3;ANO6;TCF7;CUL3;WDR19;SEC24C;HFE;SCFD1;OPA1;TUBGCP2;WASL;WASF1;MDM4;LEO1;GEMIN5;PML;SEC24B;SMARCA4;GOLGA2;PYGO1;AXIN2;SH3PXD2B
prerank,acylglycerol catabolic process (GO:0046464),-0.3524381899795765,-1.1142498427721612,0.2775,0.7227543851366829,1.0,10/30,28.37%,MGLL;ABHD2;LIPE;ABHD6;LPL;PNPLA3;FAAH;LIPH;FABP3;LIPC
prerank,prostaglandin metabolic process (GO:0006693),0.39924479786753786,1.114147781068196,0.3181818181818182,0.7676481620722374,1.0,3/26,6.87%,PTGS1;PLA2G4A;PTGR1
prerank,regulation of protein dephosphorylation (GO:0035304),-0.3299649471170925,-1.1139737474473097,0.26976744186046514,0.7224883361375012,1.0,8/37,7.96%,PPP1R16B;CAMTA1;CALM1;CALM2;PTBP1;CALM3;SYMPK;MFHAS1
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),0.3216179571458361,1.1139531851854492,0.2874617737003058,0.7673003174774087,1.0,16/79,12.69%,SULF1;ADAMTS12;SMURF2;BMPR1A;FSTL3;NBL1;CASK;NEDD4;BMP2;ATP2B4;SKI;SMAD6;SMAD4;CADM4;PTPN1;NOG
prerank,positive regulation of autophagy (GO:0010508),0.32139387352887494,1.1138694548739232,0.2785185185185185,0.7666700940955931,1.0,19/81,14.55%,RNF152;PRKAA2;DAPK1;DCN;MTDH;OPTN;TRIM5;PIK3C2A;GSK3B;WAC;PHB2;LRRK2;TPCN1;SESN1;FOXO3;MAP3K7;TRIM21;TICAM1;TBK1
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.45982018114180867,1.113622339955025,0.33271719038817005,0.7665075201476735,1.0,2/13,4.44%,NFAT5;IL6
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.4086646985664807,1.1134766402349079,0.329246935201401,0.7660281717335481,1.0,7/26,13.48%,ANAPC11;ESPL1;UBE2C;CUL3;NSMCE2;HECW2;CDC27
prerank,cellular biogenic amine biosynthetic process (GO:0042401),0.45137390767822805,1.1128775973068976,0.3346456692913386,0.7668137101033513,1.0,1/15,0.80%,MOXD1
prerank,negative regulation of JUN kinase activity (GO:0043508),0.49751869021947015,1.1122167714418316,0.3466666666666667,0.7678436827587861,1.0,3/10,10.35%,DUSP10;PTPN22;HIPK3
prerank,sterol metabolic process (GO:0016125),0.34133302804700527,1.1119329413480918,0.2940251572327044,0.7677751071052119,1.0,10/60,12.77%,PRKAG2;APOA2;CYP7B1;APOF;CYP27A1;INSIG2;SOAT1;LBR;CH25H;OSBPL5
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),-0.29441641544013275,-1.11158181503183,0.26649076517150394,0.7284414556603217,1.0,25/75,23.01%,PTPRJ;SORL1;DAB2IP;RASIP1;SLC8A1;PRKAR1A;INPP5K;BMP4;AKT1;PAQR3;TFAP4;LRP6;HHEX;LYN;PRKAR2B;LRP5;PKIG;MEN1;PKIB;PYCARD;CDKN1C;HEXIM2;DUSP7;SPRY4;TESK1
prerank,regulation of RNA export from nucleus (GO:0046831),0.4775001573236245,1.111495094400124,0.3392857142857143,0.7681235457702428,1.0,5/11,23.45%,TPR;IWS1;SETD2;KHDRBS1;DHX9
prerank,relaxation of cardiac muscle (GO:0055119),-0.44027905646046983,-1.1113410736097113,0.3347457627118644,0.7280575316245851,1.0,5/13,7.24%,ATP1B1;KCNJ2;ATP1A1;SLC8A1;CAMK2D
prerank,positive regulation of axonogenesis (GO:0050772),0.35727947162616325,1.1110127732942099,0.2981878088962109,0.7685911090726649,1.0,7/43,7.53%,PLXNA2;ROBO1;TIAM2;NTN1;MAP6;DBN1;NGFR
prerank,regulation of protein localization to plasma membrane (GO:1903076),0.3229023053249645,1.1110046532518096,0.2764350453172205,0.7677488801212047,1.0,15/78,10.73%,PDPK1;PID1;SPTBN1;EPHA3;NUMB;SORBS1;MMP14;ATP2B4;PTPN9;KIF5B;RHOQ;DLG1;STX8;APPL1;BCL2L1
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),-0.34808944246161433,-1.1104683987853168,0.28463476070528965,0.7295553859461782,1.0,12/32,19.25%,THBS1;KDR;NOTCH1;GATA2;HDAC7;HDAC9;VEGFA;FGF2;KLF4;SRPX2;DLL4;CARD10
prerank,regulation of intracellular transport (GO:0032386),-0.3245876156469511,-1.11026975148796,0.2857142857142857,0.729056447174835,1.0,13/38,23.09%,WWC1;REEP5;DYNC1H1;AAAS;NEFH;CAPN10;MLC1;LAMP1;MAP2;LCP1;SPAG5;ATP9A;HAP1
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),0.44013122073400623,1.109917452984838,0.3424408014571949,0.7699008182988815,1.0,4/17,18.72%,PLA2G4A;PLA2G4C;LPGAT1;PLA2G5
prerank,regulation of cell-substrate junction assembly (GO:0090109),-0.389064952539489,-1.1095589104805406,0.3097949886104784,0.7300605862771231,1.0,6/21,4.28%,LIMCH1;EFNA5;PEAK1;GPM6B;MACF1;ACTG1
prerank,axon extension (GO:0048675),0.4111041085507918,1.10927164053934,0.3296903460837887,0.7709468300665328,1.0,6/23,11.84%,ALCAM;AUTS2;NRP1;USP9X;PPP3CB;SPG11
prerank,regulation of nucleocytoplasmic transport (GO:0046822),0.4751147800944417,1.109170440763844,0.33976833976833976,0.7703700716204814,1.0,4/12,11.99%,NEDD4;PTPN14;TPR;IFI27
prerank,positive regulation of kinase activity (GO:0033674),0.3106547759736662,1.1088727378208485,0.2844702467343977,0.7703080110005542,1.0,24/107,12.63%,EPHA7;PDGFRA;PRKAG2;FGFR1;AXL;DDR2;INSRR;LMO4;EPHA3;EPHA8;KIT;ROR1;RAD50;EPHA1;PDGFRB;SNX9;EPHA4;MST1R;MUSK;PTK2;DSTYK;CSF1;EPHA2;EEF1A2
prerank,protein heterooligomerization (GO:0051291),-0.4083311414254424,-1.1087622294082136,0.32409381663113007,0.7312596623841789,1.0,7/17,24.16%,KCNC2;GRIN2B;GRIN1;TMEM120B;FARSB;HSD17B8;MAT2A
prerank,negative regulation of lymphocyte migration (GO:2000402),-0.4768124927047203,-1.1085449418467246,0.35234215885947046,0.7308136189097353,1.0,3/10,7.21%,LRCH1;APOD;AKT1
prerank,renal filtration (GO:0097205),0.49849575071862595,1.108373888890179,0.3611111111111111,0.7708162480681793,1.0,1/10,0.15%,SULF1
prerank,regulation of mitochondrion organization (GO:0010821),0.3530122315392241,1.1083672576386019,0.30303030303030304,0.7699617928457796,1.0,16/47,21.76%,PID1;STAT2;STOX1;HAX1;GSK3B;LRRK2;DNM1L;USP36;CSNK2A2;MUL1;RHOT1;MYO19;RHOT2;SREBF1;VPS35;FBXW7
prerank,cellular response to oxygen-containing compound (GO:1901701),0.27823352522131056,1.1082895842967073,0.22536945812807882,0.769288620090235,1.0,35/291,8.47%,RORA;ROCK2;CXCL10;PDGFRA;WNT6;PID1;AXL;IGFBP5;WNT10B;LDOC1;WNT3A;SHMT1;EPHA3;PTK7;VIM;FER;NCOA3;DAPK1;IL6;WNT5B;TLR4;TPM1;SERPINE1;ZNF35;NR1H3;ATP2B4;MPV17;CPEB1;SSH1;CDC73;CCL2;LY96;CD274;FAM210B;WNT5A
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),0.46545562953551745,1.1080668291670952,0.3371212121212121,0.7690500061789558,1.0,3/12,9.94%,KDELR3;INSIG2;TAPT1
prerank,dendritic cell migration (GO:0036336),-0.40122361283099367,-1.1077707287323868,0.32207207207207206,0.73193370380699,1.0,12/16,45.17%,EPS8;HMGB1;CCL19;TRPM2;ALOX5;CCL5;CCR1;PIK3CG;CCR5;CCR6;CXCR2;TRPM4
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.2840352223615995,1.107390569269772,0.2571059431524548,0.7701260574164648,1.0,42/214,15.95%,TGFBR3;CCN2;FN1;EPHA7;PDGFRA;NOTCH2;FPR2;MTURN;TIMP3;GLIPR2;NRP1;FBLN1;DUSP10;ANGPT1;BMP2;ROR1;TLR4;PRKCZ;PTPN22;PDGFRB;PTPN2;CCL2;ACKR3;LGALS9;PHB2;DLG1;PTPN6;SMAD4;DSTYK;P2RY6;EPHA2;PTPN1;MAP2K1;ARRB1;ZDHHC17;P2RY1;CCL25;PTPRR;NTRK3;PRKD2;APP;ICAM1
prerank,presynapse organization (GO:0099172),-0.46437939753755,-1.107368192363607,0.37777777777777777,0.7320275144047771,1.0,4/10,10.22%,NLGN1;LRRTM3;NLGN3;DVL1
prerank,heart morphogenesis (GO:0003007),0.3504181129733928,1.1070710515096887,0.33003300330033003,0.7701502261940566,1.0,6/50,5.16%,FLRT2;TGFBR3;DLC1;BMPR1A;BMP2;TGFBR1
prerank,regulation of phosphorylation (GO:0042325),0.3053043559552409,1.1068603943693354,0.2895480225988701,0.7699213069584817,1.0,26/120,17.01%,FN1;PRKAG2;STAT2;PHIP;DYNLL1;CDH5;NRP1;FER;LDB2;BMP7;RANBP2;TPR;JMJD8;CDKN2B;FNIP1;PTK2;CADM4;POM121;KCTD20;PML;ILK;APP;INHA;NUP37;NDUFS4;PPP2CA
prerank,oogenesis (GO:0048477),0.45881546416977864,1.1066729649539324,0.33579335793357934,0.769548473163446,1.0,2/15,6.49%,PTN;NANOS2
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.4325364100545209,1.1065409681786817,0.3377609108159393,0.7690376734663786,1.0,5/20,11.93%,GRK3;CRY1;MGRN1;PLEK;RPGRIP1L
prerank,protein localization to cilium (GO:0061512),0.3859234359633972,1.1063199664517978,0.3213644524236984,0.7688195027688005,1.0,10/32,20.39%,INVS;ARL3;ODAD4;TMEM107;TULP2;WDR19;IFT20;TTC21B;ARL6;TULP1
prerank,calcium ion import (GO:0070509),-0.35166137923231433,-1.1062502612800444,0.3215962441314554,0.7342442548675456,1.0,11/28,17.85%,CACNA1E;CACNB2;MCUB;TRPC4;SLC8A1;CACNA1G;CACNA1D;SMDT1;ATP2A2;MAIP1;CACNA1A
prerank,organophosphate catabolic process (GO:0046434),0.4894442521193977,1.1060520732864954,0.34685598377281945,0.7687217732724014,1.0,2/11,10.74%,APOA2;ENPP2
prerank,protein O-linked mannosylation (GO:0035269),0.4367671479219779,1.1058903546835204,0.3420074349442379,0.768341053389511,1.0,5/18,7.26%,TMTC4;TMTC1;LARGE1;RXYLT1;POMT2
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),-0.34712436851886946,-1.1057314240978087,0.29591836734693877,0.7346668654060958,1.0,19/29,44.09%,CADM1;CYRIB;RAET1E;LAMP1;STX7;RASGRP1;FADD;TYROBP;SLAMF6;NECTIN2;CD226;IL12A;CRTAM;IL12RB1;STAP1;IL23A;ITGAM;KLRD1;CD160
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),-0.3676088971215214,-1.1051689836594114,0.28465346534653463,0.7351727433362248,1.0,8/25,19.91%,PGK1;PKM;ALDOC;GPI;TPI1;PGAM1;ENO1;GAPDHS
prerank,synaptic vesicle localization (GO:0097479),-0.43408506154373205,-1.1051529180120518,0.35625,0.7341372775263441,1.0,6/13,16.98%,NLGN1;RAB27A;SYNDIG1;KIF5C;KIF5A;SNAPIN
prerank,regulation of response to cytokine stimulus (GO:0060759),0.42587468377724513,1.1051208907759424,0.33586337760910817,0.7696596275478378,1.0,7/19,15.89%,ELF1;PARP9;WNT5A;MAP2K5;SH2B3;IFIH1;TAF9
prerank,icosanoid biosynthetic process (GO:0046456),0.5086663839249062,1.1051063688533609,0.3661417322834646,0.7688396293133773,1.0,1/10,1.37%,PLA2G4A
prerank,sodium ion transport (GO:0006814),-0.28206551014598347,-1.1045769064275517,0.2195845697329377,0.7347221948858021,1.0,18/85,12.37%,SLC6A6;SLC12A2;SLC9B2;ATP1B1;SLC24A2;SLC6A1;SCN1A;HCN1;SLC5A5;SLC8A1;SLC5A6;HCN2;SCN2A;NEDD4L;FGF13;SCN8A;SCN9A;SLC6A5
prerank,RNA biosynthetic process (GO:0032774),0.38190040205838816,1.1045735598440494,0.32521739130434785,0.7694957368611665,1.0,5/31,10.12%,TERT;NCOA6;POLA2;PRIM2;TAF7
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.47304172174237546,1.1044361067861486,0.3365570599613153,0.7690421096111663,1.0,4/12,12.53%,ADAMTS12;DCN;ATP2B4;CADM4
prerank,positive regulation of vasoconstriction (GO:0045907),-0.44316065836018603,-1.104326958575657,0.3426724137931034,0.7343754600540255,1.0,10/13,54.85%,ADRA1B;CAV1;SMTNL2;ADRA1A;ADRA1D;TRPM4;OXTR;SMTNL1;AVPR1A;F2R
prerank,protein secretion (GO:0009306),0.3392428231808572,1.1040470238988767,0.3284552845528455,0.7692675817942385,1.0,7/56,5.71%,WLS;ARFGAP3;STEAP3;ANXA1;RAB10;MIA3;FAM3B
prerank,positive regulation of glial cell differentiation (GO:0045687),0.44572263853470645,1.1038915196594514,0.36151079136690645,0.7688779713378512,1.0,6/17,15.74%,PTN;IL34;BMP2;SERPINE2;EGR2;CXCR4
prerank,regulation of melanin biosynthetic process (GO:0048021),0.4806420684783138,1.1038044691049502,0.35135135135135137,0.7682881938698035,1.0,3/10,16.52%,ZEB2;APPL1;OPN3
prerank,cell junction maintenance (GO:0034331),0.4623080218577294,1.1034835860289554,0.3471698113207547,0.7683097047666223,1.0,4/14,11.28%,PARD6A;CLDN1;MYADM;NLGN2
prerank,B cell activation (GO:0042113),-0.2936960220098745,-1.1029297730836567,0.2559366754617414,0.7373841151679661,1.0,19/68,17.66%,PTPRJ;MEF2C;PRKCB;PLCG2;TPD52;ITGA4;HDAC9;TCF3;HHEX;MALT1;CD86;CD40;PIK3CD;DCAF1;PTPRC;LAT2;CLCF1;RABL3;CHRNA4
prerank,metal ion export (GO:0070839),0.3794561638460305,1.1025469964933206,0.32432432432432434,0.7700404638950364,1.0,2/31,0.51%,ATP1A2;KCNT2
prerank,regulation of axon extension involved in axon guidance (GO:0048841),-0.3713545038994455,-1.1021891874876177,0.3169164882226981,0.7385175527557787,1.0,10/24,12.74%,SEMA6D;SEMA4D;SEMA3C;SEMA6A;SEMA7A;SEMA3E;VEGFA;SEMA3G;SEMA6B;SEMA3A
prerank,negative regulation of response to external stimulus (GO:0032102),0.3120868816571831,1.1019871796635685,0.30453879941434847,0.7707354132837848,1.0,16/105,12.41%,ENPP3;RORA;FPR2;CASK;CDH5;TNFAIP8L2;SERPINE1;NR1H3;PPARA;PTPN2;EPHA4;PPM1B;IRAK3;EPPK1;TRIM21;CD109
prerank,negative regulation of kinase activity (GO:0033673),0.32907897985607226,1.101661890846037,0.2934609250398724,0.7708359308261522,1.0,4/62,2.17%,PDPK1;DEPTOR;PRKAG2;PPM1E
prerank,negative regulation of innate immune response (GO:0045824),0.3781764920725099,1.101638950456539,0.31751227495908346,0.7700494729236183,1.0,9/34,17.64%,USP18;STAT2;SERPING1;PTPN2;IRAK3;TRIM21;MUL1;FAM3A;USP15
prerank,regulation of nuclear division (GO:0051783),-0.3908923044938979,-1.1012731466180243,0.32599118942731276,0.7400471028279556,1.0,12/20,39.62%,BORA;CAV2;CCDC8;L3MBTL1;PRMT5;MKI67;KIF20B;CUL9;DAPK3;PIN1;PDXP;CDC25C
prerank,regulation of endothelial cell proliferation (GO:0001936),-0.2771997604276763,-1.1012024856221314,0.2774390243902439,0.7391808603063399,1.0,27/88,16.67%,TEK;PPP1R16B;TIE1;NRP2;THBS1;BMPR2;KDR;VEGFC;F3;ACVRL1;PTPRM;ATP5F1A;BMP4;AKT1;VEGFA;EGFL7;SCG2;CAV2;FGF2;PIK3CD;CAV1;RGCC;PRKD1;KRIT1;EGF;HTR2B;EMC10
prerank,positive regulation of vasculature development (GO:1904018),0.3123772033617745,1.1011453733507703,0.27906976744186046,0.7706347493694619,1.0,15/94,9.37%,PDPK1;SASH1;FGF1;ECM1;GATA6;CDH5;ITGB8;VEGFD;ANXA3;MTDH;SERPINE1;EPHA1;CTSH;WNT5A;ADAM12
prerank,activation of GTPase activity (GO:0090630),0.31393962369203626,1.101129930430901,0.3032069970845481,0.7698148510593638,1.0,16/89,13.71%,ARHGAP29;RASGRF1;TIAM2;ARHGAP42;TBC1D16;EPHA1;GRTP1;SYDE1;GMIP;DOCK7;NGEF;SIPA1L2;EPHA2;RAP1GAP;GPR65;TBC1D7
prerank,"wound healing, spreading of cells (GO:0044319)",0.4120324177368809,1.101119763420696,0.3480565371024735,0.7690074678197231,1.0,3/24,5.81%,PDPN;ITGA5;COL5A1
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),0.45055591435386805,1.1011000161077047,0.3490909090909091,0.7682125584373555,1.0,5/15,18.00%,CD55;GLI3;IHH;IL23R;HSPH1
prerank,neurotrophin signaling pathway (GO:0038179),-0.3826229459286555,-1.1009367688353113,0.32505643340857787,0.738894334575851,1.0,9/21,16.45%,NTRK2;RAPGEF2;DDIT4;ZFYVE27;BCAR1;NGF;SORT1;RAP1A;NTF3
prerank,endothelial cell migration (GO:0043542),0.3769120704878969,1.1005572957815974,0.33503401360544216,0.7689148676695605,1.0,8/37,11.85%,DPP4;FSTL1;CDH5;NRP1;STAT1;CDH13;EGR3;NR4A1
prerank,lamellipodium assembly (GO:0030032),-0.3653229049158458,-1.100368961886338,0.3225806451612903,0.7393711957043615,1.0,8/26,13.65%,PARVB;SPATA13;ARHGEF6;CCDC88A;S1PR1;PTPRO;ARHGEF7;RAC1
prerank,regulation of protein modification process (GO:0031399),0.34875939592303573,1.1003631044541393,0.3260135135135135,0.7686161875303379,1.0,17/50,18.72%,FN1;STAT2;PHIP;CDH5;FER;IGF2;PPP1R16A;FNIP1;PTK2;CADM4;PML;KAT2B;NDUFS4;PPP2CA;ATG10;PLXNB2;FKTN
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.38137004064667124,1.099899056840817,0.3270547945205479,0.7691021275183066,1.0,3/32,4.20%,PDPK1;CXCL10;F2RL3
prerank,negative regulation of TOR signaling (GO:0032007),0.36962266934835086,1.099733042133732,0.32358003442340794,0.7687580809913197,1.0,8/36,14.52%,DEPTOR;RNF152;PRKAA2;FNIP1;SESN1;NPRL3;TBC1D7;MAPKAPK5
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.4836735386066799,1.0994179944573252,0.34074074074074073,0.7679521051799352,1.0,3/12,3.11%,TACSTD2;KANK1;FBLN1
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.4836735386066799,1.0994179944573252,0.34074074074074073,0.7679521051799352,1.0,3/12,3.11%,TACSTD2;KANK1;FBLN1
prerank,regulation of MAP kinase activity (GO:0043405),0.3181703448919866,1.0990211237383556,0.2950310559006211,0.7682412480442301,1.0,17/92,12.68%,ROBO1;FGFR1;FGF1;KSR1;IL34;KIT;BMP7;PDGFRB;PPEF2;LRRK2;PIK3R5;MST1R;CDK12;FGF18;IRAK3;SH2B3;PTPN1
prerank,positive regulation of receptor internalization (GO:0002092),-0.3672355833485128,-1.0989191175842599,0.3325740318906606,0.7426218756861644,1.0,9/22,18.68%,INSR;AHI1;SCYL2;VEGFA;ATAD1;SFRP4;EGF;NTF3;TBC1D5
prerank,cGMP metabolic process (GO:0046068),-0.4504058281743135,-1.0988095783399345,0.3551020408163265,0.7418697783934378,1.0,4/12,10.66%,GUCY1B1;PDE2A;GUCY1A1;NPR1
prerank,positive regulation of dephosphorylation (GO:0035306),-0.3525006497969542,-1.0984953841505132,0.3006396588486141,0.7417070954726414,1.0,7/27,7.58%,PPP1R16B;CAMTA1;CALM1;CALM2;PTBP1;CALM3;SYMPK
prerank,positive regulation of neuroinflammatory response (GO:0150078),0.47837824847956467,1.0983932905992135,0.3704414587332054,0.7690729004733557,1.0,3/12,7.50%,NUPR1;IL6;IL18
prerank,sulfur compound transport (GO:0072348),-0.3559661639175365,-1.0983191456170645,0.3115468409586057,0.7411687404425897,1.0,3/27,0.51%,ABCG2;SLC6A6;SLC26A7
prerank,cyclooxygenase pathway (GO:0019371),0.49446330419504586,1.0983092811033894,0.35887850467289717,0.7684764359461188,1.0,4/10,22.64%,PTGS1;PTGES2;PTGS2;PTGES3
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.34176191285960245,1.0978180321386248,0.303125,0.7690107015230128,1.0,8/59,12.53%,ALDH1A2;CYP7B1;CYP27A1;AMACR;SCP2;SLC27A2;ABCD3;CH25H
prerank,purine-containing compound biosynthetic process (GO:0072522),0.40025095789761456,1.097713133252256,0.3121869782971619,0.7684800976516671,1.0,5/25,9.24%,AMPD3;SHMT1;MTHFD1;PAICS;PRPSAP1
prerank,regulation of sequestering of calcium ion (GO:0051282),-0.4352834427452012,-1.0976676010125626,0.34557235421166305,0.7420101102887582,1.0,3/12,2.25%,UBASH3B;RYR2;PTK2B
prerank,gluconeogenesis (GO:0006094),-0.3244739261612232,-1.0971861566938503,0.2975871313672922,0.7423942771049085,1.0,15/39,21.55%,PGK1;SLC39A14;ALDOC;GPI;TPI1;ATF4;MDH1;PGAM1;ENO1;PER2;SLC25A13;CRTC2;GAPDHS;SLC25A12;MDH2
prerank,acute-phase response (GO:0006953),0.473441326423818,1.0970829293910003,0.35094339622641507,0.7693290115928932,1.0,4/12,18.84%,IL6;CRP;IL22;CEBPB
prerank,polarized epithelial cell differentiation (GO:0030859),0.46280449629414244,1.0970357690540438,0.3587360594795539,0.7686177383673672,1.0,2/13,5.76%,RAB10;MYO9A
prerank,bile acid biosynthetic process (GO:0006699),0.40341690380439094,1.0969075224222902,0.3362521891418564,0.7681662176014188,1.0,7/24,15.36%,CYP7B1;CYP27A1;AMACR;SCP2;SLC27A2;CH25H;OSBPL9
prerank,relaxation of muscle (GO:0090075),-0.4389622266919412,-1.09623226475404,0.34913793103448276,0.7440041568720928,1.0,5/13,7.24%,ATP1B1;KCNJ2;ATP1A1;SLC8A1;CAMK2D
prerank,positive regulation of viral process (GO:0048524),0.3352703893840505,1.096096644217746,0.3284072249589491,0.7696317659778565,1.0,14/60,15.71%,AXL;POLR2D;PPARA;KPNA6;STAU1;PPID;POLR2C;TMEM39A;ADAR;IFIT1;SRPK1;POLR2F;TARBP2;PKN2
prerank,regulation of cytoplasmic translation (GO:2000765),-0.42665719845216543,-1.0960497885229694,0.33617021276595743,0.7434449834861317,1.0,6/14,20.10%,CPEB2;PKM;UNK;CNBP;CPEB4;RBM24
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),-0.4722509505983123,-1.0959662619786625,0.3473684210526316,0.7426550850710164,1.0,6/10,28.27%,PDE8A;PARK7;GPR37;STK26;GPR37L1;PYCR1
prerank,membrane fusion (GO:0061025),-0.34116030813402487,-1.0958787680087319,0.30679156908665106,0.7418175068804372,1.0,6/33,9.06%,DNM3;RIMS1;NSF;DYSF;NSFL1C;VPS33B
prerank,response to chemokine (GO:1990868),0.46448031253532085,1.0949474749239747,0.35477582846003897,0.7719828078081029,1.0,3/13,1.80%,STK39;OXSR1;FOXC1
prerank,cognition (GO:0050890),-0.31971977996465867,-1.0948707082893774,0.31155778894472363,0.7437387083831369,1.0,13/42,22.52%,GRM5;PTCHD1;SHROOM4;FAM107A;DOP1B;SLC1A4;MFSD2A;ST3GAL4;CHMP2B;CHRNA4;CHRNA7;TTC8;LHCGR
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),0.47518686473489924,1.0947127857113195,0.3527204502814259,0.7718232689201202,1.0,2/11,6.96%,STK39;ACTN2
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.49076438306815207,1.0946848426841789,0.3648393194706994,0.7710596196230867,1.0,1/10,1.09%,SP100
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.35762558351611057,1.0943662172497228,0.32231404958677684,0.771165580720982,1.0,7/43,7.09%,CBLB;SNX6;TGFA;ERRFI1;PTPN3;PTPN2;MVP
prerank,cellular biogenic amine metabolic process (GO:0006576),-0.4376409747503649,-1.0942767311675838,0.35517970401691334,0.7443206798831324,1.0,5/12,19.92%,MAOA;OAZ2;DDC;SMS;SRM
prerank,regulation of intracellular signal transduction (GO:1902531),0.26430686856959656,1.094218813955492,0.23875432525951557,0.7707163274799973,1.0,60/420,10.43%,ARHGAP29;PTPN13;PDPK1;ARHGAP6;TIAM2;AKAP13;ARHGAP21;ARHGAP10;NRK;PRKAG2;ARHGAP20;ARHGAP18;FGF1;PRKAA2;ZFAND6;TPTE;AKAP12;DLC1;ARHGAP28;ARHGAP32;TRIP10;FGD4;ARHGAP12;TRAF5;PRDM11;TAOK3;WRN;NEK8;ARAF;PTPN22;RAD50;OPTN;CPNE1;MYO9A;WWC2;RHOF;BIRC3;FAM13B;TAGAP;FBXO9;RALBP1;PLEKHG2;ARHGEF11;MAP2K6;WNT5A;STK3;ARHGAP26;RHOQ;PJA2;DLG1;SYDE1;GMIP;LRRK2;ARHGEF12;SOS2;RPA3;NGEF;TAF7;MAPK14;TTC5
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.4837002798192083,1.0940354933217615,0.362763915547025,0.7704406317982081,1.0,1/11,1.09%,SP100
prerank,C21-steroid hormone biosynthetic process (GO:0006700),-0.4506078074448461,-1.0934182196771962,0.3653061224489796,0.7456934288350405,1.0,2/12,8.51%,STARD3NL;FDXR
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",-0.43862028393758784,-1.0929954292185717,0.35294117647058826,0.7459541881505655,1.0,8/13,21.71%,RPL26;SPRED2;ATM;EEF1E1;SPRED3;SPRED1;MSX1;ATR
prerank,positive regulation of neuron apoptotic process (GO:0043525),0.3970916758194011,1.0929789669279066,0.3381818181818182,0.7725468543251642,1.0,5/24,11.85%,EPHA7;NUPR1;MCL1;BAX;FOXO3
prerank,protein localization to plasma membrane (GO:0072659),-0.26077667823095046,-1.0926207111950255,0.2103448275862069,0.7459969837803095,1.0,33/129,14.01%,DPP10;BSG;KCNB2;EFR3B;CACNB2;TNIK;ATP1B1;CDH1;KCNIP4;GAS6;ANK3;MAP7;EMP2;TSPAN14;DPP6;STXBP1;INPP5K;RAPGEF2;CCDC88A;RAB3C;TMED2;LRP6;RAMP2;ZDHHC2;KCNB1;FGF13;ZFYVE27;RAB12;RAPGEF6;RAB40B;F11R;EHD4;CLASP2
prerank,neuron migration (GO:0001764),-0.3167381153401496,-1.0923709974499771,0.27918781725888325,0.7456465759473865,1.0,19/48,14.19%,ADGRL3;MEF2C;GPM6A;NTRK2;NRCAM;NDNF;RAPGEF2;ASTN1;ASTN2;MAP1B;VEGFA;SPOCK1;DNER;DDIT4;FGF13;MARK1;SEMA3A;RAC1;RELN
prerank,regulation of sequestering of triglyceride (GO:0010889),0.43972361681870387,1.0922184322862578,0.3413173652694611,0.7738365048753941,1.0,4/15,18.20%,OSBPL8;PPARA;PLIN3;ABHD5
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),-0.40689157722588853,-1.0921707124445599,0.34811529933481156,0.7451881160177486,1.0,13/16,49.60%,SLC39A14;PRMT5;ACP3;GRP;C3;MRAP2;PDE6G;NECAB2;MRAP;PDE6H;CHGA;F2;PRKCA
prerank,regulation of leukocyte chemotaxis (GO:0002688),0.4320648761365109,1.092136605357599,0.3727598566308244,0.7732163625794584,1.0,3/18,4.44%,PTN;CAMK1D;IL6
prerank,positive regulation of cell projection organization (GO:0031346),0.3024646671475349,1.0920556355643378,0.3121301775147929,0.7726235841492625,1.0,12/115,5.28%,PLXNA2;ROBO1;DPYSL3;PTN;TIAM2;CAMK1D;EPHA3;PTK7;ROR1;MAP6;PLK5;CBFA2T2
prerank,regulation of B cell proliferation (GO:0030888),-0.31262429165425676,-1.091809626763783,0.34594594594594597,0.745185349072839,1.0,11/44,17.70%,MEF2C;TFRC;CD38;CD74;LYN;ATM;CD40;TNFRSF21;PTPRC;CLCF1;CD320
prerank,dopaminergic neuron differentiation (GO:0071542),-0.3955264750110558,-1.0917233190398092,0.34134615384615385,0.7443721817577188,1.0,4/19,10.88%,CTNNB1;VEGFA;LRP6;MANF
prerank,negative regulation of protein-containing complex assembly (GO:0031333),0.3436083317851289,1.091654353556194,0.3457364341085271,0.772951819447486,1.0,8/49,9.65%,PPM1A;LDLRAD4;DACT1;PMEPA1;PRKCZ;OPRD1;GSK3B;SMAD6
prerank,mitotic cytokinesis (GO:0000281),0.35395136678108297,1.0915664157364382,0.33278145695364236,0.7723876095519197,1.0,9/47,8.98%,ROCK2;SPTBN1;ARL3;RASA1;STAMBP;KLHDC8B;SNX9;ESPL1;USP8
prerank,transferrin transport (GO:0033572),-0.3358400350473778,-1.0914529602230725,0.3054187192118227,0.744101288064562,1.0,12/33,21.84%,ATP6V0A1;TFRC;ATP6V1B2;ATP6V0C;ATP6V1D;ARHGAP1;ATP6V0A2;ATP6V1G2;ATP6V0E2;ATP6V1F;ATP6V0D2;ATP6AP1
prerank,histone lysine methylation (GO:0034968),0.3789223102543881,1.0912674027245588,0.34183673469387754,0.7724413060664368,1.0,2/33,4.07%,KMT2A;WDR5B
prerank,protein insertion into mitochondrial membrane (GO:0051204),-0.3671681615810267,-1.0910730707530967,0.3295194508009153,0.7442475116844355,1.0,13/23,31.76%,HSPA4;SAMM50;TIMM8B;HSP90AA1;BMF;MAIP1;TIMM22;BAD;NDUFA13;TIMM10;PMAIP1;TIMM13;TOMM22
prerank,endodermal cell fate commitment (GO:0001711),0.4839472649084377,1.0910639999876723,0.3682092555331992,0.7721526391017995,1.0,5/10,15.83%,CDC73;RTF1;PAF1;LEO1;POU5F1
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),-0.35858541903337793,-1.0909888450911818,0.3097949886104784,0.7434361673843404,1.0,8/25,22.20%,ANKRD13A;ATXN2;SDCBP;RAC1;ARF6;RIN3;MTMR2;ANKRD13B
prerank,response to peptide (GO:1901652),0.37372649548025855,1.0904408509721089,0.3362218370883882,0.7731160938879342,1.0,6/33,11.53%,STAT2;ANXA1;STAT5B;STAT1;EIF2B3;STAT4
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),-0.3368046715031335,-1.0903852420586218,0.32066508313539194,0.7441682279098767,1.0,3/31,1.99%,DLG2;LRRC7;LIN7A
prerank,regulation of cell adhesion (GO:0030155),-0.2630898744923429,-1.0902541040700318,0.2379182156133829,0.7435060965276832,1.0,28/129,12.92%,FRMD5;PTPRJ;PLXNA4;EFNA5;PDE3B;PTK2B;ZFHX3;CYTH1;STX3;PPP2R1A;ACVRL1;SEMA4D;TGFBI;ADGRG1;ADAM22;YTHDF2;ARHGDIB;VEGFA;CXCL12;LYN;PRKX;MINK1;ATM;ZDHHC2;RET;FES;ARHGDIA;EPB41L4B
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),-0.33782299512126746,-1.089830004216278,0.30864197530864196,0.7436638357688069,1.0,18/32,37.13%,HINT1;JMY;STK11;BAG6;PPP1R13B;DDIT4;PYCARD;BCL3;MYBBP1A;HIPK2;CDIP1;PMAIP1;TP53;TMEM109;POU4F1;BOK;AEN;PDK2
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),0.48671024488478537,1.089698750525534,0.3624031007751938,0.774349686275533,1.0,1/10,0.45%,ATP1A2
prerank,cholesterol biosynthetic process (GO:0006695),-0.3506278567542358,-1.089400614833813,0.3237410071942446,0.7438383655049127,1.0,14/31,32.03%,HMGCS1;NSDHL;SQLE;INSIG1;ACLY;SC5D;HSD17B7;DHCR7;LSS;MVD;MSMO1;DHCR24;IDI1;PLPP6
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.3954014778856452,1.0891164096271033,0.3475177304964539,0.7742871176535799,1.0,6/23,11.51%,ZEB2;TGFB1I1;CREBBP;CDKN2B;RNF111;SMAD4
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.3954014778856452,1.0891164096271033,0.3475177304964539,0.7742871176535799,1.0,6/23,11.51%,ZEB2;TGFB1I1;CREBBP;CDKN2B;RNF111;SMAD4
prerank,activation of protein kinase activity (GO:0032147),0.3030262365479716,1.0886122228130166,0.31020408163265306,0.7748738799150461,1.0,16/106,8.57%,PDPK1;NRK;FGF1;GHR;OSBPL8;ANGPT1;TNFSF15;TAOK3;ADCY5;ADCY7;TGFBR2;ADCY1;IL18;PHB2;WNT5A;STK3
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),0.46185255179518825,1.0884226328937676,0.3424124513618677,0.7745576783229763,1.0,5/11,23.45%,WTIP;PUM2;AJUBA;XPO5;DHX9
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),-0.43103797257902254,-1.0883969485620804,0.34598214285714285,0.7458059486132568,1.0,6/13,35.25%,TMSB4X;HEY1;PER2;SOX11;HEY2;DDIT3
prerank,neutrophil activation involved in immune response (GO:0002283),-0.22526665758758438,-1.0883468387064414,0.1171875,0.7449218701703296,1.0,88/428,15.28%,PTPRB;ATP8A1;PECAM1;PTPRJ;LRRC7;CST3;ATP6V0A1;HSPA8;RAB27A;PTPRN2;ACTR10;CD93;ATP11B;CTSC;CTSB;STK10;SNAP25;FTH1;STOM;DOCK2;TSPAN14;HEXB;FTL;PSMC3;ATP11A;EEF1A1;HMGB1;PKM;PRG2;PRCP;SRP14;CTSD;HSP90AB1;KPNB1;ATP6V0C;EEF2;SCAMP1;CEACAM1;SDCBP;TNFRSF1B;CTSS;PSMD14;DYNC1H1;PSMD3;B2M;ALDOC;MLEC;NEU1;ARL8A;CD53;QPCT;RHOG;GDI2;HMOX2;FCER1G;DBNL;PSMD6;ATP6V1D;NBEAL2;CAPN1;FRMPD3;NFASC;GPI;GUSB;SYK;HRNR;HSP90AA1;ACLY;PGLYRP1;GRN;LAIR1;CYBB;TMBIM1;RAC1;TNFAIP6;RAB5C;PLAUR;PNP;ATP6AP2;TMEM30A;GM2A;TUBB4B;ARHGAP45;PGAM1;PPIA;PTPRC;QSOX1;CFP
prerank,regulation of RNA splicing (GO:0043484),-0.2904837019854859,-1.0879403123704734,0.27380952380952384,0.7450338907733071,1.0,12/69,9.53%,QKI;PIK3R1;MBNL1;KHDRBS2;SETX;PTBP1;KHDRBS3;RPS13;HNRNPK;HNRNPH2;AHNAK2;RPS26
prerank,cellular response to alcohol (GO:0097306),0.3528127501410965,1.0872750164167324,0.33766233766233766,0.7768404832559732,1.0,8/42,7.28%,GRAMD1C;ADCY5;ADCY7;CTNNA1;ADCY1;SPIDR;MAP4K1;KLF9
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.4202688328743489,1.086854636688372,0.35665529010238906,0.7772129084190107,1.0,6/20,10.73%,BCL2;MCL1;GSK3B;BAX;APPL1;BCL2L1
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),-0.3364195713847948,-1.0865773645243346,0.3057471264367816,0.748031085188558,1.0,18/32,42.93%,CDK17;CDK14;CDK15;POLA1;HINFP;CDC45;E2F7;CDK5;PCNA;CCNE1;CDC6;KLF11;E2F1;RRM2;CDK18;TYMS;BACH1;CDT1
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.30627509998798585,1.0865146328472948,0.3190883190883191,0.7772886911434623,1.0,14/100,7.50%,PTPN13;FN1;SELP;PDGFRA;FGFR1;OSM;NEDD4;KIT;DCN;ROR1;HAX1;PDGFRB;STAMBP;IL18
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),-0.33535169684370875,-1.0864793259247434,0.3165829145728643,0.7472516772273383,1.0,11/36,19.63%,AQP11;RPL11;HSP90AB1;SDCBP;RYBP;BAG6;CCAR2;CAMLG;PARK7;N4BP1;EIF3H
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.2983581421949696,1.0862257142207936,0.3255172413793103,0.777247327315381,1.0,19/124,12.35%,TCF7L2;WNT4;PRICKLE1;SMURF2;FZD2;TNRC6B;PARD6A;PLCB3;CELSR1;PSMB10;TNRC6A;WNT5A;MOV10;PSMA3;PSME4;PSMA5;PPP3CB;MAP3K7;DVL3
prerank,pigment granule transport (GO:0051904),-0.39169097597714,-1.0860383999457217,0.3655913978494624,0.7465225456752216,1.0,12/18,41.97%,RAB27A;RAB27B;MLPH;BBS2;BBS7;MREG;RAB11A;MKKS;GPR143;RAB17;BBS5;BLOC1S3
prerank,melanosome transport (GO:0032402),-0.39169097597714,-1.0860383999457217,0.3655913978494624,0.7465225456752216,1.0,12/18,41.97%,RAB27A;RAB27B;MLPH;BBS2;BBS7;MREG;RAB11A;MKKS;GPR143;RAB17;BBS5;BLOC1S3
prerank,positive regulation of epithelial cell migration (GO:0010634),0.30963879942909656,1.0855647612652584,0.312874251497006,0.7782393742247115,1.0,14/92,8.87%,RIN2;ROCK2;SASH1;DOCK5;FGF1;FOXC2;GLIPR2;NRP1;ANXA3;ANGPT1;CLASP1;CTSH;WNT5A;INSL3
prerank,phosphatidylinositol biosynthetic process (GO:0006661),-0.26575979720779447,-1.0851488814252992,0.2670807453416149,0.7480245398653208,1.0,27/119,13.42%,PIP5K1B;INPP4B;EFR3B;PLCG2;ITPKB;INPP5D;PIK3R1;PIK3R6;MTMR6;PLEKHA1;PIK3C2B;BMX;PIK3R3;INPP5K;MPPE1;MTMR12;IP6K2;PIGM;PIGU;PI4K2A;IMPA1;FGF2;PIGQ;PIGH;DPM2;PIK3CD;CDIPT
prerank,regulation of macromolecule metabolic process (GO:0060255),0.286659836857539,1.0850025553535412,0.3038821954484605,0.7789763976508735,1.0,40/170,18.37%,ROCK2;PRDM6;AFF3;TRIM10;NELL1;TBC1D16;PRDM11;PTHLH;TRIM17;STOX1;IGF2BP1;MTMR3;TRIM5;RASA1;POGZ;NOVA1;TAPBP;FUBP1;RFXANK;IGF2BP2;IHH;NFKBIZ;TRIM21;CRNN;TRIM26;RNF39;ZNF462;AFF1;PRDM5;HNRNPDL;TXK;POU5F1;APP;AFF2;ARF1;AFF4;GDNF;C1D;BMI1;PCBP2
prerank,regulation of interferon-beta production (GO:0032648),0.3509298290349467,1.0848328942149754,0.33974358974358976,0.7786582137853605,1.0,10/46,14.55%,TRIM56;TLR4;RNF216;RIPK2;PPM1B;POLR3F;TLR2;OAS2;IFIH1;TBK1
prerank,insulin receptor signaling pathway (GO:0008286),-0.2877478062328415,-1.0848150365444544,0.3024523160762943,0.7479881744544228,1.0,17/69,12.91%,GRB14;BCAR3;ATP6V0A1;FOXO1;INSR;PIK3R1;GAB1;ATP6V1B2;PIK3R3;NAMPT;ATP6V0C;AKT1;SLC39A14;CAV2;ATP6V1D;BCAR1;FOXO4
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.30567768974366233,1.084723654282391,0.32748538011695905,0.7781404047466868,1.0,16/95,9.68%,UST;GPC6;CHST15;HSPG2;SDC2;ANGPT1;DCN;NDST1;OMD;DSE;CHSY1;NDST2;B4GALT1;GLCE;PRELP;GPC2
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),-0.46859636984647723,-1.0843642460912655,0.3720430107526882,0.748249275082782,1.0,5/10,20.95%,ESR1;PSMC3;HMGB1;PSMC6;PSMC5
prerank,regulation of cellular component size (GO:0032535),-0.3424681461178598,-1.0839441690457459,0.319047619047619,0.7484205742296943,1.0,12/30,27.45%,EPS8;RAP1GAP2;PPP1CA;VAV1;RAC1;RIN3;PEX11A;PPP1R15A;RAB3B;LAMTOR4;AP2M1;PEX11B
prerank,cAMP biosynthetic process (GO:0006171),0.48278721697552424,1.083472107217376,0.3815028901734104,0.780884208133542,1.0,3/10,7.01%,ADCY5;ADCY7;ADCY1
prerank,neutrophil mediated immunity (GO:0002446),-0.22292975181962124,-1.0834595426133453,0.1297709923664122,0.7487523930801085,1.0,88/432,15.28%,PTPRB;ATP8A1;PECAM1;PTPRJ;LRRC7;CST3;ATP6V0A1;HSPA8;RAB27A;PTPRN2;ACTR10;CD93;ATP11B;CTSC;CTSB;STK10;SNAP25;FTH1;STOM;DOCK2;TSPAN14;HEXB;FTL;PSMC3;ATP11A;EEF1A1;HMGB1;PKM;PRG2;PRCP;SRP14;CTSD;HSP90AB1;KPNB1;ATP6V0C;EEF2;SCAMP1;ACE;CEACAM1;SDCBP;TNFRSF1B;CTSS;PSMD14;DYNC1H1;PSMD3;B2M;ALDOC;MLEC;NEU1;ARL8A;CD53;QPCT;RHOG;GDI2;HMOX2;FCER1G;DBNL;PSMD6;ATP6V1D;NBEAL2;CAPN1;FRMPD3;NFASC;GPI;GUSB;HRNR;HSP90AA1;ACLY;PGLYRP1;GRN;LAIR1;CYBB;TMBIM1;RAC1;TNFAIP6;RAB5C;PLAUR;PNP;ATP6AP2;TMEM30A;GM2A;TUBB4B;ARHGAP45;PGAM1;PPIA;PTPRC;QSOX1;CFP
prerank,hexose transmembrane transport (GO:0008645),-0.38126160165094464,-1.0833179483776563,0.34615384615384615,0.7481469060615052,1.0,10/21,32.83%,SLC2A1;PPARD;SLC2A9;SLC50A1;SLC2A4;SLC45A3;SLC2A2;SLC2A10;SLC5A3;SLC2A3
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),-0.45938196640968804,-1.0829485837013153,0.3991683991683992,0.7482937037829949,1.0,5/11,20.91%,ST18;FAS;PLAUR;PARK7;PRR7
prerank,DNA integrity checkpoint signaling (GO:0031570),-0.3261189498577814,-1.0828646077546644,0.3194103194103194,0.7474795236207511,1.0,14/36,24.83%,INTS7;CLSPN;DOT1L;MAP3K20;ATM;HINFP;CDC45;RAD1;CHEK1;ATRIP;ATR;DONSON;FBXO6;RHNO1
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.36361114970283376,1.0822416782792246,0.3339222614840989,0.7834621688305803,1.0,7/33,8.89%,KANK2;DACT1;PLK5;CDC73;CCL2;CDKN2B;DLG1
prerank,cellular response to retinoic acid (GO:0071300),0.3511127914676491,1.0820283256340002,0.3374233128834356,0.78326592712754,1.0,8/42,8.47%,WNT6;WNT10B;WNT3A;EPHA3;PTK7;WNT5B;ZNF35;WNT5A
prerank,positive regulation of B cell activation (GO:0050871),-0.3057327435323017,-1.0820251590968197,0.3076923076923077,0.748892285803707,1.0,13/50,17.70%,MEF2C;TFRC;SH3KBP1;CD38;CD74;CD40;SYK;HMCES;PTPRC;CLCF1;NOD2;CD27;CD320
prerank,neutrophil degranulation (GO:0043312),-0.22357382270687565,-1.0819158494008165,0.13385826771653545,0.7482071376025968,1.0,87/425,15.28%,PTPRB;ATP8A1;PECAM1;PTPRJ;LRRC7;CST3;ATP6V0A1;HSPA8;RAB27A;PTPRN2;ACTR10;CD93;ATP11B;CTSC;CTSB;STK10;SNAP25;FTH1;STOM;DOCK2;TSPAN14;HEXB;FTL;PSMC3;ATP11A;EEF1A1;HMGB1;PKM;PRG2;PRCP;SRP14;CTSD;HSP90AB1;KPNB1;ATP6V0C;EEF2;SCAMP1;CEACAM1;SDCBP;TNFRSF1B;CTSS;PSMD14;DYNC1H1;PSMD3;B2M;ALDOC;MLEC;NEU1;ARL8A;CD53;QPCT;RHOG;GDI2;HMOX2;FCER1G;DBNL;PSMD6;ATP6V1D;NBEAL2;CAPN1;FRMPD3;NFASC;GPI;GUSB;HRNR;HSP90AA1;ACLY;PGLYRP1;GRN;LAIR1;CYBB;TMBIM1;RAC1;TNFAIP6;RAB5C;PLAUR;PNP;ATP6AP2;TMEM30A;GM2A;TUBB4B;ARHGAP45;PGAM1;PPIA;PTPRC;QSOX1;CFP
prerank,regulation of mitotic sister chromatid separation (GO:0010965),0.44015788648476284,1.0818400197146267,0.3542039355992844,0.7829886845303827,1.0,5/15,13.48%,TPR;ANAPC1;UBE2C;HECW2;CDC27
prerank,protein sumoylation (GO:0016925),0.346637625116044,1.0818162729061653,0.3355048859934853,0.7822433808160381,1.0,10/49,16.55%,EYA1;RANBP2;TPR;PIAS1;SUMO1;NSMCE2;EGR2;POM121;IFIH1;NUP37
prerank,post-Golgi vesicle-mediated transport (GO:0006892),-0.2697402814403663,-1.081665099647543,0.30618892508143325,0.7479006324979931,1.0,20/88,10.31%,EXOC6;HSPA8;SORCS1;FTH1;SORL1;FTL;SH3GL2;DOP1B;CLINT1;GOPC;EXOC4;CLVS1;SCAMP1;AP1S1;STEAP2;STXBP6;AP1S2;SCAMP2;CORO7;KLHL20
prerank,cellular sodium ion homeostasis (GO:0006883),-0.4146577805339045,-1.0814311480169017,0.37554585152838427,0.7475991522130522,1.0,5/15,9.49%,SLC12A2;ATP1B1;ATP1A1;SLC8A1;NEDD4L
prerank,cellular component assembly (GO:0022607),0.2726754554924436,1.0811111367808683,0.28465346534653463,0.7833762964357933,1.0,50/253,15.32%,KMT2A;DPYSL3;PAWR;LAMC1;SPTBN1;PARVA;CALD1;TEAD1;QRICH2;WNT3A;SHROOM2;MYO1B;FLNC;BAIAP2L1;CDAN1;MYO9A;ST13;CREBBP;FBLIM1;SNX9;RSPH9;TEAD2;SYCP2;WNT5A;YAP1;RHOQ;TAPBP;MNAT1;LIMA1;TUBGCP4;PPID;DNM1L;NLGN2;WDR19;EPPK1;HFE;TEX12;TUBGCP2;GORASP2;WASL;WASF1;RTN4;RHOU;MDM4;GEMIN5;P3H4;PML;ILK;BAIAP2;TOGARAM1
prerank,phosphatidylinositol-mediated signaling (GO:0048015),0.3215797587467208,1.0808657934770072,0.30505952380952384,0.7832286403221801,1.0,10/69,6.63%,PDGFRA;FGFR1;TPTE;GAB2;PLCD3;PI4KA;PLCE1;PDGFRB;PLCB3;PIK3C2A
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),-0.44724879216051155,-1.080114695250367,0.394273127753304,0.7503116451667117,1.0,5/11,15.57%,MERTK;GAS6;CXCL12;CCL19;NOD2
prerank,protein localization to kinetochore (GO:0034501),-0.4123228351467873,-1.0799506503463911,0.34549356223175964,0.7497719665987798,1.0,11/14,42.53%,RCC2;ZWILCH;CENPT;SPDL1;ZW10;CDK1;MIS12;BUB3;KNL1;AURKB;CHAMP1
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),-0.39744857007047074,-1.0799229642543398,0.3577586206896552,0.7488492282377883,1.0,2/17,3.12%,CTNNA2;NCKAP1
prerank,regulation of cardiac muscle cell action potential (GO:0098901),-0.36067007099110643,-1.0797011430199237,0.3438914027149321,0.7484938335616727,1.0,9/25,13.61%,CTNNA3;RYR2;NOS1AP;CALM1;CALM3;CAMK2D;FGF13;CAV1;ATP2A2
prerank,regulation of programmed necrotic cell death (GO:0062098),0.4174743076686699,1.0789477359659152,0.3720073664825046,0.7877530697366324,1.0,3/20,6.41%,NUPR1;CFLAR;BIRC3
prerank,regulation of MHC class II biosynthetic process (GO:0045346),0.47525139979960146,1.0787779922800746,0.3588709677419355,0.7873814956887073,1.0,5/11,26.26%,TAF7;HDAC2;XBP1;TMEM106A;JAK2
prerank,mesenchyme morphogenesis (GO:0072132),-0.4020118996395278,-1.0785585537352729,0.357630979498861,0.7507792932104338,1.0,7/17,14.61%,NOS3;TGFB2;NOTCH1;ACVRL1;TBX2;ACVR1;HEY1
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.3946222782138242,-1.0783775825655766,0.3595505617977528,0.7503029340695309,1.0,6/17,16.31%,COX6C;COX4I1;COX8A;NDUFA4;COX6A1;COX7B
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.2744263753239274,1.0779450135531194,0.29784537389100124,0.7888340637286142,1.0,44/234,14.46%,SMAD3;CAMK1D;DDR2;PLPP3;EIF2AK2;ZIC2;FER;TRAF5;ANXA3;FZD2;KIT;SLCO3A1;CFLAR;IL6;IKBKE;ROR1;TLR4;PRKCZ;MTDH;TRIM5;HDAC4;EDA;ADCY1;IL18;OPRD1;LGALS9;RIPK2;PHB2;WNT5A;STK3;CRTC1;UBE2V1;TLR2;IRAK3;CRTC3;MAP3K7;TRIM21;CRNN;TRIM26;MAP3K13;ARID5B;TICAM1;FLOT2;ALK
prerank,regulation of receptor-mediated endocytosis (GO:0048259),-0.3329611885729762,-1.0778058724186312,0.3488372093023256,0.7509170114475617,1.0,11/35,15.18%,SGIP1;HIP1;HIP1R;HNRNPK;B2M;LDLRAP1;SNAP91;CBL;TNK2;RAC1;CCL19
prerank,organic hydroxy compound transport (GO:0015850),-0.3259834943143016,-1.0773008748720383,0.32038834951456313,0.7514187390165222,1.0,5/36,8.59%,ABCC4;SLCO1C1;CEACAM1;SLC16A1;ATP8B1
prerank,negative regulation of Rho protein signal transduction (GO:0035024),0.42284862113282806,1.076425814284447,0.3736654804270463,0.7922253227599196,1.0,3/18,2.34%,HEG1;DLC1;KANK1
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.3982396192218307,1.0763042311615962,0.3590664272890485,0.7917503617408845,1.0,6/25,11.72%,FBXL17;ZYG11B;POMT2;KLHL15;UGGT2;CUL3
prerank,negative regulation of cell death (GO:0060548),-0.27109029343887064,-1.0763025615091386,0.29518072289156627,0.7533135659102405,1.0,39/88,32.03%,MECOM;PDE8A;CD34;SNCA;TM7SF3;CCN3;SORL1;CCN5;BMP4;AKT1;TNFRSF1B;PINK1;FGF2;PAX2;NPAS2;PARK7;PRKD1;BTBD10;HTR2B;PACRG;BNIP3L;SRGAP2;PSMC5;NUP62;SRSF6;CHMP2A;ADNP2;CDK5;EIF4G1;SOX11;WNT16;AMIGO2;CLU;RAD18;TRAF2;DCPS;GPNMB;MT3;TMEM109
prerank,cellular modified amino acid catabolic process (GO:0042219),0.4370084708536124,1.0755777384822995,0.35940409683426444,0.7929469059453931,1.0,6/15,20.73%,GGACT;ALDH4A1;SARDH;PRODH;DPEP1;HOGA1
prerank,regulation of immune response (GO:0050776),0.2931502557583042,1.0754621049336082,0.31456043956043955,0.7924711736940261,1.0,14/135,9.78%,CXADR;RSAD2;COL3A1;COLEC12;ICAM4;ADCY7;PTPN22;APPL2;FOXP3;VCAM1;BIRC3;IFITM1;ERAP1;APPL1
prerank,signal transduction in response to DNA damage (GO:0042770),-0.3029645871157552,-1.0752860891475347,0.29396325459317585,0.7552212819911017,1.0,17/49,24.83%,ACER2;INTS7;CLSPN;DOT1L;MAP3K20;ATM;HINFP;CASP9;RAD1;BCL3;CHEK1;E2F7;ATRIP;ATR;DONSON;FBXO6;RHNO1
prerank,regulation of receptor binding (GO:1900120),-0.4699791434619387,-1.0751629374917662,0.3987473903966597,0.7545657545453226,1.0,4/10,13.61%,ADAM15;ATP2A3;B2M;ATP2A2
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.40169331945548004,1.074993239077349,0.387037037037037,0.7921327129908085,1.0,6/21,17.31%,CUL4A;RPA3;GTF2H4;ERCC5;ERCC1;GTF2H2
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.40169331945548004,1.074993239077349,0.387037037037037,0.7921327129908085,1.0,6/21,17.31%,CUL4A;RPA3;GTF2H4;ERCC5;ERCC1;GTF2H2
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),0.4266978365173312,1.0748098925324714,0.37213740458015265,0.7918721387627465,1.0,7/17,15.47%,RBPJ;CREBBP;STAT1;PBX1;HEYL;MAML2;KAT2B
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.38574300813492624,1.073935807168324,0.39649122807017545,0.7935458365940812,1.0,5/27,11.67%,CTPS1;RRM1;NUDT13;AK5;RRM2B
prerank,lamellipodium organization (GO:0097581),-0.34250998056069343,-1.07390739834522,0.34236453201970446,0.7571935172953759,1.0,8/29,13.65%,PARVB;SPATA13;ARHGEF6;CCDC88A;S1PR1;PTPRO;ARHGEF7;RAC1
prerank,neuromuscular junction development (GO:0007528),0.40350372798292145,1.0735477860150968,0.35567970204841715,0.7938203858099065,1.0,6/24,9.85%,PDZRN3;NEDD4;UNC13B;LRP4;LRRK2;MUSK
prerank,inositol phosphate dephosphorylation (GO:0046855),-0.441608106202577,-1.0733602406345106,0.3522267206477733,0.7566320161811944,1.0,6/11,25.18%,INPP5K;IMPA1;IMPA2;INPP5J;INPP5B;SYNJ1
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),-0.441608106202577,-1.0733602406345106,0.3522267206477733,0.7566320161811944,1.0,6/11,25.18%,INPP5K;IMPA1;IMPA2;INPP5J;INPP5B;SYNJ1
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.3694243484199663,1.073111679457189,0.3422818791946309,0.7941694399361944,1.0,9/33,13.47%,ADAMTS1;ANXA1;GLI1;CCND3;CDC73;PHB2;ANKRD17;CRNN;PAF1
prerank,cellular response to chemokine (GO:1990869),0.3467257062605029,1.0728900227203741,0.3550387596899225,0.7940018353434469,1.0,6/46,7.77%,CXCL10;STK39;OXSR1;FOXC1;CCL2;ACKR3
prerank,formation of extrachromosomal circular DNA (GO:0001325),0.48115408092455747,1.0725873330201021,0.3822314049586777,0.7923956026539354,1.0,5/10,19.43%,WRN;SLX4;ERCC1;SMARCAL1;DNA2
prerank,t-circle formation (GO:0090656),0.48115408092455747,1.0725873330201021,0.3822314049586777,0.7923956026539354,1.0,5/10,19.43%,WRN;SLX4;ERCC1;SMARCAL1;DNA2
prerank,telomere maintenance via telomere trimming (GO:0090737),0.48115408092455747,1.0725873330201021,0.3822314049586777,0.7923956026539354,1.0,5/10,19.43%,WRN;SLX4;ERCC1;SMARCAL1;DNA2
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.3854250683183281,1.0721510551604942,0.3618881118881119,0.7927532916507758,1.0,8/24,15.77%,VTN;ITGA5;NEDD4;ARNT;CADM4;PTPN1;NIBAN2;PRKD2
prerank,response to cAMP (GO:0051591),-0.3220903461420433,-1.0718675426435833,0.32839506172839505,0.7599910636303847,1.0,8/37,12.24%,AKAP6;HCN1;SLC5A5;INPP5K;HCN2;RAPGEF2;PDE2A;KCNQ1
prerank,cilium assembly (GO:0060271),0.2656210547366553,1.071691638077502,0.2978723404255319,0.7931619796200519,1.0,77/296,21.93%,DCDC2;TNPO1;NINL;PARVA;SPATA6;CYS1;ASAP1;DYNLL1;ALMS1;ARL13B;SDCCAG8;RFX3;IFT88;ARL3;CLASP1;TTC39C;HYLS1;IFT57;ARF4;TMEM107;CEP152;EXOC2;DYNC2I1;DNAAF1;NPHP1;CCDC13;HAUS8;C2CD3;RSPH9;NUDCD3;IFT81;DYNC2LI1;CC2D2A;NEDD1;CDC14A;CCDC57;RPGRIP1L;WDR19;RAB3IP;CFAP221;IQCB1;IFT20;TRAPPC14;FBF1;CCDC66;RFX2;NPHP3;ACTR1A;CEP250;TOGARAM1;CPLANE1;GBF1;AVIL;TTBK2;GAS8;EXOC7;EXOC1;YWHAE;TTC21B;RPGR;IFT52;ARL6;CCDC39;WDR11;KIF3C;CEP131;CEP63;SSX2IP;CEP78;B9D2;OFD1;RP2;ACTR3;TRIP11;DZIP1L;PKD1;LZTFL1
prerank,peptidyl-lysine methylation (GO:0018022),0.385880324905404,1.07158503550957,0.37542087542087543,0.7926515877192032,1.0,11/26,26.96%,METTL21C;ETFBKMT;SETD4;SETD7;ATPSCKMT;SETD2;SMYD3;EHMT2;SUV39H1;SETD6;SMYD2
prerank,phospholipid biosynthetic process (GO:0008654),-0.3228104937899785,-1.071529701885505,0.34285714285714286,0.7598456450198485,1.0,15/36,28.11%,SGMS1;SRD5A3;MBOAT1;PCYT2;NUS1;SGMS2;DOLPP1;CPNE7;AGPAT5;CLN3;DHDDS;FADS1;HDHD5;MVD;SAMD8
prerank,response to axon injury (GO:0048678),0.41936151446533443,1.0710830153311333,0.39365671641791045,0.7932253380613717,1.0,2/18,5.80%,DPYSL3;NREP
prerank,regulation of cellular response to heat (GO:1900034),-0.28207140112072904,-1.071080557583833,0.32212885154061627,0.760191505774398,1.0,27/77,26.61%,HSPA8;CD34;MAPK3;HSP90AB1;CAMK2D;BAG1;CAMK2A;HSBP1;CCAR2;ATM;AAAS;NUP93;AKT1S1;HSP90AA1;RAE1;MAPT;FKBP4;MLST8;BAG4;NUP62;ATR;NUP188;NUP54;CAMK2G;NUP210;NUP42;NUP153
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),0.4474676730485235,1.0706841693612352,0.39883268482490275,0.7935172553762478,1.0,3/13,10.14%,SP100;TPR;SUFU
prerank,glutamate metabolic process (GO:0006536),-0.3801162179803219,-1.0704591375349235,0.3678646934460888,0.7610253359245399,1.0,6/19,21.90%,ALDH5A1;GCLC;GLS;GLS2;GGT1;MTHFS
prerank,cell cycle G2/M phase transition (GO:0044839),0.2905745013477345,1.0704320501666609,0.3283173734610123,0.7934202078532351,1.0,40/129,21.56%,PHLDA1;NINL;DYNLL1;FBXL17;ALMS1;SDCCAG8;CLASP1;OPTN;CEP152;HAUS8;FBXL3;CDKN2B;CCNH;MNAT1;CDK7;PPP1R12B;FBXL7;PPP1CB;NEDD1;NES;CCDC57;BTRC;MASTL;FBXW11;KDM8;ACTR1A;CEP250;FBXL12;YWHAE;PPP2R2A;CCNY;CEP131;KHDRBS1;AJUBA;CEP63;CEP78;PKMYT1;OFD1;CHEK2;CUL1
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),-0.35659137460530865,-1.070263136530296,0.35964912280701755,0.7606118260130648,1.0,7/26,16.20%,EFNA5;ANO1;EPHA5;KLF7;LRP5;BRSK2;ADCY8
prerank,regulation of erythrocyte differentiation (GO:0045646),0.3621833933895856,1.0701351734103113,0.36860670194003525,0.7934312388030702,1.0,8/35,11.85%,STAT5B;ARNT;BRD1;STAT1;FAM210B;MAFB;MAPK14;FOXO3
prerank,cellular response to acid chemical (GO:0071229),-0.3431582677408719,-1.0694978940103879,0.3493150684931507,0.7618937302892062,1.0,11/27,26.20%,KLF2;VEGFA;RRAGB;CPEB4;SPAAR;RRAGC;GLRA2;GLRA1;LAMTOR2;NSMF;LAMTOR4
prerank,erythrocyte differentiation (GO:0030218),0.34436967899425897,1.0694338031200317,0.3705501618122977,0.7945466632847832,1.0,13/44,18.98%,TGFBR3;MPIG6B;KIT;UBA5;PTPN2;ACIN1;SH2B3;ALAS2;INHA;HSPA9;CASP3;ATP5IF1;DMTN
prerank,phospholipid metabolic process (GO:0006644),0.3185934850504943,1.0692716811193865,0.3389570552147239,0.7941545235563724,1.0,9/71,11.23%,SMPD3;PLA2G4A;PLPP3;APOA2;AGPAT4;PLA2G4C;PLPPR3;ENPP2;AGPAT3
prerank,regulation of JUN kinase activity (GO:0043506),0.37263415471573197,1.06837767181778,0.363013698630137,0.7957622977593355,1.0,8/33,12.35%,SASH1;DUSP10;TAOK3;PTPN22;PPEF2;HIPK3;MAP3K7;DVL3
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),0.3169204011534645,1.0683469588782109,0.3560371517027864,0.79501682880809,1.0,22/72,20.65%,POLR2D;CUL4A;RFC1;CCNH;MNAT1;CDK7;RPA3;XRCC1;TCEA1;POLR2C;PRPF19;POLR2F;GTF2H4;ERCC5;ERCC6;ERCC1;GTF2H2;UVSSA;USP7;ERCC8;POLR2K;POLD3
prerank,cytokine-mediated signaling pathway (GO:0019221),0.2539244415366338,1.0679090092309318,0.29003359462486,0.7954515986065454,1.0,97/532,16.17%,RORA;LEPR;TEC;RSAD2;FN1;CXCL10;SP100;IL16;GHR;IL31RA;GBP2;FOXC1;STAT2;IL6ST;GAB2;OSM;VIM;IL11;ANXA2;FER;TRAF5;IFIT2;IL34;ANXA1;KIT;TNFSF15;STAT5B;BRWD1;IFI35;IL6;BCL2;MCL1;APPL2;PELI2;TRIM5;VCAM1;TNFRSF12A;BIRC3;BST2;NOS2;SNRPA1;EDA;OASL;IL18;OPRD1;STAT1;CCL2;ACKR3;TNFRSF14;RIPK2;PSMB10;YAP1;ZEB1;PSMA3;IL13RA1;PSME4;CNN2;IFITM1;APPL1;PSMA5;IFNLR1;PTPN6;BCL2L1;UBE2V1;OAS2;IRAK3;SMAD4;STAT4;SH2B3;FOXO3;IFI27;CSF1;ADAR;MAP3K7;TRIM21;IFIT1;BTRC;FBXW11;TRIM26;JAK1;IL22;POU2F1;RHOU;IFIT3;GREM2;CCL25;PML;ILK;SMARCA4;IL23R;SOCS6;HNRNPDL;IRF9;ICAM1;IFNAR2;MUC1;HSPA9
prerank,peptidyl-serine phosphorylation (GO:0018105),0.28367693632447,1.0676801876446733,0.3209054593874834,0.795277536274965,1.0,38/153,18.60%,PDPK1;ROCK2;CAMK1D;STK32B;STK39;IKBKE;PRKCZ;TOP1;LATS2;TGFBR1;MORC3;TGFBR2;MAP4K1;GSK3B;LRRK2;TLK2;MAPK14;AKT3;HIPK3;RPS6KA3;MASTL;MAP3K13;MAPK9;WNK1;MAPKAPK5;TBK1;CSNK2A2;EIF2AK3;STK4;PKN2;PRKD2;TTBK2;MKNK2;RICTOR;SMG1;DMPK;MAPKAPK3;RPS6KB2
prerank,negative regulation of interleukin-8 production (GO:0032717),0.4186366682858681,1.0676625984329906,0.3886861313868613,0.7945269484067246,1.0,5/17,13.07%,ANXA1;PTPN22;ANXA4;MAP2K5;ARRB1
prerank,negative regulation of extracellular matrix organization (GO:1903054),-0.46509500015611527,-1.0674491748603179,0.37393162393162394,0.7666870447097548,1.0,5/10,8.00%,CST3;NOTCH1;FAP;EMILIN1;TNFRSF1B
prerank,stress granule assembly (GO:0034063),-0.37275606851171117,-1.0672215474284443,0.3786848072562358,0.7663641808013697,1.0,4/20,8.39%,RPS23;ATXN2;YTHDF2;DYNC1H1
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.29033231107862717,1.0668156759303948,0.332421340629275,0.7960987626249398,1.0,40/128,21.56%,PHLDA1;NINL;DYNLL1;FBXL17;ALMS1;SDCCAG8;CLASP1;OPTN;CEP152;HAUS8;FBXL3;CDKN2B;CCNH;MNAT1;CDK7;PPP1R12B;FBXL7;PPP1CB;NEDD1;NES;CCDC57;BTRC;MASTL;FBXW11;KDM8;ACTR1A;CEP250;FBXL12;YWHAE;PPP2R2A;CCNY;CEP131;KHDRBS1;AJUBA;CEP63;CEP78;PKMYT1;OFD1;CHEK2;CUL1
prerank,peroxisomal membrane transport (GO:0015919),-0.34308179102538505,-1.0665205357153624,0.36596736596736595,0.767428652569712,1.0,15/27,34.73%,ABCD4;ATAD1;PEX26;GDAP1;PEX10;ABCD2;PEX16;PEX19;PXMP4;RAB8B;PEX3;PEX11B;ALDH3A2;PEX1;PEX13
prerank,protein targeting to mitochondrion (GO:0006626),-0.29825498015478596,-1.0664914903183862,0.34554973821989526,0.766508166590409,1.0,16/52,22.67%,MFF;HSPA4;MFN2;GDAP1;SAMM50;TIMM8B;HSP90AA1;DNLZ;GRPEL2;AIP;TOMM40L;TOMM20;TIMM22;IMMP2L;NDUFA13;TIMM10
prerank,muscle cell migration (GO:0014812),-0.44501075567684556,-1.0664415216222276,0.38065843621399176,0.7656536826433091,1.0,7/10,34.44%,SIX1;CCN3;MEGF10;THBS4;DDR1;ITGB1BP1;AAMP
prerank,sodium ion transmembrane transport (GO:0035725),-0.27237158580389365,-1.0651549898181838,0.3391812865497076,0.7683446169860186,1.0,12/84,6.69%,SLC6A6;SLC12A2;SLC9A2;ATP1B1;SLC24A2;SLC6A1;SCN1A;HCN1;ATP1A1;SLC8A1;HCN2;SCN2A
prerank,activation of phospholipase C activity (GO:0007202),0.3799761953449995,1.0651150877860054,0.38669064748201437,0.8000703164388747,1.0,7/29,15.64%,ARHGAP6;LPAR1;PHB2;NMUR1;P2RY6;BDNF;TXK
prerank,negative regulation of protein localization to nucleus (GO:1900181),0.4172273306744474,1.0648724256481619,0.3970315398886827,0.7999226854396887,1.0,4/18,10.14%,LATS2;CTNNA1;GSK3B;SUFU
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),-0.39400534517697483,-1.064839590361106,0.38137472283813745,0.7682565215457534,1.0,6/17,29.71%,AKT1;PPIA;SOD1;TREM2;VNN1;HSPB1
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),-0.4453592161640346,-1.064568801775612,0.385395537525355,0.7680203963203854,1.0,2/11,4.39%,SLIT2;CCN3
prerank,T cell migration (GO:0072678),0.4577133340612112,1.064452158708549,0.39311594202898553,0.8002892245514983,1.0,2/13,1.76%,CXCL10;CXCL16
prerank,homotypic cell-cell adhesion (GO:0034109),0.3575406282300001,1.0644450233980016,0.36394557823129253,0.799508039389954,1.0,8/39,10.49%,FN1;PDGFRA;PLPP3;GP1BA;VCL;CSRP1;DSC2;PLEK
prerank,modification-dependent protein catabolic process (GO:0019941),0.2774632774514552,1.06436801523485,0.3324572930354796,0.7989189045906341,1.0,37/193,15.98%,RNF213;SPSB1;SMURF2;RNF217;FBXO11;TRIP12;NEDD4;TTC3;RC3H1;RNF19A;SPSB4;SIAH2;DTX3L;ANAPC11;NTAN1;RNF20;KLHL15;NUB1;RNF111;ANAPC1;AMFR;UBR4;UBE2C;FBXL7;KEAP1;CUL3;BTRC;ARRB1;CDC27;BFAR;RNF43;FBXL4;RCHY1;BIRC6;UBE2R2;RNF146;RNF185
prerank,I-kappaB phosphorylation (GO:0007252),0.4718824300687904,1.0641436296270945,0.39807692307692305,0.7987281273605795,1.0,3/10,12.26%,TLR4;TLR2;MAP3K7
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),-0.39577736660967033,-1.0641267656007987,0.3778801843317972,0.7683017715658997,1.0,2/17,1.17%,PRKG1;MEF2C
prerank,negative regulation of response to stimulus (GO:0048585),0.3289845885599375,1.0639449249459145,0.36553945249597425,0.7984568156697662,1.0,8/60,6.03%,IGFBP3;COL3A1;MPIG6B;CASK;TERT;APPL2;NR1H3;FOXP3
prerank,response to steroid hormone (GO:0048545),0.37027528671912124,1.063801253984379,0.3696763202725724,0.7980263235358389,1.0,5/31,9.42%,TFPI;ATP1A2;NR1H3;YAP1;CATSPER4
prerank,glycolipid metabolic process (GO:0006664),-0.3050164351200433,-1.0636405703639156,0.3573200992555831,0.7686523200920473,1.0,10/47,14.61%,ST6GALNAC3;ST3GAL6;ST8SIA6;HEXB;GLTP;ST6GALNAC4;NEU1;CERK;GM2A;ST3GAL4
prerank,regulation of myotube differentiation (GO:0010830),-0.3488624845707534,-1.063583231283121,0.3656884875846501,0.7678352689850121,1.0,6/24,9.20%,NOTCH1;CCN3;ATP11A;HDAC9;SIK1;HDAC1
prerank,positive regulation of transferase activity (GO:0051347),-0.25217491723931734,-1.0635777596250433,0.2733812949640288,0.7668607761258416,1.0,35/142,14.70%,TEK;MERTK;ERBB4;TIE1;SERINC1;INSR;EPHA5;KDR;NTRK2;FLT1;PRKCQ;MET;NEK7;SORL1;EPHB1;PARM1;CTNNB1;SERINC5;MRE11;MAPK3;HSP90AB1;RPS2;PINK1;EPHA6;CD74;RET;DCUN1D2;NVL;EGFR;KLF4;HSP90AA1;CSF1R;DCUN1D5;DCUN1D1;PNKP
prerank,regulation of glycogen biosynthetic process (GO:0005979),0.3904974234504091,1.0635649921264894,0.3858407079646018,0.7978720343454365,1.0,5/24,8.99%,ENPP1;SORBS1;EPM2AIP1;GSK3B;IGF2
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.34184249539308886,1.0634137527868648,0.35426731078904994,0.7975139378877953,1.0,4/47,6.08%,WNT4;ROCK2;CRY1;ATP2B4
prerank,cellular response to organic cyclic compound (GO:0071407),0.28849999177275953,1.063216500879682,0.35207496653279785,0.79720413414793,1.0,28/141,16.82%,RORA;TFPI;ATP1A2;ROCK2;DIAPH1;IGFBP5;NCOA3;ADCY5;SSH1;CTNNA1;ADCY1;SPIDR;IL18;CCL2;FAM210B;LRRK2;TIPARP;P2RY6;NR3C1;CIB2;SLC26A6;P2RY1;ADCY6;PKD2;GNG2;URI1;P2RX4;RAPGEF3
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),-0.3987546087549001,-1.06302663571742,0.37199124726477023,0.7674434914034298,1.0,2/16,7.92%,CLDN5;CLDN14
prerank,digestive tract morphogenesis (GO:0048546),0.44490020276538744,1.0630036828212073,0.39299610894941633,0.7969861308378603,1.0,2/14,4.69%,PDGFRA;GLI1
prerank,negative regulation of viral entry into host cell (GO:0046597),-0.42805360611666143,-1.0627847014689704,0.38074398249452956,0.7671915239539915,1.0,5/12,15.41%,LY6E;SNX3;MID2;IFITM3;IFITM2
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.3701165993773234,1.0624395911498257,0.35800344234079173,0.7976649574234399,1.0,10/30,18.98%,PARP14;PRKCZ;PTPN2;MVP;PTPN6;SH2B3;CADM4;NF2;PPP2CA;DMTN
prerank,protein K48-linked ubiquitination (GO:0070936),0.33291399221247275,1.0621142402221493,0.3518225039619651,0.7977422045274518,1.0,14/54,15.52%,RNF152;TTC3;RNF216;DTX3L;AMFR;UBE2C;FBXO38;CUL3;IFI27;UBE2E3;UBE2Q2;BFAR;UBE2R2;RNF146
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.3071941715666992,1.0620808418781658,0.3466666666666667,0.7970349360529377,1.0,20/88,16.03%,SAMD4A;EIF2AK2;IGFBP5;SHMT1;NELL1;CSTB;DAPK1;IGF2BP1;NANOS2;SERPINE2;DNAJC1;IGF2BP2;EIF4ENIF1;ILF3;DDX6;PLAT;GIGYF2;EIF2AK3;CNOT9;CPEB3
prerank,regulation of adenylate cyclase activity (GO:0045761),-0.36081688928927247,-1.0616613875681764,0.36995515695067266,0.7694445263730316,1.0,3/22,3.31%,GRM3;CAP2;GABBR2
prerank,renal absorption (GO:0070293),-0.45812629987969705,-1.0610834596684962,0.38846153846153847,0.7701563848216716,1.0,3/10,12.24%,KLHL3;SLC15A2;KCNQ1
prerank,neural crest cell migration (GO:0001755),0.35609683413836096,1.0609933113840933,0.3793103448275862,0.7992141307115554,1.0,5/36,6.28%,SEMA3D;FN1;RADIL;NRP1;SEMA4B
prerank,embryo development ending in birth or egg hatching (GO:0009792),-0.3980962029139687,-1.0608200613641408,0.3760869565217391,0.7699285427062581,1.0,3/15,2.61%,STOX2;TGFB2;CELF4
prerank,dephosphorylation (GO:0016311),0.2805894005432193,1.060419843368767,0.3548387096774194,0.8000145092901896,1.0,33/147,12.79%,PTPN13;PLPP3;TPTE;PPM1E;PPM1A;DUSP10;PTPN14;PTPN4;DUSP28;PTPN3;PTPN22;PTPRA;MTMR3;DUSP16;PTPN9;SSH1;PTPN21;PPEF2;PPP4R2;CTDSP2;PLPPR3;NT5C;PPP4R1;PPM1B;PTPN6;PPP1CB;PTPRU;PPP3CB;DUSP5;BTRC;PTPN1;PTPN18;FBXW11
prerank,response to ATP (GO:0033198),-0.3848314152787605,-1.0603451823009153,0.37831858407079644,0.7702787176022924,1.0,3/18,4.62%,TRPC3;ABCC9;RYR3
prerank,carnitine metabolic process (GO:0009437),0.4566350741663736,1.0601436372769342,0.404296875,0.8000033054486035,1.0,2/12,9.64%,SHMT1;TMLHE
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.3083050929301974,1.0601150522144231,0.3558823529411765,0.7992888915580619,1.0,27/84,22.77%,SAMD4A;EIF2AK2;IGFBP5;SHMT1;RTN1;DAPK1;IGF2BP1;NANOS2;IGF2BP2;EIF4ENIF1;ILF3;DDX6;RTN4;GIGYF2;EIF2AK3;CNOT9;CPEB3;ABCA7;FXR2;DHX36;NANOS1;ROCK1;RNF139;GGA3;EPRS1;NCL;GAPDH
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.3056993759329852,1.0598651997275015,0.3562231759656652,0.7992187585328021,1.0,18/95,14.46%,CXCL10;AXL;LDOC1;VIM;IL6;TLR4;SERPINE1;NR1H3;CDC73;CCL2;LY96;CD274;WNT5A;MAPK14;TLR2;PAF1;TICAM1;PABPN1
prerank,protein homotetramerization (GO:0051289),0.3320056689215922,1.0597770646606917,0.34551495016611294,0.798711312410867,1.0,4/49,6.33%,ALDH1A2;SHMT1;APPL2;GBP5
prerank,DNA dealkylation (GO:0035510),0.4759805425196677,1.0593204773347111,0.39097744360902253,0.7984190712387984,1.0,4/10,16.28%,ASCC3;FTO;ALKBH1;MGMT
prerank,DNA dealkylation involved in DNA repair (GO:0006307),0.4759805425196677,1.0593204773347111,0.39097744360902253,0.7984190712387984,1.0,4/10,16.28%,ASCC3;FTO;ALKBH1;MGMT
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),0.4551547134398426,1.058576007017372,0.4041353383458647,0.7996815586586219,1.0,3/12,8.99%,SORBS1;PRKCZ;IGF2
prerank,necroptotic process (GO:0070266),0.4235508656745702,1.0584698595463415,0.37777777777777777,0.7992062967413527,1.0,6/16,21.65%,TLR4;LY96;DNM1L;TICAM1;TRPM7;RIPK1
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),-0.3970560643495896,-1.0579932978433093,0.3900226757369615,0.7761703303456728,1.0,15/16,51.12%,CYRIB;CEACAM1;PTPRC;STX7;LILRB1;FADD;IL12A;IL12RB1;IL23A;KLRD1;IL12B;RIPK3;XCL1;KLRC1;AGER
prerank,TOR signaling (GO:0031929),-0.347764200286115,-1.0572727752092734,0.38333333333333336,0.7773078502811732,1.0,5/26,8.21%,PRR5L;RPS6;CCDC88A;AKT1;PINK1
prerank,anterior/posterior pattern specification (GO:0009952),0.3316257070847296,1.0572458874841781,0.36490683229813664,0.801705435296772,1.0,12/53,16.33%,WLS;HOXC6;HOXC4;BMP2;TGFBR1;TIFAB;SKI;HEYL;BHLHE41;HOXB4;ACVR2B;SMAD2
prerank,regulation of ion transmembrane transporter activity (GO:0032412),-0.3122483307650952,-1.0564549310311533,0.3497536945812808,0.7787897057872021,1.0,9/39,9.86%,CHRM3;FGF12;FXYD5;HOMER1;UTRN;YWHAH;TRPC6;NEDD4L;CACNA1D
prerank,positive regulation of telomere capping (GO:1904355),-0.38062128445308263,-1.0563204360808383,0.3897216274089936,0.7781909154142101,1.0,5/17,16.15%,PRKCQ;NEK7;MAPK3;PNKP;PKIB
prerank,potassium ion export across plasma membrane (GO:0097623),0.4491492134237363,1.0562685013642346,0.4232209737827715,0.8035898883488858,1.0,1/13,0.51%,KCNT2
prerank,negative regulation of apoptotic process (GO:0043066),0.2548231914009923,1.0561783455176583,0.31285551763367464,0.8030596787429115,1.0,83/444,16.28%,PDPN;FHL2;FSTL1;ARHGAP10;RNF213;TLE1;AXL;NOTCH2;PRKAA2;OSR1;IL31RA;ZFAND6;NUPR1;IL6ST;PHIP;GATA6;PRAP1;SNX6;NFATC4;SH3RF1;ITGA5;ANXA1;ANGPT1;CFLAR;IL6;BCL2;ARAF;MTDH;MCL1;HAX1;SIAH2;ARF4;ANXA4;BIRC3;RASA1;CTSH;GLO1;NGFR;GSK3B;CCL2;ANXA5;RIPK2;PHB2;WNT5A;YAP1;UBE2Z;NAA16;USP47;SMAD6;DNAJC3;HIPK3;GRK5;BCL2L1;TJP1;FNIP1;PTK2;NAA15;MAP2K5;EGR3;DSTYK;RPS6KA3;API5;SUPV3L1;OPA1;CBX4;TMEM14A;BDNF;BFAR;ERCC5;IFIT3;NUAK2;VHL;NIBAN2;BIRC6;HDAC2;CSNK2A2;FIGNL1;KDM2B;DAB2;TAF9;IGF1R;HSPA9;MGMT
prerank,regulation of androgen receptor signaling pathway (GO:0060765),-0.3372428335476544,-1.056029698339181,0.3691275167785235,0.7780180135587674,1.0,7/30,14.75%,H3-3A;PKN1;HDAC6;HDAC1;TRIM68;KDM4C;PARK7
prerank,cell differentiation in hindbrain (GO:0021533),-0.4466456833858321,-1.0560056547480527,0.40836653386454186,0.7770956197855535,1.0,1/11,0.38%,GRID2
prerank,cell junction organization (GO:0034330),0.3131136936868004,1.0556919671573708,0.3653250773993808,0.8035330617475712,1.0,9/71,7.37%,SDK1;SDK2;SMAD3;CXADR;FLNC;MYO9A;LRP4;FBLIM1;CLDN1
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),-0.2967935285384797,-1.0548230523753568,0.35149863760217986,0.7796184997996799,1.0,15/51,12.25%,CNTNAP2;TNIK;GPM6A;NCKAP1;TRIO;PAK1;NYAP2;DAB2IP;DCLK1;SHTN1;UBB;MINK1;DBNL;ALS2;NGF
prerank,regulation of leukocyte activation (GO:0002694),-0.4142805103257883,-1.0546486622168332,0.39655172413793105,0.7791389103668042,1.0,5/14,21.87%,MFHAS1;CD74;LYN;MYO18A;MIF
prerank,regulation of DNA biosynthetic process (GO:2000278),-0.3470352649680094,-1.0545019966065463,0.38095238095238093,0.7786250273783962,1.0,7/27,15.23%,DACH1;BMPR2;ACVRL1;ATM;FGF2;RGCC;CDKN1A
prerank,nucleoside diphosphate metabolic process (GO:0009132),0.4421184242005078,1.0544611118936837,0.40111940298507465,0.8061258850033619,1.0,3/15,9.45%,CMPK2;ENTPD7;AK5
prerank,positive regulation of natural killer cell activation (GO:0032816),0.4526381638897726,1.0544431276915258,0.4011299435028249,0.8053824466591034,1.0,4/13,15.47%,AXL;IL18;TICAM1;IL23R
prerank,positive regulation of immune response (GO:0050778),0.32032428735482393,1.0540827069317107,0.37161084529505584,0.8054888525268978,1.0,7/64,7.85%,RSAD2;IL6ST;FPR2;MYB;IFI35;GBP5;LGALS9
prerank,cellular response to ketone (GO:1901655),0.36238332533942313,1.0540526299641428,0.37373737373737376,0.8047968939878495,1.0,9/35,17.32%,ROCK2;ADCY5;ADCY1;MAP4K1;KLF9;NR3C1;ADCY6;GNG2;PCK2
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),-0.4364433918397922,-1.0540315805049223,0.4054621848739496,0.7788901013493144,1.0,4/10,16.37%,DGKH;GAP43;PLPP1;HTR2B
prerank,regulation of protein secretion (GO:0050708),0.2909315765011071,1.0538995723219415,0.3587570621468927,0.804409097459715,1.0,14/119,10.58%,BMP6;DPP4;RAPGEF4;RSAD2;ITPR1;RFX3;APBB1;IL6;UNC13B;NOS2;CACNA1C;DNAJC1;PPID;DNM1L
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),-0.2983085915573277,-1.0538642085018037,0.37142857142857144,0.7783450378862363,1.0,13/50,14.75%,THBS1;GAS6;SNCA;ARL6IP1;AKT1;RFFL;VEGFA;PAX2;RPS6KA1;NGF;KLF4;PLAUR;PARK7
prerank,maintenance of protein localization in organelle (GO:0072595),-0.37395609684446035,-1.0536085650388374,0.38177874186550975,0.7780974769184587,1.0,9/19,22.69%,AKT1;TAF3;PINK1;TAF8;HSPA5;BCL3;ARL2;SKP1;CHCHD10
prerank,fatty acid biosynthetic process (GO:0006633),-0.2832075826238718,-1.0534816394965962,0.34054054054054056,0.7774945971310576,1.0,34/63,43.97%,ELOVL5;ABHD2;ELOVL7;TECR;ACACA;TECRL;ACLY;SCD;ACSBG1;HACD3;LPL;HSD17B8;HPGD;MCAT;FADS1;LIPH;LIPC;ELOVL2;ALOX5;LIAS;CYP2E1;ACOT7;OLAH;GSTM4;GPX4;CBR4;ABCD1;DEGS1;CYP1A1;LTC4S;ACSM3;ELOVL4;ELOVL6;ALOX12
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.33191952073750464,1.0534539298296548,0.3878887070376432,0.8048840948940956,1.0,7/49,8.81%,KMT2A;MTURN;TNRC6B;GP1BA;KMT2C;TNRC6A;MOV10
prerank,protein modification by small protein conjugation or removal (GO:0070647),0.44121282032198644,1.053396009951246,0.4149139579349904,0.8042714821907806,1.0,6/13,25.87%,UBA5;SENP6;ATG10;ATG7;DESI1;DESI2
prerank,GPI anchor biosynthetic process (GO:0006506),-0.33309509576729235,-1.05325511103541,0.3548387096774194,0.7771925354753193,1.0,8/30,15.91%,MPPE1;PIGM;PIGU;PIGK;PIGQ;PIGH;DPM2;PIGO
prerank,oligodendrocyte development (GO:0014003),-0.39801140209271846,-1.052909384180536,0.3788546255506608,0.7772358401264235,1.0,7/15,33.41%,PLP1;EIF2B2;TPPP;B4GALT6;CNTNAP1;PRDM8;B4GALT5
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.3716426047533616,1.0527476179371722,0.3905429071803853,0.8052549062093346,1.0,9/29,19.03%,CUL4A;CCNH;MNAT1;CDK7;RPA3;GTF2H4;ERCC5;GTF2H2;XPC
prerank,negative regulation of cellular protein catabolic process (GO:1903363),0.4771579811801891,1.0525761710308787,0.40643863179074446,0.8049286870292767,1.0,4/10,12.74%,ANXA2;NELL1;EPHA4;EFNA1
prerank,negative regulation of DNA biosynthetic process (GO:2000279),-0.3457519122781416,-1.0525572429617833,0.3722627737226277,0.77731684230313,1.0,8/30,18.28%,DACH1;BMPR2;ACVRL1;TERF1;GNL3L;CDKN1A;MEN1;TINF2
prerank,membrane raft organization (GO:0031579),0.4326834247577719,1.0520024797783278,0.408203125,0.8056346715594425,1.0,6/15,17.50%,ANXA2;S100A10;NPC1;MYADM;FLOT2;ABCA7
prerank,autonomic nervous system development (GO:0048483),0.41389225892056114,1.0519319092919075,0.3989169675090253,0.8050265356706451,1.0,2/17,2.97%,FN1;NRP1
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",-0.2921258660642563,-1.0519251422882123,0.372972972972973,0.7781489155891615,1.0,10/52,8.42%,NOVA2;MBNL1;CELF4;KHDRBS2;RBFOX3;RBFOX1;PTBP1;PUF60;KHDRBS3;DDX17
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),0.43836655421396586,1.0518196324528448,0.4071969696969697,0.8045317734665508,1.0,3/13,10.49%,BMP2;DKK3;PLEK
prerank,membrane depolarization during action potential (GO:0086010),-0.3491010602338954,-1.0517548639872545,0.39086294416243655,0.7776967033676484,1.0,10/26,11.70%,KCNJ2;SCN1A;SLC8A1;HCN2;SCN2A;CACNA1G;YWHAH;CACNA1D;SCN8A;SCN9A
prerank,regulation of axonogenesis (GO:0050770),0.3335073540825848,1.0512565442168498,0.379585326953748,0.8052530497952342,1.0,8/51,8.24%,PLXNA2;ROBO1;TIAM2;MAP6;LRP4;NGFR;GSK3B;EPHA4
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),-0.3283376874527893,-1.0511111571983756,0.37740384615384615,0.77851971818249,1.0,8/32,17.26%,PRKCQ;NEK7;CTNNB1;MAPK3;ATM;PNKP;PKIB;CCT5
prerank,regulation of apoptotic process (GO:0042981),0.24701069258090916,1.0508617678297845,0.32282608695652176,0.8054967800061879,1.0,116/676,14.82%,IGFBP3;PDPN;FHL2;PAWR;TIAM2;AKAP13;FSTL1;ARHGAP10;PHLDA1;CXCL10;AXL;NOTCH2;PRKAA2;OSR1;IL31RA;ZFAND6;NUPR1;WNT10B;IL6ST;PHIP;GATA6;PRAP1;FGD4;PNMA3;STEAP3;FBXO11;SH3RF1;IFIT2;ADAMTSL4;ANXA1;ANGPT1;DAPK1;BMP2;CFLAR;WRN;APBB1;IL6;PLK5;BCL2;ARAF;LATS2;MTDH;UNC13B;ZBP1;MCL1;HAX1;IFT57;SIAH2;ARF4;ANXA4;TNFRSF12A;BIRC3;RASA1;CREBBP;ACTN2;USP27X;CTSH;GLO1;PLEKHG2;ANP32E;NGFR;STAT1;PDCD5;GSK3B;ARHGEF11;TRIM24;ANXA5;QRICH1;RIPK2;PHB2;CHM;BAX;WNT5A;STK3;UBE2Z;NAA16;CALHM2;USP47;ARHGEF12;SMAD6;SOS2;NGEF;DNAJC3;HIPK3;PPID;GRK5;DNM1L;PTPN6;BCL2L1;TJP1;PTK2;NAA15;ANO6;EGR3;DSTYK;FOXO3;RPS6KA3;API5;DAPK2;SUPV3L1;OPA1;CBX4;TMEM14A;RBM5;BFAR;RTN4;ERCC5;ACVR1C;IFIT3;USP36;ALK;NUAK2;VHL;NIBAN2;BIRC6;HDAC2
prerank,regulation of protein polymerization (GO:0032271),0.35606075983925667,1.0508484824116633,0.38608695652173913,0.8047491665676462,1.0,6/35,7.40%,ARHGAP18;ARHGAP28;HAX1;RASA1;PLEKHG2;DBN1
prerank,response to hydrogen peroxide (GO:0042542),-0.2977829779957349,-1.0507020209962914,0.3671875,0.7786933967805039,1.0,13/45,21.51%,NET1;SETX;MAP3K5;RPS3;PLEKHA1;RHOB;HDAC6;PAX2;PARK7;SOD1;ECT2;STK26;TRPM2
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),-0.4453818509103316,-1.0506806661731416,0.42578125,0.7778030204650379,1.0,3/10,6.57%,IL33;KDR;NAMPT
prerank,positive regulation of chondrocyte differentiation (GO:0032332),0.46835932959242077,1.0506253242287433,0.4230769230769231,0.804580602891047,1.0,1/10,0.35%,SOX5
prerank,cortical actin cytoskeleton organization (GO:0030866),0.3976331609166729,1.0504470324703175,0.3924268502581756,0.8042800636520381,1.0,6/20,13.26%,ROCK2;RHOQ;FMNL2;DLG1;PLEK;LLGL2
prerank,positive regulation of cartilage development (GO:0061036),0.4184695194918389,1.0492035240009436,0.38768115942028986,0.8068832175159784,1.0,3/17,4.47%,SOX5;BMP2;BMP1
prerank,response to ketone (GO:1901654),-0.3503285862611388,-1.0489739745432518,0.3793103448275862,0.7817113517388464,1.0,4/24,2.48%,SLIT2;TGFB2;THBS1;ABHD2
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.28895103368398656,1.0489053196228448,0.36903039073806077,0.806951895949116,1.0,19/118,9.30%,PHLDB2;SH3D19;SP100;PID1;STAT2;PHIP;SDC2;DAG1;NEDD4;RC3H1;IL6;CLASP1;PHLDB1;BCL9L;GSK3B;CAPZB;EPHA4;FMNL2;LRRK2
prerank,positive regulation of protein phosphorylation (GO:0001934),0.256477566230491,1.0488618619005674,0.35096153846153844,0.8063047110949891,1.0,72/348,16.13%,LEPR;BMP6;TEC;ROCK2;VTN;PRKAG2;FGF1;DDR2;GHR;FPR2;WNT3A;BMPR1A;OSM;IL11;FAM20A;NRP1;TWSG1;ITGA5;VEGFD;IL34;ANGPT1;BMP2;SLCO3A1;IL6;BMP7;ARAF;STOX1;TGFBR1;CCND3;RAD50;HAX1;PELI2;ATP2B4;CREBL2;RALBP1;BMP8B;OPRD1;FBH1;TNFRSF14;RIPK2;SNX9;IGF2;LRRK2;RAP2C;DOCK7;MUSK;FGF18;ENPP2;FNIP1;PTK2;SMAD4;CSF1;DVL3;HFE;RARRES2;EFNA1;ARRB1;MTCP1;BDNF;TBK1;P2RY1;GDF11;NTRK3;GDF15;ILK;IQGAP1;STK4;DAB2;PRKD2;APP;CNOT9;INHA
prerank,positive regulation of T cell activation (GO:0050870),0.31629781052119144,1.0487751232289002,0.3717357910906298,0.8057578454116856,1.0,9/62,7.89%,ZMIZ1;IL6ST;ANXA1;IL6;VCAM1;CD47;CCL2;LGALS9;CD274
prerank,positive regulation of exocytosis (GO:0045921),-0.3176356201232898,-1.048774582852185,0.3708133971291866,0.7812833604918217,1.0,15/35,27.64%,RAB27A;CADPS;SNCA;RAB27B;SDCBP;CLASP2;EXPH5;RAB15;SYTL4;ATP6AP1;SNF8;CHMP2A;SDC4;HGS;UNC13D
prerank,ureteric bud development (GO:0001657),0.4174580070761439,1.0487334182431642,0.40816326530612246,0.8051065074713504,1.0,5/17,5.23%,OSR1;FOXC1;BMP2;BMP7;SALL1
prerank,organophosphate biosynthetic process (GO:0090407),-0.3246039499595285,-1.0483125247174412,0.4045226130653266,0.7816850478476448,1.0,10/37,15.55%,ITPKB;GPHN;MBOAT1;PCYT2;IP6K2;FGF2;TKT;TPI1;PPIP5K2;PPIP5K1
prerank,negative regulation of programmed necrotic cell death (GO:0062099),0.45698834437297237,1.0481461061803172,0.4158607350096712,0.8059322809413382,1.0,5/11,21.65%,NUPR1;BIRC3;SLC25A4;PELI1;RIPK1
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),-0.42091252492690157,-1.048036410799821,0.425531914893617,0.7815314370088656,1.0,2/13,1.72%,PLCB1;IL33
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.40872941320059725,1.0479781054533646,0.4056437389770723,0.8055951799687133,1.0,7/18,20.82%,RFX3;ODAD4;DNAAF1;NPHP3;SPEF2;CCDC39;OFD1
prerank,double-strand break repair (GO:0006302),0.2781485644379274,1.0479614139736917,0.3569482288828338,0.8048872025814224,1.0,46/158,21.52%,EYA1;PARP9;NHEJ1;NUCKS1;WRN;APBB1;TONSL;SLX4;RAD50;PARP3;DTX3L;SPIDR;SFR1;FBH1;AP5Z1;BAZ1B;XRCC4;SUMO1;NABP1;RPA3;XRCC1;DCLRE1A;RFWD3;RBBP8;NSMCE2;KDM2A;RAD51B;PRPF19;ERCC5;UIMC1;ERCC1;SMARCAL1;ACTR8;TDP2;BRCC3;DNA2;CYREN;RIF1;SMC6;NABP2;UBXN1;EYA3;INO80;CHEK2;PALB2;NSMCE1
prerank,negative regulation of calcium ion transport (GO:0051926),0.41723513312609606,1.0477904390240602,0.4251012145748988,0.8045749981489176,1.0,1/15,0.45%,ATP1A2
prerank,sensory perception of sound (GO:0007605),0.3011371216283259,1.0476178000797434,0.38936781609195403,0.804266177018714,1.0,8/88,6.55%,COL4A3;EYA1;DCDC2;ADGRV1;KIT;ROR1;GSDME;CCDC50
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),-0.4018584126677689,-1.04735205599638,0.38832997987927564,0.7824970120429832,1.0,3/14,8.54%,GAS6;CCDC3;RFFL
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),0.39937197204139596,1.046924197800133,0.4103942652329749,0.8053970700353479,1.0,7/20,17.46%,STK39;OSR1;NEDD4;ACTN2;HECW2;ADRA2A;YWHAE
prerank,DNA replication initiation (GO:0006270),0.3564170311481713,1.0468907324530914,0.389351081530782,0.8047160928430835,1.0,10/37,17.14%,ORC5;POLA2;PRIM2;RPA3;MCM4;GMNN;MCM6;ORC3;ORC4;LRWD1
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.32305912634608647,1.046148215465822,0.37480314960629924,0.8059083507160544,1.0,8/57,8.87%,LPAR1;FPR2;AKAP12;HRH3;ADCY5;ADCY7;ADCY1;INSL3
prerank,response to tumor necrosis factor (GO:0034612),0.3006006965746976,1.0459960387624452,0.3885630498533724,0.8055216673113825,1.0,9/91,7.87%,PID1;ADAMTS12;ZFAND6;GBP2;CXCL16;AFF3;GSDME;CCL2;NUB1
prerank,regulation of histone H3-K9 methylation (GO:0051570),0.4722882963034506,1.0456759184594466,0.42424242424242425,0.8055880156262326,1.0,5/10,24.69%,MYB;JARID2;KDM1A;RIF1;ATRX
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),-0.3078621533658532,-1.0450311111361474,0.35917312661498707,0.78822816383176,1.0,15/40,16.45%,SGIP1;HIP1;INSR;AHI1;SCYL2;HNRNPK;B2M;LDLRAP1;VEGFA;ATAD1;CBL;SFRP4;CCL19;EGF;NTF3
prerank,negative regulation of DNA replication (GO:0008156),0.4424296283257857,1.0450012850403014,0.419921875,0.8066420668640397,1.0,5/13,16.44%,CDAN1;GMNN;TSPYL2;PDS5A;S100A11
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),-0.3668725023998032,-1.044522679685855,0.39514348785871967,0.7886718962461831,1.0,9/19,35.35%,BAG6;DDIT4;PYCARD;BCL3;HIPK2;CDIP1;TP53;TMEM109;AEN
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),-0.43273004176149565,-1.0444913475810065,0.4087136929460581,0.7877728508302668,1.0,5/11,16.80%,GFPT2;PGM3;GFPT1;RENBP;GNPNAT1
prerank,ventricular septum development (GO:0003281),0.34912748058342047,1.0439804432924598,0.39215686274509803,0.8086708599281989,1.0,11/37,14.12%,ROBO1;TGFBR3;BMPR1A;TGFBR1;SALL1;TGFBR2;HEYL;SMAD4;HECTD1;NOG;MDM4
prerank,ERBB signaling pathway (GO:0038127),0.31917145417493575,1.0436208223881294,0.3858267716535433,0.8088244278777718,1.0,7/64,7.09%,PDPK1;EFEMP1;DGKD;TGFA;PLCE1;PIK3C2A;MVP
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.3399780434743245,1.0428102312415373,0.39074960127591707,0.8102382460897153,1.0,11/45,13.23%,SMAD3;FOXC1;BTG3;BMP7;PTPN3;BTG4;PRCC;ZWINT;NABP1;TOM1L2;HECA
prerank,cellular response to topologically incorrect protein (GO:0035967),-0.3307359327814574,-1.0427283912145937,0.39635535307517084,0.7920016622597043,1.0,5/31,8.06%,HSPA8;TM7SF3;DAB2IP;HSPA14;HDAC6
prerank,T cell mediated immunity (GO:0002456),-0.41812031755764467,-1.042667349673646,0.40421052631578946,0.7912069223859242,1.0,3/13,11.28%,CADM1;EMP2;CD46
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.3979607243419531,1.0422984158335027,0.4136690647482014,0.810854015096654,1.0,2/20,3.96%,WNT4;BMP2
prerank,negative regulation of insulin secretion (GO:0046676),-0.3809544325150192,-1.0420500307450848,0.3986784140969163,0.7919923814917615,1.0,4/17,13.96%,KLF7;CCN3;KCNB1;INHBB
prerank,heart contraction (GO:0060047),0.3428363228331297,1.041944011406919,0.3877551020408163,0.8110510742994947,1.0,4/41,4.92%,TNNC1;ATP1A2;CSRP3;TPM1
prerank,histone H4-K8 acetylation (GO:0043982),-0.38436958903062546,-1.0419007558105393,0.41134751773049644,0.7904840088979204,1.0,6/15,24.14%,JADE3;PHF20;JADE1;KAT7;ING4;MCRS1
prerank,histone H4-K5 acetylation (GO:0043981),-0.38436958903062546,-1.0419007558105393,0.41134751773049644,0.7904840088979204,1.0,6/15,24.14%,JADE3;PHF20;JADE1;KAT7;ING4;MCRS1
prerank,amino sugar biosynthetic process (GO:0046349),-0.41945936855974286,-1.0415316703737427,0.4132231404958678,0.7905302709094685,1.0,5/12,16.80%,GFPT2;PGM3;GFPT1;RENBP;GNPNAT1
prerank,protein mannosylation (GO:0035268),0.3921967944697461,1.0412741267191805,0.4221014492753623,0.8121914131521559,1.0,5/22,7.26%,TMTC4;TMTC1;LARGE1;RXYLT1;POMT2
prerank,actin filament-based transport (GO:0099515),0.39679194719051986,1.0406333881785794,0.42504409171075835,0.813201087670869,1.0,10/21,19.11%,SYNE2;MYO1B;MYO1A;WASL;MYO15A;MYO1E;MYO1C;MYO5A;MYO19;MYO5B
prerank,regulation of protein sumoylation (GO:0033233),0.41648770227424703,1.0405246644637616,0.4199623352165725,0.8127185529307125,1.0,3/17,8.24%,ZMIZ1;HDAC4;PIAS1
prerank,epiboly involved in wound healing (GO:0090505),0.42231622851772643,1.0404061505183426,0.42602495543672014,0.8123019790774957,1.0,1/16,0.30%,PDPN
prerank,DNA metabolic process (GO:0006259),0.2621253548281031,1.0401847383089458,0.3757725587144623,0.8121113737858884,1.0,67/270,20.65%,TCF7L2;SP100;PDS5B;DCTPP1;ORC5;POLH;TERT;WRN;TOP1;SLX4;UBE2U;RAD50;PARP3;POLA2;TOP2B;PRIM2;RFC1;POLG;NTHL1;DDX23;MNAT1;PSME4;SUMO1;NABP1;UVRAG;RPA3;XRCC1;MCM4;GMNN;ADPRS;RBBP8;OGG1;SUPV3L1;MCM6;RAD51B;INTS3;GTF2H4;ERCC5;ORC3;RAD9A;DNASE1L1;PDS5A;ALKBH1;ERCC1;ORC4;USP45;MGMT;DDX21;AXIN2;KMT5C;RAN;LRWD1;SMARCAL1;FANCC;RNASEH1;PARP4;XPC;DFFB;DNA2;NSMCE3;USP7;LONP1;RIF1;CTC1;NABP2;KMT5B;POLD3
prerank,negative regulation of viral life cycle (GO:1903901),-0.3889327936780619,-1.0400078082714899,0.40486725663716816,0.7939717105862919,1.0,6/15,15.41%,LY6E;SNX3;MID2;IFITM3;PPIA;IFITM2
prerank,regulation of autophagy (GO:0010506),0.26690505827537475,1.0398706131535034,0.36538461538461536,0.8121534173826377,1.0,59/216,22.08%,LEPR;ITPR1;RNF152;PRKAG2;PRKAA2;NUPR1;SNX6;NEDD4;DAPK1;DCN;BCL2;MTDH;PTPN22;MCL1;KLHL22;HAX1;OPTN;MTMR3;TRIM5;PIK3C2A;GSK3B;LRRK2;TLK2;TPCN1;DNM1L;KEAP1;FOXO3;SLC38A9;TRIM21;EEF1A2;DAPK2;PIP4K2B;ATP6V0B;TICAM1;USP36;WDR6;CSNK2A2;ATP6V1E1;ATP6V1C1;GOLGA2;EXOC7;EXOC1;CASP3;ABL2;USP10;PIP4K2C;PLEKHF1;VPS26B;ROCK1;TRIM8;SREBF1;SIRT2;MTMR4;TRIM65;VPS35;FBXW7;ATG13;ZC3H12A;RRAGD
prerank,arachidonic acid metabolic process (GO:0019369),0.35773224157653516,1.0398048477499338,0.4240924092409241,0.8115640324075175,1.0,5/35,10.27%,PTGS1;PLA2G4A;PLA2G4C;ALOXE3;EPHX1
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),-0.28692213945823,-1.0394845428241148,0.36895674300254455,0.794507642511764,1.0,20/57,21.03%,NOD1;MAP3K5;GRIN2A;PERP;GRIN2B;HMGB1;CTSD;LGMN;SOX7;GRIN1;MALT1;AIM2;SYK;TTBK1;FOXL2;PYCARD;PPM1F;CASP1;BAD;NDUFA13
prerank,regulation of chemokine production (GO:0032642),0.34699405083713597,1.039394892314998,0.3986135181975737,0.8118474942403023,1.0,7/36,11.12%,EIF2AK2;IL6;TLR4;IL18;LGALS9;WNT5A;TLR2
prerank,embryonic hemopoiesis (GO:0035162),0.4480833463213991,1.0393435513947593,0.4154786150712831,0.8112357870084959,1.0,5/12,13.95%,KMT2A;KIT;TGFBR2;SH2B3;THOC5
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.3076552552034309,1.039154136749247,0.402457757296467,0.8109878464410021,1.0,11/73,10.29%,KMT2A;EIF2AK2;FOXC1;OSM;MYB;TCF12;PSMB10;YAP1;PSMA3;PSME4;PSMA5
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.45900478012071555,1.0389032938327203,0.42857142857142855,0.8108905622879088,1.0,3/11,7.89%,TWSG1;LGALS9;CD274
prerank,cellular response to UV (GO:0034644),-0.270793771357969,-1.0387411454527478,0.3743016759776536,0.795675256309231,1.0,30/76,32.69%,PTPRK;RPL26;STK11;NPM1;YY1;ATF4;COPS9;CASP9;BMF;CDKN1A;MFAP4;MMP1;N4BP1;CHEK1;NOC2L;POLD1;ATR;POLK;DDB2;TIMP1;RHNO1;HYAL3;MMP2;MMP3;MYC;PCNA;TMEM161A;TP53;HYAL2;RUVBL2
prerank,regulation of sprouting angiogenesis (GO:1903670),0.3572714976214777,1.038733652838632,0.413265306122449,0.8106270368830665,1.0,10/33,13.11%,PDPK1;FGF1;CEMIP2;ITGA5;JMJD8;GLUL;FGF18;TJP1;EPN1;JAK1
prerank,semaphorin-plexin signaling pathway (GO:0071526),0.34912846986952717,1.03869359449379,0.3996447602131439,0.8099715019861193,1.0,3/35,2.97%,PLXNA2;SEMA3D;NRP1
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),0.4243170412794983,1.038245525142485,0.428842504743833,0.810375589854402,1.0,6/15,17.12%,BMP2K;DGKD;AAK1;WASL;DAB2;NEU3
prerank,lysine metabolic process (GO:0006553),0.4351001040544822,1.0380793922743632,0.4118773946360153,0.8093422648670373,1.0,2/12,6.12%,HYKK;PHYKPL
prerank,lysine catabolic process (GO:0006554),0.4351001040544822,1.0380793922743632,0.4118773946360153,0.8093422648670373,1.0,2/12,6.12%,HYKK;PHYKPL
prerank,myeloid cell activation involved in immune response (GO:0002275),0.4076041816128385,1.0379879803929362,0.42344045368620037,0.8088333778884232,1.0,2/18,4.25%,ENPP3;IFI35
prerank,glycolytic process (GO:0006096),-0.3392771914058782,-1.03796460693472,0.39855072463768115,0.7970224562471838,1.0,8/28,15.67%,PGK1;PKM;ALDOC;GPI;TPI1;PGAM1;PGAM4;ENO1
prerank,negative regulation of catabolic process (GO:0009895),0.328692566873312,1.0379425799718576,0.40099833610648916,0.8082151040642644,1.0,12/47,15.39%,NUPR1;APOA2;SNX12;HDAC4;PPARA;AZIN2;SF3B3;HCAR2;IRAK3;MDM4;ALK;ADRA2A
prerank,vasculature development (GO:0001944),0.4142551274930081,1.0378394968149312,0.4110320284697509,0.80772446823139,1.0,4/16,6.11%,PDGFRA;CDH5;ERRFI1;PDGFRB
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),0.4494966616530278,1.0376970756880326,0.418018018018018,0.8073890988437487,1.0,3/12,15.47%,IL17D;IL18;IL23R
prerank,positive regulation of cellular metabolic process (GO:0031325),-0.2562456849638772,-1.037506731866339,0.34276729559748426,0.7973983111156375,1.0,21/98,13.06%,SLCO1C1;THBS1;INSR;NSF;SNCA;PPARD;AHI1;SCYL2;CHCHD2;ECE1;AKT1;IFNAR1;PRELID1;VEGFA;ATAD1;GHITM;ACE2;SFRP4;ACACA;KLF4;ACLY
prerank,cellular respiration (GO:0045333),-0.30055550697698186,-1.0371630163310017,0.4020100502512563,0.7974180975017744,1.0,17/41,36.50%,SDHC;ME3;NDUFS7;UQCRH;NR4A3;ATP5F1D;SLC25A13;COQ10B;MTFR1L;MDH2;UQCR10;COX4I2;NDUFS1;MTLN;CYCS;BLOC1S1;UQCRB
prerank,embryonic limb morphogenesis (GO:0030326),0.3501040338573511,1.037030718208995,0.41480206540447506,0.8083575123580348,1.0,7/34,8.79%,OSR1;AFF3;GLI3;SALL1;CREBBP;SKI;CACNA1C
prerank,positive regulation of lyase activity (GO:0051349),-0.39750782082177893,-1.0369920426157626,0.3917748917748918,0.7969442606977986,1.0,5/14,18.69%,NOS3;CACNA1D;NOS1;PARK7;AKAP5
prerank,keratinocyte differentiation (GO:0030216),0.36313816501208623,1.0369471558693018,0.39152542372881355,0.8078590951773864,1.0,10/29,21.26%,ANXA1;CLIC4;WNT5A;EPHA2;OPN3;TXNIP;CASP3;DSP;PIP5K1A;TGM1
prerank,regulation of trophoblast cell migration (GO:1901163),0.43263233837409876,1.0366159377017083,0.40417457305502846,0.8079827206020961,1.0,4/14,14.05%,SMURF2;GJA1;SYDE1;ACVR1C
prerank,T cell receptor signaling pathway (GO:0050852),-0.2418745177143239,-1.0366135413058801,0.36678200692041524,0.7970994577869119,1.0,38/138,21.19%,PDE4D;PTPRJ;PDE4B;PLCG2;INPP5D;RFTN1;PIK3R1;MOG;PAK1;PRKCQ;PSMC3;EIF2B2;PSMD14;PSMD3;LCP2;MALT1;PSMD4;PSMD6;PSMA6;PSMA4;BCAR1;PAK3;PSMB8;PIK3CD;TNFRSF21;PSMA8;PTPRC;PLCG1;PSME1;PRAM1;PSMD7;PSMC6;IKBKB;CD276;PSMB5;CD247;PSMC5;PSMB1
prerank,positive regulation of cell motility (GO:2000147),0.26926458277895915,1.035994662774089,0.381389252948886,0.8089874776354619,1.0,24/205,7.37%,SEMA3D;PDPN;ROCK2;PDGFRA;FGF1;SYNE2;CXCL16;FAM110C;CDH5;FER;NUMB;SMIM22;KIT;BMP2;NTN1;WNT5B;TGFBR1;FAM83H;MMP14;EPHA1;PDGFRB;SEMA4B;CTSH;CLDN1
prerank,regulation of mast cell activation (GO:0033003),-0.4467090561146784,-1.0357785243052238,0.44016227180527384,0.7985311756170296,1.0,8/10,48.76%,LYN;CD84;TSLP;NECTIN2;CD226;MILR1;PLSCR1;CD300LF
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.35242414467302663,1.035090687971419,0.41354723707664887,0.8106795456899297,1.0,7/31,9.72%,KANK2;DACT1;CDC73;CCL2;CDKN2B;DLG1;SUSD2
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.35704897548011094,1.0347609899324182,0.40703517587939697,0.8107948463657587,1.0,3/32,4.20%,PDPK1;CXCL10;F2RL3
prerank,pore complex assembly (GO:0046931),0.394529634181012,1.03469580873584,0.42010771992818674,0.8102256272565685,1.0,5/19,13.84%,AFDN;TPR;ANO6;AHCTF1;RTN4
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.2794840123131917,1.034668350562928,0.3975069252077562,0.8095588900828194,1.0,28/140,18.11%,LPAR1;PDGFRA;FPR2;ACKR2;CCR9;CD55;F2RL3;ADCY5;C5AR2;PLCE1;BDKRB2;SPPL3;ACKR3;CACNA1C;JPH1;GPR65;JPH3;CIB2;P2RY1;CCRL2;CACNA2D1;CCKBR;CXCR4;JPH4;P2RX4;TAC4;ABL2;GPR157
prerank,recombinational repair (GO:0000725),0.3004253724617944,1.034170513636549,0.38950715421303655,0.8101502626343421,1.0,17/77,14.03%,NUCKS1;WRN;TONSL;SLX4;RAD50;SPIDR;SFR1;FBH1;AP5Z1;NABP1;RPA3;XRCC1;RFWD3;RBBP8;NSMCE2;RAD51B;ERCC5
prerank,aorta development (GO:0035904),0.4279316110000069,1.034082125112739,0.42452830188679247,0.8096601196091217,1.0,3/14,6.11%,ROBO1;EFEMP2;PDGFRB
prerank,detection of mechanical stimulus (GO:0050982),-0.36729244597889,-1.0338004471924087,0.4121475054229935,0.8031980908028731,1.0,3/19,5.47%,PIEZO2;CDH2;CTNNB1
prerank,error-free translesion synthesis (GO:0070987),0.3879587841303249,1.0337635576696613,0.425891181988743,0.8097633161953144,1.0,6/22,14.53%,POLH;RFC1;REV1;RPA3;POLDIP2;RCHY1
prerank,base-excision repair (GO:0006284),0.3322974585151935,1.0336981945192794,0.41025641025641024,0.8091958625094001,1.0,12/48,14.06%,WRN;RFC1;POLG;NTHL1;USP47;RPA3;XRCC1;HUWE1;ADPRS;OGG1;ERCC5;ERCC6
prerank,vasoconstriction (GO:0042310),-0.4262927928797398,-1.0335615494225128,0.43724696356275305,0.8029042028030569,1.0,3/11,6.28%,EDNRA;SLC8A1;ACTA2
prerank,inorganic anion transport (GO:0015698),0.3197681519595908,1.0334724246420235,0.38079470198675497,0.8090852291267158,1.0,10/53,12.18%,ENPP3;SLC13A4;ENPP1;SLC26A9;SLC4A11;CLIC4;ANO10;NMUR1;ANO6;ANO8
prerank,Notch signaling pathway (GO:0007219),0.3128573055723883,1.0333760050928047,0.39545454545454545,0.8086121097519545,1.0,12/59,12.43%,RBPJ;NOTCH2;GMDS;BMP2;DTX4;DTX1;DTX3L;CREBBP;STAT1;PBX1;HEYL;MAML2
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),-0.24818955543583268,-1.0333759431411267,0.3504823151125402,0.8024190597760948,1.0,36/114,25.30%,ST18;TMSB4X;PTK2B;PSMC3;COMMD7;TNFRSF1B;PSMD14;PSMD3;PSMD4;PSMD6;CD40;PSMA6;AIM2;EIF5A;PSMA4;PSMB8;ACTN4;PSMA8;CD27;LTBR;PSME1;PYCARD;PSMD7;PSMC6;IKBKB;PSMB5;PSMC5;BAG4;PSMB1;TRAF1;TNFRSF11A;TNFRSF9;PSMD11;TNFSF13;PSMD8;TXNDC17
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),-0.4001838750006307,-1.0333618643505433,0.4188911704312115,0.8014877095838372,1.0,7/15,15.27%,TMSB4X;KDR;MET;LGMN;VEGFA;FGF2;PRKD1
prerank,regulation of microtubule depolymerization (GO:0031114),-0.3431632915825001,-1.0332802484293242,0.40274599542334094,0.8007275851905314,1.0,7/25,17.33%,NAV3;ARHGEF2;STMN2;MAP1B;FGF13;CLASP2;MID1IP1
prerank,regulation of chromatin binding (GO:0035561),0.46188232273232444,1.0332460392656555,0.40585009140767825,0.8081888216876763,1.0,3/10,10.51%,PARP9;DTX3L;GMNN
prerank,substrate-dependent cell migration (GO:0006929),0.4320578129629459,1.0327863715280934,0.44669117647058826,0.8087234078010672,1.0,4/14,8.07%,EPHA8;NRP1;NTN1;ITGA11
prerank,pyrimidine nucleoside catabolic process (GO:0046135),0.4707451830076301,1.0327714929364864,0.42350746268656714,0.8080341833221962,1.0,3/10,8.91%,DPYD;UPP1;NT5C
prerank,response to molecule of bacterial origin (GO:0002237),0.30853815115801253,1.0323860990004623,0.39849624060150374,0.8082847029492559,1.0,14/69,15.47%,SELP;FER;IL6;TLR4;PTPN22;NOS2;LY96;LGALS9;NOCT;SMAD6;IRAK3;RPS6KA3;TRIB1;IL23R
prerank,microtubule depolymerization (GO:0007019),-0.3728341878294825,-1.0322820107180133,0.382830626450116,0.8026346026915621,1.0,8/17,28.04%,STMN2;KIF18A;NCKAP5;STMN4;STMN1;KIF14;STMN3;KIF19
prerank,double-strand break repair via homologous recombination (GO:0000724),0.28972596940115247,1.0321424655312892,0.39064856711915535,0.8082340493803399,1.0,20/95,14.03%,NUCKS1;WRN;TONSL;SLX4;RAD50;SPIDR;SFR1;FBH1;AP5Z1;NABP1;RPA3;XRCC1;MCM4;FANCM;RFWD3;RBBP8;NSMCE2;MCM6;RAD51B;ERCC5
prerank,protein modification process (GO:0036211),-0.27344726963901206,-1.0321299869930964,0.3798219584569733,0.8021284016614548,1.0,17/76,16.63%,ST8SIA4;CHRM3;ST3GAL6;CPE;MSRA;RPN2;FBXL2;MMP15;SERP1;QPCT;PIGH;UBA52;PHEX;SEPHS1;PLOD2;ERO1A;UBE2D3
prerank,aggrephagy (GO:0035973),0.37195230595646467,1.0318705179919017,0.431858407079646,0.808235777557211,1.0,4/27,4.24%,DYNLL1;VIM;ARL13B;IFT88
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.3467097038739849,1.0318130708320936,0.4237588652482269,0.8076513279006527,1.0,9/35,16.38%,LEPROT;GHR;KIT;IL6;CRLF3;SH2B3;VHL;OCIAD1;NF2
prerank,muscle organ development (GO:0007517),-0.2856827587423162,-1.03162446174292,0.3696808510638298,0.802639832207314,1.0,9/54,7.13%,MEF2C;DMD;SGCD;COL6A3;TEAD4;TBX1;UTRN;MKX;SOX6
prerank,cellular protein localization (GO:0034613),-0.2230089730505313,-1.0312296213612522,0.31952662721893493,0.8028323961465751,1.0,74/285,20.03%,CNTNAP2;GRID2;ESAM;PTPRK;DMD;TBC1D8;NSF;CPE;SYNDIG1;STX3;REEP1;ID1;EMP2;ARF5;TBC1D30;FBLN5;CTNNB1;AHI1;ARHGEF2;STXBP1;RAB6B;CEP68;YWHAH;STX16;RIC3;RAB38;HERC2;AMOT;TM9SF3;ARL1;SCG5;JAM3;CNTLN;HDAC6;NPM1;SGSM1;TMED2;VPS33B;CNTN2;RRAGB;CD74;ATG9A;HHEX;MFN2;PIGU;PIGK;TBC1D22B;TBC1D8B;TBC1D14;CPLANE2;EGFR;NAPA;RUNDC1;RAB5C;SNX8;ABHD17A;EVI5;TBC1D12;VIPAS39;DNAJC27;TMED7;RRAGC;RABL3;AP3D1;BBS2;RAB1B;ARF6;TBC1D5;ARL4D;SAR1B;IFT22;TBC1D1;SNX17;LAMTOR2
prerank,long-chain fatty acid metabolic process (GO:0001676),0.31206575713192286,1.0311009403341767,0.42543171114599687,0.8087903656631811,1.0,11/64,10.80%,PLA2G4A;AIG1;ACSL1;PLA2G4C;ALOXE3;SCP2;SLC27A2;ACOT1;EPHX1;SLC27A3;HACL1
prerank,B cell homeostasis (GO:0001782),-0.44307914056039793,-1.0306658965803865,0.43803418803418803,0.8034201315332827,1.0,4/10,14.09%,MEF2C;DOCK10;LYN;CAMLG
prerank,organelle transport along microtubule (GO:0072384),0.36024234167915853,1.030574592501215,0.42346938775510207,0.8094306117314081,1.0,9/31,21.23%,ARHGAP21;TRAK1;UXT;KIF5B;FBXW11;RHOT1;RHOT2;BORCS5;PEX14
prerank,endothelial tube morphogenesis (GO:0061154),0.4690990656221372,1.0304570157495025,0.423728813559322,0.8090365246119557,1.0,2/10,2.44%,RBPJ;CCM2
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),-0.3552134177547078,-1.0303860348587364,0.42093023255813955,0.803227320766259,1.0,10/22,33.17%,ESR1;PSMC3;MED30;PSMC6;PSMC5;SRF;MED13;TP53;PAXIP1;SUB1
prerank,negative regulation of MAP kinase activity (GO:0043407),-0.2973948646854279,-1.0300324058676913,0.40476190476190477,0.8032422443611706,1.0,8/44,10.04%,PTPRJ;SORL1;DAB2IP;INPP5K;BMP4;PAQR3;LYN;MAPK8IP1
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),0.4419347338527101,1.0297243666689742,0.4358490566037736,0.8102497370855408,1.0,7/12,26.83%,PCGF5;RBM15;LRIF1;PCGF3;RLIM;SMCHD1;YTHDC1
prerank,toxin transport (GO:1901998),0.4640984753151962,1.0296068926211979,0.4411214953271028,0.809849451780408,1.0,4/10,21.36%,ANTXR1;SLC22A2;ANTXR2;SLC22A3
prerank,eye photoreceptor cell differentiation (GO:0001754),0.442349276871996,1.0295892409867982,0.44,0.8091689587991053,1.0,1/12,0.31%,SDK2
prerank,protein localization to endoplasmic reticulum (GO:0070972),0.4089598386220936,1.0295250157880966,0.42429906542056073,0.8086295928702875,1.0,8/16,21.53%,MIA3;VAPA;LRRK2;TAPT1;GBF1;ANK2;SEC16A;BCAP31
prerank,skeletal muscle organ development (GO:0060538),0.36963389391094303,1.0294497783740277,0.41824440619621345,0.808081529847341,1.0,6/26,10.19%,CSRP3;CFLAR;LARGE1;IGSF8;POPDC2;MSC
prerank,serine family amino acid catabolic process (GO:0009071),0.4631390123843796,1.0289644274417238,0.4165029469548134,0.8085839999476812,1.0,2/10,8.48%,SHMT1;AMT
prerank,macrophage chemotaxis (GO:0048246),0.4528218729983563,1.0288415674315603,0.427734375,0.8081773630263626,1.0,2/10,7.71%,CKLF;CCL2
prerank,regulation of protein localization to cell periphery (GO:1904375),0.39654310254523784,1.0288159917803887,0.43087971274685816,0.8075145840108017,1.0,5/18,9.78%,SPTBN1;MMP14;MISP;STX8;APPL1
prerank,phagosome maturation (GO:0090382),-0.3166822290304187,-1.0287457059430885,0.4257907542579075,0.8059496807030863,1.0,12/35,21.48%,ATP6V0A1;ATP6V1B2;ATP6V0C;RAB38;ATP6V1D;RAB39A;ATP6V0A2;ATP6V1G2;ATP6V0E2;ATP6V1F;RAB32;ATP6V0D2
prerank,secretory granule organization (GO:0033363),0.46652573778318485,1.0285929339519173,0.4397705544933078,0.8073916827886375,1.0,4/10,14.75%,F2RL3;DTNBP1;SRGN;ABCA1
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),-0.42202533126133657,-1.0285643601443604,0.4342629482071713,0.805511852713791,1.0,3/12,9.11%,PLCG2;RAB27A;GRIN1
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),-0.3811560436548088,-1.0285620109403883,0.4269911504424779,0.8045593665698593,1.0,6/17,5.50%,ATP1B1;RYR2;ATP1A1;GJC1;GJD3;SLC8A1
prerank,aminoglycan catabolic process (GO:0006026),0.365404221905468,1.0283424951431186,0.400359066427289,0.8072707524694748,1.0,3/28,2.58%,GPC6;HSPG2;SDC2
prerank,response to organophosphorus (GO:0046683),-0.38308874360396483,-1.0281602591232326,0.4188911704312115,0.8047257973110489,1.0,2/16,2.03%,TRPC3;ABCC9
prerank,regulation of cellular component organization (GO:0051128),-0.24271925982975,-1.0275866762904036,0.4136690647482014,0.8053828650166014,1.0,30/135,16.16%,NRG3;HIP1;HSPA8;TFRC;NET1;RIT2;SEMA4D;PRKCQ;HIP1R;DAB2IP;FAM107A;RAPGEF2;PAK5;CAMK2D;ERMN;CEACAM1;STK11;PINK1;SSRP1;SPOCK1;ANKRA2;BCAR1;HSP90AA1;DCUN1D5;RAB5C;PARK7;PAK4;IRGM;SLITRK2;RAP1A
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.3191899396283284,1.0275377916059878,0.41363636363636364,0.8086871329632981,1.0,10/60,13.36%,TCF7L2;CDK8;TNRC6B;IL6;BAX;TNRC6A;MOV10;ATF7IP;MED12;MED20
prerank,innate immune response (GO:0045087),0.26430670151760566,1.0274661895595123,0.4027603513174404,0.8081503180826585,1.0,40/217,15.87%,STYK1;CXCL10;SP100;COLEC12;CXCL16;TRIM56;TRIM10;FER;BPIFB1;TLR4;TRIM17;TRIM5;BST2;NOS2;CRP;NUB1;RIPK2;PHB2;PJA2;ANKRD17;IFITM1;IFNLR1;TLR2;PTK2;IFI27;ADAR;TRIM21;IFIT1;RARRES2;TRIM26;SRPK1;ANKHD1;RNF39;TIFA;IFIH1;TBK1;FRK;PML;IL23R;APP
prerank,secondary alcohol biosynthetic process (GO:1902653),-0.3324051477918264,-1.0274373913760102,0.40476190476190477,0.8048282651296262,1.0,13/30,32.03%,HMGCS1;NSDHL;SQLE;INSIG1;ACLY;HSD17B7;DHCR7;LSS;MVD;MSMO1;DHCR24;IDI1;PLPP6
prerank,regulation of stress-activated MAPK cascade (GO:0032872),-0.2910726596016761,-1.0273957088823633,0.40512820512820513,0.8039709718550476,1.0,14/47,15.73%,TGFB2;FOXO1;MID1;PHLPP1;EPHB1;DAB2IP;MAPK3;FAS;MAPK8IP1;EGFR;MAPK8IP3;PPIA;NOD2;COPS5
prerank,regulation of macrophage activation (GO:0043030),0.35654258358440677,1.0273735826459254,0.4273789649415693,0.8076842865231747,1.0,6/30,8.78%,IL31RA;IL6;TLR4;NR1H3;WNT5A;PJA2
prerank,regulation of cytokine production (GO:0001817),0.28177163880167616,1.0268570798527505,0.39759036144578314,0.8082663560857115,1.0,25/126,15.64%,LGR4;EIF2AK2;TRIM56;TWSG1;PLA2R1;ANXA1;IL6;DTX4;C5AR2;IGF2BP1;ZBP1;FOXP3;NOS2;CD47;CRP;LGALS9;MAPK14;IGF2BP2;TRIM21;ATP2B1;SRGN;IFIH1;TBK1;ADRA2A;TXK
prerank,cellular response to light stimulus (GO:0071482),-0.2758551212992289,-1.0265996934100199,0.38526912181303113,0.8052867597594028,1.0,26/66,32.69%,PTPRK;RPL26;NPM1;YY1;ATF4;COPS9;CASP9;BMF;PDE6A;GPR88;N4BP1;NOC2L;POLD1;ATR;POLK;SAG;RHNO1;MYC;PDE6G;PCNA;TMEM161A;RRH;TP53;OPN1MW3;OPN1MW;RUVBL2
prerank,superoxide anion generation (GO:0042554),-0.4025431384022917,-1.0263138909248322,0.4153225806451613,0.8051345425857312,1.0,9/13,43.97%,NCF2;CYBB;TAFA4;NOX4;NCF1;NOX3;NCF4;DUOX1;ALOX12
prerank,copper ion homeostasis (GO:0055070),-0.375722101887291,-1.026085999513673,0.4232456140350877,0.8048293806096932,1.0,9/17,34.85%,ATOX1;SLC31A1;SLC31A2;MT2A;CCDC22;COX19;ABCB6;XIAP;ANKRD9
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.3486383796163309,1.02567649318203,0.4161073825503356,0.8106708423531995,1.0,9/36,12.26%,TCF7L2;FZD2;TNRC6B;PLCB3;TNRC6A;WNT5A;MOV10;PPP3CB;MAP3K7
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.2928984769704417,1.0255097692639605,0.41810344827586204,0.8103987869743623,1.0,14/87,9.48%,ROCK2;PDGFRA;ARHGAP18;NOTCH2;DLC1;EPHA3;SMIM22;RHOBTB2;PDGFRB;RHOF;BST2;CELSR1;RHOQ;IQGAP2
prerank,regulation of systemic arterial blood pressure (GO:0003073),-0.38196721013669305,-1.025065482558347,0.4326710816777042,0.8068634518592837,1.0,3/16,7.34%,BMPR2;PRCP;ACE
prerank,nuclear export (GO:0051168),0.2975495101932342,1.0250636629034093,0.4,0.8107872908718168,1.0,16/80,17.93%,RANBP3L;ATXN1;WASHC4;TPR;SLU7;SRSF4;EGR2;MAGOHB;STRADB;DDX39A;THOC5;POM121;SRSF5;RAN;LSG1;RANBP17
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),0.4579673602898098,1.0250390713291193,0.4405010438413361,0.8094145095198362,1.0,2/10,8.09%,SMPD3;PLA2G6
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),0.4579673602898098,1.0250390713291193,0.4405010438413361,0.8094145095198362,1.0,2/10,8.09%,SMPD3;PLA2G6
prerank,negative regulation of endopeptidase activity (GO:0010951),0.32798875732139665,1.0248626696844474,0.4362745098039216,0.809146274726273,1.0,12/47,16.68%,VTN;TIMP3;SERPING1;SERPINB7;SERPINE1;TIMP2;SERPINE2;SERPINB8;SERPINE3;RECK;ANXA8;ANXA8L1
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),0.32135020773133255,1.024653710718719,0.41262135922330095,0.8089556415640908,1.0,18/53,23.52%,EYA2;EYA1;PLA2R1;FBH1;EYA4;HIC1;ERCC6;UIMC1;FXR2;BRCC3;DDX5;ERCC8;EYA3;NSMCE1;NACC2;SMCHD1;DHX9;CEBPG
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),0.4165565979059014,1.0244461064460728,0.4375,0.8087939184321591,1.0,3/16,8.03%,ROCK2;IL6ST;MEF2A
prerank,positive regulation of protein import (GO:1904591),0.3556378733800424,1.0243227026293713,0.43500866551126516,0.8084084388522336,1.0,4/30,7.63%,SMAD3;ZIC1;TPR;PDCD5
prerank,B cell mediated immunity (GO:0019724),-0.4394935656830325,-1.0243180779892458,0.46153846153846156,0.8080154329102736,1.0,7/10,43.94%,CD74;FCER1G;CD27;TLR8;FCGR2B;CARD9;SLA2
prerank,glycosaminoglycan catabolic process (GO:0006027),0.3144506389942505,1.0242108173521598,0.4059900166389351,0.8079666012081985,1.0,10/55,12.59%,GPC6;CEMIP2;HSPG2;SDC2;DCN;OMD;PRELP;GPC2;LYVE1;ARSB
prerank,toll-like receptor 3 signaling pathway (GO:0034138),0.45516234254054866,1.0241023453442577,0.425,0.8075479972761019,1.0,5/11,21.65%,COLEC12;SCARA3;TICAM1;UNC93B1;RIPK1
prerank,cellular response to glucagon stimulus (GO:0071377),0.4032270253417569,1.0240759093011425,0.42245989304812837,0.8069023719156541,1.0,4/17,7.01%,GCGR;ADCY5;ADCY7;ADCY1
prerank,tetrahydrofolate metabolic process (GO:0046653),0.45796688588165535,1.0240639338655217,0.42337164750957856,0.8062259952342378,1.0,2/10,3.94%,SHMT1;MTHFD1
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),-0.40563366528319345,-1.0237056048644975,0.4243027888446215,0.8087748438868406,1.0,6/12,31.59%,B3GNT2;B3GNT9;B3GNT3;B4GAT1;B3GNT6;B3GALT1
prerank,negative regulation of DNA metabolic process (GO:0051053),-0.3416839694554225,-1.0236260011963956,0.42857142857142855,0.8080591284602875,1.0,5/24,5.63%,DACH1;BMPR2;ACVRL1;RPS3;MSH3
prerank,Ras protein signal transduction (GO:0007265),0.27521613558229924,1.0233792858333988,0.39355742296918766,0.8072904613863954,1.0,37/137,20.42%,ARHGAP29;PDPN;ARHGAP6;ROCK2;PLD1;KSR1;RRAS2;NTN1;PLCE1;CELSR1;NGFR;ARHGEF11;USP8;RAP2C;RALGDS;CDC42EP4;MAPK14;CDH13;SHOC2;WASF1;SHC2;BRAP;MAPKAPK5;LIMK1;ADRA2A;RIT1;RAPGEF3;COL1A2;RAP2B;SOS1;SHC1;FARP2;NRAS;SETDB1;RASSF1;ROCK1;CRKL
prerank,macrophage activation involved in immune response (GO:0002281),-0.4110378675504145,-1.0227816937810539,0.4574898785425101,0.8094762976732158,1.0,4/13,13.25%,PLCG2;DYSF;SYK;GRN
prerank,RNA processing (GO:0006396),0.26611403959208657,1.0226813332578326,0.42231075697211157,0.8083805829698715,1.0,43/176,18.58%,CELF2;ATXN1;RBMS1;TUT4;RBMS2;FASTKD5;SNRPA1;ZRSR2;LSM1;NOVA1;HNRNPH1;HNRNPC;SF3B3;DDX23;SLU7;CDK12;RBM39;RNPC3;SRSF4;DHX16;HNRNPH3;ADAR;MAGOHB;USB1;DHX8;RBM5;SRPK1;ZMAT5;RBM6;TENT2;PABPN1;FUS;SRSF5;CSTF3;HNRNPR;HNRNPA2B1;PPP2CA;NUFIP1;WBP4;SCAF11;TUT7;USP39;PRPF3
prerank,nucleic acid-templated transcription (GO:0097659),0.3274878591972252,1.0224937346877874,0.4230118443316413,0.8081525921090414,1.0,11/42,13.75%,POLR2D;TERT;BAZ2A;DTX1;CREBL2;MEF2A;EPC1;POLR2C;THAP1;MED20;POLR2F
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),-0.4068462619922408,-1.0222872381028654,0.4482758620689655,0.8099353875188183,1.0,3/13,6.57%,IL33;KDR;NAMPT
prerank,negative regulation of double-strand break repair (GO:2000780),0.357038526698812,1.0219949279284057,0.43447037701974867,0.8087263897804774,1.0,15/30,27.82%,TRIP12;KLHL15;FBH1;OGG1;ERCC6;SHLD2;UBR5;CYREN;RIF1;SMCHD1;SHLD1;TFIP11;FANCB;CGAS;HMGA2
prerank,acetyl-CoA metabolic process (GO:0006084),-0.3887869095066353,-1.0219390850325663,0.45358649789029537,0.8099263177976184,1.0,4/15,13.06%,HMGCS1;HMGCS2;ACACA;ACLY
prerank,cellular response to unfolded protein (GO:0034620),-0.33677208926031427,-1.021806782229713,0.43683083511777304,0.8093559725634102,1.0,4/26,5.59%,HSPA8;TM7SF3;DAB2IP;HSPA14
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),-0.2767796247741316,-1.0216797613766289,0.4404432132963989,0.8087808970789869,1.0,26/57,32.57%,FOXN3;MRE11;CLSPN;CCND1;BABAM1;ATM;MDC1;CDK2;CDKN1A;BRCA1;CHEK1;DTL;DONSON;TAOK2;CDC14B;BLM;HUS1B;TOPBP1;PLK1;CDK1;TP53;PRKDC;FBXO31;NEK11;TICRR;MUS81
prerank,proteoglycan metabolic process (GO:0006029),0.3686834190706268,1.021583570816993,0.4359430604982206,0.8090889233022647,1.0,2/26,1.66%,SULF1;ADAMTS12
prerank,activation of adenylate cyclase activity (GO:0007190),0.3547671391118353,1.0213947279553968,0.41824440619621345,0.8088977802668382,1.0,6/35,8.73%,LGR4;ADCY5;ADCY7;RXFP2;ADCY1;ACR
prerank,ncRNA metabolic process (GO:0034660),0.33991018092510134,1.0212595095308583,0.4423407917383821,0.8085313555771041,1.0,11/37,21.46%,TUT4;PIWIL4;EXD1;DTD2;TARBP2;RAN;TUT7;KHSRP;PARN;TENT4B;XPO5
prerank,regulation of calcium ion transport (GO:0051924),-0.28415594143654,-1.0211624739765484,0.4025,0.8092859221396315,1.0,12/54,12.86%,EPB41;CACNB2;HOMER1;CTNNB1;INPP5K;TRPC6;CAMK2A;MYLK;CACNA1D;NOS1;CD84;SRI
prerank,amide transport (GO:0042886),-0.3389494265183828,-1.0211350450731198,0.4376417233560091,0.8084422954427785,1.0,6/26,6.82%,ABCG2;CERT1;SLC38A5;AQP11;SLC5A6;GLTP
prerank,regulation of cellular respiration (GO:0043457),-0.38098797849673666,-1.0211288458330958,0.43043478260869567,0.8075208292761711,1.0,4/17,8.19%,PRDM16;CBFA2T3;IFNAR1;PRELID1
prerank,monoacylglycerol metabolic process (GO:0046462),0.43482049179351817,1.0210791933654502,0.42300194931773877,0.8082913943962149,1.0,3/13,12.05%,PLA2G4A;MOGAT3;DGAT2
prerank,catecholamine biosynthetic process (GO:0042423),-0.42244324544154743,-1.021078748204073,0.4462474645030426,0.8067379994625552,1.0,4/11,10.31%,TGFB2;SNCA;DDC;GCH1
prerank,negative regulation of amyloid fibril formation (GO:1905907),-0.4120416785169942,-1.0210392560954347,0.4192872117400419,0.8059063242769721,1.0,7/12,31.45%,PFDN5;PFDN2;PFDN4;VBP1;TREM2;CLU;LDLR
prerank,negative regulation of cell adhesion (GO:0007162),-0.26872037614690936,-1.0209813576726152,0.4110787172011662,0.8051259916063667,1.0,20/72,16.83%,PLXNA4;PDE3B;ACER2;NOTCH1;CDH1;ACVRL1;SEMA4D;SEMA6A;TGFBI;ADAM22;NEXMIF;JAM3;ARHGDIB;SPOCK1;PTPRO;ARHGDIA;FZD4;PTPRC;CBLL1;PLXND1
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.360226469973689,1.0209293301362552,0.4236111111111111,0.8079971234349622,1.0,9/27,20.27%,TLR4;MAP3K1;LY96;TLR2;IRAK3;MAP3K7;TAB1;TNIP1;CD36
prerank,regulation of blood circulation (GO:1903522),0.3448844765066098,1.0205399078966226,0.44197952218430037,0.8082681390542746,1.0,4/34,7.04%,CELF2;DES;TPM1;BDKRB2
prerank,negative regulation of autophagy (GO:0010507),0.31477564844862227,1.0202359545876192,0.42040185471406494,0.8083056279845448,1.0,8/54,9.46%,LEPR;NUPR1;BCL2;PTPN22;MCL1;KLHL22;LRRK2;TLK2
prerank,endoderm formation (GO:0001706),-0.3149909855159462,-1.0199827091948723,0.4014962593516209,0.8070760949129864,1.0,9/35,9.60%,COL8A1;ITGA4;SOX17;LAMA3;MMP15;COL12A1;SOX7;COL6A1;ITGA7
prerank,C21-steroid hormone metabolic process (GO:0008207),-0.3637960613192755,-1.0197940129868406,0.44719101123595506,0.8066508736650417,1.0,4/20,21.43%,STARD3NL;FDXR;HSD17B10;CYP46A1
prerank,protein peptidyl-prolyl isomerization (GO:0000413),-0.3508411140933676,-1.0197313112798552,0.44036697247706424,0.8059120205401158,1.0,7/20,25.72%,FKBP1A;PPIA;PPIB;FKBP4;NKTR;PPIL6;PPIL3
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.37379633159959,1.0196745574994026,0.4511545293072824,0.8090697422803619,1.0,2/27,4.20%,LPAR1;F2RL3
prerank,regulation of integrin activation (GO:0033623),0.41557053551666606,1.019588761749216,0.45863309352517984,0.8086045320658629,1.0,3/15,10.49%,SELP;FBLIM1;PLEK
prerank,positive regulation of epithelial cell differentiation (GO:0030858),-0.3721907879883565,-1.019407131360645,0.4424778761061947,0.8058921462528539,1.0,7/17,20.73%,AHI1;BMP4;SFRP4;FGF2;NKX6-1;BTG1;BAD
prerank,secondary alcohol metabolic process (GO:1902652),0.3373869361045005,1.0193350750594274,0.4066666666666667,0.8085496741238519,1.0,9/42,14.75%,APOA2;APOF;CYP27A1;IDH1;SOAT1;CH25H;OSBPL5;IDH2;ABCA1
prerank,positive regulation of GTPase activity (GO:0043547),-0.234145502993018,-1.0192396655790277,0.4110169491525424,0.8054458106956464,1.0,49/188,16.45%,DOCK9;ITGA6;RALGAPA2;BCAR3;ABR;TBC1D8;DOCK10;NET1;TIAM1;SEMA4D;ARHGEF15;TBC1D30;RAP1GAP2;RAB3GAP1;CCL14;RAPGEF2;RGS7;RGS6;CCDC125;SGSM1;ARHGAP27;BCR;RHOG;RACK1;ARHGEF26;CAV2;CD40;TBC1D22B;DOCK8;ALS2;TBC1D8B;TBC1D14;ARHGEF7;RALGAPA1;RGP1;RUNDC1;RAPGEF6;SIPA1L3;F11R;HRAS;AGRN;ARHGAP45;EVI5;SNX18;ARHGAP24;CCL19;TBC1D12;RAP1A;NTF3
prerank,oligodendrocyte differentiation (GO:0048709),-0.35714151593042337,-1.0188688415788276,0.44097995545657015,0.8055593516026488,1.0,8/19,34.58%,EIF2B2;SOX6;TPPP;PTPRZ1;CDK5;SLC8A3;PRDM8;SOX8
prerank,negative regulation of fibroblast proliferation (GO:0048147),0.39759977091195153,1.01864520269964,0.4491682070240296,0.8096212266464027,1.0,5/18,13.46%,MORC3;PARP10;CDC73;SKI;PEX2
prerank,extracellular matrix assembly (GO:0085029),-0.35010469162932584,-1.0186390501514968,0.4376470588235294,0.8052411315841047,1.0,13/23,24.93%,NTN4;GPM6B;GAS6;MYH11;FBLN5;EMILIN1;RAMP2;QSOX1;MFAP4;NTNG1;NTNG2;HAS1;HAS3
prerank,positive regulation of mRNA metabolic process (GO:1903313),0.43090099334862364,1.018332114095824,0.44360902255639095,0.8096701217179115,1.0,3/13,8.81%,ZC3HAV1;RC3H1;MOV10
prerank,negative regulation of protein localization to membrane (GO:1905476),0.36778382589592645,1.01833208436313,0.4421052631578947,0.8089648341554395,1.0,9/24,23.55%,PID1;NUMB;RHOQ;BCL2L1;DAB2;PPFIA1;DMTN;LZTFL1;TGFB1
prerank,sodium ion homeostasis (GO:0055078),-0.35853669776798497,-1.0183168257770372,0.4289044289044289,0.8052436131493822,1.0,5/21,9.49%,SLC12A2;ATP1B1;ATP1A1;SLC8A1;NEDD4L
prerank,microtubule-based transport (GO:0099111),-0.4087895044926497,-1.0179537582464597,0.43680709534368073,0.8053033305883076,1.0,7/12,34.12%,DYNC1I2;ADCY10;SPAG17;HTT;CABYR;DNAAF2;CCDC40
prerank,import into nucleus (GO:0051170),0.3025819718953824,1.0173340677078837,0.41550387596899224,0.8108791519145239,1.0,11/73,14.29%,PRICKLE1;TNPO1;GEMIN4;APPL2;TPR;PHB2;APPL1;IPO7;EIF4ENIF1;POM121;GEMIN5
prerank,macromolecule catabolic process (GO:0009057),0.3717720151779881,1.0170679969400076,0.4424778761061947,0.810870875276504,1.0,5/26,12.19%,NEDD4;CLN5;TRIM24;UVRAG;CLPX
prerank,regulation of protein localization to membrane (GO:1905475),0.371152181158558,1.016988432810617,0.4594594594594595,0.810378978624792,1.0,6/28,9.78%,GPC6;SPTBN1;MMP14;GPC2;STX8;APPL1
prerank,negative regulation of macroautophagy (GO:0016242),0.36229043594941873,1.0165991484616441,0.420863309352518,0.810739273720846,1.0,9/26,17.20%,NUPR1;LRRK2;TMEM39A;SCFD1;USP36;CHMP4A;CHMP4B;FEZ2;SMG1
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),-0.3503131711939174,-1.0161562847705277,0.43457943925233644,0.809595105094823,1.0,4/21,8.85%,TOX;CTNNB1;FZD3;VEGFA
prerank,lymphocyte differentiation (GO:0030098),0.30245249958419845,1.0156977148958881,0.42902711323763953,0.8123680787266964,1.0,9/68,6.52%,LEPR;AXL;IL11;NHEJ1;KIT;PTPN22;VCAM1;HDAC4;PTPN2
prerank,protein-containing complex subunit organization (GO:0043933),0.28255212285725606,1.015449387082071,0.4410480349344978,0.8123196800429723,1.0,22/109,15.00%,KMT2A;LAMC1;TEAD1;TPR;ST13;CREBBP;SNX9;TEAD2;YAP1;TAPBP;MNAT1;TUBGCP4;PPID;DNM1L;WDR19;HFE;TUBGCP2;WASL;WASF1;MDM4;GEMIN5;PML
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.2994138047674835,1.0153882142300354,0.4380952380952381,0.8117767447636526,1.0,22/73,16.82%,WNT3A;OSM;IL11;IL6;ARAF;STOX1;HAX1;ATP2B4;CREBL2;OPRD1;RIPK2;DOCK7;FNIP1;MTCP1;BDNF;TBK1;NTRK3;STK4;PRKD2;APP;CNOT9;RAPGEF3
prerank,positive regulation of endocytosis (GO:0045807),-0.2982865995479254,-1.0152848926856175,0.42318059299191374,0.811176186290503,1.0,9/45,10.74%,NLGN1;SGIP1;HIP1;SNCA;HNRNPK;B2M;LDLRAP1;NEDD4L;CBL
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),0.4522071531731603,1.01490996847821,0.4527938342967245,0.8123546936660465,1.0,5/11,15.67%,MLLT3;WNT5B;PLEKHA4;NKD1;DAB2
prerank,glycosaminoglycan metabolic process (GO:0030203),-0.2887676146429786,-1.014834826497258,0.4358288770053476,0.8115497617607018,1.0,14/54,14.02%,GPC5;HS3ST1;HS6ST2;HS3ST5;XYLT1;SDC3;EXT1;B3GAT2;CHST9;HS3ST2;GUSB;SGSH;AGRN;NAGLU
prerank,negative regulation of oxidoreductase activity (GO:0051354),-0.4359399797017118,-1.0147335655570127,0.4288747346072187,0.8108956710658196,1.0,3/10,14.26%,SNCA;HDAC6;AOC3
prerank,negative regulation of organelle assembly (GO:1902116),0.3406415206710278,1.0141542903409038,0.4166666666666667,0.8135416881422726,1.0,13/35,16.15%,NUPR1;YAP1;LRRK2;SMAD4;TMEM39A;SCFD1;TBC1D7;RBM14;CHMP4A;CHMP4B;KAT2B;FEZ2;ODF2L
prerank,peptidyl-serine modification (GO:0018209),0.2693484601945108,1.013801417170474,0.42953929539295393,0.8136860745084045,1.0,37/166,17.20%,PDPK1;ROCK2;CAMK1D;STK32B;STK39;IKBKE;PRKCZ;TOP1;LATS2;TGFBR1;MORC3;GALNT2;GALNT1;TGFBR2;MAP4K1;GSK3B;LRRK2;TLK2;MAPK14;AKT3;HIPK3;RPS6KA3;MASTL;MAP3K13;MAPK9;WNK1;MAPKAPK5;TBK1;CSNK2A2;EIF2AK3;STK4;PKN2;PRKD2;TTBK2;MKNK2;RICTOR;SMG1
prerank,positive regulation of endopeptidase activity (GO:0010950),-0.33384734643720093,-1.0133490844736297,0.4510250569476082,0.8137409029178412,1.0,10/26,17.54%,GRIN2B;MBP;PRELID1;GRIN1;LYN;AIM2;TTBK1;PSENEN;PSME1;PYCARD
prerank,mammary gland epithelium development (GO:0061180),0.4233768966730428,1.0127724523855188,0.4417293233082707,0.8155655022090872,1.0,1/14,0.44%,WNT4
prerank,response to UV-A (GO:0070141),-0.3943686218739496,-1.0124525352772904,0.452914798206278,0.8153976462040715,1.0,7/14,28.63%,AKT1;CCND1;EGFR;MMP1;TIMP1;MMP2;MMP3
prerank,regulation of fibrinolysis (GO:0051917),-0.3975055233606231,-1.0122941986702616,0.4327731092436975,0.8148774447061978,1.0,3/13,12.50%,THBS1;FAP;USF1
prerank,microtubule anchoring (GO:0034453),0.4196910444538741,1.012101572043417,0.4361493123772102,0.8165609252468314,1.0,2/12,4.99%,DAG1;CLASP1
prerank,negative regulation of platelet activation (GO:0010544),-0.37384685433414466,-1.011843671457638,0.4562899786780384,0.8151572211746693,1.0,3/16,7.57%,PRKG1;NOS3;CEACAM1
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.3169422985633476,1.0117668881390798,0.4341692789968652,0.8167359259745327,1.0,9/52,8.89%,PDPK1;SPTBN1;EPHA3;SORBS1;EPB41L2;ATP2B4;PTPN9;KIF5B;DLG1
prerank,low-density lipoprotein particle remodeling (GO:0034374),0.44520012452316843,1.0112176272026112,0.4652908067542214,0.817451765925171,1.0,1/11,2.03%,APOA2
prerank,mitotic G2/M transition checkpoint (GO:0044818),-0.2937459513805559,-1.0111916457602723,0.43640897755610975,0.8161020460344576,1.0,19/43,32.15%,FOXN3;MRE11;CLSPN;BABAM1;ATM;CDKN1A;BRCA1;CHEK1;DTL;DONSON;TAOK2;CDC14B;BLM;HUS1B;TOPBP1;PLK1;CDK1;CDC6;TICRR
prerank,ATP-dependent chromatin remodeling (GO:0043044),0.3343457636429397,1.011184823911133,0.43769968051118213,0.8168394155752434,1.0,17/42,19.51%,MBD2;ANP32E;HNRNPC;VPS72;GATAD2B;CECR2;ACTL6A;SRCAP;ERCC6;HDAC2;SMARCA4;SMARCC1;CHD8;CHD4;ARID1B;ACTR8;NASP
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),0.4589141218344849,1.0111468661768919,0.4398496240601504,0.816231467517153,1.0,2/10,3.84%,FPR2;KIT
prerank,nucleoside salvage (GO:0043174),-0.43079290202853066,-1.0110253151244202,0.4536290322580645,0.8156335145960585,1.0,5/10,22.06%,UCK2;UPP2;UCKL1;UCK1;HPRT1
prerank,microtubule polymerization or depolymerization (GO:0031109),-0.3345937879601435,-1.011017620192401,0.43400447427293065,0.8147268008570943,1.0,8/24,18.17%,STMN2;KIF18A;FGF13;NCKAP5;MAPT;STMN4;TPPP;STMN1
prerank,sodium ion export across plasma membrane (GO:0036376),0.42345079687031134,1.0109501271312105,0.45419103313840153,0.816028745734758,1.0,1/13,0.45%,ATP1A2
prerank,positive regulation of positive chemotaxis (GO:0050927),-0.38680118416130416,-1.0106355858506526,0.44155844155844154,0.8148796157670165,1.0,6/15,9.68%,KDR;VEGFC;F3;VEGFA;CXCL12;SCG2
prerank,membrane protein ectodomain proteolysis (GO:0006509),0.3836574776316049,1.0106086999923416,0.4490161001788909,0.8162101412393636,1.0,4/21,11.82%,DAG1;SPPL3;ERAP1;ADAM19
prerank,positive chemotaxis (GO:0050918),0.4032744322987807,1.0105949286084652,0.4510166358595194,0.8155458184563688,1.0,3/17,3.83%,FPR2;NRP1;ANGPT1
prerank,cellular response to interleukin-1 (GO:0071347),-0.2328573673510756,-1.010528039102569,0.4117647058823529,0.814256625881415,1.0,35/143,21.19%,PLCB1;ST18;RPS6KA5;IL1R1;NOD1;IL1RAP;PSMC3;DAB2IP;CCL14;MAPK3;PSMD14;UBB;PSMD3;PSMD4;PSMD6;CD40;PSMA6;PSMA4;PSMB8;PTGIS;UBA52;PSMA8;CCL19;NOD2;PSME1;PYCARD;TOLLIP;IRAK1;PSMD7;PSMC6;IKBKB;PSMB5;UPF1;PSMC5;PSMB1
prerank,negative regulation of heart contraction (GO:0045822),0.44564160241022843,1.0103970196116163,0.45714285714285713,0.8153700790871983,1.0,1/11,0.45%,ATP1A2
prerank,positive regulation of transport (GO:0051050),0.28856832087804746,1.0101919106532122,0.4434782608695652,0.8151846329410759,1.0,10/85,8.35%,KMT2A;CAMK1D;FPR2;APOA2;ANXA2;ANXA1;NR1H3;CD47;GSK3B;BAX
prerank,cellular response to decreased oxygen levels (GO:0036294),0.30488781568644346,1.0100062106348302,0.4556765163297045,0.8149453431441555,1.0,8/65,7.58%,RORA;GATA6;TERT;EPAS1;BMP7;CPEB1;NPEPPS;OPRD1
prerank,regulation of dendrite development (GO:0050773),0.33523761109792494,1.0098072888017646,0.4596375617792422,0.8147322704470064,1.0,7/37,7.66%,PTN;CAMK1D;SDC2;NEDD4;BMP7;DBN1;GSK3B
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),0.386265622354867,1.0097291225553668,0.44756554307116103,0.8142791656933323,1.0,4/21,6.98%,CGNL1;ARHGAP12;SYNGAP1;STAMBP
prerank,phosphatidic acid biosynthetic process (GO:0006654),0.33124832614124494,1.009620710381024,0.4354066985645933,0.8138492734603292,1.0,4/46,3.04%,PLD1;PLA2G4A;AGPAT4;DGKD
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),-0.3297859129327931,-1.009577496945096,0.4400921658986175,0.8160456314092231,1.0,5/27,5.42%,CSGALNACT1;CSPG4;XYLT1;B3GAT2;CHST9
prerank,negative regulation of secretion by cell (GO:1903531),0.3383500780890982,1.009537686537778,0.45320197044334976,0.813379423892347,1.0,5/38,4.42%,RSAD2;OSM;IL11;ANXA1;HRH3
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),-0.39552581809912657,-1.0094954647854293,0.4732510288065844,0.815300815488482,1.0,5/13,16.80%,GFPT2;PGM3;GFPT1;RENBP;GNPNAT1
prerank,phosphatidic acid metabolic process (GO:0046473),0.33046832026938944,1.0093365499566573,0.43890675241157556,0.8131626013805536,1.0,7/48,11.23%,PLD1;PLA2G4A;AGPAT4;DGKD;PLA2G6;GPD1L;AGPAT3
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),0.43800294153238084,1.0090324879920698,0.468,0.8132752564789856,1.0,1/12,0.67%,ROCK2
prerank,positive regulation of cellular component movement (GO:0051272),0.3690454479708446,1.0089535626500155,0.4537671232876712,0.8127665062057813,1.0,3/24,5.16%,PDPN;NTN1;TGFBR1
prerank,N-glycan processing (GO:0006491),0.401924960861307,1.0089493200677093,0.4658703071672355,0.8120848274377765,1.0,3/18,3.00%,MAN1C1;PRKCSH;MAN2A1
prerank,regulation of myeloid cell differentiation (GO:0045637),-0.27456907732833924,-1.0088502211093158,0.41621621621621624,0.8162227739314413,1.0,16/62,12.39%,MEF2C;MEIS2;PRKCB;THBS1;PTK2B;H3-3A;PRKCQ;CDK6;HOXB8;ZBTB16;ZFPM1;HDAC1;LYN;RUNX1;CBFB;FES
prerank,regulation of cell motility (GO:2000145),0.27573054319019225,1.0080518727244787,0.45323741007194246,0.81371047390068,1.0,13/121,6.82%,PLXNA2;ROCK2;DIAPH1;ARHGAP18;FGF1;LMO4;TACSTD2;FBLN1;LDB2;NTN1;AMOTL1;MGAT3;SPINT2
prerank,negative regulation of transferase activity (GO:0051348),-0.318933386808636,-1.007639850325385,0.43953488372093025,0.8187146258477517,1.0,8/28,19.80%,SMAD7;INPP5K;TERF1;PARK7;MAPT;MEN1;CDKN1C;EIF4A2
prerank,positive regulation of cellular amide metabolic process (GO:0034250),0.2906286269420155,1.0076122011851725,0.43157894736842106,0.8141453189831708,1.0,20/80,20.80%,ROCK2;PLD1;SMPD3;SAMD4A;VIM;IL6;PLA2G6;EPHA4;ZCCHC4;EFNA1;SOX4;CPEB3;UPF3A;CASP3;FXR2;PLXNB2;SIRT3;ERBB2;ELAVL1;SPHK2
prerank,negative regulation of protein transport (GO:0051224),0.3706000404784112,1.007453596105317,0.47543859649122805,0.8138340193238525,1.0,3/25,10.31%,RSAD2;SNX12;WWP2
prerank,amino acid transmembrane transport (GO:0003333),0.3228462365884311,1.0069748109213794,0.4383116883116883,0.8143579252905404,1.0,3/45,3.88%,SLC7A11;SLC6A13;SLC16A2
prerank,platelet aggregation (GO:0070527),0.34627026800760086,1.0065595773765916,0.44521739130434784,0.8147037674042251,1.0,5/33,5.48%,FN1;PDGFRA;GP1BA;VCL;CSRP1
prerank,import into cell (GO:0098657),0.32594787840292977,1.0065155789801494,0.4462809917355372,0.8141260070385544,1.0,5/41,3.88%,ATP1A2;SLC1A3;SLC6A13;SLC19A1;SLC16A2
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),0.3147654568139686,1.0064635352384557,0.4532488114104596,0.8135615621977574,1.0,10/56,11.97%,ROCK2;SPTBN1;ARL3;RASA1;STAMBP;SNX9;ESPL1;USP8;CECR2;RHOC
prerank,coenzyme A biosynthetic process (GO:0015937),0.4430726059507956,1.0061579965318774,0.45972495088408644,0.8122899814254924,1.0,7/11,31.10%,PANK2;ACAT1;PANK3;PPCS;PPCDC;DCAKD;COASY
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.4430726059507956,1.0061579965318774,0.45972495088408644,0.8122899814254924,1.0,7/11,31.10%,PANK2;ACAT1;PANK3;PPCS;PPCDC;DCAKD;COASY
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.4430726059507956,1.0061579965318774,0.45972495088408644,0.8122899814254924,1.0,7/11,31.10%,PANK2;ACAT1;PANK3;PPCS;PPCDC;DCAKD;COASY
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),-0.390416230507298,-1.00599733212413,0.4726166328600406,0.8224112174397039,1.0,6/14,20.46%,PCYT2;ETNK1;SELENOI;LPIN3;CEPT1;CHKA
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),-0.41283379610347176,-1.0057272997239775,0.45934959349593496,0.8221970645167719,1.0,4/12,13.74%,SIX1;VEGFA;PAX2;SIX4
prerank,calcium ion transmembrane transport (GO:0070588),0.28968419643733545,1.0054093334437462,0.4407796101949025,0.813472961779337,1.0,13/86,11.41%,TRPM3;MCU;TRPM6;MICU1;NALCN;SLC24A3;ATP2B4;PHB2;CACNA1C;TMEM165;TRPC1;PMPCB;ANO6
prerank,negative regulation of protein kinase B signaling (GO:0051898),-0.30162328878295175,-1.0051004159898724,0.43795620437956206,0.8230511515810628,1.0,7/38,13.98%,PTPRJ;PHLPP1;PLEKHA1;INPP5K;AKT1;RACK1;PPP2R5B
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.3119016185243516,1.0049910977757286,0.44764795144157815,0.8138764982414995,1.0,7/59,8.81%,TCF7L2;CDK8;TNRC6B;IL6;BAX;TNRC6A;MOV10
prerank,selective autophagy (GO:0061912),0.3110484045894234,1.004579113134792,0.4416403785488959,0.8142007763653845,1.0,9/56,11.43%,DYNLL1;VIM;AMBRA1;ARL13B;IFT88;UBA5;PHB2;UBE2V1;STBD1
prerank,monocarboxylic acid transport (GO:0015718),-0.28826659195555376,-1.004565453999377,0.4666666666666667,0.8235877747942789,1.0,9/51,8.59%,ABCG2;ABCC4;SLCO1C1;SLCO2A1;SLC16A9;SLC5A6;CEACAM1;SLC16A1;ATP8B1
prerank,endoplasmic reticulum membrane organization (GO:0090158),-0.4087740542937868,-1.0044277755026196,0.4666666666666667,0.8230473664139467,1.0,8/11,35.93%,ARL6IP1;VCPIP1;ATL2;STX18;BNIP1;TRDN;LPCAT3;MOSPD3
prerank,regulation of mitochondrial membrane permeability (GO:0046902),0.3944634420724302,1.00430962181131,0.4664246823956443,0.8141908226183846,1.0,6/18,18.47%,BCL2;HEBP2;BCL2L1;SLC25A4;MUL1;SLC25A31
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",-0.4053836803417725,-1.003950255686105,0.46804123711340206,0.8234178209087899,1.0,4/12,19.83%,GNL3L;GNL3;CCT5;WRAP53
prerank,sulfur amino acid catabolic process (GO:0000098),-0.42808740157982295,-1.0039384392914703,0.46218487394957986,0.8225225574893054,1.0,5/10,23.01%,TXN2;MTRR;CTH;ADO;MPST
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),-0.407811347436568,-1.0038789634986482,0.44871794871794873,0.821764919404805,1.0,3/12,11.68%,PROM1;PTPRO;BASP1
prerank,L-amino acid transport (GO:0015807),0.3625755600882311,1.003129811316505,0.4612736660929432,0.8164812378426244,1.0,2/28,0.80%,SLC7A2;SLC1A3
prerank,plasma membrane organization (GO:0007009),0.30313907273124796,1.0030574016154972,0.44617784711388453,0.8159713305602354,1.0,11/61,11.41%,MYOF;SPTBN1;A4GALT;COL5A1;PACSIN2;SNX9;MICALL1;PLSCR4;STX2;PLSCR2;ANO6
prerank,positive regulation of transforming growth factor beta production (GO:0071636),0.4357195098565359,1.0029333413308694,0.451171875,0.8156140171523193,1.0,3/11,7.85%,GATA6;BMPR1A;LGALS9
prerank,arachidonate transport (GO:1903963),0.4602149816415947,1.0028994713796786,0.4678714859437751,0.8143457292731646,1.0,2/10,7.04%,ANXA1;BDKRB2
prerank,arachidonic acid secretion (GO:0050482),0.4602149816415947,1.0028994713796786,0.4678714859437751,0.8143457292731646,1.0,2/10,7.04%,ANXA1;BDKRB2
prerank,GPI anchor metabolic process (GO:0006505),-0.33115501061496744,-1.0028334734073538,0.4646017699115044,0.8238132913451337,1.0,7/26,15.91%,MPPE1;PIGM;PIGU;PIGQ;PIGH;DPM2;PIGO
prerank,regulation of vasculogenesis (GO:2001212),-0.3954817019666397,-1.0026203328067498,0.46421267893660534,0.8235393450958322,1.0,7/14,16.16%,KDR;CD34;EMP2;RAPGEF2;CEACAM1;HEY1;RAP1A
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.30231913985104536,1.0025751135427594,0.46904024767801855,0.814452886696048,1.0,6/67,3.68%,SULF1;ROCK2;AXL;NRP1;VEGFD;SHB
prerank,response to exogenous dsRNA (GO:0043330),0.39164231915483644,1.00256133153382,0.4655493482309125,0.8137980025140571,1.0,6/18,15.52%,COLEC12;IRAK3;IFIT1;TICAM1;IFIH1;MUL1
prerank,regulation of neuroinflammatory response (GO:0150077),0.38781600882480843,1.0025316730292142,0.4652014652014652,0.8131856427050617,1.0,3/19,7.50%,NUPR1;IL6;IL18
prerank,endochondral bone morphogenesis (GO:0060350),-0.41864662831600097,-1.0024638324071706,0.44420600858369097,0.823075391361865,1.0,4/11,13.13%,MEF2C;BMPR2;BMP4;BMPR1B
prerank,cilium organization (GO:0044782),0.2537751507846213,1.0023681627908816,0.4597402597402597,0.812905489851491,1.0,54/209,22.19%,DCDC2;PARVA;CYS1;ASAP1;DYNLL1;ARL13B;RFX3;IFT88;ARL3;TTC39C;HYLS1;ARF4;TMEM107;EXOC2;DYNC2I1;DNAAF1;NUDCD3;IFT81;CC2D2A;CDC14A;CCDC57;WDR19;RAB3IP;CFAP221;IQCB1;IFT20;TRAPPC14;FBF1;CCDC66;RFX2;NPHP3;CEP250;CPLANE1;PKD2;GBF1;AVIL;TTBK2;EXOC7;EXOC1;RPGR;IFT52;ARL6;WDR11;CEP131;SSX2IP;CEP78;B9D2;OFD1;RP2;ACTR3;DZIP1L;PKD1;LZTFL1;CFAP410
prerank,regulation of macrophage differentiation (GO:0045649),0.41731898740226137,1.0023511831134508,0.47610294117647056,0.8122738039582946,1.0,4/15,16.13%,IL34;PTPN2;CSF1;INHA
prerank,phosphate ion homeostasis (GO:0055062),0.4442361639209821,1.0022872910738518,0.4548872180451128,0.8117801231170292,1.0,1/10,1.45%,ENPP1
prerank,cytoplasmic sequestering of protein (GO:0051220),0.4170178933088308,1.0017831555336065,0.448210922787194,0.8124224768228211,1.0,7/13,21.85%,DBN1;SUFU;KEAP1;PKD2;NFKBIE;GET4;PKD1
prerank,positive regulation of macrophage activation (GO:0043032),-0.3691319442147727,-1.0013745458333128,0.4579831932773109,0.8252585449532375,1.0,4/17,12.72%,IL33;THBS1;KARS1;TTBK1
prerank,peptidyl-proline modification (GO:0018208),-0.3292248776624488,-1.0013602843213425,0.42168674698795183,0.8243937253961368,1.0,8/25,25.72%,FKBP1A;FKBP7;PPIA;PPIB;FKBP4;NKTR;PPIL6;PPIL3
prerank,positive regulation of DNA repair (GO:0045739),0.32067589084152465,1.0013345200844475,0.4366883116883117,0.8128914391177569,1.0,17/46,23.82%,EYA2;EYA1;SPIDR;SLF2;XRCC1;EYA4;ERCC6;UIMC1;MGMT;BRCC3;ERCC8;EYA3;SPIRE1;SMCHD1;DHX9;CEBPG;ZCWPW1
prerank,regulation of mast cell degranulation (GO:0043304),0.4236893129060746,1.001104862182049,0.4756554307116105,0.8127630481491659,1.0,3/14,7.85%,GAB2;FER;LGALS9
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),-0.39297206420899844,-1.0009996862214505,0.44166666666666665,0.8243771171212138,1.0,6/13,31.59%,B3GNT2;B3GNT9;B3GNT3;B4GAT1;B3GNT6;B3GALT1
prerank,synaptic membrane adhesion (GO:0099560),-0.4006666351665854,-1.0000889938013935,0.47098214285714285,0.825928175639822,1.0,7/14,20.67%,PTPRD;LRRC4C;LRRC4B;SLITRK2;SLITRK1;LRFN5;NTNG1
prerank,apical junction assembly (GO:0043297),0.31315349195758113,0.9996043672058433,0.46215780998389694,0.8158163932068473,1.0,13/53,16.05%,AFDN;CDH5;PARD6G;PARD6A;VCL;CTNNA1;CLDN1;DLG1;RHOC;FBF1;CLDN11;PKN2;PATJ
prerank,insulin secretion (GO:0030073),-0.3512464220451044,-0.9995406239621568,0.47477064220183485,0.826638275548088,1.0,9/19,27.01%,RIMS2;PTPRN2;SNX19;PARK7;RAB11FIP5;PTPRN;SELENOT;CAMK2G;MAFA
prerank,organonitrogen compound biosynthetic process (GO:1901566),-0.233964056007876,-0.9993979120460672,0.4552238805970149,0.8261521683053898,1.0,35/151,20.68%,SGMS1;ACER3;DMD;ELOVL5;ACER2;CERS4;CERT1;PPM1L;DEGS2;ELOVL7;PCYT1B;LPCAT2;GPHN;SPNS2;SLC44A5;ALAS1;GCH1;SGMS2;GCNT1;GSTM5;MFSD2A;PLPP1;ST3GAL4;PRKD1;HACD3;SPTSSA;STARD7;SGPP1;GSTO2;LPIN3;CEPT1;GSTO1;TYW5;CHKA;PCSK5
prerank,regulation of ERBB signaling pathway (GO:1901184),0.40998226053080905,0.9993233061655171,0.47522935779816516,0.8158003916888314,1.0,4/15,12.72%,RBPJ;FER;CDH13;PTPN18
prerank,positive regulation of glucose import (GO:0046326),0.37668610974141453,0.9990498151118172,0.44761904761904764,0.8158078011416802,1.0,5/21,9.78%,OSBPL8;SORBS1;CREBL2;RHOQ;APPL1
prerank,positive regulation of locomotion (GO:0040017),-0.3217309905780912,-0.9989104957465825,0.45982142857142855,0.8266162831719078,1.0,3/27,3.24%,SPOCK2;THBS1;STX3
prerank,positive regulation of cytokine production (GO:0001819),0.24835441008630577,0.9988429690239925,0.47863247863247865,0.8156548649109907,1.0,31/292,8.47%,SULF1;RORA;ROCK2;IL16;SPTBN1;EIF2AK2;IL6ST;APOA2;OSM;PLA2R1;ANXA1;IL17D;IL6;TLR4;ARNT;LACC1;PRKCZ;PTPN22;ZBP1;SERPINE1;GBP5;NOS2;CREBBP;POLR1C;IL18;LGALS9;CD274;TNFRSF14;RIPK2;SETD4;WNT5A
prerank,regulation of purine nucleotide metabolic process (GO:1900542),0.3334373117299803,0.998548661182441,0.46434494195688225,0.8157251746647006,1.0,5/41,7.19%,PRKAG2;LACC1;RANBP2;TPR;JMJD8
prerank,protein homooligomerization (GO:0051260),0.2739820164132385,0.9985470780017212,0.45064377682403434,0.8150569602883252,1.0,8/114,6.33%,ALDH1A2;RNF213;MICU1;SHMT1;PRF1;CLYBL;APPL2;GBP5
prerank,NIK/NF-kappaB signaling (GO:0038061),-0.26202788356946666,-0.9985455651839577,0.4264264264264264,0.8266969269074826,1.0,25/72,24.51%,PSMC3;AKT1;PSMD14;PSMD3;MALT1;PSMD4;PSMD6;PSMA6;PSMA4;PSMB8;PSMA8;PSME1;DICER1;IRAK1;CARD10;PSMD7;PSMC6;PSMB5;PSMC5;TNFRSF10B;PSMB1;NFKB2;SKP1;PSMD11;PSMD8
prerank,ephrin receptor signaling pathway (GO:0048013),0.29049058189082344,0.9983234341057293,0.46805349182763745,0.814982980487363,1.0,16/82,13.45%,EFNB2;ROCK2;EPHA7;EPHA3;SDC2;EPHA8;EPHA1;RASA1;EPHA4;DNM1;NGEF;PTK2;EPHA2;EFNA1;EFNB1;WASL
prerank,regulation of cellular component biogenesis (GO:0044087),-0.29340549138367217,-0.9982792818911295,0.4567901234567901,0.8265051733422877,1.0,12/39,16.16%,TIE1;HSPA8;NOTCH1;DAB2IP;RAPGEF2;PINK1;ANKRA2;HSP90AA1;SPTY2D1;CCL19;IRGM;RAP1A
prerank,regulation of mitochondrial fusion (GO:0010635),0.44466537190407823,0.9982155257770878,0.46588693957115007,0.8145726483935746,1.0,3/11,15.52%,PID1;HUWE1;MUL1
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),-0.30010359545815374,-0.9981517015933042,0.4621026894865526,0.8259608058742227,1.0,13/37,19.63%,RPL5;RPS7;RPL11;HSP90AB1;SDCBP;RYBP;BAG6;CCAR2;RPL23;CAMLG;PARK7;N4BP1;EIF3H
prerank,telomere maintenance via recombination (GO:0000722),0.44139460254752344,0.9980557585041583,0.4723809523809524,0.8143066177708731,1.0,5/11,21.67%,RAD50;NSMCE2;ERCC1;SMC6;TEP1
prerank,membrane repolarization (GO:0086009),-0.37758868601246115,-0.9978564917084752,0.45751633986928103,0.8258752822494431,1.0,6/15,13.29%,ATP1B1;KCNJ2;ATP1A1;KCND3;KCNQ1;KCNE4
prerank,negative regulation of cytokine production (GO:0001818),0.2641884816782988,0.9977473457108917,0.46143617021276595,0.814421841788235,1.0,31/163,15.47%,LGR4;FN1;AXL;APOA2;TWSG1;ANXA1;IL6;IKBKE;ADCY7;TLR4;C5AR2;PTPN22;APPL2;RNF216;FOXP3;ANXA4;PPARA;LGALS9;CD274;NLRX1;PTPN6;IRAK3;MAP2K5;HOMER3;ARRB1;ATP2B1;SRGN;IFIH1;TBK1;RARA;IL23R
prerank,positive regulation of interleukin-1 production (GO:0032732),0.3125714868133849,0.997706579878317,0.4444444444444444,0.813856775301516,1.0,8/51,10.22%,IL16;IL6;TLR4;GBP5;LGALS9;RIPK2;WNT5A;PANX1
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",-0.2542186284891582,-0.9974125097054816,0.47337278106508873,0.8262071865110739,1.0,13/84,8.46%,QKI;NOVA2;MBNL1;CELF4;KHDRBS2;RBFOX3;RBFOX1;PTBP1;PUF60;KHDRBS3;HNRNPK;DDX17;TRA2A
prerank,cellular response to fatty acid (GO:0071398),0.42653503872606235,0.9970295057177665,0.4727954971857411,0.8148342142686161,1.0,2/12,12.05%,PID1;DGAT2
prerank,regulation of vesicle-mediated transport (GO:0060627),-0.2460127159601909,-0.9969020045836148,0.48255813953488375,0.8267581382051427,1.0,19/91,14.81%,SYT1;RIMS2;HIP1;RIT2;NSF;HIP1R;STXBP5L;MAPK3;MBTPS1;SCARB1;RAB3C;CPLX1;SYT7;CPLANE2;FES;RAB12;SYK;RAB5C;PTPRC
prerank,regulation of keratinocyte proliferation (GO:0010837),0.37862678850482323,0.9968179466592083,0.4607142857142857,0.8146736088926878,1.0,5/22,12.61%,NOTCH2;CASK;KLF9;EPPK1;CRNN
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),-0.35864681834350864,-0.9967524808112638,0.4486607142857143,0.8262920976198176,1.0,7/20,21.34%,ENTPD1;HSP90AB1;PSTPIP1;P2RX7;PYCARD;CASP1;C3
prerank,regulation of supramolecular fiber organization (GO:1902903),0.3782670654011697,0.9965577124777275,0.489945155393053,0.8146714869406755,1.0,3/22,4.96%,AKAP13;EFEMP2;AEBP1
prerank,positive regulation of leukocyte proliferation (GO:0070665),0.4347764582062099,0.9961971345635735,0.4766355140186916,0.8149120933554038,1.0,4/12,12.04%,IL34;BST2;PTK2;CSF1
prerank,organelle disassembly (GO:1903008),0.33580711486878334,0.9961545931902684,0.4559322033898305,0.8143425554667776,1.0,10/33,21.38%,UBA5;PLK5;KIF5B;KLC1;ATG2A;GBF1;GOLGA2;MCTS1;MRRF;ZFAND1
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.3801567479024621,0.996141729358437,0.4865350089766607,0.8137165554929546,1.0,3/20,5.16%,ZMIZ1;EPAS1;TGFBR1
prerank,positive regulation of response to cytokine stimulus (GO:0060760),0.41612828256830653,0.9958855233371,0.4622823984526112,0.8137215942232993,1.0,5/13,19.42%,AXL;WNT5A;IFIH1;TAF9;IL7
prerank,regulation of activated T cell proliferation (GO:0046006),0.3532915220406642,0.9952979533839527,0.462738301559792,0.8145797544868173,1.0,6/30,8.99%,RC3H1;FOXP3;IL18;LGALS9;CD274;IGF2
prerank,intracellular protein transmembrane transport (GO:0065002),-0.2897200693193467,-0.9950886010860865,0.4692874692874693,0.8300664085720204,1.0,15/42,27.55%,PEX26;PEX10;ZFAND2B;PEX16;C2CD5;DNLZ;HSPA5;GRPEL2;TOMM40L;SEC61A1;TOMM20;SEC61G;RTN2;TIMM21;SEC61B
prerank,response to histamine (GO:0034776),0.44771801460931937,0.9950090823494947,0.44793713163064836,0.8146564423792837,1.0,1/10,0.81%,DIAPH1
prerank,cellular response to glucose stimulus (GO:0071333),0.3544965029724072,0.99490136380475,0.462738301559792,0.8142658199827815,1.0,3/30,5.35%,ZBTB20;PRKAA2;UNC13B
prerank,response to lipid (GO:0033993),0.28097286556734113,0.9948679315178969,0.45454545454545453,0.813687682846973,1.0,19/105,12.46%,SELP;GATA6;FER;RBP4;ANXA1;STAT5B;TLR4;PTPN22;PPARA;NOS2;CTSH;LY96;LGALS9;STRN3;NOCT;SMAD6;IRAK3;FOXO3;RPS6KA3
prerank,vesicle cytoskeletal trafficking (GO:0099518),-0.2940478292596112,-0.9947262756837547,0.45187165775401067,0.830107376915626,1.0,4/39,2.04%,MYO1D;PPFIA2;FNBP1L;TANC2
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.4261935827685354,0.9946951003704855,0.4758220502901354,0.8134610985407869,1.0,7/12,20.92%,RESF1;ATF7IP;TASOR;PPHLN1;SETDB1;MPHOSPH8;TET1
prerank,negative regulation of mRNA processing (GO:0050686),-0.3764580781170592,-0.993989098703323,0.46187363834422657,0.8312060494053292,1.0,6/15,21.65%,PTBP1;BARD1;RNPS1;SRSF9;C1QBP;SRSF6
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),-0.3080267920200772,-0.9938240075460256,0.4396135265700483,0.8307983377754533,1.0,11/32,18.90%,NAV3;SNCA;ARHGEF2;STMN2;TUBB4A;FGF13;CLASP2;MAP2;MID1IP1;STMN1;FKBP4
prerank,positive regulation of heart contraction (GO:0045823),0.3899521045210408,0.9935552801559039,0.45569620253164556,0.8156316896975918,1.0,3/19,8.56%,ATP1A2;SCN3B;ADM
prerank,cellular response to hormone stimulus (GO:0032870),0.2999427829419995,0.9935015301498467,0.4514200298953662,0.8150886977922269,1.0,10/69,7.82%,TFPI;ATP1A2;GHR;NCOA3;STAT5B;CTSH;SFR1;KLF9;RAMP1;TRIM24
prerank,calcium ion transport (GO:0006816),-0.24019343848734956,-0.9932077041421986,0.4666666666666667,0.8316008528116571,1.0,25/113,13.61%,CACNA1E;CACNB2;GRIN3A;TRPC3;SLC24A2;RYR2;TPT1;FKBP1A;GAS6;TRPC5;TRPC4;RYR3;ATP2C1;SLC8A1;ATP2A3;CACNA1G;TRPC6;CAMK2A;RAMP2;CACNA1D;CRACR2B;TMCO1;CAV1;SLC3A2;ATP2A2
prerank,phosphatidylinositol metabolic process (GO:0046488),0.2715431199760033,0.9931735193277077,0.4732272069464544,0.8152579734734884,1.0,12/109,6.63%,PTPN13;PLEKHA2;PLA2G4A;TPTE;PI4KA;PDGFRB;MTMR11;MTMR3;PLCB3;PLEKHA4;PLA2G4C;PIK3C2A
prerank,regulation of ERAD pathway (GO:1904292),-0.4164799948816327,-0.9930410723231121,0.4613733905579399,0.8311427484686124,1.0,6/11,28.13%,AQP11;BAG6;USP13;ATXN3;TMEM259;HERPUD1
prerank,superoxide metabolic process (GO:0006801),-0.31902846954092556,-0.9929846253347575,0.4752941176470588,0.8303944102797154,1.0,9/29,23.77%,NOS3;SH3PXD2A;NCF2;PREX1;CYBB;SOD1;PRDX2;TAFA4;NOX4
prerank,negative regulation of developmental growth (GO:0048640),-0.3151397840953599,-0.9929137173903978,0.47877358490566035,0.8296804022879952,1.0,9/30,17.37%,DIP2B;DCC;WWC1;SEMA3G;FGF13;ULK1;CDKN1A;MAP2;BBS2
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.31903819538654005,0.9927786626858298,0.453525641025641,0.8155756198745935,1.0,6/48,7.19%,PRKAG2;GCGR;RANBP2;TPR;NOS2;JMJD8
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",-0.31976438197752705,-0.9920062752210947,0.43765281173594134,0.831269088185563,1.0,12/27,28.36%,CD74;SPRED2;ATM;EEF1E1;PTTG1IP;SPRED3;SPRED1;MSX1;ATR;MIF;YJU2;PMAIP1
prerank,tRNA aminoacylation (GO:0043039),-0.29963050128545565,-0.9917066040818503,0.455470737913486,0.8311992554986716,1.0,14/37,33.70%,LARS2;KARS1;CARS1;EEF1E1;IARS1;RARS2;HARS1;YARS2;FARSB;YARS1;TARS1;WARS2;NARS1;QARS1
prerank,mitochondrial translation (GO:0032543),-0.24679610734173282,-0.9915996330755463,0.4754601226993865,0.8305709924442838,1.0,45/104,35.82%,MRPL4;LARS2;GFM1;MRPS18A;EARS2;MRPL1;MRPS30;MRPS23;FASTKD2;MRPL57;RARS2;MRPL28;MRPL47;AURKAIP1;MTRF1;MRPL35;MRPS5;MRPL34;HARS1;MRPS2;MRPL52;MRPL23;MRPL9;MRPS31;MRPL49;MRPS12;TUFM;MRPL11;MRPL50;MRPS16;MRPS22;MRPS25;MRPL44;CHCHD1;MRPL51;MRPL32;MRPL54;MRPL43;MRPL2;MRPL24;MRPL37;ERAL1;MTIF2;MRPL45;MRPL30
prerank,positive regulation of cell-matrix adhesion (GO:0001954),0.3268965774707937,0.9915365981513831,0.46440677966101696,0.8180116004569727,1.0,7/42,7.66%,PLEKHA2;RIN2;NRP1;S100A10;EFEMP2;EPHA1;GSK3B
prerank,positive regulation of amyloid-beta formation (GO:1902004),0.3810507470605499,0.9914268541666115,0.455743879472693,0.8176286855411108,1.0,3/18,12.74%,ROCK2;EPHA4;EFNA1
prerank,myotube cell development (GO:0014904),-0.4228398488543934,-0.9913656827284612,0.5009746588693957,0.8303235609233773,1.0,3/10,10.78%,SIX1;SELENON;CAV2
prerank,multivesicular body assembly (GO:0036258),-0.3144552836526475,-0.9913176902501406,0.4580335731414868,0.8295529380618581,1.0,12/30,27.49%,VPS37B;VPS37A;CHMP1A;CHMP1B;CHMP7;CHMP2B;VPS28;SNF8;CHMP2A;HGS;CHMP6;CHMP4C
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.41320921364662083,0.9910277097372454,0.4635514018691589,0.8179633615882268,1.0,4/13,16.03%,TNRC6B;TNRC6A;EIF4ENIF1;CPEB3
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.2859663898959398,0.9910154449934935,0.47291361639824303,0.8173281215446936,1.0,27/76,24.22%,PRICKLE1;RNF217;ZYG11B;RNF19A;GSK3B;NUB1;PIAS1;LRRK2;SUMO1;KEAP1;PTK2;HECTD1;DDA1;TRIB1;RCHY1;DAB2;RNF180;DNAJB2;RNF139;SIRT2;PTEN;FBXW7;CDK5RAP3;CEBPA;RNF14;TAF1;COP1
prerank,nucleoside phosphate biosynthetic process (GO:1901293),0.4209898504952822,0.9909782561046356,0.47195357833655704,0.8167584805347277,1.0,2/14,9.45%,CMPK2;AK5
prerank,high-density lipoprotein particle remodeling (GO:0034375),0.4116007194329077,0.990122031899108,0.4731977818853974,0.8182795996288976,1.0,1/15,2.03%,APOA2
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.29300626915872485,0.9901039050236424,0.45864661654135336,0.8176739447346196,1.0,16/76,15.52%,PRICKLE1;ANGPT1;CRY1;MYCBP2;HDAC4;BIRC3;RIPK2;PIAS1;LRRK2;FBXO4;HUWE1;CENPX;CUL3;TBC1D7;RCHY1;MUL1
prerank,limb development (GO:0060173),0.35013531869605463,0.990043054761434,0.5,0.8171690332424294,1.0,9/28,20.75%,GLI3;SALL1;LRP4;NOG;IQCE;KAT2B;RSPO2;PTCH1;MEGF8
prerank,positive regulation of protein sumoylation (GO:0033235),0.44970710076706366,0.9895038683062946,0.48096192384769537,0.8178745227237952,1.0,3/10,15.52%,HDAC4;PIAS1;MUL1
prerank,regulation of lymphocyte migration (GO:2000401),-0.42727503631746805,-0.9894706477049263,0.4852941176470588,0.8338285068818075,1.0,3/10,7.21%,STK10;JAM2;AKT1
prerank,neutrophil migration (GO:1990266),-0.27236695460239746,-0.9892854593238882,0.45535714285714285,0.8334451895719956,1.0,10/58,15.18%,BSG;PECAM1;PDE4B;TGFB2;CCL14;FCER1G;SYK;PIK3CD;PPIA;CCL19
prerank,post-transcriptional gene silencing by RNA (GO:0035194),0.37466574889327475,0.9891643105865243,0.46415770609318996,0.8180353533463897,1.0,5/20,19.70%,TNRC6B;TNRC6A;MOV10;WTIP;AJUBA
prerank,protein localization to cell-cell junction (GO:0150105),0.40375264335030425,0.9889892978028199,0.46564885496183206,0.8178048715539454,1.0,2/15,2.80%,CGNL1;CDH5
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.33432453946491586,0.9888937319885113,0.4779050736497545,0.8173907443016001,1.0,8/33,12.74%,DPP4;FOXC2;EPHA8;SERPINE1;PLAU;PTK2;EPHA2;EFNA1
prerank,response to estradiol (GO:0032355),0.3459592081902978,0.9886427783841862,0.4880952380952381,0.8173371936618807,1.0,5/31,8.59%,NCOA3;ANXA1;STAT5B;FAM210B;STRN3
prerank,regulation of cell division (GO:0051302),0.2935738249833935,0.9882686153786624,0.47131782945736433,0.8175948812079116,1.0,18/72,18.08%,FGF1;MLLT3;NCOA3;PLK5;KLHL21;UVRAG;SUSD2;BCL2L1;KLHL13;AHCTF1;ENTR1;FSD1;TLE6;BIRC6;POU5F1;TXNIP;NLRP5;MYO19
prerank,myeloid cell differentiation (GO:0030099),0.3206882338928688,0.9882489827872182,0.4773462783171521,0.8169881892265565,1.0,15/47,17.68%,MPIG6B;IL11;KIT;UBA5;NCOA6;PTPN2;CDKN2B;ACIN1;TET2;KAT6A;ALAS2;INHA;HSPA9;CASP3;ATP5IF1
prerank,regulation of microtubule-based movement (GO:0060632),-0.4107078502627687,-0.988205803474509,0.49586776859504134,0.8354682893787617,1.0,6/11,26.73%,HDAC6;NEFH;LAMP1;MAP2;HAP1;CCDC65
prerank,cell projection organization (GO:0030030),0.34650430539193827,0.9879036243269318,0.47920133111480867,0.8171715924756527,1.0,8/30,14.00%,PARVA;QRICH2;PACSIN2;NPHP1;RHOQ;PLEK;ATP1B2;RHOU
prerank,negative regulation of interleukin-12 production (GO:0032695),-0.3753952489223978,-0.9877046922125158,0.44731182795698926,0.8358824227486465,1.0,5/14,28.10%,THBS1;CMKLR1;C1QBP;JAK3;LILRB1
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.27832174121253334,0.9875062271024528,0.4823529411764706,0.8174576508483109,1.0,14/102,9.79%,PDPK1;ENPP1;FER;GCGR;TRARG1;RAB10;SORBS1;ADCY5;ADCY7;CPEB1;ADCY1;INSIG2;RHOQ;OTOP1
prerank,actomyosin structure organization (GO:0031032),0.28296413714122404,0.9874082901005957,0.47058823529411764,0.8170590353017714,1.0,9/75,6.96%,ROCK2;TMOD3;CSRP3;SORBS1;EPB41L5;TPM1;EPB41L2;CSRP1;ACTN2
prerank,"transcription, DNA-templated (GO:0006351)",0.25364957720701037,0.9872935902351617,0.5044814340588989,0.816706997905648,1.0,46/207,18.57%,SOX5;MLLT3;MAF;POLR2D;PIR;GLIS3;NCOA6;BAZ2A;DTX1;CREBL2;POLR1C;CDC73;TRIM24;MEF2A;CCNH;EPC1;MNAT1;NOCT;CDK7;TAF7;HIPK3;TCEA1;POLR2C;IWS1;RTF1;FOXO3;THAP1;NFIC;MED20;PKNOX1;PAF1;POLR2F;GTF2H4;ERCC6;LEO1;MLLT1;SNAPC3;IRF9;TAF9;POLR3H;DDX21;AFF4;GTF2H2;TTF1;PMF1;NFYA
prerank,regulation of cellular ketone metabolic process (GO:0010565),-0.2653489990646293,-0.9868656067062404,0.4732394366197183,0.8373899001452471,1.0,22/61,24.51%,PSMC3;OAZ1;PSMD14;OAZ2;SIRT5;PSMD3;PSMD4;PSMD6;PSMA6;PSMA4;PSMB8;CAV1;PSMA8;PSME1;PSMD7;PSMC6;PSMB5;PSMC5;PSMB1;FGFR4;PSMD11;PSMD8
prerank,positive regulation of blood coagulation (GO:0030194),-0.3544419067920943,-0.9868470303337005,0.4863013698630137,0.8365497942601818,1.0,4/17,14.61%,THBS1;F3;USF1;ST3GAL4
prerank,protein transport (GO:0015031),-0.20969537958251938,-0.9868256976703976,0.5087719298245614,0.835709268992546,1.0,83/332,19.54%,LRP1B;PRKCB;ATP6V0A1;TBC1D8;TFRC;NSF;SYNDIG1;STX3;ANK3;MACF1;SCAMP5;ARF5;TBC1D30;ATP6V1B2;SEL1L;LMAN2L;ARHGEF2;STXBP1;RAB6B;TVP23B;YWHAH;STX16;TANGO6;ATP6V0C;RAB38;SCAMP1;HERC2;RAB3C;ARL1;SCG5;HDAC6;GCC2;NPM1;SCAMP2;SGSM1;TMED2;VMP1;VPS33B;RAMP2;CD74;SCG2;SLC10A7;ATP6V1D;TBC1D22B;ARHGAP1;TBC1D8B;TBC1D14;NAPA;VLDLR;RUNDC1;RAB12;KIF3B;RAB5C;PPY;SNX8;MIA2;EVI5;CHMP1A;TBC1D12;VIPAS39;ATP6V0A2;DNAJC27;CHMP1B;CEP290;TMED7;RABL3;AP3D1;ATP6V1G2;TVP23A;BBS2;CHMP2B;NECAB3;BBS1;LRSAM1;RAB1B;RAB15;ARF6;TBC1D5;ARL4D;SAR1B;ATP6V0E2;IFT22;TBC1D1
prerank,response to interleukin-1 (GO:0070555),0.2898163940875834,0.9868027407943495,0.4649122807017544,0.8173210776173275,1.0,14/73,16.20%,ADAMTS12;GBP2;ANXA1;RC3H1;HDAC4;CD47;CCL2;LGALS9;IRAK3;ADAMTS7;CCL25;APP;TAF9;GBP3
prerank,regulation of epithelial cell differentiation (GO:0030856),-0.35430324019522647,-0.9866515470650913,0.4678492239467849,0.8353197308761457,1.0,7/17,20.22%,KLF7;APOLD1;CEACAM1;PRKX;CAV1;MAFF;DLL1
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.28070036944958476,0.9866487408538118,0.4809384164222874,0.8170098188523502,1.0,15/94,12.29%,PDK1;ITPR1;IKBKE;BCL2;MCL1;CASP4;CUL4A;FHIT;QRICH1;BAX;STK24;BCL2L1;RRP8;CUL3;EPHA2
prerank,synaptic vesicle membrane organization (GO:0048499),-0.35658502658173047,-0.9866284026524001,0.45083932853717024,0.8344823291212989,1.0,9/17,32.16%,STX3;SNAP25;SYNGR2;AP3D1;SNAP29;STX1B;TOR1A;SYNGR1;STX19
prerank,positive regulation of type I interferon production (GO:0032481),0.296491304619378,0.9865293888794135,0.49453978159126366,0.8166555549714773,1.0,24/73,24.27%,TRIM56;TLR4;PTPN22;ZBP1;CREBBP;POLR1C;STAT1;RIPK2;POLR3F;TLR2;OAS2;POLR2F;IFIH1;TBK1;POLR3H;RNF135;DHX36;SETD2;POLR2K;RIOK3;GAPDH;DHX9;TOMM70;POLR3B
prerank,regulation of interleukin-17 production (GO:0032660),0.34283422066457464,0.9863016435089259,0.4797979797979798,0.8165944779674917,1.0,5/31,7.50%,OSM;IL6;TLR4;FOXP3;IL18
prerank,maintenance of protein location in nucleus (GO:0051457),-0.3431300455617316,-0.9861328936736149,0.47276688453159044,0.8349525475250713,1.0,9/20,22.69%,SYNE1;TAF3;TAF8;BARD1;PARK7;BCL3;ARL2;SKP1;CHCHD10
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),0.39370844265504645,0.9852310428249031,0.4991181657848324,0.8186422735341018,1.0,3/18,2.80%,ROCK2;KANK1;CDH5
prerank,positive regulation of lipid catabolic process (GO:0050996),0.38092324457896726,0.9849512031484452,0.49162011173184356,0.818691307696564,1.0,7/19,27.14%,APOA2;PPARA;ABHD5;ANGPTL3;DAGLB;IRS2;PRKCD
prerank,mitochondrion localization (GO:0051646),0.3843518968174756,0.9847296827915685,0.46605504587155966,0.818551325452963,1.0,6/19,15.52%,TRAK1;MEF2A;LRRK2;ATCAY;TLE6;MUL1
prerank,mesenchyme development (GO:0060485),0.40354221951094255,0.9842471709237843,0.4971537001897533,0.8190607195128724,1.0,3/15,5.16%,BMP2;BMP7;TGFBR1
prerank,positive regulation of protein metabolic process (GO:0051247),0.2768306700435912,0.9838243285177324,0.4801762114537445,0.8194749862281551,1.0,19/110,12.85%,ROCK2;SMURF2;SLC6A9;NEDD4;DACT1;IL17D;NR1H3;IL18;GSK3B;WNT5A;TIPARP;SLC25A37;WWP2;HUWE1;NKD1;MAP2K5;CSF1;HECW2;ASB5
prerank,glucan catabolic process (GO:0009251),0.3992160964817776,0.9829918408906584,0.516728624535316,0.8208990230504734,1.0,4/15,11.43%,PYGB;MGAM;PYGM;STBD1
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.2841625370356029,0.98293456056243,0.4818181818181818,0.820384915310872,1.0,17/78,15.97%,PRICKLE1;RNF217;ZYG11B;RNF19A;GSK3B;NUB1;PIAS1;SGTA;LRRK2;SUMO1;KEAP1;HECTD1;DDA1;TRIB1;RCHY1;DAB2;RNF180
prerank,neural crest cell differentiation (GO:0014033),-0.3534602034963538,-0.9825609694712064,0.4786516853932584,0.8438035613239644,1.0,2/18,1.17%,CDH2;MEF2C
prerank,sensory perception (GO:0007600),-0.28131423773580877,-0.9820242735745189,0.49604221635883905,0.84431926570505,1.0,13/45,20.93%,PCDH15;TMEM150C;GNAS;OPRM1;SCN9A;KCNA2;NTSR2;GNAL;P2RX7;CHRNA4;CHRNA7;PENK;TTC8
prerank,stress fiber assembly (GO:0043149),0.39639074834173205,0.981993096624659,0.4826325411334552,0.8213335830798729,1.0,3/15,13.07%,SORBS1;CUL3;ARRB1
prerank,contractile actin filament bundle assembly (GO:0030038),0.39639074834173205,0.981993096624659,0.4826325411334552,0.8213335830798729,1.0,3/15,13.07%,SORBS1;CUL3;ARRB1
prerank,regulation of glucose transmembrane transport (GO:0010827),-0.35323169423131306,-0.9816497333550054,0.4861751152073733,0.8444501221955947,1.0,8/18,25.75%,SLC2A1;PRKCB;INPP5K;NR4A3;C2CD5;C3;OCLN;RTN2
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),0.4289536448229169,0.981608377565251,0.4868686868686869,0.8216366104254155,1.0,5/12,9.50%,DOCK5;IGFBP5;ADAMTS1;TPM1;DOCK7
prerank,negative regulation of viral release from host cell (GO:1902187),0.4192912404224275,0.9815907359503382,0.5037174721189591,0.8210250541456653,1.0,7/13,24.18%,TRIM5;TRIM21;TRIM26;CHMP3;PML;TRIM8;TRIM32
prerank,positive regulation of protein catabolic process (GO:0045732),0.28632089009494494,0.9813643024938234,0.4803767660910518,0.8209088279192026,1.0,15/84,12.85%,SH3D19;SMURF2;NEDD4;DACT1;NRDC;GSK3B;SNX9;WNT5A;TIPARP;WWP2;HUWE1;NKD1;VGLL4;HECW2;ASB5
prerank,regulation of cytokine production involved in immune response (GO:0002718),0.36733720643264045,0.9810358739370222,0.49547920433996384,0.8210762640316402,1.0,4/22,8.47%,APOA2;LACC1;TNFRSF14;WNT5A
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),0.3213193910260109,0.9804570316063342,0.4918300653594771,0.8217922928438868,1.0,13/45,15.95%,SP100;GBP2;TRIM5;VCAM1;OASL;STAT1;OAS2;TRIM21;TRIM26;JAK1;PML;IRF9;ICAM1
prerank,response to growth factor (GO:0070848),0.3248144952393405,0.9797156378677798,0.5195246179966044,0.8229229237573704,1.0,16/41,20.47%,GATA6;BMPR1A;STAT5B;PLK5;TGFBR1;TGFBR2;MAP2K5;EPHA2;TBC1D7;ACVR1C;ACVR2B;URI1;SHC1;EMD;ERBB2;MAPK7
prerank,apoptotic process (GO:0006915),-0.22313050322100614,-0.9795214196425209,0.5023255813953489,0.8494403445365291,1.0,42/203,15.08%,HIP1;EFNA5;FOXO1;ELMO1;PTK2B;DCC;CIT;ADAM15;NCKAP1;PPP2R1A;TBX1;PLAGL1;TRPC5;SEMA6A;ARHGEF6;CASP7;PPARD;MAL;FAP;PRUNE2;SCN2A;PAK5;ZBTB16;AKT1;STK11;RHOB;RFK;NUDT2;BAG6;FAS;TRAF7;DDIT4;MRPS30;FASTKD2;TNFRSF21;CASP9;JADE1;PPIA;PAK4;AKAP1;BMF;VDAC1
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),0.3768374432218311,0.9794785031232978,0.4876325088339223,0.8228630528111877,1.0,5/20,17.14%,TERT;SNIP1;TARBP2;ZC3H7B;PUM2
prerank,negative regulation of telomere maintenance (GO:0032205),0.4042336970675494,0.9791653416737135,0.47058823529411764,0.8230131112297258,1.0,5/15,16.18%,SLX4;RAD50;SMG6;ERCC1;TNKS2
prerank,negative regulation of cell-cell adhesion (GO:0022408),0.3246263986848825,0.9790602052316314,0.48327759197324416,0.8226165661741119,1.0,11/39,17.19%,BMP6;BMP2;MIA3;PPARA;SPINT2;MYADM;PTK2;MAP2K5;WNK1;NF2;PODXL
prerank,growth hormone receptor signaling pathway (GO:0060396),0.3941877205888742,0.9789532476545927,0.4569789674952199,0.8222512279891618,1.0,4/14,12.68%,GHR;STAT5B;PTK2;PTPN1
prerank,programmed necrotic cell death (GO:0097300),0.38376348775367175,0.9788000965188561,0.47387387387387386,0.8219964815662151,1.0,6/18,21.65%,TLR4;LY96;DNM1L;TICAM1;TRPM7;RIPK1
prerank,positive regulation of innate immune response (GO:0045089),0.3437563620367235,0.978386182964423,0.4691358024691358,0.8223673779277544,1.0,6/30,11.03%,FPR2;IFI35;ZBP1;GBP5;WNT5A;POLR3F
prerank,ubiquinone biosynthetic process (GO:0006744),-0.37682245984827933,-0.9782721886884289,0.4939759036144578,0.8519424836081818,1.0,7/15,23.92%,COQ9;FDXR;COQ10B;COQ8A;COQ3;COQ5;NDUFA9
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),-0.3055974144098464,-0.9780657120949725,0.507537688442211,0.8516326773199454,1.0,11/33,23.09%,HIP1;BCAR3;HIP1R;CCDC88A;AKT1;CBL;PLAUR;EGF;AFAP1L2;NUP62;HAP1
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),-0.2597687373753089,-0.9780581066859515,0.5075528700906344,0.8507487089138679,1.0,15/71,14.25%,CTSC;CTSB;OTUD7A;FAP;LGMN;CTSS;HDAC6;UBB;BAG6;MALT1;ZRANB1;CTSL;PSMA6;UBA52;PSMA8
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),-0.2499345807609858,-0.9779984501242173,0.5085714285714286,0.850001921747744,1.0,26/84,24.51%,PSMC3;CDC26;PSMD14;UBB;PSMD3;PTTG1;PSMD4;PSMD6;PSMA6;UBE2E1;PSMA4;PSMB8;UBA52;PSMA8;CDK2;BUB1B;UBE2D1;PSME1;PSMD7;PSMC6;PSMB5;PSMC5;PSMB1;ECRG4;PSMD11;PSMD8
prerank,peptide hormone secretion (GO:0030072),0.35084055692776905,0.9778675380257535,0.47183098591549294,0.8230123112510636,1.0,5/26,10.26%,GHRH;ANXA1;IL6;FAM3B;CDK16
prerank,regulation of cell-cell adhesion (GO:0022407),0.3215548892186421,0.9778650772647358,0.5115511551155115,0.8223726413116556,1.0,7/39,8.23%,DPP4;EPHA7;AFDN;FSTL3;CD47;SPINT2;FUT4
prerank,regulation of protein kinase activity (GO:0045859),0.2693506873953328,0.9777379364030693,0.4906474820143885,0.8220431943333619,1.0,15/106,12.04%,PDPK1;DEPTOR;PRKAG2;DDR2;PPM1E;PLCE1;EPHA1;SNX9;DTNBP1;RAP2C;UVRAG;TAF7;PTK2;TSPYL2;CSF1
prerank,neuron projection organization (GO:0106027),-0.3768962212994701,-0.9775792391451624,0.5165562913907285,0.8501896456419773,1.0,6/15,21.20%,INSR;LGMN;ABCD2;ATP1A3;CHRNA7;DCTN1
prerank,regulation of monocyte chemotaxis (GO:0090025),0.3624226442888388,0.9774732505596064,0.49733570159857904,0.8220399866702879,1.0,4/24,5.64%,CXCL10;FPR2;NBL1;SERPINE1
prerank,inorganic ion transmembrane transport (GO:0098660),-0.39350009423501864,-0.977453894875422,0.49897750511247446,0.849652498016778,1.0,2/12,11.40%,ABCC9;KCNJ8
prerank,response to insulin (GO:0032868),0.2807841785509928,0.9772377089835137,0.484304932735426,0.8219911572524156,1.0,11/80,9.79%,PDPK1;ENPP1;FER;TRARG1;RAB10;SORBS1;EPM2AIP1;CPEB1;INSIG2;RHOQ;OTOP1
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),-0.30582136719381114,-0.97714265541223,0.4976190476190476,0.849606634703094,1.0,6/30,11.92%,TPT1;RPS3;CXCL12;CD74;CCAR2;PTTG1IP
prerank,regulation of endothelial cell apoptotic process (GO:2000351),0.3251294895423411,0.9769478223744616,0.5087719298245614,0.82207233886184,1.0,6/39,7.71%,PDPK1;IL11;CDH5;ANGPT1;SERPINE1;CCL2
prerank,cellular response to fluid shear stress (GO:0071498),-0.38827957121337775,-0.976851712007218,0.4810126582278481,0.8494841929894125,1.0,2/12,3.29%,MEF2C;KLF2
prerank,positive regulation of viral life cycle (GO:1903902),0.3626637826041316,0.9766651887918266,0.5026929982046678,0.8221040420234883,1.0,3/22,7.85%,AXL;KPNA6;LGALS9
prerank,peptide catabolic process (GO:0043171),0.36210149749255083,0.9766009995364514,0.49391304347826087,0.8216357319016142,1.0,5/23,9.70%,CPQ;ANPEP;NPEPPS;CTSH;ERAP1
prerank,negative regulation of T cell proliferation (GO:0042130),0.3453937293004011,0.9764906874383222,0.47027972027972026,0.8212568455394212,1.0,5/28,7.90%,RC3H1;FOXP3;LGALS9;CD274;TNFRSF14
prerank,regulation of protein localization to nucleus (GO:1900180),0.31755127676239664,0.9760694238848265,0.48776508972267535,0.8216496744638194,1.0,9/43,8.62%,PARP9;LATS2;TPR;DTX3L;CTNNA1;NGFR;GSK3B;GLUL;YAP1
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",0.3547943137771171,0.9760656823741221,0.49730700179533216,0.8210223443473837,1.0,9/24,20.89%,SUZ12;EPC1;JARID2;TASOR;DNMT3A;PPHLN1;BMI1;MPHOSPH8;PHF1
prerank,negative regulation of microtubule polymerization (GO:0031115),-0.3976427936716196,-0.9760357097611275,0.5119305856832972,0.8507976082770605,1.0,6/12,18.17%,SNCA;STMN2;TUBB4A;ARHGEF7;MAP2;STMN1
prerank,ubiquinone metabolic process (GO:0006743),-0.3774503792021121,-0.9760267787825948,0.4949698189134809,0.8499265210133138,1.0,7/15,23.86%,COQ9;FDXR;COQ10B;COQ8A;COQ3;COQ5;AIFM2
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.37248678418712694,0.9759308736637453,0.4991055456171735,0.8207310357245997,1.0,5/22,14.68%,ROCK2;CRY2;GSK3B;MASTL;BOD1L1
prerank,release of cytochrome c from mitochondria (GO:0001836),0.38705181566276947,0.9757070183487119,0.48007590132827327,0.8206517831538626,1.0,4/17,10.73%,BCL2;BAX;DNM1L;BCL2L1
prerank,ventricular septum morphogenesis (GO:0060412),0.34719332042160866,0.9754487332744552,0.48080438756855576,0.8206292892092785,1.0,8/27,12.69%,ROBO1;TGFBR3;BMPR1A;TGFBR1;TGFBR2;HEYL;SMAD4;NOG
prerank,response to organic cyclic compound (GO:0014070),0.3091963980602307,0.9751783485405628,0.4960998439937597,0.8206641766585493,1.0,9/52,10.07%,IGFBP5;ANXA1;STAT5B;IL18;CCL2;STRN3;LRRK2;HLCS;TIPARP
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.4353092274250692,0.9751776317675033,0.5028901734104047,0.820030232896052,1.0,4/10,21.76%,TGFA;ADRA2A;HBEGF;FBXW7
prerank,calcium ion transport into cytosol (GO:0060402),-0.3373592890843107,-0.9749061895943705,0.4966139954853273,0.8521244114168184,1.0,5/21,9.11%,RYR2;GRIN2A;SLC8A1;GRIN2B;GRIN1
prerank,positive regulation of chromatin organization (GO:1905269),-0.3937181578873322,-0.9747989849035767,0.4957805907172996,0.8515177225895674,1.0,4/12,18.28%,H3-3A;TERF1;TAL1;TINF2
prerank,negative regulation of mRNA catabolic process (GO:1902373),0.3396190635241854,0.9747601951135241,0.4769503546099291,0.8204354457939168,1.0,8/29,17.71%,TENT5A;PKP3;DHX34;NOCT;EIF4ENIF1;FUS;AXIN2;GDNF
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),-0.38686943563423287,-0.9747215842594327,0.4901185770750988,0.8508295014995241,1.0,3/13,6.94%,GRIN2A;PERP;LGMN
prerank,positive regulation of apoptotic process (GO:0043065),0.2416842624254386,0.9746843018970115,0.5232704402515723,0.8199886023252784,1.0,38/293,10.58%,IGFBP3;PAWR;TIAM2;AKAP13;EPHA7;PHLDA1;NUPR1;WNT10B;DLC1;FGD4;PNMA3;IFIT2;ADAMTSL4;PRDM11;DAPK1;BMP2;APBB1;IL6;LATS2;TGFBR1;UNC13B;ZBP1;TNFRSF12A;USP27X;PLEKHG2;NGFR;PDCD5;ARHGEF11;QRICH1;BAX;STK3;UBE2Z;CALHM2;ARHGEF12;SOS2;NGEF;PPID;DNM1L
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.28935078258344166,0.974541671001896,0.5114503816793893,0.8196876290685341,1.0,14/75,11.85%,PDPK1;FGFR1;ECM1;NRP1;VEGFD;BMP2;ARNT;TGFBR1;WNT5A;IGF2;AKT3;CDH13;EGR3;NR4A1
prerank,lipid droplet formation (GO:0140042),0.43240880046979663,0.9744771031606124,0.4952561669829222,0.8192157434198075,1.0,2/10,6.30%,SMIM22;PLA2G4C
prerank,negative regulation of macrophage activation (GO:0043031),0.4002370555118409,0.97435961333829,0.4822064056939502,0.8188610010626752,1.0,2/16,6.02%,IL31RA;NR1H3
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.34520286774065984,0.9739314825422606,0.4956063268892794,0.8192460415062318,1.0,12/28,26.14%,PARP9;PARP3;DTX3L;ERCC6;SHLD2;KMT5C;CYREN;RIF1;KMT5B;SMCHD1;SHLD1;TFIP11
prerank,regulation of mRNA polyadenylation (GO:1900363),0.3892365737327508,0.9739106835981877,0.5136612021857924,0.8186758455819733,1.0,3/17,8.00%,CPEB1;RNF20;ZC3H3
prerank,thyroid hormone generation (GO:0006590),0.43670545681709805,0.9734934529215054,0.49604743083003955,0.8190394548999375,1.0,2/10,10.14%,CPQ;DIO2
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),-0.36750822759620916,-0.9734668158759116,0.5063559322033898,0.8534461825551882,1.0,3/15,9.94%,AKT1;PRELID1;GHITM
prerank,transcription by RNA polymerase I (GO:0006360),0.3297702590499146,0.9731325911469709,0.5016666666666667,0.8192901909605439,1.0,18/34,27.68%,POLR1C;CCNH;MNAT1;POLR1G;CDK7;POLR2F;GTF2H4;GTF2H2;CAVIN1;TTF1;POLR2K;UBTF;TAF1;POLR2H;POLR1A;ERCC2;ERCC3;TAF1D
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),-0.38732708018907536,-0.9729993089357984,0.5194274028629857,0.8538490404963366,1.0,4/13,9.73%,EPN2;DAB2IP;EMILIN1;HHEX
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.30817895175644944,0.9729298496069382,0.5016181229773463,0.8191567206207828,1.0,9/48,10.63%,PDPK1;FGFR1;FOXC2;ANXA1;ANGPT1;PIK3C2A;MAPK14;AKT3;FGF18
prerank,camera-type eye morphogenesis (GO:0048593),-0.42090548663826494,-0.972862926475694,0.5192307692307693,0.853302827701771,1.0,4/10,9.04%,TENM3;TBX2;VEGFA;LRP6
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),-0.40748170328705746,-0.9726227437436884,0.47265625,0.8530539732432924,1.0,6/10,29.29%,INSIG1;YOD1;UBE2J1;UBAC2;SVIP;UBE2G2
prerank,establishment of protein localization to mitochondrion (GO:0072655),-0.279794134864004,-0.9722778584149737,0.5216284987277354,0.8531210531031397,1.0,12/46,19.73%,AKT1;MFF;PINK1;MFN2;GDAP1;TIMM8B;DNLZ;GRPEL2;AIP;TOMM40L;TOMM20;TIMM22
prerank,regulation of interferon-gamma production (GO:0032649),-0.2562426383848163,-0.9722210523782858,0.5157232704402516,0.8523791707363685,1.0,9/71,9.14%,PDE4D;PDE4B;SLC7A5;IL1R1;GAS6;HMGB1;CYRIB;ZFPM1;HAVCR2
prerank,female gonad development (GO:0008585),0.3765884553559611,0.9721381804192868,0.4772313296903461,0.8204020595808595,1.0,2/19,3.84%,NR2F2;KIT
prerank,positive regulation of actin filament polymerization (GO:0030838),-0.2797748581405667,-0.9720716062692605,0.5234159779614325,0.8518984297196699,1.0,14/44,21.33%,PTK2B;NCKAP1;LMOD1;ARPC4;CDC42EP3;VASP;CDC42EP1;CDC42EP5;EVL;PYCARD;ARF6;PFN2;CARMIL1;PRKCE
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),0.3513081606952302,0.9719670998700497,0.495,0.8201768024814086,1.0,3/27,2.88%,SLC7A2;SLC1A3;SLC6A9
prerank,chemical homeostasis (GO:0048878),0.29951473730075456,0.9717769895658162,0.5256198347107438,0.8200004109852692,1.0,6/61,7.96%,ZBTB20;RBP1;ACOXL;SLC4A11;NR1H3;WNK4
prerank,response to ionizing radiation (GO:0010212),0.2883545802881109,0.9712428696286516,0.5163297045101088,0.8206074847684708,1.0,14/70,15.16%,EYA1;XRRA1;NHEJ1;ANXA1;IKBIP;SPIDR;XRCC4;NABP1;MAPK14;RFWD3;INTS3;RAD9A;UIMC1;FIGNL1
prerank,regulation of granulocyte chemotaxis (GO:0071622),0.3703772803443667,0.9710951445034398,0.5102040816326531,0.8203229608541429,1.0,5/19,12.67%,CAMK1D;IL34;PTK2;CSF1;RARRES2
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),-0.3903352631498871,-0.9710054069707101,0.5182926829268293,0.8540205357855774,1.0,5/12,17.57%,HMGB1;MBP;CD74;KLF4;LPL
prerank,iron ion transport (GO:0006826),-0.27322182252986615,-0.970895944276299,0.5104712041884817,0.8534354660035708,1.0,17/47,21.84%,ATP6V0A1;TFRC;SLC40A1;FTH1;ATP6V1B2;ATP6V0C;SLC39A14;ATP6V1D;ARHGAP1;TTYH1;ATP6V0A2;SCARA5;ATP6V1G2;ATP6V0E2;ATP6V1F;ATP6V0D2;ATP6AP1
prerank,myeloid dendritic cell activation (GO:0001773),-0.3996784506685829,-0.9708632527943136,0.5287128712871287,0.8526338088735763,1.0,4/12,17.73%,DOCK2;HMGB1;PYCARD;CAMK4
prerank,regulation of receptor recycling (GO:0001919),0.3861371447488082,0.9708218818502202,0.5061295971978984,0.82035688447604,1.0,3/16,5.68%,ANXA2;TBC1D16;OPTN
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.2778233000398388,-0.9702982236626122,0.5388471177944862,0.8533482602965935,1.0,10/44,12.59%,THBS1;GAS6;SNCA;ARL6IP1;AKT1;VEGFA;PAX2;RPS6KA1;NGF;KLF4
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.35865344085162876,0.9700821191579378,0.4899817850637523,0.8215144864908305,1.0,9/24,21.39%,SLX4;DCP2;HNRNPC;XRN1;TNKS2;EXOSC10;TEN1;CTC1;TENT4B
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),0.34695619852174925,0.9698830782508414,0.5153153153153153,0.8213749286033505,1.0,4/27,7.71%,NFAT5;IL6;CD47;CCL2
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),0.28065261313118045,0.9698588203177254,0.5216095380029806,0.8208038669119395,1.0,9/93,4.01%,SASH1;CCN2;EIF2AK2;MTURN;RELL1;TRAF5;SH3RF1;BMP2;TAOK3
prerank,peptidyl-arginine modification (GO:0018195),-0.3627258418051028,-0.9697380109051716,0.5098039215686274,0.8540386302256046,1.0,3/15,19.68%,ART3;PARK7;PRMT5
prerank,regulation of sodium ion transmembrane transport (GO:1902305),-0.3148948799235518,-0.9697173029166424,0.5,0.8532044476607159,1.0,7/27,10.30%,FGF12;FXYD5;UTRN;YWHAH;CAMK2D;NEDD4L;NOS1
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),0.3591762226491203,0.9696807806841661,0.51138353765324,0.8205908136401421,1.0,8/23,22.98%,PLK5;PRCC;ZWINT;NABP1;INTS3;NABP2;CDK5RAP3;WEE1
prerank,regulation of viral life cycle (GO:1903900),0.3763697672418376,0.9695642196411105,0.5053191489361702,0.8202467636155745,1.0,4/21,12.33%,AXL;TRIM5;KPNA6;TRIM21
prerank,regulation of Notch signaling pathway (GO:0008593),0.2849168060271845,0.9693538836958296,0.5146627565982405,0.8201456624139549,1.0,10/76,6.75%,TSPAN5;RBPJ;ZMIZ1;IL6ST;BMP2K;AAK1;DLK1;DTX1;MMP14;CREBBP
prerank,cellular response to dsRNA (GO:0071359),0.3898248410848187,0.9692031159383276,0.5072992700729927,0.8198965550212093,1.0,4/15,15.52%,COLEC12;IFIT1;IFIH1;MUL1
prerank,extrinsic apoptotic signaling pathway (GO:0097191),0.2867226539697087,0.9690275818734311,0.5022288261515602,0.8196885389428258,1.0,10/70,11.99%,PDPK1;SMAD3;BCL2;MCL1;GSK3B;BAX;CASP8AP2;APPL1;BCL2L1;IFI27
prerank,positive regulation of protein import into nucleus (GO:0042307),0.34067670218032975,0.9688376887379513,0.4903339191564148,0.8195577647264435,1.0,3/28,5.83%,SMAD3;ZIC1;TPR
prerank,Golgi ribbon formation (GO:0090161),-0.3773681444676163,-0.9685605004486397,0.5053304904051172,0.8555052702475027,1.0,7/13,28.14%,STX16;GCC2;VTI1A;MYO18A;PRMT5;TMED5;GOLPH3
prerank,negative regulation of nervous system development (GO:0051961),-0.3511634989131806,-0.9680965839821619,0.5154004106776181,0.8558952040074808,1.0,4/17,8.76%,ROBO2;NOTCH1;SORL1;B2M
prerank,protein N-linked glycosylation (GO:0006487),-0.2618607328995514,-0.9680940398852931,0.5071225071225072,0.8550102556790884,1.0,21/66,20.57%,FUT8;MGAT5;ALG14;RPN2;SRD5A3;ALG5;GFPT2;LMAN1;MGAT4A;DPM2;DOLPP1;PGM3;GFPT1;SLC39A8;GAL3ST1;OSTC;ALG6;PMM2;STT3B;MOGS;UBE2J1
prerank,positive regulation of programmed cell death (GO:0043068),0.240696694062483,0.9678278438990218,0.52875,0.8214006239595929,1.0,36/272,10.58%,IGFBP3;PAWR;TIAM2;AKAP13;PHLDA1;WNT10B;PRF1;FGD4;PNMA3;IFIT2;ADAMTSL4;DAPK1;BMP2;APBB1;IL6;LATS2;UNC13B;ZBP1;TNFRSF12A;NOS2;USP27X;PLEKHG2;NGFR;PDCD5;ARHGEF11;QRICH1;BAX;STK3;UBE2Z;CALHM2;LRRK2;ARHGEF12;SOS2;NGEF;PPID;DNM1L
prerank,positive regulation of cell death (GO:0010942),0.2930639812714351,0.9666436062251924,0.5371517027863777,0.8236033211704691,1.0,7/59,9.30%,EFNB2;SLC6A13;GSK3B;RIPK2;WNT5A;HEBP2;LRRK2
prerank,fatty acid derivative biosynthetic process (GO:1901570),-0.2971734361754989,-0.9666223174769342,0.5256723716381418,0.8582055270506155,1.0,18/35,30.45%,FAR2;HMGCS2;GGT5;ACACA;ACLY;SCD;GGT7;GGT1;HSD17B8;HPGD;FASN;HMGCLL1;GCDH;BDH1;HMGCL;ALOX5AP;ALOX5;BDH2
prerank,regulation of peptide hormone secretion (GO:0090276),0.28616540280287633,0.966437573585838,0.5038759689922481,0.8234735704205289,1.0,16/67,19.78%,DPP4;RAPGEF4;ITPR1;RFX3;IL6;NOS2;CACNA1C;PPP3CB;HFE;ADRA2C;ADRA2A;RAPGEF3;CLOCK;ITPR2;UQCC2;KCNS3
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.39135620578449876,0.9662554771714559,0.4936708860759494,0.8232643727663074,1.0,7/16,22.79%,RC3H1;MOV10;CPEB3;DHX36;KHSRP;ZC3H12A;ZFP36L2
prerank,cellular response to superoxide (GO:0071451),-0.4226502000480734,-0.9660772160565224,0.5274261603375527,0.8587518634541587,1.0,3/10,21.77%,NOS3;SOD1;PRDX2
prerank,tricarboxylic acid metabolic process (GO:0072350),0.4324192785062171,0.9650978645733795,0.5139146567717996,0.8253766621919256,1.0,6/12,20.78%,IDH1;SIRT4;ACO1;IDH2;IREB2;ASS1
prerank,small GTPase mediated signal transduction (GO:0007264),0.2708752708915411,0.9650932288438898,0.5213549337260678,0.8247606291521251,1.0,16/103,10.27%,RIN2;TIAM2;PLD1;ARHGAP18;KSR1;RRAS2;ARHGAP32;NTN1;ARL3;PLCE1;SIAH2;RALBP1;RRAD;USP8;RALGDS;MAPK14
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.3267513772924059,0.9648588483593382,0.495,0.8246892580512324,1.0,5/34,9.66%,DOCK5;NRP1;S100A10;MYADM;TRIOBP
prerank,regulation of lymphocyte differentiation (GO:0045619),-0.34869354130670366,-0.9642541937969127,0.4918793503480278,0.862799811630651,1.0,12/18,50.22%,PRELID1;XRCC6;PRKDC;IKZF3;CRTAM;PRDM1;CCR2;TBX21;ABL1;SLAMF8;NCKAP1L;CD2
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.3786780968369524,0.9638678196160826,0.5255474452554745,0.8266038035098716,1.0,5/18,15.52%,GSK3B;BAX;TMEM14A;ZNF205;MUL1
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),-0.31659509780686823,-0.963862685315155,0.5080831408775982,0.8629966684417584,1.0,12/26,31.96%,PLCG2;RAB27A;SNCA;GRIN1;ABCD2;PARK7;SLC18A2;ADGRB1;SLC30A10;TLR6;ALOX5;SLC5A3
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.26518661145766126,-0.9638261045493403,0.5699208443271768,0.8621995763168038,1.0,18/55,24.51%,PSMC3;PSMD14;PSMD3;PSMD4;PSMD6;PSMA6;PSMA4;PSMB8;PSMA8;PSME1;PSMD7;PSMC6;PSMB5;PSMC5;PSMB1;SKP1;PSMD11;PSMD8
prerank,positive regulation of interleukin-8 production (GO:0032757),0.30276590040676565,0.9637509095265341,0.49919743178170145,0.8262894483714638,1.0,7/49,7.85%,APOA2;IL17D;IL6;TLR4;SERPINE1;NOS2;LGALS9
prerank,pinocytosis (GO:0006907),-0.41131648920944086,-0.9637484414211344,0.5169491525423728,0.861548955733391,1.0,5/10,27.57%,DOCK2;PYCARD;CARMIL1;SNX33;AHSG
prerank,transepithelial transport (GO:0070633),0.39831466198725096,0.9636746731530805,0.5302752293577981,0.825868387295429,1.0,2/15,0.80%,CXADR;SLC1A3
prerank,negative regulation of Ras protein signal transduction (GO:0046580),-0.2863040864880985,-0.9635288283067838,0.5218446601941747,0.861284783494949,1.0,9/35,10.15%,TGFB2;MET;DAB2IP;ARHGAP44;RASIP1;MYOC;CCDC125;MFN2;ITGA3
prerank,regulation of oxidative phosphorylation (GO:0002082),0.39514316749799083,0.9633614605211156,0.508411214953271,0.8259863876688879,1.0,1/16,1.78%,NUPR1
prerank,positive regulation of nuclear division (GO:0051785),0.3550488369350436,0.9632616823391539,0.5,0.8255918426786362,1.0,4/25,8.99%,PHIP;TGFA;PDGFRB;IGF2
prerank,positive regulation of cellular process (GO:0048522),0.2271207255498804,0.9631678137429753,0.6042363433667781,0.8251956931915637,1.0,58/565,9.48%,EFNB2;PDPN;BMP6;PTN;DPP4;CAMK1D;CCN2;FN1;PDGFRA;FGFR1;COLEC12;FGF1;PRKAA2;IL31RA;CXCL16;NUPR1;IL6ST;PHIP;GHRH;FPR2;APOA2;WNT3A;GAB2;OSM;IL11;FER;VEGFD;TGFA;IL34;PTHLH;GLP2R;IL6;TLR4;GLI1;BCL2;TPM1;STOX1;TGFBR1;KLHL22;MMP14;EPHA1;PDGFRB;HDAC4;CD47;TGFBR2;STAMBP;CTSH;NOXO1;RIPK2;ECHDC3;EPHA4;WNT5A;IGF2;IL13RA1;DNAJA2;ANKRD17;USP47;MST1R
prerank,regulation of centrosome cycle (GO:0046605),-0.32774705510780605,-0.9630956952568013,0.5,0.8615939761097822,1.0,11/21,34.99%,NPM1;CHMP1A;CHMP1B;CHMP2B;GEN1;CHMP2A;CHMP4C;FBXW5;AURKA;PKHD1;VPS4B
prerank,regulation of cell communication (GO:0010646),0.3301050956928295,0.9629623335687213,0.5147313691507799,0.8250614270780576,1.0,4/35,3.55%,CXADR;GRK3;IGFBPL1;ANXA1
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.43819262243720236,0.9624989095743428,0.4970414201183432,0.8255022048110876,1.0,1/10,0.40%,BMP6
prerank,negative regulation of locomotion (GO:0040013),0.3944817123800267,0.9620423120204812,0.4970873786407767,0.825978131075051,1.0,4/12,6.82%,TACSTD2;FBLN1;PTPN2;SPINT2
prerank,intracellular lipid transport (GO:0032365),0.36070022344369146,0.9620187914135472,0.5009345794392523,0.8254295254397619,1.0,2/21,1.61%,PRKAG2;PRKAA2
prerank,protein targeting to membrane (GO:0006612),-0.24886067432495446,-0.9616070082314506,0.56,0.8648167919726707,1.0,29/83,24.06%,ARL6IP1;AQP11;VPS37B;SRP14;SDCBP;ZDHHC14;ZDHHC20;ATAD1;PEX26;ZDHHC2;GDAP1;TRAM1;ZDHHC24;NACA;RABGEF1;ABCD2;SSR2;VPS37A;PEX16;ZDHHC7;PEX19;SEC61A1;PXMP4;YIF1B;ZDHHC23;SGTB;ZDHHC9;TAOK2;RAB8B
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.29912369861378235,0.961146287259919,0.507177033492823,0.8268563346890209,1.0,11/48,16.30%,ZMIZ1;ELOF1;POLR1C;BAZ1B;POLR1G;SERTAD2;POLR2F;ERCC6;MYO1C;KAT2B;DDX21
prerank,regulation of multicellular organismal development (GO:2000026),0.34582414511199855,0.9611065951815634,0.5174825174825175,0.8263239344584802,1.0,4/25,11.25%,PTN;TRIP12;MYSM1;OAS2
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.3124474947819405,0.9609256930730852,0.5366269165247018,0.8261260373832375,1.0,9/46,14.97%,TIMP3;FBLN1;DUSP10;TLR4;PTPN2;DLG1;SMAD4;PTPN1;PTPRR
prerank,barbed-end actin filament capping (GO:0051016),0.36738935267146233,0.9608151967317072,0.5200729927007299,0.8251447392269718,1.0,8/18,22.17%,ADD3;VILL;CAPZB;TRIOBP;AVIL;CAPZA1;CAPG;TWF2
prerank,actin filament capping (GO:0051693),0.36738935267146233,0.9608151967317072,0.5200729927007299,0.8251447392269718,1.0,8/18,22.17%,ADD3;VILL;CAPZB;TRIOBP;AVIL;CAPZA1;CAPG;TWF2
prerank,cobalamin metabolic process (GO:0009235),0.38111159852865034,0.960600743894512,0.536723163841808,0.8250288599523748,1.0,2/17,8.52%,MMAB;LMBRD1
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),0.316241805248583,0.9601853098610181,0.5187074829931972,0.8253947876737174,1.0,5/38,6.64%,ROCK2;SMAD3;TLR4;ATP2B4;CD47
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),0.3372087522685846,0.9597208245762727,0.5160744500846024,0.8259184179609389,1.0,2/29,1.51%,RASGRF1;NOTCH2
prerank,endoderm development (GO:0007492),0.4116437141891537,0.959260693568911,0.523719165085389,0.8263890426926936,1.0,1/13,0.60%,LAMC1
prerank,hemopoiesis (GO:0030097),0.2799028536374959,0.9589734149621921,0.5376661742983752,0.8264907557082601,1.0,15/87,11.60%,KMT2A;TGFBR3;NOTCH2;WNT10B;WNT2B;FSTL3;KIT;NCOA6;SBDS;TGFBR2;WNT5A;FUT10;PLEK;SH2B3;MFAP5
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),0.3887654022238606,0.95881390237015,0.4867924528301887,0.8262700093964759,1.0,7/16,21.48%,SLX4;SMG5;SMG6;TNKS2;HNRNPA2B1;DHX36;RTEL1
prerank,leukocyte cell-cell adhesion (GO:0007159),-0.32217248895646416,-0.9588015588592195,0.535632183908046,0.8715350141685694,1.0,6/24,13.57%,PECAM1;ITGA4;SEMA4D;SYK;GFUS;F11R
prerank,endodermal cell differentiation (GO:0035987),0.33481528223776597,0.9587234150797398,0.4982876712328767,0.8258664820007778,1.0,8/31,14.19%,VTN;FN1;ITGA5;MMP14;CDC73;RTF1;PAF1;LEO1
prerank,mitotic sister chromatid cohesion (GO:0007064),0.37905919931801335,0.9585700594643917,0.5186500888099467,0.8256110888570938,1.0,5/16,18.55%,PDS5B;POGZ;PDS5A;NIPBL;DSCC1
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.37366353287223864,0.9584761423162108,0.4956521739130435,0.8252194883343204,1.0,4/18,17.32%,ANXA1;KLF9;NR3C1;PCK2
prerank,positive regulation of keratinocyte differentiation (GO:0045618),0.42826361273319036,0.9582619133663115,0.5159362549800797,0.8251353783260922,1.0,2/10,3.02%,FOXC1;NCOA3
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.38784845109837834,0.9580090441815802,0.5121495327102804,0.8244887385894427,1.0,6/15,22.79%,TNRC6B;NANOS2;CPEB3;DHX36;NANOS1;ZFP36L2
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.38784845109837834,0.9580090441815802,0.5121495327102804,0.8244887385894427,1.0,6/15,22.79%,TNRC6B;NANOS2;CPEB3;DHX36;NANOS1;ZFP36L2
prerank,purine nucleotide metabolic process (GO:0006163),0.3591188728635584,0.9579607117757832,0.5357766143106457,0.8239968085204104,1.0,9/24,21.77%,MTHFD1;FHIT;NT5C;PRPSAP1;ITPA;PRPSAP2;NT5C1A;XDH;ADSL
prerank,nucleic acid metabolic process (GO:0090304),0.28798501061696546,0.9574489930535762,0.5362095531587057,0.8245755379787646,1.0,15/69,16.84%,ENPP1;RBFOX2;POLR2D;WRN;RAD50;LSM1;POLG;HNRNPH1;HNRNPC;POLR2C;POLR2F;DNASE1L1;HNRNPR;HNRNPA2B1;RAN
prerank,protein localization to Golgi apparatus (GO:0034067),-0.30813014507949926,-0.9574108481285369,0.511520737327189,0.8744147356055265,1.0,5/27,8.25%,CSNK1D;SORL1;PAQR3;ARL1;GCC2
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),-0.3772852708810095,-0.9573946008749609,0.5163398692810458,0.8735651039625507,1.0,2/12,3.81%,STX3;SNAP25
prerank,metanephros development (GO:0001656),0.3450871759631202,0.9573502793945755,0.5239786856127886,0.8241835578154129,1.0,4/26,7.04%,FOXD1;OSR1;BMP7;CTSH
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),-0.24746144008981558,-0.957134411085273,0.5643835616438356,0.8733738053388683,1.0,10/75,8.05%,PLCB1;RGS5;RGS3;MGLL;CALM1;RGS12;RGS4;RGS6;SLC39A14;CAMK2A
prerank,positive regulation of exosomal secretion (GO:1903543),0.39610925831974125,0.9569138862912128,0.5258126195028681,0.824585872970581,1.0,1/15,1.31%,SMPD3
prerank,regulation of ruffle assembly (GO:1900027),-0.3230748396517972,-0.956830522440995,0.5197368421052632,0.8733392211812477,1.0,9/23,20.74%,NLGN1;EPS8;ABI3;CAV1;HRAS;EVL;ARHGAP24;PFN2;FAM98A
prerank,artery development (GO:0060840),0.35132027388773596,0.9568108034491962,0.5088028169014085,0.8242282285018254,1.0,4/23,5.16%,ROBO1;NRP1;EFEMP2;TGFBR1
prerank,ESCRT complex disassembly (GO:1904896),-0.4082019423730888,-0.9565753869937219,0.5485232067510548,0.8722857418314758,1.0,5/10,23.36%,CHMP1A;CHMP1B;CHMP7;CHMP2B;CHMP2A
prerank,ESCRT III complex disassembly (GO:1904903),-0.4082019423730888,-0.9565753869937219,0.5485232067510548,0.8722857418314758,1.0,5/10,23.36%,CHMP1A;CHMP1B;CHMP7;CHMP2B;CHMP2A
prerank,pattern recognition receptor signaling pathway (GO:0002221),-0.263865266105032,-0.9564815432502157,0.5230352303523035,0.8716795271544915,1.0,11/56,15.57%,PLCG2;NOD1;CTSB;HMGB1;LGMN;CTSS;UBB;CTSL;S100A1;UBA52;NOD2
prerank,positive regulation of protein transport (GO:0051222),-0.2504170495003776,-0.9563970370924666,0.5698005698005698,0.8710051159224766,1.0,27/67,28.15%,TGFB2;PRR5L;ACSL3;FRMD4A;ATP2C1;OAZ1;OAZ2;TGFB3;PCNT;RACK1;PPIA;MYOM1;MYO18A;CEP290;EXPH5;ADAM8;ARF6;SYTL4;VPS28;TTN;CLN3;B3GAT3;APBB3;TREM2;PDCD10;GOLPH3;VAMP2
prerank,piRNA metabolic process (GO:0034587),0.37065986727965844,0.9563439605849109,0.5045207956600362,0.8246995533762256,1.0,2/19,8.18%,PIWIL4;EXD1
prerank,response to laminar fluid shear stress (GO:0034616),-0.3998606074049973,-0.9558792549567846,0.5192697768762677,0.871588928937947,1.0,3/10,12.59%,SMAD7;KLF2;KLF4
prerank,amide biosynthetic process (GO:0043604),-0.27529392670738834,-0.9551792106616946,0.5390625,0.8725347941562296,1.0,4/47,3.39%,SGMS1;DMD;CERS4;DEGS2
prerank,glycine metabolic process (GO:0006544),0.40526100083775973,0.9542725614724348,0.5111524163568774,0.8289578435105757,1.0,2/12,8.48%,SHMT1;AMT
prerank,positive regulation of catabolic process (GO:0009896),0.28729211611211375,0.9537430763228628,0.5039246467817896,0.8295905858330682,1.0,12/65,12.85%,SMURF2;APOA2;NEDD4;DACT1;GSK3B;WNT5A;TIPARP;WWP2;HUWE1;NKD1;HECW2;ASB5
prerank,cellular response to DNA damage stimulus (GO:0006974),0.23648839461490653,0.9532472703009506,0.5783132530120482,0.8301178177366847,1.0,83/336,20.40%,PRAP1;PDS5B;ZBTB4;POLH;TRIP12;TAOK3;SPATA18;CRY1;WRN;APBB1;IKBKE;PLK5;BCL2;SLX4;NCOA6;MCL1;UBE2U;RAD50;PARP3;CUL4A;DTX3L;SUSD6;SPIDR;CCDC13;WAC;FBH1;NEK4;MAP2K6;BAX;BAZ1B;YAP1;MNAT1;SIRT4;PSME4;USP47;SUMO1;SLF2;NABP1;TLK2;UVRAG;NUPR2;MAPK14;SETD7;BCL2L1;RFWD3;ADPRS;RBBP8;EPHA2;OGG1;MASTL;RAD51B;HIC1;INTS3;GTF2H4;BOD1L1;RAD9A;PML;PDS5A;ALKBH1;ERCC1;TAF9;USP45;MGMT;NFATC2;MACROD1;KMT5C;NIPBL;SMARCAL1;FANCC;SHPRH;ATF2;PARP4;USP10;XPC;UBR5;NSMCE3;RIF1;SMC6;CEP63;NABP2;ERCC8;BLK;KMT5B
prerank,regulation of protein autophosphorylation (GO:0031952),0.323615436114722,0.9532091613979717,0.527027027027027,0.8296049635285075,1.0,6/36,9.46%,EPHA7;ENPP1;ERRFI1;RAD50;MVP;RAP2C
prerank,regulation of vacuole organization (GO:0044088),0.36845952899219064,0.9530820734177617,0.5,0.8292945635989881,1.0,10/20,25.01%,ANXA2;IFT88;MTMR3;IFT20;NPRL3;RAB5A;ADPRH;UBQLN2;MTM1;NPRL2
prerank,mesoderm development (GO:0007498),-0.34897269104298023,-0.9528660953691649,0.5421412300683371,0.8780324263591925,1.0,12/18,36.93%,TIE1;TBX1;BMX;VEGFA;IKZF1;TBX6;MEST;TCF15;MESD;IKZF3;HES7;BTK
prerank,positive regulation of intracellular transport (GO:0032388),-0.2898024223955928,-0.9525247708066666,0.5456919060052219,0.8780835084640736,1.0,19/38,34.17%,PRR5L;SORL1;OAZ1;STK11;OAZ2;DYNC1H1;PCNT;CAPN10;MLC1;CEP290;SPAG5;B3GAT3;STX18;PDCD10;VAMP2;PGAP1;KIF20B;PLA2G4E;BCAS3
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),-0.30378036388853835,-0.9521520119435832,0.5221445221445221,0.8782485701269415,1.0,8/28,17.40%,CRADD;DAB2IP;GABARAP;DDX47;DEDD;NGF;SORT1;DEDD2
prerank,cellular response to oxidative stress (GO:0034599),-0.23064692644331528,-0.952047562608247,0.5724381625441696,0.877647937779155,1.0,26/118,15.43%,PTPRK;FOXO1;PRR5L;SETX;SNCA;MAPK8;RPS3;CPEB2;MSRA;NCF2;MAPK3;CHCHD2;AKT1;PINK1;NUDT2;EGFR;ATF4;PYROXD1;CYBB;PPIA;PARK7;SOD1;ERO1A;PRKD1;PYCR2;MAPT
prerank,protein localization to cell junction (GO:1902414),0.35671533204173433,0.9519806211299198,0.5350553505535055,0.8311716926677915,1.0,5/22,13.11%,CGNL1;HEG1;TJP1;NLGN2;JAK1
prerank,positive regulation of macrophage differentiation (GO:0045651),0.42127567688738604,0.951891867399773,0.5155038759689923,0.8307884649023803,1.0,4/11,23.55%,IL34;CSF1;RIPK1;TGFB1
prerank,copper ion transport (GO:0006825),-0.4051652770764548,-0.9517029197129422,0.5229166666666667,0.8777013422652932,1.0,4/11,10.91%,ATOX1;SLC31A1;STEAP2;SLC31A2
prerank,limb morphogenesis (GO:0035108),-0.33980262536911326,-0.9516565166831661,0.5148305084745762,0.8769292570697421,1.0,5/20,13.13%,TGFB2;MBNL1;FBXW4;LRP6;BMPR1B
prerank,glutathione metabolic process (GO:0006749),-0.2819598558188008,-0.9513061677180322,0.5149253731343284,0.8769811929095325,1.0,21/38,43.26%,OPLAH;GGT5;GSTM5;GCLC;PARK7;SOD1;GGT7;GGT1;HAGH;ETHE1;MGST2;GCLM;GSTA4;GSR;HPGDS;NAT8;GSTM4;GPX1;GLRX2;GSTP1;GGCT
prerank,peripheral nervous system development (GO:0007422),-0.32737561376783664,-0.9511647300955314,0.5079006772009029,0.876487347951951,1.0,6/23,16.45%,ADGRG6;SERPINI1;SCN8A;NFASC;NGF;NTF3
prerank,mitochondrion organization (GO:0007005),0.24770594614514388,0.9511359989804229,0.5435967302452316,0.831962342086796,1.0,33/165,15.52%,CXADR;PID1;TRAK1;IFIT2;TERT;SPATA18;GABPB1;HAX1;MPV17;TIMM17A;MEF2A;PHB2;BAX;SIRT4;NIPSNAP2;LRRK2;DNM1;MTFP1;AFG1L;TMEM70;AKT3;DNM1L;BCL2L1;ATCAY;SUPV3L1;OPA1;MTFR1;WASF1;NRF1;TIMM9;SLC25A4;MIEF1;MUL1
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.35918922052446156,0.9511208943106281,0.5424954792043399,0.8313993799287048,1.0,3/20,10.74%,NR2F2;LATS2;IPO7
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),0.4045549965357187,0.9507619187326498,0.519455252918288,0.8316225702796801,1.0,4/12,14.09%,MIA3;PPARA;FUT4;WNK1
prerank,histone H3 acetylation (GO:0043966),-0.28076076875971656,-0.9504970389654147,0.5452127659574468,0.8774249361731719,1.0,12/40,23.62%,LEF1;TADA2A;JADE3;JADE1;BRCA2;TAF5L;KAT7;KAT2A;SGF29;BRPF1;POLE3;ING4
prerank,glycerophospholipid metabolic process (GO:0006650),-0.25130766647499597,-0.9503447552085136,0.5623100303951368,0.876947226485025,1.0,24/75,22.65%,GPCPD1;PLCB1;DGKH;SERINC1;GDPD1;ABCA3;SERINC5;ENPP6;PIGM;PIGQ;PIGH;DPM2;CSF1R;PGP;GDE1;PLCG1;ABHD6;PNPLA6;CPNE7;PNPLA3;PIGB;PLA2G7;CLN3;PLA2G4F
prerank,regulation of apoptotic signaling pathway (GO:2001233),-0.2892563320172515,-0.9500843215262207,0.5188679245283019,0.8767539128313958,1.0,7/36,9.77%,SGMS1;CRADD;TPD52L1;RPS3;DAB2IP;FAS;TRAF7
prerank,atrial septum morphogenesis (GO:0060413),-0.41289029110788344,-0.9496047482968432,0.5190677966101694,0.8771698189687265,1.0,4/10,12.80%,TGFB2;BMPR2;ZFPM1;ACVR1
prerank,morphogenesis of an epithelium (GO:0002009),-0.3132898951731801,-0.9495329622195372,0.5270588235294118,0.8764710259056967,1.0,6/25,9.91%,ACTB;LAMA3;ACTG1;AHI1;LRP6;PRKX
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),-0.2464662548460402,-0.9489346167158398,0.5767045454545454,0.8771648300695948,1.0,18/80,13.77%,NLGN1;FNBP1L;TENM2;GPM6A;EPS8;PIK3R1;NCKAP1;CCDC88A;CDC42EP3;ARPC2;TGFB3;CDC42EP1;CDC42EP5;ANLN;WASHC1;HRAS;RAC1;AGRN
prerank,axonal transport of mitochondrion (GO:0019896),-0.38921385966680866,-0.9487969390764066,0.524731182795699,0.8766814937124184,1.0,2/11,2.69%,SYBU;ACTR10
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.35912091465227575,0.9487432603366669,0.5297113752122241,0.8356951531929431,1.0,8/21,23.55%,LRRK2;BCL2L1;OPA1;NCK1;EIF2AK3;XBP1;TXNDC12;SYVN1
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.311675808414353,0.9484340471865955,0.5393258426966292,0.8358415873364895,1.0,7/43,11.49%,TLR4;C5AR2;PTPN22;LGALS9;CD274;PTPN6;IRAK3
prerank,positive regulation of protein ubiquitination (GO:0031398),0.27759808373662553,0.9481200504410758,0.5365853658536586,0.835971453005544,1.0,15/80,14.53%,PRICKLE1;ANGPT1;CRY1;MYCBP2;SPSB4;BIRC3;RIPK2;LRRK2;FBXO4;FANCM;HUWE1;CENPX;CUL3;TBC1D7;RCHY1
prerank,vesicle transport along actin filament (GO:0030050),-0.33570657421204414,-0.9479205980867107,0.5295454545454545,0.8780875423883854,1.0,2/19,1.44%,MYO1D;FNBP1L
prerank,positive regulation of mitochondrion organization (GO:0010822),0.2933843311190245,0.9472326329849485,0.5435816164817749,0.8374270389905333,1.0,10/57,15.52%,MCU;DCN;RALBP1;PDCD5;GSK3B;BAX;DNM1L;ZNF205;MIEF1;MUL1
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.3016863341377298,0.9472284263414308,0.5504273504273505,0.8368256345200342,1.0,11/45,17.14%,PARP9;RC3H1;PKP3;TDRD7;FOXO3;METTL16;GEMIN5;MAPKAPK5;ZC3H7B;APP;PUM2
prerank,regulation of organelle organization (GO:0033043),0.275746663850089,0.9469033658962898,0.5601217656012176,0.8370027483657874,1.0,19/80,19.72%,ZEB2;DIAPH1;STOX1;CLIC4;SYDE1;ARMH3;DNM1L;TJP1;PTK2;TMEM33;TMED9;RAB33B;MUL1;SAR1A;MYO5A;RHOT1;USP6NL;RHOT2;TBC1D25
prerank,positive regulation of lipid kinase activity (GO:0090218),0.3330531426617825,0.946865576054462,0.5049342105263158,0.8364798095682155,1.0,5/29,6.11%,PDGFRA;AMBRA1;EPHA8;KIT;PDGFRB
prerank,negative regulation of cellular senescence (GO:2000773),-0.3749261329583509,-0.945655271777969,0.532,0.883361904571603,1.0,3/13,7.60%,CDK6;YBX1;RBL1
prerank,cardiac atrium morphogenesis (GO:0003209),-0.3526678372999578,-0.9455271782911507,0.5129310344827587,0.8828057944047313,1.0,3/16,2.33%,TGFB2;BMPR2;NOTCH1
prerank,RNA destabilization (GO:0050779),0.3623990777945336,0.9451853490180252,0.5249110320284698,0.8397332108951698,1.0,4/18,14.87%,ROCK2;FTO;METTL16;GIGYF2
prerank,negative regulation of mitochondrion organization (GO:0010823),-0.29159978924482344,-0.94514535801894,0.5419664268585132,0.8829305704223079,1.0,5/33,9.94%,TFRC;AKT1;PRELID1;PINK1;GHITM
prerank,positive regulation of protein processing (GO:0010954),0.354696469235677,0.9451389077621031,0.5242369838420108,0.8392317041608179,1.0,3/19,12.38%,CLEC3B;PLGRKT;CCBE1
prerank,negative regulation of ERBB signaling pathway (GO:1901185),-0.28552549680564315,-0.9447545476230512,0.5655339805825242,0.8830839088393025,1.0,10/39,15.98%,PTPRJ;SH3KBP1;DAB2IP;SH3GL2;LGMN;CBL;ARHGEF7;EGFR;RNF126;EGF
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.34385193382619716,0.9447396786829196,0.5277280858676208,0.8395268274930822,1.0,9/25,23.09%,CDC73;ZMYND11;CDK12;BRD4;LEO1;CDK13;EAPP;ELL;HEXIM1
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.2328397694257887,0.94423913681184,0.6088516746411483,0.8400420929422561,1.0,57/341,15.01%,RNF213;SPSB1;TBL1XR1;SMURF2;RNF217;FBXO11;FBXL17;TRIP12;NEDD4;TGFB1I1;TTC3;NHLRC3;RC3H1;RNF19A;KLHL22;UBE2U;SPSB4;RNF216;SIAH2;CUL4A;DTX3L;ANAPC11;NTAN1;USP9X;RNF20;KLHL15;NUB1;PSMB10;RNF111;ANAPC1;AMFR;UBR4;UBE2C;PSMA3;PSME4;FBXL7;PSMA5;WWP2;KEAP1;UBXN2A;HUWE1;SPOPL;CUL3;IFI27;BTRC;HECW2;FBXW11;ARRB1;CDC27;BFAR;RNF43;FBXL4;RCHY1;BIRC6;KCTD5;PML;UBE2R2
prerank,stress-activated MAPK cascade (GO:0051403),-0.25427872977125504,-0.9441076627805405,0.5606936416184971,0.8839595728032269,1.0,11/61,10.09%,NOD1;MAP3K5;MAPK8;ARHGEF6;MAPK10;MAPK3;MAP3K11;UBB;MAP4K3;MAP3K20;MINK1
prerank,homocysteine metabolic process (GO:0050667),-0.3907083334757632,-0.943752200380138,0.5460526315789473,0.8840386759894476,1.0,5/11,23.77%,MTHFR;MTRR;CTH;MPST;NOX4
prerank,Golgi to endosome transport (GO:0006895),-0.34897623640576075,-0.9430521796457836,0.5365296803652968,0.8849998841754063,1.0,6/16,15.36%,DOP1B;AP1AR;CORO7;KLHL20;KIF16B;SORT1
prerank,positive regulation of response to stimulus (GO:0048584),-0.2773885719787281,-0.9428901923878387,0.5423728813559322,0.8845510174894996,1.0,8/40,10.91%,TGFB2;HOMER1;YPEL3;SELENON;B2M;ABI3;CD80;EEF1E1
prerank,telomere maintenance (GO:0000723),0.29694853737654386,0.9424439358406286,0.5779967159277504,0.8435702987341857,1.0,16/50,22.64%,SP100;TERT;WRN;RAD50;PARP3;RPA3;NSMCE2;TEN1;DNA2;RIF1;SMC6;CTC1;POLD3;RTEL1;TEP1;PTGES3
prerank,vitamin transport (GO:0051180),0.3351111412617246,0.9422334965182024,0.5568561872909699,0.8434500811145298,1.0,2/29,2.57%,PDPN;SLC19A1
prerank,cAMP metabolic process (GO:0046058),0.396905222155232,0.9421368057553282,0.5458015267175572,0.8430669154577027,1.0,6/13,15.73%,PTHLH;ADCY5;ADCY7;ADCY1;EPHA2;ADCY6
prerank,regulation of transposition (GO:0010528),0.38755709322827714,0.9419213435583897,0.5124282982791587,0.8429916450533341,1.0,1/13,3.26%,PIWIL4
prerank,positive regulation of proteolysis (GO:0045862),0.2888653817577928,0.9415695905308703,0.5516666666666666,0.8431806340036752,1.0,16/55,22.02%,SH3D19;NRDC;CTSH;SNX9;CCBE1;BTRC;FBXW11;HDAC2;ADRA2A;CYFIP2;ATP5IF1;ASPH;TNIP1;IST1;RCN3;ZC3H12A
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),0.3346793724688077,0.9414204385822408,0.5498281786941581,0.8429174507654531,1.0,6/25,12.26%,CD55;KIT;LACC1;TNFRSF14;WNT5A;MAP3K7
prerank,amyloid fibril formation (GO:1990000),-0.26747325224515833,-0.9412252054823437,0.554726368159204,0.8880264563423712,1.0,9/51,8.76%,CST3;FKBP1A;H3-3A;SNCA;TGFBI;SORL1;TSPAN14;UBB;B2M
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),-0.35353234052602345,-0.9409578290030757,0.525974025974026,0.8878935907452946,1.0,8/17,26.80%,ALG14;SRD5A3;NUS1;DOLPP1;ALG6;DHDDS;ALG13;MVD
prerank,regulation of aerobic respiration (GO:1903715),-0.3569670323947377,-0.9407257177019059,0.5394456289978679,0.887596472046102,1.0,2/15,8.21%,CBFA2T3;PINK1
prerank,L-glutamate transmembrane transport (GO:0015813),0.43179502202520176,0.9406148942980146,0.5346153846153846,0.8441296458572746,1.0,1/10,0.80%,SLC1A3
prerank,intracellular protein transport (GO:0006886),0.23252574943512455,0.940517431452374,0.5880195599022005,0.8437171477695227,1.0,79/304,22.03%,RANBP3L;WLS;PRICKLE1;TNPO1;COPZ2;ARFGAP3;SNX6;TRAK1;TBC1D16;TRARG1;RAB22A;LAMP2;RAB43;APPL2;TPR;ARF4;GRTP1;SIL1;SRPRA;NGFR;SNX9;PHB2;SCFD2;SLU7;AP4E1;ARF3;STX8;APPL1;STX2;FUT10;STX11;IPO7;KIF13B;COX18;ARCN1;HOMER3;SNX27;EIF4ENIF1;EGR2;SCFD1;STRADB;POM121;TMED9;VPS26C;ARL4A;MYO1C;COPZ1;SAR1A;RAB5A;TRIM23;AP4M1;ARF1;RAN;SEC31A;RPGR;RANBP17;AP3B1;RAB19;ARL6;USP6NL;WDR11;SEC16A;NUP85;ARFIP2;TBC1D25;VPS26B;VPS33A;FAM91A1;SNX15;HIKESHI;UNC93B1;GGA3;RAB14;VPS35;XPO5;MYO6;PKD1;OXA1L;NAPG
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),-0.3310912751220664,-0.9402509569027022,0.5394456289978679,0.8880676014339192,1.0,5/20,10.30%,RPS6KA5;DIP2B;TADA2A;MAPK3;NOS1
prerank,positive regulation of metabolic process (GO:0009893),-0.22981852455398064,-0.9402260822083817,0.5993690851735016,0.8872558869146564,1.0,20/103,13.10%,ADIPOR2;EBF2;INSR;GATM;PRDM16;KSR2;GNAS;UCP2;DYNC1H1;VEGFA;MFN2;ADRB2;CMKLR1;GADD45G;ACACA;SYK;PRLR;CAV1;ACLY;SCD
prerank,regulation of lipid catabolic process (GO:0050994),0.362243075560157,0.940144882575273,0.5434380776340111,0.843964068599151,1.0,5/19,15.39%,APOA2;HCAR2;RARRES2;ALK;ADRA2A
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",-0.32101491437273766,-0.9401326511564441,0.5450643776824035,0.8866301762618143,1.0,11/24,26.04%,UBB;UBA52;POLD2;POLE;LIG3;RFC4;POLD1;POLB;POLK;RFC5;RFC2
prerank,tight junction assembly (GO:0120192),-0.26765257954081817,-0.9400132540245029,0.5923076923076923,0.8860280880617485,1.0,10/49,14.33%,PECAM1;CLDN5;ESAM;ACTG1;LSR;CLDN14;RAMP2;MICALL2;F11R;MPP7
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.4301549688399264,0.9397305116845581,0.551660516605166,0.8443222305709907,1.0,4/10,19.29%,WNT3A;WNT5A;RYK;WNT2
prerank,regulation of primary metabolic process (GO:0080090),0.2536110792175137,0.9396308908811234,0.5968660968660968,0.8439322264068271,1.0,13/126,10.29%,CHD9;ROCK2;C1QTNF2;TBL1XR1;NFYC;NCOA6;PPARA;CREBBP;LACTB;PSMB10;PSMA3;PSME4;PSMA5
prerank,negative regulation of neuroinflammatory response (GO:0150079),-0.36430928969847637,-0.939469833478197,0.5329218106995884,0.8865843194574079,1.0,8/14,42.97%,TNFRSF1B;GRN;PTPRC;TREM2;LDLR;IL4;CST7;TAFA3
prerank,atrial cardiac muscle cell action potential (GO:0086014),-0.3763825956550244,-0.9394063180275144,0.5470085470085471,0.8858696863405652,1.0,3/13,4.82%,CACNB2;KCNJ3;GJC1
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),0.32223064607809476,0.9391513609561962,0.5614617940199336,0.8444931447594286,1.0,17/32,27.68%,POLR1C;CCNH;MNAT1;POLR1G;CDK7;POLR2F;GTF2H4;GTF2H2;CAVIN1;POLR2K;UBTF;TAF1;POLR2H;POLR1A;ERCC2;ERCC3;TAF1D
prerank,hematopoietic stem cell proliferation (GO:0071425),-0.386448956490615,-0.9386601932393515,0.5469728601252609,0.8869070229907343,1.0,4/11,11.11%,MECOM;CD34;YTHDF2;RUNX1
prerank,regulation of metal ion transport (GO:0010959),0.377589654473461,0.9386168881122,0.5657894736842105,0.8451099858095981,1.0,5/16,15.11%,IL16;BCL2;DLG1;GRIN3B;CACNA2D1
prerank,mRNA catabolic process (GO:0006402),0.3045577693273227,0.9384721063597747,0.5711947626841244,0.8448658249628616,1.0,12/44,19.63%,TUT4;RC3H1;DHX34;NANOS2;DCP2;XRN1;SLFN14;SUPV3L1;METTL16;EXOSC10;TUT7;DDX5
prerank,establishment of spindle localization (GO:0051293),0.38303906338648486,0.9382791955134865,0.5341959334565619,0.8447045375366053,1.0,6/14,18.03%,CLASP1;ESPL1;LLGL2;MAP4;TLE6;NLRP5
prerank,sterol transport (GO:0015918),0.3612615595270833,0.9380342729640593,0.551304347826087,0.8446797565376103,1.0,3/19,12.77%,APOA2;NPC1;OSBPL5
prerank,positive regulation of protein localization to cell surface (GO:2000010),-0.3714579757736097,-0.9380266288364142,0.5454545454545454,0.887728409850545,1.0,3/13,6.85%,STX3;HSP90AB1;RIC3
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.39014538279883176,0.9373863831558756,0.5408348457350273,0.8455007086838833,1.0,6/14,23.55%,LRRK2;BCL2L1;OPA1;XBP1;TXNDC12;SYVN1
prerank,T cell homeostasis (GO:0043029),-0.3984893292298495,-0.9371750708457427,0.5737373737373738,0.88920045592839,1.0,6/10,28.36%,AKT1;FAS;ZC3H8;JAK3;FADD;PMAIP1
prerank,cell cycle checkpoint signaling (GO:0000075),0.4099924447850571,0.9365409709335311,0.5276679841897233,0.8469443604148893,1.0,3/12,9.40%,PRCC;ZWINT;NABP1
prerank,regulation of mitotic cell cycle (GO:0007346),-0.21452721352018947,-0.9365186912231961,0.6566037735849056,0.8900483504683118,1.0,45/171,21.28%,BRINP3;MEIS2;BRINP1;NEK7;BRINP2;PSMC3;CDC26;LGMN;SDCBP;PSMD14;SIK1;PSMD3;TFAP4;TTC28;TAL1;PSMD4;BORA;CAV2;CCDC8;PSMD6;PSMA6;UBE2E1;ANGEL2;PSMA4;PSMB8;DYNLT3;PSMA8;CYLD;BUB1B;BTG1;ASNS;UBE2D1;PSME1;L3MBTL1;MAEA;CDKN1C;PRMT5;PSMD7;PSMC6;PSMB5;USP2;MKI67;PSMC5;PSMB1;AFAP1L2
prerank,apoptotic DNA fragmentation (GO:0006309),-0.34886807609517834,-0.9360847354046938,0.5491071428571429,0.8903365952466731,1.0,5/16,18.02%,HMGB1;KPNB1;H1-0;FOXL2;DICER1
prerank,regulation of interleukin-6 production (GO:0032675),0.26653773255790364,0.9359619433053578,0.5797101449275363,0.8477409004349763,1.0,14/96,11.49%,IL16;IL17D;IL6;TLR4;C5AR2;PTPN22;NOS2;CD47;LGALS9;SETD4;WNT5A;PTPN6;TLR2;IRAK3
prerank,histone deacetylation (GO:0016575),0.30394732921567635,0.935884594631392,0.540133779264214,0.8473161191300925,1.0,11/43,17.36%,TBL1XR1;MIER3;BAZ2A;MIER1;HDAC4;PRDM5;RBM14;HDAC2;ELK4;TBL1X;MIDEAS
prerank,atrioventricular valve morphogenesis (GO:0003181),0.3668959922814911,0.9358809831073376,0.5163776493256262,0.8467213385994597,1.0,9/19,15.56%,BMPR1A;BMP2;TGFBR2;SMAD6;HEYL;SMAD4;EFNA1;MDM4;SOX4
prerank,regulation of oligodendrocyte differentiation (GO:0048713),0.3610111763686037,0.935743397487284,0.5254545454545455,0.846415490792172,1.0,2/18,3.52%,PTN;IL34
prerank,transition metal ion homeostasis (GO:0055076),0.3360930243416149,0.9356752482465959,0.5431654676258992,0.8459723984265309,1.0,1/28,0.17%,CP
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),-0.3419365909226433,-0.93564619855922,0.5603644646924829,0.8905667148932909,1.0,7/18,29.71%,AKT1;PINK1;PPIA;PARK7;NONO;VNN1;HSPB1
prerank,regulation of immunoglobulin production (GO:0002637),0.34207685000407784,0.9354579281960198,0.546594982078853,0.8458766739638082,1.0,3/23,8.25%,RBP4;IL6;PHB2
prerank,negative regulation of leukocyte activation (GO:0002695),0.3897938332627636,0.9352645875308471,0.5585585585585585,0.845694289942839,1.0,2/15,6.02%,IL31RA;NR1H3
prerank,dendritic cell chemotaxis (GO:0002407),-0.3522563966978394,-0.9350378972034584,0.5232815964523282,0.8912776253965731,1.0,11/14,47.90%,HMGB1;CCL19;TRPM2;CCL5;CCR1;PIK3CG;CCR5;CCR6;CXCR2;TRPM4;CCR2
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),0.3811023655196677,0.9347786228681284,0.5370705244122965,0.8461970183239496,1.0,3/15,4.50%,RNF213;DACT1;WNT5B
prerank,positive regulation of filopodium assembly (GO:0051491),0.34467518044531936,0.934722127983359,0.5569176882661997,0.8457331537719237,1.0,3/24,2.97%,DPYSL3;DOCK11;NRP1
prerank,epidermis development (GO:0008544),0.290129428723855,0.9346206709743096,0.5518867924528302,0.8453724958354262,1.0,5/56,6.60%,CCN2;GATA6;PTHLH;GLI1;SVEP1
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),-0.30675130239287385,-0.9344953581366164,0.5619469026548672,0.8918531000490332,1.0,3/24,8.69%,ABCG2;SUCLA2;ALAS1
prerank,chromatin assembly (GO:0031497),-0.2726951036458796,-0.9335857434903688,0.5758354755784062,0.8934353869095031,1.0,11/38,23.29%,H3-3A;LIN54;NPM1;SART3;ASF1A;H1-0;ANP32B;SPTY2D1;NOC2L;NAP1L2;POLE3
prerank,receptor internalization (GO:0031623),-0.2705766782854823,-0.9334852358148044,0.5732984293193717,0.8928437661881122,1.0,10/44,12.95%,DNM3;TFRC;SNCA;SCYL2;CEACAM1;LDLRAP1;RAMP2;FCER1G;SYK;CAV1
prerank,tetrapyrrole metabolic process (GO:0033013),0.3628031654322901,0.9333956917921168,0.5685185185185185,0.8475382060938901,1.0,2/18,8.52%,MMAB;LMBRD1
prerank,positive regulation of keratinocyte migration (GO:0051549),-0.3970073736232045,-0.9326172513048706,0.5491452991452992,0.8942561988363306,1.0,3/10,18.62%,IQSEC1;EPB41L4B;ARF6
prerank,regulation of organelle assembly (GO:1902115),0.2740439310106757,0.9324324026210471,0.5802469135802469,0.8492116666096273,1.0,12/72,16.33%,DCDC2;TBC1D16;ALMS1;SDCCAG8;IFT88;MTMR3;DYNC2LI1;SENP6;IFT20;NPRL3;SPICE1;RAB5A
prerank,response to interferon-beta (GO:0035456),0.3540690935291906,0.932222252943119,0.5646630236794171,0.8491002917696444,1.0,9/22,23.67%,IKBKE;BST2;STAT1;IFITM1;IFNAR2;SHFL;UBE2K;PNPT1;XAF1
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),0.34072218207194244,0.9320067000609754,0.5596491228070175,0.8489427829838465,1.0,12/24,21.88%,SEC23A;SEC24D;TAPBP;ERAP1;SEC24C;HFE;SEC24B;SEC31A;TAP2;ABCB9;BCAP31;PDIA3
prerank,sodium-independent organic anion transport (GO:0043252),-0.39941048643023414,-0.9318073183153825,0.5441478439425051,0.8955213162860346,1.0,2/10,1.10%,SLCO1C1;SLCO2A1
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",-0.34520572565235275,-0.931610534070812,0.5388026607538803,0.8951390257563906,1.0,13/17,44.92%,ZWILCH;SPDL1;CENPA;CTCF;ZW10;CDK1;MIS12;BUB3;KNL1;BOD1;AURKB;CHAMP1;HASPIN
prerank,steroid catabolic process (GO:0006706),-0.3979250422739034,-0.9315885137708355,0.5539112050739958,0.8943416241785478,1.0,3/10,15.92%,YWHAH;SPP1;HSD11B1
prerank,negative regulation of cilium assembly (GO:1902018),-0.37825179578251145,-0.9314627937334199,0.5387755102040817,0.8938150560195367,1.0,2/12,4.90%,LIMK2;TBC1D30
prerank,regulation of nervous system process (GO:0031644),-0.34093518328225214,-0.9313353986280334,0.5240274599542334,0.8932935058425929,1.0,4/18,4.33%,NOS3;HTR2C;DLGAP1;DLGAP2
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),-0.38266640544260366,-0.9313277035477203,0.5621052631578948,0.8924522355612655,1.0,4/11,12.62%,MEF2C;RAPGEF2;LYN;PIK3CD
prerank,vesicle transport along microtubule (GO:0047496),-0.3066711448231863,-0.9312562548238279,0.5573770491803278,0.8917762902756389,1.0,9/23,23.43%,KIF1C;DYNC1H1;KIF3B;NDE1;BICDL1;KIF5A;CLN3;HAP1;HTT
prerank,carbohydrate transport (GO:0008643),-0.38748240806217477,-0.9311243908721756,0.5517970401691332,0.8912582115979961,1.0,5/11,29.51%,AQP11;SLC50A1;SLC2A2;SLC23A1;SLC23A2
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),-0.2854000913422742,-0.9307819871460188,0.5547445255474452,0.8912830980540111,1.0,8/35,17.26%,PRKCQ;NEK7;CTNNB1;MAPK3;ATM;PNKP;PKIB;CCT5
prerank,DNA geometric change (GO:0032392),0.3396345607883515,0.9298290418916006,0.5495652173913044,0.8533768784137564,1.0,11/24,24.40%,ANXA1;WRN;ASCC3;RAD50;SUPV3L1;HNRNPA2B1;DHX36;DNA2;RTEL1;DHX9;ZRANB3
prerank,regulation of protein localization to centrosome (GO:1904779),0.42231016388009984,0.9297397770358761,0.5583657587548638,0.8529709456846191,1.0,3/10,15.15%,PARD6A;GSK3B;CEP250
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),-0.21874345640225634,-0.9295550213124778,0.6604477611940298,0.8936578553441743,1.0,49/145,24.51%,PPP2R1A;CSNK1D;PSMC3;KCNH5;RCC2;PSMD14;DYNC1H1;PSMD3;CCND1;PCNT;PSMD4;TUBA1A;PSMD6;TUBB4A;PSMA6;PSMA4;PRKAR2B;PSMB8;HSP90AA1;CEP43;DYNC1I2;NDE1;TUBB4B;PSMA8;CEP135;PLK4;CDK2;CDK4;CEP290;PSME1;SSNA1;TUBG1;PSMD7;PSMC6;CDK5RAP2;PSMB5;CEP41;PSMC5;PSMB1;DCTN1;CENPF;SKP1;DTL;HMMR;CEP70;PSMD11;KIF14;MAPRE1;PSMD8
prerank,response to alcohol (GO:0097305),-0.30541801480920516,-0.9294212574141146,0.5432098765432098,0.8931424452806578,1.0,7/27,15.18%,SLIT2;GRIN3A;GRIN2A;GRIN2B;GRIN1;SOD1;CCL19
prerank,sensory perception of mechanical stimulus (GO:0050954),0.26991475730951553,0.9291763294965588,0.5903790087463557,0.8536266609527456,1.0,7/85,6.55%,COL4A3;EYA1;DCDC2;ADGRV1;ROR1;GSDME;CCDC50
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.26152197381745895,0.9289065867336487,0.5959885386819485,0.8536413968103151,1.0,26/101,19.81%,ROBO1;FGFR1;FGF1;IL34;KIT;CCND3;ATP2B4;PDGFRB;WNT5A;LRRK2;PIK3R5;MST1R;FGF18;PARP16;MAP2K1;MTCP1;ADRA2A;PKD2;PSRC1;PPP2CA;TENM1;MAPRE3;DIRAS1;CCNY;ERBB2;SLC27A1
prerank,dopamine metabolic process (GO:0042417),-0.336105312191115,-0.9288520182649537,0.5657015590200446,0.8938459281584529,1.0,4/18,10.31%,TGFB2;SNCA;MAOA;GCH1
prerank,purine ribonucleotide catabolic process (GO:0009154),-0.32127787337622427,-0.9288226553502141,0.5739130434782609,0.8930703134046952,1.0,8/21,22.06%,PDE4D;HINT1;PDE2A;PNP;NT5C2;NUDT18;NUDT3;HPRT1
prerank,cellular response to hypoxia (GO:0071456),0.2534291487664309,0.92863963209128,0.5980392156862745,0.8536747008921255,1.0,16/126,10.29%,RORA;GATA6;HIF3A;TERT;EPAS1;ARNT;BMP7;STOX1;CPEB1;NPEPPS;CREBBP;OPRD1;PSMB10;PSMA3;PSME4;PSMA5
prerank,neuron apoptotic process (GO:0051402),-0.33088652918830774,-0.9282409642699968,0.5570776255707762,0.8937963135400083,1.0,5/19,13.40%,CIT;TRPC5;SCN2A;FAS;TNFRSF21
prerank,positive regulation of leukocyte activation (GO:0002696),-0.3354477376259594,-0.928231099307416,0.5524625267665952,0.8929687413029846,1.0,3/18,9.81%,IL33;THBS1;KARS1
prerank,positive regulation of immune effector process (GO:0002699),0.3358627592242255,0.9282284241749296,0.5947826086956521,0.8539735248096391,1.0,5/27,9.25%,DDX60;MYB;APPL2;LGALS9;ANKRD17
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),-0.3873042235162715,-0.9278774968287933,0.586,0.8930521913447593,1.0,3/11,7.21%,PLCB1;PIK3R1;AKT1
prerank,cellular polysaccharide catabolic process (GO:0044247),0.3687919954051086,0.9277874124692254,0.572463768115942,0.8543771165620312,1.0,4/16,11.43%,PYGB;MGAM;PYGM;STBD1
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),-0.22480864139848317,-0.9277668659945619,0.6402640264026402,0.8924750623556239,1.0,34/109,21.19%,PLCG2;PIK3R1;PAK1;CALM1;MAPK8;PRKCQ;PSMC3;MAPK10;MAPK3;PSMD14;PSMD3;LYN;LCP2;MALT1;FCER1G;PSMD4;PSMD6;PSMA6;PSMA4;PSMB8;VAV1;SYK;RAC1;PSMA8;LAT2;NR4A3;PLCG1;PSME1;PSMD7;PSMC6;IKBKB;PSMB5;PSMC5;PSMB1
prerank,tRNA processing (GO:0008033),-0.24976370622922353,-0.9273233069979607,0.6086956521739131,0.8927780955539859,1.0,26/61,34.90%,CSTF2;KARS1;THUMPD1;QTRT2;RPP30;PUS3;ELP5;DTWD2;WDR4;TSEN54;TYW5;CDKAL1;TRMT6;TRMT9B;TRUB1;TRMT10C;CPSF1;ADAT2;POP7;CTU2;TRMT61A;TSEN34;ADAT1;TRMT10A;DDX1;THG1L
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.3380157464469027,0.9272870583348679,0.5582191780821918,0.8548962470897453,1.0,10/27,23.42%,PCF11;NYNRIN;XRN1;SLFN14;ZC3H12B;CSTF3;RNASEH1;PARN;ZC3H12A;KHNYN
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),0.38334617977120367,0.9272742378696647,0.5238095238095238,0.854325101935973,1.0,3/14,3.32%,FOXC1;NRP1;VEGFD
prerank,sulfur compound biosynthetic process (GO:0044272),0.25778406488517935,0.9270508236438081,0.5985401459854015,0.8542089325939948,1.0,12/104,9.21%,UST;CHST15;GGTA1;ANGPT1;DCN;OMD;DSE;CHSY1;B4GALT1;GLCE;GSTK1;PRELP
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),-0.23440846386669345,-0.9268622639816795,0.61198738170347,0.8931417305616761,1.0,17/90,13.10%,ADIPOR2;EBF2;GATM;PRDM16;KSR2;GNAS;UCP2;DYNC1H1;VEGFA;MFN2;ADRB2;CMKLR1;GADD45G;SYK;PRLR;CAV1;SCD
prerank,negative regulation of protein depolymerization (GO:1901880),0.33120943297111777,0.9266048965498119,0.5501792114695341,0.8545858571385598,1.0,5/24,11.21%,PLEKHH2;CLASP1;HDGFL3;LIMA1;ATXN7
prerank,positive regulation of double-strand break repair (GO:2000781),0.30762350078105793,0.9264255648878474,0.5630252100840336,0.8543758096615028,1.0,17/39,24.79%,PARP9;PARP3;DTX3L;SPIDR;SLF2;ERCC6;FUS;SHLD2;MGMT;KMT5C;RIF1;KMT5B;SPIRE1;SMCHD1;ARID2;ZCWPW1;SHLD1
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),-0.286895856217298,-0.9260926233796813,0.5504807692307693,0.894298263996198,1.0,7/32,15.49%,RPS19;RPL39;RPL30;DEFA6;PGLYRP1;RNASE7;HMGN2
prerank,regulation of interleukin-10 production (GO:0032653),0.297892585308393,0.9259997472151053,0.5688816855753647,0.8547205953390458,1.0,7/44,7.89%,IL6;TLR4;PRKCZ;FOXP3;CD47;LGALS9;CD274
prerank,ventricular cardiac muscle cell action potential (GO:0086005),-0.3460618954119798,-0.9259071467637814,0.5541125541125541,0.8939240482261669,1.0,5/17,13.29%,RYR2;NEDD4L;KCNJ8;KCNQ1;KCNE4
prerank,regulation of glycogen metabolic process (GO:0070873),-0.368431716813462,-0.9256184080210659,0.5548387096774193,0.8938575372955009,1.0,4/12,15.96%,PPP1R3B;INPP5K;AKT1;PPP1R3C
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),-0.33415905875944435,-0.9256164799080315,0.5550660792951542,0.8930116187950692,1.0,6/18,11.23%,KDR;GATA2;HDAC7;HDAC9;VEGFA;FGF2
prerank,dendrite morphogenesis (GO:0048813),0.3115246675375595,0.9251757170815595,0.5538720538720538,0.8559918994372113,1.0,6/35,8.03%,PTN;DCDC2;SDC2;MAP6;LRP4;MEF2A
prerank,lymphocyte mediated immunity (GO:0002449),0.39460225933449533,0.9250759151028117,0.5371747211895911,0.8556083431855941,1.0,1/12,2.47%,CD55
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),-0.29706137894518947,-0.9250228229137183,0.583743842364532,0.893762213327183,1.0,10/30,19.63%,RPL11;HSP90AB1;SDCBP;RYBP;BAG6;CCAR2;CAMLG;PARK7;N4BP1;EIF3H
prerank,negative regulation of catalytic activity (GO:0043086),-0.31247652008363436,-0.9243935922519663,0.611904761904762,0.8945211964836944,1.0,12/24,31.63%,NOTCH1;CAMK2A;HDAC6;CCAR2;NOS1;TMBIM1;APBA3;CLN3;TIMP1;PLN;MT3;TP53
prerank,cardiac left ventricle morphogenesis (GO:0003214),-0.367102535029207,-0.9236895099256089,0.5673469387755102,0.8954620444561281,1.0,3/13,3.09%,RYR2;NOTCH1;CPE
prerank,membrane protein proteolysis (GO:0033619),0.3122444971559254,0.9236613303942106,0.5694915254237288,0.8582654564492785,1.0,6/37,11.82%,DAG1;CTSH;SPPL3;NGFR;ERAP1;ADAM19
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),-0.32693497928996534,-0.9235296200177646,0.5666666666666667,0.8941577137064968,1.0,9/22,28.89%,ZDHHC14;ZDHHC20;ZDHHC2;ZDHHC24;ZDHHC7;ZDHHC23;ZDHHC9;ZDHHC4;GOLGA7B
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),-0.32693497928996534,-0.9235296200177646,0.5666666666666667,0.8941577137064968,1.0,9/22,28.89%,ZDHHC14;ZDHHC20;ZDHHC2;ZDHHC24;ZDHHC7;ZDHHC23;ZDHHC9;ZDHHC4;GOLGA7B
prerank,nucleotide-excision repair (GO:0006289),0.258713632212639,0.9233556040451804,0.6204379562043796,0.8583600987717008,1.0,28/101,20.65%,POLR2D;SLX4;CUL4A;RFC1;RNF111;CCNH;MNAT1;CDK7;RPA3;XRCC1;TCEA1;POLR2C;OGG1;PRPF19;POLR2F;GTF2H4;ERCC5;ERCC6;ERCC1;USP45;GTF2H2;FANCC;UVSSA;XPC;USP7;ERCC8;POLR2K;POLD3
prerank,response to amino acid (GO:0043200),-0.28917494765173735,-0.9229988876746199,0.5933014354066986,0.894717966750565,1.0,11/31,26.20%,GLRA3;GRIN1;RRAGB;CPEB4;SPAAR;RRAGC;GLRA2;GLRA1;LAMTOR2;NSMF;LAMTOR4
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),0.3437598734513459,0.9229295402148646,0.5670840787119857,0.8587336364341871,1.0,3/21,7.53%,EPHA7;BIRC3;NGFR
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),0.3901227976794077,0.92248939853185,0.5652173913043478,0.8591577823525455,1.0,3/12,8.99%,SORBS1;EPM2AIP1;IGF2
prerank,tRNA 5'-end processing (GO:0099116),-0.35157926847788723,-0.9224055992974184,0.5382882882882883,0.8953718858470927,1.0,6/15,26.42%,PRORP;RPP30;HSD17B10;RPP25L;TRMT10C;POP7
prerank,cellular response to reactive oxygen species (GO:0034614),0.2850605537449862,0.922214744736075,0.573268921095008,0.8591827948220098,1.0,7/59,6.20%,PDGFRA;OSER1;FER;ANXA1;IL6;TPM1;MPV17
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),-0.325368140158095,-0.9220550920315368,0.5691609977324263,0.8954753056867543,1.0,6/20,15.74%,THBS1;ITGA4;SFRP4;CD40;RGCC;PLCG1
prerank,regulation of protein-containing complex disassembly (GO:0043244),-0.3378573045202906,-0.9218422599779369,0.5698198198198198,0.8951711111291757,1.0,6/16,22.59%,INSR;HDAC6;MTRF1;UPF1;GSPT1;CLN3
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),0.3049462754074407,0.9218045320064852,0.5663265306122449,0.85950255456986,1.0,15/42,23.13%,SPIDR;KLHL15;FBH1;PPP4R2;ERCC6;FUS;FIGNL1;SHLD2;KDM1A;SETD2;RIF1;RTEL1;PPP4C;SMCHD1;ARID2
prerank,mitotic DNA replication (GO:1902969),-0.3944189209466959,-0.9217636073228943,0.5734989648033126,0.894540301782241,1.0,3/10,16.39%,GINS3;POLA1;CDC45
prerank,stress-activated protein kinase signaling cascade (GO:0031098),-0.3022828218162861,-0.9215529950441362,0.5927835051546392,0.8942278292220459,1.0,10/27,23.84%,MAP3K5;MAPK8;MAPK3;UBB;MAP3K20;UBA52;KAT7;IKBKB;SKP1;TAOK2
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),0.39581958787128824,0.9214348812907496,0.5511363636363636,0.8597592790347647,1.0,3/12,11.01%,PLK5;WAC;RFWD3
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),-0.3717377398171126,-0.9213013337469431,0.5670103092783505,0.893998558578706,1.0,4/12,15.10%,UCK2;UPP2;UCKL1;UCK1
prerank,purine-containing compound catabolic process (GO:0072523),0.39063475297913325,0.9209468225920968,0.5626168224299065,0.8602583486221841,1.0,5/13,20.56%,DPYD;NT5C;ITPA;NT5C1A;XDH
prerank,regulation of cilium assembly (GO:1902017),0.27861554200560457,0.9208651212014813,0.5905511811023622,0.8598490882328271,1.0,11/62,14.44%,DCDC2;TBC1D16;SDCCAG8;IFT88;YAP1;TAPT1;DYNC2LI1;ENTR1;IFT20;TBC1D7;CROCC
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),0.33917514922309744,0.9208008199688348,0.5510204081632653,0.8593962697355686,1.0,5/22,14.28%,BMP7;MYADM;MAP2K5;WNK1;FLOT2
prerank,negative regulation of protein dephosphorylation (GO:0035308),-0.32166172857827463,-0.9198695421060706,0.5849889624724062,0.896706115077102,1.0,4/21,8.46%,PPP1R16B;FKBP1A;MFHAS1;PPP1R11
prerank,generation of neurons (GO:0048699),0.2406322092147892,0.9195523001672423,0.6384105960264901,0.8616218112750288,1.0,17/190,5.24%,WNT4;DCDC2;WNT6;FGFR1;AUTS2;WNT10B;WNT3A;WNT2B;NRP1;SH3RF1;FZD2;SDCCAG8;WNT5B;EN2;BTG4;NIF3L1;OTP
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.34267494905697615,0.9194815726406479,0.5845896147403685,0.8611812708425791,1.0,4/23,8.04%,PRKAG2;BMP7;STOX1;RIPK2
prerank,regulation of cellular protein localization (GO:1903827),0.3019910645441927,0.9193039373918013,0.6010016694490818,0.8609811701323199,1.0,14/45,19.59%,GPC6;PRKAA2;SPIDR;GPC2;DVL3;HFE;PTPN1;CCDC66;BDNF;GBF1;GPC1;KDM1A;GPC4;SETD2
prerank,positive regulation of interleukin-12 production (GO:0032735),0.31564658512843907,0.919265251275154,0.5578231292517006,0.8604658615374047,1.0,6/31,11.12%,IL16;TLR4;LGALS9;RIPK2;MAPK14;TLR2
prerank,membrane lipid metabolic process (GO:0006643),0.34248503033554034,0.9189027239128099,0.5719237435008665,0.8607049318642604,1.0,1/22,0.19%,AGMO
prerank,mesonephric tubule development (GO:0072164),0.37407650161429873,0.9187851763870298,0.5551257253384912,0.8603845614022164,1.0,4/15,5.23%,OSR1;FOXC1;BMP7;SALL1
prerank,sympathetic nervous system development (GO:0048485),-0.35381315410995395,-0.91867794003064,0.5602678571428571,0.8989283867495615,1.0,4/15,12.74%,NRP2;CTNNB1;FZD3;SEMA3A
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),-0.36888238158770503,-0.9185415947795479,0.5592515592515592,0.8984520865561585,1.0,8/12,48.12%,CLSPN;HUS1B;TOPBP1;CDC6;TICRR;RAD17;SETMAR;HUS1
prerank,negative regulation of endocytosis (GO:0045806),-0.3142500615739864,-0.9185221432352101,0.585812356979405,0.897649390153799,1.0,11/24,28.10%,MCTP1;SCAMP5;CAV1;RAC1;PRKD1;LRSAM1;ARF6;MTMR2;SNX33;NR1H2;LILRB1
prerank,negative regulation of gluconeogenesis (GO:0045721),-0.37440753638026447,-0.9182030958339361,0.5668789808917197,0.8975998644852183,1.0,3/11,14.88%,C1QTNF3;SIK1;PGP
prerank,chromosome condensation (GO:0030261),-0.27918143389948596,-0.9181631880010647,0.6150234741784038,0.8968816150587751,1.0,18/36,37.95%,MCPH1;SMC2;H1-0;CHMP1A;SET;NCAPH2;NCAPH;TENT4A;TTN;BANF1;CSNK2B;NCAPD2;PLK1;CDK1;NCAPD3;INCENP;CCNB1;BANF2
prerank,regulation of biosynthetic process (GO:0009889),-0.3745412630900925,-0.9180608754192078,0.5869120654396728,0.8962757491757963,1.0,10/11,53.06%,SNCA;MID1IP1;ALOX5;THRSP;GSTP1;CCN6;SLC25A33;PIKFYVE;UCP1;PCK1
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),0.33247537432527224,0.9171736563186071,0.5616438356164384,0.8634960107165204,1.0,10/27,21.01%,NR1H3;PPARA;CRP;IL18;CSF1;MAPK9;ABCA1;PLA2G5;CD36;AGT
prerank,negative regulation of neuron differentiation (GO:0045665),-0.31695803413732004,-0.9170218759212982,0.5844155844155844,0.8980441646827968,1.0,8/22,20.22%,CNTN4;B2M;CALR;HEY1;HES1;NEPRO;SOX2;DLL1
prerank,mitochondrial fission (GO:0000266),-0.3449385409710971,-0.9168710133208589,0.5778251599147122,0.8975771314688251,1.0,3/16,10.98%,DNM3;MFF;GDAP1
prerank,striated muscle cell development (GO:0055002),-0.35762855150773487,-0.916666504824881,0.5665236051502146,0.8972303669015441,1.0,2/14,6.20%,PGM5;LMOD1
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),-0.24299848257319878,-0.9160854611473698,0.6263736263736264,0.8979058975702066,1.0,15/73,17.94%,PTPRJ;PLCG2;IL33;THBS1;HMGB1;ARHGEF2;HAVCR2;CD86;SYK;PTPRC;CCL19;NOD2;PYCARD;LPL;ADAM8
prerank,negative regulation of T cell differentiation (GO:0045581),0.40924800712348597,0.9160515726761777,0.5661080074487895,0.8654412470116185,1.0,2/10,11.55%,GLI3;IHH
prerank,glucosamine-containing compound metabolic process (GO:1901071),0.3827664038683621,0.915706667214391,0.5570342205323194,0.8656080711561258,1.0,5/13,19.93%,LARGE1;MGAT3;EXTL2;NAGK;CHST3
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),-0.30858814297719284,-0.9154469479318427,0.5846153846153846,0.8987916186477284,1.0,7/25,12.81%,INSR;NOS1AP;KLF2;HSP90AB1;AKT1;KLF4;HSP90AA1
prerank,positive regulation of ERBB signaling pathway (GO:1901186),-0.30138608828649804,-0.9153020128275513,0.5818181818181818,0.8983515510051487,1.0,7/25,13.77%,HIP1;BCAR3;HIP1R;CCDC88A;AKT1;CBL;PLAUR
prerank,positive regulation of cellular biosynthetic process (GO:0031328),0.24023905296515424,0.915248949759417,0.6551724137931034,0.8660767057124884,1.0,41/166,20.78%,SMAD3;ZEB2;PLD1;SAMD4A;VIM;SLC6A9;SORBS1;IL6;TLR4;GLI1;ARNT;NR1H3;EPM2AIP1;PDGFRB;PTPN2;IGF2;APPL1;SLC25A37;ZCCHC4;SMOC2;ZNF205;STAR;SOX4;PRKD2;PKD2;CPEB3;OPN3;LPGAT1;P2RX4;UPF3A;FXR2;PLXNB2;DNA2;ERBB2;SLC27A1;CTC1;CD36;PTGS2;SREBF1;ELAVL1;ASS1
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),-0.31824380426165455,-0.9152353089519584,0.5959367945823928,0.8976667101721274,1.0,6/20,13.86%,HSP90AB1;AKT1;CCND1;EGFR;TTBK1;RGCC
prerank,positive regulation of cytoplasmic transport (GO:1903651),-0.3820506105960044,-0.9151372769146695,0.5789473684210527,0.8970962338740583,1.0,6/11,37.88%,SORL1;MTMR2;MSN;PTPN23;EIPR1;EZR
prerank,protein localization to nucleus (GO:0034504),0.2566611669912761,0.9151177766782737,0.6273653566229985,0.865782700436136,1.0,21/102,18.28%,PRICKLE1;TNPO1;GBP2;WRN;BMP7;MORC3;APPL2;TPR;PHB2;APPL1;TOR1AIP1;IPO7;EIF4ENIF1;PAF1;POM121;PML;RAN;YWHAE;ABCA7;RANBP17;INTS13
prerank,histone H3-K36 demethylation (GO:0070544),0.41235372702665823,0.9151073264724521,0.5589430894308943,0.8652076753111714,1.0,4/10,15.61%,KDM7A;KDM2A;KDM8;KDM2B
prerank,negative regulation of nuclear division (GO:0051784),0.40003287133346555,0.9151048143424743,0.5490566037735849,0.8646152781869038,1.0,5/11,22.28%,BMP7;NANOS2;TOM1L2;TOM1L1;NME6
prerank,negative regulation of phagocytosis (GO:0050765),-0.3455857212803134,-0.9147346059847423,0.5720620842572062,0.8972564712330006,1.0,4/17,10.37%,SNX3;HMGB1;DYSF;RACK1
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),-0.34503991867142386,-0.9145123967995367,0.6030368763557483,0.8970040869015062,1.0,4/16,9.99%,TPT1;RPS3;CXCL12;CCAR2
prerank,regulation of histone acetylation (GO:0035065),0.3126556660717298,0.9140447907907149,0.6042402826855123,0.8663728511091457,1.0,8/33,16.82%,KMT2A;FOXP3;GLYR1;TAF7;IWS1;ARRB1;SETD5;RAPGEF3
prerank,RNA modification (GO:0009451),-0.2570376039842437,-0.9139709545859648,0.6311475409836066,0.8975837045160642,1.0,16/54,23.06%,ADARB1;PUS7;FTSJ3;THUMPD1;QTRT2;PUS3;ELP5;DTWD2;WDR4;TYW5;RBM15B;CDKAL1;TRMT6;TRMT9B;TFB1M;TRUB1
prerank,muscle cell development (GO:0055001),0.3182812680512089,0.9138910032479632,0.5576271186440678,0.866106999132203,1.0,4/30,4.79%,CXADR;MYOF;EFEMP2;NEBL
prerank,nucleus organization (GO:0006997),-0.25835611645783474,-0.9138715567811474,0.6422976501305483,0.8970049058972058,1.0,17/47,30.83%,SYNE1;RPS19;NUP93;CTDNEP1;CHMP1A;CHMP1B;CHMP7;CHMP2B;CHMP2A;CEP55;NUP54;CHMP6;CHMP4C;REEP4;NDC1;PITPNB;TOR1A
prerank,positive regulation of chemotaxis (GO:0050921),-0.26427603583267684,-0.9135936677432199,0.6228710462287105,0.8968603022309009,1.0,11/43,15.27%,TMSB4X;THBS1;KDR;F3;STX3;MET;LGMN;VEGFA;FGF2;CCL19;PRKD1
prerank,regulation of amyloid fibril formation (GO:1905906),-0.3483226722183794,-0.913371121698328,0.5807174887892377,0.8965729926624584,1.0,8/15,31.45%,PFDN5;PFDN2;PFDN4;CHRNA7;VBP1;TREM2;CLU;LDLR
prerank,regulation of interleukin-1 production (GO:0032652),0.3752443688993368,0.9132118695701751,0.5698324022346368,0.867093698682123,1.0,2/15,4.67%,ANXA1;TLR4
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.3042984529679988,0.9127422131689454,0.5852842809364549,0.8675362407478405,1.0,7/37,10.73%,NUPR1;GSDME;BCL2;FBH1;BAX;DNM1L;BCL2L1
prerank,retinoic acid receptor signaling pathway (GO:0048384),-0.38817562977446984,-0.9125234246420064,0.5831533477321814,0.8978669818930334,1.0,4/10,17.25%,TBX1;RXRB;ACTN4;RXRA
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.2766903735224823,0.9115326115754591,0.6049766718506998,0.8696396470992798,1.0,10/59,14.55%,ROCK2;TLR4;BIRC3;LY96;RIPK2;TLR2;MAP3K7;TIFA;TICAM1;TBK1
prerank,Golgi to plasma membrane protein transport (GO:0043001),0.32345671203723014,0.9113934681843767,0.5803571428571429,0.869350169819368,1.0,4/30,5.68%,SPTBN1;VAMP5;RAB10;OPTN
prerank,positive regulation of isotype switching (GO:0045830),-0.347046060800723,-0.9113762560932115,0.5723014256619144,0.8998616740649904,1.0,4/15,15.24%,TFRC;CD40;HMCES;CLCF1
prerank,cellular response to nutrient levels (GO:0031669),0.28267676717729234,0.9110874907596787,0.5974643423137876,0.8694340398327947,1.0,11/62,11.14%,PRKAA2;GCGR;WRN;LAMP2;CARTPT;PPARA;CDKN2B;STK24;LRRK2;NUPR2;FNIP1
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),-0.2807707325676882,-0.9110049459205061,0.6188118811881188,0.8999668666551521,1.0,6/35,8.46%,FKBP1A;CALM1;CALM2;HSP90AB1;CALM3;PPP1R11
prerank,antibacterial humoral response (GO:0019731),-0.3436714276104825,-0.9106495011049922,0.6130536130536131,0.9000329305708415,1.0,3/16,14.16%,RPL39;DEFA6;RNASE7
prerank,protein-DNA complex assembly (GO:0065004),0.25568328297920356,0.9106085416011758,0.6390870185449358,0.8699052088050452,1.0,19/116,15.44%,TCF4;ORC5;CUL4A;PSMB10;CCNH;KAT6B;PSMA3;MNAT1;PSME4;CDK7;RPA3;MCM4;PSMA5;GMNN;MCM6;GTF2H4;ERCC5;ORC3;ORC4
prerank,neuron fate commitment (GO:0048663),-0.3451002894279076,-0.9102020168583578,0.5982905982905983,0.9003180415171737,1.0,7/14,35.38%,MYT1L;POU3F2;DLL4;DLL1;POU4F1;PAX6;ASCL1
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),-0.2791070527946081,-0.9100660186663431,0.6116751269035533,0.8998357703067271,1.0,11/35,13.60%,TEK;ESAM;PTK2B;SEMA3E;ARHGDIB;ABI3;FES;ARHGDIA;CSF1R;F11R;HRAS
prerank,positive regulation of histone modification (GO:0031058),-0.28386046932895465,-0.9097581152679037,0.6264236902050114,0.8997862335027436,1.0,8/33,17.04%,RPS6KA5;TADA2A;MAPK3;SART3;NOS1;CTBP1;APLNR;BRCA1
prerank,fatty acid transmembrane transport (GO:1902001),0.3516203465189217,0.9096977017819877,0.5785288270377733,0.8713332383037146,1.0,2/19,1.61%,PRKAG2;PRKAA2
prerank,N-terminal protein amino acid modification (GO:0031365),0.37264733718777715,0.9094590241563916,0.5872420262664165,0.8712625607577249,1.0,6/14,21.68%,NAA16;NAA15;PDF;NAA35;NAA40;METAP2
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),-0.35866011811977233,-0.9092730581048865,0.5877192982456141,0.9001540517771386,1.0,10/13,48.64%,CYRIB;MR1;STX7;FADD;NECTIN2;IL12A;IL12RB1;IL23A;IL12B;XCL1
prerank,PERK-mediated unfolded protein response (GO:0036499),0.3988327223112515,0.9082975083916983,0.5651302605210421,0.8732893327601355,1.0,3/10,15.08%,CCL2;QRICH1;EIF2AK3
prerank,ovarian follicle development (GO:0001541),-0.35483302677215145,-0.9070426984632556,0.5778251599147122,0.9049726816498521,1.0,6/13,22.52%,EIF2B2;VEGFA;INHBB;SOD1;FOXL2;LHCGR
prerank,establishment of spindle orientation (GO:0051294),0.3226427678957219,0.9066354496284443,0.5779334500875657,0.8763949863382736,1.0,6/28,13.67%,GJA1;CLASP1;MISP;FBXW11;LLGL2;MAP4
prerank,regulation of chromatin organization (GO:1902275),0.3802626504218411,0.9065392923789298,0.551923076923077,0.8759855808405341,1.0,4/14,15.34%,MLLT3;IGF2;TLK2;SETD5
prerank,positive regulation of histone acetylation (GO:0035066),-0.3112982130238724,-0.9062217079607506,0.594170403587444,0.9061973807287829,1.0,7/23,18.18%,RPS6KA5;TADA2A;MAPK3;SMARCB1;NOS1;BRCA1;KAT7
prerank,cellular response to insulin stimulus (GO:0032869),0.2485419717219363,0.9060000963543625,0.6403508771929824,0.8765942741211085,1.0,30/124,17.32%,PDPK1;ENPP1;PHIP;FOXC2;FER;TRARG1;RAB10;SORBS1;PTPN2;PIK3C2A;CPEB1;GSK3B;INSIG2;RHOQ;IGF2;ZNF106;APPL1;OTOP1;RARRES2;TCIRG1;ATP6V0B;DENND4C;BAIAP2;KAT2B;ATP6V1E1;IGF1R;ATP6V1C1;MYO5A;LPIN2;PCK2
prerank,aminoglycan biosynthetic process (GO:0006023),-0.2589741496559459,-0.905515019871449,0.6349614395886889,0.9071367698421118,1.0,7/49,4.93%,GPC5;HS3ST1;HS6ST2;HS3ST5;XYLT1;SDC3;EXT1
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),0.4078434500956788,0.9054519684718895,0.5821782178217821,0.8771794949248739,1.0,2/10,11.55%,EMC2;EMC9
prerank,negative regulation of secretion (GO:0051048),0.4052484697137453,0.9054314799840377,0.5604838709677419,0.8766346394551091,1.0,5/10,23.21%,NR1H3;TIFAB;ERBB3;PTGER3;NRG1
prerank,negative regulation of cyclase activity (GO:0031280),-0.3540558050094076,-0.9047804180428819,0.5861344537815126,0.9081225271517717,1.0,2/14,3.31%,GRM3;GABBR2
prerank,cellular iron ion homeostasis (GO:0006879),0.28010008269709774,0.904128205073823,0.6086286594761171,0.8789380624183831,1.0,2/55,0.40%,CP;BMP6
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.3203873789522351,0.9040521176935032,0.5953237410071942,0.8785117050853798,1.0,7/25,15.00%,QRICH2;EPHA4;SGTA;HFE;EFNA1;CSNK2A2;PML
prerank,carbohydrate catabolic process (GO:0016052),-0.2712970357748943,-0.903962925382866,0.6435897435897436,0.9093325401417474,1.0,9/38,15.67%,PGK1;PKM;ALDOC;NEU1;GPI;TPI1;PGAM1;PGAM4;ENO1
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),-0.3092630082869914,-0.9039182839081142,0.5969162995594713,0.9086225603132224,1.0,4/21,11.52%,RPL5;RPS7;RPL11;RPL23
prerank,regulation of actin filament-based movement (GO:1903115),0.40571641386852036,0.9038705581809995,0.574468085106383,0.8783123850829543,1.0,1/10,0.30%,PDPN
prerank,organic cation transport (GO:0015695),-0.31051700728449394,-0.9037646061229884,0.5981735159817352,0.908179936138193,1.0,4/19,15.72%,SLC47A1;SLC25A42;SLC22A5;SLC25A19
prerank,negative regulation of adenylate cyclase activity (GO:0007194),-0.3597779589212903,-0.9037223106990161,0.5979381443298969,0.9074619583578323,1.0,2/13,3.31%,GRM3;GABBR2
prerank,negative regulation of microtubule depolymerization (GO:0007026),-0.3149171036190576,-0.9036851903957879,0.594170403587444,0.9067161902541435,1.0,6/21,17.33%,NAV3;ARHGEF2;STMN2;FGF13;CLASP2;MID1IP1
prerank,regulation of protein catabolic process (GO:0042176),-0.2266195364295691,-0.9035370658595205,0.6837349397590361,0.9062539930644907,1.0,15/99,12.13%,FMN2;FOXO1;WWP1;HECW1;NSF;SORL1;EEF1A1;DAB2IP;SNX3;OAZ1;OAZ2;NEDD4L;ZDHHC2;BARD1;EGFR
prerank,long-chain fatty acid transport (GO:0015909),0.3148460834582394,0.9028815437366566,0.5848056537102474,0.8799416732563097,1.0,5/30,12.51%,PRKAG2;PRKAA2;ACSL1;SLC27A2;ABCD3
prerank,cellular response to glucose starvation (GO:0042149),0.30029132950355164,0.9025262269988785,0.6027397260273972,0.8801316083699479,1.0,8/41,15.08%,PRKAG2;PRKAA2;MTMR3;RRP8;SESN1;FOXO3;NUAK2;EIF2AK3
prerank,endomembrane system organization (GO:0010256),0.23296028088094883,0.9025082196936239,0.6818181818181818,0.8795650979658771,1.0,43/178,19.30%,ARHGAP21;MYOF;SPTBN1;A4GALT;RAB22A;MIA3;WASHC4;CLASP1;RAB43;OPTN;VAPA;GOLGA5;GOLGA8B;FAM174B;USP8;LRRK2;DNM1;DNM1L;UBXN2A;HUWE1;TMCC1;GORASP2;TJAP1;SRGN;COG2;LMAN1L;TMED9;EIF2AK3;GBF1;ATL1;GOLGA2;ANXA8;ANXA8L1;SEC31A;HOOK1;DMPK;DNAJC28;LYSMD3;PLEKHF1;USP6NL;SEC16A;ARFGEF2;PLEKHM2
prerank,carbohydrate derivative biosynthetic process (GO:1901137),0.32281833971293183,0.9024864195675589,0.6039076376554174,0.8790119407982542,1.0,6/26,11.67%,LARGE1;RRM1;GBGT1;GK5;ALG11;RRM2B
prerank,regulation of cellular response to stress (GO:0080135),-0.22003452713522575,-0.9024610788644701,0.7052980132450332,0.9081495182691914,1.0,42/115,26.66%,HSPA8;OPRM1;MAPK3;CHCHD2;HSP90AB1;CAMK2D;BAG1;CAMK2A;PINK1;NPM1;HSBP1;CCAR2;ATM;AAAS;MANF;NUP93;ATF4;NPAS2;AKT1S1;HSP90AA1;CASP9;RAE1;MAPT;ARMT1;ADCY8;FKBP4;VASH1;MLST8;BAG4;NUP62;ATR;NUP188;CLN3;SLC38A2;AIFM2;NUP54;CAMK2G;NUP210;MBTPS2;NUP42;NUP153;EIF4G1
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),-0.27234575458399257,-0.9023595433819923,0.631578947368421,0.9075717437344935,1.0,8/39,12.62%,EFR3B;ITPKB;PIK3R1;PIK3C2B;PIK3R3;IP6K2;PI4K2A;PIK3CD
prerank,chromatin remodeling (GO:0006338),0.2559187066911565,0.902253963769356,0.6528571428571428,0.8789334128275538,1.0,28/100,19.06%,MYB;MBD2;TOP1;BAZ2A;FOXP3;HDAC4;HNRNPC;BAZ1B;GATAD2B;JARID2;CECR2;BAZ1A;MYSM1;ACTL6A;KDM5B;SRCAP;BPTF;ERCC6;HDAC2;SMARCA4;KAT2B;SMARCC1;CHD8;INO80C;CHD4;HCFC2;ARID1B;ACTR8
prerank,regulation of cell size (GO:0008361),0.33526898787984405,0.9021961724353668,0.5709090909090909,0.8784654315430218,1.0,1/23,0.53%,DEPTOR
prerank,positive regulation of cytoskeleton organization (GO:0051495),-0.23377370046046062,-0.9021779773489464,0.6840490797546013,0.9071792211860648,1.0,24/76,21.61%,TEK;PTK2B;NCKAP1;LMOD1;CDC42EP3;DYNC1H1;VASP;CDC42EP1;CDC42EP5;PFDN2;FES;HRAS;EVL;PLK4;NTF3;P2RX7;PYCARD;ARF6;PFN2;SPAG5;CARMIL1;HCLS1;PRKCE;NUP62
prerank,translational termination (GO:0006415),-0.22520601937360268,-0.9021778462637636,0.6773255813953488,0.9063604673763299,1.0,38/95,34.00%,MRPL4;MRPS18A;MRPL1;MRPS30;GSPT2;MRPS23;MRPL57;MRPL28;MRPL47;AURKAIP1;MTRF1;MRPL35;MRPS5;MRPL34;MRPS2;MRPL52;MRPL23;MRPL9;GSPT1;MRPS31;MRPL49;MRPS12;MRPL11;N6AMT1;MRPL50;MRPS16;MRPS22;MRPS25;MRPL44;CHCHD1;MRPL51;MRPL32;MRPL54;MRPL43;MRPL2;MRPL24;MRPL37;ERAL1
prerank,fatty acid catabolic process (GO:0009062),0.27014341351928794,0.9019746703758496,0.631083202511774,0.878330539419595,1.0,22/67,23.01%,PCCA;AIG1;PCCB;SCP2;SLC27A2;HACL1;ACAT1;ABCD3;PEX2;PECR;HAO1;PHYH;ACADS;LPIN2;ABHD3;ACOX1;HADHA;ACBD5;NUDT19;HADH;MMUT;LPIN1
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),-0.3339181062955462,-0.9019651075461437,0.6114790286975718,0.9060920177599859,1.0,6/17,9.86%,CACNB2;KCNJ2;SLC8A1;HCN2;CACNA1G;CACNA1D
prerank,cholesterol transport (GO:0030301),0.2917759567068515,0.9014465248704906,0.6211878009630819,0.8789190729398585,1.0,9/45,17.50%,APOA2;NPC1;LIMA1;SOAT1;OSBPL5;STAR;ABCA1;SERAC1;ABCA7
prerank,telomere organization (GO:0032200),0.2950304886790121,0.901163707287836,0.606418918918919,0.878968869938128,1.0,5/43,5.63%,SP100;TERT;WRN;RAD50;PARP3
prerank,positive regulation of superoxide anion generation (GO:0032930),0.38035292440753066,0.9011188226615467,0.604040404040404,0.8784658530797109,1.0,2/13,6.65%,FPR2;CRP
prerank,quinone biosynthetic process (GO:1901663),-0.35354678103606685,-0.9008159073041724,0.5722772277227722,0.908032305234742,1.0,6/14,23.50%,COQ9;FDXR;COQ10B;COQ8A;COQ3;COQ5
prerank,histone H4 acetylation (GO:0043967),0.289774475117777,0.9006047626346882,0.6348228043143297,0.8790122336569738,1.0,10/47,17.72%,KMT2A;APBB1;EPC1;JADE2;ACTL6A;BRD8;ZZZ3;TRIM16;KANSL1;ATF2
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.34133933362199265,0.9004894577018603,0.5827338129496403,0.8786620294094768,1.0,2/20,3.96%,RBPJ;BMP2
prerank,protein deacetylation (GO:0006476),0.29936027989633346,0.90034688626846,0.6006711409395973,0.8784024805152503,1.0,12/41,18.56%,TBL1XR1;MIER3;BAZ2A;MIER1;HDAC4;SIRT4;PRDM5;RBM14;HDAC2;TBL1X;MIDEAS;SIRT3
prerank,negative regulation of inclusion body assembly (GO:0090084),-0.3774141497625554,-0.9003143216591543,0.592292089249493,0.9084103656217493,1.0,4/10,24.43%,SORL1;DNAJA4;SACS;HSPA2
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),-0.3024812703937188,-0.8999179789205751,0.6075388026607539,0.908568993424082,1.0,7/26,12.81%,INSR;NOS1AP;KLF2;HSP90AB1;AKT1;KLF4;HSP90AA1
prerank,regulation of sodium ion transport (GO:0002028),0.3052227852446092,0.8997484189307343,0.6065292096219931,0.8791523803671193,1.0,10/34,14.09%,NKAIN4;NEDD4;SNTA1;ATP2B4;WNK4;SCN3B;DLG1;GPD1L;SLMAP;WNK1
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.3148459861339365,0.899728507416497,0.6350877192982456,0.8786022897287905,1.0,4/29,8.62%,KANK2;UBA5;STRN3;YAP1
prerank,positive regulation of DNA replication (GO:0045740),-0.33404512797754,-0.8991800985090023,0.6157112526539278,0.9095383187294405,1.0,5/16,18.18%,BCAR3;EGFR;ATAD5;EGF;KAT7
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),0.3766639556019365,0.8990549779594352,0.6049149338374291,0.8794949130875668,1.0,3/13,12.48%,PARP9;PARP10;PARP16
prerank,G1/S transition of mitotic cell cycle (GO:0000082),-0.23219100752267657,-0.898841816811346,0.703030303030303,0.909547907847043,1.0,17/83,16.39%,USP29;CDK17;CDK14;CDK6;MAX;CAMK2A;CCND1;CDK15;POLA1;BCAT1;ACVR1;HINFP;USP37;CDK2;CDKN1A;CDK4;CDC45
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),0.39910917609895424,0.8983689292703243,0.59375,0.8803817388106765,1.0,4/11,19.29%,WNT3A;WNT5A;RYK;WNT2
prerank,cranial nerve development (GO:0021545),0.3889646552327478,0.8979755989056984,0.5939849624060151,0.8806926703049048,1.0,2/11,7.71%,SALL1;TIFAB
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),-0.22089083447321564,-0.8978062763625138,0.7266187050359713,0.9104852850588152,1.0,27/104,21.19%,PLCG2;RPS6KA5;PAK1;PSMC3;PSMD14;PSMD3;LYN;MALT1;FCER1G;PSMD4;PSMD6;ICAM2;PSMA6;PSMA4;PAK3;PSMB8;SYK;HRAS;KRAS;PSMA8;PSME1;PSMD7;PSMC6;IKBKB;PSMB5;PSMC5;PSMB1
prerank,cellular response to lectin (GO:1990858),-0.22089083447321564,-0.8978062763625138,0.7266187050359713,0.9104852850588152,1.0,27/104,21.19%,PLCG2;RPS6KA5;PAK1;PSMC3;PSMD14;PSMD3;LYN;MALT1;FCER1G;PSMD4;PSMD6;ICAM2;PSMA6;PSMA4;PAK3;PSMB8;SYK;HRAS;KRAS;PSMA8;PSME1;PSMD7;PSMC6;IKBKB;PSMB5;PSMC5;PSMB1
prerank,very long-chain fatty acid metabolic process (GO:0000038),-0.28251556579741455,-0.8976670051503797,0.6221719457013575,0.9099778312987616,1.0,8/30,15.87%,ELOVL5;ELOVL7;ABCD4;TECR;TECRL;ABCD2;ACSBG1;HACD3
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.2688778705028284,0.8973260936646862,0.6337579617834395,0.8815099699628666,1.0,6/67,4.24%,DCDC2;PLD1;FER;TBC1D16;SDCCAG8;IFT88
prerank,regulation of superoxide anion generation (GO:0032928),0.3734437299164003,0.8971625071828758,0.6064908722109533,0.8812910037849926,1.0,2/14,6.65%,FPR2;CRP
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.24969546351843663,0.897137427894336,0.6610169491525424,0.880745621857819,1.0,15/116,10.90%,GHRH;ADORA2A;PTHLH;GLP2R;IL6;ADCY5;ADCY7;MC2R;RXFP2;ADCY1;RAMP1;ADM;INSL3;MAPK14;GPR39
prerank,estrogen metabolic process (GO:0008210),0.36676949140926,0.8971040939427939,0.5854545454545454,0.8802225635491635,1.0,3/15,16.54%,HSD17B1;HSD17B14;SULT1A1
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.32547397244506693,0.8963236069717049,0.5858407079646017,0.8813838730285041,1.0,4/23,8.20%,GHR;KIT;IL6;CRLF3
prerank,histone mRNA metabolic process (GO:0008334),0.32026377406846573,0.8961590205280909,0.5913978494623656,0.8811440157875657,1.0,9/27,18.21%,TUT4;LSM1;DCP2;XRN1;TENT2;SSB;EXOSC10;TUT7;SLBP
prerank,regulation of type I interferon production (GO:0032479),0.2594683203612026,0.8959888955098609,0.648766328011611,0.8809514940593234,1.0,32/84,27.25%,TRIM56;IKBKE;DTX4;PTPN22;ZBP1;RNF216;CREBBP;POLR1C;NLRX1;POLR3F;TRIM21;POLR2F;IFIH1;TBK1;POLR3H;RNF135;PCBP2;DHX36;POLR2K;NLRP4;OTUD5;GAPDH;TAX1BP1;DHX9;TRIM32;POLR3B;POLR2H;UBE2L6;STAT6;ISG15;CRCP;CGAS
prerank,regulation of heart contraction (GO:0008016),0.258608572925076,0.8957041659695305,0.6318181818181818,0.8809954488082034,1.0,9/90,7.74%,CELF2;ATP1A2;ITPR1;TMEM65;DES;TPM1;ATP2B4;CORIN;NPPC
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.23791441459691612,0.8956685006608263,0.6827676240208878,0.880481145866664,1.0,17/151,8.25%,CCN2;PDGFRA;NOTCH2;FPR2;MTURN;GLIPR2;NRP1;ANGPT1;BMP2;ROR1;PRKCZ;PTPN22;PDGFRB;CCL2;ACKR3;LGALS9;PHB2
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),-0.31895478184630743,-0.89547588553381,0.6111111111111112,0.9144922595184966,1.0,2/19,0.90%,DLG2;LRRC7
prerank,cellular response to pH (GO:0071467),0.3477630704351302,0.895474190125952,0.6100178890876565,0.8803656981824135,1.0,2/17,10.21%,INSRR;PKD1L3
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),-0.3732926403457153,-0.8953112790516053,0.592741935483871,0.9140653854039236,1.0,3/12,11.10%,PIK3R1;DAB2IP;ATF6
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),0.40469387527621103,0.8949926116379273,0.611439842209073,0.8808234873953165,1.0,4/11,10.71%,IGF2BP1;RASA1;NOVA1;IGF2BP2
prerank,clathrin-dependent endocytosis (GO:0072583),-0.29693497416293796,-0.8946189942913023,0.6398963730569949,0.9149599742227088,1.0,10/26,27.43%,SGIP1;FNBP1L;SNAP91;AP2B1;DLL1;ITSN2;AP2A2;AP2A1;CLTA;AP2M1
prerank,cardiac cell development (GO:0055006),-0.37335661656009556,-0.8945091340705004,0.6129032258064516,0.9143893958296245,1.0,4/11,8.85%,NOTCH1;MYH11;SLC8A1;VEGFA
prerank,negative regulation of JNK cascade (GO:0046329),0.3103017701369102,0.8944322476586485,0.6104553119730185,0.881429697591022,1.0,6/31,10.35%,DUSP10;DACT1;TAOK3;PTPN22;ZMYND11;HIPK3
prerank,positive regulation of mononuclear cell migration (GO:0071677),0.3163937677113716,0.8941664286765305,0.6109154929577465,0.881427661412784,1.0,5/29,11.41%,CXCL10;FPR2;SERPINE1;LGALS9;ANO6
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.3367387098419035,0.8938721825510921,0.6129629629629629,0.881477622176097,1.0,4/22,8.20%,GHR;KIT;IL6;CRLF3
prerank,iron ion homeostasis (GO:0055072),0.27293860245557117,0.8937178708884963,0.6213292117465224,0.8812274497549639,1.0,2/58,0.40%,CP;BMP6
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),-0.21950949114489193,-0.893442352342447,0.7427536231884058,0.9162138926520629,1.0,27/105,21.19%,PLCG2;RPS6KA5;PAK1;PSMC3;PSMD14;PSMD3;LYN;MALT1;FCER1G;PSMD4;PSMD6;ICAM2;PSMA6;PSMA4;PAK3;PSMB8;SYK;HRAS;KRAS;PSMA8;PSME1;PSMD7;PSMC6;IKBKB;PSMB5;PSMC5;PSMB1
prerank,negative regulation of interleukin-1 production (GO:0032692),-0.3044901377231648,-0.8932067879321858,0.6344827586206897,0.9159667460757753,1.0,2/23,7.57%,GAS6;CEACAM1
prerank,mitochondrial translational elongation (GO:0070125),-0.2273989988030464,-0.8931067781509712,0.72,0.9154023204193533,1.0,38/88,35.82%,MRPL4;GFM1;MRPS18A;MRPL1;MRPS30;MRPS23;MRPL57;MRPL28;MRPL47;AURKAIP1;MRPL35;MRPS5;MRPL34;MRPS2;MRPL52;MRPL23;MRPL9;MRPS31;MRPL49;MRPS12;TUFM;MRPL11;MRPL50;MRPS16;MRPS22;MRPS25;MRPL44;CHCHD1;MRPL51;MRPL32;MRPL54;MRPL43;MRPL2;MRPL24;MRPL37;ERAL1;MRPL45;MRPL30
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.2670225457191097,0.8925746791984799,0.6335403726708074,0.883166248921433,1.0,8/66,8.62%,SMAD3;PARP9;ZIC1;TERT;TPR;DTX3L;NGFR;YAP1
prerank,AMP metabolic process (GO:0046033),0.37916504481650304,0.8925324570836753,0.5803402646502835,0.8826739953208166,1.0,1/13,1.05%,AMPD3
prerank,cytosolic calcium ion transport (GO:0060401),0.3129662424528874,0.8924310546210293,0.616580310880829,0.8822809226065992,1.0,8/28,16.74%,MCU;MICU1;CACNA1C;JPH1;ATP2B1;JPH3;CACNA2D1;JPH4
prerank,regulation of cell differentiation (GO:0045595),0.23694187399450087,0.8922744906374771,0.6938202247191011,0.882030881341117,1.0,14/148,6.75%,PHLDB2;CCN2;FGFR1;EIF2AK2;EPHA3;DAG1;PTHLH;SUZ12;CLASP1;TGFBR1;MBOAT2;PHLDB1;NREP;CREBBP
prerank,negative regulation of myotube differentiation (GO:0010832),-0.3590300618491148,-0.8917165931623419,0.6033402922755741,0.9178881280868606,1.0,3/12,9.20%,NOTCH1;CCN3;HDAC1
prerank,regulation of fibroblast migration (GO:0010762),-0.3187408422809893,-0.8915408797376717,0.6336633663366337,0.9174801969071198,1.0,10/20,22.74%,THBS1;PRR5L;RFFL;FGF2;ARHGEF7;RAC1;GNA12;PRKCE;CLN3;HAS1
prerank,mRNA splice site selection (GO:0006376),0.3103401948456396,0.8911093244396537,0.6137820512820513,0.8840267893199776,1.0,1/30,0.13%,CELF2
prerank,protein import into peroxisome membrane (GO:0045046),-0.3023414186044433,-0.8901655665703224,0.6136363636363636,0.9200607814814744,1.0,10/22,27.45%,ATAD1;PEX26;GDAP1;ABCD2;PEX16;PEX19;PXMP4;RAB8B;PEX3;PEX11B
prerank,cellular response to radiation (GO:0071478),-0.26530942245518996,-0.8900769070061199,0.6285714285714286,0.9194580215307312,1.0,17/40,31.95%,NET1;INTS7;RHOB;KDM4D;CDKN1A;RAD51;RAD1;GPR88;ECT2;RHNO1;RAD51AP1;BLM;EEF1D;RRH;TP53;OPN1MW3;OPN1MW
prerank,establishment of endothelial intestinal barrier (GO:0090557),0.38758856513835566,0.8898758270723821,0.5823970037453183,0.8861727189557418,1.0,3/11,11.06%,AFDN;RAP2C;TJP1
prerank,organelle organization (GO:0006996),0.21544664999537497,0.8894868646258449,0.7692307692307693,0.8864028683883148,1.0,90/388,19.98%,MICAL3;CXADR;DIAPH1;ARHGAP21;ARHGAP10;SH3D19;SYNE3;PHIP;FGD4;TERT;BRWD1;DES;GABPB1;MIA3;TPM1;CLASP1;RAB43;PLCE1;HAX1;OPTN;PACSIN2;CAPZB;CCL2;VAPA;GOLGA5;GOLGA8B;PHB2;FMNL2;FAM174B;SIRT4;NIPSNAP2;LRRK2;CNN2;AFG1L;CECR2;ZFYVE16;SPRYD3;PPID;GEM;DNM1L;UBXN2A;HUWE1;RAB34;ATXN7;TMCC1;ZMYM6;ABCD3;OPA1;MTFR1;GORASP2;TJAP1;WASL;PEX2;NRF1;COG2;LMAN1L;CHMP3;RHOU;BRWD3;TMED9;EIF2AK3;FAF2;CHMP4A;CHMP4B;PDZD8;PKD2;GBF1;ZMYM3;ATL1;GOLGA2;SAR1A;WTIP;PYROXD2;SEC31A;RHOT1;DNAJC28;PLD2;SIRT3;ESRRA;LYSMD3;PLEKHF1;USP6NL;DMTN;SEC16A;RHOT2;PLEKHM2;AJUBA;CHMP5;COG4;LONP1
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.2595206603708685,0.8893193528951978,0.6630602782071098,0.8862005043156761,1.0,21/73,20.89%,SUZ12;HDAC4;POLR1C;BAZ1B;EPC1;IGF2;POLR1G;JARID2;TASOR;POLR2F;ERCC6;MYO1C;KAT2B;DDX21;DNMT3A;PPHLN1;BMI1;MPHOSPH8;POLR2K;SPHK2;PHF1
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.25498566137197515,0.8888979363073817,0.6446153846153846,0.8864981209995642,1.0,18/85,15.98%,PRICKLE1;NUPR1;RNF217;ZYG11B;RNF19A;GSK3B;NUB1;PIAS1;LRRK2;SUMO1;KEAP1;HECTD1;DDA1;TRIB1;RCHY1;DAB2;RNF180;RNF185
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),-0.2995027736872975,-0.8888466927798316,0.6318181818181818,0.9216252033307266,1.0,7/25,15.08%,SLIT2;LIMK2;TBC1D30;ARHGAP44;ABI3;EVL;ARHGAP24
prerank,steroid metabolic process (GO:0008202),0.2696585592467687,0.8887233828026632,0.6516129032258065,0.8862959617419711,1.0,7/72,8.39%,CYP7B1;HSD17B1;CYP27A1;RDH5;NPC1;AMACR;SCP2
prerank,establishment of protein localization to organelle (GO:0072594),0.26275830399169453,0.8887083914072369,0.6686838124054463,0.8857478285749645,1.0,13/72,17.93%,PRICKLE1;TNPO1;LAMP2;APPL2;TPR;PHB2;APPL1;IPO7;EIF4ENIF1;POM121;RAN;HK1;RANBP17
prerank,negative regulation of potassium ion transport (GO:0043267),-0.35044279162914577,-0.8886225742911258,0.6205450733752621,0.9213491500194879,1.0,5/13,14.47%,PTK2B;NEDD4L;NOS1;CAV1;CASQ2
prerank,positive regulation of interleukin-10 production (GO:0032733),0.30568983668261446,0.8877253785348124,0.6267123287671232,0.8872848712680844,1.0,5/30,7.89%,IL6;TLR4;PRKCZ;LGALS9;CD274
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.28179489264636204,0.8876891161698498,0.6400651465798045,0.8867838150195259,1.0,8/48,11.27%,AMPD3;ADCY5;ADCY7;PANK2;ADCY1;NPPC;AK5;ACAT1
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.28574121820361503,0.8875621142013825,0.6283783783783784,0.8864874074819431,1.0,6/47,6.94%,PID1;FPR2;TLR4;PDGFRB;CRP;TGFBR2
prerank,regulation of acrosome reaction (GO:0060046),-0.38296038088857376,-0.8875072555776506,0.5980769230769231,0.9231630421390012,1.0,1/10,0.97%,PLCB1
prerank,sulfate transport (GO:0008272),-0.3536116468568077,-0.8865066823783565,0.6149193548387096,0.9246719722604961,1.0,2/14,1.62%,SLC26A7;SLC26A2
prerank,DNA synthesis involved in DNA repair (GO:0000731),0.28912784986064877,0.8863952278493583,0.6362098138747885,0.8884318414158442,1.0,6/42,9.92%,POLH;WRN;PARP10;RFC1;REV1;RPA3
prerank,vesicle organization (GO:0016050),-0.25489657598322113,-0.8862966989182441,0.6761658031088082,0.9243802566450195,1.0,20/46,29.47%,FNBP1L;CD34;ALS2CL;VPS33B;PI4K2A;CAV2;ALS2;CAV1;SORT1;CHMP2B;SAR1B;DNAJC13;SNX33;VPS18;LAPTM4B;PHETA2;PI4K2B;SNX10;SQSTM1;SNX11
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),-0.27601998745713213,-0.886200159814281,0.6536585365853659,0.9238206913909239,1.0,10/33,19.39%,PIK3R1;NYAP2;PLEKHA1;PIK3C2B;AKT1;PIK3CD;MYO16;HTR2B;HTR2A;C1QBP
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),-0.37174235591273963,-0.8861233154412165,0.6007984031936128,0.9231845922462357,1.0,6/11,33.66%,MFHAS1;LYN;TREM2;TLR6;TLR1;TIRAP
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.2586481693655568,0.8856390374619303,0.6523736600306279,0.8894984299767343,1.0,10/74,10.29%,RBPJ;HIF3A;EPAS1;ARNT;STOX1;CREBBP;PSMB10;PSMA3;PSME4;PSMA5
prerank,positive regulation of phagocytosis (GO:0050766),0.2809242404277772,0.8855893633539536,0.6416938110749185,0.8890312735496618,1.0,7/47,8.09%,CAMK1D;FPR2;APOA2;APPL2;CD47;CCL2;C2
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.36165453997187325,0.8855162910186777,0.6149425287356322,0.8885942549325544,1.0,3/16,6.37%,ADCY7;APPL2;PPARA
prerank,response to glucocorticoid (GO:0051384),-0.2897152316557476,-0.8852727851788471,0.6357142857142857,0.9244330553526833,1.0,2/26,5.15%,SLIT2;FAM107A
prerank,sphingoid metabolic process (GO:0046519),0.3740959943384392,0.8851034148835796,0.6,0.8889107869412985,1.0,2/12,8.11%,PLPP3;NAAA
prerank,MAPK cascade (GO:0000165),0.21920308469031857,0.8844899335483025,0.7487980769230769,0.8897127462230198,1.0,48/295,13.11%,RASGRF1;NRK;PDGFRA;FGFR1;FGF1;SPTBN1;IL31RA;KSR1;CCM2;FRS2;TGFA;KL;ANGPT1;KIT;TAOK3;PTPN3;ARAF;PTPRA;PDGFRB;SYNGAP1;RASA1;ACTN2;CTSH;IL18;CCL2;LGALS9;MEF2A;PSMB10;PSMA3;DLG1;RGL3;PSME4;LRRK2;RALGDS;PSMA5;FGF18;BCL2L1;PPP1CB;PTK2;CUL3;DUSP5;MAP3K7;FNTB;BTRC;MAP2K1;FBXW11;SHOC2;JAK1
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),0.3384867401066234,0.8844654013783191,0.6196428571428572,0.8891851855262349,1.0,2/19,4.00%,AMPD3;TERT
prerank,negative regulation of protein metabolic process (GO:0051248),-0.25343240706818027,-0.8844259991028058,0.6585365853658537,0.9255637022662386,1.0,17/48,28.39%,FMN2;SNX3;HSP90AB1;PFDN5;CD84;EGFR;PFDN2;INHBB;EIF2AK1;PFDN4;EDNRB;VBP1;TREM2;ADGRB1;EDN1;AZIN1;CLU
prerank,smooth muscle contraction (GO:0006939),0.36924584724831744,0.8842988003833645,0.6272727272727273,0.8889271649845625,1.0,4/14,9.49%,ROCK2;PIK3C2A;BDKRB2;NMUR1
prerank,regulation of transferase activity (GO:0051338),0.3542858940493089,0.884281903178432,0.6442831215970962,0.8883720259241944,1.0,6/17,20.15%,LDB2;JMJD8;SMG6;HMBOX1;PARP4;NABP2
prerank,negative regulation of cell aging (GO:0090344),-0.3340254202335914,-0.8842035852895284,0.6046511627906976,0.9252915862487051,1.0,3/16,7.60%,CDK6;YBX1;RBL1
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.27823368771647883,0.8841832730464694,0.6292682926829268,0.8879991685261306,1.0,8/52,8.89%,PDPK1;SPTBN1;EPHA3;SORBS1;ATP2B4;PTPN9;KIF5B;DLG1
prerank,autophagosome maturation (GO:0097352),-0.2725704695181714,-0.8841805763645658,0.6211031175059952,0.9245346509189013,1.0,12/32,26.98%,CALM1;GABARAP;GABARAPL1;VMP1;VPS33B;TECPR1;ATP2A2;VIPAS39;LIX1;CLN3;SNAP29;MAP1LC3B
prerank,sensory perception of taste (GO:0050909),0.38806251176802864,0.8836796757207536,0.5866388308977035,0.8884560327570378,1.0,10/10,61.22%,PKD1L3;CD36;ASIC2;TAS1R3;GNAT3;TAS1R2;ASIC1;PKD2L1;TAS1R1;ASIC3
prerank,protein exit from endoplasmic reticulum (GO:0032527),-0.2950680806787751,-0.8832904796695622,0.6666666666666666,0.925784813182493,1.0,11/23,36.74%,SEL1L;LMAN1;TECPR2;PREB;RANGRF;SEC61B;HERPUD1;UFD1;SEC13;AUP1;DERL1
prerank,regulation of defense response to virus (GO:0050688),0.37021182587074786,0.8832450704553054,0.6015037593984962,0.8888024876170234,1.0,3/14,10.66%,RNF216;PPM1B;IFNLR1
prerank,mammary gland development (GO:0030879),0.3379806660569264,0.8827673589876609,0.6195652173913043,0.8892397255990485,1.0,1/21,0.44%,WNT4
prerank,cellular senescence (GO:0090398),0.3227714129009515,0.8821310664419763,0.6236933797909407,0.8900079441133438,1.0,8/27,15.00%,CDKN2B;MAPK14;NSMCE2;MAP2K1;OPA1;KAT6A;MAPKAPK5;PML
prerank,positive regulation of supramolecular fiber organization (GO:1902905),-0.2227056381385266,-0.8819534552475053,0.7585139318885449,0.9281304998980623,1.0,24/86,21.74%,NAV3;PTK2B;NCKAP1;PAK1;RPS3;MET;LMOD1;STMN2;CDC42EP3;VASP;CDC42EP1;CDC42EP5;FES;RAC1;EVL;MAPT;PYCARD;ARF6;CDK5RAP2;PFN2;CARMIL1;DCTN1;PRKCE;ARL2
prerank,protein localization to condensed chromosome (GO:1903083),-0.3521300858043388,-0.8812182513339843,0.605543710021322,0.929031795093999,1.0,9/12,42.53%,ZWILCH;SPDL1;ZW10;CDK1;MIS12;BUB3;KNL1;AURKB;CHAMP1
prerank,myeloid leukocyte differentiation (GO:0002573),0.2628909138315114,0.8811866066102702,0.6586538461538461,0.8914709635123202,1.0,13/65,15.00%,IL31RA;GAB2;KIT;PIR;TGFBR2;GLO1;LGALS9;MAPK14;CSF1;EPHA2;THOC5;RARA;PML
prerank,DNA-dependent DNA replication (GO:0006261),-0.21098870826990018,-0.8811067158237943,0.782608695652174,0.9284843392825826,1.0,46/128,27.76%,REV3L;PSMC3;GINS3;PSMD14;UBB;PSMD3;PSMD4;POLA1;MGME1;PSMD6;PSMA6;PSMA4;PSMB8;ORC6;UBA52;PSMA8;TWNK;PNKP;POLD2;CDK2;RAD51;CDC45;PSME1;POLE;RFC4;SIRT7;PSMD7;PSMC6;POLD1;PSMB5;PSMC5;PSMB1;POLB;POLE3;PSMD11;WRNIP1;MCM10;PSMD8;SRPK2;RFC5;RFC2;RECQL;CDC34;GINS4;BLM;CDK2AP1
prerank,regulation of neuroblast proliferation (GO:1902692),0.3639043821864701,0.8811034299570606,0.631768953068592,0.8910695254283105,1.0,1/15,0.48%,PTN
prerank,regulation of mRNA processing (GO:0050684),-0.27805327477729735,-0.8808881779634068,0.6587112171837709,0.9281595224683782,1.0,5/32,11.59%,QKI;KHDRBS2;KHDRBS3;HNRNPK;PTCD2
prerank,regulation of bicellular tight junction assembly (GO:2000810),-0.3126263107234615,-0.8806928460040185,0.6398104265402843,0.9277918793940614,1.0,5/19,13.57%,PRKCH;CLDN5;RUNX1;CBFB;F11R
prerank,negative regulation of protein secretion (GO:0050709),-0.2661018381439608,-0.8800551516413978,0.6758793969849246,0.9285412887618663,1.0,8/38,14.87%,RAB11FIP1;CCN3;OPRM1;RAB11FIP3;KCNB1;INHBB;RHBDF2;RAB11FIP5
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.25564683689295337,0.8794922986993924,0.6671686746987951,0.8938910995481324,1.0,16/80,15.81%,PLPP3;COPZ2;ARFGAP3;KDELR3;ARF4;TAPBP;ERGIC1;ARF3;COPE;UVRAG;ARCN1;SCFD1;KLC1;TMED9;COPZ1;GBF1
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.2324973389662442,0.879397670422425,0.728882833787466,0.8935134080514466,1.0,44/173,21.58%,SPTBN1;COPZ2;DYNLL1;CD55;ARFGAP3;TGFA;KDELR3;MIA3;SEC23A;ARF4;SEC24D;CAPZB;VAPA;DCTN5;PROS1;ERGIC1;COPE;GOSR1;ARCN1;CUL3;SEC24C;SCFD1;COG2;LMAN1L;TMED9;ACTR1A;COPZ1;SEC24B;GBF1;SPTBN2;GOLGA2;SAR1A;SEC31A;CAPZA1;ANK2;SEC16A;F5;COG4;COG1;DCTN4;VAMP7;IER3IP1;BCAP31;TRIP11
prerank,spindle assembly (GO:0051225),0.25854621500598407,0.8793340494047145,0.6869300911854104,0.8930669370125733,1.0,22/67,23.81%,MAP9;STAG1;CLASP1;HAUS8;GOLGA8B;MISP;TUBGCP4;TUBGCP2;TUBGCP5;TOGARAM1;TOGARAM2;SPICE1;GOLGA2;CCDC61;MAPRE3;CEP63;OFD1;INO80;CHEK2;STAG2;MAPRE2;NEK6
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),-0.3249646470769867,-0.879091851913656,0.6367713004484304,0.9299581124256695,1.0,6/17,33.21%,RFFL;CD74;PTTG1IP;MIF;YJU2;MDM2
prerank,T cell proliferation (GO:0042098),-0.35078647453634126,-0.8783617414265261,0.62882096069869,0.9308494983369157,1.0,1/13,0.07%,CADM1
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),-0.30207391159099917,-0.8781991549298825,0.6625615763546798,0.9304276416754689,1.0,10/22,30.63%,NOL11;DDX11;SMARCB1;PWP1;ATF4;HEATR1;RASL11A;LYAR;WDR75;PIH1D1
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),-0.35719940226787567,-0.8780029237337716,0.6478260869565218,0.9300839275604861,1.0,3/12,19.78%,KLF2;CALR;ASXL1
prerank,protein processing (GO:0016485),-0.21890030421419346,-0.8774886134869162,0.7821782178217822,0.9304530731347074,1.0,23/102,22.59%,F3;CPE;PCSK2;MMP16;LGMN;ECE1;FAM111A;CTSS;CPD;SPCS2;SEC11C;CTSL;SPCS1;PCSK7;PHEX;PSENEN;ADAMTS3;CPXM1;CASP1;GGT1;PCSK5;CPZ;CLN3
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.3265375427795822,0.8773838317888294,0.6234234234234234,0.8966190565313342,1.0,3/22,10.74%,NR2F2;LATS2;IPO7
prerank,pre-replicative complex assembly (GO:0036388),-0.23524685472148138,-0.8770870438388128,0.7251461988304093,0.93056100105489,1.0,18/64,21.19%,PSMC3;PSMD14;UBB;PSMD3;PSMD4;PSMD6;PSMA6;PSMA4;PSMB8;ORC6;UBA52;PSMA8;PSME1;PSMD7;PSMC6;PSMB5;PSMC5;PSMB1
prerank,positive regulation of protein localization to membrane (GO:1905477),-0.22003393424631468,-0.8770189581348365,0.7738853503184714,0.9298975648049354,1.0,30/98,23.39%,DPP10;PRKCH;PIK3R1;STX3;ANK3;MAPK8;CEMIP;YWHAH;AKT1;MTCL1;MFF;PPP1R13B;ITGA3;RHOG;KCNB1;EGFR;HRAS;STAC;STAC3;C2CD5;YWHAQ;ARF6;AKAP5;ITGB2;BAD;PRKCE;NKD2;CD81;YWHAZ;CNPY4
prerank,regulation of developmental growth (GO:0048638),-0.28305373996564337,-0.8768476631308398,0.6455399061032864,0.9295124462115066,1.0,9/29,16.05%,PLCB1;INSR;SIX1;NRCAM;MBD5;MFSD2A;SIX4;SOD1;SPAAR
prerank,cellular lipid catabolic process (GO:0044242),0.3142007918927134,0.8768372646465995,0.6436567164179104,0.8972488572922405,1.0,9/27,23.01%,APOA2;ENPP2;LPIN2;ACOX1;ANGPTL3;SIRT2;ACBD5;NUDT19;LPIN1
prerank,pre-miRNA processing (GO:0031054),0.369507689127092,0.876624731951039,0.6181474480151229,0.8971173341693977,1.0,4/14,18.15%,TUT4;ADAR;TARBP2;TUT7
prerank,ear morphogenesis (GO:0042471),0.329643386818283,0.8766093470546267,0.6018181818181818,0.8965612893131326,1.0,4/20,12.69%,OSR1;ZIC1;TIFAB;NOG
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),-0.37196057634023194,-0.8759331440676199,0.616,0.930789561779092,1.0,4/10,19.50%,ELOVL5;ABCD2;MID1IP1;SLC45A3
prerank,phospholipid dephosphorylation (GO:0046839),-0.2654052169356822,-0.875834150207909,0.6333333333333333,0.9302136109538262,1.0,18/37,25.38%,MTMR6;PLPPR1;PLPP5;INPP5K;MTMR12;PLPP1;PLPPR2;SGPP1;PIP4P1;MTMR7;PLPPR5;MTMR2;INPP5J;INPP5B;PLPPR4;MTMR1;SYNJ1;MTMR9
prerank,regulation of extracellular matrix organization (GO:1903053),0.35865963410177476,0.8758248884223201,0.6165413533834586,0.8976605591675458,1.0,3/15,4.96%,DDR2;EFEMP2;AEBP1
prerank,negative regulation of fatty acid metabolic process (GO:0045922),-0.3230880261287452,-0.8756254380452523,0.6365638766519823,0.9298757399716419,1.0,4/16,17.04%,CEACAM1;ERLIN1;ACADVL;BRCA1
prerank,cGMP biosynthetic process (GO:0006182),-0.37799045507909634,-0.8753057410108082,0.640973630831643,0.9297949975144381,1.0,3/10,10.66%,GUCY1B1;GUCY1A1;NPR1
prerank,pharyngeal system development (GO:0060037),-0.3292352619488383,-0.8749808487518801,0.6107660455486542,0.9297117150473752,1.0,4/15,7.09%,TGFB2;BMPR2;TBX1;BMP4
prerank,chromosome organization (GO:0051276),0.24752624445600832,0.874908165496378,0.6929698708751794,0.8990426393179801,1.0,10/99,11.01%,TCF7L2;NUCKS1;BRWD1;CDAN1;CUL4A;TOP2B;TCF7L1;SETD7;GEM;RFWD3
prerank,positive regulation of vasculogenesis (GO:2001214),-0.383403328777871,-0.8748972806496481,0.6440329218106996,0.929124401937236,1.0,4/10,7.57%,KDR;CD34;RAPGEF2;CEACAM1
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),-0.3750960712452369,-0.8741318377471897,0.6446808510638298,0.9301081644502075,1.0,5/10,37.13%,SIRT7;ZNF692;DGKQ;GNMT;PDK2
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),-0.30116962176564066,-0.873807093712958,0.6504629629629629,0.9300756035416178,1.0,8/23,15.98%,SIX1;BMP4;VEGFA;FGF2;PAX2;PIK3CD;SIX4;EGF
prerank,DNA double-strand break processing (GO:0000729),-0.3190461177967391,-0.8734366948943106,0.6388308977035491,0.9301534638287129,1.0,6/18,17.04%,UBE2V2;MRE11;ATM;BARD1;EXD2;BRCA1
prerank,beta-catenin destruction complex disassembly (GO:1904886),0.3398881609024069,0.873234399053263,0.6313932980599647,0.9020057804659884,1.0,4/21,12.35%,WNT3A;FZD2;GSK3B;DVL3
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),-0.33388914855379004,-0.8730885293808445,0.657258064516129,0.9301289234454342,1.0,5/15,13.74%,SIX1;BMP4;VEGFA;PAX2;SIX4
prerank,atrioventricular valve development (GO:0003171),-0.3430121434553498,-0.8730057343114216,0.6442105263157895,0.929528668136056,1.0,6/14,14.08%,TGFB2;BMPR2;NOTCH1;ZFPM1;ACVR1;APLNR
prerank,monocyte differentiation (GO:0030224),0.38062765899174167,0.8725235554856046,0.620817843866171,0.9029546012209331,1.0,2/10,4.89%,IL31RA;PIR
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),-0.3280537787074121,-0.8723793335309353,0.6468085106382979,0.9300773057028547,1.0,4/16,12.29%,PIGM;PIGQ;PIGH;DPM2
prerank,T cell activation involved in immune response (GO:0002286),-0.3512921149621338,-0.8723527521760869,0.6186440677966102,0.9293530575745655,1.0,3/12,17.58%,CD74;FCER1G;LCP1
prerank,stem cell development (GO:0048864),-0.32443716961516145,-0.8722265010848634,0.6501079913606912,0.9288241343684981,1.0,9/16,42.23%,CDH2;PTPRC;SOX11;KBTBD8;SOX8;CYP26C1;NOLC1;KLHL12;SNAI2
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.30670404324278383,0.8718423708217354,0.6245791245791246,0.9037859380332719,1.0,6/29,14.55%,IKBKE;TLR4;BIRC3;LY96;TICAM1;TBK1
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),-0.3283165725893846,-0.8717355193992518,0.6292372881355932,0.9291408580083453,1.0,9/14,32.10%,PLCG2;SEMA7A;CD74;NR4A3;CAMK4;LILRB1;LAPTM5;GPRC5B;BCL10
prerank,macrophage migration (GO:1905517),0.36305301307222154,0.8716986387316237,0.6393129770992366,0.9035074480412283,1.0,3/13,16.78%,CKLF;CCL2;P2RX4
prerank,adrenergic receptor signaling pathway (GO:0071875),-0.3088891571096537,-0.8715985507642887,0.6108490566037735,0.9286360229512245,1.0,4/20,11.45%,PDE4D;ADRA1B;RAPGEF2;ADRB2
prerank,phosphate-containing compound metabolic process (GO:0006796),0.22631754284259747,0.8714635959763432,0.7470355731225297,0.9034331308745004,1.0,28/198,12.11%,ENPP3;EPHA7;PLA2G4A;ENPP1;PLPP3;TPTE;PPM1A;ACYP2;DUSP10;PLCD3;PI4KA;DUSP28;TOP1;PLCE1;PANK2;PLCB3;PLA2G4C;DUSP16;PLPPR3;NT5C;HKDC1;GK5;LRRK2;PFKM;INPP1;XYLB;PPP3CB;DUSP5
prerank,skeletal muscle tissue development (GO:0007519),0.30130649193321923,0.8712935725860093,0.6366782006920415,0.9032025235916188,1.0,7/32,12.36%,CSRP3;CFLAR;IGSF8;POPDC2;SKI;MSC;EGR2
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.24245871444530095,0.8712302924474492,0.7203389830508474,0.9027535412456772,1.0,15/117,10.90%,GHRH;ADORA2A;PTHLH;GLP2R;IL6;ADCY5;ADCY7;MC2R;RXFP2;ADCY1;RAMP1;ADM;INSL3;MAPK14;GPR39
prerank,regulation of cardiac conduction (GO:1903779),0.27106908543137476,0.8710246521716176,0.6499189627228525,0.9026162478461223,1.0,9/54,13.14%,ATP1A2;ITPR1;TMEM65;ATP2B4;CORIN;NPPC;TRPC1;ATP1B2;ATP2B1
prerank,regulation of myoblast fusion (GO:1901739),0.38299199671820405,0.8709668869245766,0.615686274509804,0.9021606712712856,1.0,2/11,10.27%,CFLAR;MAPK14
prerank,establishment of vesicle localization (GO:0051650),-0.3122422314276528,-0.8707231103239937,0.639080459770115,0.9298221842887747,1.0,9/18,26.34%,LIMK2;RAB27A;KIF5C;KIF5A;SNAPIN;TESK1;CDK5;SYNJ1;F8A1
prerank,B cell differentiation (GO:0030183),-0.24965778639304315,-0.8703307065448949,0.6889952153110048,0.9299526553297015,1.0,11/46,16.85%,PTPRJ;PLCG2;TPD52;ITGA4;HDAC9;TCF3;HHEX;DCAF1;PTPRC;CLCF1;RABL3
prerank,regulation of protein tyrosine kinase activity (GO:0061097),-0.2585645184167499,-0.8703166597848424,0.6822660098522167,0.9291845655347485,1.0,10/38,14.81%,GRM5;GAS6;ACE;LRP8;SH3BP5L;SRCIN1;CAV1;CSF1R;RELN;PTPRC
prerank,positive regulation of histone deacetylation (GO:0031065),-0.3595198848807515,-0.8702194933378016,0.6402439024390244,0.9286258660394162,1.0,4/12,15.27%,VEGFA;CTBP1;APLNR;PRKD1
prerank,rRNA pseudouridine synthesis (GO:0031118),-0.3705952474568305,-0.8700090108970789,0.6236786469344608,0.9282813079430945,1.0,5/10,33.13%,RPUSD2;RPUSD3;RPUSD1;NOP10;NHP2
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.24625595337714387,0.870003100425062,0.7166416791604198,0.903593198756949,1.0,22/100,15.97%,PRICKLE1;RNF217;ZYG11B;ARAF;RNF19A;FHIT;GSK3B;WAC;NUB1;PIAS1;LRRK2;SUMO1;TLK2;KEAP1;HECTD1;HFE;DDA1;TRIB1;RCHY1;DAB2;TAF9;RNF180
prerank,glycerophospholipid catabolic process (GO:0046475),-0.28332061552923776,-0.8697370243399704,0.6395348837209303,0.9281019337992554,1.0,3/27,5.90%,GPCPD1;GDPD1;ENPP6
prerank,aspartate family amino acid metabolic process (GO:0009066),-0.31906925436611394,-0.8696630079403342,0.6334841628959276,0.927492810857364,1.0,6/18,21.32%,MTHFR;MSRA;SMS;ASNS;SLC25A13;SLC25A12
prerank,reverse cholesterol transport (GO:0043691),0.36856525482554675,0.8695902643044746,0.6421845574387948,0.9038843053547712,1.0,1/13,2.03%,APOA2
prerank,establishment of protein localization to membrane (GO:0090150),0.25704404412683335,0.8694319279257982,0.695852534562212,0.9036379669402704,1.0,13/66,14.71%,SYNE3;AFDN;RAB10;ZDHHC3;NPC1;CHM;MICALL1;COX18;GRIN3B;RAB3IP;GORASP2;MYO1C;SEC63
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.3103764929440775,0.8690801376997004,0.6434782608695652,0.9037780104335922,1.0,5/28,8.35%,ITPR1;BCL2;CASP4;QRICH1;BAX
prerank,macrophage differentiation (GO:0030225),0.3592279180501545,0.8683331990889075,0.6148007590132827,0.9047773342422291,1.0,2/13,12.04%,IL31RA;CSF1
prerank,protein depolymerization (GO:0051261),0.31465342323942924,0.8683216761528082,0.652542372881356,0.904214292067468,1.0,3/27,7.61%,MICAL3;NCKAP5L;DSTN
prerank,serine family amino acid biosynthetic process (GO:0009070),-0.35013060555605513,-0.8678938128849221,0.648068669527897,0.9305454222829233,1.0,6/12,20.13%,SERINC3;SERINC5;PSPH;SEPHS1;CTH;GGT1
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),-0.32909617326678037,-0.8675331314990349,0.621900826446281,0.9305278853750795,1.0,2/15,2.99%,PIEZO2;SCN1A
prerank,spliceosomal complex assembly (GO:0000245),0.27420347842786075,0.8675304805131366,0.6624803767660911,0.9053173092467256,1.0,10/46,18.43%,CELF2;ZRSR2;DDX23;RBM5;SRPK1;PRPF19;SRSF5;TXNL4A;SCAF11;USP39
prerank,establishment of skin barrier (GO:0061436),-0.3303963961214924,-0.8673680058862284,0.6581196581196581,0.9293017690521437,1.0,6/15,24.09%,MET;LSR;HRNR;STMN1;UGCG;FA2H
prerank,regulation of water loss via skin (GO:0033561),-0.3303963961214924,-0.8673680058862284,0.6581196581196581,0.9293017690521437,1.0,6/15,24.09%,MET;LSR;HRNR;STMN1;UGCG;FA2H
prerank,regulation of ceramide biosynthetic process (GO:2000303),0.35261269821939795,0.8673554225307434,0.615234375,0.9051146709675197,1.0,2/15,8.09%,SMPD3;PLA2G6
prerank,regulation of establishment of planar polarity (GO:0090175),0.2514014224901713,0.8669603429768635,0.7050359712230215,0.9053528087270138,1.0,11/88,10.29%,PRICKLE1;SMURF2;FZD2;DACT1;PARD6A;CELSR1;PSMB10;WNT5A;PSMA3;PSME4;PSMA5
prerank,positive regulation of cell cycle (GO:0045787),-0.23294847381168549,-0.8668786477103105,0.7321937321937322,0.9296312441427734,1.0,15/62,18.55%,MEIS2;TGFB2;RPS15A;LGMN;AKT1;RAD23A;CCND1;LRP6;CALR;TAL1;EGFR;RGCC;CDK4;ASNS;CHEK1
prerank,response to UV (GO:0009411),-0.2132142763189038,-0.8666076360822449,0.811046511627907,0.9294841650772779,1.0,26/95,23.75%,PTPRK;RPL26;MAPK8;AKT1;NPM1;MAP4K3;YY1;CCND1;CCAR2;EGFR;ATF4;USF1;COPS9;CASP9;BMF;MEN1;MFAP4;BCL3;N4BP1;NOC2L;POLD1;ATR;DCUN1D3;DTL;POLK;DDB2
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.27580642747233275,0.8665271169983032,0.6688102893890675,0.9056906940198122,1.0,11/49,16.19%,NUPR1;GSDME;BCL2;MCL1;BAX;DNM1L;BCL2L1;NDUFS3;DAPK2;EIF2AK3;URI1
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),-0.3332091776978361,-0.8662310811463519,0.6560364464692483,0.9295497785977268,1.0,1/15,0.19%,PRKCH
prerank,negative regulation of binding (GO:0051100),0.25122200148324697,0.8661625646581435,0.6866566716641679,0.9058537904865007,1.0,11/81,9.34%,SP100;CFHR2;ARHGAP28;IFIT2;DACT1;CPNE1;EFHB;GSK3B;BAX;LRRK2;SUMO1
prerank,positive regulation of TOR signaling (GO:0032008),-0.2527584172758673,-0.8659504099369391,0.7198177676537585,0.929367202277954,1.0,16/40,32.04%,GPR137C;GAS6;SMCR8;RRAGB;RRAGC;PIP4P1;LAMTOR2;MLST8;TREM2;MIOS;LAMTOR4;HTR6;GOLPH3;WDR24;PIH1D1;SEC13
prerank,regulation of DNA damage checkpoint (GO:2000001),0.38426380485808126,0.8655884416006367,0.6214689265536724,0.9064357377994833,1.0,3/10,13.95%,CRY1;RFWD3;THOC5
prerank,chondroitin sulfate metabolic process (GO:0030204),-0.27686316732264915,-0.8655870931652473,0.6558139534883721,0.9293856735737984,1.0,5/30,6.60%,CSGALNACT1;CSPG4;HEXB;CHST9;NDNF
prerank,snRNA metabolic process (GO:0016073),-0.3195651461874636,-0.8653220876289666,0.6526548672566371,0.9291782537940703,1.0,9/17,31.31%,INTS7;INTS10;INTS12;ZCCHC8;INTS11;INTS1;INTS5;INTS2;RBM7
prerank,ribosomal subunit export from nucleus (GO:0000054),-0.33676938836382836,-0.8651532918663835,0.6701030927835051,0.928785593727594,1.0,3/13,11.77%,RPS15;NPM1;XPO1
prerank,regulation of protein localization (GO:0032880),0.2688196510533851,0.8651315310714411,0.6661264181523501,0.9067535569351499,1.0,11/58,12.35%,AFDN;TRIM17;AAK1;TPR;TRIM5;DLG1;USP8;SUMO1;ATCAY;TRIM21;DVL3
prerank,regulation of intracellular protein transport (GO:0033157),-0.2710870361335844,-0.8650372411524015,0.671604938271605,0.9282664895721359,1.0,10/32,20.44%,PRR5L;OAZ1;BMP4;GCC2;OAZ2;PCNT;CEP290;LCP1;SIRT7;UHMK1
prerank,positive regulation of glycogen metabolic process (GO:0070875),0.3583911693184936,0.8643330221629205,0.6457142857142857,0.9077951212295134,1.0,3/13,8.99%,SORBS1;EPM2AIP1;IGF2
prerank,negative regulation of protein catabolic process (GO:0042177),0.2884271815764567,0.8637830818594473,0.6786324786324787,0.9083983976433937,1.0,8/40,11.49%,TIMP3;NELL1;PTPN3;SNX12;TIMP2;AZIN2;SF3B3;IRAK3
prerank,establishment of epithelial cell polarity (GO:0090162),-0.3078277672485833,-0.8637456848240329,0.6552511415525114,0.9303290960298156,1.0,2/19,2.90%,CYTH3;CYTH1
prerank,positive regulation of chemokine production (GO:0032722),0.277389857511273,0.86360509091122,0.6688524590163935,0.9081780072495534,1.0,7/44,11.12%,EIF2AK2;IL6;TLR4;IL18;LGALS9;WNT5A;TLR2
prerank,mitotic cell cycle phase transition (GO:0044772),0.2214081551412158,0.8635585226441456,0.7683397683397684,0.9076908302785731,1.0,59/203,23.03%,PHLDA1;NINL;DYNLL1;FBXL17;ALMS1;SDCCAG8;CLASP1;LATS2;CCND3;OPTN;CUL4A;CEP152;HAUS8;FBXL3;CDKN2B;CRLF3;ANAPC1;CCNH;UBE2C;MNAT1;CDK7;PPP1R12B;FBXL7;PPP1CB;NEDD1;NES;CCDC57;CUL3;BTRC;MASTL;FBXW11;CDC27;KDM8;ACTR1A;CEP250;CHMP4B;FBXL12;CDKN3;YWHAE;PPP2R2A;CCNY;CEP131;NASP;CCNG2;KHDRBS1;AJUBA;CEP63;CEP78;PKMYT1;OFD1;CHEK2;CUL1;USP26;CUL2;FBXL6;SPAST;PHF8;WEE1;UBE2S
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),0.3135645492365353,0.8634348430339549,0.6460481099656358,0.9073672755107476,1.0,6/26,11.56%,STK39;NEDD4;ACTN2;DLG1;WWP2;ATP1B2
prerank,muscle tissue development (GO:0060537),0.361412616020656,0.8629046307318643,0.6106719367588933,0.9079145725024953,1.0,2/13,5.48%,CSRP3;CSRP1
prerank,regulation of translation (GO:0006417),0.2266982034219711,0.862862726479848,0.7705570291777188,0.9074359510870633,1.0,38/173,19.46%,PLD1;SAMD4A;EIF2AK2;IGFBP5;SHMT1;VIM;DAPK1;PKP3;IL6;IGF2BP1;NANOS2;IGF2BP2;CTIF;TRAP1;FOXO3;ZCCHC4;EIF4ENIF1;ILF3;RPS6KA3;DDX6;GEMIN5;MAPKAPK5;GIGYF2;EIF2AK3;ALKBH1;SOX4;APP;CNOT9;CPEB3;UPF3A;OGFOD1;FXR2;SHFL;PLXNB2;DHX36;EIF4H;NANOS1;ERBB2
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.347890038920299,0.8627530968568877,0.6228893058161351,0.9071181445214619,1.0,4/15,16.03%,TNRC6B;TNRC6A;EIF4ENIF1;CPEB3
prerank,modulation by host of viral genome replication (GO:0044827),0.3596605941537891,0.8626829226562533,0.630057803468208,0.906692145439595,1.0,3/13,11.99%,NUCKS1;VAPA;IFI27
prerank,granulocyte chemotaxis (GO:0071621),0.2661440968839072,0.8626452360908843,0.6965098634294385,0.9061897884831799,1.0,5/55,7.71%,CXADR;CXCL10;ANXA1;CKLF;CCL2
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),-0.2932942792248035,-0.8624996963071906,0.6768149882903981,0.9315739035694787,1.0,10/23,33.91%,MAPK8;YWHAH;PPP1R13B;YWHAQ;BAD;YWHAZ;PPP3CC;PMAIP1;TP53;E2F1
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),-0.2932942792248035,-0.8624996963071906,0.6768149882903981,0.9315739035694787,1.0,10/23,33.91%,MAPK8;YWHAH;PPP1R13B;YWHAQ;BAD;YWHAZ;PPP3CC;PMAIP1;TP53;E2F1
prerank,mononuclear cell differentiation (GO:1903131),0.318090505668637,0.8624409514431057,0.6402116402116402,0.9060134473452428,1.0,3/24,4.89%,AXL;IL31RA;PIR
prerank,homologous chromosome segregation (GO:0045143),-0.31057593619202173,-0.8623030043516055,0.6529680365296804,0.9312103815491793,1.0,4/20,18.56%,FMN2;PTTG1;MEI4;SIRT7
prerank,mesenchymal to epithelial transition (GO:0060231),-0.3730630818533351,-0.8622589868617954,0.6521739130434783,0.9305093643192492,1.0,3/10,11.68%,BMP4;PAX2;BASP1
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),-0.34711019391478054,-0.8619642485030672,0.657563025210084,0.9304132674444401,1.0,1/12,0.98%,TMEFF2
prerank,epithelial cell-cell adhesion (GO:0090136),0.37337103427283475,0.8619392000860906,0.6237816764132553,0.9065223558625544,1.0,3/11,11.09%,KIT;VCL;SERPINB8
prerank,positive regulation of glucose transmembrane transport (GO:0010828),0.3078858398075436,0.8618166289884576,0.6648936170212766,0.9062011864360359,1.0,5/26,9.78%,OSBPL8;SORBS1;CREBL2;RHOQ;APPL1
prerank,glycerophospholipid biosynthetic process (GO:0046474),0.22634928260571677,0.8615000457903917,0.7694369973190348,0.9062422974742279,1.0,18/172,9.73%,PTPN13;PLEKHA2;PLD1;PLA2G4A;APOA2;AGPAT4;DGKD;PI4KA;CPNE1;MTMR3;PLEKHA4;PLA2G4C;PIK3C2A;ETNK2;STARD10;PIK3R5;ARF3;GPD1L
prerank,neuron projection fasciculation (GO:0106030),-0.37394610882058443,-0.861063945289589,0.6626262626262627,0.9316017094189635,1.0,4/10,19.95%,CNTN4;NRCAM;EPHB3;AMIGO1
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),0.26400712842678964,0.8607209066054328,0.6608,0.9072811212973398,1.0,9/55,10.73%,NUPR1;WWOX;GSDME;BCL2;TGFBR1;TNFRSF12A;BAX;DNM1L;BCL2L1
prerank,protein O-linked glycosylation via serine (GO:0018242),-0.37164861606898225,-0.860556385549934,0.6633663366336634,0.9319009210237316,1.0,4/10,18.37%,GALNT13;GALNT3;GALNT4;POGLUT3
prerank,protein deubiquitination (GO:0016579),-0.19020806037958032,-0.8604578837570175,0.8878048780487805,0.9313304098269555,1.0,72/242,25.03%,USP29;IL33;SMAD7;ACTB;ESR1;PSMC3;OTUD7A;SNX3;USP31;NFRKB;CLSPN;RAD23A;PSMD14;UBB;MBD5;PSMD3;YY1;BABAM1;EIF3F;USP13;PSMD4;SMAD1;ZRANB1;PSMD6;BARD1;ADRB2;PSMA6;PSMA4;PSMB8;USP3;FOXO4;TFPT;USP46;USP37;UBA52;PSMA8;TAF9B;VCPIP1;OTUD1;MINDY2;CYLD;COPS5;YOD1;USP38;SUDS3;BRCA1;UBE2D1;PSME1;TOMM20;KAT2A;PSMD7;PSMC6;ASXL1;MINDY1;USP42;PSMB5;USP2;PSMC5;PSMB1;POLB;ATXN3;OTUB2;SHMT2;USP22;KDM1B;PSMD11;DDB2;MCRS1;PSMD8;USP11;RAD23B;JOSD2
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",-0.32913175020307983,-0.8603589853036121,0.647191011235955,0.9307565336831334,1.0,3/16,16.84%,CELF4;TRA2A;RBM3
prerank,snRNA processing (GO:0016180),-0.3127970844564468,-0.8598730985014634,0.62882096069869,0.9310332739984285,1.0,9/16,30.92%,INTS7;INTS10;INTS6L;INTS12;TOE1;INTS11;INTS1;INTS5;INTS2
prerank,positive regulation of tumor necrosis factor production (GO:0032760),-0.23001773237471376,-0.8598274167957914,0.7438692098092643,0.9303407995012729,1.0,13/69,17.57%,PTPRJ;PLCG2;IL33;THBS1;HMGB1;ARHGEF2;HAVCR2;SYK;PTPRC;CCL19;NOD2;PYCARD;LPL
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.2988155271023519,0.8597540924349105,0.6363636363636364,0.9087022836051609,1.0,6/30,14.55%,IKBKE;TLR4;BIRC3;LY96;TICAM1;TBK1
prerank,positive regulation of axon extension (GO:0045773),-0.29985647088016204,-0.859663452291906,0.6621004566210046,0.9299388282147616,1.0,8/22,15.43%,MACF1;SEMA7A;SHTN1;VEGFA;L1CAM;DBNL;ZFYVE27;MAPT
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.38217403029523767,0.8595046791557951,0.6533864541832669,0.9086157807439184,1.0,7/11,26.52%,BCL2;TAF9;MUC1;KDM1A;CD44;TRIAP1;ING2
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.3204329927834212,0.859450120816309,0.6519434628975265,0.9081597923432434,1.0,4/22,10.49%,DYNLL1;BMP7;CDKN2B;PLEK
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.3599697734827459,0.8593411247704801,0.6365280289330922,0.9078141408864238,1.0,3/14,15.47%,IL17D;IL18;IL23R
prerank,regulation of response to oxidative stress (GO:1902882),-0.3579570286121181,-0.8588248572449677,0.652452025586354,0.9309684500074765,1.0,7/11,29.92%,MCTP1;PINK1;SELENON;GGT7;AIFM2;ACOX2;ALOX5
prerank,replication fork processing (GO:0031297),0.29211346892872647,0.8588203947691168,0.6765734265734266,0.9082521675058916,1.0,7/38,11.01%,NUCKS1;WRN;TONSL;FBH1;FANCM;CENPX;RFWD3
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),0.3392277900473857,0.8587351533621786,0.6238185255198487,0.9078637848458354,1.0,8/16,27.25%,KLHL15;FBH1;SHLD2;RIF1;SMCHD1;SHLD1;FANCB;CGAS
prerank,central nervous system neuron axonogenesis (GO:0021955),-0.360334508336509,-0.8586647379701454,0.6718403547671841,0.930521059283015,1.0,8/12,33.80%,EPHB1;HSP90AB1;HSP90AA1;B4GALT6;EPHB6;SPTBN4;B4GALT5;EPHB2
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.3342279176406233,0.8586525093840992,0.659217877094972,0.9074580441709947,1.0,8/18,24.03%,TERT;IL6;MAP2K1;DDX5;RIPK1;ZC3H12A;TGFB1;ZC3H10
prerank,regulation of mRNA catabolic process (GO:0061013),0.2362997985627949,0.8584452642876214,0.7335285505124451,0.9073234478817594,1.0,15/121,11.13%,TNPO1;ZC3HAV1;SAMD4A;VIM;RC3H1;PKP3;IGF2BP1;DCP2;PSMB10;MOV10;PSMA3;PSME4;PSMA5;IGF2BP2;XRN1
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),0.38112774376008157,0.858217749854143,0.623046875,0.9072326640179983,1.0,3/10,11.69%,RC3H1;FOXP3;NFKBIZ
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.36278971528658954,0.8577799919729477,0.6367041198501873,0.9075855180943485,1.0,4/13,19.24%,VDAC2;BAX;RHOT1;RHOT2
prerank,modulation by symbiont of entry into host (GO:0052372),-0.3174619900743896,-0.8569352931250874,0.6600877192982456,0.9335800706532352,1.0,5/16,16.46%,HS3ST5;TRIM68;TRIM62;CAV1;FUCA2
prerank,negative regulation of lyase activity (GO:0051350),-0.31931151293085913,-0.8569056238365967,0.6832298136645962,0.932875480728323,1.0,2/16,3.31%,GRM3;GABBR2
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.23913998388932622,0.8568199714993197,0.7257824143070045,0.9089778941579231,1.0,24/94,20.82%,NINL;DYNLL1;ALMS1;SDCCAG8;CLASP1;CEP152;NPHP1;HAUS8;C2CD3;CC2D2A;NEDD1;RPGRIP1L;RAB3IP;IQCB1;FBF1;ACTR1A;CEP250;TTBK2;YWHAE;CEP131;CEP63;CEP78;B9D2;OFD1
prerank,regulation of lysosomal lumen pH (GO:0035751),0.37349430574545534,0.8565834589769692,0.6585365853658537,0.9088978974864577,1.0,5/12,20.16%,CLN5;LRRK2;TMEM165;TMEM9;VPS33A
prerank,positive regulation of secretion by cell (GO:1903532),-0.22405061178531752,-0.8564943964652268,0.7593123209169055,0.9329679077114658,1.0,18/70,18.92%,SLC12A2;TGFB2;RAB27A;CADPS;FRMD4A;SNCA;RAB27B;TGFB3;KCNB1;RGCC;CLASP2;PPIA;MYOM1;MYO18A;EXPH5;ADAM8;ARF6;SYTL4
prerank,regulation of fatty acid biosynthetic process (GO:0042304),0.3051414861441629,0.8559863450510748,0.6904347826086956,0.9095151410116381,1.0,3/26,6.02%,PRKAG2;PRKAA2;NR1H3
prerank,heterocycle biosynthetic process (GO:0018130),-0.32727616361955825,-0.8559315043899712,0.6717724288840262,0.9334029362328344,1.0,7/14,33.04%,GPHN;GCH1;PYCR2;PYCR1;ALOX5;LIAS;MOCS2
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),-0.22376411393211557,-0.8558296098671905,0.7987804878048781,0.9328586340486679,1.0,30/82,24.47%,PPP2R1A;CSNK1D;KCNH5;NPM1;DYNC1H1;PCNT;TUBA1A;TUBB4A;PRKAR2B;ATAD5;HSP90AA1;CEP43;NEK10;DYNC1I2;NDE1;TUBB4B;CEP135;PLK4;CDK2;CEP290;SSNA1;TUBG1;CDK5RAP2;CEP41;DCTN1;CENPF;HMMR;CEP70;KIF14;MAPRE1
prerank,calcium ion import across plasma membrane (GO:0098703),-0.3308933643894273,-0.8550062627718555,0.6776180698151951,0.9338046049231559,1.0,2/14,5.50%,SLC24A2;SLC8A1
prerank,regulation of cell death (GO:0010941),-0.21387751207977396,-0.854884149082932,0.817629179331307,0.9332856581314817,1.0,23/94,21.65%,ACER3;PDE8A;ACER2;DCC;SNCA;CCN3;EPHB1;CCN5;BMP4;TNFRSF1B;UBB;FGF2;NPAS2;PARK7;PRKD1;HTR2B;PACRG;BNIP3L;SRGAP2;CHRNA7;PRR7;SNCG;SRSF6
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),-0.2556968121991949,-0.854703555378654,0.7240506329113924,0.9329016548563914,1.0,12/41,20.28%,GRM5;NTRK2;GAS6;DOCK3;ACE;LRP8;SRCIN1;CSF1R;RELN;EGF;FCGR1A;DLG3
prerank,microtubule nucleation (GO:0007020),0.3278086003145671,0.8546301774847352,0.6628787878787878,0.9116837147157941,1.0,7/19,16.24%,CLASP1;TUBGCP4;SLAIN2;CCDC57;TUBGCP2;TUBGCP5;GOLGA2
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),0.3616894992667364,0.8546205278100539,0.6467065868263473,0.9111330943566677,1.0,3/13,11.55%,GLI3;TGFBR2;IHH
prerank,positive regulation of interleukin-17 production (GO:0032740),-0.29285305141529167,-0.8544545079061153,0.6744730679156908,0.9326556747718929,1.0,3/22,4.35%,SLC7A5;RFTN1;PRKCQ
prerank,regulation of DNA metabolic process (GO:0051052),0.2746234157372572,0.8544434230525031,0.6799363057324841,0.9109246528029455,1.0,12/44,21.26%,POLH;NUCKS1;STOX1;MPV17;UBE2V1;SMG5;SMG6;SMG1;IL7R;MPHOSPH8;WDR70;TOM1L1
prerank,negative regulation of hydrolase activity (GO:0051346),-0.24341624703943257,-0.854141700621271,0.7165775401069518,0.9325746616435543,1.0,11/49,13.60%,CST3;LRCH1;CPEB2;DAB2IP;RCC2;SLC39A14;CAMK2A;TMED2;NOS1;F11R;HRAS
prerank,regulation of DNA binding (GO:0051101),-0.2549300494093999,-0.853645537063785,0.6981627296587927,0.9328814189442853,1.0,11/44,17.84%,LEF1;MAPK8;HMGB1;MDFI;DOT1L;TFAP4;NGF;PLAUR;EGF;HES1;BCL3
prerank,snRNA 3'-end processing (GO:0034472),-0.29903450596246267,-0.8536229497427897,0.6941964285714286,0.9321619166685913,1.0,9/19,30.92%,INTS7;INTS6L;EXOSC2;INTS12;EXOSC4;TOE1;INTS1;INTS5;INTS2
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),-0.2959867369990654,-0.8535638287404259,0.6885245901639344,0.9315175946216911,1.0,6/21,23.30%,NOS1AP;CACNA1D;KCNQ1;KCNE4;GJA5;SCN1B
prerank,positive regulation of interleukin-1 beta production (GO:0032731),0.27306630284942257,0.8533998553638523,0.6812080536912751,0.9124387407661945,1.0,7/45,10.22%,IL6;TLR4;GBP5;LGALS9;RIPK2;WNT5A;PANX1
prerank,mucosal immune response (GO:0002385),0.3472943780594129,0.8532303830762598,0.6455223880597015,0.9122089606025732,1.0,3/15,10.66%,BPIFB1;NOS2;IFNLR1
prerank,positive regulation of JUN kinase activity (GO:0043507),-0.2911815854121714,-0.8526041089716303,0.6734234234234234,0.9327890453631666,1.0,5/23,7.34%,PAK1;MAP3K5;RPS3;DAB2IP;MAP3K11
prerank,termination of RNA polymerase II transcription (GO:0006369),-0.25890343415526984,-0.8524426479170524,0.7250608272506083,0.9323847274273905,1.0,7/33,18.38%,SETX;CSTF2;CPSF2;SYMPK;SNRPB;CSTF2T;SNRPF
prerank,genitalia development (GO:0048806),0.37512631721333567,0.8522198165469993,0.6555772994129159,0.9137172923362018,1.0,2/12,8.47%,TIFAB;WNT5A
prerank,Golgi to plasma membrane transport (GO:0006893),0.2768680881206375,0.8518868990196301,0.7124394184168013,0.9138386196594567,1.0,7/47,7.15%,SPTBN1;VAMP5;RAB10;ARL3;OPTN;EXOC2;VPS35L
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),0.3357109842992802,0.8518816302594587,0.6421052631578947,0.9132771268810362,1.0,1/17,0.72%,AKAP13
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),-0.2598444764061075,-0.8518492850301449,0.7192513368983957,0.9328439541108737,1.0,11/37,16.48%,SMAD7;CALM1;CALM2;CEMIP;INPP5K;CALM3;SPRED2;DDIT4;IRGM;EGF;SPRED3
prerank,protein insertion into membrane (GO:0051205),-0.26641751940203734,-0.8516859745744598,0.6821345707656613,0.9324597520301937,1.0,14/32,28.15%,REEP1;SERP1;TRAM1;EGFR;CCDC47;MAIP1;WDR83OS;SEC61G;CYB5A;HMOX1;TRAM1L1;GET1;SEC61B;VAMP2
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),0.31837396492750947,0.8516665993225274,0.6486486486486487,0.9131455570402599,1.0,1/20,1.80%,FOXC1
prerank,negative regulation of tumor necrosis factor production (GO:0032720),0.2815406371836427,0.8516597696783401,0.6974110032362459,0.9125943389021023,1.0,7/41,14.88%,TLR4;C5AR2;PTPN22;LGALS9;PTPN6;IRAK3;RARA
prerank,neurogenesis (GO:0022008),0.2744412905104347,0.8514609225319066,0.6766169154228856,0.9124505724347916,1.0,5/43,7.98%,LPAR1;TRAK1;ANXA1;CLN5;DCHS1
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),-0.2891573931411687,-0.851079991136126,0.6946386946386947,0.9329706840217066,1.0,8/25,15.10%,DMD;ATP1B1;ANK3;TRPC6;CTSS;NDUFA4;STAC;GLRX
prerank,negative regulation of DNA recombination (GO:0045910),0.27474132565154663,0.8509447629523883,0.66890756302521,0.9129556961909734,1.0,18/43,27.25%,POLR2D;PARP3;KLHL15;FBH1;POLR2C;POLR2F;SHLD2;RIF1;POLR2K;RTEL1;MSH2;SMCHD1;ZRANB3;ATRX;SHLD1;POLR2H;FANCB;CGAS
prerank,C-terminal protein amino acid modification (GO:0018410),-0.3572600504014542,-0.8508796313339216,0.663135593220339,0.9326140906697445,1.0,1/11,0.95%,AGBL4
prerank,regulation of interleukin-12 production (GO:0032655),0.26918640198283755,0.8503913510149893,0.7127158555729984,0.9134808674031596,1.0,8/47,11.49%,IL16;TLR4;CD47;LGALS9;RIPK2;MAPK14;TLR2;IRAK3
prerank,protein deacylation (GO:0035601),-0.2872100438467345,-0.8500174027173152,0.6605504587155964,0.9336771398832605,1.0,6/23,18.56%,HDAC7;HDAC6;SIRT5;HDAC1;ABHD17A;SIRT7
prerank,protein import (GO:0017038),0.24658613946360003,0.8500156721485277,0.7443267776096822,0.9136814328516457,1.0,13/84,14.16%,PRICKLE1;TNPO1;LAMP2;APPL2;TPR;PHB2;PXMP2;APPL1;IPO7;EIF4ENIF1;ABCD3;PEX2;POM121
prerank,regulation of establishment of protein localization to telomere (GO:0070203),-0.35224400288965074,-0.8495684430482179,0.6646216768916156,0.9338309289591994,1.0,3/11,19.83%,TERF1;CCT5;WRAP53
prerank,cellular response to leucine starvation (GO:1990253),-0.3588537974588023,-0.8492856255491404,0.6837782340862423,0.9336298587644188,1.0,2/10,9.31%,SESN3;RRAGB
prerank,protein K48-linked deubiquitination (GO:0071108),-0.287318377091002,-0.8490356913583628,0.7161862527716186,0.933372593934027,1.0,8/23,22.71%,OTUD7A;USP37;VCPIP1;MINDY2;YOD1;MINDY1;ATXN3;OTUB2
prerank,regulation of telomere capping (GO:1904353),-0.2849187157348948,-0.848951268243746,0.6933638443935927,0.9327954344726296,1.0,6/23,16.15%,PRKCQ;NEK7;MAPK3;ATM;PNKP;PKIB
prerank,innate immune response in mucosa (GO:0002227),0.3786421444159165,0.8489099166517742,0.6571428571428571,0.9154488640840174,1.0,2/10,6.49%,BPIFB1;NOS2
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),-0.3213679029879052,-0.8479276416171303,0.6637931034482759,0.9341706952984681,1.0,4/14,19.85%,TMSB4X;MDFI;NFKBIB;CCDC22
prerank,nitrogen compound transport (GO:0071705),0.22968602769296714,0.847832357884698,0.7542613636363636,0.9169761381381089,1.0,7/141,4.73%,SLC7A11;PDPN;SLC7A2;SLC6A13;SLC6A12;SLC7A14;MIA3
prerank,glycoprotein catabolic process (GO:0006516),0.3360264988432439,0.8475969807497364,0.6380255941499086,0.9168502013082004,1.0,2/17,8.25%,ADAMTS12;MANBA
prerank,protein glycosylation (GO:0006486),0.23298645517496788,0.8475154899572749,0.7619047619047619,0.9164625098998229,1.0,22/125,13.87%,MAN1C1;GALNTL5;GALNT18;TRAK1;LARGE1;GALNT2;ALG9;MGAT3;NPC1;GALNT1;POMT2;B4GALT1;GCNT4;FUT4;C1GALT1C1;FUT10;TMEM165;ALG11;TET2;TUSC3;MGAT4C;ALG1
prerank,mitochondrial translational termination (GO:0070126),-0.21492080474072317,-0.8469769903044364,0.8130311614730878,0.9353964469306363,1.0,37/88,35.82%,MRPL4;MRPS18A;MRPL1;MRPS30;MRPS23;MRPL57;MRPL28;MRPL47;AURKAIP1;MTRF1;MRPL35;MRPS5;MRPL34;MRPS2;MRPL52;MRPL23;MRPL9;MRPS31;MRPL49;MRPS12;MRPL11;MRPL50;MRPS16;MRPS22;MRPS25;MRPL44;CHCHD1;MRPL51;MRPL32;MRPL54;MRPL43;MRPL2;MRPL24;MRPL37;ERAL1;MRPL45;MRPL30
prerank,leukocyte tethering or rolling (GO:0050901),0.3408208939659732,0.8469048229337462,0.6529850746268657,0.917120476447269,1.0,2/17,6.20%,SELP;VCAM1
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.35392576348718324,0.8464044978271346,0.6142322097378277,0.9175220950124563,1.0,3/13,6.49%,PID1;PPARA;NOS2
prerank,hematopoietic progenitor cell differentiation (GO:0002244),0.2988171305962322,0.8463022155570527,0.6938053097345133,0.9171716224602228,1.0,5/30,10.49%,MLLT3;FSTL3;KIT;SBDS;PLEK
prerank,phosphatidylcholine metabolic process (GO:0046470),0.25598189336799926,0.8462894399667963,0.7304075235109718,0.916632291240168,1.0,16/70,19.81%,PLA2G4A;APOA2;MBOAT2;NR1H3;PLA2G4C;PLA2G6;STARD10;ENPP2;CSNK2A2;PCYT1A;LPIN2;ABHD3;PEMT;PLA2G5;SLC44A2;SLC27A1
prerank,histone H2A monoubiquitination (GO:0035518),0.33090312763015167,0.8459917770957661,0.6593806921675774,0.9166708275237286,1.0,8/17,21.94%,BCOR;PCGF5;KDM2B;RING1;RNF2;BMI1;PCGF3;PCGF2
prerank,proteasomal protein catabolic process (GO:0010498),0.21832854626314782,0.8459585609809616,0.8103225806451613,0.9161693202529325,1.0,51/201,22.39%,SPSB1;TBL1XR1;SMURF2;FBXL17;NEDD4;NHLRC3;KLHL22;UBE2U;SPSB4;RNF216;SIAH2;CUL4A;PSMB10;PSMA3;PSME4;PSMA5;WWP2;ERLEC1;UBXN2A;HUWE1;SPOPL;CUL3;IFI27;BTRC;HECW2;FBXW11;ARRB1;PRPF19;BFAR;KCTD5;PML;SOCS6;RNF185;TBL1X;UBE4B;PPP2R5C;TRIM3;PCBP2;CLOCK;PSMC2;ERCC8;RNF139;UBE2K;SIRT2;RCN3;UBXN1;PELI1;RMND5B;FBXW7;PSMD1;RMND5A
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),-0.3198548187160651,-0.8457057550211523,0.7172995780590717,0.937202934396699,1.0,8/14,37.28%,ENTPD1;ADPRM;NUDT18;NUDT16;NUDT1;ENTPD2;NUDT15;ENTPD3
prerank,signal transduction by p53 class mediator (GO:0072331),-0.2665282613847653,-0.8456361173376699,0.6950354609929078,0.9365926124220946,1.0,14/30,33.89%,ACER2;HINT1;JMY;STK11;PPP1R13B;PYCARD;BCL3;E2F7;MYBBP1A;PMAIP1;TP53;POU4F1;PAXIP1;BOK
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),-0.21519478773951056,-0.8455741077121163,0.838006230529595,0.935960613591756,1.0,28/86,25.13%,KLF2;PSMC3;PSMD14;UBB;PSMD3;ELOB;VEGFA;PSMD4;PSMD6;PSMA6;PSMA4;PSMB8;ATF4;UBA52;PSMA8;PSME1;CHEK1;PSMD7;PSMC6;PSMB5;PSMC5;HIGD1A;PSMB1;HIF1AN;PSMD11;EPO;PSMD8;HMOX1
prerank,keratan sulfate metabolic process (GO:0042339),-0.2643050463431602,-0.8454958168386455,0.7297297297297297,0.9353480933763512,1.0,13/31,29.50%,ST3GAL6;HEXB;B3GNT2;B4GALT4;ST3GAL4;LUM;B3GNT3;B4GALT6;CHST5;B4GALT2;B4GAT1;GALNS;ST3GAL2
prerank,histone methylation (GO:0016571),0.3087586120146727,0.8451908927235919,0.669051878354204,0.9171540121216839,1.0,10/26,26.96%,NSD3;CREBBP;NSD1;CARM1;SMYD3;PRMT1;EHMT2;SUV39H1;SETD6;SMYD2
prerank,protein targeting to lysosome (GO:0006622),-0.29597610057023227,-0.8450171586314861,0.6984126984126984,0.9355856139422695,1.0,5/20,11.75%,HSPA8;SORL1;GCC2;M6PR;SCARB2
prerank,regulation of cell cycle (GO:0051726),0.20816445303965123,0.8445763590229836,0.8574938574938575,0.917826195620049,1.0,50/271,16.38%,TCF7L2;SMAD3;NOTCH2;NUPR1;GATA6;SMIM22;FBXL17;PRDM11;BMP2;APBB1;BMP7;BTG4;TGFBR1;PRCC;BIRC3;RNF20;FBXL3;CDKN2B;MAP2K6;CRLF3;ANKRD17;CDK7;E4F1;NUPR2;SND1;GMNN;GRK5;RRP8;CDC14A;NR4A1;TSPYL2;TRIM21;NUDT6;MASTL;THAP1;MAP2K1;WDR6;RARA;CSNK2A2;PML;FIGNL1;FBXL12;IQGAP1;KAT2B;WDR12;LIN9;PKD2;GBF1;INHA;NF2
prerank,protein localization to organelle (GO:0033365),-0.2016536288239872,-0.844194605810211,0.8494623655913979,0.9365178542060564,1.0,40/133,22.17%,CSNK1D;SCG3;SIX1;SORL1;RPL11;YBX1;CEP68;BMP4;PAQR3;ARL1;CNTLN;GCC2;RAB35;CALR;HHEX;TUB;SERP1;DVL1;TRAM1;ATP6V1D;SIX4;DCP1A;TMEM30A;LAMP5;CCDC47;TOR1B;CTDNEP1;LAMP1;WDR83OS;BBS2;BBS1;TOLLIP;ARF6;SEC61G;MSX1;MTCH2;UBAC2;CYB5A;PPP1R15A;CD68
prerank,cortical cytoskeleton organization (GO:0030865),0.2724518884359703,0.8436749410330007,0.6812297734627831,0.9190407619875642,1.0,9/41,13.26%,ROCK2;RHOBTB2;RHOF;RHOQ;FMNL2;DLG1;PLEK;RHOC;LLGL2
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.36044812774119217,0.8436743923964615,0.6377649325626205,0.9184739566856555,1.0,2/12,4.44%,TERT;IL6
prerank,respiratory electron transport chain (GO:0022904),-0.32890479870835354,-0.8436419047708178,0.673773987206823,0.9368770543667613,1.0,3/14,21.32%,GPD2;SLC25A13;SLC25A12
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.37658383887157354,0.842934820472087,0.6737044145873321,0.9193542320466271,1.0,3/10,13.97%,TLR4;MIA3;TICAM1
prerank,regulation of programmed cell death (GO:0043067),0.22074956569942542,0.8428985140751898,0.7965194109772423,0.9188487132924078,1.0,18/161,8.35%,IGFBP3;KANK2;CXCL10;STEAP3;FBXO11;DAPK1;WRN;PLK5;HAX1;IFT57;BIRC3;CREBBP;ACTN2;ANP32E;STAT1;TRIM24;CHM;BAX
prerank,regulation of mesenchymal cell proliferation (GO:0010464),0.3638314217776514,0.84285521195032,0.6570841889117043,0.9183612592502476,1.0,3/11,8.47%,TGFBR2;STAT1;WNT5A
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),0.3078817769862865,0.8428393130810615,0.6810035842293907,0.9178275249069858,1.0,1/25,0.36%,LEPROT
prerank,negative regulation of cell activation (GO:0050866),0.3502111087387858,0.8428101045790597,0.665406427221172,0.9173232805653683,1.0,1/14,1.10%,PDGFRA
prerank,nuclear pore complex assembly (GO:0051292),0.38261822535754375,0.842733602028868,0.6411764705882353,0.9169145050569553,1.0,3/10,13.84%,TPR;AHCTF1;RTN4
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),-0.248954884922919,-0.8424647451396257,0.7742718446601942,0.9386437033366763,1.0,12/40,20.33%,PTK2B;RPL5;RPS7;RPL11;RAD23A;RPL23;XPO1;GNA12;FOXF2;UBQLN4;CCDC22;UFL1
prerank,positive regulation of protein acetylation (GO:1901985),0.36350579049677134,0.842244429096169,0.6764132553606238,0.9173233419263923,1.0,1/12,1.61%,PRKAA2
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",-0.2635035863499936,-0.8412552803957294,0.691566265060241,0.9403247913241901,1.0,12/31,27.37%,DIS3L2;EXOSC2;DCP1A;HBS1L;EXOSC4;CNOT8;LSM4;EXOSC1;EDC3;LSM2;POLR2G;LSM3
prerank,bicellular tight junction assembly (GO:0070830),0.26963669380458016,0.8412282011751975,0.7017828200972447,0.9188126905737107,1.0,6/46,8.89%,AFDN;CDH5;PARD6G;PARD6A;CLDN1;DLG1
prerank,regulation of amyloid-beta formation (GO:1902003),0.2814785385266071,0.8409764888587363,0.6927175843694494,0.9187339103145665,1.0,9/34,21.02%,ROCK2;RTN1;EPHA4;EFNA1;RTN4;ABCA7;CASP3;ROCK1;GGA3
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),-0.2833989556014379,-0.8409038068011085,0.6867749419953596,0.9402718482419953,1.0,11/23,41.50%,CALM1;PDE6A;SAG;NMT2;PDE6G;GUCA1B;PDE6B;GUCY2D;GUCY2F;FNTA;GRK4
prerank,cardiac ventricle development (GO:0003231),0.31357733432879087,0.8407206266004494,0.6616257088846881,0.9186552268370675,1.0,5/20,14.12%,TMEM65;SALL1;HEYL;HECTD1;MDM4
prerank,regulation of protein processing (GO:0070613),0.3144119318700457,0.8406322361577114,0.6666666666666666,0.918269031393729,1.0,6/21,20.29%,SNX12;SERPINE2;LRRK2;CCBE1;GAS1;RNF139
prerank,cellular response to leucine (GO:0071233),0.3742688711240903,0.8405571505472732,0.6506986027944112,0.9172924433340225,1.0,4/10,22.08%,KLHL22;SESN1;LARS1;RRAGD
prerank,response to leucine (GO:0043201),0.3742688711240903,0.8405571505472732,0.6506986027944112,0.9172924433340225,1.0,4/10,22.08%,KLHL22;SESN1;LARS1;RRAGD
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",-0.32531298534360026,-0.8401858378935975,0.6971677559912854,0.9410088837022373,1.0,5/14,21.65%,PTBP1;RNPS1;SRSF9;C1QBP;SRSF6
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),-0.33356486389947954,-0.840019882967649,0.683083511777302,0.9405862660420133,1.0,1/12,1.77%,IL1R1
prerank,vesicle coating (GO:0006901),-0.23194310361011958,-0.8399106440240081,0.7983651226158038,0.9385351310749344,1.0,17/61,21.85%,GRIA1;NSF;CTSC;CSNK1D;TMED2;TRAPPC4;CNIH1;LMAN1;NAPA;ANKRD28;TRAPPC6B;COL7A1;RAB1B;SAR1B;TRAPPC3;PPP6C;SEC22B
prerank,COPII vesicle coating (GO:0048208),-0.23194310361011958,-0.8399106440240081,0.7983651226158038,0.9385351310749344,1.0,17/61,21.85%,GRIA1;NSF;CTSC;CSNK1D;TMED2;TRAPPC4;CNIH1;LMAN1;NAPA;ANKRD28;TRAPPC6B;COL7A1;RAB1B;SAR1B;TRAPPC3;PPP6C;SEC22B
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",-0.23194310361011958,-0.8399106440240081,0.7983651226158038,0.9385351310749344,1.0,17/61,21.85%,GRIA1;NSF;CTSC;CSNK1D;TMED2;TRAPPC4;CNIH1;LMAN1;NAPA;ANKRD28;TRAPPC6B;COL7A1;RAB1B;SAR1B;TRAPPC3;PPP6C;SEC22B
prerank,negative regulation of defense response to virus (GO:0050687),0.3706359477182924,0.8396197872803971,0.6641074856046065,0.918617437570378,1.0,4/10,18.37%,PPM1B;TARBP2;MUL1;PCBP2
prerank,very-low-density lipoprotein particle assembly (GO:0034379),-0.34351184615527264,-0.8395512080497757,0.6782608695652174,0.9384780639857414,1.0,2/12,13.08%,ACSL3;MFSD2A
prerank,hematopoietic stem cell differentiation (GO:0060218),0.38340953665532707,0.8394886487351833,0.6692759295499021,0.9183116114924652,1.0,1/10,1.62%,MLLT3
prerank,regulation of presynapse organization (GO:0099174),0.32970287077114574,0.839476188476869,0.6793893129770993,0.9172157226835953,1.0,2/18,2.09%,GPC6;WNT3A
prerank,regulation of presynapse assembly (GO:1905606),0.32970287077114574,0.839476188476869,0.6793893129770993,0.9172157226835953,1.0,2/18,2.09%,GPC6;WNT3A
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.3429862901876018,-0.8393640399700312,0.691358024691358,0.9381139561471062,1.0,2/12,2.18%,CTNNA3;RYR2
prerank,lipid biosynthetic process (GO:0008610),0.24581008322429623,0.8390403797777517,0.7264705882352941,0.9175227071975137,1.0,11/77,16.00%,PRKAA2;AGPAT4;HSD17B1;PAM;ACSL1;SCP2;SCD5;AGPAT3;ABCD3;STAR;PDSS1
prerank,DNA catabolic process (GO:0006308),0.37205745544539726,0.8386957861678244,0.6470588235294118,0.917618497057556,1.0,3/11,19.29%,FBH1;DNASE1L1;DFFB
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.32109576730125944,0.8385711154985667,0.6618444846292948,0.9173154047124894,1.0,6/19,18.89%,ENPP1;TPST1;SULT1A1;ABHD14B;SULT6B1;PAPSS1
prerank,purine-containing compound salvage (GO:0043101),0.3553634919271881,0.8382748614809392,0.6741573033707865,0.9173118710829512,1.0,1/12,1.05%,AMPD3
prerank,microtubule polymerization (GO:0046785),0.2938120263741903,0.8380980792235643,0.6920222634508348,0.9170996911504501,1.0,8/28,16.24%,CLASP1;HDGFL3;TUBGCP4;SLAIN2;CCDC57;TUBGCP2;TUBGCP5;GOLGA2
prerank,cellular response to misfolded protein (GO:0071218),0.3149973303707016,0.8377402994830625,0.6843971631205674,0.9172252094956163,1.0,5/20,15.98%,POMT2;KLHL15;UGGT2;CUL3;RNF185
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",0.3798259483724429,0.8376476569479367,0.6618556701030928,0.9168364115850788,1.0,2/10,11.41%,APPL2;ANO6
prerank,regulation of cell cycle phase transition (GO:1901987),-0.21160731376008154,-0.8375549941954019,0.8284789644012945,0.9409495128529579,1.0,26/91,24.51%,PSMC3;CDC26;PSMD14;PSMD3;TFAP4;PSMD4;PSMD6;PSMA6;UBE2E1;PSMA4;PSMB8;NEK10;PSMA8;CDKN1A;BUB1B;UBE2D1;PSME1;PSMD7;PSMC6;PSMB5;PSMC5;PSMB1;SKP1;PSMD11;TCIM;PSMD8
prerank,spermatid development (GO:0007286),0.2886743140369179,0.8369437137991594,0.6715686274509803,0.9176336217765326,1.0,2/32,3.09%,GALNTL5;ZMYND15
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),0.2800379669704791,0.836708224413638,0.6945898778359512,0.9175219793590699,1.0,6/36,8.89%,DUSP10;DACT1;TAOK3;PTPN22;ZMYND11;DLG1
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.3152531389738184,0.8363085601061641,0.6920222634508348,0.9177227936205661,1.0,3/22,12.74%,ROCK2;EPHA4;EFNA1
prerank,histone H2A acetylation (GO:0043968),0.33521221554717306,0.8362084078594303,0.6452173913043479,0.9173494452247658,1.0,9/16,30.30%,EPC1;ACTL6A;BRD8;NAA40;SPHK2;EP400;ING3;RUVBL1;MORF4L1
prerank,myelin assembly (GO:0032288),-0.3589746094327079,-0.835869697572056,0.6729166666666667,0.9436205787357345,1.0,7/10,35.53%,TENM4;TPPP;NCMAP;DICER1;CNTNAP1;ABCA2;CD9
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.22391822533756545,0.8355712333362277,0.8032564450474898,0.9179905086467552,1.0,26/149,14.46%,EIF2AK2;FER;TRAF5;SLCO3A1;CFLAR;IL6;ROR1;TLR4;PRKCZ;MTDH;TRIM5;EDA;IL18;LGALS9;RIPK2;WNT5A;UBE2V1;TLR2;IRAK3;MAP3K7;TRIM21;CRNN;MAP3K13;TICAM1;FLOT2;ALK
prerank,mitochondrial fusion (GO:0008053),-0.3014718668563293,-0.8354999176526003,0.7023255813953488,0.9436647939711825,1.0,4/18,11.20%,MFF;MFN2;GDAP1;MFN1
prerank,regulation of synapse organization (GO:0050807),-0.2788693848656183,-0.8351354809090893,0.7188940092165899,0.9436568102349012,1.0,3/26,3.96%,CTNNA2;MEF2C;IL1RAPL1
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.20888702056274902,0.8350884442754478,0.8482587064676617,0.9183734652496118,1.0,72/259,22.55%,DCDC2;PARVA;CYS1;ASAP1;DYNLL1;FGD4;NRP1;ARL13B;KIT;RFX3;IFT88;NTN1;ARL3;VCL;TTC39C;HYLS1;ARF4;TMEM107;EXOC2;ACTN2;DYNC2I1;DNAAF1;PMP22;MTSS1;RAP2C;NUDCD3;IFT81;CC2D2A;CDH13;ANO6;CDC14A;CCDC57;WDR19;RAB3IP;CFAP221;IQCB1;IFT20;TRAPPC14;FBF1;CCDC66;RFX2;NPHP3;CEP250;CPLANE1;GBF1;AVIL;TTBK2;RAP2B;EXOC7;EXOC1;RPGR;IFT52;ARL6;WDR11;DMTN;CEP131;ARFIP2;SSX2IP;B9D2;PIP5K1A;OFD1;RP2;ACTR3;DZIP1L;FGD1;PKD1;LZTFL1;CFAP410;FSCN1;CYFIP1;RAP2A;RHOD
prerank,mRNA 3'-end processing (GO:0031124),0.24463707540254992,0.8350186545344673,0.7529761904761905,0.9179607909752995,1.0,29/78,24.64%,POLR2D;PCF11;RPRD2;PAPOLG;CDC73;SLU7;SRSF4;MAGOHB;PAF1;DDX39A;THOC5;LEO1;TENT2;PABPN1;SRSF5;CSTF3;APP;PAPOLB;SLBP;GRSF1;WDR33;RPRD1B;TENT4B;SRSF3;SRSF11;CLP1;DDX39B;PAPOLA;SRSF7
prerank,proteolysis (GO:0006508),0.21076338850308957,0.8349196964724184,0.842911877394636,0.9175964752344831,1.0,37/252,14.02%,DPP4;ADAMTS12;CPQ;ADGRV1;PRSS57;ANPEP;BMP1;AEBP1;CASP4;CPNE1;MMP14;DPP8;NPEPPS;LACTB;CTSH;SPPL3;PLAU;CPB2;ERAP1;SUFU;CTSW;CAPN15;NLN;ADAM19;SENP6;ENDOU;CLPX;DPP7;CELA1;PLAT;SENP1;FBXO3;SRGN;RNPEP;ADAMTS7;CPXM2;LNPEP
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),-0.32533417475414655,-0.8348159102248603,0.7142857142857143,0.9435851777936557,1.0,6/15,15.36%,NTRK2;DDIT4;ZFYVE27;BCAR1;NGF;SORT1
prerank,sphingosine metabolic process (GO:0006670),-0.3089262238206079,-0.8347054534497392,0.7094017094017094,0.9430526889960198,1.0,2/17,2.19%,ACER3;ACER2
prerank,regulation of protein metabolic process (GO:0051246),-0.24463589871541808,-0.8345873768160627,0.7543424317617866,0.942519398555668,1.0,10/44,13.77%,KLF2;FKBP1A;MAPK8;HSP90AB1;ACE;SPOP;NEDD4L;ZDHHC2;KLF4;PLAUR
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),-0.34318225414616954,-0.8343162985814225,0.6883910386965377,0.9423457441713614,1.0,5/11,30.43%,TIMM8B;TIMM22;NDUFA13;TIMM10;TIMM13
prerank,regulation of mRNA stability (GO:0043488),0.2217843867145265,0.834068276476785,0.8256130790190735,0.9186964146595069,1.0,21/145,14.96%,ROCK2;TNPO1;SAMD4A;TENT5A;VIM;RC3H1;IGF2BP1;DCP2;FTO;PSMB10;PSMA3;PSME4;NOCT;PSMA5;IGF2BP2;XRN1;EIF4ENIF1;METTL16;FUS;GIGYF2;DIS3
prerank,regulation of necroptotic process (GO:0060544),0.3105900374387435,0.8338233127518917,0.6791808873720137,0.918586439930728,1.0,5/23,14.28%,CFLAR;ZBP1;BIRC3;SLC25A4;FLOT2
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.2998063433086947,0.8338091590525005,0.7147887323943662,0.9174980922926531,1.0,4/29,11.27%,ACOT11;ACOT9;ACOT1;ACAT1
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.2998063433086947,0.8338091590525005,0.7147887323943662,0.9174980922926531,1.0,4/29,11.27%,ACOT11;ACOT9;ACOT1;ACAT1
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),0.30160611337424137,0.8337414376482979,0.6887298747763864,0.9170744837585891,1.0,7/29,15.14%,COPZ2;GOLGA5;COPE;GOSR1;COG2;RAB33B;COPZ1
prerank,activation of protein kinase A activity (GO:0034199),0.33423344188324333,0.833032946090774,0.6710280373831776,0.9179041462754133,1.0,3/16,7.01%,ADCY5;ADCY7;ADCY1
prerank,mitochondrial gene expression (GO:0140053),-0.25096172207220585,-0.8325598407131838,0.7444717444717445,0.9450123498395099,1.0,14/42,24.76%,LARS2;MRPS18A;FASTKD2;TWNK;MRPL57;RARS2;MRPL47;HARS1;MRPS2;TFB2M;MRPL23;MRPS12;POLRMT;MRPS16
prerank,DNA repair (GO:0006281),0.20876791820208396,0.8320381865228663,0.8644278606965174,0.9192599667177839,1.0,69/284,21.52%,EYA1;PDS5B;PARP9;POLH;NUCKS1;WRN;APBB1;SLX4;ASCC3;UBE2U;RAD50;PARP3;DTX3L;FTO;FBH1;BAZ1B;XRCC4;MNAT1;PSME4;USP47;SUMO1;NABP1;UVRAG;RPA3;XRCC1;FANCM;HUWE1;DCLRE1A;CENPX;UBE2V1;RFWD3;ADPRS;RBBP8;FANCE;OGG1;RAD51B;INTS3;GTF2H4;ERCC5;ERCC6;RAD9A;PDS5A;UIMC1;ALKBH1;ERCC1;USP45;MGMT;KMT5C;SMARCAL1;GTF2H2;FANCC;PARP4;WDR33;XPC;ACTR8;TDP2;BRCC3;DNA2;SETD2;NSMCE3;NABP2;ERCC8;KMT5B;POLD3;UBXN1;EYA3;INO80;CHEK2;NSMCE1
prerank,positive regulation of interleukin-6 production (GO:0032755),0.2469369475330222,0.8320270770509647,0.7550387596899225,0.918729047359079,1.0,8/68,8.47%,IL16;IL17D;IL6;TLR4;NOS2;LGALS9;SETD4;WNT5A
prerank,regulation of protein kinase A signaling (GO:0010738),0.3177774238787785,0.8320249248972312,0.6894639556377079,0.9181776130731473,1.0,4/20,9.30%,AKAP12;ADGRV1;PJA2;LRRK2
prerank,cyclic purine nucleotide metabolic process (GO:0052652),0.31885539392864565,0.8317579851368074,0.6758241758241759,0.9181618590597942,1.0,6/21,15.73%,ADCY5;ADCY7;ADCY1;NPPC;GUCY2C;ADCY6
prerank,regulation of microtubule nucleation (GO:0010968),-0.3570407658452822,-0.8314265907756241,0.6918238993710691,0.9464559570937628,1.0,4/10,27.40%,PAK1;ARHGEF7;DCTN1;RANGRF
prerank,positive regulation of CREB transcription factor activity (GO:0032793),0.3286878817673865,0.8313810553634697,0.698292220113852,0.9183274855754362,1.0,5/18,11.87%,CAMK1D;ADCY1;OPRD1;CRTC1;CRTC3
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),-0.31057753593285015,-0.8312486680364588,0.6884531590413944,0.9460590694594394,1.0,3/16,8.42%,ESR1;DDX54;DDX17
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),-0.3046048663048371,-0.8311482897945712,0.7083333333333334,0.9455403081769786,1.0,3/17,7.57%,PTPRJ;DGKZ;CEACAM1
prerank,negative regulation of biosynthetic process (GO:0009890),-0.31916617707101735,-0.8311258710839604,0.6961451247165533,0.9448334200715677,1.0,5/16,14.75%,ASXL3;EMILIN1;CEACAM1;ABCD2;PARK7
prerank,production of siRNA involved in RNA interference (GO:0030422),0.3798602892769092,0.830521604355982,0.67578125,0.9193909628826817,1.0,2/10,14.33%,TERT;TARBP2
prerank,regulation of DNA replication (GO:0006275),0.2601887430851148,0.830495836183315,0.7227564102564102,0.9188979069569926,1.0,15/49,20.10%,ORC5;NUCKS1;GLI1;CDAN1;ANKRD17;GMNN;ESCO1;TSPYL2;ORC3;PDS5A;S100A11;PPP2CA;DSCC1;DNA2;CTC1
prerank,stem cell differentiation (GO:0048863),0.2764738744884127,0.8304147036208058,0.711892797319933,0.918519688773508,1.0,6/39,9.97%,MLLT3;OSR1;FBXL17;KIT;JARID2;SOX21
prerank,negative regulation of viral transcription (GO:0032897),-0.33470057449550017,-0.8303518858940514,0.6845637583892618,0.9456643243000515,1.0,3/13,13.64%,MID2;TRIM62;IFITM3
prerank,cochlea morphogenesis (GO:0090103),-0.35147484296198594,-0.830314398605931,0.6802443991853361,0.9449830648186487,1.0,2/10,11.27%,TBX1;PAX2
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.23866413664462047,0.8299902416807475,0.7737556561085973,0.9187947803420949,1.0,11/80,12.46%,UACA;EPHA7;SH3RF1;DAPK1;SIAH2;NGFR;PDCD5;USP47;FNIP1;MAP2K5;RPS6KA3
prerank,in utero embryonic development (GO:0001701),0.2983697769824585,0.8297816280764038,0.7075812274368231,0.918655241933568,1.0,4/25,8.99%,ARNT2;BMP2;TGFBR1;IGF2
prerank,RNA stabilization (GO:0043489),0.2815253360192445,0.8296877204475964,0.711864406779661,0.9182953945191672,1.0,10/33,20.84%,TENT5A;NOCT;EIF4ENIF1;TENT2;FUS;AXIN2;GDNF;DHX36;ELAVL1;PARN
prerank,receptor metabolic process (GO:0043112),-0.23372120931372636,-0.8288128304730954,0.7967479674796748,0.9471172925983018,1.0,10/53,14.29%,DNM3;TFRC;SNCA;LGMN;LDLRAP1;RAMP2;FCER1G;SYK;CAV1;KIF16B
prerank,hexose biosynthetic process (GO:0019319),-0.24230424578783705,-0.8286841458786455,0.7588075880758808,0.9466087543299687,1.0,15/42,21.55%,PGK1;SLC39A14;ALDOC;GPI;TPI1;ATF4;MDH1;PGAM1;ENO1;PER2;SLC25A13;CRTC2;GAPDHS;SLC25A12;MDH2
prerank,rRNA 3'-end processing (GO:0031125),-0.3619488071386735,-0.828648980543583,0.696652719665272,0.9459300004501273,1.0,3/10,17.35%,RPS21;EXOSC2;ERI1
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),0.3317995913691057,0.8284850670375173,0.6760828625235404,0.9200564265786686,1.0,5/18,13.62%,FRS2;BMP2;HDAC4;BHLHE41;BDNF
prerank,DNA duplex unwinding (GO:0032508),0.2634298411844985,0.8279481827523987,0.7246376811594203,0.9205443091406844,1.0,9/50,14.02%,ANXA1;WRN;ASCC3;RAD50;CUL4A;MCM4;SUPV3L1;MCM6;GTF2H4
prerank,establishment of protein localization to extracellular region (GO:0035592),0.27264789556960495,0.8271493723637517,0.7272727272727273,0.9215243071946522,1.0,4/39,4.73%,ARFGAP3;STEAP3;RAB10;MIA3
prerank,icosanoid secretion (GO:0032309),0.3609725734579905,0.8270182869156262,0.6666666666666666,0.9212289470336055,1.0,3/12,7.04%,ANXA1;NOS2;BDKRB2
prerank,positive regulation of cellular protein localization (GO:1903829),0.24688907619399716,0.8264992824039605,0.7473684210526316,0.9216441184941888,1.0,18/69,17.50%,PRKAA2;PARP9;PARD6A;DTX3L;NGFR;GSK3B;YAP1;GPD1L;ENTR1;RTN4;CROCC;EIF2AK3;CEP250;MEAK7;TM9SF4;WWTR1;GAS8;ABCA7
prerank,organelle assembly (GO:0070925),0.19895719900065462,0.8262815671091346,0.9105882352941177,0.9215116188873369,1.0,79/384,18.96%,DCDC2;TMOD3;PARVA;CYS1;ASAP1;DYNLL1;AMBRA1;SMIM22;ARL13B;RC3H1;RFX3;SYNPO;IFT88;ARL3;RAB43;TTC39C;HYLS1;ARF4;TMEM107;PLA2G4C;EXOC2;POGZ;DYNC2I1;DNAAF1;HAUS8;GOLGA8B;HPS1;TUBGCP4;NUDCD3;IFT81;CC2D2A;UBXN2A;ATG12;CDC14A;CCDC57;WDR19;UBAP2L;EIF4ENIF1;RAB3IP;CFAP221;IQCB1;DDX6;IFT20;TRAPPC14;WDR45B;TUBGCP2;FBF1;CCDC66;GORASP2;CHMP3;RFX2;RBM14;NPHP3;TUBGCP5;CEP250;CHMP4A;CHMP4B;CPLANE1;ATG2A;GBF1;AVIL;GOLGA2;TTBK2;SH3PXD2B;CENPC;EXOC7;EXOC1;CCDC61;OGFOD1;WIPI2;RPGR;PATL1;RAB19;MAPRE3;IFT52;PRRC2C;ARL6;FARP2;WDR11
prerank,calcium ion import into cytosol (GO:1902656),-0.31329394323572457,-0.8259275484088635,0.6987704918032787,0.9503330677463574,1.0,2/15,5.50%,SLC24A2;SLC8A1
prerank,miRNA metabolic process (GO:0010586),0.30985491250624886,0.8250824056742921,0.7001795332136446,0.9231706557327316,1.0,9/20,21.46%,TUT4;SND1;TARBP2;RAN;TUT7;KHSRP;PARN;TENT4B;XPO5
prerank,regulation of secretion (GO:0051046),-0.33021838290375577,-0.8249566877658536,0.7142857142857143,0.9514048765959648,1.0,7/13,32.55%,ACSL3;KCNQ1;EGF;SGK1;POFUT2;FGF10;SCIN
prerank,regulation of carbohydrate catabolic process (GO:0043470),0.2738505492135812,0.8244277069793935,0.7370184254606366,0.9238190624433255,1.0,4/41,7.19%,PRKAG2;RANBP2;TPR;JMJD8
prerank,protein acetylation (GO:0006473),0.2820151843279287,0.8243997108580038,0.7215815485996705,0.9233295155835504,1.0,10/30,20.13%,CREBBP;NAA16;ESCO1;NAA15;KAT6A;KAT2B;NAA35;DSCC1;CLOCK;NAA40
prerank,mesenchymal cell development (GO:0014031),-0.29622873021150514,-0.8239627392723453,0.7265135699373695,0.9525492818109618,1.0,2/18,2.33%,CDH2;NOTCH1
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),-0.3177122342402923,-0.8238692475600697,0.7246049661399548,0.9519699482113275,1.0,8/14,34.37%,PHACTR4;EMP2;PRKD1;LIMS2;TIMP1;BST1;SLC2A10;ITGB1BP1
prerank,lipoprotein transport (GO:0042953),-0.3555337205237628,-0.8237761000986674,0.711864406779661,0.951408643085384,1.0,2/10,8.69%,PRKCB;VMP1
prerank,mitotic nuclear division (GO:0140014),0.2431926622584529,0.8235755903301606,0.7757296466973886,0.9243055061732535,1.0,22/71,23.03%,MAP9;STAG1;CLASP1;KLHL22;KLHDC8B;ESPL1;MISP;UBE2C;ZWINT;CHMP4B;TOGARAM1;TOGARAM2;SPICE1;GOLGA2;RAN;CCDC61;OFD1;INO80;CHEK2;STAG2;SPAST;UBE2S
prerank,NAD biosynthetic process (GO:0009435),0.3081757610051061,0.8229526253018956,0.6790780141843972,0.9249143133401656,1.0,7/20,22.06%,PARP9;PARP10;PARP16;PTGS2;NADSYN1;QPRT;HAAO
prerank,protein stabilization (GO:0050821),0.21560970033585994,0.8228150057546835,0.8393854748603352,0.9246258897293798,1.0,35/168,16.58%,PLPP3;PARVA;WNT10B;APOA2;LAMP2;AAK1;MORC3;CREBL2;USP27X;CTNND1;USP9X;EPHA4;PHB2;STK3;CCNH;NAA16;SUMO1;CDK7;ATF7IP;NAA15;ATP1B2;DVL3;EFNA1;RTN4;MDM4;USP36;FLOT2;VHL;STK4;MUL1;SOX4;PER3;TAF9;TBL1X;CCT6A
prerank,positive regulation of lymphocyte migration (GO:2000403),0.3545023298839677,0.8224951437688792,0.6776699029126214,0.9246819230559445,1.0,2/12,7.90%,CXCL10;TNFRSF14
prerank,regulation of cell-substrate adhesion (GO:0010810),0.27154335994963347,0.8221377610134828,0.7557755775577558,0.92481560268102,1.0,2/42,1.76%,PDPN;ECM2
prerank,regulation of ATP biosynthetic process (GO:2001169),0.3357441506674355,0.8219582233292483,0.6690777576853526,0.92460599855162,1.0,2/16,6.37%,PID1;PPARA
prerank,midbody abscission (GO:0061952),-0.30204596524377764,-0.8217974177839593,0.7226890756302521,0.9545065639009207,1.0,9/17,30.18%,CHMP1A;CHMP1B;CHMP7;CHMP2B;CHMP2A;CEP55;CHMP6;CHMP4C;KIF20A
prerank,dorsal/ventral pattern formation (GO:0009953),0.3160664682123224,0.8217542168200644,0.6910420475319927,0.9244302404886113,1.0,2/20,2.59%,BMPR1A;NBL1
prerank,phospholipid catabolic process (GO:0009395),0.29897112340386617,0.8216751829106073,0.6897810218978102,0.9240225465138013,1.0,4/24,10.74%,PLA2G4A;APOA2;PLA2G4C;ENPP2
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.3306982956481527,0.82136375751035,0.696798493408663,0.924067200221132,1.0,2/16,9.14%,AMPD3;PAICS
prerank,Fc receptor signaling pathway (GO:0038093),0.229138895841975,0.8209277661422865,0.8160919540229885,0.9243176499874495,1.0,15/110,13.33%,PDPK1;TEC;GAB2;FER;KIT;MAP3K1;PSMB10;PSMA3;PSME4;PSMA5;PPP3CB;MAP3K7;BTRC;FBXW11;MAPK9
prerank,negative regulation of hippo signaling (GO:0035331),-0.329421277477063,-0.8209243303131989,0.6952965235173824,0.955408124089778,1.0,3/12,7.27%,CIT;SHANK2;WWC1
prerank,organelle fission (GO:0048285),-0.2737273453620573,-0.8207909486763297,0.722972972972973,0.9548926026470709,1.0,6/24,21.13%,DNM3;MFF;GDAP1;PEX19;PEX11A;MTFR1L
prerank,positive regulation of calcium ion import (GO:0090280),0.353696941885002,0.8202919055548834,0.6910112359550562,0.9249711664649143,1.0,2/12,7.71%,PDGFRB;CCL2
prerank,negative regulation by host of viral process (GO:0044793),0.36988643463796184,0.8202541018740915,0.6699029126213593,0.9244959681201205,1.0,2/10,7.87%,CRP;VAPA
prerank,glycolipid biosynthetic process (GO:0009247),-0.24646579120724116,-0.8195336148292383,0.8,0.9564578780023252,1.0,13/38,22.26%,ST8SIA6;MPPE1;ST6GALNAC5;PIGM;PIGU;PIGQ;PIGH;DPM2;ST3GAL4;PIGO;ST8SIA5;B4GALT6;PIGB
prerank,regulation of long-term synaptic potentiation (GO:1900271),0.29299994585031247,0.8195163470559566,0.7035775127768313,0.9253067581252999,1.0,4/28,8.24%,PTN;ADCY1;GSK3B;EPHA4
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",0.30362532524120917,0.8194249790938798,0.7200704225352113,0.9249276821683562,1.0,8/22,23.94%,MAN1C1;AMFR;UGGT2;RNF185;EDEM2;RNF139;SYVN1;EDEM1
prerank,negative regulation of gene silencing by miRNA (GO:0060965),0.35368525927094985,0.8188439304962123,0.696526508226691,0.9254472694271606,1.0,6/12,24.03%,TERT;POU5F1;ELAVL1;ZC3H12A;TGFB1;ZC3H10
prerank,gastrulation (GO:0007369),0.33461900230863384,0.8187710487480416,0.6771217712177122,0.9250236166877945,1.0,5/15,20.75%,LMBRD1;TASOR;NPHP3;SMAD2;MEGF8
prerank,lipoprotein localization (GO:0044872),0.3606150911939936,0.8186911780867534,0.6981132075471698,0.9246292562655933,1.0,5/11,20.27%,MIA3;ZDHHC3;ZDHHC17;LRP1;CD36
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",-0.31665556270651063,-0.8185961267290144,0.693304535637149,0.9574629516690958,1.0,5/13,33.21%,CD74;PTTG1IP;MIF;YJU2;MDM2
prerank,ERK1 and ERK2 cascade (GO:0070371),-0.2779248549649419,-0.817630769682041,0.711864406779661,0.9586035464381759,1.0,5/21,16.37%,KDR;MAPK3;KARS1;EGF;HTR2B
prerank,glycogen catabolic process (GO:0005980),0.33299759127302014,0.817517556357895,0.7,0.9262311846914113,1.0,5/15,20.05%,PYGB;PYGM;STBD1;PHKB;PHKA2
prerank,negative regulation of T cell mediated immunity (GO:0002710),-0.3374980739783029,-0.8173903598633638,0.7384937238493724,0.9582865417404887,1.0,3/11,14.81%,SMAD7;CEACAM1;PTPRC
prerank,interleukin-12-mediated signaling pathway (GO:0035722),-0.23419926146370781,-0.816930088795537,0.7938144329896907,0.9583960679409738,1.0,14/46,24.27%,PLCB1;PITPNA;RPLP0;TALDO1;PPIA;HNRNPF;SOD1;CFL1;AIP;LCP1;GSTO1;MIF;IL12RB2;MTAP
prerank,dicarboxylic acid metabolic process (GO:0043648),0.25687318991202146,0.8167819401096373,0.7626582278481012,0.9270495840643723,1.0,15/52,22.31%,SHMT1;SLC19A1;MTHFD1;IDH1;ME2;MDH1B;D2HGDH;IDH2;PHYH;ADHFE1;HOGA1;ASS1;MTHFD2L;HAAO;MTHFD1L
prerank,cellular protein catabolic process (GO:0044257),-0.2247920394221723,-0.8167020891432505,0.8412698412698413,0.9580384459095058,1.0,11/59,12.58%,CTSC;CTSB;DAB2IP;FAP;LGMN;CTSS;MALT1;CTSL;PSMA6;VLDLR;RAB12
prerank,positive regulation of calcium-mediated signaling (GO:0050850),-0.338615071367012,-0.8164824324777533,0.7056367432150313,0.9577096866916124,1.0,1/11,1.55%,PLCG2
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),-0.1949295665184834,-0.8164134001022862,0.9366197183098591,0.9570881167017953,1.0,48/125,30.93%,RPS27;KPNB1;EFHC2;RCC2;DYNC1H1;PCNT;KIF18A;XPO1;KIF3B;DYNC1I2;NDE1;CLASP2;PPP1CC;NEK9;CENPU;SKA2;BUB1B;DYNLL2;ZWILCH;CENPT;CENPQ;CENPL;STMN1;TUBG1;MAD1L1;NSL1;CENPN;CENPF;KIF4A;DSN1;KNTC1;SPDL1;TUBG2;DCTN6;CENPA;BCCIP;MAPRE1;SGO1;STIL;BIRC5;ITGB3BP;CLIP1;TBCE;PLK1;ZW10;DLGAP5;NUF2;AURKA
prerank,cellular response to interferon-beta (GO:0035458),-0.31848288224106525,-0.8163764250368724,0.7214912280701754,0.956414226353535,1.0,6/14,29.29%,AIM2;IFITM2;IRGM;NDUFA13;CDC34;UBE2G2
prerank,cellular response to amino acid starvation (GO:0034198),-0.21613361011801296,-0.816313428378439,0.8206521739130435,0.9557720447304116,1.0,25/71,27.30%,MAP3K5;MAPK8;ATP6V1B2;DAPL1;MAPK3;SESN3;ATP6V0C;FAS;RRAGB;ATP6V1D;ATF4;CDKN1A;PRKD1;RRAGC;ATP6V1G2;ATP6V0E2;LAMTOR2;ATP6V1F;MLST8;ATP6V0D2;DEPDC5;SH3GLB1;MIOS;LAMTOR4;ITFG2
prerank,regulation of response to DNA damage stimulus (GO:2001020),0.2723380466631452,0.8161672736722245,0.7418244406196214,0.9276198464968354,1.0,6/40,11.01%,POLH;CRY1;MCL1;NEK4;UBE2V1;RFWD3
prerank,rRNA catabolic process (GO:0016075),0.33375461912797977,0.8159060300412875,0.7029702970297029,0.9275557859330099,1.0,6/16,16.37%,XRN1;DIS3L;SLFN14;DIS3;ERN2;EXOSC10
prerank,regulation of epidermal cell differentiation (GO:0045604),0.3031421338622719,0.8158596166939869,0.6985294117647058,0.9270990882457358,1.0,2/21,4.74%,ROCK2;ERRFI1
prerank,negative regulation of interleukin-1 beta production (GO:0032691),0.3195805074101986,0.8155992939573317,0.7158469945355191,0.9270296715676565,1.0,19/19,68.08%,ZC3H12A;CARD16;CD33;MEFV;GHSR;FFAR1;GHRL;NLRP2B;IGF1;TNFAIP3;CX3CL1;FFAR4;PYDC1;APOA1;GSTP1;GIT1;CPTP;CX3CR1;NLRP3
prerank,regulation of mitochondrial depolarization (GO:0051900),0.3662834134409086,0.8144733574337807,0.6908396946564885,0.9285436754507956,1.0,3/10,9.30%,DCN;BCL2;LRRK2
prerank,positive regulation of leukocyte degranulation (GO:0043302),0.3411084079866348,0.8143505856430318,0.7129629629629629,0.9282264727069094,1.0,1/13,2.18%,GAB2
prerank,renal water homeostasis (GO:0003091),0.3038344368556083,0.8138332779526638,0.7039007092198581,0.92860042969013,1.0,7/23,21.44%,ADCY5;ADCY7;ADCY1;ADCY6;MYO5B;RAB11FIP2;PRKAR1B
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),0.3428929788031212,0.8138028949442077,0.693609022556391,0.9281141193087568,1.0,1/12,4.75%,BMP7
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),0.344760804584481,0.8137489260102067,0.724,0.9276741492799262,1.0,6/12,23.92%,UBE2C;BTRC;GOLGA2;PTEN;UBE2S;GORASP1
prerank,histone H2A ubiquitination (GO:0033522),0.32292579267039184,0.8135502274725483,0.7092337917485265,0.9274777035523556,1.0,5/17,16.98%,BCOR;DTX3L;KDM2B;RING1;RNF2
prerank,regulation of protein ubiquitination (GO:0031396),0.22830304446231323,0.8132766688694192,0.8112676056338028,0.9274100641173529,1.0,17/108,14.53%,SASH1;PRICKLE1;ANGPT1;CRY1;MYCBP2;TGFBR1;BIRC3;RIPK2;LRRK2;FBXO4;HUWE1;SPOPL;CENPX;CUL3;ARRB1;TBC1D7;RCHY1
prerank,sensory organ development (GO:0007423),-0.22906466491573182,-0.8132029213074332,0.8115577889447236,0.9607579109656583,1.0,10/51,13.74%,MEIS2;TGFB2;PBX3;AHI1;ECE1;FREM2;ATF6;BMPR1B;SIPA1L3;SIX4
prerank,regulation of cholesterol transport (GO:0032374),0.3143269382036945,0.8126793261258923,0.6758747697974218,0.9279598782618551,1.0,2/20,6.02%,APOA2;NR1H3
prerank,regulation of hippo signaling (GO:0035330),0.32002722113702997,0.8123323963352683,0.7192660550458716,0.9280472878081514,1.0,8/17,19.70%,NEK8;WWC2;MAPK14;VGLL4;NF2;WTIP;DLG5;AJUBA
prerank,metallo-sulfur cluster assembly (GO:0031163),-0.2776460681845181,-0.812118189623109,0.7430406852248393,0.9619685069532736,1.0,8/22,32.97%,MMS19;NDOR1;HSCB;CIAO3;IBA57;ISCU;GLRX5;NUBPL
prerank,cytoplasmic microtubule organization (GO:0031122),0.254679045347319,0.8117337217488426,0.7586206896551724,0.9285658520318167,1.0,12/54,15.16%,CLASP1;CLIP4;KATNAL1;CCDC13;DLG1;TUBGCP4;FIGN;SLAIN2;FSD1;TUBGCP2;TUBGCP5;FIGNL1
prerank,mitotic spindle assembly (GO:0090307),0.2636704877294961,0.811670344834242,0.77491961414791,0.9281379937168417,1.0,12/42,22.72%,MAP9;STAG1;CLASP1;MISP;TOGARAM1;TOGARAM2;SPICE1;GOLGA2;CCDC61;OFD1;CHEK2;STAG2
prerank,positive regulation of T cell differentiation (GO:0045582),0.2795678718980169,0.811399920318077,0.7336601307189542,0.9280832709488477,1.0,3/36,3.59%,ZMIZ1;GLI3;DUSP10
prerank,nucleocytoplasmic transport (GO:0006913),0.26806961516408756,0.8113536745498302,0.7633333333333333,0.927624305367362,1.0,2/40,2.08%,ATXN1;GEMIN4
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),0.347976575135565,0.8112046348768411,0.6753246753246753,0.9273314877311791,1.0,2/13,6.02%,NUPR1;NR1H3
prerank,regulation of neuron projection arborization (GO:0150011),-0.30917760785575066,-0.8104183629195192,0.7396061269146609,0.9643805659149639,1.0,7/15,20.67%,MACF1;GRIP1;DVL1;MFSD2A;FZD4;NTNG1;NTNG2
prerank,epithelial cell differentiation (GO:0030855),0.23389665163808704,0.8104118797510397,0.8330733229329174,0.9282289029861795,1.0,9/88,8.12%,FSTL1;GATA6;MAF;ANXA1;RAB10;GLI1;ANXA4;GSTK1;ANXA7
prerank,cell cycle G1/S phase transition (GO:0044843),-0.2191434066399811,-0.8099712124263304,0.8083333333333333,0.9644813739840576,1.0,13/61,15.59%,USP29;CDK6;MAX;MAP3K11;CAMK2A;CCND1;BCAT1;ACVR1;HINFP;USP37;CDK2;CDKN1A;CDK4
prerank,positive regulation of translation (GO:0045727),-0.20126338243621814,-0.8098296519976991,0.8986928104575164,0.9639865107547171,1.0,32/94,27.88%,THBS1;RPS9;RPL26;RPL5;PKM;RPS4X;EEF2;CNBP;NPM1;YTHDF2;EIF5A;EIF5AL1;CDC123;FASTKD2;PASK;EIF5A2;RBM3;BCL3;POLDIP3;C1QBP;UHMK1;NIBAN1;PYM1;EIF6;RCC1L;TRMT10C;POLR2G;HNRNPD;METTL14;RPUSD3;PRR16;BOLL
prerank,UV protection (GO:0009650),0.36768817947292054,0.8096735916462399,0.6686746987951807,0.9290229506928172,1.0,2/10,14.03%,SCARA3;ERCC5
prerank,regulation of cellular biosynthetic process (GO:0031326),0.28940760852751735,0.8094465950768108,0.7213403880070547,0.9289031061284401,1.0,3/28,6.64%,PRKAG2;PRKAA2;CD47
prerank,regulation of dendritic cell apoptotic process (GO:2000668),-0.346846564139646,-0.8094337471165817,0.7367303609341825,0.9639854820153676,1.0,5/10,15.18%,GAS6;RAPGEF2;CXCL12;LYN;CCL19
prerank,heterochromatin assembly (GO:0031507),0.31217249732519664,0.8086739992438394,0.7174280879864636,0.9297105987313705,1.0,10/20,27.82%,MBD2;BAZ2A;RRP8;ZNFX1;SIRT2;SMCHD1;EZH1;CENPV;SUV39H1;HMGA2
prerank,peptide metabolic process (GO:0006518),0.24018575057705716,0.8086471559968476,0.7823439878234398,0.929210296989369,1.0,13/75,14.02%,CPQ;ANPEP;AEBP1;MGAT3;NPEPPS;CLN5;SPPL3;GSTK1;ERAP1;NLN;GSTA3;CPXM2;LNPEP
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),-0.3259476523984493,-0.8075640082578603,0.729490022172949,0.966539352697832,1.0,8/13,35.53%,FCER1G;SYK;LPL;ITGB2;CD81;LDLR;PPARG;CD9
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.2917253446215983,0.8075035331796618,0.7183333333333334,0.9306887171939511,1.0,4/26,9.25%,ADAMTS1;ANXA1;CCND3;ANKRD17
prerank,regulation of T cell cytokine production (GO:0002724),0.3312997457532087,0.8072997114198321,0.7126436781609196,0.9305120699136109,1.0,4/15,12.58%,CD55;FOXP3;MAP3K7;HFE
prerank,positive regulation of fatty acid metabolic process (GO:0045923),-0.31104858773088695,-0.807111047746425,0.7349896480331263,0.9665964828462149,1.0,5/15,19.50%,ELOVL5;PPARD;NR4A3;MID1IP1;SLC45A3
prerank,outer dynein arm assembly (GO:0036158),0.32769877126518454,0.8070127959535535,0.6896551724137931,0.9304840425826971,1.0,3/14,10.13%,ODAD4;DNAAF1;DNAL1
prerank,cellular response to heat (GO:0034605),0.2801983264094048,0.8069549248479702,0.7374784110535406,0.9300523905346979,1.0,5/35,9.34%,FGF1;POLR2D;TPR;SLU7;SUMO1
prerank,regulation of mitotic spindle organization (GO:0060236),0.2770788866080084,0.8066303890031263,0.7265372168284789,0.930105573450004,1.0,8/35,16.64%,MAP9;PARP3;TPR;FSD1;CHMP3;CHMP4B;PSRC1;EML3
prerank,negative regulation of phosphatase activity (GO:0010923),-0.2663329560899782,-0.8065015303813142,0.7608695652173914,0.9669635794866271,1.0,4/25,8.46%,TGFB2;FKBP1A;SEMA4D;PPP1R11
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),-0.24823998135896547,-0.8061836688160349,0.7929292929292929,0.9667921347398147,1.0,13/30,30.67%,NOS3;ARHGEF2;RFFL;FAS;TMBIM1;PARK7;BRCA1;BMP5;TNFRSF10B;HMOX1;FADD;TRAF2;TRADD
prerank,response to amino acid starvation (GO:1990928),-0.21320547382429955,-0.8061462764601479,0.8482384823848238,0.9661185943944152,1.0,25/72,27.30%,MAP3K5;MAPK8;ATP6V1B2;DAPL1;MAPK3;SESN3;ATP6V0C;FAS;RRAGB;ATP6V1D;ATF4;CDKN1A;PRKD1;RRAGC;ATP6V1G2;ATP6V0E2;LAMTOR2;ATP6V1F;MLST8;ATP6V0D2;DEPDC5;SH3GLB1;MIOS;LAMTOR4;ITFG2
prerank,positive regulation of epidermal cell differentiation (GO:0045606),0.3280281864819742,0.8059648557657398,0.6979362101313321,0.9307654573406682,1.0,2/15,3.02%,FOXC1;NCOA3
prerank,regulation of platelet aggregation (GO:0090330),0.3225196103161451,0.8059199128306893,0.7134935304990758,0.9302942668736328,1.0,1/17,0.30%,PDPN
prerank,regulation of exosomal secretion (GO:1903541),0.3170475702773242,0.8058220109316082,0.7467166979362101,0.9299275506029271,1.0,1/19,1.31%,SMPD3
prerank,chromatin remodeling at centromere (GO:0031055),-0.24785286406374707,-0.8057521785055092,0.7872860635696821,0.9660711621315882,1.0,11/31,26.66%,NPM1;HELLS;CENPU;CENPT;CENPQ;CENPL;CENPN;MIS18BP1;CENPA;RBBP7;ITGB3BP
prerank,cellular response to starvation (GO:0009267),0.21594854028348584,0.8053674408331307,0.8533519553072626,0.9301850316778365,1.0,27/147,16.27%,RNF152;PRKAG2;PRKAA2;EIF2AK2;GCGR;WRN;LAMP2;MTMR3;CARTPT;PPARA;STK24;LRRK2;NUPR2;FNIP1;RRP8;SESN1;FOXO3;SLC38A9;TCIRG1;WDR45B;NPRL3;ATP6V0B;NUAK2;EIF2AK3;ATP6V1E1;ATP6V1C1;LARS1
prerank,steroid hormone biosynthetic process (GO:0120178),-0.2569994127632603,-0.8051624510047611,0.762589928057554,0.9664167648259074,1.0,6/29,20.59%,STARD3NL;SRD5A3;FDXR;HSD17B7;DHCR7;HSD17B8
prerank,regulation of interleukin-13 production (GO:0032656),-0.31973681801352255,-0.8051504193651164,0.7336244541484717,0.9656939942484395,1.0,1/13,0.14%,LEF1
prerank,positive regulation of reproductive process (GO:2000243),0.28212327173816676,0.8045664316026786,0.7657342657342657,0.9311068110854477,1.0,3/31,3.59%,SMURF2;LHFPL2;FAM170B
prerank,protein complex oligomerization (GO:0051259),0.23612588103552976,0.8043432162041434,0.8164179104477612,0.9309483207604979,1.0,23/85,23.12%,MCU;RNF213;MICU1;PRF1;CLDN1;DNM1L;CUTC;OPA1;TIFA;FUS;PKD2;ATL1;RNF135;IKZF4;JMJD6;ELAVL1;SLC9A1;NACC2;OXA1L;ZC3H12A;PNPT1;SPAST;PRMT1
prerank,regulation of gene silencing by miRNA (GO:0060964),0.2449808076083839,0.8040868852006741,0.7958860759493671,0.9308677795928304,1.0,20/62,25.23%,POLR2D;RANBP2;TPR;TNRC6A;POLR2C;POLR2F;POM121;POU5F1;NUP37;WTIP;PUM2;NUP85;AJUBA;POLR2K;ELAVL1;DHX9;TGFB1;NUP160;NUP107;POLR2H
prerank,heme biosynthetic process (GO:0006783),-0.27203985866051894,-0.8035116137915618,0.7790178571428571,0.9677985784465842,1.0,1/22,0.19%,ABCG2
prerank,toll-like receptor 4 signaling pathway (GO:0034142),0.3107208931892822,0.8033643562518238,0.7261698440207972,0.9315555304117742,1.0,3/19,7.85%,TLR4;LY96;LGALS9
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",-0.34319195757996934,-0.8029414121553741,0.7156862745098039,0.9680480239118965,1.0,3/10,11.66%,HMGB1;RUNX1;CBFB
prerank,establishment of apical/basal cell polarity (GO:0035089),0.33624207420428165,0.8028594009429757,0.7090239410681399,0.9319267166965507,1.0,14/14,66.41%,MYO9A;PATJ;FSCN1;RAP2A;SH3BP1;SCRIB;CAMSAP3;RHOA;OPHN1;CDC42;EZR;SYNE4;FOXJ1;MSN
prerank,protein modification by small protein removal (GO:0070646),-0.1749588037941187,-0.802780145827243,0.970873786407767,0.9675995748060361,1.0,73/252,25.03%,USP29;IL33;SMAD7;ACTB;ESR1;PSMC3;OTUD7A;SNX3;USP31;NFRKB;CLSPN;RAD23A;PSMD14;UBB;MBD5;PSMD3;YY1;BABAM1;EIF3F;USP13;COPS6;PSMD4;SMAD1;ZRANB1;PSMD6;BARD1;ADRB2;PSMA6;PSMA4;PSMB8;USP3;FOXO4;TFPT;USP46;USP37;UBA52;PSMA8;TAF9B;VCPIP1;OTUD1;CYLD;COPS5;COPS2;YOD1;USP38;SUDS3;BRCA1;UBE2D1;PSME1;GPS1;TOMM20;KAT2A;PSMD7;PSMC6;ASXL1;USP42;PSMB5;USP2;PSMC5;PSMB1;POLB;ATXN3;COPS4;OTUB2;USP22;KDM1B;PSMD11;DDB2;MCRS1;PSMD8;USP11;RAD23B;JOSD2
prerank,regulation of macroautophagy (GO:0016241),-0.20101451750730814,-0.8027204360396532,0.9113924050632911,0.9669552936936139,1.0,29/105,22.76%,ATP6V0A1;KDR;MAPK8;SCOC;ATP6V1B2;EXOC4;SESN3;ATP6V0C;AKT1;SMCR8;HDAC6;PINK1;RRAGB;EPM2A;ATP6V1D;CAPN1;ULK1;CAPNS1;QSOX1;ATP6V0A2;RRAGC;ATP6V1G2;BNIP3L;ATP6V0E2;LAMTOR2;MLST8;ATP6V0D2;CLN3;PAFAH1B2
prerank,regulation of cell projection organization (GO:0031344),-0.3219405326770079,-0.8023868906426752,0.7441860465116279,0.9668009408547287,1.0,7/13,20.67%,SEMA4D;MACF1;ERMN;MFSD2A;CCL19;NTNG1;NTNG2
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.2141878472457346,-0.8019960448889459,0.8715083798882681,0.9667691643764369,1.0,19/65,24.51%,PSMC3;PSMD14;PSMD3;PSMD4;PSMD6;PSMA6;PSMA4;PSMB8;PSMA8;PSME1;CHEK1;PSMD7;PSMC6;PSMB5;PSMC5;PSMB1;SKP1;PSMD11;PSMD8
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.35089855108680645,0.8019340490712178,0.6924643584521385,0.9330102200466506,1.0,5/11,23.55%,IL6;MAP2K1;DDX5;RIPK1;TGFB1
prerank,positive regulation of RNA metabolic process (GO:0051254),-0.23422111488286523,-0.8017242621648509,0.800498753117207,0.9665246974992343,1.0,10/45,23.15%,PIK3R1;LIN28B;SETX;BMP4;EGFR;HRAS;SIRT7;HNRNPLL;HEATR1;SLC38A2
prerank,plasma membrane repair (GO:0001778),0.3396295081138932,0.8016420804447587,0.7145631067961165,0.9329573488585768,1.0,1/13,1.42%,MYOF
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),0.32345969065678565,0.8013127299540562,0.7257769652650823,0.9329978135626147,1.0,1/15,0.46%,TEC
prerank,exit from mitosis (GO:0010458),-0.32398269692032844,-0.8010513780727574,0.7188755020080321,0.9669453022478516,1.0,6/12,23.36%,EPS8;CTDP1;CLASP2;CHMP7;SIRT7;CHMP2A
prerank,positive regulation of cell cycle process (GO:0090068),-0.20433013514652354,-0.800956803715959,0.8766233766233766,0.9663642253509176,1.0,36/91,33.32%,INSR;CIT;RCC2;NSFL1C;DDX11;DYNC1H1;MAP3K20;RANBP1;LRP5;RGCC;PLK4;EGF;ECT2;GEN1;KIF23;SPAG5;E2F7;PRKCE;WIZ;NUP62;RACGAP1;KIF14;CDC14B;RHNO1;EDN1;UBXN2B;RAD21;NUDT16;AURKA;CDC6;FEN1;E2F8;KIF20B;OPN1MW;DBF4;DRD3
prerank,response to endoplasmic reticulum stress (GO:0034976),0.22239617914718868,0.8007665057417082,0.8391812865497076,0.9333948308770235,1.0,10/107,8.35%,RASGRF1;ITPR1;CREB3L2;UBA5;BCL2;CASP4;CREB3L3;GSK3B;QRICH1;BAX
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.2340296203654957,0.7995191637753808,0.825,0.9350081816851331,1.0,10/85,10.29%,PRICKLE1;SMURF2;FZD2;PARD6A;CELSR1;PSMB10;WNT5A;PSMA3;PSME4;PSMA5
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),0.3170845104177946,0.7990766409557637,0.7185185185185186,0.9352543787416873,1.0,2/18,6.20%,SELP;VCAM1
prerank,lipoprotein biosynthetic process (GO:0042158),0.3444265471832794,0.7985885909680397,0.7045454545454546,0.9355126259560208,1.0,6/11,26.21%,PORCN;WDR45B;ATG10;WIPI2;ATG7;APOE
prerank,autophagosome assembly (GO:0000045),-0.22697617362261688,-0.798103086301994,0.8296703296703297,0.9706333354822376,1.0,13/52,19.24%,GABARAP;NSFL1C;GABARAPL1;ATG16L1;VMP1;ATG9A;MFN2;TP53INP2;ULK1;ATP2A2;IRGM;RAB1B;PIK3C3
prerank,response to interleukin-6 (GO:0070741),0.35971164292281743,0.798073785647452,0.7279549718574109,0.9358249237481043,1.0,1/10,1.34%,PID1
prerank,positive regulation of T cell proliferation (GO:0042102),0.24584463380830646,0.7978187266497958,0.7772435897435898,0.935757209362227,1.0,7/55,8.99%,IL6ST;ANXA1;IL6;VCAM1;IL18;CD274;IGF2
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.263416191222836,0.7976820088681845,0.7461669505962522,0.9354377350116196,1.0,7/40,11.01%,NUCKS1;WRN;TONSL;FBH1;FANCM;CENPX;RFWD3
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),-0.2776532581126304,-0.7971777171778899,0.7801932367149759,0.9714898389997008,1.0,13/22,41.53%,VPS37B;MVB12B;RNF126;VPS37A;VPS28;SNF8;PLAA;PTPN23;VPS4B;STAM;UBAP1L;UBAP1;VPS25
prerank,phosphatidylglycerol metabolic process (GO:0046471),0.2958177465106732,0.7964951073564723,0.7079646017699115,0.936988428227104,1.0,5/24,19.81%,PLA2G4A;SERAC1;LPGAT1;PLA2G5;SLC27A1
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),-0.18580172656846938,-0.795839941909914,0.9509433962264151,0.9730417028215647,1.0,51/148,27.65%,RPS15;RPL5;RPL11;TAF15;MRE11;JMY;RPS20;AKT1;PHF20;STK11;TAF3;SSRP1;RFFL;HDAC1;PPP1R13B;ATM;BARD1;RPL23;TAF9B;TAF11;CDK2;RMI2;BRCA1;RPL37;RAD1;CCNG1;PIP4P1;L3MBTL1;RFC4;CHEK1;NOC2L;PRMT5;MLST8;USP2;ATRIP;ATR;BRPF1;PRR5;SGK1;CDK5;RBBP7;EXO1;PIP4K2A;RHNO1;RFC5;HIPK2;RFC2;CSNK2B;BLM;CHD5;MAPK11
prerank,endoplasmic reticulum tubular network organization (GO:0071786),-0.3066144323212607,-0.7953853540237529,0.7329192546583851,0.9730693357284563,1.0,6/15,22.27%,REEP1;ARL6IP1;ZFYVE27;ATL2;RTN3;RAB18
prerank,glucose import (GO:0046323),-0.31582550382982,-0.7952378152504419,0.7303822937625755,0.9725600227646708,1.0,4/13,19.14%,SLC2A1;SORT1;ZDHHC7;SLC2A4
prerank,rhodopsin mediated signaling pathway (GO:0016056),-0.33927539028999476,-0.7947868160472039,0.7453027139874739,0.9725942923822986,1.0,4/10,35.51%,PDE6A;SAG;PDE6G;PDE6B
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),-0.2961550981130691,-0.7947801366342475,0.7575757575757576,0.9718645874093684,1.0,7/15,37.59%,CCT5;NOP10;RUVBL2;NHP2;CCT7;SHQ1;CCT8
prerank,chondroitin sulfate catabolic process (GO:0030207),-0.31704668586772267,-0.7947268161681158,0.7137176938369781,0.9712210713544173,1.0,2/13,4.85%,CSPG4;HEXB
prerank,embryonic axis specification (GO:0000578),0.3322404560855837,0.7945315186959284,0.7096774193548387,0.9397699327507839,1.0,4/15,18.82%,SMAD6;TASOR;SMAD2;PTCH1
prerank,atrial septum development (GO:0003283),-0.3147938988058479,-0.79428189045735,0.7414529914529915,0.9712247945015837,1.0,3/13,9.13%,TGFB2;BMPR2;ZFPM1
prerank,nucleotide biosynthetic process (GO:0009165),0.31151055079125145,0.793989816688238,0.7373029772329247,0.9401839273068642,1.0,4/18,11.67%,MTHFD1;RRM1;PRPSAP1;RRM2B
prerank,regulation of protein import into nucleus (GO:0042306),0.2644905048699072,0.793025314142711,0.765017667844523,0.9412574259058683,1.0,3/36,5.83%,SMAD3;ZIC1;TPR
prerank,regulation of phosphatase activity (GO:0010921),0.2910654337028368,0.7929903542098719,0.7531531531531531,0.9407783509152008,1.0,7/24,23.63%,BMP2;PPP1R35;PPP6R3;URI1;SH2D4A;CDK5RAP3;PPP1R2
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.3129617963258828,0.792572687966708,0.7542662116040956,0.9409551431761299,1.0,3/16,13.28%,WRN;MCM4;MCM6
prerank,positive regulation of signaling receptor activity (GO:2000273),0.2679028867677919,0.792439727707492,0.7797202797202797,0.9406618454831108,1.0,8/36,15.39%,NRP1;NCOA3;TGFA;CCL2;HFE;ADRA2C;HDAC2;ADRA2A
prerank,protein-containing complex disassembly (GO:0032984),-0.21752781510705443,-0.7923826819906526,0.8774928774928775,0.9737093361798713,1.0,11/54,12.95%,HSPA8;CTNNB1;GABARAP;GABARAPL1;LRP6;VPS33B;DVL1;PPP1CA;RPL23;TECPR1;CAV1
prerank,response to organonitrogen compound (GO:0010243),-0.24023767392185963,-0.7920669146890865,0.8152709359605911,0.9735319638121996,1.0,11/38,21.51%,GLRA3;SEL1L;BRSK2;CCDC47;RRAGC;KAT7;GLRA2;GLRA1;UBXN6;KYNU;TRPM2
prerank,RNA splicing (GO:0008380),0.22557028109759428,0.7919426105582785,0.8406432748538012,0.9409733158722227,1.0,27/95,20.27%,SNRPA1;ZRSR2;LSM1;NOVA1;HNRNPC;SF3B3;DDX23;SLU7;CDK12;RNPC3;SRSF4;DHX16;HNRNPH3;MAGOHB;USB1;DHX8;SRPK1;ZMAT5;FUS;TXNL4A;PPP2CA;WBP4;SCAF11;USP39;PRPF3;SNRNP40;KHSRP
prerank,nucleosome organization (GO:0034728),-0.21894792126838147,-0.7919240720406681,0.8290598290598291,0.9730336439206803,1.0,12/55,16.30%,H3-3A;ZNHIT1;LIN54;NPM1;SART3;SMARCB1;ASF1A;H1-0;ANP32B;SPTY2D1;DMAP1;SET
prerank,monosaccharide transmembrane transport (GO:0015749),-0.3024516527953647,-0.7918193345845062,0.7441860465116279,0.9724772214751474,1.0,8/16,31.96%,SLC2A9;SLC50A1;SLC45A3;SLC2A2;SLC23A1;SLC23A2;SLC2A10;SLC5A3
prerank,modification-dependent macromolecule catabolic process (GO:0043632),-0.3395355158977145,-0.7915135252459148,0.7393075356415478,0.9722431562605525,1.0,3/10,13.69%,DIS3L2;UBB;UBA52
prerank,keratan sulfate catabolic process (GO:0042340),0.34400331662668954,0.7912492960277618,0.7049504950495049,0.9415995582713342,1.0,3/11,17.17%,OMD;PRELP;OGN
prerank,primary alcohol metabolic process (GO:0034308),0.29114500475316846,0.7907761030907576,0.7470489038785835,0.9418339049028747,1.0,5/25,16.06%,RDH10;RBP4;NAAA;PECR;NAPEPLD
prerank,chondroitin sulfate biosynthetic process (GO:0030206),0.29620269275843414,0.7902532600686164,0.7518382352941176,0.9421808780785742,1.0,3/21,5.90%,CHST15;DCN;CHSY1
prerank,negative regulation of MAPK cascade (GO:0043409),0.2252305277689162,0.7900988964805837,0.8322981366459627,0.9419027245308242,1.0,13/87,12.68%,TIMP3;DAG1;FBLN1;DUSP10;TLR4;BMP7;PTPN2;PPEF2;DLG1;IRAK3;SMAD4;SH2B3;PTPN1
prerank,regulation of activin receptor signaling pathway (GO:0032925),0.3219685161218383,0.7900469115967127,0.7131931166347992,0.9414465744334822,1.0,3/15,7.92%,FSTL3;DACT1;SKI
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",-0.28029155836694825,-0.7899992490459318,0.7510729613733905,0.9740232646992126,1.0,7/17,36.74%,SEL1L;SEC61B;HERPUD1;UFD1;HM13;AUP1;DERL1
prerank,protein tetramerization (GO:0051262),0.23359386237284221,0.7899881814690338,0.8064,0.941000381887358,1.0,4/67,6.33%,ALDH1A2;SHMT1;APPL2;GBP5
prerank,mitotic sister chromatid segregation (GO:0000070),-0.19462073267651456,-0.7896950261607544,0.8850931677018633,0.973753932359708,1.0,50/98,37.67%,DIS3L2;MCPH1;KPNB1;NAA50;KIF18A;SMC2;CHMP1A;SET;CHMP1B;PRC1;CHMP7;CHMP2B;NCAPH2;TUBG1;KNSTRN;NCAPH;KIF23;SPAG5;TENT4A;TTN;NUP62;NSL1;KIF22;REC8;CHMP2A;DSN1;KIF14;SPDL1;TUBG2;CEP55;SGO1;RAD21;CSNK2B;NCAPD2;CHMP6;CHMP4C;PLK1;ZW10;DLGAP5;CDK1;SMC1A;MIS12;NCAPD3;KIFC1;VPS4B;NUDC;RAB11A;CDC23;KIF2C;CCNB1
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.2324609848562931,0.7892265890128358,0.8185840707964602,0.9417526433381221,1.0,13/76,15.49%,LPAR1;FPR2;F2RL3;C5AR2;PLCE1;ACTN2;OPRD1;NMUR1;P2RY6;GPR65;P2RY1;ADRA2A;CCKBR
prerank,negative regulation of lipid catabolic process (GO:0050995),-0.29043054289920933,-0.7892126251878916,0.7657657657657657,0.9738300467676083,1.0,4/17,13.08%,PDE3B;SORL1;AKT1;MFSD2A
prerank,phosphatidylinositol dephosphorylation (GO:0046856),0.28614265297929553,0.7881923043180266,0.7638640429338104,0.9429853948433649,1.0,3/23,6.16%,TPTE;MTMR11;MTMR3
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",0.2587208470110612,0.7878059023419509,0.7819420783645656,0.9430717041327256,1.0,9/39,17.31%,CUL4A;RFC1;NTHL1;RPA3;OGG1;GTF2H4;ERCC5;ERCC1;GTF2H2
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),0.3349421079939353,0.7867795098919402,0.7603773584905661,0.9442098013845636,1.0,4/12,15.27%,SGTA;SEC63;CHMP4A;CHMP4B
prerank,peptidyl-lysine acetylation (GO:0018394),0.3552258907151319,0.786628666047273,0.7123287671232876,0.9439354765669531,1.0,3/10,15.47%,CREBBP;ESCO1;KAT2B
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.2835906086909203,0.7862010256222414,0.7513227513227513,0.9441328636791474,1.0,11/26,26.27%,PPM1B;IRAK3;TRIM21;TRIB1;MUL1;PCBP2;SIRT2;NMI;MAPKBP1;CARD16;TYRO3
prerank,L-serine metabolic process (GO:0006563),0.3471598739965551,0.7861916601108754,0.7041984732824428,0.9436139265769408,1.0,2/10,4.11%,SHMT1;PHGDH
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),0.33887946091797777,0.7858119938816731,0.7296222664015904,0.9437117934288365,1.0,3/12,15.67%,HEYL;SMARCA4;DAB2
prerank,snRNA transcription by RNA polymerase II (GO:0042795),0.2348229904466058,0.785584840751881,0.8288854003139717,0.9435792208511018,1.0,23/69,22.93%,POLR2D;RPRD2;INTS9;NABP1;CDK7;POLR2C;INTS14;POLR2F;POU2F1;INTS3;INTS8;SNAPC3;TAF9;INTS13;SNAPC5;RPRD1B;INTS6;NABP2;POLR2K;SNAPC4;SRRT;SP1;ELL
prerank,positive regulation of cellular protein metabolic process (GO:0032270),0.22043217233704238,0.7851060859677196,0.8586156111929307,0.94384095056917,1.0,29/101,23.55%,PLD1;SAMD4A;VIM;DACT1;IL6;NR1H3;ZCCHC4;CSF1;VGLL4;BTRC;FBXW11;HDAC2;SOX4;CPEB3;CYFIP2;UPF3A;ATG10;FXR2;PLXNB2;ASPH;ERBB2;ELAVL1;IST1;AGT;VPS35;ATG7;METTL5;YTHDF3;TGFB1
prerank,natural killer cell activation (GO:0030101),0.2925957567934493,0.7844446390980309,0.7460035523978685,0.9443898309053018,1.0,4/23,12.03%,AXL;ELF4;PBX1;SNX27
prerank,protein localization to chromatin (GO:0071168),-0.2834237327683846,-0.7844306716772705,0.7551487414187643,0.981050242131777,1.0,8/18,32.69%,ESR1;MCM9;CHMP7;SGF29;RAD21;PLK1;PIH1D1;RUVBL2
prerank,dendritic cell differentiation (GO:0097028),0.295288482296063,0.7843869417760918,0.7445255474452555,0.9439665070426149,1.0,3/22,7.85%,AXL;TGFBR2;LGALS9
prerank,protein heterotetramerization (GO:0051290),-0.31124185482726663,-0.784219828863562,0.7322175732217573,0.9806574705205527,1.0,4/13,20.59%,GRIN2B;GRIN1;FARSB;HSD17B8
prerank,proton transmembrane transport (GO:1902600),0.2621133388983484,0.7841796946274013,0.7675585284280937,0.9437497723049053,1.0,4/36,9.79%,ATP1A2;SLC4A11;NNT;OTOP1
prerank,global genome nucleotide-excision repair (GO:0070911),0.2856719034392531,0.7840583164335834,0.776386404293381,0.9434148634108714,1.0,7/26,19.03%,CUL4A;RNF111;GTF2H4;ERCC1;USP45;GTF2H2;XPC
prerank,regulation of endocytosis (GO:0030100),-0.21208080313446936,-0.7837150101109109,0.8714285714285714,0.980712593784417,1.0,15/61,20.22%,HIP1;RIT2;MCTP1;SNCA;SCAMP5;HIP1R;NEDD4L;RAB5C;CCL19;PRKD1;CBLL1;LRSAM1;MTMR2;SNX17;DLL1
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.2404920802462638,0.7835652689674982,0.802773497688752,0.9437034707666195,1.0,7/55,10.27%,PID1;ARF4;PDGFRB;MPV17;TGFBR2;NOXO1;MAPK14
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),-0.323358763551037,-0.7834984186481966,0.7384937238493724,0.9803074078343109,1.0,7/11,35.25%,ATF6;ATF4;HSPA5;CREB3L1;MBTPS2;TP53;DDIT3
prerank,peptidyl-serine dephosphorylation (GO:0070262),0.3217673027842516,0.7829663680497574,0.72552783109405,0.9441463486454678,1.0,4/14,18.46%,PPP2R2B;NCK1;PPP2CA;PPP2R2A
prerank,histone lysine demethylation (GO:0070076),-0.26384008831903216,-0.7828526267093219,0.7875536480686696,0.9806214913777217,1.0,8/25,17.19%,JMJD1C;RIOX2;KDM4D;KDM4C;KDM4A;KDM5C;PHF2;HR
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.24909035968403545,0.7826890731211127,0.810064935064935,0.9440553682316513,1.0,7/48,10.41%,DOCK5;NRP1;S100A10;MYADM;CUX1;TRIOBP;CUX2
prerank,error-prone translesion synthesis (GO:0042276),0.29871098831631554,0.7822062891760133,0.7546816479400749,0.9442870729462778,1.0,4/21,9.92%,POLH;RFC1;REV1;RPA3
prerank,regulation of spindle organization (GO:0090224),0.315703314295981,0.7820968546404595,0.7266313932980599,0.9439171044917387,1.0,5/18,16.56%,MAP9;PARP3;SENP6;FSD1;PSRC1
prerank,endoplasmic reticulum organization (GO:0007029),-0.2104370271968555,-0.7819993733272608,0.8583569405099151,0.9812489870365557,1.0,31/72,31.46%,REEP1;DOP1B;LMAN2L;REEP5;SHTN1;SERP1;CAV2;TRAM1;LMAN1;VCPIP1;CCDC47;TOR1B;WDR83OS;SEC61A1;ATL2;SEC61G;RTN3;CYB5A;TOR1AIP2;RAB18;HMOX1;TRAM1L1;GET1;SEC61B;STX18;REEP4;VAMP2;SPTSSB;BNIP1;TRDN;LPCAT3
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),-0.19154635466102743,-0.7817805809165681,0.9273927392739274,0.9808661037108466,1.0,20/104,17.66%,ACTB;CALM1;SNCA;CALM2;DAB2IP;SLC8A1;CALM3;AKT1;CCND1;LRP6;ADRB2;CNPPD1;LRP5;SERTAD1;CSF1R;CDKN1A;IRGM;CCNF;PYCARD;CCNG1
prerank,positive regulation of telomere maintenance (GO:0032206),-0.24453678314995564,-0.7816465100158969,0.7799043062200957,0.9803445874061497,1.0,9/31,19.98%,PRKCQ;NEK7;MRE11;MAPK3;ATM;PNKP;PKIB;GNL3;PPP1R10
prerank,negative regulation of epithelial cell differentiation (GO:0030857),0.3203253029434313,0.780635004302709,0.7316176470588235,0.9457646629029908,1.0,2/14,8.67%,OSR1;ZEB1
prerank,negative regulation of ion transport (GO:0043271),-0.25741059063225546,-0.7805576982554895,0.8008849557522124,0.9813578815406697,1.0,5/24,10.30%,PTK2B;GPM6B;SNCA;INPP5K;NOS1
prerank,"base-excision repair, gap-filling (GO:0006287)",0.2664126736992289,0.7805322370617516,0.8067375886524822,0.9454101892192404,1.0,7/35,12.43%,RFC1;POLG;NTHL1;RPA3;XRCC1;ADPRS;OGG1
prerank,regulation of protein transport (GO:0051223),-0.25825497838449385,-0.7804978677510445,0.8133971291866029,0.980708650799379,1.0,7/27,19.62%,HSPA8;SNX3;STXBP5L;RHBDF2;LCP1;PPM1F;DISP1
prerank,acyl-CoA biosynthetic process (GO:0071616),-0.28225176169156874,-0.7794463733637365,0.782051282051282,0.9816774755301642,1.0,6/16,22.51%,ACACA;ACLY;SCD;HSD17B8;FASN;GCDH
prerank,establishment of mitotic spindle localization (GO:0040001),0.2756606185169699,0.778544281089092,0.7735507246376812,0.9480027218402444,1.0,5/28,12.79%,GJA1;CLASP1;ESPL1;MISP;FBXW11
prerank,regulation of calcium-mediated signaling (GO:0050848),0.27611743060614446,0.778495808110312,0.756896551724138,0.9475416246493285,1.0,4/25,11.03%,ITPR1;LRRK2;PLEK;CDH13
prerank,endosome organization (GO:0007032),-0.22776470306082675,-0.7782368571111576,0.8365853658536585,0.982878235169883,1.0,16/41,28.24%,RAB27A;CLCN3;SNX3;ALS2CL;VPS33B;PI4K2A;ALS2;CHMP2B;DNAJC13;SNX33;VPS18;LAPTM4B;PHETA2;PI4K2B;SNX10;SQSTM1
prerank,autophagy of mitochondrion (GO:0000422),0.2570810882616872,0.7774411865885356,0.8143322475570033,0.9487558876633204,1.0,8/38,17.87%,AMBRA1;SPATA18;PHB2;ATG12;WDR45B;ATG2A;FUNDC1;WIPI2
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.29664159659934464,0.7774105388846259,0.7814814814814814,0.9482702530775845,1.0,4/22,10.29%,PSMB10;PSMA3;PSME4;PSMA5
prerank,positive regulation of ERAD pathway (GO:1904294),-0.3124337431204723,-0.7773818425423247,0.7782515991471215,0.9835735840861646,1.0,6/13,28.13%,BAG6;USP13;CAV1;ATXN3;TMEM259;HERPUD1
prerank,regulation of T cell proliferation (GO:0042129),0.23495524174761312,0.7765832227979216,0.8328267477203647,0.9490855662797446,1.0,6/61,7.89%,IL6ST;ANXA1;IL6;FOXP3;VCAM1;CD274
prerank,positive regulation of macroautophagy (GO:0016239),0.24499274102776503,0.7755204912145331,0.7955271565495208,0.9502526318947503,1.0,10/48,14.55%,PRKAA2;DCN;OPTN;WAC;UVRAG;SESN1;MAP3K7;PIP4K2B;SLC25A4;TBK1
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),0.316007873255536,0.7749986189724881,0.7631067961165049,0.9505320245562124,1.0,4/15,12.58%,APOA2;FOXP3;IRAK3;HFE
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),-0.32516319225743556,-0.7748758647795931,0.7767653758542141,0.9868274311251329,1.0,2/11,10.15%,PRKCQ;MALT1
prerank,positive regulation of organelle assembly (GO:1902117),-0.22458367821303912,-0.7747962306739806,0.8238341968911918,0.9862306928492734,1.0,15/44,27.62%,RAB3GAP1;CCDC88A;SDCBP;DYNC1H1;PLK4;CNOT2;LCP1;LRSAM1;SPAG5;NUP62;HTT;SDC4;PIP4K2A;SH3GLB1;STX18
prerank,regulation of fatty acid beta-oxidation (GO:0031998),-0.29381123749286325,-0.7747464225547751,0.780040733197556,0.9855884626762744,1.0,9/14,41.00%,AKT1;MFSD2A;ABCD2;IRS1;LONP2;MTLN;TYSND1;PLIN5;ABCD1
prerank,DNA replication-independent nucleosome assembly (GO:0006336),-0.23153599907338918,-0.7743885348653934,0.8376288659793815,0.9853820954388636,1.0,15/38,29.84%,H3-3A;NPM1;ASF1A;CENPU;CENPT;CENPQ;CENPL;CENPN;MIS18BP1;IPO4;CENPA;RBBP7;ITGB3BP;ASF1B;OIP5
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),0.3475442726768948,0.7742031270718762,0.7379032258064516,0.9513075616518964,1.0,1/10,1.61%,PRKAA2
prerank,negative regulation of chemokine production (GO:0032682),0.31472539057846216,0.7741432323065783,0.7519083969465649,0.9508758972689338,1.0,4/14,15.52%,IL6;LGALS9;MAP2K5;MUL1
prerank,regulation of myelination (GO:0031641),0.288906223882597,0.7740215715861822,0.7915254237288135,0.9505478243070373,1.0,1/25,0.48%,PTN
prerank,positive regulation of small molecule metabolic process (GO:0062013),-0.2963495514852004,-0.7739385127886214,0.767337807606264,0.9853466260276523,1.0,6/15,23.13%,PPARD;AKT1;LDLRAP1;SLC45A3;PRKCE;IRS1
prerank,mitotic metaphase plate congression (GO:0007080),-0.21561731189878752,-0.7737471432434878,0.8763440860215054,0.9848931510723787,1.0,32/51,42.93%,KPNB1;KIF18A;CHMP1A;CHMP1B;CHMP7;CHMP2B;MAD1L1;NUP62;KIF22;CHMP2A;KIF14;SPDL1;CEP55;CHMP6;CHMP4C;ZW10;NUF2;MIS12;KIFC1;VPS4B;NUDC;RAB11A;CDC23;KIF2C;CCNB1;DCTN2;RRS1;BOD1;PINX1;CENPE;CHAMP1;CDT1
prerank,B cell proliferation (GO:0042100),0.31033309766195694,0.7736113875196641,0.7518518518518519,0.9506764854281161,1.0,2/17,4.90%,CTPS1;BCL2
prerank,positive regulation of cholesterol efflux (GO:0010875),-0.2697989056324394,-0.7732085126085914,0.7825112107623319,0.9850307468063567,1.0,7/21,27.48%,ABCA3;EEPD1;CAV1;RXRA;TREM2;GPS2;NR1H2
prerank,visual system development (GO:0150063),-0.23590654078225637,-0.7728367983729394,0.8354430379746836,0.9848646877851792,1.0,13/37,25.78%,MEIS2;TGFB2;PBX3;FREM2;ATF6;BMPR1B;SIPA1L3;SMOC1;SOX2;C3;RAB18;MAB21L2;HIPK2
prerank,positive regulation of macrophage chemotaxis (GO:0010759),-0.29513653688757535,-0.7726961815518681,0.7697095435684648,0.9843417789528166,1.0,4/14,13.22%,THBS1;MAPK3;CMKLR1;CSF1R
prerank,Golgi organization (GO:0007030),-0.18846846692863492,-0.77261094707121,0.939873417721519,0.983738129575838,1.0,22/112,16.59%,SYNE1;CSNK1D;LMAN2L;ATP8B2;STX16;ARL1;NSFL1C;GCC2;ATP8B1;TMED2;VMP1;PI4K2A;LMAN1;ARHGEF7;CLASP2;VCPIP1;VPS51;PRKD1;VTI1A;MYO18A;VRK1;TMED7
prerank,protein lipidation (GO:0006497),-0.21631474691134042,-0.7717297655556576,0.8873994638069705,0.984361842390549,1.0,19/59,26.19%,MPPE1;ZDHHC14;ZDHHC20;PIGM;PIGU;ZDHHC2;PIGQ;PIGH;DPM2;PIGO;ZDHHC7;PIK3C3;ZDHHC23;PIGB;ZDHHC9;WDR45;UGCG;ZDHHC5;SELENOK
prerank,neuromuscular process (GO:0050905),-0.2892807807002057,-0.771029177239833,0.7773109243697479,0.9846889912912633,1.0,6/16,22.59%,NRXN1;GCH1;SHANK1;KCNA1;DCTN1;CLN3
prerank,snRNA transcription (GO:0009301),0.2292417113958515,0.7701276514053275,0.8611544461778471,0.9556396810826955,1.0,23/70,22.93%,POLR2D;RPRD2;INTS9;NABP1;CDK7;POLR2C;INTS14;POLR2F;POU2F1;INTS3;INTS8;SNAPC3;TAF9;INTS13;SNAPC5;RPRD1B;INTS6;NABP2;POLR2K;SNAPC4;SRRT;SP1;ELL
prerank,negative regulation of bone remodeling (GO:0046851),0.33683418182441127,0.769897858853045,0.755859375,0.955469073884884,1.0,2/11,6.28%,IL6;CARTPT
prerank,positive regulation of hormone secretion (GO:0046887),-0.28341042258117166,-0.769527931645337,0.7927107061503417,0.9862625551069375,1.0,8/17,31.33%,C1QTNF3;SPP1;GRP;EDN1;SOX11;RASL10B;NMB;VAMP8
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",0.3149660543631741,0.7689778862063904,0.7350096711798839,0.9562800808908524,1.0,4/14,16.92%,RPL7L1;ZNHIT3;WDR12;DDX18
prerank,negative regulation of lymphocyte activation (GO:0051250),0.28820385747979405,0.7685210731321197,0.7588028169014085,0.9564563943129338,1.0,2/21,5.16%,TNFAIP8L2;PTPN22
prerank,monocyte chemotaxis (GO:0002548),0.2665000020598781,0.7684993737795366,0.7983333333333333,0.9559539472607396,1.0,4/32,7.71%,ANXA1;IL6;MSMP;CCL2
prerank,acute inflammatory response (GO:0002526),0.2877663938705111,0.7683120551127472,0.7810858143607706,0.9557199653850612,1.0,4/23,13.70%,IL6;CRP;ANO6;IL22
prerank,regulation of neural precursor cell proliferation (GO:2000177),0.2840554902700493,0.7680632086513828,0.7592920353982301,0.9555959534799545,1.0,7/22,18.40%,SLC16A2;APPL2;LRRK2;NES;DISP3;KDM2B;KDM1A
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),-0.2073352430640708,-0.7678442451527179,0.8975155279503105,0.9880392779637264,1.0,25/62,34.09%,TPT1;ARHGEF2;AKT1;PINK1;CXCL12;CCAR2;PTTG1IP;PLAUR;PPIA;PARK7;ENO1;NOC2L;CREB3L1;NDUFA13;EPO;DNAJA1;HERPUD1;CLU;VNN1;HSPB1;TMEM161A;SRC;MDM2;YBX3;CDKN2D
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),0.34061823504067523,0.7676631468678722,0.7524950099800399,0.9551514123443743,1.0,4/10,20.47%,MYADM;MAP2K5;WNK1;MAPK7
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),0.34061823504067523,0.7676631468678722,0.7524950099800399,0.9551514123443743,1.0,4/10,20.47%,MYADM;MAP2K5;WNK1;MAPK7
prerank,nucleotide catabolic process (GO:0009166),0.3098010968357931,0.7674001033958794,0.759927797833935,0.9550382255404902,1.0,5/16,20.56%,NT5C;DERA;ITPA;NT5C1A;XDH
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),0.2964715895051525,0.7668717409288786,0.7771639042357275,0.955367903068486,1.0,7/19,21.39%,DCP2;HNRNPC;XRN1;EXOSC10;TEN1;CTC1;TENT4B
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),0.2947157772108232,0.7668364904668726,0.7676579925650557,0.9548783052184321,1.0,3/17,11.55%,EMC2;SGTA;EMC9
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.2400466322031829,0.7667840731871836,0.8456591639871383,0.9544293076932935,1.0,7/52,14.94%,LEPROT;BCL2;NPEPPS;HUWE1;RHOU;USP36;CSNK2A2
prerank,smooth muscle tissue development (GO:0048745),-0.3291301034794161,-0.765894033775516,0.7724550898203593,0.9901711799653812,1.0,2/10,8.07%,BMP4;MYLK
prerank,glial cell development (GO:0021782),-0.25564599227216345,-0.7655597430145579,0.8028846153846154,0.9899693797692443,1.0,11/25,35.13%,CDK6;EIF2B2;TPPP;DLL1;CSPG5;SOX11;PICK1;PRDM8;MT3;S100A9;NRROS
prerank,glycogen biosynthetic process (GO:0005978),-0.30523314520195327,-0.7655324814489888,0.7872340425531915,0.9885552540112118,1.0,3/12,17.08%,PGM2L1;PPP1R3C;PER2
prerank,glucan biosynthetic process (GO:0009250),-0.30523314520195327,-0.7655324814489888,0.7872340425531915,0.9885552540112118,1.0,3/12,17.08%,PGM2L1;PPP1R3C;PER2
prerank,negative regulation of transport (GO:0051051),-0.2180503392297373,-0.7655235688906856,0.8951406649616368,0.9878447910706198,1.0,12/51,19.10%,MCTP1;SNCA;SCAMP5;SNX3;DYSF;RACK1;PRKD1;EGF;LRSAM1;PPM1F;YRDC;MTMR2
prerank,positive regulation of ion transport (GO:0043270),0.24260234360225866,0.7652136151337672,0.8196457326892109,0.9562703433976022,1.0,18/48,24.47%,ACTN2;SCN3B;KIF5B;DLG1;GPD1L;STIM2;ANO6;ATP2B1;ADRA2A;P2RX4;GDNF;ANK2;VAMP7;WNK3;SCN4B;CNKSR3;SCN5A;FHL1
prerank,regulation of TOR signaling (GO:0032006),0.2298603642287974,0.7650366034897885,0.8528481012658228,0.9560422203497059,1.0,12/67,17.02%,DEPTOR;PRKAA2;ARAF;FBXO9;FNIP1;TTI1;SLC38A9;NPRL3;TBC1D7;MAPKAPK5;LARS1;RICTOR
prerank,carboxylic acid metabolic process (GO:0019752),0.2578542346467787,0.7645997778963186,0.8196994991652755,0.9561893917144123,1.0,12/33,22.47%,PLA2G4A;DDO;LIPT1;SIRT4;PON3;HAO1;GRHPR;ST3GAL1;CARNMT1;AGXT;ST6GAL1;CYB5R3
prerank,autophagosome organization (GO:1905037),-0.21760730948123325,-0.7644184962289399,0.8621621621621621,0.9886842373713465,1.0,19/50,30.65%,GABARAP;NSFL1C;GABARAPL1;ATG16L1;VMP1;ATG9A;TP53INP2;ULK1;ATP2A2;IRGM;RAB1B;PIK3C3;WDR45;ULK3;UBXN2B;MAP1LC3B;STX12;RAB1A;WIPI1
prerank,protein K63-linked deubiquitination (GO:0070536),-0.24107866948337325,-0.7642487049717741,0.8275862068965517,0.988216533897147,1.0,11/31,22.81%,OTUD7A;PSMD14;BABAM1;USP13;ZRANB1;OTUD1;CYLD;YOD1;ATXN3;OTUB2;SHMT2
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),-0.27756940553183,-0.7632279114988036,0.7915742793791575,0.988998826805831,1.0,4/17,13.86%,AKT1;CCND1;EGFR;RGCC
prerank,regulation of autophagosome maturation (GO:1901096),-0.30182477056792806,-0.7631619296780805,0.8070953436807096,0.988368581314352,1.0,5/13,22.59%,SMCR8;ADRB2;IRGM;UBQLN4;CLN3
prerank,hyaluronan metabolic process (GO:0030212),-0.2615451656525949,-0.76242040158527,0.8336980306345733,0.9887774259018375,1.0,10/23,28.57%,HEXB;CEMIP;FGF2;GUSB;ABCC5;HAS1;HMMR;HAS3;HYAL3;STAB2
prerank,histone deubiquitination (GO:0016578),0.3012646550741297,0.7622450799940327,0.7705223880597015,0.9592740378068098,1.0,6/18,19.95%,ATXN7;USP36;UIMC1;USP15;BRCC3;USP7
prerank,histone H3-K9 demethylation (GO:0033169),0.3329142632540013,0.7619788079086005,0.748,0.959175803668046,1.0,2/11,5.61%,KDM7A;KDM3B
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),-0.24593124640780345,-0.7616209548518424,0.8305882352941176,0.9892632465557607,1.0,10/29,21.34%,MRE11;HSP90AB1;TERF1;HSP90AA1;PPIA;CDK2;ANKRD28;TINF2;WRAP53;PPP6C
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.22470881284627614,0.7609463780404585,0.8482003129890454,0.9602613597710947,1.0,12/72,15.40%,ENPP1;RAD50;CUL4A;RFC1;FBH1;RPA3;SPO11;OGG1;GTF2H4;ERCC5;DNASE1L1;ERCC1
prerank,glycoprotein metabolic process (GO:0009100),0.2380906506583469,0.7608625457938064,0.8305084745762712,0.959860730591691,1.0,4/53,4.37%,MAN1C1;PRKCSH;MAN2A1;LARGE1
prerank,epithelial cell morphogenesis (GO:0003382),-0.2816170035939005,-0.7601906298170965,0.8058035714285714,0.990588912826254,1.0,9/17,39.92%,MET;RILPL2;SIPA1L3;STC1;COL15A1;PKHD1;POF1B;GRHL2;RAB25
prerank,neutrophil chemotaxis (GO:0030593),0.2369506590604934,0.7599583029962798,0.8330781010719756,0.960695191659247,1.0,4/53,7.71%,CXADR;CXCL10;CKLF;CCL2
prerank,autophagy of peroxisome (GO:0030242),-0.30393507002288234,-0.7596642399763514,0.7867494824016563,0.9906284182822741,1.0,4/12,28.24%,ATM;PIK3C3;MAP1LC3B;SQSTM1
prerank,positive regulation of glucose metabolic process (GO:0010907),-0.29406733697811965,-0.7595286466730407,0.8021276595744681,0.9901100855312006,1.0,5/14,28.36%,AKT1;NNMT;SLC45A3;IRS1;PMAIP1
prerank,regulation of alcohol biosynthetic process (GO:1902930),-0.31328934849812584,-0.7594769578980981,0.7733050847457628,0.9894552547334294,1.0,6/12,33.59%,MBTPS1;KPNB1;MBTPS2;DGKQ;LPCAT3;ABCA2
prerank,negative regulation of TORC1 signaling (GO:1904262),0.31641664739120634,0.7592821733893337,0.75,0.9612244136325085,1.0,1/13,0.97%,RNF152
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.2696607843310292,0.7590902342717905,0.7932862190812721,0.9609644170209286,1.0,1/26,0.45%,ATP1A2
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.2063557817648592,0.7585601385790434,0.9248554913294798,0.9612228203807133,1.0,24/122,18.20%,PLD1;SAMD4A;VIM;SLC6A9;SORBS1;IL6;TLR4;GLI1;EPM2AIP1;PDGFRB;CCL2;IGF2;SLC25A37;TLR2;ZCCHC4;SMOC2;SOX4;PRKD2;CPEB3;NOX1;UPF3A;FXR2;HSPH1;PLXNB2
prerank,T cell differentiation in thymus (GO:0033077),0.3109732161394439,0.7581756085893651,0.7561904761904762,0.9612642363263674,1.0,1/14,2.82%,GLI3
prerank,sulfur compound catabolic process (GO:0044273),-0.22800270644907744,-0.7581574100324472,0.8461538461538461,0.9906427726163801,1.0,13/38,26.33%,CSPG4;HEXB;GGT5;TXN2;GGT7;CTH;ADO;LUM;GGT1;MPST;IDS;CSPG5;BGN
prerank,glucose 6-phosphate metabolic process (GO:0051156),-0.26719832124968396,-0.7577060563952817,0.822429906542056,0.990550366917026,1.0,5/21,13.56%,RPIA;PGM2L1;TKT;GPI;TALDO1
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.1875240723904128,0.7575676903846926,0.9695121951219512,0.9616108648860764,1.0,56/314,17.83%,SPSB1;TBL1XR1;SMURF2;FBXL17;NEDD4;NHLRC3;KLHL22;UBE2U;SPSB4;RNF216;SIAH2;CUL4A;FBXO9;ANAPC11;KLHL15;FBXL3;PSMB10;SGTA;ANAPC1;AMFR;UBE2C;PSMA3;FBXL20;PSME4;FBXL7;FBXO4;PSMA5;WWP2;FBXO38;UBXN2A;HUWE1;SPOPL;UBXN4;CUL3;IFI27;BTRC;HECW2;FBXW11;ARRB1;CDC27;BFAR;RNF103-CHMP3;FBXL4;KCTD5;PML;FBXL13;FAF2;FBXL12;RNF185;ECPAS;TBL1X;AMN1;DNAJB2;UBE4B;PPP2R5C;TRIM3
prerank,tRNA wobble uridine modification (GO:0002098),-0.2981128224544505,-0.7569706151787766,0.7930283224400871,0.9908840991451137,1.0,7/14,32.67%,ELP1;TRMT9B;DPH3;KTI12;CTU2;ELP3;ALKBH8
prerank,regulation of leukocyte migration (GO:0002685),0.3083088515201802,0.7563592802936593,0.7495395948434622,0.9628568049738861,1.0,2/16,4.73%,ANXA1;MIA3
prerank,protein transmembrane import into intracellular organelle (GO:0044743),-0.23691068636603924,-0.7561619968620142,0.8410596026490066,0.9913118579495992,1.0,7/31,18.10%,PEX26;PEX10;PEX16;DNLZ;GRPEL2;TOMM40L;TOMM20
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),0.3141272928899014,0.7559367587247229,0.7627118644067796,0.9629654307321902,1.0,4/14,13.63%,BAX;PTPN1;TMEM33;BFAR
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),-0.3077193937506316,-0.7559166312313307,0.8067415730337079,0.9909335640989965,1.0,1/12,4.35%,PRKCQ
prerank,inner ear morphogenesis (GO:0042472),0.2837302925281709,0.7556579738851281,0.8044692737430168,0.9628539558472015,1.0,3/22,7.71%,ZIC1;TTC39C;TIFAB
prerank,positive regulation of mitochondrial translation (GO:0070131),-0.2922389542268713,-0.7553605466281434,0.776824034334764,0.9910050530799139,1.0,7/14,33.08%,FASTKD2;C1QBP;RCC1L;TRMT10C;RPUSD3;MPV17L2;COA3
prerank,regulation of tube diameter (GO:0035296),0.31854603800111514,0.7553488673775359,0.7606679035250464,0.9622583530764381,1.0,1/13,0.67%,ROCK2
prerank,vascular process in circulatory system (GO:0003018),0.31854603800111514,0.7553488673775359,0.7606679035250464,0.9622583530764381,1.0,1/13,0.67%,ROCK2
prerank,melanosome organization (GO:0032438),0.27002205868413276,0.7550821905294256,0.8116197183098591,0.9621453078262364,1.0,3/26,9.35%,SHROOM2;DTNBP1;HPS1
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.21597755020344475,0.7550149978216177,0.8930163447251115,0.9617111703413972,1.0,12/87,10.29%,KANK2;DACT1;CDC73;CCL2;CDKN2B;PSMB10;PSMA3;DLG1;PSME4;USP47;FBXL7;PSMA5
prerank,positive regulation of lipid transport (GO:0032370),-0.3102811780954204,-0.7545355278575693,0.8004158004158004,0.9914778104377914,1.0,3/12,9.61%,ABCA3;PRELID1;SPP1
prerank,sensory perception of chemical stimulus (GO:0007606),0.30120690053359356,0.7543560737494001,0.7829313543599258,0.962143247524979,1.0,1/15,2.32%,BEST2
prerank,"DNA-templated transcription, termination (GO:0006353)",0.22323594972916594,0.7536980589892497,0.8786549707602339,0.962532603588107,1.0,26/68,27.68%,PCF11;POLR1C;CCNH;MNAT1;POLR1G;CDK7;MTERF2;POLR2F;GTF2H4;PABPN1;CSTF3;GTF2H2;CAVIN1;SLBP;TTF1;WDR33;POLR2K;UBTF;CLP1;PAPOLA;MAZ;POLR2H;POLR1A;ERCC2;ERCC3;TAF1D
prerank,regulation of tumor necrosis factor production (GO:0032680),-0.1839959729882273,-0.7534717567798364,0.9667673716012085,0.9921964078003749,1.0,8/112,5.88%,PTPRJ;PLCG2;IL33;THBS1;CD34;GAS6;HMGB1;ARHGEF2
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.307433351967222,0.7533082585030949,0.7744360902255639,0.9625778620047791,1.0,6/15,23.42%,NYNRIN;SLFN14;ZC3H12B;RNASEH1;ZC3H12A;KHNYN
prerank,regulation of membrane depolarization (GO:0003254),0.29407208066313845,0.753303238804326,0.7771836007130125,0.962057366514774,1.0,4/18,9.73%,PTPN3;SCN3B;LRRK2;GPD1L
prerank,protein kinase A signaling (GO:0010737),0.3221359533093977,0.7531370819762925,0.7560521415270018,0.9617648802670032,1.0,1/12,2.84%,TCP11X2
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.21722282574825033,0.7531049681218585,0.8820960698689956,0.9612838189196858,1.0,17/88,15.27%,FBXL17;CUL4A;FBXO9;FBXL3;PSMB10;PSMA3;FBXL20;PSME4;FBXL7;FBXO4;PSMA5;FBXO38;BTRC;FBXW11;FBXL4;FBXL13;FBXL12
prerank,mitochondrion transport along microtubule (GO:0047497),-0.30055753571635424,-0.7528887059242863,0.7876857749469215,0.9922675749531529,1.0,3/13,15.43%,SYBU;UBB;MAPT
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),-0.22659257654729315,-0.7524803024373188,0.890625,0.9921496823618033,1.0,12/40,28.39%,AKT1;MFF;PRELID1;PINK1;GHITM;PLAUR;BMF;PYCARD;BAD;HRK;PMAIP1;CLU
prerank,regulation of monocyte differentiation (GO:0045655),0.30958341355181573,0.7524261107895732,0.7931034482758621,0.961734444179338,1.0,3/14,12.04%,IL34;ACIN1;CSF1
prerank,morphogenesis of an epithelial sheet (GO:0002011),-0.3195206026280994,-0.7522728326354007,0.782258064516129,0.9917295499706561,1.0,5/10,20.65%,NOTCH1;PHACTR4;LRP6;DLL4;BMP5
prerank,regulation of transcription by RNA polymerase III (GO:0006359),-0.27318951693383875,-0.7521332664537907,0.8263888888888888,0.9912108007209578,1.0,6/19,21.56%,MAF1;ZNF76;POLR3C;NAB2;POLR3G;ZC3H8
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.22170715662433016,0.752093185424649,0.8838896952104499,0.9616819397668108,1.0,10/76,13.07%,MTURN;TCEAL7;BMP7;FOXP3;ANXA4;PARP10;IRAK3;MAP2K5;TRIM21;ARRB1
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),-0.322440935814754,-0.7520852389440152,0.8105906313645621,0.9905560905717488,1.0,2/10,5.14%,SEMA6A;DAB2IP
prerank,regulation of interleukin-1 beta production (GO:0032651),0.2255011441857388,0.7515599428131376,0.8580542264752791,0.9619123711618661,1.0,7/66,10.22%,IL6;TLR4;GBP5;LGALS9;RIPK2;WNT5A;PANX1
prerank,negative regulation of establishment of protein localization (GO:1904950),-0.3250356007077438,-0.7505694169474806,0.7834394904458599,0.9918839931857337,1.0,4/10,18.00%,SNX3;TERF1;MAPT;PPM1F
prerank,alpha-linolenic acid metabolic process (GO:0036109),0.3244865826573282,0.7505538565383327,0.7504798464491362,0.9627825398700068,1.0,4/12,19.26%,ACSL1;SCP2;ELOVL1;ACOX1
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.24941416802750377,0.7502595250237943,0.8245614035087719,0.9626827204703509,1.0,5/38,10.73%,SP100;CFLAR;SERPINE1;GSK3B;BCL2L1
prerank,macrophage activation (GO:0042116),-0.23242391523073075,-0.7501356848846689,0.8463302752293578,0.9917645554410385,1.0,4/34,5.89%,PLCG2;CD93;SNCA;DYSF
prerank,regulation of lamellipodium assembly (GO:0010591),-0.23136659206021679,-0.7495766174975671,0.882903981264637,0.9918034442264988,1.0,5/34,9.64%,SLIT2;PIK3R1;NCKAP1;ARPC2;ABI3
prerank,cellular component maintenance (GO:0043954),-0.3045696328005212,-0.7495337602078573,0.7931726907630522,0.9911337221987974,1.0,5/12,28.96%,INSR;ITGA3;MTMR2;TREM2;PICK1
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),-0.31889789215766323,-0.748793433524063,0.8072289156626506,0.991417756968964,1.0,6/10,36.30%,E2F7;WIZ;E2F8;DBF4;CDC7;SSBP1
prerank,protein maturation (GO:0051604),-0.18503838490331828,-0.7486629252234251,0.9589905362776026,0.9908741837618062,1.0,23/95,22.59%,F3;CPE;PCSK2;SORL1;TSPAN14;MMP16;ECE1;CTSS;CPD;NAA50;PCSK7;TASP1;PHEX;NNAT;MMS19;NAA10;PSENEN;ADAMTS3;CPXM1;TSPAN33;PCSK5;CPZ;CLN3
prerank,glycine transport (GO:0015816),-0.3210173685709857,-0.7483752173983592,0.7866108786610879,0.9905653248684873,1.0,3/10,12.37%,SLC38A5;SLC36A1;SLC6A5
prerank,regulation of neurogenesis (GO:0050767),0.23279086746574015,0.7482363539355408,0.862012987012987,0.9650449706548815,1.0,8/55,13.10%,WNT3A;NUMB;IL6;APPL2;YAP1;DOCK7;HEYL;BHLHE41
prerank,cytosolic transport (GO:0016482),-0.18363319117650723,-0.7478501770402006,0.9674267100977199,0.9905354825861785,1.0,31/108,26.43%,MYO1D;EMP2;DOP1B;RAB6B;STX16;WDR81;ARL1;GCC2;CORO7;KLHL20;RGP1;WASHC1;KIF16B;EVI5;RNF126;VPS51;SORT1;VTI1A;LAMP1;UBE2O;TBC1D5;PIK3C3;DCTN1;SNF8;CLN3;VPS13C;YKT6;TBC1D10B;PHETA2;AP2A1;SNX32
prerank,"phototransduction, visible light (GO:0007603)",0.3099310069480659,0.7478266480061482,0.8066914498141264,0.9651008384276103,1.0,1/14,1.89%,ABCA4
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),-0.25755576298816457,-0.7476929496927652,0.8381642512077294,0.9900213343169283,1.0,3/22,7.57%,PTPRJ;DGKZ;CEACAM1
prerank,regulation of centriole replication (GO:0046599),-0.2755813470779583,-0.7474360387185764,0.8385744234800838,0.989651113354859,1.0,8/17,26.43%,NPM1;PLK4;BRCA1;TRIM37;KAT2A;CDK5RAP2;NUP62;STIL
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.29103504465602714,0.7473982696960201,0.805019305019305,0.9651975535731869,1.0,2/20,9.14%,AMPD3;PAICS
prerank,regulation of TORC1 signaling (GO:1903432),-0.23262866301710944,-0.747130173457312,0.8475336322869955,0.9893797952876289,1.0,9/33,18.16%,GPR137C;SESN3;STK11;SMCR8;RRAGB;ATM;SPAAR;RRAGC;PIP4P1
prerank,chaperone-mediated protein complex assembly (GO:0051131),-0.2580634082371345,-0.747009142156548,0.8452655889145496,0.9888028001106197,1.0,8/20,30.53%,HSP90AB1;HSPA4;HSP90AA1;TMEM35A;HOPX;BBS10;CLU;PSMG2
prerank,negative regulation of histone methylation (GO:0031061),0.3283365203277595,0.7469013243198539,0.7818532818532818,0.9653594747399579,1.0,5/10,24.09%,BCOR;JARID2;KDM1A;PHF1;WDR5
prerank,positive regulation of intracellular protein transport (GO:0090316),0.20153616867694757,0.7468207142774979,0.9308885754583921,0.964948596755842,1.0,34/144,22.77%,TCF7L2;LEPROT;SMAD3;ZIC1;BCL2;TPR;NPEPPS;GSK3B;HUWE1;RHOU;USP36;MYO1C;CSNK2A2;MIEF1;TM9SF4;SAR1A;RAPGEF3;RAN;YWHAE;TENM1;EFCAB7;EMD;SEC16A;UBR5;CEP131;ERBB2;TFDP2;ZFAND1;TCAF1;FBXW7;ATG13;ZC3H12A;BAG3;HPS4
prerank,positive regulation of lipid localization (GO:1905954),0.32481468684742426,0.7467743207404607,0.7751479289940828,0.9644920202808397,1.0,4/11,24.41%,IKBKE;LRP1;ZC3H12A;HILPDA
prerank,plasma membrane tubulation (GO:0097320),0.31413986754560164,0.7464064591281061,0.7805343511450382,0.9644690488696731,1.0,4/13,15.26%,PACSIN2;SNX9;MICALL1;CHMP4A
prerank,regulation of urine volume (GO:0035809),0.3426416039341194,0.7453502540906748,0.7766798418972332,0.965461261444976,1.0,4/10,20.35%,ADM;NPR3;ADCY6;HAS2
prerank,microtubule bundle formation (GO:0001578),-0.21758310502753753,-0.7448441875958013,0.9045226130653267,0.9909078228746495,1.0,19/42,34.12%,RP1;MTCL1;AAAS;NCKAP5;CFAP46;CFAP74;SPAG16;TPPP;NAV1;CDK5RAP2;GAS2L1;DCX;TTLL3;CLIP1;PLK1;KIF20A;CFAP206;FOXJ1;CCDC40
prerank,regulation of triglyceride biosynthetic process (GO:0010866),-0.2815765906185076,-0.7444936821024394,0.8553719008264463,0.9906599825701013,1.0,7/15,31.45%,SCARB1;SIK1;MFSD2A;CTDNEP1;C3;NR1H2;LDLR
prerank,detection of visible light (GO:0009584),0.3053765319889547,0.7441428256076775,0.7745454545454545,0.966604375436353,1.0,1/16,1.89%,ABCA4
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.32173860301835877,0.7439406404473632,0.7808764940239044,0.9663352485849049,1.0,3/11,17.50%,NECAB1;SOAT1;ABCA7
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),-0.2939463878940976,-0.7439096377017276,0.8212290502793296,0.9907855272679574,1.0,5/13,21.97%,RACK1;HSPA5;PPP1R15B;UFL1;PPP1R15A
prerank,regulation of nervous system development (GO:0051960),0.2518206372658302,0.7437205447238866,0.8309859154929577,0.9661177238785553,1.0,6/37,14.83%,PTN;YAP1;DOCK7;HEYL;BHLHE41;NPHP3
prerank,adenine nucleotide transport (GO:0051503),0.29188131088514585,0.7432948348901989,0.8021778584392014,0.9661769363926324,1.0,4/17,14.25%,SLC19A1;SLC17A9;SLC25A24;SLC25A4
prerank,fatty acid oxidation (GO:0019395),-0.21052708057768027,-0.74311380261895,0.9347258485639687,0.9911336577224216,1.0,4/57,5.04%,ADIPOR2;ACAD10;ABCD4;PPARD
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.18549668646684137,0.7430760352931555,0.9792176039119804,0.9659592048948764,1.0,63/264,20.79%,GEMIN4;POLR2D;PCF11;PRCC;RBM41;SNRPA1;ZRSR2;SRRM2;NOVA1;HNRNPH1;SNIP1;HNRNPC;RBMX2;SF3B3;DDX23;SLU7;CWF19L1;PSPC1;SNRNP27;RNPC3;PRPF38A;POLR2C;SRSF4;DHX16;HNRNPH3;MAGOHB;SF3B6;DHX8;RBM5;SRPK1;STRAP;ZMAT5;DDX39A;PRPF19;POLR2F;RBM6;GEMIN5;RBM15;PABPN1;FUS;RBM14;SRSF5;CSTF3;TGS1;HNRNPR;CCAR1;TXNL4A;HNRNPA2B1;CWC22;CTNNBL1;CDK13;WBP4;SCAF11;PCBP2;USP39;PRPF3;WDR33;SNRNP40;DDX5;POLR2K;CWC25;ELAVL1;SNRNP200
prerank,nucleosome assembly (GO:0006334),-0.23144552646350042,-0.7430606065482925,0.8822115384615384,0.9904951436464161,1.0,6/31,14.79%,H3-3A;NPM1;SART3;ASF1A;ANP32B;SPTY2D1
prerank,negative regulation of cellular component organization (GO:0051129),0.22159959508234064,0.7428002893653609,0.8890532544378699,0.9658061387581441,1.0,6/74,7.66%,BMP6;APOA2;EPHA3;PRKCZ;OPRD1;GSK3B
prerank,regulation of inclusion body assembly (GO:0090083),-0.30331577929831266,-0.7419653286749431,0.8273092369477911,0.9912070545047976,1.0,4/11,24.43%,DNAJA4;SACS;SNCAIP;HSPA2
prerank,receptor recycling (GO:0001881),-0.3306161323756689,-0.741525311391825,0.804932735426009,0.9910554706730904,1.0,3/10,25.00%,SORL1;NSG1;PHETA2
prerank,intracellular cholesterol transport (GO:0032367),0.30437410448027263,0.7409671796654325,0.8015122873345936,0.9677381449242236,1.0,4/15,16.25%,NPC1;STAR;ABCA1;SERAC1
prerank,regulation of cellular catabolic process (GO:0031329),0.22309062263114177,0.7408455128944944,0.8724409448818897,0.9673811793657588,1.0,8/62,13.57%,ITPR1;NUPR1;DAPK1;MTMR3;LRRK2;KEAP1;DAPK2;PIP4K2B
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),0.3361576602020963,0.7407978283494067,0.7519230769230769,0.9669202037287065,1.0,10/10,66.41%,MYO9A;RAP2A;SH3BP1;CAMSAP3;RHOA;OPHN1;CDC42;EZR;SYNE4;MSN
prerank,protein K11-linked ubiquitination (GO:0070979),0.26618199832441825,0.7407077035324748,0.800705467372134,0.9665229626652914,1.0,5/27,13.48%,ANAPC11;ANAPC1;UBE2C;UBE2E3;CDC27
prerank,purine ribonucleotide transport (GO:0015868),0.2956397148780916,0.7402453994732734,0.7929759704251387,0.966609119882013,1.0,4/16,14.25%,SLC19A1;SLC17A9;SLC25A24;SLC25A4
prerank,receptor catabolic process (GO:0032801),-0.24317608535156676,-0.7401696156585883,0.8410138248847926,0.992132474269336,1.0,10/24,27.43%,LGMN;VLDLR;KIF16B;AP2B1;SNX25;AP2A2;AP2A1;SH3GLB1;CLTA;AP2M1
prerank,cellular response to tumor necrosis factor (GO:0071356),0.19321938338513378,0.7398516633516442,0.9595141700404858,0.966628331328413,1.0,16/175,9.21%,PID1;ADAMTS12;ZFAND6;GBP2;TRAF5;TNFSF15;GSDME;TNFRSF12A;BIRC3;EDA;STAT1;CCL2;TNFRSF14;PSMB10;PSMA3;PSME4
prerank,regulation of double-strand break repair (GO:2000779),0.24951797967438433,0.7395450621353323,0.8305084745762712,0.9665333550076454,1.0,14/39,22.07%,TRIP12;SPIDR;PPP4R2;SLF2;PML;FIGNL1;SHLD2;MGMT;KDM1A;UBR5;SETD2;SPIRE1;RTEL1;PPP4C
prerank,apoptotic nuclear changes (GO:0030262),-0.2444681892027366,-0.7393196405232358,0.8325991189427313,0.9925205719655492,1.0,6/24,18.02%,HMGB1;KPNB1;H1-0;DEDD2;FOXL2;DICER1
prerank,protein methylation (GO:0006479),0.24199827190831097,0.739227774426721,0.8733333333333333,0.9664579369109217,1.0,4/40,7.77%,NSD3;NSD1;METTL21C;ETFBKMT
prerank,positive regulation of cholesterol transport (GO:0032376),-0.23976419274183233,-0.7377993376054666,0.8479809976247031,0.9937753969003108,1.0,9/27,27.48%,ABCA3;EEPD1;CAV1;RXRA;ABCB4;ABCA13;TREM2;GPS2;NR1H2
prerank,positive regulation of coagulation (GO:0050820),-0.3118956827914418,-0.7375863900364913,0.8021739130434783,0.9925984339392525,1.0,2/10,14.61%,THBS1;ST3GAL4
prerank,positive regulation of hemostasis (GO:1900048),-0.3118956827914418,-0.7375863900364913,0.8021739130434783,0.9925984339392525,1.0,2/10,14.61%,THBS1;ST3GAL4
prerank,regulation of DNA recombination (GO:0000018),0.2554932926925504,0.7373194798531764,0.8302521008403362,0.9684721794248199,1.0,13/32,24.40%,RAD50;SPIDR;PPP4R2;FIGNL1;SHLD2;KDM1A;IL7R;SETD2;RTEL1;PPP4C;MSH2;ZCWPW1;ZRANB3
prerank,DNA replication (GO:0006260),0.20733003306218567,0.7370519674884755,0.9237536656891495,0.9683080787255042,1.0,18/105,15.44%,RBMS1;ORC5;WRN;TOP1;RAD50;POLA2;RFC1;POLG;REV1;MCMBP;RPA3;MCM4;BAZ1A;RBBP8;MCM6;ORC3;RAD9A;ORC4
prerank,telomere maintenance via telomere lengthening (GO:0010833),-0.23011510872602714,-0.7368816873804168,0.8674698795180723,0.9927615427966179,1.0,11/33,21.34%,MRE11;HSP90AB1;TERF1;HSP90AA1;CDK2;RAD51;ANKRD28;TINF2;WRAP53;ZBTB48;PPP6C
prerank,regulation of protein localization to cell surface (GO:2000008),0.2511830939758858,0.7368524883308122,0.841296928327645,0.9680496579865902,1.0,8/33,17.50%,LEPROT;ACTN2;GPD1L;HFE;BDNF;TM9SF4;GBF1;ABCA7
prerank,negative regulation of intracellular protein transport (GO:0090317),0.2752996137021466,0.73679661859848,0.8161512027491409,0.967616265771413,1.0,3/22,10.14%,SP100;LRRK2;SUFU
prerank,ureteric bud morphogenesis (GO:0060675),-0.271071084750368,-0.7365546304374292,0.8302277432712215,0.9924739509470647,1.0,4/16,11.27%,SIX1;BMP4;FGF2;PAX2
prerank,regulation of ATP metabolic process (GO:1903578),0.23014917194710108,0.7361307591784576,0.8921875,0.9679500379039402,1.0,15/54,25.39%,PRKAG2;RANBP2;TPR;JMJD8;POM121;NUP37;ATP5IF1;UQCC2;NUP85;SPHK2;HIF1A;COX7A2L;NUP160;NUP107;PRKAG1
prerank,pseudouridine synthesis (GO:0001522),-0.2873609789976797,-0.7357466331034899,0.8061855670103093,0.9927989988769969,1.0,7/13,33.13%,PUS7;PUS3;TRUB1;PUSL1;RPUSD2;NOP10;NHP2
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.24567844853790116,0.7356538470303066,0.8476357267950964,0.9680732728666476,1.0,8/37,17.31%,CUL4A;RFC1;NTHL1;RPA3;GTF2H4;ERCC5;ERCC1;GTF2H2
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),-0.26981743656930907,-0.7353541343111856,0.8296460176991151,0.9925589072618402,1.0,3/18,10.36%,PIK3R1;BAG6;USP13
prerank,mRNA stabilization (GO:0048255),0.23915987603022343,0.735166167054221,0.8569051580698835,0.9681769928026696,1.0,9/40,17.71%,TENT5A;IGF2BP1;HNRNPC;NOCT;MAPK14;EIF4ENIF1;FUS;AXIN2;GDNF
prerank,regulation of cellular protein catabolic process (GO:1903362),0.28797662101048316,0.7349794595582988,0.8287292817679558,0.9679041527989211,1.0,2/18,3.73%,NELL1;DACT1
prerank,epithelial cell development (GO:0002064),-0.25578956664558233,-0.7344491773748335,0.8388520971302428,0.9929172746030885,1.0,5/20,16.60%,ACTA2;RILPL2;SIPA1L3;SLC4A7;EXPH5
prerank,defense response to fungus (GO:0050832),-0.2626585530972777,-0.7341521803256669,0.8389830508474576,0.9925833383172062,1.0,1/17,1.55%,PLCG2
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.2940278811453782,0.7336878988836517,0.8284132841328413,0.9690821692685857,1.0,2/18,5.14%,FPR2;C5AR2
prerank,toll-like receptor signaling pathway (GO:0002224),0.21137595216015265,0.7332914370944902,0.9279411764705883,0.9690936541657694,1.0,13/84,13.97%,COLEC12;TLR4;MAP3K1;SCARA3;BIRC3;LY96;LGALS9;RIPK2;TLR2;IRAK3;MAP3K7;RPS6KA3;TICAM1
prerank,cellular response to estradiol stimulus (GO:0071392),0.2814266188551364,0.73311275296263,0.7938517179023508,0.9688123978567418,1.0,2/18,8.37%,NCOA3;FAM210B
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),-0.27500496685835024,-0.7328410696490032,0.8294243070362474,0.9935120009931606,1.0,6/15,36.74%,SEL1L;SEC61B;HERPUD1;UFD1;AUP1;DERL1
prerank,ruffle organization (GO:0031529),-0.2722003941917674,-0.7325838077789689,0.8181818181818182,0.9931362713567119,1.0,7/16,23.67%,PLEKHA1;INPP5K;CSF1R;RAC1;ARF6;CARMIL1;AIF1
prerank,regulation of autophagy of mitochondrion (GO:1903146),-0.2618580342208395,-0.7321469248104969,0.8469827586206896,0.992960615262099,1.0,7/19,23.43%,HDAC6;PINK1;PARK7;VDAC1;CAMKK2;FZD5;HTT
prerank,iron-sulfur cluster assembly (GO:0016226),-0.24650477033234786,-0.7321336220479469,0.8719646799116998,0.9922764456254329,1.0,8/24,32.97%,MMS19;NDOR1;HSCB;CIAO3;IBA57;ISCU;GLRX5;NUBPL
prerank,negative regulation of type I interferon production (GO:0032480),0.239220064504484,0.7317875569798757,0.8384,0.9700110214767369,1.0,11/40,23.15%,IKBKE;RNF216;NLRX1;PPM1B;IFIH1;TBK1;RNF135;PCBP2;REL;OTUD5;TAX1BP1
prerank,centromere complex assembly (GO:0034508),-0.22012273119498915,-0.7313555110057915,0.8805194805194805,0.992534594440312,1.0,17/36,35.39%,NPM1;HELLS;CENPU;CENPT;CENPQ;CENPL;CENPN;CENPF;MIS18BP1;CENPA;RBBP7;ITGB3BP;OIP5;DLGAP5;CENPW;MIS12;KNL1
prerank,regulation of gene silencing by RNA (GO:0060966),0.22967885865194934,0.7311254818317681,0.8929133858267716,0.9698586361169457,1.0,11/50,20.49%,POLR2D;RANBP2;TPR;TNRC6A;POLR2C;POLR2F;POM121;NUP37;PUM2;NUP85;POLR2K
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.22967885865194934,0.7311254818317681,0.8929133858267716,0.9698586361169457,1.0,11/50,20.49%,POLR2D;RANBP2;TPR;TNRC6A;POLR2C;POLR2F;POM121;NUP37;PUM2;NUP85;POLR2K
prerank,cellular response to interleukin-12 (GO:0071349),-0.2095435543736788,-0.7309766344485532,0.8986666666666666,0.9922850674331135,1.0,14/48,24.27%,PLCB1;PITPNA;RPLP0;TALDO1;PPIA;HNRNPF;SOD1;CFL1;AIP;LCP1;GSTO1;MIF;IL12RB2;MTAP
prerank,positive regulation of actin filament depolymerization (GO:0030836),0.32109096392335035,0.7299664088645318,0.77734375,0.9708169211885463,1.0,2/10,10.49%,ACTN2;PLEK
prerank,Rap protein signal transduction (GO:0032486),0.3292750471427632,0.7294655746679916,0.7755102040816326,0.9709635093399275,1.0,6/10,26.78%,RAP2C;RAPGEF3;RAP2B;RAP2A;RAPGEF1;RAP1B
prerank,regulation of protein-containing complex assembly (GO:0043254),0.20229477483896613,0.7293508319232382,0.9371428571428572,0.9706008711868264,1.0,15/110,11.97%,SELP;EIF2AK2;CDH5;PRKCZ;SPIDR;FBLIM1;OPRD1;GSK3B;BAX;SUMO1;SLF2;ATF7IP;FNIP1;HJURP;RHOC
prerank,positive regulation of lymphocyte proliferation (GO:0050671),0.22059596833053524,0.7293382074848295,0.9015384615384615,0.9700954072031479,1.0,7/63,7.89%,IL6ST;ANXA1;IL6;BCL2;VCAM1;IL18;CD274
prerank,autophagy of nucleus (GO:0044804),0.29155681006640416,0.7292773122964197,0.8342151675485009,0.9696659550890171,1.0,7/16,23.93%,ATG12;WDR45B;ATG2A;WIPI2;ATG13;ATG7;ATG3
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),-0.23094064973999645,-0.7288656181204818,0.8544600938967136,0.9941741632167289,1.0,7/29,17.54%,THBS1;RET;CAV1;CYLD;LTBR;DEDD2;PYCARD
prerank,mRNA processing (GO:0006397),0.18115756550806592,0.7287743671264182,0.9902080783353733,0.9698274106803574,1.0,67/287,20.79%,POLR2D;PCF11;PRCC;RBM41;RPRD2;SNRPA1;ZRSR2;SRRM2;NOVA1;HNRNPH1;SNIP1;HNRNPC;RBMX2;SF3B3;CCNH;DDX23;SLU7;CWF19L1;MNAT1;CDK7;PSPC1;SNRNP27;RNPC3;PRPF38A;POLR2C;SRSF4;DHX16;HNRNPH3;MAGOHB;SF3B6;DHX8;RBM5;ZMAT5;DDX39A;PRPF19;POLR2F;RBM6;THOC5;GTF2H4;GEMIN5;RBM15;PABPN1;FUS;RBM14;SRSF5;CSTF3;HNRNPR;CCAR1;TXNL4A;HNRNPA2B1;CWC22;CTNNBL1;GTF2H2;WBP4;SCAF11;PCBP2;USP39;PRPF3;WDR33;RPRD1B;SNRNP40;DDX5;RNGTT;POLR2K;CWC25;ELAVL1;SNRNP200
prerank,acyl-CoA metabolic process (GO:0006637),-0.22517383927301862,-0.7281220678465412,0.889168765743073,0.9944348110066409,1.0,8/35,19.66%,HMGCS1;SUCLA2;HMGCS2;ACACA;ACBD6;MCEE;ACSF2;ACOT2
prerank,positive regulation of cytokinesis (GO:0032467),-0.23129943507593195,-0.7279696945345896,0.8870192307692307,0.9939214912002372,1.0,19/32,45.94%,CIT;ECT2;KIF23;PRKCE;RACGAP1;KIF14;CDC14B;CDC6;KIF20B;OPN1MW;DRD3;GIPC1;MAP10;CDC42;AURKB;CXCR5;TAS1R2;AURKC;RXFP3
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.2325446999529995,0.7256448820836929,0.8679245283018868,0.9732560112548775,1.0,8/48,15.00%,IKBKE;BCL2;MCL1;BAX;BCL2L1;EPHA2;HIC1;PML
prerank,DNA conformation change (GO:0071103),0.29338809942076277,0.7251508349092277,0.8116760828625236,0.9733639341966649,1.0,3/17,13.90%,TOP1;TOP2B;KAT6A
prerank,CENP-A containing chromatin organization (GO:0061641),-0.22666293973854107,-0.7244119417383464,0.8854415274463007,0.9967887477199526,1.0,13/29,35.39%,NPM1;CENPU;CENPT;CENPQ;CENPL;CENPN;MIS18BP1;CENPA;RBBP7;ITGB3BP;OIP5;CENPW;KNL1
prerank,CENP-A containing nucleosome assembly (GO:0034080),-0.22666293973854107,-0.7244119417383464,0.8854415274463007,0.9967887477199526,1.0,13/29,35.39%,NPM1;CENPU;CENPT;CENPQ;CENPL;CENPN;MIS18BP1;CENPA;RBBP7;ITGB3BP;OIP5;CENPW;KNL1
prerank,response to acidic pH (GO:0010447),-0.2942655029967804,-0.7241303657123268,0.8310185185185185,0.9964264777227182,1.0,3/13,14.87%,LGMN;CTSS;RAB11FIP5
prerank,ncRNA catabolic process (GO:0034661),0.25580115264938785,0.7239789123961301,0.8392226148409894,0.9743463919602344,1.0,8/28,16.37%,TUT4;SND1;XRN1;DIS3L;SLFN14;DIS3;ERN2;EXOSC10
prerank,cellular response to corticosteroid stimulus (GO:0071384),0.2944993910118225,0.7237725119834132,0.8032490974729242,0.9740980278545872,1.0,2/15,13.17%,ANXA1;NR3C1
prerank,protein trimerization (GO:0070206),-0.28462669920866085,-0.7235462841700715,0.8356997971602435,0.9956983707722161,1.0,7/14,28.95%,SLC1A2;SIGMAR1;SCARA5;DISP1;MIF;STEAP4;ALOX5AP
prerank,protein homotrimerization (GO:0070207),-0.28462669920866085,-0.7235462841700715,0.8356997971602435,0.9956983707722161,1.0,7/14,28.95%,SLC1A2;SIGMAR1;SCARA5;DISP1;MIF;STEAP4;ALOX5AP
prerank,interstrand cross-link repair (GO:0036297),0.228432456755792,0.7229669205774958,0.8846153846153846,0.9745804483746363,1.0,8/53,12.36%,NUCKS1;SLX4;RPA3;FANCM;DCLRE1A;CENPX;RFWD3;FANCE
prerank,cell projection assembly (GO:0030031),0.2738621748689468,0.7229623122822746,0.8454706927175843,0.9740667215540896,1.0,2/22,2.06%,PARVA;QRICH2
prerank,cellular response to ATP (GO:0071318),0.29941521093202184,0.7227580520950322,0.7916666666666666,0.9737966160435987,1.0,6/14,24.07%,SSH1;CIB2;P2RY1;P2RX4;TAF1;P2RX3
prerank,regulation of cell aging (GO:0090342),0.31693772930460085,0.7224341438120643,0.7831325301204819,0.9736785740260203,1.0,6/11,29.72%,NEK4;PNPT1;NEK6;RSL1D1;ING2;LMNA
prerank,glutamine family amino acid catabolic process (GO:0009065),0.305695195265217,0.7221154632250139,0.8190298507462687,0.9735761893831226,1.0,3/13,8.36%,NOS2;ALDH4A1;GLUL
prerank,positive regulation of catalytic activity (GO:0043085),0.2414437718461076,0.7218732805546667,0.8401976935749588,0.9733507583139379,1.0,6/37,10.27%,NHEJ1;WRN;AZIN2;XRCC4;IGF2;MAPK14
prerank,positive regulation of phospholipid transport (GO:2001140),-0.3111605594436536,-0.7216642058947803,0.8252631578947368,0.9972536552756165,1.0,4/10,18.33%,ABCA3;PRELID1;TMEM30A;ABCB4
prerank,mRNA export from nucleus (GO:0006406),0.20438443937652034,0.7212215371437645,0.942090395480226,0.973622580206837,1.0,25/102,19.71%,NXF2;POLR2D;RANBP2;TPR;SLU7;SRSF4;IWS1;SMG5;SMG6;MAGOHB;DDX39A;THOC5;POM121;SMG7;PABPN1;SRSF5;NUP37;HNRNPA2B1;SMG1;DDX19B;SLBP;WDR33;NUP85;UPF2;AGFG1
prerank,protein localization to mitochondrion (GO:0070585),-0.29832236079935526,-0.7211520037935848,0.8259023354564756,0.9971741172019862,1.0,5/11,26.29%,AKT1;PINK1;MAIP1;MTCH2;DNAJA1
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),-0.26644092587248924,-0.7211155883883579,0.8583877995642701,0.9965201090377481,1.0,5/17,23.30%,NOS1AP;KCNQ1;KCNE4;GJA5;SCN1B
prerank,negative regulation of histone modification (GO:0031057),-0.2835105956635388,-0.7198869779856086,0.8333333333333334,0.9972810513647207,1.0,5/14,19.08%,SNCA;CTBP1;SET;BRCA1;NOC2L
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),0.30790546990464707,0.7197629189338401,0.8176352705410822,0.9748736577846533,1.0,4/12,17.35%,PLA2G6;PPP3CB;BAIAP3;C2CD2L
prerank,apoptotic mitochondrial changes (GO:0008637),0.24449049622184194,0.7193033890477641,0.8613013698630136,0.9749382468469447,1.0,5/32,10.73%,IFIT2;BCL2;BAX;DNM1L;BCL2L1
prerank,integrated stress response signaling (GO:0140467),0.29225460945136805,0.7192833321065752,0.8140417457305503,0.9744461290849666,1.0,3/14,15.08%,CCL2;QRICH1;EIF2AK3
prerank,postreplication repair (GO:0006301),0.23171413197262317,0.719253008367966,0.8953488372093024,0.9739679506670935,1.0,6/45,10.87%,POLH;PARP10;RFC1;REV1;RPA3;UBE2V1
prerank,keratan sulfate biosynthetic process (GO:0018146),-0.23125632636110383,-0.7181615298027555,0.8995327102803738,0.9985087979864916,1.0,11/26,29.50%,ST3GAL6;B3GNT2;B4GALT4;ST3GAL4;LUM;B3GNT3;B4GALT6;CHST5;B4GALT2;B4GAT1;ST3GAL2
prerank,regulation of DNA-dependent DNA replication (GO:0090329),-0.2906359059537591,-0.717729127934583,0.825531914893617,0.9983039255846834,1.0,9/12,42.93%,KAT7;WRNIP1;BLM;WDR18;TICRR;NUGGC;NBN;METTL4;CDT1
prerank,positive regulation of transmembrane transport (GO:0034764),-0.28466131410880213,-0.7164543216241569,0.8387799564270153,0.9990576759199067,1.0,6/13,21.34%,CA2;ACSL5;NR4A3;C2CD5;P2RX7;C3
prerank,nuclear pore organization (GO:0006999),0.2983150230500645,0.7160266375235781,0.8,0.9773800447575586,1.0,3/14,13.84%,TPR;AHCTF1;RTN4
prerank,lysosome organization (GO:0007040),0.2432105543220758,0.7153277681512753,0.8709677419354839,0.977744764401716,1.0,11/36,23.59%,CLN5;LRRK2;HPS1;TMEM165;ARSB;ABCA1;HOOK1;VPS33A;HPS4;TPCN2;LAMTOR1
prerank,plasma membrane invagination (GO:0099024),-0.2258639560313367,-0.7140938615921278,0.9043062200956937,1.0,1.0,9/29,25.04%,ELMO1;DOCK1;SNX18;FCGR1A;ITGB2;SNX33;AIF1;BIN2;MSR1
prerank,cellular response to estrogen stimulus (GO:0071391),0.2983161500867938,0.713997744435302,0.8149532710280374,0.9788289313687792,1.0,4/14,20.35%,SFR1;TRIM24;RARA;ARID5A
prerank,regulation of T cell migration (GO:2000404),0.2746147851909728,0.713479505518553,0.8515037593984962,0.9788922562871409,1.0,2/18,7.90%,CXCL10;TNFRSF14
prerank,synaptic vesicle transport (GO:0048489),0.315919558128886,0.7134240201067608,0.8011583011583011,0.9784485088595589,1.0,3/11,11.84%,TMEM230;KIF5B;SPG11
prerank,cellular response to interleukin-15 (GO:0071350),-0.28216338507450067,-0.7131442339838622,0.8588007736943907,1.0,1.0,1/13,0.97%,PLCB1
prerank,interleukin-15-mediated signaling pathway (GO:0035723),-0.28216338507450067,-0.7131442339838622,0.8588007736943907,1.0,1.0,1/13,0.97%,PLCB1
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.18453426645414056,0.7131095554639073,0.9784366576819407,0.9783056713404921,1.0,25/184,12.57%,NINL;DYNLL1;ALMS1;SDCCAG8;PLK5;CLASP1;APPL2;CEP152;ANAPC11;HAUS8;KLHL18;PSMB10;ANAPC1;UBE2C;PSMA3;PSME4;APPL1;PSMA5;PTPN6;NEDD1;CDC14A;CUL3;MAD2L1BP;BTRC;HECW2
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.28868043866672544,0.7125397457129498,0.8284132841328413,0.9785054306464719,1.0,2/17,4.01%,EIF2AK2;TAOK3
prerank,endocytic recycling (GO:0032456),0.2264234798152152,0.7122444867495449,0.8946515397082658,0.9783287954983992,1.0,9/50,14.31%,TRARG1;SNX12;DENND1A;VPS35L;ACAP2;MICALL1;SNX27;ENTR1;VPS26C
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.17943101092000696,0.7117020292841384,0.9887359198998749,0.9784353629975022,1.0,57/241,20.79%,POLR2D;PCF11;PRCC;RBM41;SNRPA1;ZRSR2;SRRM2;NOVA1;HNRNPH1;SNIP1;HNRNPC;RBMX2;SF3B3;DDX23;SLU7;CWF19L1;PSPC1;SNRNP27;RNPC3;PRPF38A;POLR2C;SRSF4;DHX16;HNRNPH3;MAGOHB;SF3B6;DHX8;RBM5;ZMAT5;DDX39A;PRPF19;POLR2F;RBM6;GEMIN5;RBM15;PABPN1;FUS;RBM14;SRSF5;CSTF3;HNRNPR;CCAR1;TXNL4A;HNRNPA2B1;CWC22;CTNNBL1;WBP4;PCBP2;USP39;PRPF3;WDR33;SNRNP40;DDX5;POLR2K;CWC25;ELAVL1;SNRNP200
prerank,positive regulation of immunoglobulin production (GO:0002639),0.24568871008860668,0.7100307376371565,0.8708551483420593,0.9798560483186393,1.0,8/31,21.19%,RBP4;IL6;PHB2;SHLD2;KMT5C;RIF1;KMT5B;XBP1
prerank,negative regulation of peptide hormone secretion (GO:0090278),-0.257182914388671,-0.7095636365272516,0.8571428571428571,1.0,1.0,3/18,13.96%,CCN3;KCNB1;INHBB
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),-0.24387900024865955,-0.709011365005646,0.8634259259259259,1.0,1.0,13/21,39.62%,RCC2;NPM1;CCND1;ATAD5;CDK4;DTL;CDK1;DYRK3;VPS4B;CDC7;RAB11A;CCNB1;CDC25C
prerank,cellular response to ionizing radiation (GO:0071479),0.22505686254576165,0.7088078119335119,0.9008547008547009,0.9807216022879405,1.0,12/47,18.62%,PRAP1;NUCKS1;WRN;SPIDR;YAP1;TLK2;MAPK14;RAD9A;FIGNL1;NIPBL;KDM1A;CLOCK
prerank,regulation of transcription by RNA polymerase I (GO:0006356),-0.25291546759088257,-0.7085823190413033,0.8813186813186813,1.0,1.0,7/18,28.68%,MAF1;ATF4;SIRT7;HEATR1;RASL11A;LYAR;WDR75
prerank,regulation of telomere maintenance via telomerase (GO:0032210),-0.20221808649506584,-0.7085073870236407,0.9362244897959183,1.0,1.0,11/51,18.28%,PRKCQ;NEK7;CTNNB1;MAPK3;TERF1;GNL3L;ATM;PNKP;PKIB;CCT5;TINF2
prerank,melanosome localization (GO:0032400),-0.24334700310248547,-0.7084054558050141,0.8315565031982942,1.0,1.0,4/21,11.54%,RAB27A;RAB27B;VPS33B;MLPH
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.30523474767763004,0.7082448370748202,0.8436293436293436,0.9808349481977259,1.0,11/11,69.50%,PKD1L3;RTP4;RTP2;TAS1R3;PIGR;GNAT2;GNAT3;TAS1R2;PKD2L1;RTP3;LPO
prerank,methylguanosine-cap decapping (GO:0110156),0.31408798729553183,0.7081891147982858,0.808641975308642,0.9803797443482297,1.0,2/10,7.46%,LSM1;DCP2
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",-0.23598072137822995,-0.7078995672576225,0.8785046728971962,1.0,1.0,6/24,19.11%,NOD1;UBB;UBA52;CYLD;NOD2;IRAK1
prerank,regulation of brown fat cell differentiation (GO:0090335),0.2886248608523275,0.7071974169800405,0.8372093023255814,0.9810151763636317,1.0,4/16,20.45%,BMP7;FTO;NAPEPLD;PTGS2
prerank,cardiac right ventricle morphogenesis (GO:0003215),-0.28818217338842644,-0.7069844652999094,0.8292181069958847,1.0,1.0,3/11,15.14%,TGFB2;BMP4;ZFPM2
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),0.2874607083596369,0.7062233507424421,0.8369175627240143,0.981634580219097,1.0,3/17,5.66%,NRP1;BAIAP2L1;HAX1
prerank,regulation of proteolysis (GO:0030162),-0.20315544094331112,-0.7060874004218766,0.920844327176781,1.0,1.0,18/48,31.13%,CST3;PERP;AKT1;HDAC6;SPOP;BAG6;CAV1;PLAUR;AURKAIP1;BAD;FGFR4;CLN3;CDK5;GSAP;FADD;NEDD8;PLK1;LTBP4
prerank,positive regulation of cellular respiration (GO:1901857),0.31218635528781447,0.7056378851825428,0.8265895953757225,0.9817774023764717,1.0,2/11,10.66%,NUPR1;IFNLR1
prerank,hyaluronan catabolic process (GO:0030214),-0.25539058441817136,-0.7055606349530205,0.8562367864693446,1.0,1.0,4/18,11.92%,HEXB;CEMIP;FGF2;GUSB
prerank,neuron remodeling (GO:0016322),-0.29749191062167873,-0.705430972818829,0.8439425051334702,1.0,1.0,1/10,0.84%,ADGRB3
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),0.31077153835876903,0.7050289452714327,0.8088531187122736,0.9819574131243016,1.0,2/10,7.59%,TGFBR2;STAT1
prerank,negative regulation of T cell activation (GO:0050868),0.24215064827638638,0.7048565438926385,0.8640275387263339,0.9816316409870374,1.0,4/35,7.89%,TNFAIP8L2;PTPN22;FOXP3;CD274
prerank,alcohol catabolic process (GO:0046164),0.31935966182561226,0.7047633660340712,0.8135593220338984,0.9812208817544309,1.0,1/10,3.22%,CYP27A1
prerank,negative regulation of cell cycle process (GO:0010948),0.21780704503621043,0.704644376559075,0.9233226837060703,0.9808554928688293,1.0,17/61,22.28%,SUZ12;BMP7;UXT;MGA;NANOS2;ESPL1;EPC1;RBBP8;TOM1L2;RING1;RNF2;BMI1;TOM1L1;TFDP2;PCGF2;APAF1;NME6
prerank,positive regulation of establishment of protein localization (GO:1904951),-0.25758472086539724,-0.7045488292480065,0.859538784067086,1.0,1.0,10/18,45.02%,CEP135;CCT5;WRAP53;TREM2;CCT7;CCT8;CHP1;CEP295;TNF;CCT4
prerank,phosphatidylcholine biosynthetic process (GO:0006656),0.23870712734235633,0.70439760150952,0.8836424957841484,0.9806308505847555,1.0,9/32,19.81%,APOA2;STARD10;CSNK2A2;PCYT1A;LPIN2;ABHD3;PEMT;SLC44A2;SLC27A1
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),-0.23164547745305303,-0.7034214046914586,0.8966292134831461,1.0,1.0,10/28,28.82%,CTSC;PSMC3;DAB2IP;TMTC3;PSMC6;CCDC22;PSMC5;TREM2;CLU;LAPTM5
prerank,ER-associated misfolded protein catabolic process (GO:0071712),0.3085753355935185,0.7021889691368257,0.825,0.9826036484106784,1.0,3/11,15.98%,POMT2;UGGT2;RNF185
prerank,cellular response to arsenic-containing substance (GO:0071243),-0.2638237558140534,-0.7018194622391778,0.8596881959910914,1.0,1.0,3/15,19.53%,CPEB2;GSTO2;GSTO1
prerank,regulation of G0 to G1 transition (GO:0070316),0.23817821692904115,0.7011670263383427,0.8886986301369864,0.983189036990062,1.0,12/38,22.11%,SUZ12;UXT;MGA;CDKN2B;EPC1;RBBP8;RING1;RNF2;BMI1;TFDP2;PCGF2;APAF1
prerank,regulation of cholesterol biosynthetic process (GO:0045540),0.2744699726668481,0.7010937437697818,0.8487712665406427,0.9827535661549612,1.0,1/17,1.32%,FGF1
prerank,ncRNA 3'-end processing (GO:0043628),-0.2715356802105644,-0.7009109580386287,0.8390557939914163,1.0,1.0,7/14,30.92%,INTS7;INTS6L;INTS12;ERI1;TOE1;INTS5;INTS2
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),-0.2680772157181051,-0.7003602148346593,0.8556034482758621,1.0,1.0,9/14,36.08%,HNRNPA0;ANGEL2;MYD88;BOLL;ZFP36;YBX3;TIRAP;TARDBP;DAZL
prerank,regulation of telomere maintenance (GO:0032204),0.2556693515371557,0.7001511564203456,0.872791519434629,0.9832959888460886,1.0,9/26,21.48%,RAD50;SMG5;SMG6;PML;ERCC1;SMG1;DHX36;USP7;RTEL1
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),-0.2323559505416144,-0.7001021069516107,0.8888888888888888,1.0,1.0,5/25,17.08%,DOT1L;H1-0;HEY1;PARK7;PER2
prerank,mitotic cytokinetic process (GO:1902410),-0.24683172081860716,-0.7000088918840499,0.8956916099773242,1.0,1.0,10/20,30.18%,CHMP1A;CHMP1B;CHMP7;CHMP2B;CNTROB;CHMP2A;CEP55;CHMP6;CHMP4C;KIF20A
prerank,translesion synthesis (GO:0019985),0.2297231006457117,0.6995287848134185,0.8960396039603961,0.9834977783601238,1.0,7/42,14.53%,POLH;PARP10;RFC1;REV1;RPA3;POLDIP2;RCHY1
prerank,electron transport chain (GO:0022900),0.2855886659994462,0.6991604979560364,0.8441558441558441,0.983388979384441,1.0,3/15,19.87%,POR;ETFA;UQCRFS1
prerank,regulation of store-operated calcium entry (GO:2001256),-0.2967595135345357,-0.699063813966527,0.8313008130081301,1.0,1.0,5/10,25.95%,HOMER1;CD84;SLC8B1;CASQ1;HOMER2
prerank,sister chromatid segregation (GO:0000819),0.23854009211817498,0.6985261728470522,0.8823529411764706,0.983558471167755,1.0,4/31,9.26%,KLHL22;TOP2B;ESPL1;ZWINT
prerank,protein insertion into ER membrane (GO:0045048),-0.21395468013050623,-0.6983372696748723,0.9249394673123487,1.0,1.0,14/37,28.15%,BAG6;SERP1;TRAM1;CAMLG;CCDC47;EMC10;WDR83OS;SEC61G;CYB5A;HMOX1;TRAM1L1;GET1;SEC61B;VAMP2
prerank,regulation of cell cycle process (GO:0010564),-0.17225926117256254,-0.6978073991877205,0.9817073170731707,1.0,1.0,24/104,20.81%,CALM1;CALM2;CTNNB1;RAB11FIP3;CALM3;YTHDF2;DYNC1H1;BORA;CAV2;CCDC8;CEP85;PLK4;RMI2;RAB11FIP4;PRC1;L3MBTL1;ECT2;CHEK1;PIK3C3;PRMT5;KNSTRN;MAD1L1;SPAG5;MKI67
prerank,regulation of dephosphorylation (GO:0035303),0.2823139688942029,0.6973906873282149,0.855787476280835,0.9842929997821513,1.0,5/15,14.42%,MTMR3;PPP1R16A;SMG5;SMG6;SMG7
prerank,response to gamma radiation (GO:0010332),-0.23568698011408543,-0.6969389554840277,0.8941176470588236,1.0,1.0,12/24,33.21%,RPL26;MAP3K20;ATM;HRAS;MEN1;ATR;DCUN1D3;XRCC6;MYC;TP53;TMEM109;MDM2
prerank,regulation of sister chromatid cohesion (GO:0007063),-0.28194356125479964,-0.6962881987455946,0.8340425531914893,1.0,1.0,6/12,33.35%,CTNNB1;DDX11;RAD21;CTCF;FEN1;BUB1
prerank,negative regulation of RNA metabolic process (GO:0051253),0.2794612910898851,0.6956305572645922,0.8595505617977528,0.9856597566731525,1.0,2/18,4.00%,PTBP3;TERT
prerank,regulation of mitochondrial translation (GO:0070129),-0.23960982327917912,-0.6953768211307151,0.871331828442438,1.0,1.0,9/21,33.08%,FASTKD2;MALSU1;C1QBP;SHMT2;RCC1L;TRMT10C;RPUSD3;MPV17L2;COA3
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.30900983572199436,0.6953087306769684,0.8282442748091603,0.9854799879871268,1.0,2/11,11.18%,PPARA;TRAP1
prerank,response to nutrient levels (GO:0031667),0.2748276951592447,0.6942977719165726,0.8451730418943534,0.9860601216886913,1.0,1/17,1.61%,PRKAA2
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.21454082304355018,0.6933542526614801,0.928679817905918,0.9865448001225228,1.0,17/58,20.15%,NHEJ1;RAD50;XRCC4;SUMO1;UVRAG;DCLRE1A;NSMCE2;KDM2A;PRPF19;ERCC6;UIMC1;ERCC1;SMARCAL1;BRCC3;CYREN;RIF1;ERCC8
prerank,catecholamine metabolic process (GO:0006584),0.2861785533625738,0.6931839567323352,0.8597785977859779,0.9862198599451896,1.0,3/14,19.02%,COMT;RNF180;LRTOMT
prerank,regulation of response to stress (GO:0080134),-0.2973050685367579,-0.6926863174732332,0.8622754491017964,1.0,1.0,5/10,26.66%,OPRM1;MLC1;ADCY8;SLC38A2;EIF4G1
prerank,regulation of Golgi organization (GO:1903358),0.2726149955425978,0.6926094760446928,0.8366247755834829,0.986314805552183,1.0,5/17,18.94%,ARMH3;MAP2K1;RAB33B;MYO5A;USP6NL
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.25897495898037715,0.6920812471364228,0.8787878787878788,0.9863443221062332,1.0,3/21,9.26%,KLHL22;TPR;ZWINT
prerank,RNA transport (GO:0050658),0.20594611285204717,0.6920727946390918,0.9343283582089552,0.9858423249685834,1.0,11/71,15.13%,SIDT1;NXF2;TPR;TGFBR2;SLU7;SRSF4;MAGOHB;DDX39A;THOC5;POM121;SRSF5
prerank,hydrogen peroxide catabolic process (GO:0042744),-0.28841325633944265,-0.691694403658621,0.8590308370044053,1.0,1.0,11/11,71.18%,PRDX2;PRDX5;GPX1;GPX3;PRDX4;MPO;PXDNL;PRDX1;CAT;PRDX3;PXDN
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.2686750010452701,0.6913869910895788,0.8491921005385996,0.9855048216858058,1.0,3/19,13.75%,POLR2D;POLR2C;POLR2F
prerank,regulation of DNA recombination at telomere (GO:0072695),0.2686750010452701,0.6913869910895788,0.8491921005385996,0.9855048216858058,1.0,3/19,13.75%,POLR2D;POLR2C;POLR2F
prerank,COPII-coated vesicle budding (GO:0090114),-0.1843970723047143,-0.691180042880417,0.9621621621621622,1.0,1.0,17/68,21.85%,GRIA1;NSF;CTSC;CSNK1D;TMED2;TRAPPC4;CNIH1;LMAN1;NAPA;ANKRD28;TRAPPC6B;COL7A1;RAB1B;SAR1B;TRAPPC3;PPP6C;SEC22B
prerank,regulation of lipoprotein lipase activity (GO:0051004),-0.2538649497131155,-0.6908654450542308,0.8593406593406593,1.0,1.0,8/17,35.92%,HDAC9;SORT1;LPL;PCSK5;NR1H2;LIPC;FURIN;APOH
prerank,negative regulation of response to cytokine stimulus (GO:0060761),0.3094386410219828,0.6907681065808032,0.8201581027667985,0.9856352689686408,1.0,3/10,11.59%,IRAK3;MAP2K5;SH2B3
prerank,lymphocyte proliferation (GO:0046651),0.2610245222275312,0.6906040837744059,0.8665480427046264,0.9852897530790857,1.0,4/22,11.81%,CTPS1;BCL2;ELF4;PPP3CB
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),-0.21962219943607517,-0.6903440616490135,0.9234567901234568,1.0,1.0,13/31,33.91%,MAPK8;HIP1R;YWHAH;PPP1R13B;YWHAQ;BAD;CHCHD10;YWHAZ;PPP3CC;PMAIP1;TP53;BOK;E2F1
prerank,negative regulation of translational initiation (GO:0045947),0.29057397988561795,0.690287322952404,0.8349514563106796,0.9850910055163926,1.0,1/13,5.83%,TPR
prerank,histone acetylation (GO:0016573),0.2044485824686973,0.690274371678097,0.9363507779349364,0.9845992897283338,1.0,24/69,24.34%,APBB1;BRD1;CREBBP;KAT6B;EPC1;JADE2;ACTL6A;MAP3K7;BRD8;KAT6A;ZZZ3;KAT2B;PHF20L1;TAF9;TRIM16;ATF2;NAA40;CPA4;DR1;SUPT7L;WDR5;ING5;EP400;TAF6
prerank,negative regulation of DNA binding (GO:0043392),0.2445316085894457,0.6902026310469999,0.8785834738617201,0.9841630559021399,1.0,3/28,9.34%,SP100;CPNE1;SUMO1
prerank,regulation of phospholipid metabolic process (GO:1903725),-0.29884624545180277,-0.6887485366614666,0.8520084566596194,1.0,1.0,5/10,25.38%,ABCA3;MFSD2A;MTMR2;MTMR1;MTMR9
prerank,negative regulation of RNA splicing (GO:0033119),-0.2466420066223906,-0.6886595079064355,0.9004524886877828,1.0,1.0,7/19,21.65%,PTBP1;RPS13;RPS26;RNPS1;SRSF9;C1QBP;SRSF6
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",0.20441619756089724,0.6885623848385908,0.9492307692307692,0.9853181513569541,1.0,6/80,7.41%,VPS54;DENND2A;SNX6;HEATR5A;SNX12;CLN5
prerank,positive regulation of organelle organization (GO:0010638),0.23732610098963697,0.6882785615722629,0.8775510204081632,0.9851001509848231,1.0,7/32,18.72%,ANXA2;ANXA1;GSK3B;UVRAG;TMED9;KATNBL1;PLA2G5
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.30954741119173246,0.6876389252576813,0.8256704980842912,0.9852429246279171,1.0,3/10,17.52%,ZNHIT3;TAF9;NUFIP1
prerank,response to reactive oxygen species (GO:0000302),0.21411997063838126,0.6872685543204674,0.9363784665579119,0.9850860874613503,1.0,5/54,8.57%,PDGFRA;FER;TPM1;MPV17;STK24
prerank,organelle fusion (GO:0048284),-0.2355691701065492,-0.6867609035371413,0.910958904109589,1.0,1.0,4/22,11.20%,MFF;MFN2;GDAP1;MFN1
prerank,intestinal absorption (GO:0050892),-0.27270602227105345,-0.6866369437973399,0.8853118712273642,1.0,1.0,5/13,28.34%,KCNQ1;F11R;TJP2;UGCG;SLC2A2
prerank,aromatic amino acid family metabolic process (GO:0009072),-0.28774898815056693,-0.6859427694699511,0.8501026694045175,1.0,1.0,2/10,20.96%,ASRGL1;KYNU
prerank,negative regulation of ATPase activity (GO:0032780),0.27338246877350714,0.6852988955657775,0.8476702508960573,0.9865768685374849,1.0,6/16,25.84%,IFIT1;ATP5IF1;PXK;OXA1L;THADA;TNNI3
prerank,positive regulation of protein-containing complex assembly (GO:0031334),0.1886627574185452,0.6850793694035413,0.9722222222222222,0.9862812404989618,1.0,19/113,15.40%,ASAP1;CDH5;TLR4;UNC13B;CUL4A;GBP5;SPIDR;GSK3B;BAX;SUMO1;SLF2;RPA3;PLEK;FNIP1;RHOC;GTF2H4;ERCC5;ABCA1;ERCC1
prerank,positive regulation of T cell mediated immunity (GO:0002711),0.25636364845943516,0.6847230919843853,0.8949211908931699,0.986127125778852,1.0,4/22,15.47%,CD55;FBXO38;MAP3K7;IL23R
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),-0.22370799392571522,-0.6844679154789124,0.9086651053864169,1.0,1.0,9/25,31.63%,MFF;PINK1;PLAUR;BMF;PYCARD;BAD;HRK;PMAIP1;TP53
prerank,positive regulation of TORC1 signaling (GO:1904263),-0.2540691302358803,-0.6832024664730365,0.8989690721649485,1.0,1.0,2/16,9.31%,GPR137C;RRAGB
prerank,cellular protein-containing complex assembly (GO:0034622),0.18202060300127765,0.6830241066603477,0.9816901408450704,0.9872705142110976,1.0,24/159,16.34%,TCF4;SMAD3;WNT3A;ANGPT1;PSMG1;TPR;PIK3C2A;POGZ;DNAAF1;SNX9;UVRAG;DNAI4;FCHO2;SMAD4;AHCTF1;DRC1;RTN4;CHMP3;NCK1;CHMP4A;CHMP4B;SRP19;SMAD2;TBCA
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.2925224923638299,0.6827210416093005,0.8491295938104448,0.9870633383797711,1.0,2/13,6.37%,NFATC4;PPARA
prerank,central nervous system projection neuron axonogenesis (GO:0021952),0.2996446430466751,0.6826928006202866,0.8260038240917782,0.9865814191994318,1.0,2/12,8.24%,MYCBP2;EPHA4
prerank,regulation of gluconeogenesis (GO:0006111),-0.2201672133355133,-0.6823196704663003,0.9075,1.0,1.0,8/27,28.98%,C1QTNF3;SIK1;PGP;NNMT;SIRT7;ZNF692;DGKQ;GNMT
prerank,vitamin D metabolic process (GO:0042359),-0.27517257671963774,-0.6820480353593475,0.8744769874476988,1.0,1.0,8/13,46.41%,LGMN;CYP2R1;VDR;CYP1A1;GC;CYP27B1;CYP24A1;FGF23
prerank,mitotic spindle checkpoint signaling (GO:0071174),0.2596879001384853,0.6817053705627177,0.8777372262773723,0.9860208453178455,1.0,3/20,9.26%,KLHL22;TPR;ZWINT
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),0.2596879001384853,0.6817053705627177,0.8777372262773723,0.9860208453178455,1.0,3/20,9.26%,KLHL22;TPR;ZWINT
prerank,spindle assembly checkpoint signaling (GO:0071173),0.2596879001384853,0.6817053705627177,0.8777372262773723,0.9860208453178455,1.0,3/20,9.26%,KLHL22;TPR;ZWINT
prerank,regulation of mitotic spindle assembly (GO:1901673),0.261243210618259,0.6813998964249209,0.8615107913669064,0.9858018247831598,1.0,5/19,19.76%,TPR;CHMP3;CHMP4B;EML3;CHMP5
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.2315160490339518,0.6810616950772898,0.9090909090909091,0.9856265689421534,1.0,4/33,6.52%,RC3H1;UBASH3A;PTPN22;PTPN2
prerank,response to fatty acid (GO:0070542),0.26973709241245974,0.6805643666370188,0.8830188679245283,0.9856060550520529,1.0,1/17,1.34%,PID1
prerank,miRNA mediated inhibition of translation (GO:0035278),-0.2798813201124101,-0.6790071940614262,0.8678861788617886,1.0,1.0,6/11,39.28%,NOTCH4;TNRC6C;EIF6;ZFP36;AGO4;TRIM71
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",-0.2798813201124101,-0.6790071940614262,0.8678861788617886,1.0,1.0,6/11,39.28%,NOTCH4;TNRC6C;EIF6;ZFP36;AGO4;TRIM71
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.21273889384872652,0.6782499800527828,0.9299065420560748,0.9873783631321761,1.0,5/54,6.52%,CFLAR;CASP4;CPNE1;BIRC3;PTPN2
prerank,telomere maintenance via telomerase (GO:0007004),-0.22228251550884592,-0.6779909016141007,0.9026128266033254,1.0,1.0,9/28,21.34%,MRE11;HSP90AB1;TERF1;HSP90AA1;CDK2;ANKRD28;TINF2;WRAP53;PPP6C
prerank,ERAD pathway (GO:0036503),-0.1752245424219948,-0.6775402838175844,0.9709302325581395,1.0,1.0,28/83,30.83%,SEL1L;ERLIN1;BAG6;USP13;UBXN8;BRSK2;CCDC47;HSPA5;TMUB2;YOD1;STT3B;FAM8A1;PSMC6;UBXN6;UBE2J1;SGTB;ATXN3;TMUB1;FBXO6;RNF121;FBXO2;SEC61B;HERPUD1;RNF5;UBE2G2;RHBDD2;UFD1;TOR1A
prerank,fatty acid metabolic process (GO:0006631),-0.1623470056473011,-0.6763170385790023,1.0,1.0,1.0,37/115,30.40%,ADIPOR2;ACSL3;PPARD;ACSL5;GGT5;ACACA;ACLY;ABCD2;ACSBG1;CROT;AOAH;PER2;AASDH;LPL;LPIN3;ACSF2;ACOT2;GGT1;HSD17B8;PNPLA3;HPGD;FASN;MCAT;CPT1C;FAAH;FA2H;ACOT6;ALKBH7;ADIPOR1;LIPH;MSMO1;LIPC;SLC27A6;ALOX5AP;ACOX2;ALOX5;CPT1B
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.24889046411241605,0.6751722506587441,0.8994800693240901,0.9897874559585118,1.0,2/24,5.96%,RBPJ;CREB3L3
prerank,protein palmitoylation (GO:0018345),-0.21607517108198732,-0.675149958224517,0.9358407079646017,1.0,1.0,13/30,33.47%,ZDHHC14;ZDHHC20;ZDHHC2;ZDHHC24;ZDHHC7;ZDHHC23;ZDHHC9;ZDHHC5;SELENOK;ZDHHC4;GOLGA7B;ZDHHC13;GOLGA7
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.24714684213939705,0.6748555553384353,0.9008403361344538,0.9895890418423797,1.0,9/24,23.78%,NR1H3;LRRK2;BCL2L1;OPA1;UBXN1;XBP1;TXNDC12;SYVN1;USP25
prerank,tRNA modification (GO:0006400),-0.18464222188799811,-0.6731136085985271,0.9706666666666667,1.0,1.0,22/62,32.99%,PUS7;TRMT13;THUMPD1;QTRT2;PUS3;ELP5;DTWD2;WDR4;TYW5;CDKAL1;TRMT6;TRMT9B;TRUB1;PUSL1;ADAT2;CTU2;TRMT61A;THUMPD2;BCDIN3D;ALKBH8;TRMT10A;TPRKB
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.2673648063359327,0.6729583018659999,0.8702290076335878,0.9908484263627746,1.0,6/18,21.69%,POR;GDNF;ABL2;SIRT3;AGT;PDP2
prerank,histone exchange (GO:0043486),-0.19913239792861165,-0.6724005777091889,0.9543147208121827,1.0,1.0,13/37,26.66%,ZNHIT1;NPM1;SPTY2D1;DMAP1;CENPU;CENPT;CENPQ;CENPL;CENPN;MIS18BP1;CENPA;RBBP7;ITGB3BP
prerank,covalent chromatin modification (GO:0016569),-0.26069322222623076,-0.6721291197384045,0.8738938053097345,1.0,1.0,6/14,21.95%,HDAC1;HELLS;PARK7;SIRT7;UFL1;PARP2
prerank,positive regulation of DNA binding (GO:0043388),-0.21491809343007884,-0.6718850122609494,0.9419953596287703,1.0,1.0,7/31,17.72%,HMGB1;NGF;H1-0;PLAUR;PARK7;EGF;HES1
prerank,inner dynein arm assembly (GO:0036159),0.29755852632900265,0.6713593536066655,0.8454011741682974,0.9918286228209475,1.0,10/10,70.26%,DNAAF1;CCDC39;DNAAF4;DNAAF5;ZMYND10;CFAP73;DNAI3;DNAH1;CCDC40;CFAP100
prerank,negative regulation of cell division (GO:0051782),-0.27794028945258054,-0.6710168866254232,0.8580246913580247,1.0,1.0,6/11,31.42%,ORC6;E2F7;BLM;CHMP4C;MYC;E2F8
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.24300557123367658,0.6708331397034946,0.8963093145869947,0.991818962126986,1.0,6/26,14.41%,RIPK2;MAP2K6;UBE2V1;MAP3K7;TIFA;IFIH1
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.2993110889411337,0.6705412726542301,0.8682170542635659,0.991575556591927,1.0,3/10,22.29%,ETFA;ACADS;IVD
prerank,negative regulation of B cell proliferation (GO:0030889),-0.2769860762733614,-0.6700267962741051,0.8893709327548807,1.0,1.0,3/11,13.40%,LYN;ATM;TNFRSF21
prerank,DNA alkylation (GO:0006305),-0.23259036063790173,-0.6699206638213859,0.9057017543859649,1.0,1.0,5/19,17.98%,HELLS;GATAD2A;MTRR;DMAP1;DNMT1
prerank,DNA methylation or demethylation (GO:0044728),-0.23259036063790173,-0.6699206638213859,0.9057017543859649,1.0,1.0,5/19,17.98%,HELLS;GATAD2A;MTRR;DMAP1;DNMT1
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),-0.2089530955338193,-0.6698479826050756,0.954653937947494,1.0,1.0,4/33,12.39%,LEF1;CD74;RUNX1;FES
prerank,purine nucleotide catabolic process (GO:0006195),-0.26616564051415803,-0.6696924314417172,0.8784648187633263,1.0,1.0,3/13,15.69%,HINT1;PNP;NT5C2
prerank,hydrogen peroxide metabolic process (GO:0042743),-0.23795868042392737,-0.6692141716541178,0.9133333333333333,1.0,1.0,4/19,21.77%,PARK7;SOD1;MAOB;PRDX2
prerank,sensory perception of pain (GO:0019233),-0.23028974854388506,-0.6690413989574332,0.9255079006772009,1.0,1.0,5/21,17.66%,OPRM1;SCN9A;KCNA2;P2RX7;CHRNA4
prerank,regulation of vasculature development (GO:1901342),0.24111441991005683,0.6686320192352766,0.8911070780399274,0.9928114256688799,1.0,2/26,4.44%,SP100;IL6
prerank,regulation of cholesterol metabolic process (GO:0090181),-0.23672672416759763,-0.6681896652391456,0.9343891402714932,1.0,1.0,8/20,33.59%,MBTPS1;KPNB1;LDLRAP1;ACADVL;MBTPS2;DGKQ;LPCAT3;ABCA2
prerank,cholesterol metabolic process (GO:0008203),0.20243860003585354,0.6681766321173385,0.9732283464566929,0.9927076722937663,1.0,9/68,14.75%,APOA2;APOF;CYP27A1;INSIG2;SOAT1;LBR;CH25H;OSBPL5;ABCA1
prerank,positive regulation of macrophage migration (GO:1905523),-0.23554022270310637,-0.6680083125858128,0.8983050847457628,1.0,1.0,4/19,13.22%,THBS1;MAPK3;CMKLR1;CSF1R
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),-0.20736408965327985,-0.6677549140106358,0.9482758620689655,1.0,1.0,11/31,30.04%,RPS2;PINK1;DCUN1D2;DCUN1D5;DCUN1D1;SKP1;DCUN1D3;CDC14B;RAB1A;PLK1;UBE2L3
prerank,axonemal dynein complex assembly (GO:0070286),0.2389798267887611,0.6677078145175057,0.9035714285714286,0.9926318931119805,1.0,5/27,12.62%,ODAD4;DNAAF1;DNAL1;DNAI4;DRC1
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.24619373600713612,0.6654384418535333,0.8872987477638641,0.9941632704615225,1.0,2/22,6.03%,DUSP10;FOXP3
prerank,protein acylation (GO:0043543),-0.20234005062059765,-0.665039444516075,0.9545454545454546,1.0,1.0,12/38,26.19%,FOXO1;ZDHHC14;ZDHHC20;ZDHHC2;NAA10;ZDHHC7;KAT2A;ZDHHC23;ZDHHC9;ING4;ZDHHC5;SELENOK
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),-0.27630739510961233,-0.6647354131518104,0.8842105263157894,1.0,1.0,8/11,47.78%,CAMK4;ITGB2;TYROBP;STAP1;ITGAM;MAVS;F2RL1;CD177
prerank,tRNA transport (GO:0051031),-0.20533740810687207,-0.6647285760755893,0.9501246882793017,1.0,1.0,15/35,32.92%,YBX1;AAAS;NUP93;RAE1;XPOT;TOMM20;NUP62;NUP188;NUP54;NUP210;NUP42;NUP153;NDC1;SEC13;NOL6
prerank,protein localization to chromosome (GO:0034502),-0.20284211775337016,-0.6645776161718945,0.9305555555555556,1.0,1.0,10/34,26.32%,ESR1;MCM9;SLF1;CHMP7;TINF2;ATR;IFFO1;CENPA;RAD21;CTCF
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.23444824255813368,0.6639611148670458,0.9131886477462438,0.9949314673342032,1.0,5/28,12.26%,LACC1;RIPK2;MAP2K6;UBE2V1;MAP3K7
prerank,signal peptide processing (GO:0006465),-0.2783760041249437,-0.6638476869996696,0.8824786324786325,1.0,1.0,3/11,11.32%,SPCS2;SEC11C;SPCS1
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",-0.2637202011544889,-0.6637799320895436,0.8828451882845189,1.0,1.0,6/13,29.29%,BRSK2;YOD1;UBE2J1;UBAC2;SVIP;UBE2G2
prerank,chromatin organization (GO:0006325),0.1829268312677317,0.6632910918726795,0.9763231197771588,0.9950226183022026,1.0,32/132,21.55%,MYB;NUCKS1;BRWD1;TOP1;CDAN1;BAZ2A;FOXP3;HDAC4;TCF7L1;BAZ1B;JARID2;SETD7;BAZ1A;MYSM1;ACTL6A;KDM5B;BPTF;SUPV3L1;HDAC2;SETD5;SMARCA4;KAT2B;SMARCC1;LRWD1;INO80C;HCFC2;SETD2;SETDB1;PHF1;INO80;DR1;RSF1
prerank,microglial cell activation (GO:0001774),-0.22880563641156526,-0.6628529968996507,0.9295154185022027,1.0,1.0,14/21,42.82%,SNCA;GRN;MAPT;ITGB2;AIF1;TREM2;CLU;TYROBP;C1QA;CX3CR1;IL4;C5AR1;TNF;ITGAM
prerank,tRNA 5'-leader removal (GO:0001682),-0.2638231412760832,-0.6627144410625642,0.8911111111111111,1.0,1.0,4/13,26.42%,PRORP;RPP30;RPP25L;POP7
prerank,synaptic vesicle transport along microtubule (GO:0099517),-0.2514526357006992,-0.6620140903443523,0.9222689075630253,1.0,1.0,4/15,17.02%,AP3S2;AP3B2;SNAPIN;AP3D1
prerank,anterograde synaptic vesicle transport (GO:0048490),-0.2514526357006992,-0.6620140903443523,0.9222689075630253,1.0,1.0,4/15,17.02%,AP3S2;AP3B2;SNAPIN;AP3D1
prerank,nucleotide-sugar biosynthetic process (GO:0009226),-0.24068827285667024,-0.6618402625022403,0.91792656587473,1.0,1.0,6/19,18.69%,GFPT2;PGM3;GFPT1;RENBP;GNPNAT1;PMM2
prerank,RNA interference (GO:0016246),0.2634574063077981,0.6609344230381692,0.8992395437262357,0.9965280888835472,1.0,4/17,23.45%,TERT;TARBP2;CLP1;DHX9
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),-0.270011041492169,-0.6607203009622926,0.8615071283095723,1.0,1.0,3/12,14.44%,RPL26;CD74;TAF9B
prerank,regulation of T cell differentiation (GO:0045580),0.22460689394078825,0.6597649383633339,0.9229480737018425,0.9969856558246815,1.0,2/33,6.03%,ZMIZ1;FOXP3
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),-0.17679584846236943,-0.6594872454148234,0.9751381215469613,1.0,1.0,22/69,30.68%,SEL1L;ERLIN1;BAG6;UBXN8;HSPA5;TMUB2;YOD1;STT3B;FAM8A1;PSMC6;UBE2J1;SGTB;TMUB1;FBXO6;RNF121;FBXO2;SEC61B;HERPUD1;RNF5;UBE2G2;RHBDD2;UFD1
prerank,phagosome-lysosome fusion (GO:0090385),-0.28566464601397196,-0.6592966656682142,0.8875502008032129,1.0,1.0,3/10,22.59%,SYT7;RAB39A;CLN3
prerank,DNA strand elongation (GO:0022616),0.26078296461565764,0.6590699811721363,0.8824561403508772,0.9970820719078718,1.0,3/18,10.21%,TERT;RAD50;MCM4
prerank,rRNA modification (GO:0000154),-0.23261047278109973,-0.6589151591860678,0.9315068493150684,1.0,1.0,7/21,33.13%,FTSJ3;THUMPD1;TFB2M;TFB1M;NOP10;FBL;NHP2
prerank,early endosome to late endosome transport (GO:0045022),-0.23236944399371462,-0.658843271377902,0.9230769230769231,0.9999474237118223,1.0,5/20,22.00%,EMP2;WDR81;KIF16B;PIK3C3;SNF8
prerank,regulation of endocytic recycling (GO:2001135),-0.27210280732151915,-0.6579133838702436,0.9075975359342916,0.9999728229905135,1.0,2/11,11.13%,SORL1;ARHGAP1
prerank,regulation of actin nucleation (GO:0051125),0.28702557044788235,0.6577191776424054,0.8708414872798435,0.9977124481040733,1.0,4/12,20.34%,ARPIN;ARF1;ARFIP2;CORO1B
prerank,cellular response to amino acid stimulus (GO:0071230),-0.2034158960440553,-0.6573726787742772,0.9456264775413712,0.9997249941039926,1.0,9/33,20.03%,SESN3;RRAGB;CPEB4;UBR1;SPAAR;RRAGC;GLRA2;GLRA1;LAMTOR2
prerank,hexose metabolic process (GO:0019318),0.2197685297475041,0.6558352541513612,0.9188741721854304,0.998772384689844,1.0,9/39,20.55%,CHST15;GALK2;FPGT;SLC37A4;KHK;HK1;GALM;PGM1;SORD
prerank,lipoprotein catabolic process (GO:0042159),0.28991077352756545,0.6558214517537166,0.887378640776699,0.9982802349233544,1.0,1/11,4.99%,ABHD10
prerank,regulation of calcium ion import (GO:0090279),-0.22552168224186797,-0.6557262669628662,0.9337748344370861,1.0,1.0,4/21,15.98%,CTNNB1;SLC30A1;CXCL12;EGF
prerank,regulation of T cell activation (GO:0050863),0.21689559656444046,0.6555091413206815,0.9406919275123559,0.9980193110861986,1.0,4/42,7.71%,TNFAIP8L2;PTPN22;CD47;CCL2
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.1942996714519146,0.6551941266793953,0.963963963963964,0.9977690443934167,1.0,20/78,23.09%,NR2F2;LATS2;CCND3;CDKN2B;CCNH;MNAT1;CDK7;IPO7;PKD2;PSRC1;CDKN3;MAPRE3;CCNY;CCNG2;PKMYT1;PTEN;PKD1;CDK5RAP3;CEBPA;HEXIM1
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),-0.2576103825006604,-0.6543136127759128,0.8742393509127789,1.0,1.0,1/14,2.14%,TFRC
prerank,regulation of cytoplasmic transport (GO:1903649),0.28766695254659136,0.6534706783582281,0.8618042226487524,0.9986695127300684,1.0,4/11,19.95%,LRRK2;MAP2K1;CHMP3;USP7
prerank,proteasome assembly (GO:0043248),-0.2737346123880069,-0.6534643616871569,0.8720682302771855,1.0,1.0,5/11,30.80%,PSMD4;POMP;PSMD11;PSMG2;PSMD5
prerank,establishment of mitotic spindle orientation (GO:0000132),-0.21939762609999436,-0.6532989456692528,0.930648769574944,1.0,1.0,12/23,32.89%,NSFL1C;NDE1;INSC;CDK5RAP2;DCTN1;HTT;SPDL1;CENPA;UBXN2B;PLK1;ZW10;PKHD1
prerank,organic cyclic compound biosynthetic process (GO:1901362),-0.20801370943892417,-0.6531412469721097,0.9328165374677002,0.9995231458420131,1.0,6/31,15.29%,GPHN;FDXR;GCH1;DHRS11;PRLR;PYCR2
prerank,macroautophagy (GO:0016236),0.18088741392798877,0.6524547066936129,0.9917695473251029,0.9989891753065865,1.0,31/118,24.29%,PRKAG2;PRKAA2;DYNLL1;AMBRA1;LAMP2;MTMR3;UVRAG;SNX14;ATG12;VPS16;TCIRG1;PIP4K2B;CHMP3;CSNK2A2;CHMP4A;CHMP4B;FUNDC1;ATG10;WIPI2;RUBCNL;VPS33A;VPS39;ACBD5;VAMP7;ATG13;ATG7;PRKAA1;TOMM40;ATG3;TOMM70;VTA1
prerank,mitochondrial membrane organization (GO:0007006),0.2233202580893419,0.6522377436295699,0.9235880398671097,0.9986691271638101,1.0,7/32,18.47%,MICOS10;BCL2;BCL2L1;OPA1;SLC25A4;HSPA9;SLC25A31
prerank,positive regulation of actin nucleation (GO:0051127),-0.26961981871324314,-0.6513823677076759,0.9026369168356998,1.0,1.0,1/11,3.12%,NCKAP1
prerank,Golgi inheritance (GO:0048313),0.28336467275514976,0.6512197887529311,0.8875968992248062,0.9989543892994411,1.0,3/11,16.24%,PLK5;GBF1;GOLGA2
prerank,fatty acid beta-oxidation (GO:0006635),0.20566406224219577,0.6505354684687652,0.9507154213036566,0.9990182225600832,1.0,11/51,19.43%,ACOXL;AMACR;SCP2;SLC27A2;ACAT1;ABCD3;ETFA;PEX2;ACADS;ACOX1;HADHA
prerank,regulation of lipase activity (GO:0060191),0.27726256161944557,0.6503484999022037,0.8953488372093024,0.9986453620631647,1.0,1/13,2.03%,APOA2
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),0.2870073758386632,0.6498362575672789,0.8752362948960303,0.998538668675018,1.0,2/11,9.48%,NRP1;MST1R
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",-0.1783529953103016,-0.6498265804048092,0.9720670391061452,1.0,1.0,11/54,21.16%,CRADD;RPL26;PLAGL1;ATM;RGCC;CDKN1A;RBL2;CNOT2;E2F4;CNOT8;E2F7
prerank,glycosphingolipid metabolic process (GO:0006687),0.21142751282408462,0.6495882498371001,0.9424342105263158,0.9982255717194717,1.0,4/42,7.76%,SMPD3;A4GALT;LARGE1;ESYT1
prerank,coenzyme A metabolic process (GO:0015936),0.26895100594422483,0.6493194342232537,0.8674463937621832,0.9979334811547264,1.0,2/14,11.27%,PANK2;ACAT1
prerank,mitotic nuclear membrane organization (GO:0101024),0.2079968947584703,0.649299558215923,0.9538216560509554,0.9969382794038082,1.0,20/51,25.35%,SUMO1;AHCTF1;LBR;CHMP3;POM121;CHMP4A;CHMP4B;NUP37;RAN;PPP2CA;PPP2R2A;EMD;NUP85;SIRT2;IST1;SPAST;RANGAP1;NUP160;NUP107;VPS4A
prerank,mitotic nuclear membrane reassembly (GO:0007084),0.2079968947584703,0.649299558215923,0.9538216560509554,0.9969382794038082,1.0,20/51,25.35%,SUMO1;AHCTF1;LBR;CHMP3;POM121;CHMP4A;CHMP4B;NUP37;RAN;PPP2CA;PPP2R2A;EMD;NUP85;SIRT2;IST1;SPAST;RANGAP1;NUP160;NUP107;VPS4A
prerank,negative regulation of B cell activation (GO:0050869),0.24666948496437588,0.649072466945654,0.9267461669505963,0.9966064550089877,1.0,2/21,5.63%,RC3H1;PARP3
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),-0.24013199155719428,-0.6469977798034348,0.9224137931034483,1.0,1.0,4/17,18.61%,TGFB2;RET;SYK;RAC3
prerank,regulation of keratinocyte migration (GO:0051547),-0.2667019792139531,-0.6467754645392975,0.9166666666666666,1.0,1.0,3/12,18.62%,IQSEC1;EPB41L4B;ARF6
prerank,lipid droplet organization (GO:0034389),0.2384847104260822,0.6454008991511571,0.9129662522202486,0.9989489119429624,1.0,4/22,15.17%,SMIM22;PLA2G4C;PPID;FAF2
prerank,regulation of establishment of protein localization (GO:0070201),-0.2613402576870785,-0.645135231979297,0.9057377049180327,1.0,1.0,5/13,26.29%,CTSD;CEP135;CEP290;TREM2;DNAJA1
prerank,tryptophan catabolic process (GO:0006569),0.28120971059885547,0.6448167783686088,0.88996138996139,0.9988871572912336,1.0,1/11,5.59%,AFMID
prerank,positive regulation of chromosome organization (GO:2001252),-0.2425610765858104,-0.6437899156907455,0.9161147902869757,1.0,1.0,5/15,20.36%,MRE11;DDX11;GNL3;PPP1R10;SHCBP1L
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.2672599325243112,0.6435212007817783,0.888235294117647,0.9993573579413424,1.0,7/15,26.52%,BCL2;TAF9;MUC1;KDM1A;CD44;TRIAP1;ING2
prerank,response to light stimulus (GO:0009416),0.2023021311335706,0.6432254518552563,0.9634920634920635,0.9990809443614761,1.0,20/55,27.65%,CRY2;CRY1;FECH;REV1;ERCC5;ERCC6;OPN3;GTF2H2;UBE4B;UVSSA;CLOCK;ERCC8;TRIM32;ZRANB3;USP1;GPR52;SPRTN;ERCC2;ERCC4;ERCC3
prerank,long-chain fatty acid biosynthetic process (GO:0042759),-0.2178255048443355,-0.642953209974609,0.9377880184331797,1.0,1.0,13/23,43.97%,ACSBG1;HPGD;FADS1;ALOX5;CYP2E1;ACOT7;GSTM4;GPX4;CYP1A1;LTC4S;GSTP1;ELOVL6;ALOX12
prerank,cellular response to gamma radiation (GO:0071480),-0.23410323084583107,-0.6413655181562625,0.9055299539170507,1.0,1.0,4/17,13.60%,RPL26;MAP3K20;ATM;HRAS
prerank,linoleic acid metabolic process (GO:0043651),0.25404549707263746,0.6406739093939557,0.9041353383458647,1.0,1.0,2/17,8.37%,ACSL1;ALOXE3
prerank,axonal fasciculation (GO:0007413),0.2720775433685063,0.6404795576760784,0.8824626865671642,1.0,1.0,3/12,13.84%,EPHA3;EPHA4;RTN4
prerank,protein targeting to peroxisome (GO:0006625),0.2204871387773482,0.6399767102695879,0.9429065743944637,0.9999722980557101,1.0,5/29,13.46%,ZFAND6;PXMP2;HACL1;ABCD3;PEX2
prerank,negative regulation of amyloid-beta formation (GO:1902430),-0.22956670575827404,-0.6397867506117008,0.9293361884368309,1.0,1.0,7/17,28.39%,NTRK2;SORL1;CHRNA7;RTN3;HAP1;RTN2;CLU
prerank,mismatch repair (GO:0006298),-0.210595551323844,-0.6389934989715552,0.9469026548672567,1.0,1.0,8/27,31.24%,MSH3;MCM9;PMS1;POLD2;POLD1;EXO1;PCNA;MSH5
prerank,synaptonemal complex assembly (GO:0007130),0.25817845929100647,0.6389628561575976,0.8799249530956847,0.9996983622919379,1.0,3/15,14.87%,SYCP2;TEX12;P3H4
prerank,synaptonemal complex organization (GO:0070193),0.25817845929100647,0.6389628561575976,0.8799249530956847,0.9996983622919379,1.0,3/15,14.87%,SYCP2;TEX12;P3H4
prerank,positive regulation of ATPase activity (GO:0032781),-0.18811496614847217,-0.6388805695238854,0.9755501222493888,1.0,1.0,17/41,36.30%,ATP1B1;RYR2;MSH3;VMP1;DYNLL2;AHSA1;PFN2;CHTOP;TOR1AIP2;PFN1;UHRF1;FGF10;MYL4;DNAJB11;GABARAPL2;ALDOB;SSBP1
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.20312479862722985,0.637446709901662,0.9699842022116903,1.0,1.0,5/53,7.71%,ANXA1;HRH3;MC2R;OPRD1;CCL2
prerank,negative regulation of G0 to G1 transition (GO:0070317),0.2198339701998451,0.6374196193430959,0.9444444444444444,0.9997644519257044,1.0,11/36,22.11%,SUZ12;UXT;MGA;EPC1;RBBP8;RING1;RNF2;BMI1;TFDP2;PCGF2;APAF1
prerank,tryptophan metabolic process (GO:0006568),-0.2684983724868809,-0.6373023473787153,0.9151515151515152,1.0,1.0,7/11,53.65%,KMO;KYNU;AADAT;IDO2;TDO2;IDO1;ACMSD
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),-0.1690076609514134,-0.6367629357978265,0.9825581395348837,1.0,1.0,11/63,17.56%,CRADD;RPL26;PLAGL1;CCND1;ATM;RGCC;CDK2;CDKN1A;RBL2;CNOT2;E2F4
prerank,mRNA transport (GO:0051028),-0.15760899793287494,-0.6367574835484153,0.9966329966329966,1.0,1.0,35/101,30.55%,SRSF2;CPSF2;SRSF1;SYMPK;ZC3H11A;THOC2;HHEX;AAAS;NUP93;KIF5C;RAE1;RNPS1;SRSF9;POLDIP3;NXT1;RBM15B;UPF1;ALKBH5;NUP62;SRSF6;CHTOP;CPSF3;NUP188;U2AF1;CDC40;NUP54;NUP210;CPSF1;NUP42;NUP153;MCM3AP;UPF3B;ZFP36;NDC1;DDX25
prerank,positive regulation of vacuole organization (GO:0044090),0.2835883190581861,0.6354669137509805,0.8915187376725838,1.0,1.0,3/10,18.74%,ANXA2;PIP4K2B;PIP4K2C
prerank,mitotic spindle organization (GO:0007052),-0.14684632724630556,-0.6353709407863688,1.0,1.0,1.0,69/153,38.31%,RPS27;KPNB1;EFHC2;RCC2;DYNC1H1;PCNT;AAAS;KIF18A;XPO1;KIF3B;DYNC1I2;NDE1;CLASP2;PPP1CC;NEK9;CENPU;SKA2;BUB1B;DYNLL2;PRC1;ZWILCH;CENPT;CENPQ;CENPL;STMN1;TUBG1;KIF23;MAD1L1;NSL1;CENPN;CENPF;KIF4A;DSN1;KNTC1;SPDL1;TUBG2;DCTN6;CENPA;BCCIP;MAPRE1;SGO1;STIL;BIRC5;ITGB3BP;CLIP1;TBCE;PLK1;ZW10;DLGAP5;CEP192;NUF2;AURKA;SEC13;SMC1A;CDC20;BUB1;MIS12;ABRAXAS1;KIFC1;BUB3;KNL1;NUDC;INCENP;RAB11A;MZT1;KIF2C;CCNB1;CENPM;NDEL1
prerank,isotype switching (GO:0045190),-0.26894879437290414,-0.6351814166625183,0.9014084507042254,1.0,1.0,6/10,47.32%,RNF168;EXOSC3;CCR6;LIG4;BATF;HSPD1
prerank,membrane lipid catabolic process (GO:0046466),0.2789299540761427,0.6351315087731847,0.8875502008032129,1.0,1.0,2/10,18.67%,ENPP2;SGPL1
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.21695548742007004,-0.6350071793951714,0.9294117647058824,1.0,1.0,5/24,14.44%,TPT1;CXCL12;CD74;CCAR2;TAF9B
prerank,pentose-phosphate shunt (GO:0006098),0.2777236595928938,0.6347322570362518,0.8804554079696395,1.0,1.0,2/11,9.76%,PGD;DERA
prerank,nuclear membrane reassembly (GO:0031468),0.20061679164884796,0.6346488803125111,0.9795918367346939,0.9997805358400746,1.0,21/54,25.35%,SUMO1;UBXN2A;AHCTF1;LBR;CHMP3;POM121;CHMP4A;CHMP4B;NUP37;RAN;PPP2CA;PPP2R2A;EMD;NUP85;SIRT2;IST1;SPAST;RANGAP1;NUP160;NUP107;VPS4A
prerank,regulation of exit from mitosis (GO:0007096),0.20924140823283519,0.6345477897487706,0.936026936026936,0.9993572387232581,1.0,7/38,13.48%,ANAPC11;PHB2;ANAPC1;UBE2C;CDC14A;MAD2L1BP;CDC27
prerank,histone H3 deacetylation (GO:0070932),-0.24287736035890536,-0.6342919402297906,0.9358178053830227,1.0,1.0,4/15,18.56%,HDAC9;HDAC1;PER2;SIRT7
prerank,protein catabolic process (GO:0030163),-0.17334245017758326,-0.6341092828466584,0.9773371104815864,0.9997497445911363,1.0,8/59,14.25%,HSPA8;DAB2IP;CTSD;CEACAM1;BAG6;RAB12;HSP90AA1;PSMA8
prerank,protein hydroxylation (GO:0018126),-0.2427859650432604,-0.6338941410994452,0.9240780911062907,0.9992387139848115,1.0,5/15,24.71%,VPS33B;PLOD2;VIPAS39;HIF1AN;JMJD7
prerank,negative regulation of interleukin-10 production (GO:0032693),0.25321456840569867,0.6336201074860723,0.8763250883392226,0.999511789743405,1.0,3/16,15.47%,FOXP3;CD274;IL23R
prerank,histone H4 deacetylation (GO:0070933),-0.27022815546835194,-0.6327623913027572,0.9042553191489362,0.9992958430626415,1.0,2/10,9.20%,HDAC9;HDAC1
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",-0.21343605864649268,-0.631287738546437,0.9441860465116279,0.9995525036719572,1.0,5/23,18.02%,HMGB1;KPNB1;H1-0;FOXL2;DICER1
prerank,indolalkylamine catabolic process (GO:0046218),-0.27592130448978835,-0.6311848234584417,0.893223819301848,0.9989671221732743,1.0,7/10,53.65%,KMO;KYNU;AADAT;IDO2;TDO2;IDO1;ACMSD
prerank,DNA replication checkpoint signaling (GO:0000076),-0.23697811104970828,-0.6310128256247636,0.9108695652173913,0.9984296450842349,1.0,7/16,35.43%,CLSPN;CDC45;HUS1B;TOPBP1;CDC6;TICRR;TIMELESS
prerank,regulation of coagulation (GO:0050818),-0.26377862890268394,-0.6301009357410626,0.9087048832271762,0.9983114910352223,1.0,2/11,12.95%,HS3ST5;CAV1
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),-0.2038667055301565,-0.6300329850282934,0.9536423841059603,0.9977072066612577,1.0,9/29,26.59%,SMAD7;DAB2IP;SPRED2;IL17RD;SPRED3;SPRED1;BMP5;ADIPOR1;SDHAF2
prerank,regulation of execution phase of apoptosis (GO:1900117),0.2820164033120009,0.6299761611346288,0.9015151515151515,1.0,1.0,2/11,10.73%,DLC1;BCL2L1
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),0.27499306011031494,0.6298920163359376,0.9321357285429142,1.0,1.0,4/11,19.66%,FBH1;GMNN;SMARCAL1;TIPIN
prerank,protein prenylation (GO:0018342),-0.27129523562440183,-0.6296869473901955,0.8884540117416829,0.9972482204084133,1.0,5/10,29.20%,PGGT1B;CHML;RABGGTA;RABGGTB;PTAR1
prerank,positive regulation of cell development (GO:0010720),0.22018882884785917,0.6289573171049287,0.9333333333333333,1.0,1.0,2/31,3.99%,NUMB;RFX3
prerank,positive regulation of protein deacetylation (GO:0090312),-0.2500165571457503,-0.6289418989965071,0.9327902240325866,0.997031648648388,1.0,3/14,17.30%,CTBP1;APLNR;NNMT
prerank,RNA 3'-end processing (GO:0031123),0.1865067867075161,0.6289034256552676,0.9706314243759178,1.0,1.0,24/69,24.64%,TUT4;PCF11;RPRD2;SLU7;SRSF4;MAGOHB;SUPV3L1;DDX39A;THOC5;TENT2;PABPN1;SRSF5;CSTF3;TUT7;WDR33;RPRD1B;TENT4B;SRSF3;SRSF11;PNPT1;CLP1;DDX39B;PAPOLA;SRSF7
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",-0.2195066082944283,-0.6284905113849895,0.9480812641083521,0.9966341113065362,1.0,11/21,46.71%,SETX;MED30;SRF;MED13;PAXIP1;SUB1;JUN;HNF1B;MED24;TWIST1;MED16
prerank,P-body assembly (GO:0033962),0.273017597184261,0.6283928333253191,0.8926553672316384,1.0,1.0,4/12,18.25%,RC3H1;EIF4ENIF1;DDX6;PATL1
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),-0.24503394209217255,-0.6283063122767202,0.9227557411273486,0.9961035904503569,1.0,4/13,22.46%,SORL1;TMEM30A;SAR1B;CD81
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),-0.24607410392422968,-0.627212644730725,0.925601750547046,0.9960805895680526,1.0,1/14,1.90%,ATP1B1
prerank,positive regulation of lymphocyte activation (GO:0051251),-0.20404367878686774,-0.6266590438960924,0.9558823529411765,0.995787616603729,1.0,3/28,6.43%,SH3KBP1;PRKCQ;CYRIB
prerank,positive regulation of sodium ion transport (GO:0010765),0.265807805116676,0.6258604342424444,0.9215686274509803,1.0,1.0,6/12,24.16%,SCN3B;GPD1L;WNK3;SCN4B;CNKSR3;SCN5A
prerank,monocarboxylic acid catabolic process (GO:0072329),0.23226809254972577,0.624586216730526,0.9005524861878453,1.0,1.0,8/21,23.01%,HAO1;LPIN2;ACOX1;HOGA1;ACBD5;AGXT;NUDT19;LPIN1
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.23026184357843335,0.6235938128498743,0.9307116104868914,1.0,1.0,2/24,5.56%,AUTS2;PLCE1
prerank,early endosome to Golgi transport (GO:0034498),-0.2574580143415433,-0.6233950944515602,0.9171717171717172,0.9971046122641857,1.0,2/11,14.01%,LMAN1;SNX8
prerank,intestinal lipid absorption (GO:0098856),0.27332672483993176,0.6232658550383386,0.8985801217038539,1.0,1.0,4/11,28.26%,LIMA1;CD36;CEL;SOAT2
prerank,ketone body metabolic process (GO:1902224),0.28184770082843386,0.6223374127095558,0.8937381404174574,1.0,1.0,3/10,17.44%,OXCT1;ACAT1;ACSS3
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",-0.15943104058411836,-0.6220078176939754,0.9941002949852508,0.997249625547029,1.0,12/72,17.84%,CRADD;ACER2;RPL26;PLAGL1;TFAP4;ATM;RGCC;CDKN1A;RBL2;CNOT2;E2F4;BCL3
prerank,mitochondrial transport (GO:0006839),0.19383901077559154,0.6214293689234842,0.9751937984496124,1.0,1.0,16/53,24.26%,BCL2;TIMM17A;SLC25A24;BCL2L1;COX18;TMEM14A;TIMM9;SLC25A4;TOMM34;SLC25A31;BCAP31;OXA1L;MTX2;TMEM14C;TOMM40;TOMM70
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",-0.21632604707491537,-0.620609719910431,0.9524886877828054,0.9973770657582607,1.0,12/22,43.21%,RPS21;EXOSC2;FTSJ3;ERI1;ABT1;UTP20;EXOSC3;RRS1;EXOSC8;ERI2;EXOSC9;NOP14
prerank,glutamine family amino acid metabolic process (GO:0009064),0.208746178165455,0.6192221261124108,0.9565972222222222,1.0,1.0,4/33,9.52%,ALDH4A1;GLUL;SIRT4;PYCR3
prerank,regulation of cellular amide metabolic process (GO:0034248),-0.1954025744379106,-0.6191213666414297,0.959731543624161,0.9975698298946393,1.0,5/32,16.84%,GRM5;ATXN2;PUM3;PGAM1;RBM3
prerank,DNA methylation (GO:0006306),-0.2062811479524846,-0.6173980779867494,0.958997722095672,0.9978498295355045,1.0,8/23,28.96%,HELLS;GATAD2A;MTRR;DMAP1;DNMT1;N6AMT1;FOS;PICK1
prerank,zymogen activation (GO:0031638),-0.18482625035395323,-0.6173939273795004,0.9855072463768116,0.9972084726862496,1.0,5/39,11.06%,GRIN2A;PERP;PGK1;LGMN;CTSL
prerank,Golgi to lysosome transport (GO:0090160),-0.25457395367060337,-0.6151116618779134,0.9087048832271762,0.9977484579471316,1.0,4/11,28.82%,SORT1;LAMP1;CLN3;LAPTM5
prerank,detection of light stimulus involved in visual perception (GO:0050908),0.27960190998434203,0.6150473842690137,0.888468809073724,1.0,1.0,9/10,50.17%,CEP250;TULP1;CNGB1;GRM6;RPE65;CACNA1F;GNAT2;REEP6;GNAT1
prerank,detection of light stimulus involved in sensory perception (GO:0050962),0.27960190998434203,0.6150473842690137,0.888468809073724,1.0,1.0,9/10,50.17%,CEP250;TULP1;CNGB1;GRM6;RPE65;CACNA1F;GNAT2;REEP6;GNAT1
prerank,transcription by RNA polymerase III (GO:0006383),-0.20164745445572543,-0.6143545021018288,0.973741794310722,0.9975319044652913,1.0,6/27,24.22%,IVNS1ABP;RO60;GTF3C6;POLR3G;ZC3H8;SNAPC1
prerank,protein localization to microtubule organizing center (GO:1905508),-0.23246182685478248,-0.6141907271919949,0.9426751592356688,0.9969619307997915,1.0,6/15,30.49%,CSNK1D;CEP83;SPAG5;STIL;SNX10;CEP192
prerank,phospholipid homeostasis (GO:0055091),0.2693321616871704,0.6140220586132303,0.9045801526717557,1.0,1.0,11/11,73.09%,ABCA1;ANGPTL3;RCN3;ABCG1;LIPG;ABCB11;APOA1;HNF4A;TLCD1;FABP3;TLCD2
prerank,regulation of isotype switching (GO:0045191),0.26167671885704413,0.6130688447842959,0.9127134724857685,1.0,1.0,5/14,20.40%,PARP3;SHLD2;KMT5C;RIF1;KMT5B
prerank,regulation of chromosome segregation (GO:0051983),-0.2293582660023908,-0.6130383546088878,0.9279475982532751,0.9968939406641574,1.0,9/16,41.46%,RMI2;MKI67;SMC5;RAD18;CDC6;BUB1;IHO1;KIF2C;AURKB
prerank,myelin maintenance (GO:0043217),-0.25794451411932295,-0.6121212523232054,0.934156378600823,0.9967275818914911,1.0,5/10,41.26%,ABCD2;SOD1;CLU;ABCD1;DEGS1
prerank,response to estrogen (GO:0043627),-0.19069909870748558,-0.6118911072904877,0.9730392156862745,0.9961984471801412,1.0,7/31,23.73%,SERPINB9;ESR1;CAV1;BRCA1;ASH2L;RBBP5;KRT19
prerank,lytic vacuole organization (GO:0080171),0.2099817867126131,0.6104647212532668,0.9477234401349073,1.0,1.0,9/32,23.59%,CLN5;LRRK2;HPS1;ARSB;ABCA1;HOOK1;HPS4;TPCN2;LAMTOR1
prerank,mitotic recombination (GO:0006312),0.25012682189882207,0.6100245088371251,0.9115384615384615,1.0,1.0,5/15,21.67%,RAD50;NSMCE2;ERCC1;SMC6;TEP1
prerank,cellular response to hydroxyurea (GO:0072711),0.27229156440339963,0.6095584811837892,0.9052224371373307,1.0,1.0,4/10,25.09%,SPIDR;NSMCE3;ATRX;RTF2
prerank,sterol biosynthetic process (GO:0016126),0.20849948875918894,0.60949113829987,0.949740034662045,1.0,1.0,4/33,12.53%,PRKAG2;INSIG2;LBR;CH25H
prerank,axoneme assembly (GO:0035082),-0.19519856933123078,-0.6090240019611971,0.9707317073170731,0.9970253462180558,1.0,14/30,34.12%,RP1;CFAP46;CFAP74;DNAAF3;SPAG16;SPAG1;SPAG17;DCX;TTLL3;CCDC65;DNAAF2;CFAP206;FOXJ1;CCDC40
prerank,regulation of histone methylation (GO:0031060),0.2586336598746438,0.6082063169246226,0.9035250463821892,1.0,1.0,3/13,13.47%,NSD1;JARID2;PAF1
prerank,natural killer cell mediated immunity (GO:0002228),-0.22918883745119376,-0.6070222999783395,0.9437229437229437,0.997391057884024,1.0,3/15,15.54%,RAET1E;TUBB4B;LYST
prerank,regulation of translational initiation (GO:0006446),-0.16504963034024,-0.606362791138306,0.9914772727272727,0.9970622402758982,1.0,27/63,38.07%,EIF2B2;NPM1;YTHDF2;EIF5B;EIF1B;ATF4;CDC123;EIF1;PAIP2;PPP1R15B;EIF3H;EIF4A2;PAIP1;UHMK1;CSDE1;POLR2G;EIF4G1;BOLL;HSPB1;EIF4G3;CCL5;MTIF2;DDX1;DAZL;EIF5;EIF4EBP2;EIF4EBP1
prerank,mitochondrial RNA metabolic process (GO:0000959),0.2517726802595017,0.6061047165175931,0.9099264705882353,1.0,1.0,3/14,12.16%,FASTKD5;FOXO3;MTERF2
prerank,UV-damage excision repair (GO:0070914),0.2603305574650365,0.6058496864511131,0.92578125,1.0,1.0,4/12,21.08%,ERCC1;XPC;POLD3;INO80
prerank,establishment of melanosome localization (GO:0032401),-0.21401942303472965,-0.6057961850417048,0.9357601713062098,0.9967086456796639,1.0,12/19,41.97%,RAB27A;RAB27B;MLPH;BBS2;BBS7;MREG;RAB11A;MKKS;GPR143;RAB17;BBS5;BLOC1S3
prerank,protein localization to phagophore assembly site (GO:0034497),-0.251467635089574,-0.6043476773101396,0.9338842975206612,0.9967729973195488,1.0,2/11,9.79%,ATG9A;MFN2
prerank,cellular macromolecule catabolic process (GO:0044265),0.1934621423298626,0.6040168488826019,0.9752883031301482,1.0,1.0,14/49,23.79%,SIAH2;MANBA;SND1;SUPV3L1;DNASE1L1;RNASEH1;RNASE3;DFFB;CHEK2;RIPK1;RNASEH2B;PNPT1;ADAMTS9;RNASEH2A
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.25044050100432785,0.6036339736193977,0.935361216730038,1.0,1.0,3/13,13.87%,ALG9;ALG11;ALG1
prerank,regulation of cytokinesis (GO:0032465),0.17655236066820887,0.6032382679623188,0.9910044977511244,1.0,1.0,13/78,15.71%,MAP9;PLK5;KLHL21;UVRAG;BCL2L1;CDC14A;CUL3;KLHL13;AHCTF1;ENTR1;FSD1;BIRC6;PKN2
prerank,glycerol metabolic process (GO:0006071),-0.25793887444009106,-0.6029865844355657,0.9322709163346613,0.9968074647314134,1.0,4/10,24.37%,TPI1;PGP;COQ3;GK
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),-0.24856515683602504,-0.6025206923747131,0.9230769230769231,0.9963958074675839,1.0,3/11,15.49%,SCARB1;MFSD2A;CTDNEP1
prerank,mitochondrion disassembly (GO:0061726),-0.18527253277545613,-0.602035409058211,0.9642857142857143,0.9959767392703125,1.0,5/34,11.75%,GABARAP;GABARAPL1;PINK1;ATG9A;ULK1
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),-0.21939146144129865,-0.6009805669297719,0.9596412556053812,0.9958536712206879,1.0,4/18,11.83%,ZC3H11A;THOC2;HHEX;NUP93
prerank,phosphate ion transmembrane transport (GO:0035435),-0.2474477408439843,-0.6001189184801494,0.9356846473029046,0.995621765607145,1.0,5/12,28.69%,XPR1;SLC25A30;SLC20A2;SLC37A1;SLC37A2
prerank,regulation of viral release from host cell (GO:1902186),0.22814259545255208,0.6000633864756395,0.9361702127659575,1.0,1.0,5/21,15.00%,TRIM5;TRIM21;TRIM26;CHMP3;PML
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.21331644051043663,0.5987792742832515,0.9566724436741768,1.0,1.0,7/26,15.87%,TTL;KLHL18;CCDC57;CUL3;SMOC2;PKN2;APP
prerank,male meiosis I (GO:0007141),0.2426696804169019,0.5986424554662867,0.941712204007286,1.0,1.0,16/16,75.76%,ZSCAN21;SLC25A31;FOXJ3;ING2;MYBL1;DDX4;BTBD18;MEIOC;DNMT3L;HSF2BP;CCNA1;BRDT;FOXJ2;MOV10L1;TDRD9;SYCP3
prerank,cilium-dependent cell motility (GO:0060285),0.22232988733367254,0.5983457563648394,0.9375,1.0,1.0,5/22,18.93%,RFX3;RSPH9;DRC1;GAS8;CCDC39
prerank,purine nucleotide biosynthetic process (GO:0006164),0.2630140355175767,0.5976588790178272,0.9448529411764706,1.0,1.0,2/12,9.24%,MTHFD1;PRPSAP1
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),-0.19009058122845154,-0.5969636824327342,0.9568345323741008,0.9964503603587058,1.0,11/29,30.38%,EXOSC2;DCP1A;HBS1L;EXOSC4;CNOT8;LSM4;EXOSC1;EDC3;LSM2;LSM3;DCPS
prerank,regulation of mitotic nuclear division (GO:0007088),0.1870314415385338,0.5965721720423495,0.9713831478537361,1.0,1.0,5/55,8.99%,PHIP;TGFA;BMP7;PDGFRB;IGF2
prerank,protein localization to lysosome (GO:0061462),-0.1915379058216996,-0.5964750628345321,0.9694117647058823,0.9960105546216933,1.0,5/28,12.02%,SORL1;GCC2;M6PR;SCARB2;GLMP
prerank,phagolysosome assembly (GO:0001845),-0.24282538872948378,-0.5951501480896313,0.9315352697095436,0.9959431607341052,1.0,3/12,22.59%,SYT7;RAB39A;CLN3
prerank,maturation of LSU-rRNA (GO:0000470),0.21347809165147788,0.5946204304757002,0.9620253164556962,1.0,1.0,6/26,16.92%,NSA2;RPL7L1;ZNHIT3;WDR12;RPF1;DDX18
prerank,phasic smooth muscle contraction (GO:0014821),0.2679410209502588,0.5944882374698188,0.9053254437869822,1.0,1.0,3/10,20.67%,TIFAB;GDNF;PTGER3
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),-0.2293027138251591,-0.5944506206174465,0.9436893203883495,0.9956320627338768,1.0,6/14,34.23%,RFK;ADSS2;ADSS1;IMPDH1;LHPP;PFAS
prerank,lymphocyte migration (GO:0072676),0.20578950292318737,0.5943305079679285,0.968595041322314,1.0,1.0,3/32,7.71%,CKLF;MSMP;CCL2
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-0.2518614094840335,-0.5934001848356375,0.9624724061810155,0.9954761015716797,1.0,6/10,43.61%,CEACAM1;PTPRC;LILRB1;CX3CR1;FCGR2B;KLRD1
prerank,IRE1-mediated unfolded protein response (GO:0036498),0.18679690777581556,0.5932928883269584,0.9824281150159745,1.0,1.0,15/52,24.74%,KDELR3;SRPRA;CTDSP2;DNAJC3;TSPYL2;PARP16;EXTL2;ERN2;SEC31A;SHC1;XBP1;MYDGF;SYVN1;EDEM1;YIF1A
prerank,fructose 6-phosphate metabolic process (GO:0006002),-0.2496371125976778,-0.5928324864317851,0.924892703862661,0.9951137097834759,1.0,2/10,12.96%,GFPT2;GFPT1
prerank,RNA export from nucleus (GO:0006405),0.16768176900103018,0.5923291327403484,0.9985855728429985,1.0,1.0,23/100,19.71%,NXF2;RANBP2;TPR;SLU7;SRSF4;SMG5;SMG6;MAGOHB;DDX39A;THOC5;POM121;SMG7;SRSF5;NUP37;HNRNPA2B1;RAN;SMG1;DDX19B;SLBP;WDR33;NUP85;UPF2;AGFG1
prerank,regulation of spindle assembly (GO:0090169),-0.1930372647127978,-0.5922898126298871,0.9653579676674365,0.9947313917572705,1.0,9/25,29.90%,DYNC1H1;RNF4;CHMP1A;CHMP1B;CHMP2B;SPAG5;CHMP2A;CHMP4C;PLK1
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",-0.22968662691030994,-0.5915416043691281,0.9402985074626866,0.9944264537522427,1.0,3/13,23.52%,RPS21;BMS1;ABT1
prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.21100189575906234,0.5905123620084055,0.9584775086505191,1.0,1.0,8/27,23.01%,ETNK2;PLA2G6;NAAA;NAPEPLD;LPIN2;SLC27A1;PLAAT5;LPIN1
prerank,protein-DNA complex disassembly (GO:0032986),-0.21882647380977266,-0.5902474697461209,0.9693654266958425,0.9943222271076329,1.0,8/16,37.35%,SMARCB1;RPL23;SET;SMARCC2;MYC;GRWD1;NFE2;HMGA1
prerank,carboxylic acid catabolic process (GO:0046395),-0.23626964959809996,-0.5900517600010725,0.9481641468682506,0.9937704782341613,1.0,3/12,17.91%,BCKDK;RENBP;NPL
prerank,regulation of cholesterol storage (GO:0010885),0.24216796181612327,0.5892951192471363,0.9307692307692308,1.0,1.0,2/15,6.37%,NR1H3;PPARA
prerank,regulation of protein acetylation (GO:1901983),0.2537006772971515,0.5882597147662229,0.9190207156308852,1.0,1.0,2/12,16.82%,GSK3B;RAPGEF3
prerank,reticulophagy (GO:0061709),0.25284535636945027,0.5876257568851189,0.9272388059701493,1.0,1.0,2/12,15.66%,UBA5;ATG2A
prerank,lipoxygenase pathway (GO:0019372),0.24313415896801738,0.587622116663302,0.9262589928057554,1.0,1.0,3/14,20.45%,ALOXE3;PON3;PTGS2
prerank,negative regulation of interferon-beta production (GO:0032688),-0.24522661738351648,-0.5865261947615678,0.9466950959488273,0.9945858116910025,1.0,3/10,28.10%,YY1;PYCARD;LILRB1
prerank,cellular response to interleukin-2 (GO:0071352),0.2542180940264983,0.5857054129231024,0.9161676646706587,1.0,1.0,4/11,18.45%,STAT5B;JAK1;STAT5A;SHC1
prerank,interleukin-2-mediated signaling pathway (GO:0038110),0.2542180940264983,0.5857054129231024,0.9161676646706587,1.0,1.0,4/11,18.45%,STAT5B;JAK1;STAT5A;SHC1
prerank,regulation of chromosome organization (GO:0033044),-0.19981999834953845,-0.5847805535838037,0.9638009049773756,0.9946508149180379,1.0,14/22,45.14%,MAPT;RMI2;SHCBP1L;UPF1;HNRNPD;MYC;PIF1;BUB1;TERF2IP;HDAC8;CDT1;YLPM1;SETMAR;LIG4
prerank,DNA recombination (GO:0006310),0.19603540302373867,0.583881533062866,0.9705882352941176,1.0,1.0,6/37,15.40%,WRN;RAD50;FBH1;SUPV3L1;RAD51B;ERCC1
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.16712290285100964,0.5835817858259164,0.9971469329529244,1.0,1.0,22/96,19.71%,NXF2;RANBP2;TPR;SLU7;SRSF4;SMG5;SMG6;MAGOHB;DDX39A;THOC5;POM121;SMG7;SRSF5;NUP37;HNRNPA2B1;SMG1;DDX19B;SLBP;WDR33;NUP85;UPF2;AGFG1
prerank,mitochondrial transcription (GO:0006390),-0.2475880248172628,-0.5829285927853165,0.941908713692946,0.9947098396162902,1.0,4/10,23.04%,TWNK;TFB2M;TFB1M;POLRMT
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.21174811134708388,0.5825394531873685,0.9690553745928339,1.0,1.0,6/27,15.59%,CREBBP;KAT6B;BRD8;KAT6A;KAT2B;PHF20L1
prerank,N-acetylneuraminate metabolic process (GO:0006054),0.26110922320402663,0.5822063093239622,0.9284332688588007,1.0,1.0,4/10,22.43%,AMDHD2;ST3GAL1;NAGK;ST6GAL1
prerank,peptidyl-proline hydroxylation (GO:0019511),0.25026041975147106,0.5812594763083012,0.9184060721062619,1.0,1.0,3/11,20.71%,P4HTM;OGFOD1;EGLN1
prerank,determination of left/right symmetry (GO:0007368),0.1926824924259764,0.5798992482003187,0.9784768211920529,1.0,1.0,10/36,20.82%,RFX3;ODAD4;DNAAF1;NPHP3;PKD2;ARL6;CCDC39;CITED2;MEGF8;OFD1
prerank,amyloid precursor protein metabolic process (GO:0042982),-0.2093863805169206,-0.5796968564599791,0.9584295612009238,0.9953403637742873,1.0,4/18,23.21%,LDLRAP1;PSENEN;CLN3;NSG1
prerank,mRNA metabolic process (GO:0016071),-0.14775142353327128,-0.5793534625531068,1.0,0.994838134115384,1.0,27/90,31.63%,DIS3L2;PTBP1;DHX15;SRSF2;SRSF1;HNRNPA0;YTHDF2;SNRPB;NUDT16L1;AURKAIP1;SNRPF;SRSF9;RIDA;NONO;ALKBH5;CPSF3;U2AF1;LSM2;TBRG4;NUDT16;LSM3;RNH1;ZFP36;CPSF6;PRPF8;NUDT12;TP53
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),0.2254296922065237,0.577135420459656,0.9515828677839852,1.0,1.0,4/18,20.84%,DCP2;EXOSC10;CCT6A;PARN
prerank,regulation of B cell apoptotic process (GO:0002902),-0.23289266371744716,-0.5768727013359276,0.9556962025316456,0.9951846432546126,1.0,3/12,19.08%,LYN;ORMDL3;NOC2L
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",-0.2093380069905952,-0.5747799887638781,0.9581497797356828,0.9953359766269062,1.0,3/16,14.21%,SRSF1;WBP11;SART1
prerank,regulation of histone deacetylation (GO:0031063),0.24485163409405641,0.5744429053501056,0.939922480620155,1.0,1.0,4/13,20.80%,FOXP3;SAP30BP;NIPBL;SPHK2
prerank,rRNA transcription (GO:0009303),-0.21060741309160405,-0.5737943861654593,0.9573033707865168,0.9950802553197626,1.0,7/17,33.59%,GTF3C6;SIRT7;SPIN1;POLR1E;TAF1B;NIFK;GTF3C4
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.18321627022258985,0.5727740631762579,0.984375,1.0,1.0,6/50,9.67%,STOX1;CCND3;CDKN2B;CCNH;MNAT1;CDK7
prerank,"synaptic transmission, cholinergic (GO:0007271)",-0.1998148141366796,-0.5725704336135319,0.9529411764705882,0.9948973017473189,1.0,4/19,20.27%,RIC3;CHRNA4;CHRFAM7A;CHRNA7
prerank,protein localization to vacuole (GO:0072665),-0.22296291128375162,-0.572445411629133,0.954639175257732,0.994310836758431,1.0,6/13,32.73%,GLMP;CD81;SH3GLB1;LAMTOR4;KPTN;SZT2
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),0.2368826528998515,0.5713410328970326,0.9346642468239564,1.0,1.0,2/14,12.26%,TNFSF15;MAP3K7
prerank,DNA replication-independent nucleosome organization (GO:0034724),-0.23765940548198736,-0.5712352538688581,0.9639278557114228,0.9941070874718528,1.0,2/11,10.21%,H3-3A;ASF1A
prerank,ncRNA export from nucleus (GO:0097064),-0.1744850338115143,-0.5710417653116554,0.9901234567901235,0.9935492179096661,1.0,14/36,32.92%,NPM1;AAAS;NUP93;RAE1;XPOT;NUP62;NUP188;NUP54;NUP210;NUP42;NUP153;NDC1;SEC13;NOL6
prerank,positive regulation of activated T cell proliferation (GO:0042104),-0.2078326797728926,-0.5705960374293351,0.9683257918552036,0.9930890517672265,1.0,2/18,5.86%,RPS3;HMGB1
prerank,spinal cord development (GO:0021510),0.2486261536429832,0.5678315217488055,0.9371534195933456,1.0,1.0,3/12,15.77%,LOXL3;SOX4;PKD2
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",-0.19204834338804433,-0.5673716607729523,0.9724310776942355,0.9936190402427693,1.0,6/25,20.14%,CCAR2;EAF2;EAF1;KAT7;CCNK;TCEA2
prerank,lung epithelium development (GO:0060428),0.25428334360779664,0.566378074757753,0.937007874015748,1.0,1.0,1/10,4.74%,ERRFI1
prerank,regulation of cellular protein metabolic process (GO:0032268),0.18020830049187103,0.566152878086439,0.9899497487437185,1.0,1.0,8/47,15.87%,PKP3;NR1H3;SSH1;FOXO3;CSF1;GEMIN5;MAPKAPK5;APP
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",0.2337227309570696,0.5649606841382032,0.9575289575289575,1.0,1.0,7/14,30.71%,TERT;TNKS2;NABP2;ATRX;TNKS;TERF2;ACD
prerank,protein alkylation (GO:0008213),0.20476636662180636,0.5646454346567905,0.9725776965265083,1.0,1.0,2/22,7.77%,METTL21C;ETFBKMT
prerank,regulation of early endosome to late endosome transport (GO:2000641),0.22271568019287613,0.5640949983413512,0.9612546125461254,1.0,1.0,4/18,15.67%,SNX12;MAP2K1;CHMP3;DAB2
prerank,B cell activation involved in immune response (GO:0002312),0.24362837413684874,0.5637417675980926,0.9577735124760077,1.0,1.0,13/13,75.66%,MSH2;RNF8;GPR183;MSH6;CD40LG;CD180;GAPT;CD19;BATF;LIG4;FCGR2B;EXOSC3;RNF168
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),-0.23989609043837756,-0.5632825307257121,0.9327902240325866,0.9943882867918052,1.0,4/10,37.59%,CCT5;WRAP53;CCT7;CCT8
prerank,regulation of B cell differentiation (GO:0045577),0.22858842338515245,0.5629657233493529,0.9515260323159784,1.0,1.0,4/17,22.79%,MMP14;INHA;XBP1;ZFP36L2
prerank,natural killer cell mediated cytotoxicity (GO:0042267),0.23115889296716127,0.5624840106765812,0.9716446124763705,1.0,1.0,7/16,27.37%,KIF5B;PLEKHM2;VAMP7;KLRK1;CEBPG;ULBP1;ARL8B
prerank,regulation of cholesterol efflux (GO:0010874),-0.1803297380721457,-0.5610480303549199,0.9811764705882353,0.9944528427368072,1.0,7/30,27.48%,ABCA3;EEPD1;CAV1;RXRA;TREM2;GPS2;NR1H2
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",-0.21695631319062259,-0.5607992948641466,0.9492273730684326,0.9939140395482815,1.0,5/14,34.42%,CSTF2;TSEN54;CPSF1;TSEN34;DDX1
prerank,cytoplasmic translational initiation (GO:0002183),-0.20793845792107607,-0.5603662529019767,0.9619686800894854,0.9934460015225495,1.0,7/17,36.63%,EIF4A1;EIF3A;EIF4A2;EIF3I;EIF4G1;DHX29;EIF5
prerank,kinetochore organization (GO:0051383),-0.22330622600768782,-0.5577137910625646,0.9495798319327731,0.9936692777682041,1.0,9/13,42.93%,CENPT;CENPF;CENPA;DLGAP5;NUF2;CENPW;MIS12;CENPE;CDT1
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.23400097612883686,0.5570785512215422,0.9478764478764479,1.0,1.0,1/13,5.83%,TPR
prerank,neuron maturation (GO:0042551),0.2162076384475919,0.5554321761596319,0.955719557195572,1.0,1.0,5/18,19.86%,EPHA8;CLN5;APP;FARP2;MTCH1
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",-0.22318459609813374,-0.554615658946545,0.9705263157894737,0.9939998697089422,1.0,6/13,45.58%,NELFCD;RNF168;NELFA;SUPT4H1;NELFB;LARP7
prerank,neuromuscular synaptic transmission (GO:0007274),-0.19927418302783806,-0.554250500782882,0.974477958236659,0.993509337320146,1.0,1/18,2.54%,KIF1B
prerank,positive regulation of integrin activation (GO:0033625),-0.22615875170544508,-0.5541167200279361,0.9553571428571429,0.9929339677742332,1.0,1/11,5.36%,RASIP1
prerank,phosphate ion transport (GO:0006817),-0.205724935908226,-0.5536110961775624,0.9807692307692307,0.9924634762675263,1.0,4/16,22.81%,XPR1;SLC25A30;SLC20A2;SLC37A1
prerank,amyloid precursor protein catabolic process (GO:0042987),0.22661016214370053,0.5534722285365856,0.9688073394495413,1.0,1.0,5/14,27.61%,ADAM19;ABCA7;PSEN1;NCSTN;ABCG1
prerank,positive regulation of viral transcription (GO:0050434),0.20049474680455773,0.5518988086188351,0.977859778597786,1.0,1.0,8/25,26.81%,POLR2D;POLR2C;POLR2F;POLR2K;RSF1;DHX9;POLR2H;GTF2F1
prerank,erythrocyte development (GO:0048821),0.2432889326403025,0.5480441710877609,0.9526515151515151,1.0,1.0,3/10,18.98%,SH2B3;ALAS2;DMTN
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.19122539951711617,0.5474456044329082,0.987783595113438,1.0,1.0,7/31,20.30%,RC3H1;FOXP3;CD274;DLG5;VTCN1;CEBPB;BLK
prerank,amyloid-beta metabolic process (GO:0050435),0.2159057858074777,0.5469623428641249,0.9570093457943926,1.0,1.0,5/16,25.82%,MGAT3;ABCA7;APEH;PSEN1;NCSTN
prerank,positive regulation of lamellipodium organization (GO:1902745),0.18791699930996186,0.5434870495668905,0.9785714285714285,1.0,1.0,9/32,22.50%,AUTS2;PLCE1;ENPP2;AVIL;CORO1B;ACTR3;TWF2;FSCN1;CYFIP1
prerank,positive regulation of cellular protein catabolic process (GO:1903364),-0.19696656374454266,-0.543111576404604,0.9823008849557522,0.994742035927788,1.0,3/18,12.81%,CTSC;PTTG1IP;HSP90AA1
prerank,regulation of mRNA metabolic process (GO:1903311),0.23356402028745393,0.5430130511149933,0.9390243902439024,1.0,1.0,2/11,13.16%,IWS1;SRPK1
prerank,lysosome localization (GO:0032418),0.17994065583872196,0.5420456442087047,0.9911032028469751,1.0,1.0,9/37,21.66%,KIT;MAP6;KIF5B;RAB34;PLEKHM2;VPS33A;BORCS5;DEF8;KXD1
prerank,positive regulation of protein depolymerization (GO:1901881),0.23569240751916185,0.5415557353851186,0.9462151394422311,1.0,1.0,2/11,11.37%,PLEK;NES
prerank,telomere capping (GO:0016233),-0.19998853553088747,-0.5410638958324928,0.9660633484162896,0.9946748416449163,1.0,8/16,35.37%,MRE11;TERF1;DCLRE1C;TINF2;STN1;DCLRE1B;PRKDC;TERF2IP
prerank,endoplasmic reticulum mannose trimming (GO:1904380),0.21264151718906832,0.5401917032031665,0.9775700934579439,1.0,1.0,8/18,27.33%,AMFR;UGGT2;RNF185;EDEM2;RNF139;SYVN1;OS9;UGGT1
prerank,double-strand break repair via break-induced replication (GO:0000727),0.2337636593209465,0.5398726020512224,0.9568345323741008,1.0,1.0,2/12,13.28%,MCM4;MCM6
prerank,positive regulation of osteoclast differentiation (GO:0045672),0.21846945822085492,0.536956397151085,0.9692898272552783,1.0,1.0,14/14,78.17%,CSF1;IL23R;TRAF6;POU4F2;IFNG;IL12B;TNF;IL23A;OCSTAMP;TNFSF11;CCR1;POU4F1;TYROBP;ATP6AP1
prerank,extracellular transport (GO:0006858),0.22992906911053906,0.5363940863083642,0.9591078066914498,1.0,1.0,12/12,77.02%,WWP2;SPEF2;ROPN1L;DNAAF4;TSG101;SPA17;ARRDC1;CCDC40;DNAAF2;CABYR;SPAG17;ADCY10
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.24642956477612024,0.5360013684933408,0.9610136452241715,1.0,1.0,6/10,30.71%,DCLRE1A;RIF1;RTEL1;TFIP11;TERF2;ACD
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),-0.20356779208669373,-0.535587925600848,0.970276008492569,0.9954549400809439,1.0,7/15,38.24%,CD53;TREM2;ADGRB1;TYROBP;SCGB3A1;ADAM9;IL4
prerank,protein localization to centrosome (GO:0071539),0.20758275009671143,0.5353281851176173,0.979890310786106,1.0,1.0,3/17,11.21%,C2CD3;NUDCD3;NEDD1
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),-0.18897496874612713,-0.5337877471429279,0.9910112359550561,0.9952615446274004,1.0,4/20,15.03%,CAMK2D;TMCO1;ATP2A2;CCDC47
prerank,regulation of cilium movement (GO:0003352),0.24183761473176302,0.5311368592682372,0.9636711281070746,1.0,1.0,3/10,18.93%,DNAAF1;DRC1;CCDC39
prerank,nuclear body organization (GO:0030575),-0.2088765338124834,-0.530856408336782,0.9770833333333333,0.9953321680972674,1.0,5/12,34.84%,WRAP53;SRPK2;HIPK2;USPL1;DYRK3
prerank,regulation of B cell activation (GO:0050864),-0.17769278629947788,-0.5296703098468916,0.9830917874396136,0.994985691257152,1.0,10/25,40.66%,SH3KBP1;NOD2;SAMSN1;LAPTM5;IKZF3;THEMIS2;FOXJ1;IL4;FCGR2B;CD22
prerank,RNA catabolic process (GO:0006401),0.17072576693201832,0.5293063284667566,0.9967373572593801,1.0,1.0,13/46,23.79%,NANOS2;DCP2;SND1;SLFN14;SUPV3L1;METTL16;RNASEH1;RNASE3;DNA2;RNASEH2B;PNPT1;ZFP36L2;RNASEH2A
prerank,chromatin assembly or disassembly (GO:0006333),0.237593867367861,0.5283032083369424,0.9603024574669187,1.0,1.0,1/11,5.72%,CDAN1
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.20353692954864055,0.5274048084804667,0.9647887323943662,1.0,1.0,3/18,13.34%,STOX1;BRD4;RAD51B
prerank,regulation of centrosome duplication (GO:0010824),-0.1657787143140323,-0.5269524994852882,1.0,0.9950003590783191,1.0,12/29,34.99%,NPM1;CCNF;CHMP1A;CHMP1B;CHMP2B;GEN1;CHMP2A;STIL;CHMP4C;FBXW5;PKHD1;VPS4B
prerank,alpha-amino acid metabolic process (GO:1901605),0.1699678047142192,0.5230313206040236,0.993485342019544,1.0,1.0,11/45,22.84%,MTHFD1;ASPA;GLUL;PYCR3;THAP4;SRR;DPEP1;NAALAD2;ASS1;DDAH2;MMUT
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.19834953327868468,0.522929903074901,0.9697542533081286,1.0,1.0,6/19,21.02%,RTN1;RTN4;FLOT2;ABCA7;ROCK1;GGA3
prerank,tRNA export from nucleus (GO:0006409),0.18223816657275294,0.5207542095562935,0.9916805324459235,1.0,1.0,7/32,19.56%,RANBP2;TPR;POM121;SSB;NUP37;RAN;NUP85
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.18223816657275294,0.5207542095562935,0.9916805324459235,1.0,1.0,7/32,19.56%,RANBP2;TPR;POM121;SSB;NUP37;RAN;NUP85
prerank,regulation of pH (GO:0006885),0.2313302066633721,0.5196104400831698,0.9506398537477148,1.0,1.0,3/11,20.72%,LACC1;SLC9A7;SLC9A1
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",-0.1956876905740271,-0.5182636902958005,0.9716157205240175,0.9963134132454691,1.0,5/15,34.42%,CSTF2;TSEN54;CPSF1;TSEN34;DDX1
prerank,carbohydrate derivative catabolic process (GO:1901136),0.20240464060661678,0.5159150139352601,0.975925925925926,1.0,1.0,2/18,9.76%,MANBA;DERA
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),-0.20252083575589536,-0.5156310686230922,0.9764453961456103,0.9962255914302611,1.0,8/13,50.37%,MMS19;YAE1;GLRX5;LTO1;CISD3;ISCA2;GLRX3;BOLA2
prerank,placenta development (GO:0001890),0.22037653888526912,0.5154028541347088,0.9584905660377359,1.0,1.0,2/12,11.82%,PTK2;ADAM19
prerank,transcription preinitiation complex assembly (GO:0070897),0.21894920110361665,0.5153021952967868,0.9566003616636528,1.0,1.0,4/12,23.90%,TAF7;BDP1;DR1;TAF1
prerank,regulation of phosphate metabolic process (GO:0019220),0.20263740945919262,0.5149851769498001,0.9815157116451017,1.0,1.0,8/16,28.97%,SMG5;SMG6;SMG7;SIRT2;MCM7;PSEN1;IGBP1;GNB3
prerank,DNA modification (GO:0006304),0.19350938057238723,0.5138304072788055,0.9858156028368794,1.0,1.0,3/22,12.43%,PARP3;NTHL1;OGG1
prerank,nuclear envelope organization (GO:0006998),0.19343951768035936,0.5130451896595708,0.9841269841269841,1.0,1.0,7/20,25.35%,TOR1AIP1;NEMP1;DMPK;EMD;LEMD3;SUN1;VPS4A
prerank,protein import into mitochondrial matrix (GO:0030150),-0.18698597481936036,-0.5101297877217329,0.98125,0.9966785836137564,1.0,4/18,18.10%,DNLZ;GRPEL2;TOMM40L;TOMM20
prerank,positive regulation of mRNA processing (GO:0050685),0.19236698770992097,0.50961608509247,0.9821428571428571,1.0,1.0,11/21,29.35%,CDC73;PAF1;LEO1;DHX36;NCL;DAZAP1;RBMX;SF3B4;NUP98;TRA2B;THRAP3
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),-0.2070470966111221,-0.5072563083494224,0.9762419006479481,0.9965700831345451,1.0,8/12,42.93%,MAD1L1;NUF2;MIS12;KIF2C;BOD1;CENPE;CHAMP1;CDT1
prerank,tRNA wobble base modification (GO:0002097),0.212442714545797,0.5065705549674924,0.9798534798534798,1.0,1.0,14/14,78.77%,CTU1;ALKBH1;URM1;ELP4;GTPBP3;MTO1;MOCS3;ALKBH8;ELP3;CTU2;ADAT2;KTI12;DPH3;TRMT9B
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.1703522094682854,0.5033440150966519,0.9886363636363636,1.0,1.0,12/37,23.95%,ENTPD7;SND1;SUPV3L1;DNASE1L1;RNASEH1;RNASE3;DFFB;RNASEH2B;PNPT1;ENTPD6;RNASEH2A;ENTPD5
prerank,positive regulation of lipid storage (GO:0010884),0.1881112594148509,0.5028246945300092,0.9906890130353817,1.0,1.0,2/21,12.07%,IKBKE;PLIN3
prerank,adipose tissue development (GO:0060612),0.22403213520960752,0.5026057231199702,0.9696969696969697,1.0,1.0,4/11,21.19%,DGAT2;ARID5B;SH3PXD2B;XBP1
prerank,RNA methylation (GO:0001510),-0.1399137980270514,-0.5024229562245911,1.0,0.9968187433518835,1.0,18/60,32.93%,TRMT13;FTSJ3;VIRMA;ZC3H13;CBLL1;RBM15B;TRMT6;TFB2M;TFB1M;METTL8;TRMT10C;METTL14;TRMT61A;THUMPD2;BCDIN3D;FBL;ALKBH8;TRMT10A
prerank,positive regulation of cilium assembly (GO:0045724),0.19318457139245418,0.50036564952422,0.9804270462633452,1.0,1.0,3/18,14.44%,TAPT1;ENTR1;CROCC
prerank,respiratory chain complex IV assembly (GO:0008535),-0.1735389876961859,-0.4987369378553349,0.9934782608695653,0.9967911491389744,1.0,8/21,33.08%,COX20;COX19;BCS1L;PET100;TIMM21;COA5;SCO2;COA3
prerank,regulation of viral transcription (GO:0046782),0.16383575402523468,0.49780624205903895,0.998330550918197,1.0,1.0,13/39,26.81%,POLR2D;POLR2C;TRIM21;POLR2F;TARBP2;POLR2K;RSF1;HEXIM1;DHX9;TRIM32;POLR2H;UBP1;GTF2F1
prerank,cilium movement (GO:0003341),-0.14002815077507896,-0.49771992330725173,1.0,0.996332610296589,1.0,21/47,37.75%,CFAP251;DNAH11;CFAP54;CFAP70;ODAD2;ADCY10;SPAG17;CABYR;ODAD3;DNAAF2;CFAP100;DNAH17;DNAH9;CFAP206;CFAP61;CCDC40;CCDC63;TTC29;CFAP91;TEKT5;DNAH1
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),-0.18170218261430668,-0.495871182875571,0.9913232104121475,0.9959829582353585,1.0,8/18,33.08%,COX20;COX19;BCS1L;PET100;TIMM21;COA5;SCO2;COA3
prerank,positive regulation of translational initiation (GO:0045948),0.19281985547569908,0.49585461437892486,0.9786476868327402,1.0,1.0,1/18,3.35%,POLR2D
prerank,spliceosomal snRNP assembly (GO:0000387),0.16560616061314215,0.4956929836433282,0.9966101694915255,1.0,1.0,7/38,19.16%,GEMIN4;STRAP;PRPF19;GEMIN5;TGS1;PRPF3;USP4
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),-0.19918499892844668,-0.49559678361772797,0.9855670103092784,0.9954133918447217,1.0,5/13,32.28%,SART3;LSM2;SRSF12;PRPF8;DDX20
prerank,nuclear membrane organization (GO:0071763),0.19317140418326853,0.49469546347788235,0.9982876712328768,1.0,1.0,5/19,19.00%,TOR1AIP1;UBXN2A;NEMP1;CHMP4B;EMD
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.17599610476066252,0.4899176059052353,0.9948630136986302,1.0,1.0,4/29,14.87%,SYCP2;MAJIN;TEX12;P3H4
prerank,positive regulation of brown fat cell differentiation (GO:0090336),0.20992851133006968,0.48979237706759643,0.9783889980353635,1.0,1.0,3/13,20.45%,BMP7;NAPEPLD;PTGS2
prerank,ncRNA transcription (GO:0098781),0.20534255703423548,0.4880146259820759,0.9676113360323887,1.0,1.0,3/13,17.70%,POLR1G;SNAPC3;CAVIN1
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),-0.19779047140794676,-0.48668792877045036,0.9896694214876033,0.9960896171427541,1.0,12/12,80.24%,NELFCD;RNF168;NELFA;NELFB;LARP7;NELFE;RECQL5;HNRNPU;TCERG1;RNF8;HEXIM1;EAPP
prerank,positive regulation of triglyceride metabolic process (GO:0090208),0.1956088294621008,0.4862542324549132,0.9854545454545455,1.0,1.0,5/16,22.09%,NR1H3;ABHD5;SLC27A1;SREBF1;DAGLB
prerank,regulation of microglial cell activation (GO:1903978),0.19896492740267394,0.4843720320820617,0.9888475836431226,1.0,1.0,1/15,4.44%,IL6
prerank,"base-excision repair, AP site formation (GO:0006285)",0.19415784188377638,0.4823201750826014,0.9852125693160814,1.0,1.0,3/17,14.03%,NTHL1;OGG1;ERCC5
prerank,protein autoprocessing (GO:0016540),-0.17450433694046544,-0.47790901384131357,0.9822222222222222,0.9966421741735277,1.0,5/17,30.16%,FAM111A;CTSL;CASP1;OMA1;PIDD1
prerank,regulation of oxidoreductase activity (GO:0051341),-0.1874717649099491,-0.47638352957754915,0.9889624724061811,0.9962075209559044,1.0,2/13,15.57%,HDAC6;NOD2
prerank,mitochondrial protein processing (GO:0034982),0.21202414542271544,0.474470776828448,0.9703153988868275,1.0,1.0,5/11,30.78%,PMPCB;AFG3L2;STOML2;PMPCA;YME1L1
prerank,glutathione derivative biosynthetic process (GO:1901687),0.1815910857987212,0.47160141691567486,0.9907063197026023,1.0,1.0,2/20,11.84%,GSTK1;GSTA3
prerank,glutathione derivative metabolic process (GO:1901685),0.1815910857987212,0.47160141691567486,0.9907063197026023,1.0,1.0,2/20,11.84%,GSTK1;GSTA3
prerank,response to hydroxyurea (GO:0072710),0.20476868915105667,0.46759108332352756,0.9846743295019157,1.0,1.0,4/11,25.09%,SPIDR;NSMCE3;ATRX;RTF2
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),0.20401639609590252,0.46712634318012736,0.9856262833675564,1.0,1.0,4/12,24.58%,PAICS;GMPS;ADSL;ATIC
prerank,positive regulation of cell division (GO:0051781),0.1547458463143423,0.46513038318361094,0.9967320261437909,1.0,1.0,1/38,1.32%,FGF1
prerank,regulation of rRNA processing (GO:2000232),0.18693079897669848,0.46376817728913355,0.9836956521739131,1.0,1.0,3/16,15.47%,UTP15;USP36;KAT2B
prerank,cellular response to UV-A (GO:0071492),-0.1891459380378197,-0.4571288584748525,0.9875,0.99765642598035,1.0,4/11,28.63%,MMP1;TIMP1;MMP2;MMP3
prerank,rRNA methylation (GO:0031167),0.17155391547021573,0.45448842373563075,0.9876760563380281,1.0,1.0,6/22,23.92%,ZCCHC4;METTL16;FDXACB1;METTL15;METTL5;MTERF4
prerank,positive regulation of protein maturation (GO:1903319),0.19787796480260444,0.45376408307288535,0.9881889763779528,1.0,1.0,2/11,15.56%,CCBE1;SOX4
prerank,fatty acid transport (GO:0015908),0.17512300939851394,0.44868694481889326,0.9870848708487084,1.0,1.0,4/17,20.27%,ACSL1;SLC27A3;SLC27A1;CD36
prerank,aromatic amino acid family catabolic process (GO:0009074),0.17851617574209716,0.44331682039303383,0.9961538461538462,1.0,1.0,1/15,7.97%,HGD
prerank,tRNA metabolic process (GO:0006399),0.17678504721237392,0.44220699498315763,0.99812734082397,1.0,1.0,3/17,16.09%,TRPT1;DTD2;SSB
prerank,chromatin disassembly (GO:0031498),0.18361159650123468,0.44059542589817935,0.9904761904761905,1.0,1.0,7/14,26.18%,SMARCA4;SMARCC1;SMARCD3;ARID2;SMARCE1;SMARCD1;ARID1A
prerank,nucleosome disassembly (GO:0006337),0.18361159650123468,0.44059542589817935,0.9904761904761905,1.0,1.0,7/14,26.18%,SMARCA4;SMARCC1;SMARCD3;ARID2;SMARCE1;SMARCD1;ARID1A
prerank,positive regulation of DNA recombination (GO:0045911),0.15907076413408705,0.43587115484619166,0.993006993006993,1.0,1.0,11/27,27.20%,ERCC6;FUS;SHLD2;KMT5C;RIF1;KMT5B;ARID2;ZCWPW1;SHLD1;FANCB;ERCC2
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.1838532902680224,0.42996069729787767,0.9940357852882704,1.0,1.0,1/12,6.37%,PPARA
prerank,eosinophil migration (GO:0072677),0.1770851538973081,0.42796818216482824,0.9908256880733946,1.0,1.0,1/14,7.71%,CCL2
prerank,eosinophil chemotaxis (GO:0048245),0.1770851538973081,0.42796818216482824,0.9908256880733946,1.0,1.0,1/14,7.71%,CCL2
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",0.1581626491346964,0.42036532548626865,0.9963503649635036,1.0,1.0,4/22,19.03%,CUL4A;GTF2H4;GTF2H2;XPC
prerank,tRNA methylation (GO:0030488),0.1445884192575359,0.41932448432128755,0.998272884283247,1.0,1.0,11/34,24.63%,THUMPD3;WDR6;TYW3;FTSJ1;METTL1;DALRD3;METTL2B;METTL2A;METTL6;TARBP1;THADA
prerank,positive regulation of rRNA processing (GO:2000234),0.18558965668737837,0.41438562842621607,1.0,1.0,1.0,10/10,81.45%,UTP15;RIOK2;RIOK1;TRMT112;BUD23;DIMT1;WDR43;WDR75;HEATR1;SIRT7
prerank,regulation of lymphocyte proliferation (GO:0050670),0.17116939615915244,0.4129771583081845,0.9944954128440368,1.0,1.0,1/16,5.16%,PTPN22
prerank,membrane protein intracellular domain proteolysis (GO:0031293),-0.14466844396438688,-0.41245820413642476,0.997737556561086,0.9999400674589721,1.0,5/20,31.23%,MBTPS1;PSENEN;MBTPS2;RELA;HM13
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),-0.15071225171038177,-0.4015931068455881,1.0,0.9996975517609642,1.0,5/15,32.57%,MRE11;MDC1;HUS1B;NEK11;MUS81
prerank,regulation of amyloid-beta clearance (GO:1900221),0.16080329050977343,0.4008101177787991,1.0,1.0,1.0,4/16,20.25%,LRPAP1;ABCA7;LRP1;ROCK1
prerank,DNA packaging (GO:0006323),0.15792911623133005,0.39261531710739095,0.9982363315696648,1.0,1.0,2/16,13.90%,CDAN1;KAT6A
prerank,sno(s)RNA 3'-end processing (GO:0031126),-0.1637584735124278,-0.39069091577760895,1.0,0.9993705100208172,1.0,11/11,83.64%,EXOSC2;EXOSC4;FBL;EXOSC3;FBLL1;LARP7;DKC1;EXOSC5;TENT4B;PARN;EXOSC10
prerank,positive regulation of protein localization to Cajal body (GO:1904871),0.1725458197338688,0.3902208534933067,0.9919354838709677,0.9998445968796332,1.0,11/11,82.76%,CCT6A;CCT3;DKC1;TCP1;MEPCE;CCT2;LARP7;CCT4;CCT8;CCT7;CCT5
prerank,regulation of protein localization to Cajal body (GO:1904869),0.1725458197338688,0.3902208534933067,0.9919354838709677,0.9998445968796332,1.0,11/11,82.76%,CCT6A;CCT3;DKC1;TCP1;MEPCE;CCT2;LARP7;CCT4;CCT8;CCT7;CCT5
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.1565697783916126,0.3761850829684585,0.9981132075471698,0.9997704213920556,1.0,14/14,84.36%,ERCC6;FUS;ARID2;FANCB;WDR48;OOEP;PARP1;MRNIP;ACTR2;WAS;TIMELESS;RAD51AP1;WRAP53;MMS19
prerank,meiosis I (GO:0007127),0.11035546998643175,0.2927282311785585,1.0,0.999993160254329,1.0,22/23,75.76%,ZSCAN21;SLC25A31;FOXJ3;ZCWPW1;ING2;MEIOB;BCL2L11;MYBL1;DDX4;BTBD18;MEIOC;DNMT3L;MEI1;HSF2BP;CCNA1;BRDT;FOXJ2;MEIKIN;MOV10L1;TDRD9;SGO1;SYCP3
